Citrus Sinensis ID: 024572
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 265 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C958 | 361 | Serine/threonine-protein | yes | no | 0.890 | 0.653 | 0.796 | 1e-107 | |
| P43291 | 363 | Serine/threonine-protein | no | no | 0.890 | 0.650 | 0.810 | 1e-106 | |
| Q7XQP4 | 359 | Serine/threonine-protein | yes | no | 0.883 | 0.651 | 0.743 | 1e-101 | |
| Q6ZI44 | 365 | Serine/threonine-protein | no | no | 0.773 | 0.561 | 0.806 | 1e-99 | |
| Q9FFP9 | 360 | Serine/threonine-protein | no | no | 0.743 | 0.547 | 0.822 | 3e-95 | |
| Q5N942 | 360 | Serine/threonine-protein | no | no | 0.867 | 0.638 | 0.732 | 5e-95 | |
| Q7XKA8 | 370 | Serine/threonine-protein | no | no | 0.890 | 0.637 | 0.692 | 6e-95 | |
| P43292 | 353 | Serine/threonine-protein | no | no | 0.871 | 0.654 | 0.748 | 9e-93 | |
| O64812 | 339 | Serine/threonine-protein | no | no | 0.818 | 0.640 | 0.714 | 1e-87 | |
| P0C5D6 | 334 | Serine/threonine-protein | no | no | 0.822 | 0.652 | 0.677 | 1e-81 |
| >sp|Q9C958|SRK2B_ARATH Serine/threonine-protein kinase SRK2B OS=Arabidopsis thaliana GN=SRK2B PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 387 bits (993), Expect = e-107, Method: Compositional matrix adjust.
Identities = 196/246 (79%), Positives = 211/246 (85%), Gaps = 10/246 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS PKSTVGTPAYIAPEVLSR E
Sbjct: 116 AMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK+ADVWSCGVTLYVMLVGAYPFEDQEDPKNF+KTI RIMAV+YKIPDYVHISQDC++
Sbjct: 176 YDGKMADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFV N ++RITI +IK HPWFLKNLPRELTE AQA Y+RKENPTFSLQSVEEI KI
Sbjct: 236 LLSRIFVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDG---------DEKEEETDADEEDEYEKTVKEAQQS- 259
VEEAK P VSRSIG FGWGG ED + +E E + DEEDEY+KTVK+ S
Sbjct: 296 VEEAKTPARVSRSIGAFGWGGGEDAEGKEEDAEEEVEEVEEEEDEEDEYDKTVKQVHASM 355
Query: 260 GEVSVS 265
GEV VS
Sbjct: 356 GEVRVS 361
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 385 bits (988), Expect = e-106, Method: Compositional matrix adjust.
Identities = 201/248 (81%), Positives = 214/248 (86%), Gaps = 12/248 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 AMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK+ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI +IMAVQYKIPDYVHISQDC+N
Sbjct: 176 YDGKMADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIQKIMAVQYKIPDYVHISQDCKN 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFVAN +RITI EIK H WFLKNLPRELTETAQA Y++KENPTFSLQ+VEEI KI
Sbjct: 236 LLSRIFVANSLKRITIAEIKKHSWFLKNLPRELTETAQAAYFKKENPTFSLQTVEEIMKI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEK------------EEETDADEEDEYEKTVKEAQ 257
V +AK PPPVSRSIGGFGWGG D D K E E + D+EDEY+KTVKE
Sbjct: 296 VADAKTPPPVSRSIGGFGWGGNGDADGKEEDAEDVEEEEEEVEEEEDDEDEYDKTVKEVH 355
Query: 258 QSGEVSVS 265
SGEV +S
Sbjct: 356 ASGEVRIS 363
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 369 bits (946), Expect = e-101, Method: Compositional matrix adjust.
Identities = 180/242 (74%), Positives = 208/242 (85%), Gaps = 8/242 (3%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 91
QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS+PKSTVGTPAYIAPEVLSRREYD
Sbjct: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYD 177
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
GK ADVWSCGVTLYVMLVGAYPFED +DPKNFRKTI RIM++QYKIP+YVH+SQDCR LL
Sbjct: 178 GKTADVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIMSIQYKIPEYVHVSQDCRQLL 237
Query: 152 SRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN--PTFSLQSVEEITKI 209
SRIFVANP++RITI+EI++HPWFLKNLPRELTE AQA+YY+K+N PT+S+QSVEEI KI
Sbjct: 238 SRIFVANPAKRITIREIRNHPWFLKNLPRELTEAAQAMYYKKDNSAPTYSVQSVEEIMKI 297
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEKEEE------TDADEEDEYEKTVKEAQQSGEVS 263
VEEA+ PP S + GFGW E++ ++ ++ + D EDEY+K VK+ SGE
Sbjct: 298 VEEARTPPRSSTPVAGFGWQEEDEQEDNSKKPEEEQEEEEDAEDEYDKQVKQVHASGEFQ 357
Query: 264 VS 265
+S
Sbjct: 358 LS 359
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZI44|SAPK6_ORYSJ Serine/threonine-protein kinase SAPK6 OS=Oryza sativa subsp. japonica GN=SAPK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 362 bits (929), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 167/207 (80%), Positives = 189/207 (91%), Gaps = 2/207 (0%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 91
QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS+PKSTVGTPAYIAPEVLSRREYD
Sbjct: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYD 177
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
GK+ADVWSCGVTLYVMLVGAYPFED +DPKNFRKTI RI+++QYKIP+YVHISQDCR LL
Sbjct: 178 GKMADVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIVSIQYKIPEYVHISQDCRQLL 237
Query: 152 SRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP--TFSLQSVEEITKI 209
SRIFVANP++RITI+EI++HPWF+KNLPRELTE AQA YY+K+N TFS Q+V+EI KI
Sbjct: 238 SRIFVANPAKRITIREIRNHPWFMKNLPRELTEAAQAKYYKKDNSARTFSDQTVDEIMKI 297
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDE 236
V+EAK PPP S + GFGW EE+ ++
Sbjct: 298 VQEAKTPPPSSTPVAGFGWTEEEEQED 324
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFP9|SRK2H_ARATH Serine/threonine-protein kinase SRK2H OS=Arabidopsis thaliana GN=SRK2H PE=1 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (893), Expect = 3e-95, Method: Compositional matrix adjust.
Identities = 162/197 (82%), Positives = 178/197 (90%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAP LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SLQICHRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK ADVWSCGVTLYVMLVG YPFED +DP+NFRKTI RIMAVQYKIPDYVHISQ+CR+
Sbjct: 176 YDGKHADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFV N ++RIT+KEIK HPW+LKNLP+ELTE AQA YY++E P+FSLQSVE+I KI
Sbjct: 236 LLSRIFVTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYKRETPSFSLQSVEDIMKI 295
Query: 210 VEEAKVPPPVSRSIGGF 226
V EA+ P P S ++ GF
Sbjct: 296 VGEARNPAPSSNAVKGF 312
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5N942|SAPK4_ORYSJ Serine/threonine-protein kinase SAPK4 OS=Oryza sativa subsp. japonica GN=SAPK4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 347 bits (890), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 178/243 (73%), Positives = 202/243 (83%), Gaps = 13/243 (5%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 91
QICHRDLKLEN LLDGSPAPRLKICDFGYSKSS+LHSRPKS VGTPAYIAPEVLSRREYD
Sbjct: 118 QICHRDLKLENVLLDGSPAPRLKICDFGYSKSSVLHSRPKSAVGTPAYIAPEVLSRREYD 177
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
GKLADVWSCGVTLYVMLVGAYPFEDQ+DPKN RKTI RIM+VQYKIPDYVHIS +C+ L+
Sbjct: 178 GKLADVWSCGVTLYVMLVGAYPFEDQDDPKNIRKTIQRIMSVQYKIPDYVHISAECKQLI 237
Query: 152 SRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN--PTFSLQSVEEITKI 209
+RIFV NP RRIT+KEIKSHPWFLKNLPRELTETAQA+YYR++N P+FS Q+ EEI KI
Sbjct: 238 ARIFVNNPLRRITMKEIKSHPWFLKNLPRELTETAQAMYYRRDNSVPSFSDQTSEEIMKI 297
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGD-------EKEEETDADEEDEYEKTVKEAQQSGEV 262
V+EA+ P SR+ G+ + D E+ EE + +EEDEY+K VKE SGE+
Sbjct: 298 VQEARTMPKSSRT----GYWSDAGSDEEEKEEEERPEENEEEEEDEYDKRVKEVHASGEL 353
Query: 263 SVS 265
+S
Sbjct: 354 RMS 356
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XKA8|SAPK5_ORYSJ Serine/threonine-protein kinase SAPK5 OS=Oryza sativa subsp. japonica GN=SAPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 347 bits (890), Expect = 6e-95, Method: Compositional matrix adjust.
Identities = 173/250 (69%), Positives = 204/250 (81%), Gaps = 14/250 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 AMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFED +DPKNFRKTISRIM+VQYKIP+YVH+SQ CR+
Sbjct: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDPKDPKNFRKTISRIMSVQYKIPEYVHVSQPCRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP------------- 196
LLSRIFVANP +RI++ EIKSHPWFLKNLPREL E AQA+YY +
Sbjct: 236 LLSRIFVANPYKRISMGEIKSHPWFLKNLPRELKEEAQAVYYNRRGADHAASSASSAAAA 295
Query: 197 -TFSLQSVEEITKIVEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKE 255
FS QSVE+I +IV+EA+ P + + G+GWG ++D D+++ + DEED+Y++TV+E
Sbjct: 296 AAFSPQSVEDIMRIVQEAQTVPKPDKPVSGYGWGTDDDDDDQQPAEEEDEEDDYDRTVRE 355
Query: 256 AQQSGEVSVS 265
S ++ +S
Sbjct: 356 VHASVDLDMS 365
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43292|SRK2G_ARATH Serine/threonine-protein kinase SRK2G OS=Arabidopsis thaliana GN=SRK2G PE=1 SV=2 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 9e-93, Method: Compositional matrix adjust.
Identities = 176/235 (74%), Positives = 199/235 (84%), Gaps = 4/235 (1%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SLQICHRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK ADVWSCGVTLYVMLVGAYPFED DPKNFRKTI RIMAVQYKIPDYVHISQ+C++
Sbjct: 176 YDGKHADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFV N ++RIT+KEIK+HPW+LKNLP+EL E+AQA YY+++ +FSLQSVE+I KI
Sbjct: 236 LLSRIFVTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDT-SFSLQSVEDIMKI 294
Query: 210 VEEAKVPPPVSRSIGGFGWG---GEEDGDEKEEETDADEEDEYEKTVKEAQQSGE 261
V EA+ P P + ++ G G EE+ E E E + D+EDEYEK VKEAQ E
Sbjct: 295 VGEARNPAPSTSAVKSSGSGADEEEEEDVEAEVEEEEDDEDEYEKHVKEAQSCQE 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64812|SRK2J_ARATH Serine/threonine-protein kinase SRK2J OS=Arabidopsis thaliana GN=SRK2J PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 158/221 (71%), Positives = 178/221 (80%), Gaps = 4/221 (1%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 91
QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEV R EYD
Sbjct: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYD 177
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
GK DVWSCGV LYVMLVGAYPFED +DP+NFRKT+ +IMAV YKIP YVHIS+DCR LL
Sbjct: 178 GKSVDVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLL 237
Query: 152 SRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP--TFSLQSVEEITKI 209
SRIFVANP R T+KEIKSH WFLKNLPREL E AQAIYY++ FS Q VEEI KI
Sbjct: 238 SRIFVANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKI 297
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYE 250
V EA+ P +SR + G ++ D++EE DA++E+ Y+
Sbjct: 298 VGEARTIPNLSRPVESL--GSDKKDDDEEEYLDANDEEWYD 336
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0C5D6|SAPK3_ORYSJ Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. japonica GN=SAPK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (775), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 149/220 (67%), Positives = 176/220 (80%), Gaps = 2/220 (0%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S +ICHRDLKLENTLLDGSP PR+KICDFGYSKS+LLHS+PKSTVGTPAYIAPEVLSR+E
Sbjct: 117 SLEICHRDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKE 176
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK+ADVWSCGVTLYVMLVG+YPFED DP+NFRKTISRI+ VQY IPDYV +S DCR
Sbjct: 177 YDGKVADVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRR 236
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLS+IFVA+PS+RITI EIK H WFLKNLP+E++E +A Y+ + Q+VEEI +I
Sbjct: 237 LLSQIFVADPSKRITIPEIKKHTWFLKNLPKEISEREKAD-YKDTDAAPPTQAVEEIMRI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEY 249
++EAKVP ++ + E + EEE ADE D Y
Sbjct: 296 IQEAKVPGDMAAADPALLAELAELKSDDEEEA-ADEYDTY 334
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 265 | ||||||
| 356543422 | 359 | PREDICTED: serine/threonine-protein kina | 0.886 | 0.654 | 0.869 | 1e-116 | |
| 357445405 | 351 | Serine/threonine protein kinase [Medicag | 0.890 | 0.672 | 0.872 | 1e-115 | |
| 388490962 | 351 | unknown [Medicago truncatula] | 0.890 | 0.672 | 0.868 | 1e-115 | |
| 357445407 | 275 | Serine/threonine protein kinase [Medicag | 0.890 | 0.858 | 0.872 | 1e-114 | |
| 224118462 | 353 | predicted protein [Populus trichocarpa] | 0.890 | 0.668 | 0.894 | 1e-114 | |
| 225448215 | 356 | PREDICTED: serine/threonine-protein kina | 0.890 | 0.662 | 0.871 | 1e-113 | |
| 147864363 | 357 | hypothetical protein VITISV_028464 [Viti | 0.890 | 0.661 | 0.851 | 1e-112 | |
| 297739581 | 335 | unnamed protein product [Vitis vinifera] | 0.758 | 0.6 | 0.930 | 1e-111 | |
| 356525969 | 352 | PREDICTED: serine/threonine-protein kina | 0.890 | 0.670 | 0.881 | 1e-111 | |
| 441433481 | 352 | sucrose non-fermenting-1-related protein | 0.886 | 0.667 | 0.848 | 1e-111 |
| >gi|356543422|ref|XP_003540159.1| PREDICTED: serine/threonine-protein kinase SRK2B-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1087), Expect = e-116, Method: Compositional matrix adjust.
Identities = 213/245 (86%), Positives = 221/245 (90%), Gaps = 10/245 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFEDQ+DPKNFRKTI+RIMAVQYKIPDYVHISQDCR+
Sbjct: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQDDPKNFRKTINRIMAVQYKIPDYVHISQDCRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFVANP+RRITIKEIKSHPWFLKNLPRELTE AQA YYRKENPTFSLQS+E I I
Sbjct: 236 LLSRIFVANPARRITIKEIKSHPWFLKNLPRELTEVAQAAYYRKENPTFSLQSIEGIMNI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEKEEE---------TDADEEDEYEKTVKEAQQSG 260
VEEAK PPP SRSIGGFGWGGEE+ DE +EE T+A EEDEYEK VKEAQ SG
Sbjct: 296 VEEAKTPPPASRSIGGFGWGGEEEEDETKEEEDETKEEAVTEA-EEDEYEKRVKEAQASG 354
Query: 261 EVSVS 265
E VS
Sbjct: 355 EFHVS 359
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357445405|ref|XP_003592980.1| Serine/threonine protein kinase [Medicago truncatula] gi|55140609|gb|AAV41842.1| stress kinase [Medicago truncatula] gi|55140611|gb|AAV41843.1| stress kinase [Medicago truncatula] gi|355482028|gb|AES63231.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1079), Expect = e-115, Method: Compositional matrix adjust.
Identities = 206/236 (87%), Positives = 220/236 (93%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFEDQ+DPKNFRKTI+RIMAVQYKIPDYVHISQ+CR+
Sbjct: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQDDPKNFRKTINRIMAVQYKIPDYVHISQECRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFVA+P+RRITIKEIKSHPWFLKNLPRELTE AQA+YYRKENPT+SLQS+E+I KI
Sbjct: 236 LLSRIFVASPARRITIKEIKSHPWFLKNLPRELTEMAQAVYYRKENPTYSLQSIEDIMKI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS 265
VEEAK PP SRS+GGFGWGGEED DE E EEDEYEK VKEAQ+SGE+ V+
Sbjct: 296 VEEAKNPPQASRSVGGFGWGGEEDDDEINEAEAELEEDEYEKRVKEAQESGEIHVN 351
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388490962|gb|AFK33547.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 419 bits (1076), Expect = e-115, Method: Compositional matrix adjust.
Identities = 205/236 (86%), Positives = 219/236 (92%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFEDQ+DPKNFRKTI+RIMAVQYKIPDYVHISQ+CR+
Sbjct: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQDDPKNFRKTINRIMAVQYKIPDYVHISQECRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFVA+P+RRITIKEIKSHPWFLKNLPRELTE AQA+YYRKENPT+SLQS+E+I KI
Sbjct: 236 LLSRIFVASPARRITIKEIKSHPWFLKNLPRELTEMAQAVYYRKENPTYSLQSIEDIMKI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS 265
VEEAK PP SRS+GGFGWGGEED DE E EEDEYEK VKEAQ+SGE+ +
Sbjct: 296 VEEAKNPPQASRSVGGFGWGGEEDDDEINEAEAELEEDEYEKRVKEAQESGEIHAN 351
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357445407|ref|XP_003592981.1| Serine/threonine protein kinase [Medicago truncatula] gi|355482029|gb|AES63232.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1074), Expect = e-114, Method: Compositional matrix adjust.
Identities = 206/236 (87%), Positives = 220/236 (93%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 40 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 99
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFEDQ+DPKNFRKTI+RIMAVQYKIPDYVHISQ+CR+
Sbjct: 100 YDGKLADVWSCGVTLYVMLVGAYPFEDQDDPKNFRKTINRIMAVQYKIPDYVHISQECRH 159
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFVA+P+RRITIKEIKSHPWFLKNLPRELTE AQA+YYRKENPT+SLQS+E+I KI
Sbjct: 160 LLSRIFVASPARRITIKEIKSHPWFLKNLPRELTEMAQAVYYRKENPTYSLQSIEDIMKI 219
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS 265
VEEAK PP SRS+GGFGWGGEED DE E EEDEYEK VKEAQ+SGE+ V+
Sbjct: 220 VEEAKNPPQASRSVGGFGWGGEEDDDEINEAEAELEEDEYEKRVKEAQESGEIHVN 275
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224118462|ref|XP_002331488.1| predicted protein [Populus trichocarpa] gi|222873566|gb|EEF10697.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1074), Expect = e-114, Method: Compositional matrix adjust.
Identities = 213/238 (89%), Positives = 222/238 (93%), Gaps = 2/238 (0%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI+RIMAVQYKIPDYVHISQDCR+
Sbjct: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTINRIMAVQYKIPDYVHISQDCRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFVANP RRITIKEIKSHPWFLKNLPRELTE AQA+YYRKENPTFSLQSVEEI KI
Sbjct: 236 LLSRIFVANPIRRITIKEIKSHPWFLKNLPRELTEAAQAMYYRKENPTFSLQSVEEIMKI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGG--EEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS 265
VEEAK+PPPVSRSIGGFGW G ++D E + E + +EEDEYEK VKEAQ SGEV VS
Sbjct: 296 VEEAKIPPPVSRSIGGFGWVGEEDDDVKEDDAEEEEEEEDEYEKRVKEAQASGEVHVS 353
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225448215|ref|XP_002269221.1| PREDICTED: serine/threonine-protein kinase SRK2B isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 413 bits (1061), Expect = e-113, Method: Compositional matrix adjust.
Identities = 210/241 (87%), Positives = 224/241 (92%), Gaps = 5/241 (2%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR+
Sbjct: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LL+RIFVANPSRR+TIK+IK+HPWFLKNLPRELTE AQA+YYR+ENPTFSLQS+E+I KI
Sbjct: 236 LLARIFVANPSRRVTIKDIKNHPWFLKNLPRELTEAAQALYYRRENPTFSLQSIEDIMKI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGG-----EEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSV 264
V+EAK PPPVSRSIGGFGWGG EE+ E+E ET+ +EEDEYEK VKEA SGEV V
Sbjct: 296 VDEAKTPPPVSRSIGGFGWGGEEEEEEEEEKEEEVETEEEEEDEYEKQVKEAHASGEVHV 355
Query: 265 S 265
S
Sbjct: 356 S 356
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147864363|emb|CAN78793.1| hypothetical protein VITISV_028464 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 410 bits (1055), Expect = e-112, Method: Compositional matrix adjust.
Identities = 206/242 (85%), Positives = 221/242 (91%), Gaps = 6/242 (2%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR+
Sbjct: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LL+RIFVANPSRR+TIK+IK+HPWFLKNLPRELTE AQA+YYR+ENPTFSLQS+E+I KI
Sbjct: 236 LLARIFVANPSRRVTIKDIKNHPWFLKNLPRELTEAAQALYYRRENPTFSLQSIEDIMKI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKT------VKEAQQSGEVS 263
V+EAK PPPVSRSIGGFGWGGEE +E+EEE + + E E E+ VKEA SGEV
Sbjct: 296 VDEAKTPPPVSRSIGGFGWGGEEKKEEEEEEKEEEVETEEEEEDEYEKQVKEAHASGEVH 355
Query: 264 VS 265
VS
Sbjct: 356 VS 357
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297739581|emb|CBI29763.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 407 bits (1046), Expect = e-111, Method: Compositional matrix adjust.
Identities = 187/201 (93%), Positives = 197/201 (98%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR+
Sbjct: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LL+RIFVANPSRR+TIK+IK+HPWFLKNLPRELTE AQA+YYR+ENPTFSLQS+E+I KI
Sbjct: 236 LLARIFVANPSRRVTIKDIKNHPWFLKNLPRELTEAAQALYYRRENPTFSLQSIEDIMKI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGG 230
V+EAK PPPVSRSIGGFGWGG
Sbjct: 296 VDEAKTPPPVSRSIGGFGWGG 316
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356525969|ref|XP_003531593.1| PREDICTED: serine/threonine-protein kinase SRK2B-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 407 bits (1045), Expect = e-111, Method: Compositional matrix adjust.
Identities = 209/237 (88%), Positives = 221/237 (93%), Gaps = 1/237 (0%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI+RIMAVQYKIPDYVHISQDCR+
Sbjct: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTINRIMAVQYKIPDYVHISQDCRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFVANP+RRITIKEIKSHPWF+KNLPRELTE AQA YYRKENPTFSLQS+E+I I
Sbjct: 236 LLSRIFVANPARRITIKEIKSHPWFVKNLPRELTEVAQAAYYRKENPTFSLQSIEDIMNI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDAD-EEDEYEKTVKEAQQSGEVSVS 265
VEEAK PPP SRSIGGFGWGGEE+ +++ +E A+ EEDEYEK VKEAQ SGE VS
Sbjct: 296 VEEAKAPPPASRSIGGFGWGGEEEEEDETKEAVAETEEDEYEKRVKEAQASGEFHVS 352
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|441433481|gb|AGC31662.1| sucrose non-fermenting-1-related protein kinase [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 406 bits (1044), Expect = e-111, Method: Compositional matrix adjust.
Identities = 202/238 (84%), Positives = 216/238 (90%), Gaps = 3/238 (1%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGS APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SLQICHRDLKLENTLLDGSAAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT+ +IM V YKIPD+VH+SQ+CR+
Sbjct: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTMKKIMGVHYKIPDHVHMSQECRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFVANP+RRITIK+IK+HPWFLKNLPRELTE AQ IYYRKENPTFS Q+VE+I KI
Sbjct: 236 LLSRIFVANPARRITIKDIKNHPWFLKNLPRELTEAAQIIYYRKENPTFSPQTVEDIMKI 295
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEK--EEETDADEEDEYEKTVKEAQQSGEVSVS 265
VEEAK+PPPVSRSIGGF W GEEDGD K E + +EEDEY KTVKE SGEVSVS
Sbjct: 296 VEEAKIPPPVSRSIGGFSW-GEEDGDTKEEVEGEEEEEEDEYVKTVKEVHASGEVSVS 352
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 265 | ||||||
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.732 | 0.537 | 0.876 | 8.3e-90 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.732 | 0.538 | 0.824 | 1.4e-85 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.728 | 0.546 | 0.804 | 8.2e-83 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.724 | 0.566 | 0.778 | 2.1e-77 | |
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.720 | 0.527 | 0.698 | 5.3e-72 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.709 | 0.548 | 0.706 | 7e-70 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.728 | 0.534 | 0.670 | 9.2e-68 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.698 | 0.528 | 0.686 | 1.2e-67 | |
| DICTYBASE|DDB_G0277165 | 833 | DDB_G0277165 "BRSK subfamily p | 0.513 | 0.163 | 0.460 | 1.4e-30 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.513 | 0.305 | 0.438 | 2.5e-28 |
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 896 (320.5 bits), Expect = 8.3e-90, P = 8.3e-90
Identities = 170/194 (87%), Positives = 180/194 (92%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS PKSTVGTPAYIAPEVLSR E
Sbjct: 116 AMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK+ADVWSCGVTLYVMLVGAYPFEDQEDPKNF+KTI RIMAV+YKIPDYVHISQDC++
Sbjct: 176 YDGKMADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFV N ++RITI +IK HPWFLKNLPRELTE AQA Y+RKENPTFSLQSVEEI KI
Sbjct: 236 LLSRIFVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKI 295
Query: 210 VEEAKVPPPVSRSI 223
VEEAK P VSRSI
Sbjct: 296 VEEAKTPARVSRSI 309
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
Identities = 160/194 (82%), Positives = 176/194 (90%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAP LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SLQICHRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK ADVWSCGVTLYVMLVG YPFED +DP+NFRKTI RIMAVQYKIPDYVHISQ+CR+
Sbjct: 176 YDGKHADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFV N ++RIT+KEIK HPW+LKNLP+ELTE AQA YY++E P+FSLQSVE+I KI
Sbjct: 236 LLSRIFVTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYKRETPSFSLQSVEDIMKI 295
Query: 210 VEEAKVPPPVSRSI 223
V EA+ P P S ++
Sbjct: 296 VGEARNPAPSSNAV 309
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 156/194 (80%), Positives = 176/194 (90%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRRE
Sbjct: 116 SLQICHRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRRE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK ADVWSCGVTLYVMLVGAYPFED DPKNFRKTI RIMAVQYKIPDYVHISQ+C++
Sbjct: 176 YDGKHADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFV N ++RIT+KEIK+HPW+LKNLP+EL E+AQA YY+++ +FSLQSVE+I KI
Sbjct: 236 LLSRIFVTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDT-SFSLQSVEDIMKI 294
Query: 210 VEEAKVPPPVSRSI 223
V EA+ P P + ++
Sbjct: 295 VGEARNPAPSTSAV 308
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 779 (279.3 bits), Expect = 2.1e-77, P = 2.1e-77
Identities = 151/194 (77%), Positives = 163/194 (84%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 91
QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEV R EYD
Sbjct: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYD 177
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
GK DVWSCGV LYVMLVGAYPFED +DP+NFRKT+ +IMAV YKIP YVHIS+DCR LL
Sbjct: 178 GKSVDVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLL 237
Query: 152 SRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE-NP-TFSLQSVEEITKI 209
SRIFVANP R T+KEIKSH WFLKNLPREL E AQAIYY++ N FS Q VEEI KI
Sbjct: 238 SRIFVANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKI 297
Query: 210 VEEAKVPPPVSRSI 223
V EA+ P +SR +
Sbjct: 298 VGEARTIPNLSRPV 311
|
|
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 5.3e-72, P = 5.3e-72
Identities = 137/196 (69%), Positives = 165/196 (84%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ Q+CHRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++E
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK+ADVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRH 252
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE--TAQAIYYRKENPTFSLQSVEEIT 207
L+SRIFVA+P++RI+I EI++H WFLKNLP +L T + + P QS+EEI
Sbjct: 253 LISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIM 309
Query: 208 KIVEEAKVPPPVSRSI 223
+I+ EA VPP ++++
Sbjct: 310 QIIAEATVPPAGTQNL 325
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 708 (254.3 bits), Expect = 7.0e-70, P = 7.0e-70
Identities = 137/194 (70%), Positives = 159/194 (81%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGS APR+KICDFGYSKS +LHS+PK+TVGTPAYIAPEVLS +E
Sbjct: 116 SLQICHRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK+ADVWSCGVTLYVMLVGAYPFED DPK+FRKTI RI+ QY IPDYV +S +CR+
Sbjct: 176 YDGKIADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
LLSRIFVANP +RITI+EIK+H WFLKNLP E+ E + + P S Q+VEEI I
Sbjct: 236 LLSRIFVANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMM----NGP--STQTVEEIVWI 289
Query: 210 VEEAKVPPPVSRSI 223
+EEA+ P V+ +
Sbjct: 290 IEEARKPITVATGL 303
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 9.2e-68, P = 9.2e-68
Identities = 130/194 (67%), Positives = 160/194 (82%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R+E
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK+ADVWSCGVTLYVMLVGAYPFED E+P+++RKTI RI++V+Y IPD + IS +C +
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
L+SRIFVA+P+ RI+I EIK+H WFLKNLP +L + +E P +QS++ I +I
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE-PEQPMQSLDTIMQI 312
Query: 210 VEEAKVPPPVSRSI 223
+ EA +P +R +
Sbjct: 313 ISEATIPAVRNRCL 326
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 687 (246.9 bits), Expect = 1.2e-67, P = 1.2e-67
Identities = 129/188 (68%), Positives = 153/188 (81%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ QICHRDLKLENTLLDGSP+ LKICDFGYSKSS+LHS+PKSTVGTPAY+APEVLSR+E
Sbjct: 116 AMQICHRDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y+GK+ADVWSCGVTLYVMLVGAYPFED EDP+N R TI RI++V Y IPDYV IS +C++
Sbjct: 176 YNGKIADVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKH 235
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKN---LPRELTETAQAIYYRKENPTFSLQSVEEI 206
LLSRIFVA+P +RIT+ EI+ HPWFLK +P E + + +E QSVEEI
Sbjct: 236 LLSRIFVADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGVEEEEEEEEKCRQSVEEI 295
Query: 207 TKIVEEAK 214
KI+EEA+
Sbjct: 296 VKIIEEAR 303
|
|
| DICTYBASE|DDB_G0277165 DDB_G0277165 "BRSK subfamily protein kinase DDB_G0277165" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 347 (127.2 bits), Expect = 1.4e-30, P = 1.4e-30
Identities = 70/152 (46%), Positives = 100/152 (65%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVL 85
S+ ICHRDLK EN LL G R+KI DFG K LLH+ + G+P Y +PEV+
Sbjct: 126 SRNICHRDLKPENLLLSGDK--RIKIADFGMGSIVRKDMLLHT----SCGSPHYASPEVV 179
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
S +YDG+ ADVWSCGV LY +L G PF+D+ N R+ ++++ + +P Y+H +
Sbjct: 180 SGIDYDGQKADVWSCGVILYALLTGKLPFDDE----NIRRLLNKVKNGAFSMPPYIH--K 233
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
D ++LL+++ +PS+RI+IKEIK HPWF+ N
Sbjct: 234 DAQDLLTKMLTVDPSKRISIKEIKEHPWFVSN 265
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 297 (109.6 bits), Expect = 2.5e-28, Sum P(2) = 2.5e-28
Identities = 68/155 (43%), Positives = 91/155 (58%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSLLHSRPKSTVGTPAYIAP 82
S+ + HRDLK EN LLD + LKI DFG S + LLH++ GTPAY+AP
Sbjct: 128 SRGVSHRDLKPENLLLDENGD--LKISDFGLSALPEQILQDGLLHTQ----CGTPAYVAP 181
Query: 83 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142
EVL ++ YDG AD+WSCGV LYV+L G PF+D+ +RK I ++ P +
Sbjct: 182 EVLKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRK----IFRADFEFPPW-- 235
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
S + R L+S++ V +P RRI+I I PW KN
Sbjct: 236 FSPEARRLISKLLVVDPDRRISIPAIMRTPWLRKN 270
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9C958 | SRK2B_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7967 | 0.8905 | 0.6537 | yes | no |
| Q7XQP4 | SAPK7_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7438 | 0.8830 | 0.6518 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 265 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-35 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-30 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-28 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-25 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-24 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-23 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-22 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-22 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-22 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-22 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-21 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-21 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-20 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-19 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-18 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-17 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-16 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-15 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-11 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-09 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-05 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.001 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.001 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.001 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.002 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.004 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 7e-50
Identities = 51/146 (34%), Positives = 77/146 (52%), Gaps = 7/146 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S+ I HRDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVL +
Sbjct: 115 SKGIVHRDLKPENILLDEDG--HVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG 172
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVHISQDCR 148
Y D+WS GV LY +L G PF + + +I + P IS + +
Sbjct: 173 YGKA-VDIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAK 228
Query: 149 NLLSRIFVANPSRRITIKEIKSHPWF 174
+L+ ++ V +P +R+T +E HP+F
Sbjct: 229 DLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-41
Identities = 60/148 (40%), Positives = 81/148 (54%), Gaps = 6/148 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S I HRDLK EN LLD + +KI DFG +K L S +T VGTP Y+APEVL
Sbjct: 116 SNGIIHRDLKPENILLDENG--VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH--ISQD 146
G DVWS GV LY +L G PF E+ + + I RI+ + + S++
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWF 174
++L+ + +PS+R T +EI HPWF
Sbjct: 233 AKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-35
Identities = 60/151 (39%), Positives = 85/151 (56%), Gaps = 17/151 (11%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLS 86
S I +RDLK EN LLD G +K+ DFG +K SR + GTP Y+APEVL
Sbjct: 111 SLGIIYRDLKPENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
+ Y GK D WS GV LY ML G PF ED K + +I+ + P+++ S +
Sbjct: 167 GKGY-GKAVDWWSLGVLLYEMLTGKPPFYA-EDRK---EIYEKILKDPLRFPEFL--SPE 219
Query: 147 CRNLLSRIFVANPSRRIT---IKEIKSHPWF 174
R+L+S + +P++R+ +EIK+HP+F
Sbjct: 220 ARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-32
Identities = 52/152 (34%), Positives = 81/152 (53%), Gaps = 20/152 (13%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
S I +RDLK EN LLD G +KI DFG++K + R + GTP Y+APE++
Sbjct: 119 SLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEIILS 172
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
+ Y GK D W+ G+ +Y ML G PF D + + K I+ + + P S D
Sbjct: 173 KGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK----ILEGKVRFP--SFFSPDA 225
Query: 148 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
++L+ + + ++R+ + +IK+HPWF
Sbjct: 226 KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-30
Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 34/170 (20%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSLLHS 68
S+ I HRDLK EN LLD +KI DFG +K
Sbjct: 120 SKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 128
R S VGT Y++PE+L+ + GK +D+W+ G +Y ML G PF + F+K
Sbjct: 178 RFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK--- 233
Query: 129 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK----EIKSHPWF 174
I+ ++Y P + D ++L+ ++ V +P R+ + E+K+HP+F
Sbjct: 234 -ILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-30
Identities = 57/154 (37%), Positives = 84/154 (54%), Gaps = 19/154 (12%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKST---VGTPAYIAPE 83
I HRDLK +N L+D + LK+ DFG SK L L+ K VGTP YIAPE
Sbjct: 114 IIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 84 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
V+ + + K D WS G LY LVG PF + + I+ + + P+ V +
Sbjct: 172 VILGQGH-SKTVDWWSLGCILYEFLVGIPPFHG----ETPEEIFQNILNGKIEWPEDVEV 226
Query: 144 SQDCRNLLSRIFVANPSRRI---TIKEIKSHPWF 174
S + +L+S++ V +P +R+ +I+EIK+HP+F
Sbjct: 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-30
Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 27/157 (17%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLS 86
S I HRD+K N L+D +K+ DFG +K S GTP ++APEV+
Sbjct: 119 SNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI- 175
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--------- 137
R E G+ AD+WS G T+ M G P+ + +P MA YKI
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----------MAALYKIGSSGEPPEI 225
Query: 138 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
P+ H+S++ ++ L + +P +R T E+ HP+
Sbjct: 226 PE--HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 4e-30
Identities = 47/144 (32%), Positives = 67/144 (46%), Gaps = 39/144 (27%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEVLSRR 88
S I HRDLK EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVL +
Sbjct: 110 SNGIIHRDLKPENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y + +D+WS GV LY + + +
Sbjct: 169 GYYSEKSDIWSLGVILYEL-------------------------------------PELK 191
Query: 149 NLLSRIFVANPSRRITIKEIKSHP 172
+L+ ++ +P +R + KEI H
Sbjct: 192 DLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 55/153 (35%), Positives = 84/153 (54%), Gaps = 16/153 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
++ I +RDLK EN LLD + +K+ DFG++K + + GTP Y+APE++ +
Sbjct: 111 NRGIIYRDLKPENLLLDSNG--YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPF-EDQEDPKNFRKTISRIMAVQYKI--PDYVHISQD 146
YD D WS G+ LY +L G PF ED EDP + + I+ K+ P+Y I +
Sbjct: 169 YD-FSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNGKLEFPNY--IDKA 222
Query: 147 CRNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
++L+ ++ NP R+ IK+IK H WF
Sbjct: 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 9e-28
Identities = 56/173 (32%), Positives = 79/173 (45%), Gaps = 41/173 (23%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSK----------------------SSLLHSRPK- 71
HRD+K +N L+D +K+ DFG K + L+ R
Sbjct: 124 HRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 72 -------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR 124
STVGTP YIAPEVL Y G D WS GV LY ML G PF +
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSD----TLQ 236
Query: 125 KTISRIMAVQ--YKIPDYVHISQDCRNLLSRIFVANPSRRIT-IKEIKSHPWF 174
+T ++I+ + + P +S + +L+ R + +P R+ +EIKSHP+F
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 49/142 (34%), Positives = 76/142 (53%), Gaps = 13/142 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KSTVGTPAYIAPEVLSR 87
S++I HRD+K +N L +K+ DFG SK L + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKV-LSSTVDLAKTVVGTPYYLSPELCQN 177
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQD 146
+ Y+ K +D+WS G LY + +PFE + N + +I+ QY IP S +
Sbjct: 178 KPYNYK-SDIWSLGCVLYELCTLKHPFEGE----NLLELALKILKGQYPPIPS--QYSSE 230
Query: 147 CRNLLSRIFVANPSRRITIKEI 168
RNL+S + +P R +I +I
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 27/159 (16%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEV 84
S I HRD+K N LD + +K+ DFG + ++ + +S GTPAY+APEV
Sbjct: 117 SHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 85 LSRREYDGKL--ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK------ 136
++ + G AD+WS G + M G P+ + ++ F + +
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EF--------QIMFHVGAGHK 224
Query: 137 --IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
IPD + +S + ++ L R ++P +R T E+ HP+
Sbjct: 225 PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-25
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 12/147 (8%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
S I HRD+K N LL DG +K+ DFG S + VGTP ++APEV++
Sbjct: 116 SNGIIHRDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING 171
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIPDYVHISQD 146
+ YD K AD+WS G+T + G P+ + K + +I + + S +
Sbjct: 172 KPYDYK-ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDE 226
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPW 173
++ L + NP +R T +++ HP+
Sbjct: 227 FKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-24
Identities = 56/151 (37%), Positives = 82/151 (54%), Gaps = 15/151 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
+ I +RDLKL+N LLD +KI DFG K +L ST GTP YIAPE+LS +
Sbjct: 114 ERGIIYRDLKLDNVLLDSEG--HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y G D W+ GV LY ML G PFE ++ + F+ I+ + + P +S++ +
Sbjct: 172 PY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS----ILEDEVRYP--RWLSKEAK 224
Query: 149 NLLSRIFVANPSRRITI-----KEIKSHPWF 174
++L NP +R+ ++IK HP+F
Sbjct: 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 8e-24
Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 16/151 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 87
S+ I HRD+K +N LLD + I DF + + + +T GTP Y+APEVL R
Sbjct: 118 SKGIIHRDIKPDNILLDEQG--HVHITDFNIA--TKVTPDTLTTSTSGTPGYMAPEVLCR 173
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDY-VHISQ 145
+ Y D WS GVT Y L G P+ + R +I A Q Y S
Sbjct: 174 QGY-SVAVDWWSLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPATWST 227
Query: 146 DCRNLLSRIFVANPSRRI--TIKEIKSHPWF 174
+ + ++++ +P +R+ +K++K+HP+F
Sbjct: 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-23
Identities = 58/182 (31%), Positives = 86/182 (47%), Gaps = 22/182 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S + +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL
Sbjct: 113 SCDVVYRDLKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+Y G+ D W GV +Y M+ G PF +Q+ K F I+ + + P +S + +
Sbjct: 171 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLSPEAK 223
Query: 149 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSV 203
+LL+ + +P +R+ KEI H +F + Q + +K P F Q
Sbjct: 224 SLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF-------ASINWQDVVQKKLEPPFKPQVT 276
Query: 204 EE 205
E
Sbjct: 277 SE 278
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-23
Identities = 54/148 (36%), Positives = 88/148 (59%), Gaps = 13/148 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRR 88
S+ I +RDLKL+N LLD +KI DFG K ++L ++ + GTP YIAPE+L +
Sbjct: 114 SKGIVYRDLKLDNILLDTDG--HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDC 147
+Y D WS GV LY ML+G PF ++ + F+ +++ P Y ++++
Sbjct: 172 KY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ-------SIRMDNPCYPRWLTREA 223
Query: 148 RNLLSRIFVANPSRRITIK-EIKSHPWF 174
+++L ++FV P RR+ +K +I+ HP+F
Sbjct: 224 KDILVKLFVREPERRLGVKGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.0 bits (237), Expect = 7e-23
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 19/210 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSLLHSRPKSTVGTPAYIAP 82
S+ I HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 83 EVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-------MAV 133
EVL Y +D+WS G+TLY +L G PFE +++ +T+ I +A
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRK 193
+ IS+ +LL ++ +P R++ SH + +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL--AHLKLKESDLSDLLKPD 295
Query: 194 ENPTFSLQSVEEITKIVEEAKVPPPVSRSI 223
++ L + ++ +
Sbjct: 296 DSAPLRLSLPPSLEALISSLNSLAISGSDL 325
|
Length = 384 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-23
Identities = 50/145 (34%), Positives = 76/145 (52%), Gaps = 11/145 (7%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 92
I HRD+K EN L+D LK+ DFG S++ L K VGTP Y+APE + D
Sbjct: 118 IIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DD 171
Query: 93 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 152
K++D WS G ++ L G PF + F +SR + + S + +L++
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR--INWPEEVKEFCSPEAVDLIN 229
Query: 153 RIFVANPSRRI---TIKEIKSHPWF 174
R+ +P++R+ +EIKSHP+F
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-22
Identities = 56/148 (37%), Positives = 89/148 (60%), Gaps = 15/148 (10%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRREYD 91
I +RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV++RR +
Sbjct: 119 IIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
+ AD WS GV ++ ML G+ PF+ K+ ++T++ I+ + +P + +S + ++LL
Sbjct: 177 -QSADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLL 229
Query: 152 SRIFVANPSRRI-----TIKEIKSHPWF 174
+F NP+ R+ ++EIK HP+F
Sbjct: 230 RALFKRNPANRLGAGPDGVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-22
Identities = 53/148 (35%), Positives = 86/148 (58%), Gaps = 13/148 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
+ I +RDLKL+N LLD +KI DFG K ++ ST GTP YIAPE+L +
Sbjct: 114 KKGIIYRDLKLDNVLLDKDG--HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VHISQDC 147
+Y+ + D WS GV LY ML+G PF +++ + F ++ P + IS++
Sbjct: 172 KYNESV-DWWSFGVLLYEMLIGQSPFHGEDEDELFD-------SILNDRPHFPRWISKEA 223
Query: 148 RNLLSRIFVANPSRRITIK-EIKSHPWF 174
++ LS++F +P++R+ + +I+ HP+F
Sbjct: 224 KDCLSKLFERDPTKRLGVDGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 59/184 (32%), Positives = 82/184 (44%), Gaps = 52/184 (28%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SLLHSRPK------------ 71
HRD+K +N LLD +K+ DFG L H+ P
Sbjct: 124 HRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 72 ----------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE 115
STVGTP YIAPEV + Y K D WS GV +Y MLVG PF
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFC 240
Query: 116 DQEDPKNFRKTISRIMAVQ--YKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKS 170
++P ++T +I+ + + PD V +S + ++L+ R RR+ + EIKS
Sbjct: 241 -SDNP---QETYRKIINWKETLQFPDEVPLSPEAKDLIKR-LCCEAERRLGNNGVNEIKS 295
Query: 171 HPWF 174
HP+F
Sbjct: 296 HPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-22
Identities = 52/148 (35%), Positives = 85/148 (57%), Gaps = 13/148 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRR 88
S+ I +RDLKL+N +LD +KI DFG K ++ +R + GTP YIAPE+L
Sbjct: 114 SKGIIYRDLKLDNVMLDRDG--HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDC 147
+Y + D WS GV LY ML+G PF ++ + F +++ P Y I+++
Sbjct: 172 KYTFSV-DWWSFGVLLYEMLIGQSPFHGDDEDELFE-------SIRVDTPHYPRWITKES 223
Query: 148 RNLLSRIFVANPSRRITIK-EIKSHPWF 174
+++L ++F +P+RR+ + I+ HP+F
Sbjct: 224 KDILEKLFERDPTRRLGVVGNIRGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-22
Identities = 57/151 (37%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 90
HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEVL +
Sbjct: 165 HRDVKPDNMLLDKSG--HLKLADFGTCMKMDANGMVRC--DTAVGTPDYISPEVLKSQGG 220
Query: 91 D---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--AVQYKIPDYVHISQ 145
D G+ D WS GV LY MLVG PF + T S+IM PD + IS+
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMDHKNSLTFPDDIEISK 276
Query: 146 DCRNLLSRIFVANPSR--RITIKEIKSHPWF 174
++L+ R R + EIKSHP+F
Sbjct: 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-22
Identities = 52/149 (34%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPAYIAPEVLSRREY 90
I +RD+KLEN LLD + + DFG SK L R S GT Y+APEV+
Sbjct: 126 IIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 91 D-GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-RIMAVQYKIPDYVHISQDCR 148
K D WS GV + +L GA PF + +N + IS RI+ + P +S + R
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPK--TMSAEAR 240
Query: 149 NLLSRIFVANPSRRI---TIKEIKSHPWF 174
+ + ++ +P +R+ EIK+HP+F
Sbjct: 241 DFIQKLLEKDPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 5e-22
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 91
+ +RDLK EN LLD + +CDFG K ++ +T GTP Y+APE+L Y
Sbjct: 114 VIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
K D W+ GV LY ML G PF D+ + +RK I+ + PD +D ++LL
Sbjct: 172 -KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPD--GFDRDAKDLL 224
Query: 152 SRIFVANPSRRITI---KEIKSHPWFLK-NLPRELTETAQ-----AIYYRKENPTFSLQS 202
+ +P+RR+ +EIK+HP+F + + + L + Q A+ + F +
Sbjct: 225 IGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEF 284
Query: 203 VEE--ITKIVEEAKVPPPVSRSIGGFGW 228
E I +V+++ + V + GG+ +
Sbjct: 285 TREKPIDSVVDDSHLSETVQQQFGGWSY 312
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 7e-22
Identities = 57/174 (32%), Positives = 78/174 (44%), Gaps = 37/174 (21%)
Query: 33 ICHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSLLHS------- 68
I +RDLK EN LL S P P K G +SS+
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 69 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR 124
R S VGT YIAPEV+S + + D W+ G+ LY ML G PF+ N
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG----SNRD 238
Query: 125 KTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK----EIKSHPWF 174
+T S I+ + P +S R+L+ ++ V +PS+R+ K EIK HP+F
Sbjct: 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 57/158 (36%), Positives = 88/158 (55%), Gaps = 26/158 (16%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 92
HRDLK EN L+D S +K+ DFG SK + + S VG+P Y+APEVL + YD
Sbjct: 122 YIHRDLKPENFLIDASG--HIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDF 177
Query: 93 KLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAVQYKIPDYV----H 142
+ D WS G LY L G PF E E+ K +++T+ R P Y +
Sbjct: 178 TV-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--------PVYDDPRFN 228
Query: 143 ISQDCRNLLSRIFVANPSRRI-TIKEIKSHPWFLKNLP 179
+S + +L++++ + +PSRR ++++IK+HP+F K +
Sbjct: 229 LSDEAWDLITKL-INDPSRRFGSLEDIKNHPFF-KEVD 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-21
Identities = 58/151 (38%), Positives = 82/151 (54%), Gaps = 15/151 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
Q I +RDLK EN LLD +K+ DFG K S+ T GT Y+APE+L R
Sbjct: 118 QQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS 175
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+ GK D WS G +Y ML GA PF + N +KTI +I+ + +P Y ++ + R
Sbjct: 176 GH-GKAVDWWSLGALMYDMLTGAPPFTAE----NRKKTIDKILKGKLNLPPY--LTPEAR 228
Query: 149 NLLSRIFVANPSRRI-----TIKEIKSHPWF 174
+LL ++ NPS R+ E++SHP+F
Sbjct: 229 DLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-21
Identities = 52/147 (35%), Positives = 70/147 (47%), Gaps = 17/147 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKSTVGTPAYIAPEVLSRR 88
Q+I HRDLK N LL +KI D G SK +L K+ +GTP Y+APEV R
Sbjct: 121 EQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFE--DQEDPKNFRKTISRIMAVQY-KIPDYVHISQ 145
Y K +D+WS G LY M A PFE +D + ++ +Y IP SQ
Sbjct: 177 PYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRY------KVQRGKYPPIPP--IYSQ 227
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHP 172
D +N + + P R +I + P
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 52/149 (34%), Positives = 73/149 (48%), Gaps = 16/149 (10%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYDG 92
HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL+ DG
Sbjct: 125 HRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 93 KLA-----DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHISQ 145
K D WS GV Y M+ G PF E KT + IM Q K P+ +S
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFH--EG--TSAKTYNNIMNFQRFLKFPEDPKVSS 238
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWF 174
D +L+ + + R+ + + HP+F
Sbjct: 239 DFLDLIQSL-LCGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-20
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 24/195 (12%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 91
I +RDLKL+N LLD +KI DFG K + ST GTP ++APEVL+ Y
Sbjct: 122 IVYRDLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY- 178
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
+ D W GV +Y MLVG PF ++ + F ++ V+Y +S++ +++
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPR----FLSREAISIM 232
Query: 152 SRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF--SLQSVE 204
R+ NP RR+ +++K P+F +++ + RK P F +++ E
Sbjct: 233 RRLLRRNPERRLGSGEKDAEDVKKQPFF-RDI------NWDDLLARKIKPPFVPTIKGPE 285
Query: 205 EITKIVEEAKVPPPV 219
+++ EE PV
Sbjct: 286 DVSNFDEEFTSEAPV 300
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 3e-20
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 19/166 (11%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLS 86
SQ + HRD+K +N LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+
Sbjct: 134 SQNVIHRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI--- 143
R++Y K D+WS G+ M G P+ E P I+ IP +
Sbjct: 190 RKDYGPK-VDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLIT-----TKGIPPLKNPEKW 242
Query: 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAI 189
S + ++ L++ V +P +R + +E+ HP FLK E A I
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHP-FLKK-ACPKEEFAPLI 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 6e-20
Identities = 56/156 (35%), Positives = 76/156 (48%), Gaps = 25/156 (16%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSR---PKSTVGTPAYIAPEVL 85
S I HRD+K N L D A +K+ DFG SK + S KS GTP +++PEV+
Sbjct: 122 SNMIVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI----PDYV 141
S Y G+ ADVWS G T+ ML P+ + E MA +KI +
Sbjct: 180 SGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEA-----------MAAIFKIATQPTNPQ 227
Query: 142 ---HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
H+S D RN L R FV N +R + +E+ H +
Sbjct: 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-19
Identities = 69/216 (31%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPAYIAPEVLSRREY 90
I +RD+KLEN LLD + + DFG SK L R S GT Y+APE++ +
Sbjct: 126 IVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGG 183
Query: 91 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-RIMAVQYKIPDYVHISQDCRN 149
GK D WS G+ ++ +L GA PF E +N + +S RI+ P + I + ++
Sbjct: 184 HGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCDPPFPSF--IGPEAQD 240
Query: 150 LLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF--SLQS 202
LL ++ +P +R+ EIK HP+F K L E A+ RK NP F S+++
Sbjct: 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFF-KGLDWE------ALALRKVNPPFRPSIRN 293
Query: 203 VEEITKIVEE----------AKVPPPVSRSIGGFGW 228
++ EE A PP +R G+ +
Sbjct: 294 ELDVGNFAEEFTNLEPVYSPAGTPPSGARVFQGYSF 329
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-19
Identities = 47/143 (32%), Positives = 74/143 (51%), Gaps = 6/143 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ HRD+K N L+D + +K+ DFG +K + S KS G+P ++APEV++++
Sbjct: 120 DRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
G AD+WS G T+ M G P+ E K I R + IPD H+S + ++
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELP-PIPD--HLSDEAKD 233
Query: 150 LLSRIFVANPSRRITIKEIKSHP 172
+ + +PS R T E+ HP
Sbjct: 234 FILKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 2e-19
Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 29/155 (18%)
Query: 31 QQICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSR 87
Q + HRD+K N L DG +K+ DFG + K + + S VGTP ++APEV+
Sbjct: 118 QGVIHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--------PD 139
+D+WS G T+ +L G P+ D MA ++I P+
Sbjct: 174 SGASTA-SDIWSLGCTVIELLTGNPPYYDLNP-----------MAALFRIVQDDHPPLPE 221
Query: 140 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
IS + ++ L + F +P+ R T K++ HPW
Sbjct: 222 --GISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-19
Identities = 46/147 (31%), Positives = 70/147 (47%), Gaps = 10/147 (6%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 92
I +RDLK EN LLD R I D G + + K GTP Y+APEVL YD
Sbjct: 116 IVYRDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 93 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 152
D ++ G TLY M+ G PF +++ + R + + + PD S + ++L
Sbjct: 174 S-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCE 230
Query: 153 RIFVANPSRRI-----TIKEIKSHPWF 174
+ +P +R+ + E++ HP F
Sbjct: 231 ALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 3e-19
Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 15/147 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLS 86
+ HRDLK N LD + +K+ DFG +K +L K+ VGTP Y++PE L+
Sbjct: 128 GNTVLHRDLKPANIFLDANNN--VKLGDFGLAK--ILGHDSSFAKTYVGTPYYMSPEQLN 183
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHISQ 145
YD K +D+WS G +Y + + PF +N + S+I ++ +IP S
Sbjct: 184 HMSYDEK-SDIWSLGCLIYELCALSPPFT----ARNQLQLASKIKEGKFRRIPY--RYSS 236
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHP 172
+ ++ + +P +R + +E+ P
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-19
Identities = 53/150 (35%), Positives = 85/150 (56%), Gaps = 16/150 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S+ I +RDLK EN LLD +K+ DFG++K + R + GTP Y+APEV+ +
Sbjct: 136 SKDIIYRDLKPENLLLDNKG--HVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKG 191
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
+ GK D W+ GV LY + G PF D + P FR +I+A + K P++ R+
Sbjct: 192 H-GKAVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWF--DGRARD 244
Query: 150 LLSRIFVANPSRRI-TIK----EIKSHPWF 174
L+ + + ++R+ T+K ++K+HP+F
Sbjct: 245 LVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-19
Identities = 63/182 (34%), Positives = 90/182 (49%), Gaps = 22/182 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRR 88
S +I +RDLKLEN +LD +KI DFG K + + K+ GTP Y+APEVL
Sbjct: 113 SGKIVYRDLKLENLMLDKDG--HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN 170
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+Y G+ D W GV +Y M+ G PF +Q+ K F I+ K P +S D +
Sbjct: 171 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEDIKFPRT--LSADAK 223
Query: 149 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSV 203
+LLS + + +P++R+ KEI H +F Q +Y +K P F Q
Sbjct: 224 SLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG-------VNWQDVYDKKLVPPFKPQVT 276
Query: 204 EE 205
E
Sbjct: 277 SE 278
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 7e-19
Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 9/144 (6%)
Query: 33 ICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRRE 89
I HRD+K N L+ G KI DFG SK +T VGT Y++PE + + E
Sbjct: 121 IIHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
AD+WS G+TL +G +PF P +F + + I S + R+
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPAEEFSPEFRD 234
Query: 150 LLSRIFVANPSRRITIKEIKSHPW 173
+S +P +R + E+ HP+
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-19
Identities = 51/150 (34%), Positives = 82/150 (54%), Gaps = 16/150 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S++I +RDLK EN LLD +K+ DFG++K L R + GTP Y+APEV+ +
Sbjct: 119 SKEIVYRDLKPENILLDKEG--HIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKG 174
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
+ K D W+ G+ +Y MLVG PF D N +I+A + + P H+ ++
Sbjct: 175 H-NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILAGKLEFPR--HLDLYAKD 227
Query: 150 LLSRIFVANPSRRI-----TIKEIKSHPWF 174
L+ ++ V + +RR+ ++K+H WF
Sbjct: 228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 14/151 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S I +RDLK EN LLD L DFG K + HS+ ST GTP Y+APEVL ++
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
YD + D W G LY ML G PF ++ + + +++ + ++ +IS R
Sbjct: 172 PYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP------NISVSAR 224
Query: 149 NLLSRIFVANPSRRI----TIKEIKSHPWFL 175
+LL + + ++R+ EIK+H +F
Sbjct: 225 HLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 54/150 (36%), Positives = 85/150 (56%), Gaps = 11/150 (7%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLS 86
+Q + HRD+K ++ LL DG R+K+ DFG+ ++ S R KS VGTP ++APEV+S
Sbjct: 133 AQGVIHRDIKSDSILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVIS 188
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R Y G D+WS G+ + M+ G P+ + E P K I + + K + +S
Sbjct: 189 RLPY-GTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLK--NLHKVSPR 244
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
R+ L R+ V +P++R T E+ +HP+ K
Sbjct: 245 LRSFLDRMLVRDPAQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-18
Identities = 49/143 (34%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
++ I HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ +
Sbjct: 119 TKLILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y+ K +D+W+ G LY + FE P K +S A P S D R
Sbjct: 178 YNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-----PISDRYSPDLRQ 231
Query: 150 LLSRIFVANPSRRITIKEIKSHP 172
L+ + +PS+R + +I + P
Sbjct: 232 LILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 60/193 (31%), Positives = 78/193 (40%), Gaps = 65/193 (33%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------SSLL 66
HRD+K +N L+D +K+ DFG Y K S +
Sbjct: 124 HRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 67 HSRPK----------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG 110
R K S VGTP YIAPEVL R Y +L D WS GV LY MLVG
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVG 240
Query: 111 AYPF------EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI- 163
PF E Q N+ T+ IP +S++ +L+ R+ R+
Sbjct: 241 QPPFLADTPAETQLKVINWETTL--------HIPSQAKLSREASDLILRL-CCGAEDRLG 291
Query: 164 --TIKEIKSHPWF 174
EIK+HP+F
Sbjct: 292 KNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 49/151 (32%), Positives = 82/151 (54%), Gaps = 15/151 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S+ I +RDLKL+N +LD +KI DFG K ++ + T GTP YIAPE+++ +
Sbjct: 119 SKGIIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y GK D W+ GV LY ML G PF+ +++ + F+ IM P +S++
Sbjct: 177 PY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPK--SLSKEAV 229
Query: 149 NLLSRIFVANPSRRITI-----KEIKSHPWF 174
++ + +P++R+ ++I+ H +F
Sbjct: 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 16/156 (10%)
Query: 24 IFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 83
IF S I +RDLK EN LLD +K+ DFG++K ++ +R + GTP YIAPE
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPE 198
Query: 84 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
+L + GK AD W+ G+ +Y +LVG PF E ++K + I+ P + +
Sbjct: 199 ILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY----FPKF--L 251
Query: 144 SQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
+C++L+ ++ + ++R + +K HPWF
Sbjct: 252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 61/175 (34%), Positives = 83/175 (47%), Gaps = 26/175 (14%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 91
+ +RDLKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L EY
Sbjct: 117 VIYRDLKLDNILLDAEG--HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY- 173
Query: 92 GKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150
G D W+ GV +Y M+ G PFE D ED I+ P V +S++ ++
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDDVLYP--VWLSKEAVSI 226
Query: 151 LSRIFVANPSRRI-------TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 198
L NP++R+ IK HP+F K + L E RK P F
Sbjct: 227 LKAFMTKNPNKRLGCVASQGGEDAIKQHPFF-KEIDWVLLEQ------RKIKPPF 274
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
+ I +RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L
Sbjct: 114 DKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y G D W+ GV LY ML G PFE + + F I+ + P ++ QD
Sbjct: 172 LY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTWLS--QDAV 224
Query: 149 NLLSRIFVANPSRRITI------KEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS--L 200
++L NP+ R+ + I HP+F K L E + R+ P F +
Sbjct: 225 DILKAFMTKNPTMRLGSLTLGGEEAILRHPFF-KELDWEK------LNRRQIEPPFRPRI 277
Query: 201 QSVEEITK----IVEEAKVPPPVSRSI 223
+S E+++ ++E V P+ S+
Sbjct: 278 KSREDVSNFDPDFIKEDPVLTPIEESL 304
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 45/149 (30%), Positives = 81/149 (54%), Gaps = 11/149 (7%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 91
+I HRD+K N L++ ++K+CDFG S L++S K+ VGT +Y+APE + +Y
Sbjct: 121 KIIHRDVKPSNILVNSRG--QIKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 92 GKLADVWSCGVTLYVMLVGAYPF-EDQEDPKNFRKTISRIMAVQY---KIPDYVHISQDC 147
K +D+WS G++L + G +P+ + + P + + I V ++P S D
Sbjct: 178 VK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI--VNEPPPRLPSGKF-SPDF 233
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLK 176
++ ++ + +P R + KE+ HP+ K
Sbjct: 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 59/181 (32%), Positives = 88/181 (48%), Gaps = 22/181 (12%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRRE 89
+ + +RDLKLEN +LD +KI DFG K + + K+ GTP Y+APEVL +
Sbjct: 115 KNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y G+ D W GV +Y M+ G PF +Q+ K F I+ + + P +S + ++
Sbjct: 173 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPRT--LSPEAKS 225
Query: 150 LLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVE 204
LLS + +P +R+ KEI H +F Q +Y +K P F Q
Sbjct: 226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFF-------AGIVWQDVYEKKLVPPFKPQVTS 278
Query: 205 E 205
E
Sbjct: 279 E 279
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 56/154 (36%), Positives = 79/154 (51%), Gaps = 15/154 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVL 85
S HRD+K +N LLD S LK+ DFG +K ++ R + VGTP YI+PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVL 215
Query: 86 SRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142
+ Y G+ D WS GV LY MLVG PF + K ++ ++ + PD
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDND 273
Query: 143 ISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 174
IS++ +NL+ R R ++EIK H +F
Sbjct: 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-17
Identities = 56/183 (30%), Positives = 91/183 (49%), Gaps = 22/183 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRR 88
S+ + +RD+KLEN +LD +KI DFG K + + K+ GTP Y+APEVL
Sbjct: 113 SRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+Y G+ D W GV +Y M+ G PF +Q+ + F I+ + + P +S + +
Sbjct: 171 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAK 223
Query: 149 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSV 203
+LL+ + +P +R+ KE+ H +F L+ Q + +K P F Q
Sbjct: 224 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKPQVT 276
Query: 204 EEI 206
E+
Sbjct: 277 SEV 279
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 5e-17
Identities = 48/153 (31%), Positives = 72/153 (47%), Gaps = 27/153 (17%)
Query: 35 HRDLKLENTLL--DGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREYD 91
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ + YD
Sbjct: 121 HRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-------DYVHIS 144
K AD+WS G+T + G P D P M V + IP + S
Sbjct: 177 EK-ADIWSLGITAIELAKGEPPLSDL-HP----------MRVLFLIPKNNPPSLEGNKFS 224
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
+ ++ +S +P R + KE+ H F+K
Sbjct: 225 KPFKDFVSLCLNKDPKERPSAKELLKHK-FIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 5e-17
Identities = 46/170 (27%), Positives = 70/170 (41%), Gaps = 28/170 (16%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 87
S +I HRDLK +N L++ LK+ DFG +++ + R + V T Y APE+L
Sbjct: 116 SHRILHRDLKPQNILINRD--GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQ-------------EDPKNFRK--TI 127
+ Y + D+WS G M+ G F DQ E K
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 128 SRIMAVQYKIPDYVHIS---QDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ + +LLS++ NP++RI+ KE HP+F
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-17
Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 16/171 (9%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 91
I HRD+K N L++G+ ++K+CDFG S +L+ S K+ +G +Y+APE + +
Sbjct: 123 NIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGPN 179
Query: 92 GKL-----ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HIS 144
+DVWS G+++ M +G YP+ P+ + +++ A+ P + S
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYP----PETYANIFAQLSAIVDGDPPTLPSGYS 235
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLK--NLPRELTETAQAIYYRK 193
D ++ +++ P+RR T ++ HPW +K N ++ E RK
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTGALKRK 286
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-17
Identities = 55/163 (33%), Positives = 77/163 (47%), Gaps = 27/163 (16%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----------------KSTVGT 76
I HRDLK +N L+ + +K+ DFG SK L+ K GT
Sbjct: 122 IVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 77 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136
P YIAPEV+ R+ Y GK D W+ G+ LY LVG PF + F + IS +
Sbjct: 180 PEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----DDIE 234
Query: 137 IPDYVH-ISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFL 175
P+ + D ++L+SR+ NP R+ E+K H +FL
Sbjct: 235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-16
Identities = 55/159 (34%), Positives = 74/159 (46%), Gaps = 25/159 (15%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SLLHSRPKSTVGTPAYIAP 82
S HRD+K N LL DGS +KI DFG S S K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 83 EVLS-RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--- 138
EV+ YD K AD+WS G+T + GA P+ K T+ Q P
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTL------QNDPPSLE 228
Query: 139 ---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
DY S+ R ++S +PS+R T +E+ H +F
Sbjct: 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 45/143 (31%), Positives = 75/143 (52%), Gaps = 9/143 (6%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSR-REY 90
+ HRD+K N L+ + +K+CDFG + +S +ST VGTP ++APEV++ + Y
Sbjct: 122 VIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 91 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150
D K AD+WS G+T+Y M G P+ D + FR + + ++ D S+ R
Sbjct: 180 DTK-ADIWSLGITIYEMATGNPPYSDVD---AFRAMMLIPKSKPPRLEDN-GYSKLLREF 234
Query: 151 LSRIFVANPSRRITIKEIKSHPW 173
++ P R++ +E+ W
Sbjct: 235 VAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-16
Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 26/157 (16%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPEV 84
QI HRD+K N L+D S RL+I DFG ++ L ++ +GT A++APEV
Sbjct: 123 QIIHRDVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI------P 138
L +Y G+ DVWS G + M P+ ++ S +A+ +KI P
Sbjct: 180 LRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEK--------HSNHLALIFKIASATTAP 230
Query: 139 DY-VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
H+S R++ R P R +E+ HP F
Sbjct: 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 12/147 (8%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 91
I +RDLK EN LLD + + +CDFG SK++L ++ +T GT Y+APEVL +
Sbjct: 117 IVYRDLKPENILLDATG--HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
K D WS GV ++ M G PF ++ + +R I + + P V +S + R +
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN----IAFGKVRFPKNV-LSDEGRQFV 229
Query: 152 SRIFVANPSRRI----TIKEIKSHPWF 174
+ NP R+ E+K HP+F
Sbjct: 230 KGLLNRNPQHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-16
Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 11/153 (7%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLS 86
+Q + HRD+K ++ LL DG R+K+ DFG+ ++ S R KS VGTP ++APE++S
Sbjct: 134 AQGVIHRDIKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS 189
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R Y G D+WS G+ + M+ G P+ + E P K I + + K + +S
Sbjct: 190 RLPY-GPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLK--NLHKVSPS 245
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
+ L R+ V +P++R T E+ HP+ K P
Sbjct: 246 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 51/151 (33%), Positives = 80/151 (52%), Gaps = 15/151 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRR 88
S+ I +RDLKL+N +LD +KI DFG K ++ K+ GTP YIAPE+++ +
Sbjct: 119 SKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y GK D W+ GV LY ML G PFE +++ + F+ IM P +S++
Sbjct: 177 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPK--SMSKEAV 229
Query: 149 NLLSRIFVANPSRRITI-----KEIKSHPWF 174
+ + +P +R+ ++IK H +F
Sbjct: 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 260
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-16
Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 14/150 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S I +RDLK EN LLD + + DFG K ++ H+ ST GTP Y+APEVL ++
Sbjct: 114 SLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
YD + D W G LY ML G PF + + + +++ + ++ P+ I+ R
Sbjct: 172 PYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PN---ITNSAR 224
Query: 149 NLLSRIFVANPSRRITIK----EIKSHPWF 174
+LL + + ++R+ K EIK+H +F
Sbjct: 225 HLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-16
Identities = 46/145 (31%), Positives = 76/145 (52%), Gaps = 13/145 (8%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSR 87
++I HRD+K +N L +K+ DFG ++ +L+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
R Y+ K +D+W+ G LY M + FE N + + +I+ Y P H S D
Sbjct: 176 RPYNNK-SDIWALGCVLYEMCTLKHAFE----AGNMKNLVLKIIRGSYP-PVSSHYSYDL 229
Query: 148 RNLLSRIFVANPSRRITIKEIKSHP 172
RNL+S++F NP R ++ I
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-16
Identities = 49/148 (33%), Positives = 79/148 (53%), Gaps = 15/148 (10%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 91
I +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE+++ + Y
Sbjct: 122 IIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY- 178
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
GK D W+ GV LY ML G PF+ +++ + F+ IM P +S++ ++
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPK--SLSKEAVSIC 232
Query: 152 SRIFVANPSRRITI-----KEIKSHPWF 174
+ +PS+R+ ++I+ H +F
Sbjct: 233 KGLMTKHPSKRLGCGPEGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-16
Identities = 56/156 (35%), Positives = 80/156 (51%), Gaps = 19/156 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVL 85
S + HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL
Sbjct: 160 SMGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRC--DTAVGTPDYISPEVL 215
Query: 86 SRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDY 140
+ Y G+ D WS GV L+ MLVG PF + T S+IM + + P+
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY----ADSLVGTYSKIMDHKNSLNFPED 271
Query: 141 VHISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 174
V IS+ +NL+ R R ++EIK HP+F
Sbjct: 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 49/170 (28%), Positives = 73/170 (42%), Gaps = 27/170 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S I HRDLK EN L++ LK+ DFG ++S RP + V T Y APE+L
Sbjct: 116 SHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFE-----DQ----------EDPKNFRKTISRIMAV 133
+ D+WS G +L F DQ DP+ + K S
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233
Query: 134 QYKIPDYVHI---------SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++ P + S +LLS++ +P +RIT ++ +HP+F
Sbjct: 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 41/154 (26%), Positives = 78/154 (50%), Gaps = 17/154 (11%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 91
+I HRD+K N L++ ++K+CDFG S L++S + VGT Y++PE + +Y
Sbjct: 124 RIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYT 180
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH--------- 142
K +DVWS G+++ + +G +PF + + I+ + +I V
Sbjct: 181 VK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI---VQEPPPRLPSS 236
Query: 143 -ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175
+D R+ + + +P+ R T +++ + P F+
Sbjct: 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 59/179 (32%), Positives = 84/179 (46%), Gaps = 45/179 (25%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SLLHSRPK------------ 71
HRD+K +N LLD +K+ DFG +L H+ P
Sbjct: 124 HRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 72 -------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE 118
STVGTP YIAPEV + Y+ KL D WS GV +Y ML+G PF +
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 119 DPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWF 174
+ +RK ++ + + P V IS+ ++L+ R F + RI ++EIKSHP+F
Sbjct: 241 PQETYRKVMNWKETLVF--PPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-15
Identities = 60/172 (34%), Positives = 89/172 (51%), Gaps = 14/172 (8%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLS 86
SQ + HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+S
Sbjct: 135 SQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 190
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R Y G D+WS G+ + M+ G P+ + P K + + K+ + IS
Sbjct: 191 RTPY-GTEVDIWSLGIMVIEMVDGEPPYF-SDSPVQAMKRLRD--SPPPKLKNAHKISPV 246
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLK-NLPRELTETAQAIYYRKENPT 197
R+ L R+ P R T +E+ HP+ L+ LP L Q YRK T
Sbjct: 247 LRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPLIQQ--YRKRTST 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-15
Identities = 52/150 (34%), Positives = 83/150 (55%), Gaps = 12/150 (8%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLS 86
+Q + HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+S
Sbjct: 136 NQGVIHRDIKSDSILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS 191
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R Y G D+WS G+ + M+ G P+ ++ + R+ + ++ D +S
Sbjct: 192 RLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP---RVKDSHKVSSV 247
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
R L + V PS+R T +E+ HP FLK
Sbjct: 248 LRGFLDLMLVREPSQRATAQELLQHP-FLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRRE 89
++I +RDLK EN LLD ++I D G + S+ K GTP ++APE+L E
Sbjct: 116 RRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YD + D ++ GVTLY M+ PF + + ++ RI+ PD S ++
Sbjct: 174 YDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKS 230
Query: 150 LLSRIFVANPSRRITIK-----EIKSHPWF 174
+ +P +R+ + +++HP F
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 39/105 (37%), Positives = 60/105 (57%), Gaps = 5/105 (4%)
Query: 72 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM 131
STVGTP YIAPE+ ++ Y G+ D WS G ++ L+G PF + + +RK I+
Sbjct: 207 STVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE 265
Query: 132 AVQYKIPDYVHISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 174
+ + PD +H+S + +L+ R+ +R R EIKSHP+F
Sbjct: 266 TLYF--PDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL---- 85
+ HRD+K N LLD S +K+CDFG S L+ S+ K+ + G AY+APE +
Sbjct: 134 HGVIHRDVKPSNILLDASG--NVKLCDFGIS-GRLVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VHIS 144
+YD + ADVWS G++L + G +P+++ + F + +++I+ + S
Sbjct: 191 PNPKYDIR-ADVWSLGISLVELATGQFPYKNCK--TEF-EVLTKILQEEPPSLPPNEGFS 246
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175
D + + + +R +E+ HP+
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 64/199 (32%), Positives = 99/199 (49%), Gaps = 26/199 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPAYIAPEVLS 86
S+++ HRDLK N L P +K+ DFG+SK S+ S GTP Y+APE+
Sbjct: 187 SRKMMHRDLKSANIFL--MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE 244
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R+ Y K AD+WS GV LY +L PF+ R+ + +++ +Y P +S
Sbjct: 245 RKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSG 298
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLK---NLPRELTETAQAIYYRKENPTFSLQSV 203
+ LL + NP+ R T +++ H FLK NL +++ ++ I S
Sbjct: 299 MKALLDPLLSKNPALRPTTQQL-LHTEFLKYVANLFQDIVRHSETI---------SPHDR 348
Query: 204 EEITKIVEE--AKVPPPVS 220
EEI + ++E + PPP S
Sbjct: 349 EEILRQLQESGERAPPPSS 367
|
Length = 478 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-14
Identities = 57/168 (33%), Positives = 91/168 (54%), Gaps = 13/168 (7%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLS 86
S Q+ HRD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV++
Sbjct: 133 SNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R+ Y G D+WS G+ M+ G P+ + E+P I+ + + P+ +S
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--RLSAV 244
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE 194
R+ L+R + RR + KE+ HP FLK L + L+ I KE
Sbjct: 245 FRDFLNRCLEMDVDRRGSAKELLQHP-FLK-LAKPLSSLTPLIIAAKE 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 38/178 (21%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 91
+I HRD+K N L++ +K+CDFG S L+ S S VGT +Y++PE L Y
Sbjct: 120 KIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY- 175
Query: 92 GKLADVWSCGVTLYVMLVGAYP------------FEDQEDP---KNFRKTIS-------R 129
+D+WS G++L M +G YP F K + +S R
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 130 IMAVQYKIPDYV-----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
MA+ +++ DY+ S + ++ + + NP R +KE+ HP+ +
Sbjct: 236 PMAI-FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 54/167 (32%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 91
I +RDLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +Y
Sbjct: 117 IIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 92 GKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
+ D W+ GV ++ M+ G PF+ D D I+ Q +IP +S
Sbjct: 175 FSV-DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 231
Query: 147 CRNLLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQ 187
++L +P R+ ++IKSHP+F +N+ +L E Q
Sbjct: 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF-RNIDWDLLEQKQ 277
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 49/153 (32%), Positives = 78/153 (50%), Gaps = 14/153 (9%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPAYIAPEVLSRRE- 89
I +RD+KLEN LLD + + + DFG SK R S GT Y+AP+++ +
Sbjct: 126 IIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183
Query: 90 -YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+D K D WS GV +Y +L GA PF + + + RI+ + P +S +
Sbjct: 184 GHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALAK 240
Query: 149 NLLSRIFVANPSRRI-----TIKEIKSHPWFLK 176
+++ R+ + +P +R+ EIK HP+F K
Sbjct: 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV---- 84
+ I HRD+K N L++ A +KI DFG S+ P S+VGT AY++PE
Sbjct: 186 RRHIVHRDIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTD 243
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFE--DQEDPKNFRKTISRIMAVQYKIPDY-- 140
L+ YDG D+WS GV++ +G +PF Q D S + A+ P
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCAICMSQPPEAP 297
Query: 141 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
S++ R+ +S P++R + ++ HP+ L+ P +
Sbjct: 298 ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338
|
Length = 353 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-14
Identities = 43/134 (32%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 88
S++I HRD+K N LD +KI D G +K S + + VGTP Y++PE+ +
Sbjct: 119 SKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y+ K +DVW+ GV LY G +PF D N I +I+ + P SQ
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPF----DANNQGALILKIIRGVFP-PVSQMYSQQLA 230
Query: 149 NLLSRIFVANPSRR 162
L+ + + +R
Sbjct: 231 QLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-14
Identities = 50/151 (33%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---LLHSRPKSTVGTPAYIAPEV-- 84
S+ I HRDLK +N L+D KI DFG SK S + + S G+ ++APEV
Sbjct: 126 SKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--H 142
+ Y K+ D+WS G + M G P+ D+E K ++ A IP V +
Sbjct: 184 SYSQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP--PIPPDVSMN 240
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
+S + L+ F NP R T +E+ HP+
Sbjct: 241 LSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 4e-14
Identities = 37/146 (25%), Positives = 61/146 (41%), Gaps = 12/146 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLS 86
S++ HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 123 SKKFVHRDLAARNCLVGEDL--VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
+ K +DVWS GV L+ + +GA P+ + + + + Y++P +
Sbjct: 181 DGIFTSK-SDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRK----GYRLPKPEYCPD 234
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSH 171
+ L+ + +P R T E+
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-14
Identities = 52/150 (34%), Positives = 81/150 (54%), Gaps = 12/150 (8%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLS 86
S Q+ HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV++
Sbjct: 133 SNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R+ Y G D+WS G+ M+ G P+ + E+P I+ + + P+ +S
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAI 244
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
R+ L+R + +R + KE+ HP FLK
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 54/156 (34%), Positives = 78/156 (50%), Gaps = 27/156 (17%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRR 88
HRD+K +N LLD + RL DFG S L TV GTP YI+PE+L
Sbjct: 125 HRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 89 EYDGK-----LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI---PDY 140
E DGK D WS GV +Y ML G PF + + +T +IM + PD
Sbjct: 179 E-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKEHFQFPPDV 233
Query: 141 VHISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 174
+S++ ++L+ R+ + +R R +++ K HP+F
Sbjct: 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-14
Identities = 57/178 (32%), Positives = 83/178 (46%), Gaps = 24/178 (13%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAYIAPEVLSRR 88
I +RDLKL+N LLD +K+ D+G K L RP T GTP YIAPE+L
Sbjct: 117 IIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGL---RPGDTTSTFCGTPNYIAPEILRGE 171
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDYVHI 143
+Y G D W+ GV ++ M+ G PF+ D D I+ Q +IP +
Sbjct: 172 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SL 228
Query: 144 SQDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 195
S ++L +P R+ +I+ HP+F +N+ +L E Q + K N
Sbjct: 229 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDLMEQKQVVPPFKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 36/160 (22%)
Query: 32 QICHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAPEVLS 86
++ HRD+K +N LL + +K+ DFG S S+L R + +GTP ++APEV++
Sbjct: 133 KVIHRDIKGQNILLTKNA----EVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIA 186
Query: 87 -----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 141
YD + +DVWS G+T + G P D P M +KIP
Sbjct: 187 CDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMH-P----------MRALFKIPRNP 234
Query: 142 --------HISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
+ S+ + +S + N +R ++E+ HP+
Sbjct: 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 35/85 (41%), Positives = 56/85 (65%), Gaps = 4/85 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S +I HRD+K N L++ ++K+CDFG S + L++S K+ VGT AY+APE +S +
Sbjct: 113 SLKILHRDVKPSNMLVNTRG--QVKLCDFGVS-TQLVNSIAKTYVGTNAYMAPERISGEQ 169
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPF 114
Y G +DVWS G++ + +G +P+
Sbjct: 170 Y-GIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 14/148 (9%)
Query: 31 QQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPAYIAPEVLS 86
++I HRD+K +N L +G A K+ DFG ++ L S + VGTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIARQ-LNDSMELAYTCVGTPYYLSPEICQ 175
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R Y+ K D+WS G LY + +PFE N + + +I + P + S+D
Sbjct: 176 NRPYNNK-TDIWSLGCVLYELCTLKHPFEGN----NLHQLVLKICQGYFA-PISPNFSRD 229
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWF 174
R+L+S++F +P R +I I P+
Sbjct: 230 LRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 48/162 (29%), Positives = 67/162 (41%), Gaps = 34/162 (20%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVL 85
S ++ HRDLK N LL DG +K+ DFG S + + K + +GTP ++APEV+
Sbjct: 121 SHKVIHRDLKAGNILLTLDGD----VKLADFGVS-AKNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 86 -----SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 140
YD K AD+WS G+TL + P + M V KI
Sbjct: 176 ACETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELN-----------PMRVLLKILKS 223
Query: 141 --------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
S + L V +P R T E+ HP+
Sbjct: 224 EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 43/147 (29%), Positives = 67/147 (45%), Gaps = 9/147 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSR 87
S + HRD+K N LL+ K+ DFG S L + K + +GTP ++APEV+
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQA--KLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
Y+ K AD+WS G+T M G P+ D P I P+ S +
Sbjct: 174 IGYNNK-ADIWSLGITAIEMAEGKPPYSDIH-PMRAIFMIPNKPPPTLSDPE--KWSPEF 229
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWF 174
+ + + V +P R + ++ HP+
Sbjct: 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 52/184 (28%), Positives = 71/184 (38%), Gaps = 52/184 (28%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK----STVGTPAYIAPEVLSRR 88
I HRDLK N L+ LK+ DFG ++S P V T Y APE+L
Sbjct: 123 ILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPELLFGA 177
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAV--------- 133
+ G D+WS G +L+ PF DQ + +I
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQ---------LGKIFEALGTPTEENW 227
Query: 134 --QYKIPDYV---------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
+PDYV S D +LL R+ NP++RIT ++ HP+F
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF-S 286
Query: 177 NLPR 180
N P
Sbjct: 287 NDPA 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-13
Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 19/153 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--------RPKSTVGTPAYIA 81
++ I HRD+K N L+D +KI DFG SK +S RP S G+ ++A
Sbjct: 124 NRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARP-SLQGSVFWMA 180
Query: 82 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDY 140
PEV+ + Y K AD+WS G + ML G +PF D + I +I +IP
Sbjct: 181 PEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDC----TQLQAIFKIGENASPEIPS- 234
Query: 141 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
+IS + + L + F + ++R T E+ HP+
Sbjct: 235 -NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-13
Identities = 51/148 (34%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAPEVL 85
S I HRD+K N L D A +K+ DFG SK + + +S GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
S Y G+ ADVWS G T+ ML P+ + E I +I HIS+
Sbjct: 182 SGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISE 236
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPW 173
R+ L IFV R + +E+ HP+
Sbjct: 237 HARDFLGCIFV-EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 52/176 (29%), Positives = 76/176 (43%), Gaps = 37/176 (21%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEV- 84
S + HRDLK N LL+ LKICDFG ++ + V T Y APE+
Sbjct: 124 SANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGA--YPFED----------------QEDPKNFRKT 126
L+ + Y K D+WS G L ML +P +D QED
Sbjct: 182 LNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240
Query: 127 ISR--IMAVQYKIPDYVHISQDCRN-------LLSRIFVANPSRRITIKEIKSHPW 173
+R I ++ +K V ++ N LL ++ NP +RIT++E +HP+
Sbjct: 241 RARNYIKSLPFK--PKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-13
Identities = 47/148 (31%), Positives = 82/148 (55%), Gaps = 12/148 (8%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR-- 87
QI HRD+K +N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+ +
Sbjct: 127 NQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN--FRKTISRIMAVQYKIPDYVHISQ 145
R Y G AD+WS G T+ M G PF + +P+ F+ + +I +IP+ +S
Sbjct: 186 RGY-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP---EIPE--SLSA 239
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPW 173
+ +N + R F +P +R + ++ P+
Sbjct: 240 EAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 54/192 (28%), Positives = 100/192 (52%), Gaps = 26/192 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLS 86
S+ + HRD+K N LL + +K+ DFG+SK +++ ++ GTP Y+APE+
Sbjct: 161 SKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQ 145
R+ Y K AD++S GV LY +L PF D +N + + + +A +Y +P IS
Sbjct: 219 RKPYSKK-ADMFSLGVLLYELLTLKRPF----DGENMEEVMHKTLAGRYDPLPP--SISP 271
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHP---WFLKNLPRELTETAQAIYYRKENPTFSLQS 202
+ + +++ + ++P RR + ++ + P F+ L E+ +T P FS
Sbjct: 272 EMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGL-LEIVQTQ---------PGFSGPL 321
Query: 203 VEEITKIVEEAK 214
+ I++ +++ K
Sbjct: 322 RDTISRQIQQTK 333
|
Length = 496 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-13
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
++I +RDLK EN LLD ++I D G + + VGT Y+APEV+
Sbjct: 120 RERIVYRDLKPENILLDDY--GHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER 177
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y D W G +Y M+ G PF +++ + R+ Q + + S+ R+
Sbjct: 178 Y-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARS 234
Query: 150 LLSRIFVANPSRRITIK-----EIKSHPWF 174
+ ++ +P R+ + E+K+HP+F
Sbjct: 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 5e-13
Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 13/168 (7%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLS 86
+ Q+ HRD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV++
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R+ Y G D+WS G+ M+ G P+ + E+P I+ + + P+ +S
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSPI 244
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE 194
R+ L+R + +R + KE+ HP FLK L + L+ I KE
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHP-FLK-LAKPLSSLTPLILAAKE 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-13
Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 14/144 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAPEV 84
S++I HRD+K N + + +K+ D G SK++ HS VGTP Y++PE
Sbjct: 124 SKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSPER 177
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
+ Y+ K +D+WS G LY M PF D N +I Y H S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADHYS 234
Query: 145 QDCRNLLSRIFVANPSRRITIKEI 168
++ R+L+SR +P +R I +
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-13
Identities = 52/147 (35%), Positives = 74/147 (50%), Gaps = 12/147 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAPEVL 85
S I HRD+K N L D A +K+ DFG SK + + KS GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
S Y G+ ADVWS T+ ML P+ + E K ++ + +PD +S
Sbjct: 182 SGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTKPMLPD--GVSD 236
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHP 172
CR+ L +IFV RR T + + HP
Sbjct: 237 ACRDFLKQIFVEE-KRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 6e-13
Identities = 48/173 (27%), Positives = 71/173 (41%), Gaps = 38/173 (21%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVL-SRRE 89
I HRDLK N L+ S LKI DFG ++ S V T Y APE+L R+
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------QYK-IP 138
YD D+W+ G +L G+ F + D + ++ + +P
Sbjct: 178 YDP-GVDLWAVGCIFAELLNGSPLFPGENDIEQ----LAIVFRTLGTPNEETWPGLTSLP 232
Query: 139 DYVHISQ-------------DCR----NLLSRIFVANPSRRITIKEIKSHPWF 174
DY I+ D +LL + V +PS+R++ E HP+F
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-13
Identities = 51/146 (34%), Positives = 77/146 (52%), Gaps = 14/146 (9%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV--GTPAYIAPEVLSRR 88
++I HRDLK +N L + LKI DFG S+ L+ S +T GTP Y++PE L +
Sbjct: 125 RRILHRDLKAKNIFLKNN---LLKIGDFGVSRL-LMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHISQDC 147
YD K +D+WS G LY M A+ FE Q NF + RI+ +P+ S+
Sbjct: 181 GYDSK-SDIWSLGCILYEMCCLAHAFEGQ----NFLSVVLRIVEGPTPSLPE--TYSRQL 233
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPW 173
+++ + +PS R + EI +P+
Sbjct: 234 NSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-13
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV--GTPAYIAPEVLSRR 88
HRD+K +N LLD + RL DFG +S+V GTP YI+PE+L
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRL--ADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 89 EYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--AVQYKIPDYV- 141
E G D WS GV +Y ML G PF + + +T +IM +++ P ++
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHEERFQFPSHIT 234
Query: 142 HISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 198
+S++ ++L+ R+ + + RR+ I++ K H +F + + E +A Y +
Sbjct: 235 DVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFF-EGIDWENIRNLEAPYIPDVSSPS 292
Query: 199 SLQSVEEITKIVEEAKVPPPVSRS 222
+ + ++ ++ PP S +
Sbjct: 293 DTSNFDVDDDVLRNPEIAPPSSHT 316
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-13
Identities = 49/136 (36%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAPEVL 85
S I HRD+K N L D +K+ DFG SK L + KS GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
S Y G+ AD+WS G T+ ML P+ + E K ++ +P H+S
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVLP--PHVSD 236
Query: 146 DCRNLLSRIFVANPSR 161
CR+ L RIFV R
Sbjct: 237 HCRDFLKRIFVEAKLR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 57/179 (31%), Positives = 83/179 (46%), Gaps = 45/179 (25%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SLLHSRPK------------ 71
HRD+K +N LLD +K+ DFG +L HS P
Sbjct: 124 HRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 72 -------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE 118
STVGTP YIAPEV + Y+ KL D WS GV +Y ML+G PF +
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 119 DPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWF 174
+ ++K ++ + + P V IS+ ++L+ R F RI ++EIK++P+F
Sbjct: 241 PQETYKKVMNWKETLIF--PPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 33 ICHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR- 87
+ +RDLK N LLD R+ CDF K P ++VGT Y+APEVL +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKG 170
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
YD AD +S G L+ +L G PF Q K+ + + + ++PD S +
Sbjct: 171 VAYDSS-ADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSPEL 226
Query: 148 RNLLSRIFVANPSRRITI-----KEIKSHPWF 174
R+LL + + +RR+ +E+K HP+F
Sbjct: 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 1e-12
Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRR 88
I H D+KLEN L D + R+ +CD+G K S GT Y +PE +
Sbjct: 127 KHNIIHNDIKLENVLYDRA-KDRIYLCDYGLCK----IIGTPSCYDGTLDYFSPEKIKGH 181
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQED----PKNFRKTISRIMAVQYKIPDYVHIS 144
YD D W+ GV Y +L G +PF++ ED ++ K + K+P ++S
Sbjct: 182 NYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------KLPFIKNVS 234
Query: 145 QDCRNLLSRIFVANPSRR-ITIKEIKSHPWFLKN 177
++ + + + N + R EI HP FLK
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHP-FLKI 267
|
Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 54/167 (32%), Positives = 80/167 (47%), Gaps = 16/167 (9%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 91
I +RDLKL+N LLD +K+ D+G K L ST GTP YIAPE+L EY
Sbjct: 117 IIYRDLKLDNVLLDADG--HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY- 173
Query: 92 GKLADVWSCGVTLYVMLVGAYPFE---DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
G D W+ GV ++ M+ G PF+ D D I+ +IP + +S
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKAS 231
Query: 149 NLLSRIFVANPSRRITIK------EIKSHPWFLKNLPRELTETAQAI 189
++L +P R+ + +IKSH +F +++ +L E Q
Sbjct: 232 HVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF-RSIDWDLLEKKQVT 277
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 13/143 (9%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRRE 89
I HRD+K N L + A +K+ DFG SK S + ++ VGTP Y++PE+ +
Sbjct: 122 ILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQGVK 177
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y+ K +D+W+ G LY +L F D N + +I+ Y V+ S + +
Sbjct: 178 YNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNYTPVVSVY-SSELIS 231
Query: 150 LLSRIFVANPSRRITIKEIKSHP 172
L+ + +P +R T E+ P
Sbjct: 232 LVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S I +RDLK EN LLD + + DFG K + S +T GTP Y+APEV+ ++
Sbjct: 114 SINIVYRDLKPENILLDSQG--HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
YD D W G LY ML G PF ++ + + + + + ++ P S
Sbjct: 172 PYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR---PG---ASLTAW 224
Query: 149 NLLSRIFVANPSRRITIK----EIKSHPWF 174
++L + + RR+ K EI+ HP+F
Sbjct: 225 SILEELLEKDRQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 49/150 (32%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S I +RDLK EN LLD + + DFG K + ST GTP Y+APEVL +
Sbjct: 114 SLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
YD + D W G LY ML G PF ++ + + + + + + C
Sbjct: 172 PYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA-----C- 224
Query: 149 NLLSRIFVANPSRRITIK----EIKSHPWF 174
+LL + + RR+ K EIK+H +F
Sbjct: 225 DLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 43/111 (38%), Positives = 59/111 (53%), Gaps = 17/111 (15%)
Query: 72 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRK 125
S VGTP YIAPEVL R+ Y +L D WS GV L+ MLVG PF E Q N+
Sbjct: 207 SLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN 265
Query: 126 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 174
T+ IP V +S + +L++++ + R R +IK+HP+F
Sbjct: 266 TL--------HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-12
Identities = 50/150 (33%), Positives = 83/150 (55%), Gaps = 12/150 (8%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLS 86
S Q+ HRD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R+ Y G D+WS G+ M+ G P+ + E+P I+ + + P+ +S
Sbjct: 190 RKAY-GPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAI 245
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
R+ L+R + +R + KE+ H FLK
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQ-FLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 13/149 (8%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV--GTPAYIAPEVLSRREYDG 92
HRD+K +N L+D + RL DFG + +S+V GTP YI+PE+L E DG
Sbjct: 125 HRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME-DG 181
Query: 93 K-----LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
K D WS GV +Y ML G PF + + + K ++ Q+ +S+D
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP-AQVTDVSEDA 240
Query: 148 RNLLSRIFVANPSR--RITIKEIKSHPWF 174
++L+ R+ + R + I++ K HP+F
Sbjct: 241 KDLIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 49/150 (32%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 90
++I +RDLK EN LLD ++I D G + K VGT Y+APEV+ Y
Sbjct: 121 ERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 178
Query: 91 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDYVHISQDCRN 149
D W+ G LY M+ G PF+ Q K R+ + R++ VQ + + S D R+
Sbjct: 179 TFS-PDWWALGCLLYEMIAGQSPFQ-QRKKKIKREEVERLVKEVQEEYSE--KFSPDARS 234
Query: 150 LLSRIFVANPSRRI-----TIKEIKSHPWF 174
L + +P R+ +E+K HP F
Sbjct: 235 LCKMLLCKDPKERLGCQGGGAREVKEHPLF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 47/175 (26%), Positives = 68/175 (38%), Gaps = 39/175 (22%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEV-LSR 87
+ HRDLK N L++ + LKICDFG ++ K V T Y APE+ LS
Sbjct: 124 VIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181
Query: 88 REYDGKLADVWSCGVTLYVML---------------------VGAYPFED--QEDPKNFR 124
Y K D+WS G +L +G ED + R
Sbjct: 182 SRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240
Query: 125 KTISRIMAVQYK-----IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ + K P S + +LL ++ V +P +RIT E +HP+
Sbjct: 241 NYLKSLPKKPKKPLSKLFPG---ASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 4e-12
Identities = 43/179 (24%), Positives = 67/179 (37%), Gaps = 56/179 (31%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYDG 92
HRDLK EN L+ S +KI DFG ++ + SRP T V T Y APE+L R
Sbjct: 122 HRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLRSTSYS 177
Query: 93 KLADVWSCGVTLYVMLVGAYPFE---------DQEDPKNFRKTISRIMAV---------- 133
D+W+ G ++ Y DQ + +I +V
Sbjct: 178 SPVDIWALG----CIMAELYTLRPLFPGSSEIDQ---------LYKICSVLGTPTKQDWP 224
Query: 134 ---------QYKIPDYVHI---------SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++ P + S + +L+ + +P +R T + HP+F
Sbjct: 225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-12
Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S++I HRD+K N LL +K+CDFG S L++S + GT Y+APE + +
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ--VKLCDFGVS-GELVNSLAGTFTGTSFYMAPERIQGKP 179
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQYKIP-------DYV 141
Y +DVWS G+TL + +PF + E P + +S I V P + +
Sbjct: 180 YSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI--VNMPNPELKDEPGNGI 236
Query: 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175
S++ ++ + + +P+RR T ++ HPW
Sbjct: 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 9/141 (6%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 90
++I HRDL N +L ++ I DFG +K S+ S VGT Y PE++ Y
Sbjct: 133 KRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPY 190
Query: 91 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDCRN 149
G+ ADVW+ G LY M PF N ++I+ Y+ +P+ ++ S+D +
Sbjct: 191 -GEKADVWAFGCILYQMCTLQPPFYST----NMLSLATKIVEAVYEPLPEGMY-SEDVTD 244
Query: 150 LLSRIFVANPSRRITIKEIKS 170
+++ + R I ++ +
Sbjct: 245 VITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 38/173 (21%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
S +I HRDLK +N L+ DG ++KI DFG ++ S V T Y APEVL +
Sbjct: 125 SHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ 180
Query: 88 REYDGKLADVWSCGVTLYVM--LVGAYP-----------FE-----DQED-PKN------ 122
Y + D+WS G + + F+ +E+ P+N
Sbjct: 181 SSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239
Query: 123 -FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
F R +P+ I ++ +LL ++ NP +RI+ E HP+F
Sbjct: 240 SFPSYTPRSFKSF--VPE---ICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 37/87 (42%), Positives = 53/87 (60%), Gaps = 8/87 (9%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL--SRR 88
+I HRD+K N LLD + +K+CDFG S L+ S K+ G Y+APE + S R
Sbjct: 128 KIIHRDVKPSNILLDRNGN--IKLCDFGIS-GQLVDSIAKTRDAGCRPYMAPERIDPSAR 184
Query: 89 E-YDGKLADVWSCGVTLYVMLVGAYPF 114
+ YD + +DVWS G+TLY + G +P+
Sbjct: 185 DGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 3e-11
Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 17/145 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSLLHSRPKSTVGTPAYIAPEV 84
S+ HRDL N L+ + +KI DFG Y K + ++APE
Sbjct: 121 SKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPES 175
Query: 85 LSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
L ++ K +DVWS GV L+ + +G P+ + + + + Y++P +
Sbjct: 176 LKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPG----MSNAEVLEYLKK-GYRLPKPPNC 229
Query: 144 SQDCRNLLSRIFVANPSRRITIKEI 168
+ L+ + + +P R T E+
Sbjct: 230 PPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 47/169 (27%), Positives = 71/169 (42%), Gaps = 34/169 (20%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREY 90
I HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE L Y
Sbjct: 121 IFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDGY 175
Query: 91 DGKLADVWSCGVTLYVM--LVGAYPFEDQED-----------PK---NFRKTISRIMAVQ 134
G D+W+ G + + L +P ++ D P + SR M
Sbjct: 176 YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM--N 233
Query: 135 YKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
Y P + S + +LL ++ +P RIT K+ HP+F
Sbjct: 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-11
Identities = 42/136 (30%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS----TVGTPAYIAPEVLS 86
+++ HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 119 KRVLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
Y+ K +D+WS G LY + +PF+ +++ I ++ YK P H S +
Sbjct: 174 NMPYNNK-SDIWSLGCILYELCTLKHPFQ----ANSWKNLILKVCQGSYK-PLPSHYSYE 227
Query: 147 CRNLLSRIFVANPSRR 162
R+L+ ++F NP R
Sbjct: 228 LRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 42/145 (28%), Positives = 75/145 (51%), Gaps = 12/145 (8%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPE----VLSRRE 89
HRD+K N L++ ++K+CDFG S L+ S K+ G Y+APE L+++
Sbjct: 127 HRDVKPSNVLIN--RNGQVKLCDFGIS-GYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YD K +DVWS G+T+ + G +P++ + P F++ + ++P S + ++
Sbjct: 184 YDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLPAE-KFSPEFQD 239
Query: 150 LLSRIFVANPSRRITIKEIKSHPWF 174
+++ N R E+ HP+F
Sbjct: 240 FVNKCLKKNYKERPNYPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-11
Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 28/168 (16%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVL-SRRE 89
++ HRDLK +N L++ LK+ DFG +++ + + + V T Y AP+VL R
Sbjct: 120 RVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 90 YDGKLADVWSCGVTLYVMLVGA--YPFEDQEDP--KNFR----------KTISRIMAVQY 135
Y + D+WS G + M+ G +P + ED K FR IS++ +
Sbjct: 178 YSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 136 KIPDYVHISQ---------DCRNLLSRIFVANPSRRITIKEIKSHPWF 174
P Y +LL R+ NP RI+ + HPWF
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-11
Identities = 51/173 (29%), Positives = 77/173 (44%), Gaps = 32/173 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEV-LSR 87
S + HRDLK N LL+ + LKICDFG ++ +S V T Y APE+ L+
Sbjct: 126 SANVLHRDLKPSNLLLNANC--DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC 183
Query: 88 REYDGKLADVWSCG---------------------VTLYVMLVGAYPFEDQE--DPKNFR 124
EY DVWS G + L L+G+ ED + R
Sbjct: 184 SEY-TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242
Query: 125 KTISRIMAVQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ I R + + + H + +LL ++ V +PS+RIT++E +HP+
Sbjct: 243 RYI-RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 43/106 (40%), Positives = 57/106 (53%), Gaps = 7/106 (6%)
Query: 72 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM 131
S VGTP YIAPEVL R Y +L D WS GV LY MLVG PF Q + K I+
Sbjct: 207 SLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT 265
Query: 132 AVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWF 174
++ IP +S + +L+ ++ P R+ EIK+HP+F
Sbjct: 266 SLH--IPPQAKLSPEASDLIIKL-CRGPEDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 5e-11
Identities = 35/147 (23%), Positives = 63/147 (42%), Gaps = 17/147 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSLLHSRPKSTVGTPAYIAPEV 84
S+ HRDL N L+ + +KI DFG Y K + ++APE
Sbjct: 120 SKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPES 174
Query: 85 LSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
L ++ K +DVWS GV L+ + +G P+ + + + + Y++P +
Sbjct: 175 LKEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPG----MSNEEVLEYLKN-GYRLPQPPNC 228
Query: 144 SQDCRNLLSRIFVANPSRRITIKEIKS 170
+ +L+ + + +P R T E+
Sbjct: 229 PPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-11
Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 90
++I +RDLK EN LLD ++I D G + + VGT Y+APEV++ +Y
Sbjct: 121 ERIVYRDLKPENILLDDRG--HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 91 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150
D W G +Y M+ G PF +++ + R+ Q + + S+D +++
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSI 235
Query: 151 LSRIFVANPSRRITIK-----EIKSHPWF 174
+ NP R+ + +K HP F
Sbjct: 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-11
Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 16/151 (10%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAPEV 84
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 119 ETGKIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEV 172
Query: 85 L---SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 141
+ YDGK D+W+ G+T + P D P IS+ K+ D
Sbjct: 173 AAVERKGGYDGK-CDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKE 230
Query: 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHP 172
S + + + +P +R T ++ HP
Sbjct: 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 55/178 (30%), Positives = 79/178 (44%), Gaps = 37/178 (20%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKST--VGTPAYIAPE 83
S + HRDLK N LL+ R+K+ DFG ++S P T V T Y APE
Sbjct: 125 SGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 84 VL--SRREYDGKLADVWSCGVTLYVMLVGAYPF---------------------EDQEDP 120
+L S R Y K D+WS G L ML+G F ED E
Sbjct: 183 ILLGSTR-YT-KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240
Query: 121 K-NFRKTISRIMAVQYK--IPDYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
K F T+ + + + + + + S D +LL ++ V NP++R+T +E HP+
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 47/173 (27%), Positives = 69/173 (39%), Gaps = 32/173 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL-S 86
S I HRD+K N L++ + LKICDFG ++ T V T Y APE+L
Sbjct: 121 SAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-------------AV 133
R Y + D+WS G +L F+ Q + + A
Sbjct: 179 SRHYTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237
Query: 134 QY------KIPD----YVHISQDCR---NLLSRIFVANPSRRITIKEIKSHPW 173
+ K P Y SQ +LL R+ V +P +RI+ + +HP+
Sbjct: 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRR 88
S++ HRD+K N LL S +K+ DFG + + + + + VGTP ++APEV+ +
Sbjct: 119 SEKKIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV------H 142
YD K AD+WS G+T + G P D M V + IP
Sbjct: 177 AYDSK-ADIWSLGITAIELAKGEPPNSDMHP-----------MRVLFLIPKNNPPTLTGE 224
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
S+ + + +PS R T KE+ H + +KN
Sbjct: 225 FSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 33/83 (39%), Positives = 49/83 (59%), Gaps = 4/83 (4%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 90
QI HRD+K N L++ +K+CDFG S L+ S S VGT +Y++PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 91 DGKLADVWSCGVTLYVMLVGAYP 113
+ +D+WS G++L + +G YP
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 21/152 (13%)
Query: 33 ICHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR- 87
+ +RDLK N LLD R+ CDF K P ++VGT Y+APEVL +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKG 170
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
YD AD +S G L+ +L G PF Q K+ + + V ++PD S +
Sbjct: 171 TAYDSS-ADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTVNVELPD--SFSPEL 226
Query: 148 RNLLSRIFVANPSRRITI-----KEIKSHPWF 174
++LL + + S+R+ +E+K H +F
Sbjct: 227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 49/186 (26%), Positives = 71/186 (38%), Gaps = 35/186 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSR-PKSTVGTPAYIAPEV 84
S + HRDLK N L++ L+I DFG S S H V T Y APE+
Sbjct: 125 SANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 85 L-SRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTIS- 128
L S EY + D+WS G ML +P ++ + I
Sbjct: 183 LLSLPEYTTAI-DMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241
Query: 129 -RIMAVQYKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178
R+ +P + S + +LLS++ +P RIT+++ HP FL
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP-FLAQY 300
Query: 179 PRELTE 184
E
Sbjct: 301 HDPDDE 306
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 90
Q+I HRD+K EN ++ ++ I D G ++ ++ GT APEVL+R +Y
Sbjct: 176 QRIIHRDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKY 233
Query: 91 DGKLADVWSCGVTLYVMLVGAYPFEDQEDP 120
+ K AD+WS G+ L+ ML AYP EDP
Sbjct: 234 NSK-ADIWSAGIVLFEML--AYPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-10
Identities = 44/180 (24%), Positives = 69/180 (38%), Gaps = 53/180 (29%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL-SRREY 90
I HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+L Y
Sbjct: 129 IIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 91 DGKLADVWSCG---------------------VTLYVMLVGA-----YP----------F 114
D+W+ G + L + L+G +P F
Sbjct: 187 T-TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245
Query: 115 EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ P N K + +S+ LL+ + + +P +R T +E +F
Sbjct: 246 TLPKQPYNNLK------------HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-10
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 11/153 (7%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 90
+ +RDLK EN LLD ++I D G + + VGT Y+APEVL+ + Y
Sbjct: 121 ENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 91 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150
D W G +Y M+ G PF +++ + R++ + S++ +++
Sbjct: 179 -TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSI 235
Query: 151 LSRIFVANPSRRITIK-----EIKSHPWFLKNL 178
+ +P +R+ + E+K HP F +N+
Sbjct: 236 CKMLLTKDPKQRLGCQEEGAGEVKRHP-FFRNM 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-10
Identities = 56/168 (33%), Positives = 80/168 (47%), Gaps = 19/168 (11%)
Query: 32 QICHRDLKLENTL--LDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVL--- 85
+I HRDLK N L LDG +K+ DFG S K++ R S +GTP ++APEV+
Sbjct: 123 KIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 86 --SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
R YD K ADVWS G+TL + + P + +P I++ P
Sbjct: 179 TSKDRPYDYK-ADVWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS--RW 234
Query: 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFL--KNLP-RELTETAQA 188
S + ++ L + N R T ++ HP+ N P REL A+A
Sbjct: 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAKA 282
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-10
Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 17/148 (11%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRRE 89
+ I HRDLK +N L + +K+ D G ++ ST +GTP Y++PE+ S +
Sbjct: 121 KHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP 178
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP----DYVHISQ 145
Y+ K +DVW+ G +Y M + F + K+ + RI ++ K+P DY S
Sbjct: 179 YNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDY---SP 228
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPW 173
+ L++ + P +R ++K I P+
Sbjct: 229 ELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 8e-10
Identities = 49/176 (27%), Positives = 73/176 (41%), Gaps = 36/176 (20%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEVL 85
S I HRD+K EN L+ S + LK+CDFG++++ L +RP S V T Y APE+L
Sbjct: 118 SHNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELL 173
Query: 86 -SRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDP-----KNFRKTISRIMAVQY-- 135
Y GK DVW+ G + +L G +P + D K +
Sbjct: 174 VGDTNY-GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232
Query: 136 ------KIPDYVH---ISQDCRNLLSRI---FVAN-----PSRRITIKEIKSHPWF 174
P+ + + +S F+ P R+T E+ HP+F
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-10
Identities = 43/141 (30%), Positives = 64/141 (45%), Gaps = 14/141 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAPEV 84
S+++ HRD+K N + + +K+ D G SK++ HS VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPER 177
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
+ Y+ K +D+WS G LY M PF D N +I Y H S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 145 QDCRNLLSRIFVANPSRRITI 165
+ R L+S +P +R I
Sbjct: 235 EKLRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 55/171 (32%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEV-- 84
S +I HRDLK N LL DG +K+ DFG S K+ R S +GTP ++APEV
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 85 ---LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 141
+ YD K AD+WS G+TL + + P + +P I++ P
Sbjct: 184 CETMKDTPYDYK-ADIWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS-- 239
Query: 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK---NLP-RELTETAQA 188
S + R+ L +P R + ++ HP+ N P REL A+A
Sbjct: 240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVAEAKA 290
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 33/83 (39%), Positives = 49/83 (59%), Gaps = 4/83 (4%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 90
+I HRD+K N L++ +K+CDFG S L+ S S VGT +Y++PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 91 DGKLADVWSCGVTLYVMLVGAYP 113
+ +D+WS G++L M +G YP
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 31/170 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV-LSRR 88
S + HRDLK N L++ + LKICDFG ++ + + V T Y APE+ L+ +
Sbjct: 126 SAGVVHRDLKPSNILINENC--DLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQ 181
Query: 89 EYDGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTISRIMAVQ 134
+YD ++ D+WS G ML G +P +D + P + TI ++
Sbjct: 182 KYDVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240
Query: 135 Y--------KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
+ +P + + +LL ++ V +P +RI+ E +HP+
Sbjct: 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 35/172 (20%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVL-SRRE 89
I HRDLK N LL + LKICDFG ++ S L + V T Y APE+L +E
Sbjct: 127 ILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGAKE 183
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFR-------------KTISRIM 131
Y + D+WS G +L F DQ + K F+ +
Sbjct: 184 YSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLN-KIFKLLGTPTEKIWPGFSELPGAK 241
Query: 132 AVQYKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ Y + +S + +LL+R+ +P++RI+ ++ HP+F
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLS-R 87
+ +I HRD+K N LL +K+ DFG S + R ++VGTP ++APEV++
Sbjct: 146 NNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203
Query: 88 REYDGKL---ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
++YD DVWS G+T + G P D K K I R P +H
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPP-----PTLLHPE 257
Query: 145 QDCR---NLLSRIFVANPSRRITIKEIKSHPWFLK 176
+ CR + +S+ + + R ++ + HP F+K
Sbjct: 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHP-FIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-09
Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRRE 89
++ HRD+K +N LL + +K+ DFG S R + +GTP ++APEV++ E
Sbjct: 130 HKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 90 -----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
YD K +D+WS G+T M GA P D P I R A + K + S
Sbjct: 188 NPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW---S 242
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKSHPW 173
+ ++ + V N S+R T +++ HP+
Sbjct: 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 39/173 (22%), Positives = 66/173 (38%), Gaps = 31/173 (17%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL-S 86
S I HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 118 SNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFE---DQE------------DPKNFRKTISRIM 131
Y ++ D+WS G L + +G F+ + E +N+
Sbjct: 176 ATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234
Query: 132 AVQYKIP--------DYVH--ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
K ++ I +LL ++ +P +RI+ + H +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 14/138 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAPEV 84
S+++ HRD+K N + + +K+ D G SK++ HS VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPER 177
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
+ Y+ K +D+WS G LY M PF D N +I Y H S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 145 QDCRNLLSRIFVANPSRR 162
++ R L++ +P +R
Sbjct: 235 EELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 50/174 (28%), Positives = 74/174 (42%), Gaps = 36/174 (20%)
Query: 30 SQQICHRDLKLENTLLDGSPAPR---LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV-L 85
S+ ICHRDLK +N L+D P LK+CDFG +K+ L R S + + Y APE+ L
Sbjct: 188 SKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML 243
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS----------RIMAVQY 135
Y + D+WS G + M++G F Q + I + M Y
Sbjct: 244 GATNYTTHI-DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY 302
Query: 136 ---KIPDYVHISQDCR------------NLLSRIFVANPSRRITIKEIKSHPWF 174
K PD +D + N +S+ P +R+ E + P+F
Sbjct: 303 ADIKFPDVK--PKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 53/173 (30%), Positives = 82/173 (47%), Gaps = 34/173 (19%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL-SR 87
S ++ HRDLK +N L+D A LK+ DFG +++ + R + V T Y APE+L
Sbjct: 117 SHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGS 174
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMA---------VQYKI 137
R+Y + D+WS G M+ F D E + FR I R + V +
Sbjct: 175 RQYSTPV-DIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVTS-L 230
Query: 138 PDYV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
PDY ++ +D +LLS++ V +P++RI+ K HP+F
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 5e-09
Identities = 34/148 (22%), Positives = 60/148 (40%), Gaps = 16/148 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
S+ HRDL N L+ + +KI DFG S+ ++ + APE
Sbjct: 120 SKNFVHRDLAARNCLVTENL--VVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
L ++ K +DVWS GV L+ + +G P+ + + Y++P +
Sbjct: 176 LKDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-----YRLPRPENC 229
Query: 144 SQDCRNLLSRIFVANPSRRITIKEIKSH 171
+ L+ + + +P R T E+
Sbjct: 230 PDELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-09
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 25/157 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 87
S++ HRD+K N LL S +K+ DFG + L ++ K VGTP ++APEV+ +
Sbjct: 119 SEKKIHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDY 140
YD K AD+WS G+T + G P + PKN T+
Sbjct: 176 SAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG----------- 223
Query: 141 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
+ S+ + + PS R T KE+ H + ++
Sbjct: 224 -NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 46/169 (27%), Positives = 69/169 (40%), Gaps = 36/169 (21%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKST-VGTPAYIAPEVLSRRE 89
HRD+K N LL+ ++K+ DFG Y+ SRP + V T Y PE+L E
Sbjct: 139 HRDIKCSNILLNNKG--QIKLADFGLARLYNSEE---SRPYTNKVITLWYRPPELLLGEE 193
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------- 130
G DVWSCG L + F+ ++ + ISR+
Sbjct: 194 RYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLCGSPCPAVWPDVIKLPYFN 252
Query: 131 ---MAVQYK---IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
QY+ ++ I +LL + +PS+R T +E + PW
Sbjct: 253 TMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 8e-09
Identities = 39/117 (33%), Positives = 56/117 (47%), Gaps = 21/117 (17%)
Query: 31 QQICHRDLKLENTLLDG---------------SPAPRLKICDFGYSKSSLLHSRPKSTVG 75
+++ HRDLK +N L + P KI DFG SK+ + S S VG
Sbjct: 144 ERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVG 203
Query: 76 TPAYIAPEVL--SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 130
TP Y +PE+L + YD K +D+W+ G +Y + G PF NF + IS +
Sbjct: 204 TPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFHKA---NNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 49/180 (27%), Positives = 70/180 (38%), Gaps = 44/180 (24%)
Query: 30 SQQICHRDLKLENTL--LDGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYI 80
S + HRDLK N L D LKICDFG ++ P V T Y
Sbjct: 123 SANVLHRDLKPGNLLVNADC----ELKICDFGLARG--FSENPGENAGFMTEYVATRWYR 176
Query: 81 APEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED---------------PKNFR 124
APE+ LS + Y K DVWS G L L+G P +D +
Sbjct: 177 APEIMLSFQSYT-KAIDVWSVGCIL-AELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234
Query: 125 KTISRIMAVQY--KIPDYVHI---------SQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
I A Y +P+ + +LL ++ +P++RI+++E HP+
Sbjct: 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 30/171 (17%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 88
S ++ HRDLK +N L++ A +K+ DFG +++ + R + V T Y APE+L
Sbjct: 118 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 175
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQ--------YKIPD 139
+Y D+WS G M+ F D E + FR I R + +PD
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSLPD 233
Query: 140 YV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
Y + +D R+LLS++ +P++RI+ K +HP+F
Sbjct: 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 34/77 (44%), Positives = 45/77 (58%), Gaps = 9/77 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LS 86
S + HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV +
Sbjct: 133 SHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMD 187
Query: 87 RREYDGKLADVWSCGVT 103
+YDGK DVWS G+T
Sbjct: 188 EGQYDGK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 22/112 (19%)
Query: 22 PDIFFSSLSQQI------------CHRDLKLENTLLDGSPAPRLKICDFGYSKS------ 63
P+ F ++QI HRD+K N +L P +K+ DFG ++
Sbjct: 100 PEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML--MPNGIIKLIDFGCARRLAWVGL 157
Query: 64 SLLHSRP-KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 114
HS KS GTP ++APEV++ Y G+ +D+WS G T++ M G P
Sbjct: 158 HGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 47/179 (26%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV-LS 86
S I HRDLK N ++ LKI DFG ++ H+ + T V T Y APE+ L+
Sbjct: 136 SAGIIHRDLKPSNIAVNEDC--ELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLN 189
Query: 87 RREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKNFRKTISRIMAV----------- 133
Y+ + D+WS G + +L G +P D D + RIM +
Sbjct: 190 WMHYN-QTVDIWSVGCIMAELLTGKTLFPGSDHID------QLKRIMNLVGTPDEELLQK 242
Query: 134 --------------QYKIPDYVHI----SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
Q D+ + + +LL ++ V +P +RIT E +HP+
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 49/155 (31%), Positives = 71/155 (45%), Gaps = 23/155 (14%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S++ HRD+K N LL S +K+ DFG + ++T VGTP ++APEV+ +
Sbjct: 119 SERKIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYV 141
YD K AD+WS G+T + G P D PKN T+ QY P +
Sbjct: 177 AYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG----QYSKP-FK 230
Query: 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
+ C N +P R T KE+ H + +
Sbjct: 231 EFVEACLN-------KDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 36/174 (20%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL--S 86
S+++ HRDLK +N L+D +K+ DFG +++ + R + V T Y APEVL S
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPF--EDQEDPKNFRKTISRIMAVQ--------YK 136
R Y + D+WS G T++ + P D E + FR I RI+
Sbjct: 177 PR-YSTPV-DIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTEDVWPGVTS 231
Query: 137 IPDY----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+PDY ++ +D +LL ++ + +P++RI+ K+ +HP+F
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 88
+ ++ HRD+K +N LL + +K+ DFG S R + +GTP ++APEV++
Sbjct: 139 AHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196
Query: 89 E-----YDGKLADVWSCGVTLYVMLVGAYPFED 116
E YD + +D+WS G+T M GA P D
Sbjct: 197 ENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-08
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 9/156 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I +RD+K EN LLD RL D G + GT Y+APE+L
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y + D ++ G ++Y M+ G PF+D ++ + R + + K ++ + +++ ++
Sbjct: 171 YSYPV-DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKD 228
Query: 150 LLSRIFVANPSRRITIKEIKSHP---WFLK--NLPR 180
+ P R+ +E P F K N PR
Sbjct: 229 ICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 39/180 (21%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I HRDLK N ++ LKI DFG ++++ + V T Y APEV+
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 198
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------- 130
Y + D+WS G + ++ G+ F+ + + K I ++
Sbjct: 199 YKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV 257
Query: 131 --------MAVQYKIPDYVHISQD---------CRNLLSRIFVANPSRRITIKEIKSHPW 173
++ + PD++ S+ R+LLS++ V +P +RI++ E HP+
Sbjct: 258 ENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 29/171 (16%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 87
S + HRDLK +N L++ + LK+ DFG +++ + R S V T Y P+VL
Sbjct: 117 SHNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 174
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPD 139
+ Y + D+WS G + P D + K I R++ K+PD
Sbjct: 175 KLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233
Query: 140 YV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
Y ++ R+LL + V NP +RI+ +E HP+F
Sbjct: 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 35/103 (33%), Positives = 47/103 (45%), Gaps = 11/103 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEV 84
SQ+ HRDL N L++ +KI DFG +K L + V P + APE
Sbjct: 127 SQRYIHRDLAARNILVESED--LVKISDFGLAKV-LPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 127
L ++ +DVWS GVTLY + Y Q P F + I
Sbjct: 184 LRTSKFSSA-SDVWSFGVTLYELF--TYGDPSQSPPAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-08
Identities = 33/77 (42%), Positives = 46/77 (59%), Gaps = 9/77 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LS 86
S + HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV +
Sbjct: 139 SHNMIHRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMD 193
Query: 87 RREYDGKLADVWSCGVT 103
+YDGK+ DVWS G+T
Sbjct: 194 EGQYDGKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-08
Identities = 33/77 (42%), Positives = 47/77 (61%), Gaps = 9/77 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LS 86
S + HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV +
Sbjct: 143 SHNMIHRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMD 197
Query: 87 RREYDGKLADVWSCGVT 103
+YDGK+ DVWS G+T
Sbjct: 198 EGQYDGKV-DVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 42/194 (21%), Positives = 67/194 (34%), Gaps = 52/194 (26%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKS------TVGTPAYIA 81
S + HRDLK N L+ +G +KI D G ++ L ++ K V T Y A
Sbjct: 126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVTIWYRA 183
Query: 82 PEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPK------------------ 121
PE+ L R Y K D+W+ G +L F+ + K
Sbjct: 184 PELLLGARHYT-KAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLG 242
Query: 122 -----------------NFRKTISRIMAVQYKIPDYVHI----SQDCRNLLSRIFVANPS 160
K + ++ +LL ++ +P+
Sbjct: 243 TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPT 302
Query: 161 RRITIKEIKSHPWF 174
+RIT +E HP+F
Sbjct: 303 KRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 133
+GTP Y+APE+L + + G D W+ GV L+ L G PF D+ + F+ ++R
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR---- 595
Query: 134 QYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
IP +S + +N + + +P++R +KE+K HP F
Sbjct: 596 --DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 31/172 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 88
S ++ HRDLK +N L+D LK+ DFG +++ + R + V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPF--EDQEDPKNFRKTISRIMAVQYK--------IP 138
+ D+WS G ++ +V P D E + F+ I RI+ + +P
Sbjct: 179 RHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPGVTSLP 235
Query: 139 DYVH----------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
DY + +LLS++ +PS+RIT + H +F
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 8/143 (5%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEV--LSRREYD 91
HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV + R+
Sbjct: 129 HRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQYKIPDYVHISQDCRNL 150
+L D+W+ G+T + P D + F T S K+ D + S +
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--KLKDKMKWSNSFHHF 244
Query: 151 LSRIFVANPSRRITIKEIKSHPW 173
+ NP +R T +++ HP+
Sbjct: 245 VKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 59/230 (25%), Positives = 90/230 (39%), Gaps = 64/230 (27%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
S I HRDLK N ++ D + LKI DFG ++++ V T Y APEV+
Sbjct: 136 SAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 191
Query: 88 REYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKNFRKTISR--------IMAVQYKI 137
Y + D+WS G + M+ G +P D D N K I + + +Q +
Sbjct: 192 MGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWN--KIIEQLGTPSDEFMSRLQPTV 248
Query: 138 PDYVH-----------------------------ISQDCRNLLSRIFVANPSRRITIKEI 168
+YV + R+LLS++ V +P +RI++ +
Sbjct: 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308
Query: 169 KSHP----WFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 214
HP W+ P E+ A Y S++E VEE K
Sbjct: 309 LQHPYINVWY---DPSEVEAPPPAPYD---------HSIDEREHTVEEWK 346
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 31/83 (37%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 87
S I HRD+K EN L+ S + +K+CDFG+++ +L T V T Y APE+L
Sbjct: 118 SHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVG 174
Query: 88 REYDGKLADVWSCGVTLYVMLVG 110
G+ D+W+ G + ML G
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 32/77 (41%), Positives = 45/77 (58%), Gaps = 9/77 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LS 86
S + HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV +
Sbjct: 133 SHNMIHRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMD 187
Query: 87 RREYDGKLADVWSCGVT 103
+YDGK+ DVWS G+T
Sbjct: 188 EGQYDGKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 38/146 (26%), Positives = 59/146 (40%), Gaps = 16/146 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVL 85
Q HRDL N L+ K+ DFG ++ L S K + APE
Sbjct: 122 EQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAA 176
Query: 86 SRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
S + K +DVWS G+ LY + G P+ N + +I A Y++P
Sbjct: 177 SHGTFSTK-SDVWSFGILLYEMFTYGQVPYPG----MNNHEVYDQITA-GYRMPCPAKCP 230
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKS 170
Q+ ++ + A P R + K ++
Sbjct: 231 QEIYKIMLECWAAEPEDRPSFKALRE 256
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 6/140 (4%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYDG- 92
HRD+K N LL + +K+ DFG + K + ++ KS +GTP ++APEV + + G
Sbjct: 129 HRDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 93 -KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
+L D+W+ G+T + P D P +S+ K+ D S N +
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLH-PMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV 245
Query: 152 SRIFVANPSRRITIKEIKSH 171
NP +R T + + +H
Sbjct: 246 KISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-07
Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 17/153 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPAY-IAPEVL 85
S+Q HRDL N L++ ++KI DFG +K+ + K + +P + APE L
Sbjct: 127 SRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 86 SRREYDGKLADVWSCGVTLYVMLV----GAYP---FEDQEDPKNFRKTISRIMAV---QY 135
+ ++ +DVWS GVTLY +L + P F P + + T++R++ V
Sbjct: 185 IQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 136 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 168
++P + ++ L+ + + PS+R T + +
Sbjct: 244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 34/174 (19%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEVL 85
HRD+K EN L+ + ++K+CDFG+++ + + P V T Y APE+L
Sbjct: 118 KHNCIHRDVKPENILI--TKQGQIKLCDFGFAR---ILTGPGDDYTDYVATRWYRAPELL 172
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDP-----KNFRKTISRIMAV----Q 134
G DVW+ G +L G +P + D K I R + Q
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232
Query: 135 Y----KIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ IP+ + +IS + L +P+ R++ +E+ HP+F
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-07
Identities = 48/168 (28%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 92
I HRDLK N L + LKI DFG ++ + S V T Y APEV+ +
Sbjct: 139 IIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVILNWMHYT 194
Query: 93 KLADVWSCGVTLYVMLVGAYPFE-----DQ---------------------EDPKNFRKT 126
+ D+WS G + ML G F+ DQ ED KN+ K
Sbjct: 195 QTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKK 254
Query: 127 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ R ++ + + N+L ++ V + RIT E +HP+F
Sbjct: 255 LPRFRKKDFRSL-LPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 30/168 (17%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREYD 91
+ HRDLK +N L+D LKI D G ++ S+ + T Y APEVL +
Sbjct: 131 VMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHY 189
Query: 92 GKLADVWSCGVTLYVMLVGAYPF----EDQEDPKNFR-------KTISRIMAVQ------ 134
D+WS G M F E Q+ F+ + + ++
Sbjct: 190 STPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFP 249
Query: 135 --------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+PD +S + +LL ++ +P++RI+ K +HP+F
Sbjct: 250 QWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 43/182 (23%), Positives = 76/182 (41%), Gaps = 47/182 (25%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG----------------YSKSSLLHSR---P 70
S+ + HRDLK +N LL + I D+G + ++ +S P
Sbjct: 131 SKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIP 188
Query: 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 130
VGTP Y+APE L D+++ GV LY ML ++P+ K RK
Sbjct: 189 GKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR----KKGRK----- 238
Query: 131 MAVQYKIPDYVHIS--QDCRNLLSRI----FVANPSRRIT-----IKEIKSH-----PWF 174
++ + I + ++ ++ LS+I +P+ R + ++++ H W
Sbjct: 239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEWT 298
Query: 175 LK 176
+K
Sbjct: 299 VK 300
|
Length = 932 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 29/82 (35%), Positives = 42/82 (51%), Gaps = 7/82 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTP-AYIAPEVL 85
S++ HRDL N LL + ++KI DFG ++ H + + P A+ APE L
Sbjct: 115 SKRFIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 86 SRREYDGKLADVWSCGVTLYVM 107
R + +DVW GVTL+ M
Sbjct: 173 RTRTFS-HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 33/90 (36%), Positives = 46/90 (51%), Gaps = 11/90 (12%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 87
+ HRDL N L+ +P +KI DFG +K LL K ++A E +
Sbjct: 130 LVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 88 REYDGKLADVWSCGVTLY-VMLVGAYPFED 116
R Y K +DVWS GVT++ +M GA P+E
Sbjct: 186 RIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 32/173 (18%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRR 88
Q I HRDLK +N L+ S LK+ DFG +++ + S+ S+ V T Y P+VL
Sbjct: 122 QHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT 179
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------KIPDY 140
+Y L D+W G ML G F D + I ++ V K+P+Y
Sbjct: 180 DYSSAL-DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238
Query: 141 ------------VHISQD-------CRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ + +L S++ + P RI+ ++ HP+F
Sbjct: 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 23/152 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----KSTVGTP-AYIAPEV 84
S++ HRDL N LL S +KICDFG ++ ++ P K P ++APE
Sbjct: 191 SRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDARLPLKWMAPES 246
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFE----DQEDPKNFRKTISRIMAVQYKIPD 139
+ + Y + +DVWS GV L+ + +GA P+ D+E + ++ +R+ A +Y P+
Sbjct: 247 IFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-TRMRAPEYATPE 304
Query: 140 YVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171
I DC + NP R T E+
Sbjct: 305 IYSIMLDC-------WHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 46/174 (26%), Positives = 68/174 (39%), Gaps = 32/174 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 87
+++ HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VL
Sbjct: 121 QRRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGS 178
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------------- 132
EY L D+W G Y M G F D ++ I R++
Sbjct: 179 TEYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237
Query: 133 -VQYKIPDY------VHISQ-----DCRNLLSRIFVANPSRRITIKEIKSHPWF 174
Y P Y H + L + P +RI+ E HP+F
Sbjct: 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 42/182 (23%), Positives = 65/182 (35%), Gaps = 47/182 (25%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG--------YSKSSLLHSRPKSTVGTPAYIA 81
S + HRDLK N ++ + LKI DFG YS L + T Y +
Sbjct: 132 SANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYL----SEGLVTKWYRS 186
Query: 82 PE-VLSRREYDGKLADVWSCGVTLYVMLVG------------------AYPFEDQEDPKN 122
P +LS Y K D+W+ G ML G + P +ED
Sbjct: 187 PRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED--- 242
Query: 123 FRKTISRIMAVQYKIPD-YVH---------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 172
R + ++ + ++ + + L +I NP R+T +E HP
Sbjct: 243 -RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301
Query: 173 WF 174
+
Sbjct: 302 YM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-06
Identities = 38/103 (36%), Positives = 48/103 (46%), Gaps = 11/103 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPAY-IAPEVL 85
SQ HRDL N LLD +KI DFG +K+ + R + +P + A E L
Sbjct: 125 SQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 86 SRREYDGKLA-DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 127
+E A DVWS GVTLY +L Q PK F + I
Sbjct: 183 --KENKFSYASDVWSFGVTLYELLTHCDSK--QSPPKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-06
Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 35/174 (20%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRR 88
+++ HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P++L
Sbjct: 123 RKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 89 EYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKNFRKTISRIMA-------------- 132
+Y ++ D+W G Y M G +P E+ +F I RI+
Sbjct: 181 DYSTQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNE 236
Query: 133 --VQYKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175
Y P Y + D LLS++ +RI+ +E HP+F
Sbjct: 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-06
Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 14/144 (9%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRRE--- 89
HRD+K N LL + +K+ DFG S +S R ++VGTP ++APEV++ +
Sbjct: 147 HRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAPEVIACEQQLD 203
Query: 90 --YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
YD + DVWS G+T + G P D + K I R P+ S +
Sbjct: 204 STYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNPPPTLHQPEL--WSNEF 259
Query: 148 RNLLSRIFVANPSRRITIKEIKSH 171
+ + + + +R T+ ++ H
Sbjct: 260 NDFIRKCLTKDYEKRPTVSDLLQH 283
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 35/115 (30%), Positives = 52/115 (45%), Gaps = 8/115 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 87
+++ HRD+KLEN L+ L DFG + VGT A +PE+L+
Sbjct: 285 DKKLIHRDIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342
Query: 88 REYDGKLADVWSCGVTLYVMLVGAY-PFED--QEDPKNFRKTISRIMAVQYKIPD 139
Y ++ D+WSCG+ L ML + P D + K K I + + PD
Sbjct: 343 DGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD 396
|
Length = 501 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 38/128 (29%), Positives = 64/128 (50%), Gaps = 16/128 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----KSTVGTP-AYIAPEV 84
S++ HRDL N LL S +KICDFG ++ ++ P K + P ++APE
Sbjct: 192 SRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSARLPLKWMAPES 247
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFE----DQEDPKNFRKTISRIMAVQYKIPD 139
+ + Y + +DVWS GV L+ + +GA P+ ++E + + +R+ A + P+
Sbjct: 248 IFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG-TRMRAPENATPE 305
Query: 140 YVHISQDC 147
I C
Sbjct: 306 IYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 31/171 (18%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRRE 89
I HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+L
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 90 YDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPK-NFRKTISRIMAVQYKI--------- 137
Y GK D+WS G L + G +P E + D +K + + A Q K+
Sbjct: 178 Y-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 138 ---PDYVH-----------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
P H +S +L+ + NP+ R ++ +HP F
Sbjct: 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLS 86
S+Q HRDL N L+D +K+ DFG S+ +L S+VG+ + PEVL
Sbjct: 118 SKQFIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLL 174
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFE 115
++ K +DVW+ GV ++ V +G P+E
Sbjct: 175 YSKFSSK-SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 40/145 (27%), Positives = 66/145 (45%), Gaps = 11/145 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPA-YIAPEVLS 86
S+ HRDL N LL + +KICDFG ++ + S K P ++APE +
Sbjct: 159 SKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
Y +DVWS G+ L+ + +G+ P+ F K I Y++ H
Sbjct: 217 NCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQPEHAPA 271
Query: 146 DCRNLLSRIFVANPSRRITIKEIKS 170
+ +++ + A+P +R T K+I
Sbjct: 272 EIYDIMKTCWDADPLKRPTFKQIVQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 46/172 (26%), Positives = 72/172 (41%), Gaps = 33/172 (19%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 87
S I HRDLK N L + LKI DFG ++ H+ + T V T Y APE++
Sbjct: 138 SADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLN 191
Query: 88 REYDGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTISRIMAV 133
+ + D+WS G + +L G +P D D K IS A
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251
Query: 134 QY-----KIPD------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
Y ++P ++ + +LL ++ V + +RIT + +H +F
Sbjct: 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 39/183 (21%), Positives = 60/183 (32%), Gaps = 42/183 (22%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGY------SKSSLLHSRPKST------VGTP 77
I HRD+K N L+D LKI DFG + T V T
Sbjct: 133 ENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190
Query: 78 AYIAPE-VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--- 133
Y PE +L R Y D+W G M + + D I ++
Sbjct: 191 WYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL-IFKLCGTPTE 248
Query: 134 --------------QYKIPDYV--------HISQDCRNLLSRIFVANPSRRITIKEIKSH 171
+ +Y + + +LLS++ +P +R+T + H
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308
Query: 172 PWF 174
P+F
Sbjct: 309 PYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 20/147 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVG-TPA-YIAPEV 84
S++ HRDL N L+ + +KI DFG ++ +H K+T G P ++APE
Sbjct: 150 SKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--IHHIDYYRKTTNGRLPVKWMAPEA 205
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFR--KTISRIMAVQYKIPDYV 141
L R Y + +DVWS GV L+ + +G P+ + F+ K R+ Q +
Sbjct: 206 LFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELY 264
Query: 142 HISQDCRNLLSRIFVANPSRRITIKEI 168
H+ +DC + PS+R T K++
Sbjct: 265 HLMRDC-------WHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 45/180 (25%), Positives = 71/180 (39%), Gaps = 39/180 (21%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------MAVQYKIPDYV 141
Y + D+WS G + M+ G F + + K I ++ +Q + YV
Sbjct: 202 YKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 142 H----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
+ R+LLS++ V + S+RI++ E HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 53/186 (28%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-----VGTPAYIAP 82
+I HRD+K N L+ DG LK+ DFG +++ L K V T Y P
Sbjct: 137 RNKILHRDMKAANILITKDGI----LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192
Query: 83 EV-LSRREYDGKLADVWSCG---------------------VTLYVMLVGA-----YP-- 113
E+ L R+Y G D+W G +TL L G+ +P
Sbjct: 193 ELLLGERDY-GPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGV 251
Query: 114 -----FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 168
F+ E P+ ++ V+ ++ YV +L+ ++ V +P++RI
Sbjct: 252 DKLELFKKMELPQGQKR------KVKERLKPYVK-DPHALDLIDKLLVLDPAKRIDADTA 304
Query: 169 KSHPWF 174
+H +F
Sbjct: 305 LNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 27/150 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEVLSRR 88
+ HRDL N L+ K+ DFG +K +S K V + APE L +
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVA--KVSDFGLAKEASQGQDSGKLPV---KWTAPEALREK 174
Query: 89 EYDGKLADVWSCGVTLY-VMLVG--AYPFEDQED-----PKNFRKTISRIMAVQYKIPDY 140
++ K +DVWS G+ L+ + G YP +D K +R M P
Sbjct: 175 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR------MEAPEGCPPE 227
Query: 141 VHISQDCRNLLSRIFVANPSRRITIKEIKS 170
V+ ++ + +P++R T K+++
Sbjct: 228 VY------KVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 21/153 (13%)
Query: 28 SLSQQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 86
+L ++ I RDL N LLD +L +S+ S + Y APEV
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTY----FSRWSEVEDSCDGEAVENMYCAPEVGG 155
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
E + + D WS G L+ +L G E N T++ IP+ +S++
Sbjct: 156 ISE-ETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN--------IPE--WVSEE 204
Query: 147 CRNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
R+LL ++ NP+ R+ +++IKSHP+F
Sbjct: 205 ARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 35/128 (27%), Positives = 58/128 (45%), Gaps = 11/128 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLS 86
S+ HRDL N L+ +KICDFG ++ + S ST ++APE +
Sbjct: 257 SKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF 314
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
Y L+DVWS G+ L+ + +G P+ + + F I R Y++ H S
Sbjct: 315 NNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR----GYRMAKPAHASD 369
Query: 146 DCRNLLSR 153
+ ++ +
Sbjct: 370 EIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 53/186 (28%), Positives = 79/186 (42%), Gaps = 40/186 (21%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-LSRREY 90
I HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+V L EY
Sbjct: 124 ILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 91 DGKLADVWSCGVTLYVML--VGAYP----FEDQ------------ED------------P 120
L D+W G M+ V A+P +DQ ED P
Sbjct: 182 STCL-DMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240
Query: 121 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180
+ F + + + YV+ ++D L S++ P R++ + SH +F PR
Sbjct: 241 ERFTLYSPKNLRQAWNKLSYVNHAED---LASKLLQCFPKNRLSAQAALSHEYFSDLPPR 297
Query: 181 --ELTE 184
ELT+
Sbjct: 298 LWELTD 303
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 36/138 (26%), Positives = 65/138 (47%), Gaps = 13/138 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP----AYIAPEVL 85
S+ HRDL N LL + +KICDFG ++ ++H + G+ ++APE +
Sbjct: 255 SKNCVHRDLAARNVLL--AQGKIVKICDFGLARD-IMHDSNYVSKGSTFLPVKWMAPESI 311
Query: 86 SRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
Y L+DVWS G+ L+ + +G P+ F I Y++ H +
Sbjct: 312 FDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS----GYRMAKPDHAT 366
Query: 145 QDCRNLLSRIFVANPSRR 162
Q+ +++ + + + P +R
Sbjct: 367 QEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 51/191 (26%)
Query: 33 ICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKS------TVGTPAYIAPEV 84
+ HRDLK N L+ +G R+KI D G+++ L +S K V T Y APE+
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKN----FRKTISRIMAVQ----- 134
L + K D+W+ G +L F QED K + RI +V
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPAD 246
Query: 135 ------YKIPDYVHISQDCRN-------------------------LLSRIFVANPSRRI 163
K+P+Y + +D R LL ++ +P++RI
Sbjct: 247 KDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI 306
Query: 164 TIKEIKSHPWF 174
T ++ P+F
Sbjct: 307 TSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 39/180 (21%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------MAVQYKIPDYV 141
Y + D+WS G + M+ F ++ + K I ++ +Q + +YV
Sbjct: 195 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 142 H----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
+ R+LLS++ V +P++RI++ E HP+
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 7e-05
Identities = 36/144 (25%), Positives = 59/144 (40%), Gaps = 14/144 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPA-YIAPEVLS 86
+++ HRDL N ++ +KI DFG ++ R P ++APE L
Sbjct: 137 AKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194
Query: 87 RREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISR-IMAVQYKIPDYVHIS 144
+ K +DVWS GV L+ M + P++ + + + I + + PD
Sbjct: 195 DGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDK---- 249
Query: 145 QDCRNLLSRIFVANPSRRITIKEI 168
L+ + NP R T EI
Sbjct: 250 --LLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 46/185 (24%), Positives = 66/185 (35%), Gaps = 51/185 (27%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSK-----------SSLLHSRPK----STVGTP 77
HRDL N ++ KI DFG ++ S + + S V T
Sbjct: 140 FMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTL 197
Query: 78 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKNFRKTISRIMAV-- 133
Y APE+L E D+WS G +L G +P E++ D + RI +
Sbjct: 198 WYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID------QLGRIFELLG 251
Query: 134 ---------QYKIPDYV---------------HISQDCRNLLSRIFVANPSRRITIKEIK 169
K+P Y + S D +LL + NP RI+ KE
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 170 SHPWF 174
H +F
Sbjct: 312 KHEYF 316
|
Length = 335 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 44/169 (26%), Positives = 66/169 (39%), Gaps = 30/169 (17%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S ++ HRDLK +N L+ S ++K+ DFG ++ S V T Y APEVL +
Sbjct: 128 SHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------- 130
Y D+WS G M F D K + I
Sbjct: 186 Y-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244
Query: 131 -----MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++ + D + +D LL + NP++RI+ SHP+F
Sbjct: 245 HSKSAQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 44/184 (23%), Positives = 68/184 (36%), Gaps = 37/184 (20%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKST--VGTPAYIAPEVLSRRE 89
I HRD+K EN LD L DFG + K P+ GT +PE+L+
Sbjct: 206 IIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP 263
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------------- 134
Y K D+WS G+ L+ M V ++ + + S I +Q
Sbjct: 264 YCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322
Query: 135 -------------YKIPDYVH---ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178
Y IP + + D L++++ + R + ++I S P F K
Sbjct: 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382
Query: 179 PREL 182
L
Sbjct: 383 INLL 386
|
Length = 392 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 26/148 (17%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-----PA-YIAPEVLSRR 88
HRDL N L++ + K+ DFG S+ ++T T P + APE ++ R
Sbjct: 129 HRDLAARNILVNSNL--VCKVSDFGLSR---RLEDSEATYTTKGGKIPIRWTAPEAIAYR 183
Query: 89 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
++ +DVWS G+ ++ VM G P+ D + + I + Y++P + DC
Sbjct: 184 KFTSA-SDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAVED-GYRLPPPM----DC 233
Query: 148 RNLLSRIFV----ANPSRRITIKEIKSH 171
+ L ++ + + + R T +I S
Sbjct: 234 PSALYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 28/83 (33%), Positives = 42/83 (50%), Gaps = 9/83 (10%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKIC--DFGYS--KSSLLHSRPKSTVGTPAYIAPEVLSR 87
+I HRD+K EN ++ P +C DFG + + ++ GT A APE+L+R
Sbjct: 202 RIIHRDIKAENIFIN-HPG---DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR 257
Query: 88 REYDGKLADVWSCGVTLYVMLVG 110
Y G D+WS G+ L+ M
Sbjct: 258 DPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 51/204 (25%), Positives = 82/204 (40%), Gaps = 31/204 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I HRDLK N ++ L+I DFG ++ + V T Y APE++
Sbjct: 136 SAGIIHRDLKPSNVAVNEDC--ELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLNWM 191
Query: 90 YDGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTISRIMAVQY 135
+ + D+WS G + +L G +P D D K IS A +Y
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKY 251
Query: 136 KIPDYVHISQD------------CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 183
I H+ Q +LL ++ V + +RI+ E +HP+F + E
Sbjct: 252 -IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE 310
Query: 184 ETAQAIYYRKENPTFSLQSVEEIT 207
A+ EN +++ +E+T
Sbjct: 311 PEAEPYDESPENKERTIEEWKELT 334
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 16/96 (16%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YIA 81
S+ HRDL N LL + KI DFG S++ S + A
Sbjct: 113 SKHFVHRDLAARNVLLVNRH--QAKISDFGMSRAL----GAGSDYYRATTAGRWPLKWYA 166
Query: 82 PEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFED 116
PE ++ ++ K +DVWS GVTL+ GA P+ +
Sbjct: 167 PECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 46/168 (27%), Positives = 64/168 (38%), Gaps = 34/168 (20%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 92
I HRDLK EN L+ + ++K+ DFG ++ V T Y APEVL + Y
Sbjct: 129 IVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTY-A 185
Query: 93 KLADVWSCGVTLYVML--------------------VGAYPFEDQ-----EDPK-NFRKT 126
D+WS G M + P ED P+ F
Sbjct: 186 TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPR 245
Query: 127 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
R VQ +P+ I + LL + NP +RI+ HP+F
Sbjct: 246 GPR--PVQSVVPE---IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 37/174 (21%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I HRDLK N L + LKI DFG ++ + + V T Y APEV+
Sbjct: 135 SAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILNWM 190
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVH------ 142
+ + D+WS G + ML G F+ K++ +++I+ V P++V
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 143 ----------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
S +LL ++ + +R+T E HP+F
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 53/190 (27%), Positives = 77/190 (40%), Gaps = 42/190 (22%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK----STVGTPAYIAPEVLSRREY 90
HRDLK +N L + +LKICDFG ++ + + V T Y APE+ +
Sbjct: 126 HRDLKPKNILANADC--KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG--SF 181
Query: 91 DGKLA---DVWSCGVTLYVMLVGAYPFEDQEDPKNFR-----------KTISRI------ 130
K D+WS G +L G F + +TISR+
Sbjct: 182 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKAR 241
Query: 131 ---MAVQYKIPDYVHISQDCRN-------LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180
+++ K P V SQ N LL R+ +P R T +E + P+F K L +
Sbjct: 242 RYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF-KGLAK 298
Query: 181 ELTE-TAQAI 189
E +AQ I
Sbjct: 299 VEREPSAQPI 308
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 17/146 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPA-YIAPEVLS 86
S+ HRDL N LL + KICDFG ++ S K P ++APE +
Sbjct: 232 SKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF 289
Query: 87 RREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTIS---RIMAVQYKIPDYVH 142
Y + +DVWS G+ L+ + +G+ P+ F K I R+++ + +
Sbjct: 290 NCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD 348
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEI 168
I + C + A+P +R T K+I
Sbjct: 349 IMKSCWD-------ADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 5/82 (6%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-LSRR 88
++I HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P+V L
Sbjct: 122 RKILHRDLKPQNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 89 EYDGKLADVWSCGVTLYVMLVG 110
EY + D+W G LY M G
Sbjct: 180 EYSTPI-DMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 48/191 (25%), Positives = 75/191 (39%), Gaps = 51/191 (26%)
Query: 33 ICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKS------TVGTPAYIAPEV 84
+ HRDLK N L+ +G R+KI D G+++ L +S K V T Y APE+
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVTFWYRAPEL 186
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKN----FRKTISRIMAVQ----- 134
L + K D+W+ G +L F QED K + RI V
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPAD 246
Query: 135 ------YKIPDYVHISQDCR-------------------------NLLSRIFVANPSRRI 163
K+P++ + +D R +LL ++ +P +RI
Sbjct: 247 KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 306
Query: 164 TIKEIKSHPWF 174
T ++ P+F
Sbjct: 307 TSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 40/160 (25%), Positives = 80/160 (50%), Gaps = 18/160 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPA-YIAPEVLS 86
SQ+ HRDL N L+ + +KI DFG ++ +++ + + + P ++APE L
Sbjct: 155 SQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF 212
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
R Y + +DVWS GV ++ + +G P+ P + + +++ +++ + +
Sbjct: 213 DRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVEELFKLLKEGHRMDKPANCTN 266
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 185
+ ++ + A PS R T K++ +++L R LT T
Sbjct: 267 ELYMMMRDCWHAIPSHRPTFKQL------VEDLDRILTLT 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 14/91 (15%)
Query: 31 QQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH----------SRPKSTVGTPAY 79
Q I HRDLK +N ++ + P K+ DFG +LL +R +GTP Y
Sbjct: 98 QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG--TLLPGVRDADVATLTRTTEVLGTPTY 155
Query: 80 IAPEVLSRREYDGKLADVWSCGVTLYVMLVG 110
APE L R E +D+++ G+ L G
Sbjct: 156 CAPEQL-RGEPVTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 23/175 (13%)
Query: 8 LSEFVMLEGSVKMKPDI-----FFSSLSQQICHRDLKLENTLLDGSPAPRLKIC--DFGY 60
L E + L+ +K DI + S+ + HRDL N +L + +C DFG
Sbjct: 106 LPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLRED----MTVCVADFGL 159
Query: 61 SKS--SLLHSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
SK S + R P +IA E L+ R Y K +DVW+ GVT++ + G P+
Sbjct: 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPG 218
Query: 117 QEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171
E+ + + + K P+ + +L+ + A+P R T +++
Sbjct: 219 VENHEIYDYLRH---GNRLKQPE--DCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 33/107 (30%), Positives = 46/107 (42%), Gaps = 24/107 (22%)
Query: 19 KMKPDIFFSSL---SQQIC------------HRDLKLENTLLDGSPAPRLKICDFGYSKS 63
K + + L + QIC HRDL N L++ R+KI DFG +K
Sbjct: 100 KHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTKV 157
Query: 64 SLLHSRPKSTVGTPA-----YIAPEVLSRREYDGKLADVWSCGVTLY 105
L + V P + APE L+ ++ +DVWS GV LY
Sbjct: 158 -LPQDKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 46/151 (30%), Positives = 67/151 (44%), Gaps = 24/151 (15%)
Query: 29 LSQQIC-HRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPA-YIAPE 83
L+ + C HRD+ N LL DG A KICDFG ++ + S K P ++APE
Sbjct: 228 LASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284
Query: 84 VLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV- 141
+ Y + +DVWS G+ L+ + +G P+ F K + R Q PD+
Sbjct: 285 SIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR--GYQMSRPDFAP 341
Query: 142 ----HISQDCRNLLSRIFVANPSRRITIKEI 168
I + C NL P+ R T +I
Sbjct: 342 PEIYSIMKMCWNL-------EPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 19/97 (19%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHS------RPKSTVGTPAYI 80
+ + H+D+ N ++D ++KI D S+ H RP ++
Sbjct: 135 KRGVIHKDIAARNCVIDEEL--QVKITDNALSRDLFPMDYHCLGDNENRPVK------WM 186
Query: 81 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
A E L +EY +DVWS GV L+ +M +G P+ +
Sbjct: 187 ALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 38/147 (25%), Positives = 60/147 (40%), Gaps = 22/147 (14%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG--TPAYI---APEVLSRRE 89
HRDL N L+ +KI DFG S++ L+S V P I A E + +
Sbjct: 153 HRDLATRNCLVG--KNYTIKIADFGMSRN--LYSSDYYRVQGRAPLPIRWMAWESVLLGK 208
Query: 90 YDGKLADVWSCGVTLY--VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ-- 145
+ K +DVW+ GVTL+ + L P+E D + I +++ +
Sbjct: 209 FTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQ----QVIENAGHFFRDDGRQIYLPRPP 263
Query: 146 ----DCRNLLSRIFVANPSRRITIKEI 168
D L+ + + R T +EI
Sbjct: 264 NCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 15/96 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSLLHSRPKSTVGTPAYIA 81
S++ HRDL N +LD S +K+ DFG Y K S H+ K V ++A
Sbjct: 116 SKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMA 170
Query: 82 PEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
E L +++ K +DVWS GV L+ +M GA P+ D
Sbjct: 171 LESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.002
Identities = 34/146 (23%), Positives = 66/146 (45%), Gaps = 15/146 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTP-AYIAPEVL 85
S+ HRDL N L+ + KI DFG ++ L+ + P + APE
Sbjct: 121 SRNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 86 SRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
+ + K +DVWS G+ L ++ G P+ R+ + ++ Y++P +
Sbjct: 177 NYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQVER-GYRMPRPPNCP 230
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKS 170
++ +L+ + + +P R T + ++S
Sbjct: 231 EELYDLMLQCWDKDPEERPTFEYLQS 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 16/83 (19%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSLLHSRPKSTVGTPAYIAP 82
+ I HRD+K EN L++G IC DFG S S+ H TV T AP
Sbjct: 279 EGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGIAGTVDTN---AP 331
Query: 83 EVLSRREYDGKLADVWSCGVTLY 105
EVL+ Y + D+WS G+ ++
Sbjct: 332 EVLAGDPYTPSV-DIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 11/91 (12%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVL 85
+++ HRDL N L+ +KI DFG +K LL + K ++A E +
Sbjct: 128 RRLVHRDLAARNVLVKTPQ--HVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALESI 183
Query: 86 SRREYDGKLADVWSCGVTLY-VMLVGAYPFE 115
R Y + +DVWS GVT++ +M G+ P++
Sbjct: 184 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 27/152 (17%)
Query: 29 LSQQIC-HRDLKLENTLLDGSPAPRLKICDFG---------YSKSSLLHSRP-KSTVGTP 77
L + C HRDL N L+ + LKI DFG Y+ S L P K T
Sbjct: 109 LESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT---- 162
Query: 78 AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136
APE L+ Y + +DVWS G+ L+ +G P+ + ++T RI + Y+
Sbjct: 163 ---APEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSN----QQTRERIES-GYR 213
Query: 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEI 168
+P ++ L+ + + +P R + EI
Sbjct: 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 265 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.98 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.98 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.93 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.93 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.92 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.92 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.9 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.89 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.88 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.87 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.86 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.85 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.85 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.84 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.76 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.64 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.51 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.45 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.44 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.39 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.28 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.19 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.17 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.17 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.03 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.01 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.99 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.97 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.92 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.87 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.87 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.8 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.7 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.49 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.36 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.31 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.24 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.07 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.92 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.26 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.18 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 96.92 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.37 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.33 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.75 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 95.72 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.64 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.55 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.38 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.26 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.19 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.88 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 94.79 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.64 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.6 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.38 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.22 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 93.91 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.84 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 93.81 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 93.3 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.21 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.19 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.91 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.87 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.83 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.82 | |
| PLN02236 | 344 | choline kinase | 92.82 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.5 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 91.36 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 91.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 90.87 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 90.74 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 90.29 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.05 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 90.01 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 89.98 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 89.57 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 89.26 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 89.18 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 86.11 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 84.02 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 81.69 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=292.14 Aligned_cols=175 Identities=32% Similarity=0.467 Sum_probs=146.6
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCC-CCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
|||.++ .|.+++..++. .+|++.++.|||++||+||||||+|||+..+ ..-.+||+|||+|+.......
T Consensus 255 lE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf 334 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF 334 (475)
T ss_pred EEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccccee
Confidence 677666 99999998876 6778999999999999999999999999766 223589999999998877778
Q ss_pred CCCCcCCCCCcccccccCCcC--CCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--cCCCCCCCCH
Q 024572 70 PKSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQ 145 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 145 (265)
..+.|||+.|.|||++.+..+ +..++|+||+||++|-+++|.+||.+......+.+. +....+ ..+.|..++.
T Consensus 335 m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ---I~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 335 MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ---ILKGRYAFGPLQWDRISE 411 (475)
T ss_pred hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH---HhcCcccccChhhhhhhH
Confidence 888999999999999987553 345689999999999999999999887665433333 333333 3456778999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
+.++||.+||..||++|||+.++|+||||+...
T Consensus 412 ea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 412 EALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 999999999999999999999999999998543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=277.90 Aligned_cols=175 Identities=27% Similarity=0.439 Sum_probs=146.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
|||.++ ||.++....+ +..+++.+|.|||. ++||||||||+|||++.++. |||||||.++..... .
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~ 233 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-I 233 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-h
Confidence 889888 9999988533 36678999999995 99999999999999998877 999999999866554 6
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCC-CChHHHHHHHHHHhhh-cccCCCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ-EDPKNFRKTISRIMAV-QYKIPDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 147 (265)
..+++||..|||||.+.+..|..+ +||||||+.++|+++|++||... .........+..+... ....|.. .+|+++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef 311 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEF 311 (364)
T ss_pred cccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHH
Confidence 678899999999999999998766 99999999999999999999875 2233445555555543 2333332 499999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
++||..||.+||.+|||+.++++|||+++....
T Consensus 312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 999999999999999999999999999865543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=282.54 Aligned_cols=167 Identities=34% Similarity=0.578 Sum_probs=146.9
Q ss_pred ccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CCC
Q 024572 2 QLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP 70 (265)
Q Consensus 2 e~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~ 70 (265)
|||.. +|.++..+|+ .++||+.|+.|||+++|+|||||..|+|++.+.. |||+|||+|...... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence 78877 8888888554 4899999999999999999999999999998876 999999999876644 666
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
.+.|||+.|.|||++...+.. ..+||||+||++|.||.|++||... .+...+.++....+.+|. .++.++++|
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk----~vkety~~Ik~~~Y~~P~--~ls~~A~dL 248 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETK----TVKETYNKIKLNEYSMPS--HLSAEAKDL 248 (592)
T ss_pred ceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccc----hHHHHHHHHHhcCccccc--ccCHHHHHH
Confidence 788999999999999977765 4499999999999999999999764 456677777788888887 799999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
|.+||..||.+|||+.+||.|+||++.
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 999999999999999999999999543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.24 Aligned_cols=170 Identities=43% Similarity=0.702 Sum_probs=149.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC-CCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~-~~~~~ 69 (265)
||||.+ .|.+++..++ ..+|+.+++.|||++||+||||||+|||++.+. +++||+|||++... .....
T Consensus 99 mEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~~~~~ 177 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPGEDGL 177 (370)
T ss_pred EEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCCCCCc
Confidence 899987 9999998855 377899999999999999999999999999883 34999999999877 45567
Q ss_pred CCCCcCCCCCcccccccCCc-CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
..+.+|++.|+|||++.+.. |.++++||||+|++||.|++|+.||..... ......+....+.+|.+.. +++++
T Consensus 178 l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----~~l~~ki~~~~~~~p~~~~-S~~~~ 252 (370)
T KOG0583|consen 178 LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----PNLYRKIRKGEFKIPSYLL-SPEAR 252 (370)
T ss_pred ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH----HHHHHHHhcCCccCCCCcC-CHHHH
Confidence 78889999999999999988 998999999999999999999999988544 3344446677777777544 99999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.|+.+||..||.+|+|+.+++.||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999997
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=275.67 Aligned_cols=169 Identities=34% Similarity=0.555 Sum_probs=141.7
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
|||+.. .|.++|.+.+. ..+|+++|.|||++|||||||||+|||++.++. +||+|||.|+.+....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhcc
Confidence 355555 78888887664 667899999999999999999999999998886 9999999998543221
Q ss_pred ------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc
Q 024572 69 ------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 69 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
...+++||..|.+||++...... +.+|+|+|||++|.|+.|.+||.+.+.. .+.++++...+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~Ney----liFqkI~~l~y~ 305 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEY----LIFQKIQALDYE 305 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHH----HHHHHHHHhccc
Confidence 12457899999999999887664 5599999999999999999999987664 455566667777
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
+|. .+++.+++||+++|..||.+|+|+.+|.+||||....
T Consensus 306 fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 306 FPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred CCC--CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 776 6889999999999999999999999999999997643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=271.66 Aligned_cols=175 Identities=23% Similarity=0.351 Sum_probs=151.7
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||+-+++|.+++..|. ++.||+.+|.|+|.+|+.|||+||+|||+..+.. |||+|||+|+........
T Consensus 89 fE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 89 FEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSKPPY 166 (538)
T ss_pred HHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccCCCc
Confidence 7899999999998764 4888999999999999999999999999986655 999999999988888888
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh---------------hcc
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQY 135 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~ 135 (265)
+.++.|.||+|||++....+++.+.|+||+||+++|+.+-++.|.+.+..+++.++..-+.. ..+
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 88899999999999998888888899999999999999999999999888887777654322 122
Q ss_pred cCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 136 KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 136 ~~~~---------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+|. ...++.++.+||.+||.+||.+||||.++|+||||+..
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 2332 12368899999999999999999999999999999854
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=276.76 Aligned_cols=166 Identities=37% Similarity=0.670 Sum_probs=152.8
Q ss_pred ccchHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcC
Q 024572 5 VSSLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG 75 (265)
Q Consensus 5 ~~sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 75 (265)
++-|++++.++|. ..||+.++.|||..+|+||||||+|+|++..+. |||+|||+|..........+.||
T Consensus 96 gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLeTSCG 173 (786)
T KOG0588|consen 96 GGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLETSCG 173 (786)
T ss_pred CchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccccccCC
Confidence 4489999998874 788999999999999999999999999998876 99999999988777888888999
Q ss_pred CCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhc
Q 024572 76 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 155 (265)
Q Consensus 76 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 155 (265)
++.|.|||++.|.+|++.++||||.|||||.||+|+.||.+ ++++.++.++....+.+|. .++.++++||++||
T Consensus 174 SPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 174 SPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRML 247 (786)
T ss_pred CcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999975 5667888888889999986 79999999999999
Q ss_pred ccCCCCCCCHHHHhcCcccCCCC
Q 024572 156 VANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 156 ~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
..||.+|+|.++|++|||+.+..
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred ccCccccccHHHHhhCchhhcCC
Confidence 99999999999999999998654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=245.85 Aligned_cols=166 Identities=33% Similarity=0.612 Sum_probs=137.9
Q ss_pred chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCCCCCCCCcCC
Q 024572 7 SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSRPKSTVGT 76 (265)
Q Consensus 7 sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 76 (265)
.|...|..|. .++||++++.|+|.+||||||+||+|+|+.+.. ..-+||+|||+|...........+.||
T Consensus 96 dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~Gt 175 (355)
T KOG0033|consen 96 ELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGT 175 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCC
Confidence 4555555543 388999999999999999999999999995432 235999999999877766666778899
Q ss_pred CCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc--CCCCCCCCHHHHHHHHHh
Q 024572 77 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRNLLSRI 154 (265)
Q Consensus 77 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~ 154 (265)
+.|||||+++..+|..+ +|||+.|++||-|+.|.+||.+.+....+ .++....+. .|.+..+++++++|+++|
T Consensus 176 P~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rly----e~I~~g~yd~~~~~w~~is~~Ak~LvrrM 250 (355)
T KOG0033|consen 176 PGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLY----EQIKAGAYDYPSPEWDTVTPEAKSLIRRM 250 (355)
T ss_pred CcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHH----HHHhccccCCCCcccCcCCHHHHHHHHHH
Confidence 99999999998888654 99999999999999999999986654443 444444444 456788999999999999
Q ss_pred cccCCCCCCCHHHHhcCcccCCC
Q 024572 155 FVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 155 L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
|..||.+|+|+.|+|+|||+.+.
T Consensus 251 L~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 251 LTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred hccChhhhccHHHHhCCchhcch
Confidence 99999999999999999999754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=263.16 Aligned_cols=173 Identities=29% Similarity=0.424 Sum_probs=137.0
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcC-CCCCcEEEeccCCcccCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLL-- 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~-- 66 (265)
|||+.+ ||.+++...+ ..+||+.+|.|||++|||||||||+|||++. ++. +||+|||+++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCcccccccccc
Confidence 788877 9999999876 2788999999999999999999999999998 455 99999999875543
Q ss_pred --CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCC-CChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 67 --HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ-EDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 67 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
........||+.|||||++.+.....+++|||||||++.+|+||+.||... ... ..+-.+.........+..+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~----~~~~~ig~~~~~P~ip~~l 248 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA----EALLLIGREDSLPEIPDSL 248 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH----HHHHHHhccCCCCCCCccc
Confidence 122334679999999999986433344699999999999999999999874 221 1112222222222344469
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
+.++++||.+||..+|.+||||.++|+|||.++..+
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999999999999999976544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=253.12 Aligned_cols=174 Identities=22% Similarity=0.359 Sum_probs=142.2
Q ss_pred CcccccchHHHHHH----------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC-CCCC
Q 024572 1 MQLGVSSLSEFVML----------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~----------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~-~~~~ 69 (265)
+|||..++-+.+.+ +..+.|++.++.|||+++||||||||+||||+.++. +||||||+|+... ....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcch
Confidence 47788776655553 345888999999999999999999999999998887 9999999999776 4445
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc---------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------------- 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 134 (265)
.+.++.|.||+|||++.+...+++++||||+||++.||++|.+.|.+.++.+++..+...+....
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 55678999999999999966667779999999999999999999999998888776655432110
Q ss_pred ccCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 135 YKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 135 ~~~~~----------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
..+|. +..++.-+.+|+++||..||.+|++.++++.|+||..
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 11222 2346778899999999999999999999999999943
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=252.93 Aligned_cols=166 Identities=34% Similarity=0.528 Sum_probs=133.0
Q ss_pred cchHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CCCCCCcC
Q 024572 6 SSLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG 75 (265)
Q Consensus 6 ~sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~ 75 (265)
+.|.-.+...+. +.-|+.||.|||++|||||||||+|||++..|. ++|+|||+|+..... ....++||
T Consensus 110 GeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~~~~t~tfcG 187 (357)
T KOG0598|consen 110 GELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKDGDATRTFCG 187 (357)
T ss_pred ccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccCCCccccccC
Confidence 366666664443 556788999999999999999999999998887 999999999854433 44556799
Q ss_pred CCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhc
Q 024572 76 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 155 (265)
Q Consensus 76 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 155 (265)
|+.|||||++.+.+|+ +++|+||||+++|+|++|.+||.+.+...... .+.......+ +..++.+++++|+++|
T Consensus 188 T~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~----~I~~~k~~~~-p~~ls~~ardll~~LL 261 (357)
T KOG0598|consen 188 TPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD----KILKGKLPLP-PGYLSEEARDLLKKLL 261 (357)
T ss_pred CccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHH----HHhcCcCCCC-CccCCHHHHHHHHHHh
Confidence 9999999999999886 45999999999999999999999876544333 3333332211 2248999999999999
Q ss_pred ccCCCCCC----CHHHHhcCcccCCCCC
Q 024572 156 VANPSRRI----TIKEIKSHPWFLKNLP 179 (265)
Q Consensus 156 ~~dP~~R~----s~~ell~h~~f~~~~~ 179 (265)
..||.+|. ++.++.+||||.....
T Consensus 262 ~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 262 KRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred ccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 99999996 7899999999986543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=247.48 Aligned_cols=164 Identities=32% Similarity=0.578 Sum_probs=138.0
Q ss_pred chHHHHHH---------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCC
Q 024572 7 SLSEFVML---------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP 77 (265)
Q Consensus 7 sL~~~~~~---------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 77 (265)
-|.|++.. |.+.+++.+++.|||.++||||||||+|||++++.. +||+|||++.....+......|||+
T Consensus 109 ELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~~GekLrelCGTP 186 (411)
T KOG0599|consen 109 ELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLEPGEKLRELCGTP 186 (411)
T ss_pred hHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccCCchhHHHhcCCC
Confidence 56666653 446889999999999999999999999999998876 9999999999888888888889999
Q ss_pred CCcccccccC-----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh--cccCCCCCCCCHHHHHH
Q 024572 78 AYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--QYKIPDYVHISQDCRNL 150 (265)
Q Consensus 78 ~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 150 (265)
.|+|||.+.. .+-+++.+|+|++|+++|.|+.|.+||...... -++..++.. ++..|.|.+++...++|
T Consensus 187 gYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm----lMLR~ImeGkyqF~speWadis~~~KdL 262 (411)
T KOG0599|consen 187 GYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM----LMLRMIMEGKYQFRSPEWADISATVKDL 262 (411)
T ss_pred cccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH----HHHHHHHhcccccCCcchhhccccHHHH
Confidence 9999999864 222356699999999999999999999874332 223334443 45567888999999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
|.+||..||.+|+|++++|+||||.+
T Consensus 263 IsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 263 ISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHHeeCchhcccHHHHhcChHHHH
Confidence 99999999999999999999999953
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=254.43 Aligned_cols=179 Identities=27% Similarity=0.345 Sum_probs=140.9
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC---CC
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---HS 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~---~~ 68 (265)
+||-+..|...+.... ++.|++.++.|+||.+|+||||||.|+|++.+.. +||+|||+|+.... ..
T Consensus 105 ~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~~~~~ 182 (359)
T KOG0660|consen 105 FELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKFFEDG 182 (359)
T ss_pred hhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeeccccCccc
Confidence 3555666776666544 5889999999999999999999999999998876 99999999987653 33
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-----------------
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM----------------- 131 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------- 131 (265)
..+..+.|.+|+|||++.....++++.||||+|||+.||++|++.|.+.+...++..++..+.
T Consensus 183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~ 262 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARP 262 (359)
T ss_pred chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHH
Confidence 335567899999999998766667789999999999999999999998766555444332111
Q ss_pred --hhcccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCChh
Q 024572 132 --AVQYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181 (265)
Q Consensus 132 --~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~~ 181 (265)
......| .+.+.++.+.+|+.+||..||.+|+|++++|+||||.......
T Consensus 263 yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 263 YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 0001111 1346789999999999999999999999999999998655443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=263.63 Aligned_cols=173 Identities=26% Similarity=0.430 Sum_probs=141.9
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~ 70 (265)
|||..+ +|.|.+... .+.+.++.||.|||.+||+|||||.+|||+..++. +||+|||+|....... ..
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCcc
Confidence 777777 788876644 34666788999999999999999999999998887 9999999997665554 45
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
.+.+||++|||||++....|..+ +||||||++++||+-|.+||........+..+ .......+..+..+|+.+++|
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI---a~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred ccccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHHHH---hhcCCCCcCCccccCHHHHHH
Confidence 56689999999999999888655 99999999999999999999875543322221 223444455566899999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
|.+||..|+.+|+++.+||+||||+...+
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMAKP 531 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence 99999999999999999999999976544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=241.26 Aligned_cols=166 Identities=33% Similarity=0.544 Sum_probs=143.1
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||+.++ -|+.++++.+. ..+|..+|.|||+++|++|||||+|||+|.+|. +||+|||+|+..... .
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR--T 198 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc--E
Confidence 677666 88888887553 667888999999999999999999999999887 999999999865433 5
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
.+.|||+.|+|||++..+++. +++|.|||||++|||+.|.+||..... ..+..++......+|. .++.++++|
T Consensus 199 ~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~--~fs~~~kdL 271 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPS--YFSSDAKDL 271 (355)
T ss_pred EEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCc--ccCHHHHHH
Confidence 677999999999999998875 669999999999999999999998766 4555666777777776 589999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
|+++|+.|-.+|. ...+|..||||+..
T Consensus 272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 9999999999994 57899999999854
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=250.32 Aligned_cols=173 Identities=32% Similarity=0.527 Sum_probs=145.2
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCC-CC---CcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~-~~---~~vkl~Dfg~a~~~~~ 66 (265)
||||.+ +|++|++.++. ++||+.++.+||+++||||||||+||||+.. .. ..+||+|||+|+....
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 899995 99999999853 8899999999999999999999999999764 22 4699999999998888
Q ss_pred CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCC-CCCCCH
Q 024572 67 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQ 145 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 145 (265)
.....+.||++.|||||++....|+.+ +|+||+|+++|++++|+.||......+.+. .+.......|. ...++.
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~----~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL----YIKKGNEIVPVLPAELSN 242 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhccccccCchhhhccC
Confidence 877788899999999999998899876 899999999999999999998876544333 22222222222 234677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.+.+|+...|..+|..|.+..+-+.|+++..+.
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 788999999999999999999999999987654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=264.76 Aligned_cols=175 Identities=26% Similarity=0.360 Sum_probs=135.5
Q ss_pred CcccccchHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.++|.+++.. +.++.+++.+|.|||++||+||||||+|||++.++. .+||+|||+|+.....
T Consensus 146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~~~~~~ 224 (440)
T PTZ00036 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKNLLAG 224 (440)
T ss_pred EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccchhccCC
Confidence 78888888877653 123568899999999999999999999999986542 4999999999865544
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-------------c
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------Q 134 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------~ 134 (265)
.......+++.|+|||++.+....+.++|||||||++|+|++|.+||.+......+..++...... .
T Consensus 225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 304 (440)
T PTZ00036 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304 (440)
T ss_pred CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence 444556789999999998775444566999999999999999999998876655554444321110 0
Q ss_pred ccCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 135 YKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 135 ~~~~----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
..++ .+...+.++++||.+||.+||.+|||+.++++||||..
T Consensus 305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 0111 11246789999999999999999999999999999964
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=241.52 Aligned_cols=176 Identities=32% Similarity=0.512 Sum_probs=146.7
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~ 67 (265)
||..++ .|..-+..++ +.++|..++.|||+.+|.||||||+|+|..... +..+||+|||+|+.....
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 555555 6777776665 378899999999999999999999999996543 335899999999987777
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQ 145 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 145 (265)
....+.+-|++|.|||++...+|+ +.+|+||+|+++|-|++|.+||.+......-..+..++....+.+| .|..+|+
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe 296 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE 296 (400)
T ss_pred ccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence 777888999999999999888875 5599999999999999999999887654433444555666666555 6778999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
..+++|+.+|..+|.+|.|+.++++|||+.+.
T Consensus 297 ~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 297 AAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 99999999999999999999999999999754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=254.81 Aligned_cols=173 Identities=34% Similarity=0.529 Sum_probs=141.4
Q ss_pred Cccccc-chHHHHHHhcccc---------chHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC----
Q 024572 1 MQLGVS-SLSEFVMLEGSVK---------MKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---- 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~~~---------~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~---- 66 (265)
|||..+ .+..+++..+.+. ..+-|+..+|+.|+|||||||+|+|||..|+ +||+|||+|.....
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhhh
Confidence 787766 9999999887633 3455688899999999999999999998887 99999999852110
Q ss_pred ------------------C--C-----C-------------------CCCCcCCCCCcccccccCCcCCCchHhHHHHHH
Q 024572 67 ------------------H--S-----R-------------------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGV 102 (265)
Q Consensus 67 ------------------~--~-----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 102 (265)
. . . ....+|||-|+|||++.+.+|. ..+|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHH
Confidence 0 0 0 0134699999999999999975 5599999999
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccCCCCC
Q 024572 103 TLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLP 179 (265)
Q Consensus 103 ~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---s~~ell~h~~f~~~~~ 179 (265)
|+||||.|.+||.+......+++++... ..+.+|....++.++++||.+||. ||.+|. ++.||.+||||+..-.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr--~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWR--ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHh--hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 9999999999999988877777766543 335567667889999999999999 999998 5999999999986543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=246.47 Aligned_cols=176 Identities=26% Similarity=0.358 Sum_probs=146.4
Q ss_pred CcccccchHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
|||...+|.+++... -..-||..++.|||+.||+||||||.|+|+|.+. +.+||||||.|+.....
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKG 179 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccC
Confidence 677777888888831 1256799999999999999999999999999763 46999999999988888
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-------------
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------- 134 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 134 (265)
....+++.|..|+|||++.+...++.+.||||.||++.||+.|++.|.+.+..+++..+++-+..+.
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 8888889999999999999977667779999999999999999999999888877777665332111
Q ss_pred ccCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 YKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 ~~~~----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...| .....++++.+|+.++|.++|.+|.++.+++.||||..-
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 1111 123468999999999999999999999999999999643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=240.17 Aligned_cols=175 Identities=23% Similarity=0.287 Sum_probs=144.1
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||+|+.+|..++.... +..|+++++.|||.+.|+||||||+|+|+...|. +||+|||+|+.......
T Consensus 156 Me~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 156 MEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLKP 233 (419)
T ss_pred HHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCccc
Confidence 8899998888877544 3678899999999999999999999999998887 99999999997665533
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-cCCC---------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPD--------- 139 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~--------- 139 (265)
.+..+-|.+|+|||++.+...++.+.|+||+|||+.+++++++.|.+.+..+++.++.+.+..+.- .+|.
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 344568999999999999776677799999999999999999999999888887777665432211 0110
Q ss_pred --------------C--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 140 --------------Y--VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 140 --------------~--~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+ ..++....+|+..+|.+||.+|.||.+.|+|.||...
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 0 1145888999999999999999999999999999763
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=233.21 Aligned_cols=173 Identities=27% Similarity=0.349 Sum_probs=140.6
Q ss_pred cccccchHHHHHH----------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCC
Q 024572 2 QLGVSSLSEFVML----------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK 71 (265)
Q Consensus 2 e~~~~sL~~~~~~----------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 71 (265)
||-..+|+..+.. +.++.|++.++.|||++.|+||||||.|+||++++. +||+|||+|+.........
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence 5566667766664 345778999999999999999999999999998887 9999999999766544333
Q ss_pred -CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-cCC-----------
Q 024572 72 -STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIP----------- 138 (265)
Q Consensus 72 -~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~----------- 138 (265)
..+-|.+|+|||++.|...++..+||||.||++.||+.|.+.|.+.++-+++..+...+..+.. .+|
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 3378999999999999776667799999999999999999999999988887777654432221 111
Q ss_pred ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 139 ----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 139 ----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.+...+.++.+|+.+||.+||.+|+|+.|+++|+||+.
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 12235678899999999999999999999999999986
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=241.83 Aligned_cols=175 Identities=24% Similarity=0.320 Sum_probs=138.8
Q ss_pred CcccccchHHHHHHhc-------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLEG-------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||+....|.+++.... +..||+.++.|||+++|+||||||.||||+.++. +||+|||+|+.....
T Consensus 96 fe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlAra~~ip 173 (323)
T KOG0594|consen 96 FEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLARAFSIP 173 (323)
T ss_pred EEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchHHHhcCC
Confidence 4566666777666544 4678999999999999999999999999998776 999999999865533
Q ss_pred C-CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-----------
Q 024572 68 S-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY----------- 135 (265)
Q Consensus 68 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 135 (265)
. .....++|.+|+|||++.+...++...||||+||++++|++++..|.+..+.+++..+...+..+..
T Consensus 174 ~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~ 253 (323)
T KOG0594|consen 174 MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPD 253 (323)
T ss_pred cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccc
Confidence 3 3455679999999999999865556699999999999999999999998887776666554322211
Q ss_pred ---cCCCC----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 136 ---KIPDY----------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 136 ---~~~~~----------~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.++.+ ...+++..+++.+||.++|.+|.|+..++.||||...
T Consensus 254 ~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 254 YKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11111 1123588999999999999999999999999999764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=246.45 Aligned_cols=171 Identities=26% Similarity=0.327 Sum_probs=134.1
Q ss_pred CcccccchHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.++|.+++... .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 88 ~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 165 (290)
T cd07862 88 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMA 165 (290)
T ss_pred EccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccceEeccCCcc
Confidence 678888888887542 24678899999999999999999999999988775 99999999875544433
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-cCC----------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIP---------- 138 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~---------- 138 (265)
.....+++.|+|||.+.+..+.. ++|||||||++|+|++|++||.+......+..+......... ..+
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 244 (290)
T cd07862 166 LTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244 (290)
T ss_pred cccccccccccChHHHhCCCCCC-ccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhc
Confidence 44556899999999998777654 499999999999999999999887665555444332110000 000
Q ss_pred ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 139 ----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 139 ----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
....++..+++||.+||..||++|||+.++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=249.09 Aligned_cols=205 Identities=26% Similarity=0.323 Sum_probs=145.4
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||+|+..|..++..++ .++|++.++.++|.+||||.||||.|+|+-. | ++||+|||+|........
T Consensus 439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G--~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-G--RLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-e--eEEeeeechhcccCccccc
Confidence 8999999999887665 3788999999999999999999999999863 3 499999999986554432
Q ss_pred --CCCCcCCCCCcccccccCCcCC----------CchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI 137 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~----------~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 137 (265)
....+||+.||+||.+....+. ++++||||||||||+|+.|+.||... .+....+..+......+
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---INQIAKLHAITDPNHEI 592 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---HHHHHHHHhhcCCCccc
Confidence 2345899999999998653322 34599999999999999999999653 22334444455543322
Q ss_pred CCCCCCC-HHHHHHHHHhcccCCCCCCCHHHHhcCcccCC-CCChhhHHHHHHHh-hhcCCCCCCCcCHHHHHHHHH
Q 024572 138 PDYVHIS-QDCRNLLSRIFVANPSRRITIKEIKSHPWFLK-NLPRELTETAQAIY-YRKENPTFSLQSVEEITKIVE 211 (265)
Q Consensus 138 ~~~~~~~-~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 211 (265)
+.+..-+ .++.++++.||.+||++|||+.++|+|||+.- .++.+......... .-...+.........+.+.++
T Consensus 593 efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~~m~~~~~~~~k~~e~~~v~~d~~n~i~~ql~ 669 (677)
T KOG0596|consen 593 EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVEQMAKLTTNEMKYVEGQLVDLDSPNSILKQLK 669 (677)
T ss_pred cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccchHHHHHHHHHHHhcccCCCCcccHHHHHHHHH
Confidence 2221122 23899999999999999999999999999976 44433322221111 111334445555555544443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=245.19 Aligned_cols=176 Identities=20% Similarity=0.303 Sum_probs=131.1
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.++|.+++..+. ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 82 FEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHT 159 (303)
T ss_pred EECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCcc
Confidence 7888888888876532 4678999999999999999999999999987765 999999998643222 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc---------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------------- 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 134 (265)
.....+++.|+|||++.+....+.++||||+||++|+|++|..||.+..+.......+.......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 23456889999999987655445669999999999999999999987654322222111111000
Q ss_pred ---cc--CC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 135 ---YK--IP-------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 135 ---~~--~~-------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.. .+ ....++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00 00 0012456789999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=244.01 Aligned_cols=172 Identities=23% Similarity=0.325 Sum_probs=131.4
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.++|.+++..++ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT 159 (288)
T ss_pred EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence 6888888888876543 3567899999999999999999999999988765 9999999987433222 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh---------------c
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------Q 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 134 (265)
.....+++.|+|||++.+....+.++||||+||++|+|++|+.||.+......+.......... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 2344688999999998765444566999999999999999999998766544433332211100 0
Q ss_pred ccCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 135 YKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 135 ~~~~~---------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
...+. ...++.++++||.+||.+||.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00111 12467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=250.08 Aligned_cols=168 Identities=31% Similarity=0.618 Sum_probs=149.9
Q ss_pred ccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 2 QLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 2 e~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||+.+ .|.||||.+. ...||+.++.|||+..+|||||||+||++... .+-|||+|||++..+.+....
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK-lGlVKLTDFGFSNkf~PG~kL 175 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK-LGLVKLTDFGFSNKFQPGKKL 175 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee-cCceEeeeccccccCCCcchh
Confidence 77877 9999999764 36789999999999999999999999987643 235999999999988888888
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
.+.||++.|.|||++.+..|+.+++||||||+|||.|++|++||...++.+. +..++...+..|. .++.+|++|
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----LTmImDCKYtvPs--hvS~eCrdL 249 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----LTMIMDCKYTVPS--HVSKECRDL 249 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----hhhhhcccccCch--hhhHHHHHH
Confidence 9999999999999999999999999999999999999999999998877554 4445667777776 689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
|..||..||.+|.+.++|..|+|++.
T Consensus 250 I~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 250 IQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred HHHHHhcCchhhccHHHHhccccccC
Confidence 99999999999999999999999974
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=251.58 Aligned_cols=174 Identities=31% Similarity=0.537 Sum_probs=147.7
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCC--CcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~--~~vkl~Dfg~a~~~~~~~~ 69 (265)
||||.+ .|.+.+..+ ..+++++.++.|||+.||+||||||+|+|+..... +.+|++|||++........
T Consensus 115 mEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~ 194 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGER 194 (382)
T ss_pred EEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCce
Confidence 789986 899998876 35888999999999999999999999999976532 4699999999987766556
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++....|... +||||+|+++|.|++|.+||.+......+..+... ...+..+.+..++..+++
T Consensus 195 ~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--~~~f~~~~w~~is~~akd 271 (382)
T KOG0032|consen 195 LHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--DFDFTSEPWDDISESAKD 271 (382)
T ss_pred EeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--CCCCCCCCccccCHHHHH
Confidence 677789999999999998787655 99999999999999999999998765555533322 224456677789999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
||++||..||.+|+|+.++|+|||++..
T Consensus 272 ~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 272 FIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=242.63 Aligned_cols=173 Identities=25% Similarity=0.351 Sum_probs=133.9
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGE 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCC
Confidence 566654 7877765322 3567899999999999999999999999987765 9999999987654333
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......|+..|+|||++.+..++. ++|||||||++|+|++|+.||...............+.... ......++..+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~-~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~ 233 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTF-SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--EEYSEKFSEDAK 233 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCc-ccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--ccCCccCCHHHH
Confidence 334557899999999998877754 48999999999999999999987654332222222222222 223336889999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCcccCCCC
Q 024572 149 NLLSRIFVANPSRRIT-----IKEIKSHPWFLKNL 178 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s-----~~ell~h~~f~~~~ 178 (265)
+||.+||..||.+||+ +.++++||||....
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 9999999999999997 89999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=255.62 Aligned_cols=174 Identities=24% Similarity=0.305 Sum_probs=139.7
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
.|+.+.+|.+|+..+. +++||+.+|.+||+.||||+||||+||||...+...|||+|||.|......
T Consensus 267 fELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~-- 344 (586)
T KOG0667|consen 267 FELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR-- 344 (586)
T ss_pred ehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc--
Confidence 4788889999998654 488899999999999999999999999998776668999999998754333
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh-----------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----------------- 132 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------------- 132 (265)
..+++.+..|+|||++.|.+|+.. .||||||||++||++|.+.|.+.+..+++..++.-+..
T Consensus 345 vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~ 423 (586)
T KOG0667|consen 345 VYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFT 423 (586)
T ss_pred ceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehh
Confidence 337889999999999999999766 99999999999999999999998877776655442210
Q ss_pred h-------------------------------cccCC-CCC--------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 024572 133 V-------------------------------QYKIP-DYV--------HISQDCRNLLSRIFVANPSRRITIKEIKSHP 172 (265)
Q Consensus 133 ~-------------------------------~~~~~-~~~--------~~~~~~~~li~~~L~~dP~~R~s~~ell~h~ 172 (265)
. ....| ... .-...+.+||++||.+||.+|+|+.++|+||
T Consensus 424 ~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hp 503 (586)
T KOG0667|consen 424 SLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHP 503 (586)
T ss_pred ccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCc
Confidence 0 00011 000 0124578999999999999999999999999
Q ss_pred ccCCC
Q 024572 173 WFLKN 177 (265)
Q Consensus 173 ~f~~~ 177 (265)
||...
T Consensus 504 fl~~~ 508 (586)
T KOG0667|consen 504 FLTGT 508 (586)
T ss_pred ccccc
Confidence 99843
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=248.01 Aligned_cols=168 Identities=32% Similarity=0.503 Sum_probs=133.6
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~ 151 (323)
T cd05571 74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGAT 151 (323)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCc
Confidence 677765 8888876543 3578999999999999999999999999988765 99999999874322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+|++.|+|||++.+..+. .++|||||||++|+|++|+.||........ ...+.......| ..++.++.+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~----~~~~~~~~~~~p--~~~~~~~~~ 224 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFP--RTLSPEAKS 224 (323)
T ss_pred ccceecCccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHH
Confidence 3345699999999999887775 459999999999999999999977543222 222222233333 368999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
||.+||..||++|| ++.++++||||...
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=246.34 Aligned_cols=164 Identities=34% Similarity=0.518 Sum_probs=138.1
Q ss_pred HHHHHHhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC------CCCCCcCCCCCccc
Q 024572 9 SEFVMLEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS------RPKSTVGTPAYIAP 82 (265)
Q Consensus 9 ~~~~~~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~------~~~~~~~~~~y~aP 82 (265)
..+...|..++-+..+|.|||.+|||||||||+|+||++++. |||+|||.+....... ......||+.|+||
T Consensus 207 ls~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~AP 284 (576)
T KOG0585|consen 207 LSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAP 284 (576)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeeccceeeecccCCccccHHHHhhcCCCccccch
Confidence 345666777888899999999999999999999999998876 9999999987542221 12235799999999
Q ss_pred ccccC---CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCC
Q 024572 83 EVLSR---REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 159 (265)
Q Consensus 83 E~~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 159 (265)
|...+ ..+.+.+.||||+||+||.|+.|+.||.+... .....++......+|....+.+.+++||.+||.+||
T Consensus 285 E~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP 360 (576)
T KOG0585|consen 285 ELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDP 360 (576)
T ss_pred HhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcCh
Confidence 99877 55778889999999999999999999988544 455556667777888877889999999999999999
Q ss_pred CCCCCHHHHhcCcccCCCC
Q 024572 160 SRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 160 ~~R~s~~ell~h~~f~~~~ 178 (265)
.+|+++.+|..|||.....
T Consensus 361 ~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 361 EQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred hheeehhhheecceeccCC
Confidence 9999999999999987653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=249.97 Aligned_cols=167 Identities=29% Similarity=0.539 Sum_probs=140.1
Q ss_pred cccccchHHHHHHh---------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCC-
Q 024572 2 QLGVSSLSEFVMLE---------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK- 71 (265)
Q Consensus 2 e~~~~sL~~~~~~~---------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~- 71 (265)
|||.++|...+... .+..++..+|+|||+++|+|||+||.|||++..+. +|+||||+|+.........
T Consensus 81 e~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 81 EYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence 78888888888754 45677899999999999999999999999998876 9999999998766544333
Q ss_pred CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 024572 72 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151 (265)
Q Consensus 72 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 151 (265)
...||+.|||||++.+..|+.. +|+||+||++||+++|++||... .+...++.+......+|. ..+..+++|+
T Consensus 159 sikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~d~v~~p~--~~S~~f~nfl 231 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYAR----SITQLVKSILKDPVKPPS--TASSSFVNFL 231 (808)
T ss_pred eccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhcCCCCCcc--cccHHHHHHH
Confidence 3459999999999999888765 99999999999999999999764 334555555554444444 7899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 152 SRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 152 ~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
..+|.+||.+|.|..+++.|||+++.
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhh
Confidence 99999999999999999999998754
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=246.66 Aligned_cols=173 Identities=28% Similarity=0.427 Sum_probs=134.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 84 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~~~~ 161 (332)
T cd05614 84 LDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSEEKE 161 (332)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCccccccCCC
Confidence 677765 8888876544 3557899999999999999999999999988775 9999999987543222
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||...............+..... +.+..++..+.
T Consensus 162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 239 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--PFPSFIGPEAQ 239 (332)
T ss_pred ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHH
Confidence 2223568999999999987654456699999999999999999999754332222233333333222 23346889999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 149 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 149 ~li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
+||.+||..||++|| ++.++++||||+..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 88899999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=246.79 Aligned_cols=174 Identities=26% Similarity=0.384 Sum_probs=132.3
Q ss_pred CcccccchHHHHHH-------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVML-------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~sL~~~~~~-------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||+++++|.+++.. ..++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 105 ~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~ 182 (359)
T cd07876 105 MELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPY 182 (359)
T ss_pred EeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccccCccCCCC
Confidence 68888887776542 235778999999999999999999999999988775 999999998754444344455
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH------------------hhhcc
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------MAVQY 135 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~------------------~~~~~ 135 (265)
.+|+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+......+....... .....
T Consensus 183 ~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (359)
T cd07876 183 VVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRP 261 (359)
T ss_pred cccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCC
Confidence 78999999999988777654 999999999999999999998765433332222111 00000
Q ss_pred cCC------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 136 KIP------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 136 ~~~------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
..+ .....+..+++||.+||..||++|||+.++++||||...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 262 QYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred CCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 000 011245788999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=230.16 Aligned_cols=158 Identities=28% Similarity=0.410 Sum_probs=130.9
Q ss_pred Cccccc-chHHHHHHhc-------------cccchHHHHHhhhh--cC--ceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 1 MQLGVS-SLSEFVMLEG-------------SVKMKPDIFFSSLS--QQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------~~~~i~~~l~~lH~--~~--ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
||+|+. +|++++..-. ..-|++.+|.+||+ .. |+||||||.||+++.++. |||+|||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r 176 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGR 176 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHh
Confidence 889987 9999987532 25678899999999 56 999999999999998887 9999999998
Q ss_pred cCCCCCC-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCC
Q 024572 63 SSLLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 141 (265)
Q Consensus 63 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (265)
....... ..+.+|||.||+||++...+|+.+ +||||+||++|||+.-++||.+. ++.....++....+..-...
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPDE 251 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcHH
Confidence 6654433 345689999999999999999755 99999999999999999999986 45566666666655422224
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCH
Q 024572 142 HISQDCRNLLSRIFVANPSRRITI 165 (265)
Q Consensus 142 ~~~~~~~~li~~~L~~dP~~R~s~ 165 (265)
.+|.++..||..|+..||.+||+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCc
Confidence 689999999999999999999984
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=238.82 Aligned_cols=171 Identities=25% Similarity=0.305 Sum_probs=132.2
Q ss_pred CcccccchHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.++|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 86 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~~~~~~~ 163 (288)
T cd07863 86 FEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQMA 163 (288)
T ss_pred EcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCccccccCccc
Confidence 677777888877642 23677899999999999999999999999988775 99999999875544433
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-------ccCC----
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-------YKIP---- 138 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~---- 138 (265)
.....++..|+|||++.+..++. ++||||+||++|+|++|++||........+.++........ ...+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07863 164 LTPVVVTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAF 242 (288)
T ss_pred CCCccccccccCchHhhCCCCCC-cchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccccccc
Confidence 34456899999999998777654 59999999999999999999987665544444333211000 0000
Q ss_pred ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 139 ----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 139 ----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
....++..+.+||.+||..||.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 243 SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=244.38 Aligned_cols=172 Identities=23% Similarity=0.312 Sum_probs=138.9
Q ss_pred cccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--C
Q 024572 2 QLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R 69 (265)
Q Consensus 2 e~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~ 69 (265)
||-..+|.-++..- -..+||+.+|.|||++||+|||||.+|||||.++. +||+|||+|+...... .
T Consensus 198 eYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 198 EYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGSAP 275 (560)
T ss_pred ecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCCcc
Confidence 44455555555433 23789999999999999999999999999998887 9999999998654443 3
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc------cCCC----
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY------KIPD---- 139 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~---- 139 (265)
.+..+.|+||+|||++.|...++.++|+||.||||.||++|++.|.+....+++..+.+....... .+|.
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~ 355 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF 355 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence 456679999999999999877778899999999999999999999998887777666554322111 1111
Q ss_pred -------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 140 -------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 140 -------------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
+..++..+.+|+..||..||.+|.||.++|+|+||.
T Consensus 356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 123678899999999999999999999999999994
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=245.09 Aligned_cols=174 Identities=24% Similarity=0.369 Sum_probs=130.4
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC--
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-- 69 (265)
||+++++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 83 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 83 FELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCccccccccccCcc
Confidence 7899999998876543 3678899999999999999999999999988776 99999999874322211
Q ss_pred --CCCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-----------HH----
Q 024572 70 --PKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-----------RI---- 130 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~-----------~~---- 130 (265)
.....+++.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+............ .+
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred ccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 123468999999999865 344 4569999999999999999999977553322111100 00
Q ss_pred ----h---hhcccCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 131 ----M---AVQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 131 ----~---~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
. ......+ ....+++.+.++|.+||..||++|||+.++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0 0000000 122467889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=255.72 Aligned_cols=176 Identities=22% Similarity=0.344 Sum_probs=129.7
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhh-cCceecCCCcCcEEEcCCCC--------------CcEEEe
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPA--------------PRLKIC 56 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~--------------~~vkl~ 56 (265)
||+++++|.+++..++ ++.+++.+|.|||+ .|||||||||+|||++..+. ..+||+
T Consensus 211 ~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~ 290 (467)
T PTZ00284 211 MPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRIC 290 (467)
T ss_pred EeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEEC
Confidence 6778888988887643 46788999999998 59999999999999976542 149999
Q ss_pred ccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh----
Q 024572 57 DFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---- 132 (265)
Q Consensus 57 Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---- 132 (265)
|||.+... .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+......+..+......
T Consensus 291 DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~ 367 (467)
T PTZ00284 291 DLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE 367 (467)
T ss_pred CCCccccC--ccccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH
Confidence 99987532 2233456799999999999987775 4599999999999999999999876543332221111000
Q ss_pred ---------------hccc-CCC----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 133 ---------------VQYK-IPD----------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 133 ---------------~~~~-~~~----------------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
.... .+. .....+.+.+||.+||.+||.+|||+.++|+||||.+..+
T Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 368 WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred HHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 0000 000 0011356789999999999999999999999999986543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=245.78 Aligned_cols=174 Identities=26% Similarity=0.341 Sum_probs=132.8
Q ss_pred CcccccchHHHHHH-------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVML-------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~sL~~~~~~-------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||++.++|.+++.. ..++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 101 ~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~ 178 (355)
T cd07874 101 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 178 (355)
T ss_pred hhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCCCccccCCc
Confidence 78888888776643 234778899999999999999999999999988765 999999999765444444456
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh------------------hcc
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA------------------VQY 135 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~ 135 (265)
.++..|+|||++.+..+.. ++|||||||++|+|++|+.||.+......+...+..... ...
T Consensus 179 ~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (355)
T cd07874 179 VVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257 (355)
T ss_pred cccCCccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCC
Confidence 7899999999998877754 499999999999999999999876544333322221100 000
Q ss_pred -----cCC-------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 136 -----KIP-------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 136 -----~~~-------------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
..+ .....+..+++||.+||..||.+|||+.++++||||...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred ccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000 011235678999999999999999999999999999644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=246.61 Aligned_cols=173 Identities=27% Similarity=0.356 Sum_probs=133.0
Q ss_pred CcccccchHHHHHHh-------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLE-------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~sL~~~~~~~-------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||++.++|.+++... .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 108 ~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~ 185 (364)
T cd07875 108 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 185 (364)
T ss_pred EeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccCCCCcccCC
Confidence 788888888766432 34778899999999999999999999999988775 999999999765444344456
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc---------------ccCC
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---------------YKIP 138 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~ 138 (265)
.++..|+|||++.+..+.. ++|||||||++|+|++|+.||.+......+...+....... ...+
T Consensus 186 ~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (364)
T cd07875 186 VVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP 264 (364)
T ss_pred cccCCcCCHHHHhCCCCCc-hhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCC
Confidence 7899999999998877654 59999999999999999999987665444433332111000 0000
Q ss_pred ---------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 139 ---------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 139 ---------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.....+..+++||.+||..||.+|||+.++++||||..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred CcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00113467899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=252.64 Aligned_cols=152 Identities=33% Similarity=0.571 Sum_probs=129.3
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC-CCCCCCCCcCCCCCcccccccCCcCCCchHh
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 96 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 96 (265)
..-++.+|.|||++||||||||.+|||+|..|. +||+|||+|+... ......++|||+.|+|||++.+..|+ .++|
T Consensus 474 aAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt-~aVD 550 (694)
T KOG0694|consen 474 AAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYT-RAVD 550 (694)
T ss_pred HHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCCCCccccccCChhhcChhhhccCccc-chhh
Confidence 444677899999999999999999999998887 9999999998765 45566778999999999999998885 5599
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcC
Q 024572 97 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT-----IKEIKSH 171 (265)
Q Consensus 97 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~ell~h 171 (265)
+|||||+||+|+.|..||.+.+..+.+..++ ......|. .++.++.++|+++|.++|++|.. +.+|.+|
T Consensus 551 WW~lGVLlyeML~Gq~PF~gddEee~FdsI~----~d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 551 WWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----NDEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----cCCCCCCC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence 9999999999999999999987765554443 33444444 68999999999999999999995 5889999
Q ss_pred cccCCCC
Q 024572 172 PWFLKNL 178 (265)
Q Consensus 172 ~~f~~~~ 178 (265)
|||+...
T Consensus 625 pFFr~i~ 631 (694)
T KOG0694|consen 625 PFFRSID 631 (694)
T ss_pred CccccCC
Confidence 9998654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=239.20 Aligned_cols=165 Identities=32% Similarity=0.535 Sum_probs=131.9
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++..++ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--RT 155 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--Cc
Confidence 676654 8998887544 3567899999999999999999999999987765 99999999875432 22
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+....... ..+......++ ..++..+++|
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~l 228 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIY----EKILAGKLEFP--RHLDLYAKDL 228 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCcCCC--ccCCHHHHHH
Confidence 345689999999999887765 5599999999999999999999876543322 22333333333 3568899999
Q ss_pred HHHhcccCCCCCCC-----HHHHhcCcccCC
Q 024572 151 LSRIFVANPSRRIT-----IKEIKSHPWFLK 176 (265)
Q Consensus 151 i~~~L~~dP~~R~s-----~~ell~h~~f~~ 176 (265)
|++||..||.+|++ +.++++||||..
T Consensus 229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 99999999999995 999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=244.96 Aligned_cols=173 Identities=23% Similarity=0.301 Sum_probs=130.8
Q ss_pred CcccccchHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
||+++.+|.+++... .++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.... ....
T Consensus 99 ~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~--~~~~ 174 (343)
T cd07878 99 TNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADD--EMTG 174 (343)
T ss_pred eecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCC--CcCC
Confidence 577778887776532 34778999999999999999999999999988776 99999999875432 2344
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-------------------
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV------------------- 133 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 133 (265)
..+++.|+|||++.+....+.++|||||||++|+|++|+.||........+..........
T Consensus 175 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07878 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQS 254 (343)
T ss_pred ccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhc
Confidence 5789999999999875444566999999999999999999997755433332222110000
Q ss_pred cccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 134 QYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 134 ~~~~~------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
....+ .....++.+.+||.+||..||.+|||+.++++||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 255 LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00000 012356778999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=241.82 Aligned_cols=168 Identities=32% Similarity=0.520 Sum_probs=133.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.+ +|.+++...+ ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 72 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 72 LAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDK 149 (312)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCc
Confidence 677765 8888886554 3567899999999999999999999999988775 999999998743222 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........ ...+.......+ ..+++.+++
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~ 222 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEM----YRKILQEPLRFP--DGFDRDAKD 222 (312)
T ss_pred cccccCCcccCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHH----HHHHHcCCCCCC--CcCCHHHHH
Confidence 3345699999999999887775 459999999999999999999987554332 223333333333 368899999
Q ss_pred HHHHhcccCCCCCC---CHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRI---TIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~---s~~ell~h~~f~~~ 177 (265)
||.+||..||.+|| ++.++++||||.+.
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999999999997 57999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=241.93 Aligned_cols=168 Identities=31% Similarity=0.493 Sum_probs=133.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 75 ~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 75 MEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKT 152 (320)
T ss_pred EcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCc
Confidence 788765 8988876543 3667899999999999999999999999988776 999999998753222 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....|++.|+|||++.+..+.. ++|||||||++|+|++|+.||........ ...+.......| ..++.++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~ 225 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGP-SVDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYP--TWLSQDAVD 225 (320)
T ss_pred ccccccCccccCHHHHcCCCCCC-ccchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHHH
Confidence 33456899999999998777654 49999999999999999999987654332 223333333333 357899999
Q ss_pred HHHHhcccCCCCCCCH------HHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITI------KEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~------~ell~h~~f~~~ 177 (265)
||.+||..||.+|+++ .++++||||...
T Consensus 226 li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999998 999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=240.89 Aligned_cols=174 Identities=22% Similarity=0.302 Sum_probs=124.8
Q ss_pred CcccccchHHHHHH------------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCC--CCCcEEEeccCC
Q 024572 1 MQLGVSSLSEFVML------------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGS--PAPRLKICDFGY 60 (265)
Q Consensus 1 me~~~~sL~~~~~~------------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~--~~~~vkl~Dfg~ 60 (265)
||+++++|.+++.. +.++.|++.++.|||++||+||||||+|||+... ..+.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 67888888777653 2346789999999999999999999999999432 223599999999
Q ss_pred cccCCCCC----CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh---------HHHHHHH
Q 024572 61 SKSSLLHS----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---------KNFRKTI 127 (265)
Q Consensus 61 a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~---------~~~~~~~ 127 (265)
++...... ......+|+.|+|||++.+....+.++||||+||++|+|++|++||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 97543221 1234568999999999987654556699999999999999999999754321 1111111
Q ss_pred HHHh------------------------hhcccC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 128 SRIM------------------------AVQYKI--------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 128 ~~~~------------------------~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.... ...... ......+..+.+||.+||..||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1000 000000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=241.90 Aligned_cols=170 Identities=26% Similarity=0.326 Sum_probs=136.6
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||+|++ ++.+.+..... ++.++.++.|||+++.+|||||+.|||+...+. +||+|||++....... .
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhc
Confidence 788877 88888876655 566788999999999999999999999988865 9999999986554433 3
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
..+++||+.|||||++.+..|+.+ +||||||++.++|++|.+|+........ +..+.... +......+++.+++
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrv----lflIpk~~-PP~L~~~~S~~~kE 241 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRV----LFLIPKSA-PPRLDGDFSPPFKE 241 (467)
T ss_pred cccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceE----EEeccCCC-CCccccccCHHHHH
Confidence 367789999999999998888766 8999999999999999999987654211 11111111 11112268899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
||..||.+||+.||+|.++|+|+|+++..
T Consensus 242 FV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 99999999999999999999999998744
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=243.26 Aligned_cols=166 Identities=31% Similarity=0.507 Sum_probs=133.1
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++...+. +.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--RT 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--Cc
Confidence 687755 89888876543 467889999999999999999999999988776 99999999875432 22
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+..... ....+.......|. .++..+++|
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l 245 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFR----IYEKILAGRLKFPN--WFDGRARDL 245 (329)
T ss_pred ceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCcCCCC--CCCHHHHHH
Confidence 345789999999999887765 55999999999999999999997754322 22333333333333 578999999
Q ss_pred HHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
|.+||..||.+|++ +.++++||||.+.
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999999997 7999999999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=241.86 Aligned_cols=168 Identities=34% Similarity=0.528 Sum_probs=132.3
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 74 ~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~ 151 (328)
T cd05593 74 MEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAAT 151 (328)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccc
Confidence 677765 7877775443 3667899999999999999999999999987775 99999999875322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+|++.|+|||++.+..+. .++|||||||++|+|++|+.||....... ....+.......| ..++.++.+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~~p--~~~~~~~~~ 224 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEDIKFP--RTLSADAKS 224 (328)
T ss_pred cccccCCcCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHH----HHHHhccCCccCC--CCCCHHHHH
Confidence 2345699999999999877765 45999999999999999999997754322 2222222333333 368999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
||.+||..||.+|+ ++.++++||||...
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=240.50 Aligned_cols=169 Identities=31% Similarity=0.525 Sum_probs=133.3
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 74 ~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~ 151 (323)
T cd05595 74 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT 151 (323)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCc
Confidence 687765 8887776543 3567899999999999999999999999988765 999999998743222 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....|++.|+|||++.+..+. .++|||||||++|+|++|+.||......... ..+.......| ..+++.+.+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~----~~~~~~~~~~p--~~~~~~~~~ 224 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFP--RTLSPEAKS 224 (323)
T ss_pred cccccCCcCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCCCCC--CCCCHHHHH
Confidence 2345699999999999887765 4599999999999999999999876543222 22222233333 368999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHhcCcccCCCC
Q 024572 150 LLSRIFVANPSRRI-----TIKEIKSHPWFLKNL 178 (265)
Q Consensus 150 li~~~L~~dP~~R~-----s~~ell~h~~f~~~~ 178 (265)
||.+||..||.+|+ ++.++++|+||.+..
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999999998 899999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=234.60 Aligned_cols=171 Identities=23% Similarity=0.337 Sum_probs=127.7
Q ss_pred CcccccchHHHHHH----------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVSSLSEFVML----------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~----------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+.+.+.+.. ..++.+++.++.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccc
Confidence 67887765554433 224678899999999999999999999999987775 9999999987543222
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh---------------h
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------V 133 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~ 133 (265)
......+++.|+|||++.+..++ .++|+|||||++|+|++|+.||.................. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cccccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 12234689999999999887765 4599999999999999999999876543332222111000 0
Q ss_pred cccCCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 134 QYKIPD-----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 134 ~~~~~~-----------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
....+. ...++..+.+||.+||..||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000111 11367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=242.87 Aligned_cols=166 Identities=31% Similarity=0.505 Sum_probs=133.4
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~--~~ 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDT--RT 185 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecCC--Cc
Confidence 78875 48999987654 3567899999999999999999999999987765 99999999875432 23
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....||+.|+|||++.+..++ .++|+|||||++|+|++|+.||........ ...+.......| ..++..+.++
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~~l 258 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLI----YQKILEGIIYFP--KFLDNNCKHL 258 (340)
T ss_pred ceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHHHH
Confidence 345799999999999877665 459999999999999999999987654322 222333333333 3578999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
|++||..||.+|+ ++.++++||||.+.
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999996 89999999999753
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=242.23 Aligned_cols=172 Identities=30% Similarity=0.450 Sum_probs=130.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++..++ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCcccccccccc
Confidence 788865 8999887654 3567889999999999999999999999988765 9999999986432110
Q ss_pred ----------------------------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCC
Q 024572 69 ----------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 114 (265)
Q Consensus 69 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf 114 (265)
.....+||+.|+|||++.+..++. ++|||||||++|+|++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~-~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK-LCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC-chhhhhhHHHHHHHHhCCCCC
Confidence 012346999999999998877764 599999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCC---CCCCHHHHhcCcccCCCC
Q 024572 115 EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPS---RRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~---~R~s~~ell~h~~f~~~~ 178 (265)
.+......+..+... ......|....+++++++||.+|+. +|. .||++.++++||||+...
T Consensus 237 ~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 237 CSETPQETYKKVMNW--KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CCCCHHHHHHHHHcC--cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 876543333322211 1223344444678999999999775 444 468999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=238.34 Aligned_cols=169 Identities=32% Similarity=0.534 Sum_probs=132.2
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++..++ ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 75 MEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNR 152 (316)
T ss_pred ECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCc
Confidence 788765 8888876543 2567899999999999999999999999988775 99999999864322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+|++.|+|||++.+..++ .++|||||||++|+|++|+.||........ ...+.......|. .++.++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~ 225 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDEL----FESIRVDTPHYPR--WITKESKD 225 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHH
Confidence 3345689999999999887775 459999999999999999999987654322 2222222222332 57899999
Q ss_pred HHHHhcccCCCCCCCH-HHHhcCcccCCCC
Q 024572 150 LLSRIFVANPSRRITI-KEIKSHPWFLKNL 178 (265)
Q Consensus 150 li~~~L~~dP~~R~s~-~ell~h~~f~~~~ 178 (265)
||.+||..||.+|+++ .++++||||+...
T Consensus 226 li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 9999999999999998 5889999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=236.77 Aligned_cols=175 Identities=20% Similarity=0.303 Sum_probs=132.5
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.++|.+++...+ ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++...... .
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 83 FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKT 160 (309)
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccc
Confidence 6888888888776543 3567899999999999999999999999988765 9999999986433222 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh---------------c
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------Q 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 134 (265)
.....+++.|+|||.+.+....+.++|||||||++|+|++|+.||................... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 2334678999999998765544566999999999999999999998766544333332211000 0
Q ss_pred ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 ~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...+ ....++.++++||.+||..||.+|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0011 112468899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=238.70 Aligned_cols=168 Identities=30% Similarity=0.526 Sum_probs=132.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKT 157 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCc
Confidence 788765 8988876544 3567899999999999999999999999988765 99999999864322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+|++.|+|||++.+..+. .++||||+||++|+|++|+.||.+......+ ..+....... +..++..+.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~----~~i~~~~~~~--~~~~~~~~~~ 230 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSY--PKSLSKEAVS 230 (324)
T ss_pred eeeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCC--CCCCCHHHHH
Confidence 3345689999999999887765 4599999999999999999999876543322 2223333233 3368899999
Q ss_pred HHHHhcccCCCCCCCH-----HHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITI-----KEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~-----~ell~h~~f~~~ 177 (265)
+|.+||..||.+|++. .++++||||...
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999986 899999999764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=235.86 Aligned_cols=165 Identities=28% Similarity=0.404 Sum_probs=126.9
Q ss_pred hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC-----CCCcCCCCCccccccc-C-
Q 024572 15 EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-----KSTVGTPAYIAPEVLS-R- 87 (265)
Q Consensus 15 ~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~-~- 87 (265)
..+++.++.+|.|||.+|.||||||+.||||+++|. |||+|||.+.....+... .++.||++|||||++. .
T Consensus 129 a~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~ 206 (516)
T KOG0582|consen 129 ATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQL 206 (516)
T ss_pred HHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcc
Confidence 345888899999999999999999999999999887 999999987543332211 4557999999999954 3
Q ss_pred CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh----cccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 024572 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----QYKIPDYVHISQDCRNLLSRIFVANPSRRI 163 (265)
Q Consensus 88 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 163 (265)
.+|+ .|+||||||++..||.+|..||......+.+...++..... .........++..++.+|..||.+||.+||
T Consensus 207 ~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp 285 (516)
T KOG0582|consen 207 HGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRP 285 (516)
T ss_pred cCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCC
Confidence 4555 45999999999999999999998876655444433321100 000111234677899999999999999999
Q ss_pred CHHHHhcCcccCCCCChhh
Q 024572 164 TIKEIKSHPWFLKNLPREL 182 (265)
Q Consensus 164 s~~ell~h~~f~~~~~~~~ 182 (265)
|+.++|+|+||++......
T Consensus 286 tAskLlkh~FFk~~k~~~~ 304 (516)
T KOG0582|consen 286 TASKLLKHAFFKKAKSKEY 304 (516)
T ss_pred CHHHHhccHHHhhccchhh
Confidence 9999999999998766543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=234.69 Aligned_cols=166 Identities=32% Similarity=0.599 Sum_probs=148.0
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
|||..+ .|.||+..++. .+||.+++.|||.++++|||||.+|||+|.+++ +||+|||++..+......
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHH
Confidence 888877 89999998774 678999999999999999999999999999887 999999999877777777
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
.++||++.|.+||++.+.+|.++.+|.||||++||.|+.|..||.+.+. ..++.++....+..|. -+.++.-|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrEP~---~PSdA~gL 282 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYREPE---TPSDASGL 282 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccCCC---CCchHHHH
Confidence 8899999999999999999999999999999999999999999988654 4556666677776665 46688999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
|+.||..+|.+|.|+.+|..|=|++
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheee
Confidence 9999999999999999999997764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=238.29 Aligned_cols=168 Identities=33% Similarity=0.516 Sum_probs=133.7
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.+ +|.+++...+. +.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTV 156 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCc
Confidence 677765 89888865543 567899999999999999999999999987765 999999998643222 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....|++.|+|||++.+..+. .++|||||||++|+|++|+.||........ +..+.......| ..+++.+.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~ 229 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKT----IDKILKGKLNLP--PYLTPEARD 229 (323)
T ss_pred ccccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHH
Confidence 3345699999999999877665 459999999999999999999987654332 233333333333 357899999
Q ss_pred HHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
||.+||..+|.+|| ++.++++||||...
T Consensus 230 li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 230 LLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=242.44 Aligned_cols=170 Identities=34% Similarity=0.520 Sum_probs=134.9
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++..++ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCcc
Confidence 788754 8999887653 3667899999999999999999999999988776 9999999987543322
Q ss_pred ----------------------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh
Q 024572 69 ----------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP 120 (265)
Q Consensus 69 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 120 (265)
......||+.|+|||++.+..++ .++|||||||++|+|++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHH
Confidence 22344689999999999887765 4599999999999999999999886643
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCcccCC
Q 024572 121 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT-IKEIKSHPWFLK 176 (265)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s-~~ell~h~~f~~ 176 (265)
.....+... ......|....+++.+.+||.+||. +|.+|++ +.++++||||+.
T Consensus 237 ~~~~~i~~~--~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 237 ETYNKIINW--KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHhcc--CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 333222211 1233445444579999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=239.20 Aligned_cols=168 Identities=31% Similarity=0.498 Sum_probs=133.3
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 75 MEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVT 152 (321)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcc
Confidence 788765 8887775443 3667899999999999999999999999988775 99999999874322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....|++.|+|||++.+..+.. ++|||||||++|+|++|+.||........+ ..+.......| ..++.++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~ 225 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGP-SVDWWALGVLMYEMMAGQPPFEADNEDDLF----ESILHDDVLYP--VWLSKEAVS 225 (321)
T ss_pred ccccccCccccCHHHHcCCCCCC-ccceechhHHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHH
Confidence 33456899999999998877654 499999999999999999999876543332 22333333333 357899999
Q ss_pred HHHHhcccCCCCCC-------CHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRI-------TIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~-------s~~ell~h~~f~~~ 177 (265)
||.+||..||.+|+ ++.++++||||...
T Consensus 226 ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 99999999999999 89999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=242.98 Aligned_cols=170 Identities=29% Similarity=0.441 Sum_probs=133.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++...+ ++.+|+.++.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 75 TDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKT 152 (330)
T ss_pred EcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCC
Confidence 677755 8887776543 3678999999999999999999999999988775 99999999874322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||..|+|||++.+....+.++|||||||++|+|++|+.||....... ....+.......+. ..++..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~-~~~~~~~~~ 227 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYRNIAFGKVRFPK-NVLSDEGRQ 227 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----HHHHHHcCCCCCCC-ccCCHHHHH
Confidence 3345799999999998765534556999999999999999999998754432 22333333333333 247899999
Q ss_pred HHHHhcccCCCCCC----CHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRI----TIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~----s~~ell~h~~f~~~ 177 (265)
||.+||..||.+|| ++.++++||||...
T Consensus 228 li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 228 FVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999999999998 79999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=243.13 Aligned_cols=173 Identities=34% Similarity=0.500 Sum_probs=134.5
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--C
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||++....... .
T Consensus 122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVR 199 (370)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCccc
Confidence 788854 8988876533 3567899999999999999999999999988776 9999999987543222 2
Q ss_pred CCCCcCCCCCcccccccCCc---CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||........+..+... ......|....++..
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~ 277 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEISKQ 277 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCCHH
Confidence 23457999999999987532 2345699999999999999999999876654333332211 122334555568999
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 024572 147 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKN 177 (265)
Q Consensus 147 ~~~li~~~L~~dP~~--R~s~~ell~h~~f~~~ 177 (265)
+++||.+||..+|.+ |+|+.++++||||+..
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999999999988 9999999999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=242.04 Aligned_cols=175 Identities=25% Similarity=0.334 Sum_probs=132.1
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--C
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~ 69 (265)
||++.++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 83 ~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~~~~ 160 (372)
T cd07853 83 TELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDESKH 160 (372)
T ss_pred eeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCcccc
Confidence 6777778877765433 3678999999999999999999999999988775 9999999987543221 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH-------------------H
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR-------------------I 130 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-------------------~ 130 (265)
.....+++.|+|||++.+....+.++||||+||++|+|++|+.||.+......+..+... +
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 240 (372)
T cd07853 161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240 (372)
T ss_pred CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHH
Confidence 223457889999999987554456699999999999999999999876554433222211 0
Q ss_pred hhhcccCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 131 MAVQYKIP-------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 131 ~~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.......+ .....++.+.+||.+||..||.+|||+.++++||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00011111 122457889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=237.22 Aligned_cols=164 Identities=31% Similarity=0.414 Sum_probs=130.0
Q ss_pred Cccccc-chHHHHHHh--c---------cccchHHHHHhhhhcC-ceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLE--G---------SVKMKPDIFFSSLSQQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--~---------~~~~i~~~l~~lH~~~-ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
|||..+ +|.+++..+ . ++-+|+.++.|||+++ ||||||||+|||++.+. .++||+|||+++.....
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVIS 197 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccc
Confidence 677766 999999872 2 2445788899999999 99999999999999886 24999999999755443
Q ss_pred -CCCCCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 68 -SRPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 68 -~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
...+...||..|||||++.+ ..|+ .++||||||+++|+|+||+.||....... ....+.....+.+.+..++
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~----~~~~v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQ----VASAVVVGGLRPPIPKECP 272 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcCCCCCCCccCC
Confidence 33344689999999999994 4665 45999999999999999999999876522 2222333333444444589
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.+..||.+||..||.+||++.+++.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999999875
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=239.88 Aligned_cols=173 Identities=25% Similarity=0.346 Sum_probs=125.5
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.++|.+++..+. ++.+++.+|.|||++||+||||||+|||++..+. +||+|||+++........
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCccc
Confidence 5677778888776432 3678899999999999999999999999987775 999999998744333333
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChH----------HHHHHHHHHhhhcccCC--
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK----------NFRKTISRIMAVQYKIP-- 138 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~----------~~~~~~~~~~~~~~~~~-- 138 (265)
....||..|+|||++.+..+.. ++|||||||++|+|+++..++....... .+...+.........++
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNS-KADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecCCCCCCc-hhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 4456899999999998877754 5999999999999998655543321111 11111111100000000
Q ss_pred --------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 139 --------------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 139 --------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
....++.++.+||.+||..||.+|||+.++++||||++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 01135667888999999999999999999999999975
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=229.89 Aligned_cols=171 Identities=29% Similarity=0.449 Sum_probs=140.8
Q ss_pred Cccccc-chHHHHHHhcc-----------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC--
Q 024572 1 MQLGVS-SLSEFVMLEGS-----------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-- 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~-----------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-- 66 (265)
||||.+ +|.-+.+++.- +..++-||.|||-.|||+|||||+||||..+|. |.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPVSP 233 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCCCC
Confidence 899988 89988887653 444677899999999999999999999988886 99999988631100
Q ss_pred -------------------------------C------------------------CCCCCCcCCCCCcccccccCCcCC
Q 024572 67 -------------------------------H------------------------SRPKSTVGTPAYIAPEVLSRREYD 91 (265)
Q Consensus 67 -------------------------------~------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 91 (265)
. .....++||-.|+|||++.+.+..
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 011234688899999999998875
Q ss_pred CchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHH
Q 024572 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT----IKE 167 (265)
Q Consensus 92 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s----~~e 167 (265)
.++|+|+|||++|||+.|..||.+.+....+.+ +......+|....++..+++||+++|.+||.+|.. +.+
T Consensus 314 -sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N----Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 314 -SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN----IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred -chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH----HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 559999999999999999999999887655554 44556677777788899999999999999999997 999
Q ss_pred HhcCcccCCCC
Q 024572 168 IKSHPWFLKNL 178 (265)
Q Consensus 168 ll~h~~f~~~~ 178 (265)
|.+||||+...
T Consensus 389 IK~HpFF~gVn 399 (459)
T KOG0610|consen 389 IKRHPFFEGVN 399 (459)
T ss_pred hhcCccccCCC
Confidence 99999998643
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=241.45 Aligned_cols=173 Identities=19% Similarity=0.271 Sum_probs=126.4
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC--CC
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--~~ 69 (265)
||++.++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 162 ~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 162 LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANK 239 (391)
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccc
Confidence 5667778877775432 4677899999999999999999999999987765 999999998643221 12
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCC-------hHHHHHHHHHH------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRI------------ 130 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~-------~~~~~~~~~~~------------ 130 (265)
.....||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... ...+..++...
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 2345799999999999887765 559999999999999999988754321 11111111110
Q ss_pred ----------hhhcccCC----C---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 131 ----------MAVQYKIP----D---YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 131 ----------~~~~~~~~----~---~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.......+ . ...++.++.+||.+||..||.+|||+.++|+||||+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00000000 0 1134668999999999999999999999999999975
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=238.28 Aligned_cols=171 Identities=27% Similarity=0.448 Sum_probs=131.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++...+ ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 75 IEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCc
Confidence 688765 8888776543 3567899999999999999999999999988765 99999999874322 223
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChH-----HHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----NFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
....+||+.|+|||++.+..++ .++|+|||||++|+|++|+.||....... ........+.......| ..++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~ 229 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP--RSLS 229 (329)
T ss_pred cccccCCccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC--CCCC
Confidence 3345799999999999887765 45999999999999999999996422111 11112222333333333 3678
Q ss_pred HHHHHHHHHhcccCCCCCCC------HHHHhcCcccCC
Q 024572 145 QDCRNLLSRIFVANPSRRIT------IKEIKSHPWFLK 176 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s------~~ell~h~~f~~ 176 (265)
..+.++|.+||..||.+|++ +.++++||||..
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 99999999999999999997 789999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=241.15 Aligned_cols=169 Identities=32% Similarity=0.513 Sum_probs=133.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~ 68 (265)
||++.+ +|.+++.... ++.+++.+|.|||+ +||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 74 ~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 74 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGA 151 (325)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCc
Confidence 788765 8887776543 35678999999997 89999999999999988775 99999999874322 22
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......|++.|+|||++.+..+. .++|||||||++|+|++|+.||........ ...+.......| ..+++++.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~ 224 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFP--RTLSPEAK 224 (325)
T ss_pred ccccccCCcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHH
Confidence 22345699999999999887765 459999999999999999999987554322 222222233333 36889999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCcccCCCC
Q 024572 149 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKNL 178 (265)
Q Consensus 149 ~li~~~L~~dP~~R~-----s~~ell~h~~f~~~~ 178 (265)
+||.+||..||.+|+ ++.++++||||....
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999997 899999999998644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=233.74 Aligned_cols=174 Identities=24% Similarity=0.385 Sum_probs=130.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhc-CceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQ-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~-~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++ +|+||||||+|||++.++. +||+|||+++.... ..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~ 158 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 158 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-cc
Confidence 687766 8999887543 356788999999986 6999999999999988776 99999999875432 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH---------------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS--------------------- 128 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~--------------------- 128 (265)
.....++..|+|||++.+..++ .++|||||||++|+|++|+.||....... +...+.
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccc
Confidence 3345689999999999887765 45999999999999999999996543211 111110
Q ss_pred ----------------------HHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 129 ----------------------RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 129 ----------------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
.+............++.++++||.+||..||++|||+.++++||||+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 309 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV 309 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence 000000000011246789999999999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=232.05 Aligned_cols=172 Identities=25% Similarity=0.360 Sum_probs=131.7
Q ss_pred Cccccc-chHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++.. ..++.+++.++.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCC
Confidence 677754 78776642 123677899999999999999999999999987765 99999999865433
Q ss_pred CCC-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 67 HSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 67 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
... .....|++.|+|||++.+..++ .++|+|||||++|+|++|+.||...............+.... ...+..++.
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 226 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS--VTYPDKFSP 226 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC--CCCcccCCH
Confidence 222 2334689999999999887775 459999999999999999999986543322222222222222 222336889
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 146 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
.+.+++.+||..||.+|| +++++++||||+..
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 999999999999999999 88999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=239.37 Aligned_cols=170 Identities=29% Similarity=0.463 Sum_probs=133.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++...+ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YA 155 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--cc
Confidence 688755 8999886543 3567899999999999999999999999988765 99999999875433 33
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCC----CCCCHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY----VHISQD 146 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 146 (265)
....|++.|+|||++.+..++ .++|||||||++|+|++|..||........+....... .....|.. ..++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCCccccccCHH
Confidence 456799999999999887765 45999999999999999999998765443333222111 11112221 256899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+.+||.+||..+|.+||++.++++||||...
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 9999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=237.12 Aligned_cols=168 Identities=32% Similarity=0.512 Sum_probs=133.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++...+ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVT 157 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCc
Confidence 677754 8888876543 3667899999999999999999999999988776 99999999874332 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+|++.|+|||++.+..++ .++|||||||++|+|++|+.||........ ...+.......| ..++.++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~ 230 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYP--KSMSKEAVA 230 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCC--CcCCHHHHH
Confidence 3345689999999999887775 459999999999999999999987654332 233333333333 368999999
Q ss_pred HHHHhcccCCCCCCCH-----HHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITI-----KEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~-----~ell~h~~f~~~ 177 (265)
|+.+||..+|.+|+++ .++++||||+..
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999984 899999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=236.12 Aligned_cols=168 Identities=33% Similarity=0.536 Sum_probs=132.9
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++...+ ++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 75 MEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVT 152 (318)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCc
Confidence 688755 8888776553 3567899999999999999999999999988775 99999999864322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+++..|+|||++.+..++. ++|+|||||++|+|++|+.||........ ...+.......| ..++..+.+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslGvil~~l~~G~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~ 225 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGP-AVDWWALGVLLYEMLAGQSPFEGDDEDEL----FQSILEDEVRYP--RWLSKEAKS 225 (318)
T ss_pred ccceecCccccCHHHhcCCCCCc-chhhhhHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCCCC--CcCCHHHHH
Confidence 23446899999999998877754 59999999999999999999977553322 222223333333 357899999
Q ss_pred HHHHhcccCCCCCCCH-----HHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITI-----KEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~-----~ell~h~~f~~~ 177 (265)
||.+||..||.+|||+ .++++||||+..
T Consensus 226 li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999999999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=238.61 Aligned_cols=175 Identities=26% Similarity=0.439 Sum_probs=129.6
Q ss_pred Cccccc-chHHH-----HHHhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CCCCC
Q 024572 1 MQLGVS-SLSEF-----VMLEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST 73 (265)
Q Consensus 1 me~~~~-sL~~~-----~~~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 73 (265)
||++.+ +|.+. .....++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...... .....
T Consensus 151 ~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~ 228 (353)
T PLN00034 151 LEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSS 228 (353)
T ss_pred EecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceeccccccccccc
Confidence 566655 55432 223346788999999999999999999999999988765 9999999987543222 22345
Q ss_pred cCCCCCcccccccC----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 74 VGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 74 ~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.|+..|+|||++.. ..+.+.++|||||||++|+|++|+.||...... .+......+. ..........++..+++
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 306 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAIC-MSQPPEAPATASREFRH 306 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHh-ccCCCCCCCccCHHHHH
Confidence 78999999998753 233445699999999999999999999743322 1222222211 11122233467899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
||.+||..||++|||+.++++||||.+...
T Consensus 307 li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 307 FISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 999999999999999999999999987644
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=236.21 Aligned_cols=168 Identities=32% Similarity=0.542 Sum_probs=131.9
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 75 ~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 75 MEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGK 152 (316)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCc
Confidence 788754 8888876543 3677899999999999999999999999987765 999999998753322 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+......+ ..+....... +..++.++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~--~~~~~~~~~~ 225 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELF----DSILNDRPHF--PRWISKEAKD 225 (316)
T ss_pred cccccCCccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCC--CCCCCHHHHH
Confidence 3345689999999999887765 4499999999999999999999876543222 2222222222 3357899999
Q ss_pred HHHHhcccCCCCCCCHH-HHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITIK-EIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~-ell~h~~f~~~ 177 (265)
||.+||..+|.+||++. ++++||||...
T Consensus 226 ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 226 CLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 99999999999999864 88899999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=219.73 Aligned_cols=153 Identities=25% Similarity=0.486 Sum_probs=123.3
Q ss_pred hHHHHHhhh-hcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccC---CcCCCchHh
Q 024572 21 KPDIFFSSL-SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR---REYDGKLAD 96 (265)
Q Consensus 21 i~~~l~~lH-~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~D 96 (265)
+..+|.||. .+||+|||+||+|||+|..|. +||||||++.............|.+.|||||.+.- ..|+-. +|
T Consensus 200 ~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiR-aD 276 (391)
T KOG0983|consen 200 IVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIR-AD 276 (391)
T ss_pred HHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecccccccccCCccccCccccCCCCCCccchh-hh
Confidence 566777876 789999999999999998887 99999999987666666666789999999999854 345544 89
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh-hcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 97 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 97 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
|||||+.+++|.||+.||.+....-.. +..+.. ....++....+++++++|+..||.+|+.+||...++|+|||++
T Consensus 277 VWSlGITlveLaTg~yPy~~c~tdFe~---ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 277 VWSLGITLVELATGQYPYKGCKTDFEV---LTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred hhhhccchhhhhcccCCCCCCCccHHH---HHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence 999999999999999999987654322 222222 2233444556899999999999999999999999999999997
Q ss_pred CCCC
Q 024572 176 KNLP 179 (265)
Q Consensus 176 ~~~~ 179 (265)
..-.
T Consensus 354 ~ye~ 357 (391)
T KOG0983|consen 354 RYET 357 (391)
T ss_pred ecch
Confidence 6543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=236.18 Aligned_cols=168 Identities=30% Similarity=0.531 Sum_probs=131.8
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCCC
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~ 70 (265)
||++.+ +|..++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.... ....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCcc
Confidence 677765 776665432 24677899999999999999999999999988775 99999999874322 2223
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...+|++.|+|||.+.+..+. .++|||||||++|+|++|+.||.+....... ..+.......| ..++..+.++
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~l 231 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVF----DSIVNDEVRYP--RFLSREAISI 231 (324)
T ss_pred cccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCCHHHHHH
Confidence 345799999999999887765 4599999999999999999999876543322 22223333333 3578999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
|.+||..||.+|| ++.++++||||+..
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999999999 69999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=230.95 Aligned_cols=172 Identities=22% Similarity=0.355 Sum_probs=132.1
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ++|+|||++.......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGK 149 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCc
Confidence 677754 8887775432 3567899999999999999999999999988765 9999999987554433
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......++..|+|||++.+..++ .++|+||+||++|+|++|+.||....................... ....++.+++
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 227 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESK 227 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHH
Confidence 33445689999999999887765 459999999999999999999976543322223333322222221 1235789999
Q ss_pred HHHHHhcccCCCCCCCH----HHHhcCcccCC
Q 024572 149 NLLSRIFVANPSRRITI----KEIKSHPWFLK 176 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~----~ell~h~~f~~ 176 (265)
+||.+||..||.+||++ .+++.|+||+.
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 99999999999999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=237.46 Aligned_cols=172 Identities=27% Similarity=0.430 Sum_probs=130.6
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.... ...
T Consensus 75 ~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 75 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCc
Confidence 677765 7877765443 3567899999999999999999999999988776 99999999874322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----KNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.....||..|+|||++.+..+.. ++|+|||||++|+|++|+.||...... .........+.......| ..++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~~ 229 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLS 229 (329)
T ss_pred cccccCCccccCHHHHcCCCCCC-ccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC--CCCC
Confidence 33457899999999998877654 599999999999999999999532111 111112222233333333 3678
Q ss_pred HHHHHHHHHhcccCCCCCCC------HHHHhcCcccCCC
Q 024572 145 QDCRNLLSRIFVANPSRRIT------IKEIKSHPWFLKN 177 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s------~~ell~h~~f~~~ 177 (265)
..+.+||.+||..||.+|++ +.++++||||+..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999999999998 5799999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=235.07 Aligned_cols=168 Identities=33% Similarity=0.532 Sum_probs=131.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 75 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 75 MEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAK 152 (316)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCc
Confidence 688754 8988887543 3567899999999999999999999999988775 999999998743222 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....||..|+|||++.+..++ .++|+||+||++|+|++|+.||........ ...+.......| ..++.++++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~ 225 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEEL----FQSIRMDNPCYP--RWLTREAKD 225 (316)
T ss_pred eeeecCCccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCC--ccCCHHHHH
Confidence 2345689999999999887765 459999999999999999999987553222 222222222222 257899999
Q ss_pred HHHHhcccCCCCCCCHH-HHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITIK-EIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~-ell~h~~f~~~ 177 (265)
||.+||..||.+||++. ++++||||+..
T Consensus 226 li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 226 ILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 99999999999999996 89999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=237.82 Aligned_cols=168 Identities=30% Similarity=0.454 Sum_probs=132.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 75 LDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred EcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCc
Confidence 677766 8888776543 3678899999999999999999999999988775 999999998743222 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+|++.|+|||++.+..++ .++|||||||++|+|++|+.||........ ...+....... ...++..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~--~~~~~~~~~~ 225 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEM----YDNILNKPLRL--KPNISVSARH 225 (323)
T ss_pred cccccCChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHH----HHHHHcCCCCC--CCCCCHHHHH
Confidence 3345689999999999887765 459999999999999999999987544322 22222222222 2357899999
Q ss_pred HHHHhcccCCCCCCCH----HHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITI----KEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~----~ell~h~~f~~~ 177 (265)
+|.+||..||.+||++ .++++||||...
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred HHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999987 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=236.75 Aligned_cols=174 Identities=22% Similarity=0.304 Sum_probs=123.2
Q ss_pred CcccccchHHHHHH------------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCC--CCCcEEEeccCC
Q 024572 1 MQLGVSSLSEFVML------------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGS--PAPRLKICDFGY 60 (265)
Q Consensus 1 me~~~~sL~~~~~~------------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~--~~~~vkl~Dfg~ 60 (265)
||+++++|.+++.. ..++.+++.++.|||++||+||||||+|||+..+ ..+.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 57778887777642 2346688999999999999999999999999432 223599999999
Q ss_pred cccCCCCC----CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh---------HHHHHHH
Q 024572 61 SKSSLLHS----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---------KNFRKTI 127 (265)
Q Consensus 61 a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~---------~~~~~~~ 127 (265)
++...... ......+|+.|+|||++.+....+.++|||||||++|+|++|++||...... .......
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 97543321 1223468899999999987554456699999999999999999999754321 1111111
Q ss_pred HHHh------------------------hhccc--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 128 SRIM------------------------AVQYK--------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 128 ~~~~------------------------~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.... ..... .......+..+.+||.+||..||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 00000 00011235668899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=240.23 Aligned_cols=174 Identities=25% Similarity=0.320 Sum_probs=130.3
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC--
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-- 69 (265)
||++.++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 165 ~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 165 MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred ehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCcccccc
Confidence 6778888888875432 3667899999999999999999999999988775 99999999865433222
Q ss_pred -CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhhhc-----------
Q 024572 70 -PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQ----------- 134 (265)
Q Consensus 70 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~----------- 134 (265)
.....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.... ..+..++..+....
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 22346899999999998877754 499999999999999999999765432 12222221111000
Q ss_pred --------------ccCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 --------------YKIPD---YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 --------------~~~~~---~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+..+. ...++.++.+||.+||..||.+|||+.++++||||.+.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00110 01346788999999999999999999999999999764
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=236.33 Aligned_cols=172 Identities=28% Similarity=0.418 Sum_probs=131.6
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 75 IEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCc
Confidence 678755 8887776443 4677899999999999999999999999988776 99999999874322 223
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
....+|++.|+|||++.+..++ .++|||||||++|+|++|+.||...... .........+.......| ..++..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~ 229 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVK 229 (327)
T ss_pred eecccCCcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC--CCCCHH
Confidence 3445799999999999887775 4599999999999999999999643211 111112222222233333 357899
Q ss_pred HHHHHHHhcccCCCCCCC------HHHHhcCcccCCC
Q 024572 147 CRNLLSRIFVANPSRRIT------IKEIKSHPWFLKN 177 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s------~~ell~h~~f~~~ 177 (265)
+.++|.+||..||.+|++ +.++++||||+..
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 999999999999999998 5799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=230.12 Aligned_cols=172 Identities=26% Similarity=0.377 Sum_probs=133.8
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ++|+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGE 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCC
Confidence 677764 8887775432 2567889999999999999999999999987765 9999999987654333
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......++..|+|||++.+..++. ++|+||+||++|+|++|+.||.+.............+..... ..+..++..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 233 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTF-SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE--EYSEKFSEAAR 233 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCc-cccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc--ccCcccCHHHH
Confidence 334457899999999998776654 489999999999999999999876543333333333222222 22235789999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 149 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 149 ~li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
+||.+||..||.+|| ++.++++||||...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=240.36 Aligned_cols=171 Identities=35% Similarity=0.534 Sum_probs=132.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++...+ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceeccccccc
Confidence 788855 8999887654 3667899999999999999999999999988776 9999999986432111
Q ss_pred -------------------------------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCC
Q 024572 69 -------------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA 111 (265)
Q Consensus 69 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~ 111 (265)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCC
Confidence 01124689999999999887775 4599999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccCCC
Q 024572 112 YPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKN 177 (265)
Q Consensus 112 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~ell~h~~f~~~ 177 (265)
.||............... ......|....+++.+++||.+||. +|.+|++ +.++++||||+..
T Consensus 237 ~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 237 PPFCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999876543332222211 1122334444678999999999996 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=214.46 Aligned_cols=150 Identities=38% Similarity=0.657 Sum_probs=132.1
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhH
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 97 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 97 (265)
++|++.++.|+|.++|+||||||+|+|++..+. +||+|||.+.... .....+.|||.-|.+||...+..++.. +|+
T Consensus 130 i~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~ 205 (281)
T KOG0580|consen 130 IKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDL 205 (281)
T ss_pred HHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccch-hhH
Confidence 788999999999999999999999999988876 9999999987655 556677899999999999999888755 999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 98 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 98 wslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
|++|++.|+++.|.+||..... ....+++......+| ..++.++++||.+||.++|.+|.+..+++.|||...+
T Consensus 206 w~lgvl~yeflvg~ppFes~~~----~etYkrI~k~~~~~p--~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 206 WSLGVLCYEFLVGLPPFESQSH----SETYKRIRKVDLKFP--STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHHHHHhcCCchhhhhh----HHHHHHHHHccccCC--cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 9999999999999999988664 445555666666666 4799999999999999999999999999999998653
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=230.56 Aligned_cols=175 Identities=22% Similarity=0.316 Sum_probs=131.8
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||++....... .
T Consensus 83 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 83 FEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 160 (301)
T ss_pred EeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence 6888888888876532 3567899999999999999999999999988765 9999999986433222 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh---------------c
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------Q 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 134 (265)
.....++..|+|||.+.+....+.++|||||||++|+|++|+.||................... .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 2234578899999998765544566999999999999999999998765433332222111000 0
Q ss_pred ccCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 YKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 ~~~~~---------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...+. ...+++.+++||.+||..||.+|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 01111 12468889999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=239.17 Aligned_cols=172 Identities=28% Similarity=0.440 Sum_probs=132.8
Q ss_pred Ccccc-cchHHHHHHh-c---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE-G---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~-~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++... . ++.+++.+|.|||++||+||||||+|||++.++. +||+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKM 157 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCc
Confidence 78874 4899988765 1 3567899999999999999999999999987775 99999999875433222
Q ss_pred --CCCCcCCCCCcccccccC-----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 70 --PKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
.....+|+.|+|||++.. ....+.++|||||||++|+|++|+.||........+..+... ......|....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 235 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPK 235 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCC
Confidence 223468999999999863 222345599999999999999999999876554433332221 11123444446
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++..+.+||.+||. +|.+|||+.++++||||...
T Consensus 236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 89999999999997 99999999999999999763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=235.92 Aligned_cols=168 Identities=30% Similarity=0.449 Sum_probs=132.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 75 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGT 152 (325)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCC
Confidence 678876 8888876543 3678999999999999999999999999987765 99999999874322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+|++.|+|||++.+..++ .++|||||||++|+|++|+.||........+.. +..... .....++..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~--~~~~~~~~~~~~ 225 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPL--QLKPNITNSARH 225 (325)
T ss_pred cccccCCccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHH----HHhCCc--CCCCCCCHHHHH
Confidence 3345699999999999887765 459999999999999999999987654333222 222222 223368899999
Q ss_pred HHHHhcccCCCCCCCHH----HHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITIK----EIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~----ell~h~~f~~~ 177 (265)
+|.+||..+|.+|+++. ++++|+||...
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 226 LLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 99999999999999876 89999999653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=239.70 Aligned_cols=173 Identities=32% Similarity=0.485 Sum_probs=132.8
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--C
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 122 ~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 122 MEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCcee
Confidence 788755 8998886533 3567899999999999999999999999987765 9999999987543222 2
Q ss_pred CCCCcCCCCCcccccccCCc---CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
....+||+.|+|||++.+.. +.+.++|+||+||++|+|++|+.||........+..+... ......|....++..
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~ 277 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEISKH 277 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCCHH
Confidence 23457999999999987643 2345699999999999999999999876544333332221 122344555567999
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 024572 147 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKN 177 (265)
Q Consensus 147 ~~~li~~~L~~dP~~--R~s~~ell~h~~f~~~ 177 (265)
++++|.+||..++.+ |+++.++++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999865543 8899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=243.10 Aligned_cols=165 Identities=29% Similarity=0.385 Sum_probs=142.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||||.. .|.+.+.... |.+.|+.++.|||.+.|||||||.-||||..+.. |||+|||-++........
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTK 268 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhh
Confidence 899988 8999887654 4788999999999999999999999999988776 999999999877666677
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
..++||..|||||++++.+...+ +||||||||||+||||..||..... ..++-.+......+|.+..++..++-|
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVGsNsL~LpvPstcP~GfklL 343 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVGSNSLHLPVPSTCPDGFKLL 343 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccch----heeEEeccCCcccccCcccCchHHHHH
Confidence 78899999999999998887655 9999999999999999999977544 233444455556677777899999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCc
Q 024572 151 LSRIFVANPSRRITIKEIKSHP 172 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~ 172 (265)
|++||...|..||++.+++.|-
T Consensus 344 ~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 344 LKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHhcCCCCCccHHHHHHHH
Confidence 9999999999999999999983
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=238.43 Aligned_cols=172 Identities=31% Similarity=0.462 Sum_probs=130.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCccccccccc
Confidence 788855 8988876543 3667899999999999999999999999987765 9999999875321000
Q ss_pred ----------------------------------------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHH
Q 024572 69 ----------------------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGV 102 (265)
Q Consensus 69 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 102 (265)
.....+||+.|+|||++.+..+. .++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-Cccceeehhh
Confidence 01234699999999999887775 4599999999
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHhcCcccCCC
Q 024572 103 TLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV--ANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 103 ~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~--~dP~~R~s~~ell~h~~f~~~ 177 (265)
++|+|++|+.||...........++. .......|....+++++++||.+|+. .+|..|+++.++++||||...
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 99999999999987654333222221 11223445555689999999999654 455569999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=245.08 Aligned_cols=169 Identities=26% Similarity=0.399 Sum_probs=133.0
Q ss_pred Cccccc-chHHHHHHhc-------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 118 ~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGls~~~~~ 195 (496)
T PTZ00283 118 LDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAA 195 (496)
T ss_pred EeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecccCeeccc
Confidence 577765 8988886432 3567899999999999999999999999988775 99999999875432
Q ss_pred C---CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 67 H---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 67 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
. ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... .+..+..... .+.+..+
T Consensus 196 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~----~~~~~~~~~~-~~~~~~~ 269 (496)
T PTZ00283 196 TVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEE----VMHKTLAGRY-DPLPPSI 269 (496)
T ss_pred cccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhcCCC-CCCCCCC
Confidence 2 122345799999999999887765 55999999999999999999998754322 2222222222 2334468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++.+.+|+.+||..+|.+||++.++++|||++..
T Consensus 270 ~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 270 SPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 9999999999999999999999999999998643
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=227.10 Aligned_cols=172 Identities=24% Similarity=0.344 Sum_probs=127.4
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||+++++|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++...... .
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRC 155 (284)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCC
Confidence 578888888877542 24677899999999999999999999999987765 9999999987543222 1
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-------------cc-
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------QY- 135 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~- 135 (265)
.....++..|+|||.+.+....+.++|||||||++|+|++|..||............+...... ..
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2234578899999998776544566999999999999999998865544332222111111000 00
Q ss_pred cC----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 136 KI----------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 136 ~~----------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.. .....++..+++||.+||..||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 0112467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=240.63 Aligned_cols=171 Identities=33% Similarity=0.507 Sum_probs=131.5
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
||++.+ +|.+++...+ ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCccccccccc
Confidence 788765 8988887644 2567889999999999999999999999988776 999999997522100
Q ss_pred ---------------------------------------------CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHH
Q 024572 68 ---------------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGV 102 (265)
Q Consensus 68 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 102 (265)
......+||+.|+|||++.+..+.. ++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ-LCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC-eeeEEechH
Confidence 0011246899999999998877764 599999999
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccCCC
Q 024572 103 TLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKN 177 (265)
Q Consensus 103 ~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~ell~h~~f~~~ 177 (265)
++|+|++|+.||.............. .......|....+++++.++|.+|+ .+|.+|++ +.++++||||+..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999999987654333322221 1122334445568999999999986 59999997 9999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=231.15 Aligned_cols=168 Identities=30% Similarity=0.532 Sum_probs=132.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.+ +|.+++...+ ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCcc
Confidence 788854 8888876543 3667899999999999999999999999998775 9999999987433222 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....|++.|+|||++.+..++ .++|+||+||++|+|++|+.||........ ...+.......| ..++..+.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~~ 230 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDEL----FQSIMEHNVSYP--KSLSKEAVS 230 (323)
T ss_pred ccCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCC--ccCCHHHHH
Confidence 2345689999999999887765 459999999999999999999987654322 233333333333 367899999
Q ss_pred HHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
++.+||..+|.+|++ ..++++||||...
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999999997 4789999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=240.01 Aligned_cols=171 Identities=33% Similarity=0.507 Sum_probs=131.9
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
||++.+ +|.+++...+. +.+++.++.|||++||+||||||+|||++.++. +||+|||+|......
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCccccccccc
Confidence 788854 89999876543 567899999999999999999999999987765 999999997422100
Q ss_pred -----------------------------------------CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHH
Q 024572 68 -----------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYV 106 (265)
Q Consensus 68 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ 106 (265)
......+||+.|+|||++.+..+. .++|||||||++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeee
Confidence 001134689999999999887775 45999999999999
Q ss_pred HHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccCCC
Q 024572 107 MLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKN 177 (265)
Q Consensus 107 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---s~~ell~h~~f~~~ 177 (265)
|++|+.||.............. .......+....+++.+.++|.+|+ .+|.+|+ ++.++++||||+..
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999999987654333222211 1122334444568999999999976 5999999 99999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=238.07 Aligned_cols=171 Identities=33% Similarity=0.516 Sum_probs=131.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCccccccccc
Confidence 788865 8999887554 3667889999999999999999999999987765 9999999986432110
Q ss_pred ----------------------------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCC
Q 024572 69 ----------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 114 (265)
Q Consensus 69 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf 114 (265)
.....+||+.|+|||++.+..++. ++|||||||++|+|++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK-LCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC-cceeccccceeeecccCCCCC
Confidence 012346899999999998877764 499999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccCCC
Q 024572 115 EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKN 177 (265)
Q Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---s~~ell~h~~f~~~ 177 (265)
........+..+... ......|....++..+++||.+|+ .+|.+|+ ++.++++||||...
T Consensus 237 ~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 237 CSETPQETYRKVMNW--KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCHHHHHHHHHcC--CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 876554333322211 122234444457899999999987 4999998 48999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=238.94 Aligned_cols=171 Identities=30% Similarity=0.478 Sum_probs=130.2
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++. ++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeeccccccccccccc
Confidence 78885 48988876433 4678899999999999999999999999987765 9999999985321100
Q ss_pred ----------------------------------------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHH
Q 024572 69 ----------------------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGV 102 (265)
Q Consensus 69 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 102 (265)
.....+||+.|+|||++.+..+. .++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecch
Confidence 00124689999999999887775 4599999999
Q ss_pred HHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcccCCC
Q 024572 103 TLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRR---ITIKEIKSHPWFLKN 177 (265)
Q Consensus 103 ~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---~s~~ell~h~~f~~~ 177 (265)
++|+|++|..||........+..+... ......|....++.++++||.+||. +|.+| +++.++++||||+..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999999999999876543333322211 1223345545688999999999997 77765 599999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=227.43 Aligned_cols=171 Identities=28% Similarity=0.394 Sum_probs=130.6
Q ss_pred Ccccc-cchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCc
Confidence 56664 58988875432 2567899999999999999999999999987765 9999999987544333
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......|+..|+|||++.+..++ .++|+||+||++|+|++|+.||.................... ......+++.+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 233 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--EEYSEKFSPDAR 233 (285)
T ss_pred cccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--hhcCccCCHHHH
Confidence 33445789999999999887765 459999999999999999999987543221111111111111 112235788999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCcccCC
Q 024572 149 NLLSRIFVANPSRRIT-----IKEIKSHPWFLK 176 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s-----~~ell~h~~f~~ 176 (265)
+|+.+||..||.+||| +.++++||||+.
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=234.61 Aligned_cols=169 Identities=28% Similarity=0.410 Sum_probs=132.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 75 LDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCC
Confidence 677765 7877765443 3677899999999999999999999999988775 99999999874322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+|++.|+|||++.+..++. ++|||||||++|+|++|+.||........+. .+....... ....+..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~G~~pf~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~ 225 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDN-TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD----NILHKPLVL--RPGASLTAWS 225 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCC-cCccccccceehhhhcCCCCCCCCCHHHHHH----HHHcCCccC--CCCCCHHHHH
Confidence 33456999999999998877754 5999999999999999999998765433322 222222222 2357889999
Q ss_pred HHHHhcccCCCCCCCH----HHHhcCcccCCCC
Q 024572 150 LLSRIFVANPSRRITI----KEIKSHPWFLKNL 178 (265)
Q Consensus 150 li~~~L~~dP~~R~s~----~ell~h~~f~~~~ 178 (265)
+|.+||..+|.+||++ .+++.||||....
T Consensus 226 ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 226 ILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred HHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 9999999999999976 5899999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=226.05 Aligned_cols=172 Identities=22% Similarity=0.334 Sum_probs=128.4
Q ss_pred CcccccchHHHHHHh------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVSSLSEFVMLE------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.++|.+++... .++.+++.+|.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPV 155 (285)
T ss_pred EecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCc
Confidence 678877887776532 13678999999999999999999999999988776 9999999986443221
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh--------------h
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------------V 133 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------~ 133 (265)
......+++.|+|||++.+....+.++|+|||||++|+|++|+.||.+................ .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 1123357889999999876554456699999999999999999999876543332222211100 0
Q ss_pred cccC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 134 QYKI---------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 134 ~~~~---------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.... .....++++++++|.+||..||.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000 0122478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-33 Score=259.88 Aligned_cols=171 Identities=26% Similarity=0.342 Sum_probs=137.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||||++ +|++....-. ...|++.++.|||++|||||||||.||+++.++. +|++|||.|.....+.
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhc
Confidence 899988 8988877543 4778999999999999999999999999998886 9999999997655442
Q ss_pred ---CCCCCcCCCCCcccccccCCcC--CCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 69 ---RPKSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 69 ---~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
......||+.|||||++.+... ...++||||||||+.||+||+.||...+.. ..++..+... ...+.+..+
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~~g-h~Pq~P~~l 1466 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVAAG-HKPQIPERL 1466 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHhcc-CCCCCchhh
Confidence 1234579999999999987442 245689999999999999999999876543 3333333322 223334469
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+.+.++||.+||..||++|+++.|+++|.|-+..
T Consensus 1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 9999999999999999999999999999987643
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=235.23 Aligned_cols=168 Identities=34% Similarity=0.524 Sum_probs=133.1
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++. ++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 77 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKK 154 (318)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCc
Confidence 68775 48888876543 3678899999999999999999999999988775 999999998754333 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....|++.|+|||.+.+..+. .++|||||||++|+|++|+.||........ ...+.......| ..+++.+.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~~ 227 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKET----MTMILKAKLGMP--QFLSPEAQS 227 (318)
T ss_pred eecccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHH
Confidence 3345689999999999877665 459999999999999999999987544322 222333333333 357899999
Q ss_pred HHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
||.+||..||.+||+ +.+++.||||...
T Consensus 228 li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999999999999999 7789999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=231.88 Aligned_cols=168 Identities=29% Similarity=0.407 Sum_probs=131.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+.+.... ++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.... ...
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 75 LDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEET 152 (321)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCc
Confidence 688865 7877765433 3678999999999999999999999999988775 99999999874322 222
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+|++.|+|||++.+..++. ++|||||||++|+|++|+.||....... ....+.......+ ...+..+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~--~~~~~~~~~ 225 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDR-TVDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYDNILHKPLQLP--GGKTVAACD 225 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCC-cCcccccchhhhhhhcCCCCCCCCCHHH----HHHHHhcCCCCCC--CCCCHHHHH
Confidence 33456899999999998877654 4999999999999999999998764322 2222333222233 357889999
Q ss_pred HHHHhcccCCCCCCCH----HHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITI----KEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~----~ell~h~~f~~~ 177 (265)
+|.+||..+|.+|+++ .++++|+||...
T Consensus 226 li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 226 LLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 9999999999999975 599999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=236.60 Aligned_cols=173 Identities=33% Similarity=0.474 Sum_probs=131.7
Q ss_pred Ccccc-cchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--C
Q 024572 1 MQLGV-SSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~ 69 (265)
||++. ++|.+++.... .+.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 122 ~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 122 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCccc
Confidence 78885 48998886543 3567889999999999999999999999988765 9999999987543322 2
Q ss_pred CCCCcCCCCCcccccccCCc---CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||........+..+... ......|....++..
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~ 277 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDISKE 277 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCCCCHH
Confidence 23457999999999987543 2345699999999999999999999876543333322211 112334555578999
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 024572 147 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKN 177 (265)
Q Consensus 147 ~~~li~~~L~~dP~~--R~s~~ell~h~~f~~~ 177 (265)
+++||.+||...+.+ |+++.++++|+||++.
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999844433 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=240.55 Aligned_cols=177 Identities=23% Similarity=0.281 Sum_probs=126.7
Q ss_pred CcccccchHHHHHH--------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVSSLSEFVML--------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~sL~~~~~~--------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++..+|.+++.. +.++.+++.+|.|||++|||||||||+|||++.++. +||+|||+++....
T Consensus 242 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~--vkL~DFGla~~~~~ 319 (501)
T PHA03210 242 TQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK--IVLGDFGTAMPFEK 319 (501)
T ss_pred EeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEeCCCceecCc
Confidence 45556666665532 235778899999999999999999999999987765 99999999975443
Q ss_pred CCC--CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHHHhhhcccCC---
Q 024572 67 HSR--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED---PKNFRKTISRIMAVQYKIP--- 138 (265)
Q Consensus 67 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~--- 138 (265)
... .....|+..|+|||++.+..+. .++|||||||++|+|++|..++..... ...+.+.+..+......+|
T Consensus 320 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 398 (501)
T PHA03210 320 EREAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPP 398 (501)
T ss_pred ccccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcH
Confidence 222 2235699999999999887775 459999999999999998765433221 1222222221110000000
Q ss_pred -----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 139 -----------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 139 -----------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
....++.++.++|.+||.+||.+|||+.++|+||||.....+
T Consensus 399 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 399 CKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred HHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCch
Confidence 011356778889999999999999999999999999875443
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=238.22 Aligned_cols=173 Identities=22% Similarity=0.293 Sum_probs=126.0
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++.++|.+++..+ .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 239 ~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 239 LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWST 316 (461)
T ss_pred EEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccc
Confidence 566677787777543 24677899999999999999999999999987765 99999999875432211
Q ss_pred --CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCC-------hHHHHHHHHHHhhhc------
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQ------ 134 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~------ 134 (265)
.....||..|+|||++.+..++ .++|||||||++|+|++|..++..... ...+.+++.......
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1234689999999999887765 459999999999999998766543221 112222222211000
Q ss_pred --------------------cc---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 135 --------------------YK---IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 135 --------------------~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.. +.....++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 0111135668999999999999999999999999999974
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=237.17 Aligned_cols=170 Identities=28% Similarity=0.380 Sum_probs=132.7
Q ss_pred cccccchHHHHHH-----------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC-CCCCC
Q 024572 2 QLGVSSLSEFVML-----------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLHSR 69 (265)
Q Consensus 2 e~~~~sL~~~~~~-----------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~-~~~~~ 69 (265)
|||++---|-++. +.+.++.+++|.|||+++|||||||..|||+.-+|. |+|+|||.+... .....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhh
Confidence 7787755555543 345778899999999999999999999999988876 999999987432 22334
Q ss_pred CCCCcCCCCCcccccccC-----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 PKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
..+++||++|||||++.. .+|+. ++||||||++|.+|.-+.+|-...+....+.++ .......+..+..++
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDy-kaDiWSlGITLIEMAqiEPPHhelnpMRVllKi---aKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSEPPTLLQPSHWS 262 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchh-hhhHHhhhhHHHHHhccCCCccccchHHHHHHH---hhcCCCcccCcchhh
Confidence 567899999999998753 55654 499999999999999999997665443222222 222233344556789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
..+.+|+.+||.+||..||++.++++||||...
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 999999999999999999999999999999754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=241.02 Aligned_cols=168 Identities=29% Similarity=0.420 Sum_probs=131.9
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++..+ .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~ 221 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSD 221 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCC
Confidence 788854 898876432 13567889999999999999999999999998775 99999999975433
Q ss_pred CC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 67 HS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 67 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
.. .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||....... .+..+..... .+.+..+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~-~~~~~~~ 295 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQRE----IMQQVLYGKY-DPFPCPV 295 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCC-CCCCccC
Confidence 22 22345699999999999887765 55999999999999999999997754432 2222222222 2333468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
+..+.+||.+||..+|++||++.+++.|+|++.
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 899999999999999999999999999999853
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=224.10 Aligned_cols=171 Identities=25% Similarity=0.374 Sum_probs=129.6
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.++|.+++..+. ++.+++.++.|||++||+||||+|+||+++. + .+||+|||+++........
T Consensus 79 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~--~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 79 FELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D--ILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C--CeEEEecccccccccCCCc
Confidence 6778788887776532 3667889999999999999999999999987 4 4999999998765444443
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh--------------hhccc
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------------AVQYK 136 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--------------~~~~~ 136 (265)
....++..|+|||.+......+.++|+|||||++|+|++|..||......+.......... ...+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccccc
Confidence 4456889999999876555545669999999999999999999987654333222221100 00011
Q ss_pred CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 137 IPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 137 ~~~---------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.+. ...++..+.++|.+||..+|.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 111 12467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=227.69 Aligned_cols=174 Identities=23% Similarity=0.292 Sum_probs=131.7
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||+++++|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||++....... .
T Consensus 87 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 87 MEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKP 164 (309)
T ss_pred EecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCccCC
Confidence 688888888877652 24778899999999999999999999999987765 9999999987544322 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh---------------c
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------Q 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 134 (265)
.....++..|+|||.+.+....+.++|+|||||++|+|++|+.||........+.......... .
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 2223467889999998765544566999999999999999999998766544443333221100 0
Q ss_pred ccCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 135 YKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 135 ~~~~~---------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
+..+. ....++.+.+||.+||..||++|||+.++++||||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00000 1125788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=222.48 Aligned_cols=170 Identities=31% Similarity=0.552 Sum_probs=128.5
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC-CCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~-~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.+||++||+|+||||+||+++.++. ++|+|||.+... .....
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 577777 8998888333 3677899999999999999999999999997665 999999998642 22333
Q ss_pred CCCCcCCCCCccccccc-CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--cCCCCCCCCHH
Q 024572 70 PKSTVGTPAYIAPEVLS-RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQD 146 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 146 (265)
.....++..|+|||++. +... +.++|+||||+++|+|++|..||........ ...+........ ........+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred cccccccccccccccccccccc-cccccccccccccccccccccccccccchhh-hhhhhhcccccccccccccchhHHH
Confidence 34556899999999998 4444 5669999999999999999999987632222 222222211111 11111123479
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+.++|.+||..||++|||+.++++||||
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=236.35 Aligned_cols=146 Identities=32% Similarity=0.495 Sum_probs=121.6
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEc-CCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchH
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 95 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 95 (265)
++.+|+.++.|||++|||||||||+|||++ +.+ +++|+|||+++..... ..+.+-|..|.|||++....|+ .++
T Consensus 420 w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g--~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt-~ac 494 (612)
T KOG0603|consen 420 WAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG--HLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYT-EAC 494 (612)
T ss_pred HHHHHHHHHHHHHhcCeeecCCChhheeecCCCC--cEEEEEechhhhCchh--hcccchhhcccChhhhccCCCC-cch
Confidence 567788999999999999999999999995 444 4999999998754433 4456788999999999987776 559
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 96 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 96 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
||||||++||+|++|+.||....... .+..++....+. ..+|..+++||.+||+.||.+|+++.+++.||||
T Consensus 495 D~WSLGvlLy~ML~G~tp~~~~P~~~---ei~~~i~~~~~s----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 495 DWWSLGVLLYEMLTGRTLFAAHPAGI---EIHTRIQMPKFS----ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hhHHHHHHHHHHHhCCCccccCCchH---HHHHhhcCCccc----cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999998876652 333333322222 4789999999999999999999999999999999
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=228.30 Aligned_cols=173 Identities=24% Similarity=0.395 Sum_probs=128.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhc-CceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQ-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~-~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++...+ ++.+++.++.|||++ +|+||||||+|||++.++. +||+|||++..... ..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~ 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hc
Confidence 688854 9999887543 355688899999975 7999999999999987765 99999999864422 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHH----------------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI---------------------- 127 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~---------------------- 127 (265)
.....++..|+|||++.+..++ .++|+|||||++|+|++|+.||........ ...+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred cccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCccc
Confidence 2345689999999999876665 459999999999999999999975432111 1100
Q ss_pred -------------------HHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 128 -------------------SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 128 -------------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
..+............++.++++||.+||..||++|||+.+++.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 000000000001113578899999999999999999999999999997654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=240.78 Aligned_cols=173 Identities=29% Similarity=0.410 Sum_probs=138.4
Q ss_pred Ccc-cccchHHHHHHhcc------------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQL-GVSSLSEFVMLEGS------------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~-~~~sL~~~~~~~~~------------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||- .++||+.+++.... .+||+++|.|||.+.|||||||-+||||+.- .|.+||+|||-++....-
T Consensus 651 MEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy-SGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 651 MEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY-SGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred eecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec-cceEEecccccchhhccC
Confidence 444 45599999986542 7899999999999999999999999999752 345999999998865443
Q ss_pred -CCCCCCcCCCCCcccccccC-CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 68 -SRPKSTVGTPAYIAPEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 68 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
....++.||..|||||++-. ..-+++++|||||||++.||.||++||.....+.. .+-++.-.....|.+..++.
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFkVGmyKvHP~iPeelsa 806 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFKVGMYKVHPPIPEELSA 806 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhhhcceecCCCCcHHHHH
Confidence 34456789999999999964 33346789999999999999999999987665432 22223333344555667899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+++.||.+|+.++|..||++.++|..||++..
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999999999999754
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=223.84 Aligned_cols=172 Identities=24% Similarity=0.377 Sum_probs=132.3
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++...+ ++.+++.++.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGE 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCC
Confidence 566654 7877765432 3567899999999999999999999999987765 9999999986544333
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......++..|+|||++.+..++. ++|+|||||++|+|++|..||...............+..... .....++..+.
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 233 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTL-SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE--VYSAKFSEEAK 233 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc--ccCccCCHHHH
Confidence 334457899999999998777654 489999999999999999999876543332333222222221 22335788999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 149 NLLSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
+|+.+||..||.+||+ +.+++.|+||+..
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999999 8899999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=218.75 Aligned_cols=167 Identities=32% Similarity=0.413 Sum_probs=129.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||+|+||+++.++. ++|+|||+++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceeccccccc
Confidence 466644 8888776433 3567899999999999999999999999987765 999999998644322111
Q ss_pred ----CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 71 ----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 71 ----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
....++..|+|||.+.+..++ .++||||||+++|+|++|+.||........... ..........+..++..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSPD 235 (263)
T ss_pred cccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCHH
Confidence 234578899999999887754 559999999999999999999977544332222 22222222333467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+.++|.+||..+|.+|||+.++++|+||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=222.74 Aligned_cols=173 Identities=23% Similarity=0.300 Sum_probs=129.8
Q ss_pred CcccccchHHHHHHh--------------ccccchHHHHHhhhhcCceecCCCcCcEEEcC-CCCCcEEEeccCCcccCC
Q 024572 1 MQLGVSSLSEFVMLE--------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~~sL~~~~~~~--------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~ 65 (265)
||++.++|.+++... .++.+++.+|.|||++||+||||||+||+++. ++ .+||+|||+++...
T Consensus 85 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~--~~kl~dfg~~~~~~ 162 (295)
T cd07837 85 FEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAFS 162 (295)
T ss_pred eeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC--eEEEeecccceecC
Confidence 688888888877542 23677899999999999999999999999987 44 49999999987543
Q ss_pred CC-CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc---------
Q 024572 66 LH-SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------- 135 (265)
Q Consensus 66 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 135 (265)
.. .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.............+.....
T Consensus 163 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T cd07837 163 IPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242 (295)
T ss_pred CCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhc
Confidence 22 12223357888999999876444456699999999999999999999876655444433322110000
Q ss_pred ----cCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 136 ----KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 136 ----~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
..+ ....++..+.+||.+||..+|.+||++.+++.||||+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 0124788899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=233.50 Aligned_cols=170 Identities=26% Similarity=0.359 Sum_probs=139.8
Q ss_pred CcccccchHHHHHHhcc----------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEGS----------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~~----------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||||-+|-+|.+.++.. ....+.+|.||||++.||||||..|||+...+. |||+|||.|... ...
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~---~PA 179 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIM---APA 179 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhc---Cch
Confidence 89999999999987653 455688899999999999999999999998887 999999988643 345
Q ss_pred CCCcCCCCCcccccccC---CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 71 KSTVGTPAYIAPEVLSR---REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.+++|||+|||||++.. +.|+++ +||||||+++.+|...++|+.+.+....+..+. ....+.-....++..+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIA----QNesPtLqs~eWS~~F 254 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPTLQSNEWSDYF 254 (948)
T ss_pred hcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHH----hcCCCCCCCchhHHHH
Confidence 67899999999999864 567777 999999999999999999998876544443332 2222222234678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
++|+..||.+-|..|||.++++.|+|....-+.
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 999999999999999999999999999876553
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=230.02 Aligned_cols=176 Identities=26% Similarity=0.366 Sum_probs=132.5
Q ss_pred CcccccchHHHHHHh-------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLE-------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~sL~~~~~~~-------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||++.++|.+.+... .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++...........
T Consensus 100 ~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~ 177 (353)
T cd07850 100 MELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 177 (353)
T ss_pred EeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCCCCCCCCC
Confidence 678888888776532 24678899999999999999999999999988775 999999999765443333445
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh------------------cc
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV------------------QY 135 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------------~~ 135 (265)
.++..|+|||.+.+..+. .++|||||||++|+|++|+.||........+..++...... ..
T Consensus 178 ~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (353)
T cd07850 178 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRP 256 (353)
T ss_pred cccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCC
Confidence 688899999999887775 44999999999999999999998765433333222111000 00
Q ss_pred c--------------CCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 136 K--------------IPD-----YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 136 ~--------------~~~-----~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
. .+. ....+..+++||.+||..||.+|||+.++|.||||+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 257 KYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred CCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0 000 1124567899999999999999999999999999975543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=220.46 Aligned_cols=167 Identities=25% Similarity=0.357 Sum_probs=126.8
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~- 67 (265)
||++.+ +|.+++.... ++.+++.++.|||+++|+||||||+||+++.++. +||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV 165 (272)
T ss_pred EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceeccccc
Confidence 677765 8888776532 3557889999999999999999999999988775 999999998754322
Q ss_pred CCCCCCcCCCCCcccccccC-----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 68 SRPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
.......++..|+|||++.+ ..+ +.++|+||+||++|+|++|+.||.......... ..............
T Consensus 166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~ 240 (272)
T cd06637 166 GRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNPAPRLKSKK 240 (272)
T ss_pred ccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhcCCCCCCCCCC
Confidence 22234568899999999863 234 345999999999999999999997644322211 11111222222335
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
++..+.+||.+||..+|.+|||+.+++.||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=231.49 Aligned_cols=169 Identities=26% Similarity=0.344 Sum_probs=143.1
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
|+||++ +|.+.+..+. +.-|++.++.|||++.|+|||||+.|||+..++. |||+|||+|+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence 788988 8888887655 3667888999999999999999999999998876 8999999999877665
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
...+.+||+.|++||++.+.+|..+ +|||||||++|+|++-+++|...+......++ .... -.|.+..++.++
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki----~~~~-~~Plp~~ys~el 234 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKI----NRGL-YSPLPSMYSSEL 234 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHH----hhcc-CCCCCccccHHH
Confidence 5667789999999999999998755 99999999999999999999886654333333 3333 345556789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+.+|+.||..+|..||++.++|.+|.+...
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 999999999999999999999999887643
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=221.57 Aligned_cols=171 Identities=25% Similarity=0.333 Sum_probs=129.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++..++ ++.+++.++.|||++||+||||||+|||++.++. ++|+|||++...... ..
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~ 152 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KP 152 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-Cc
Confidence 677665 8888876543 3567889999999999999999999999987765 999999998644322 22
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+....+.++|+||+||++|+|++|..||........ ......... .....+..++.++.++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~l 229 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLT--VNVELPDSFSPELKSL 229 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhc--CCcCCccccCHHHHHH
Confidence 3346899999999986433334559999999999999999999976533221 111111111 1222233578999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
|.+||..||.+|+ |+.++++||||+..
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 9999999999999 69999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=222.06 Aligned_cols=173 Identities=27% Similarity=0.362 Sum_probs=131.4
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||+++++|.+++... .++.+++.++.|||++||+|+||||+||+++.++. ++|+|||++.......
T Consensus 78 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 78 MEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPR 155 (286)
T ss_pred ecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCC
Confidence 688877998887643 24678899999999999999999999999988765 9999999987554332
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc--------------
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-------------- 134 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 134 (265)
......++..|+|||.+.+....+.++||||+||++|+|++|.+||.+......+...........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 123446888999999987655555679999999999999999888877655444333332211000
Q ss_pred -ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 135 -YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 135 -~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
...+ .....+..+.+||.+||..+|.+|||+.++++||||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 0124578899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=226.91 Aligned_cols=146 Identities=23% Similarity=0.361 Sum_probs=112.5
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCch
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKL 94 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 94 (265)
+.+++.+|.|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..++. +
T Consensus 180 ~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~ 256 (338)
T cd05102 180 SFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT-Q 256 (338)
T ss_pred HHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCc-c
Confidence 347899999999999999999999999987765 99999999875432211 12234567899999998877654 4
Q ss_pred HhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 95 ADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 95 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+|||||||++|+|++ |..||........+...+. . ......+..+++.+.+||.+||..||.+|||+.++++
T Consensus 257 sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 257 SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK---D-GTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh---c-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999997 9999987554333222221 1 1122233467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=224.01 Aligned_cols=157 Identities=24% Similarity=0.396 Sum_probs=119.4
Q ss_pred cccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCC--cCCCc
Q 024572 17 SVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR--EYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~ 93 (265)
++.+++.++.|||+ .+|+||||||+||+++.++. +||+|||+++............++..|+|||.+.+. ...+.
T Consensus 112 i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 189 (288)
T cd06616 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDV 189 (288)
T ss_pred HHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcc
Confidence 35668889999997 59999999999999987765 999999998754443333445688899999998765 23345
Q ss_pred hHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-cC--CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 94 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI--PDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++||||+||++|+|++|+.||..... ....+........ .. .....++..+.+||.+||..+|++|||+.+++.
T Consensus 190 ~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 190 RSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred hhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 69999999999999999999976541 1122222211111 11 112347889999999999999999999999999
Q ss_pred CcccCCCC
Q 024572 171 HPWFLKNL 178 (265)
Q Consensus 171 h~~f~~~~ 178 (265)
||||+...
T Consensus 267 ~~~~~~~~ 274 (288)
T cd06616 267 HPFIKDYE 274 (288)
T ss_pred Chhhhchh
Confidence 99997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=218.27 Aligned_cols=168 Identities=29% Similarity=0.480 Sum_probs=130.2
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. .++|+|||+++.... .
T Consensus 88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~---~ 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIGT---P 163 (267)
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecCC---C
Confidence 67775 59999887653 3677899999999999999999999999987761 499999999864432 2
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||++.+..+. .++|+||+|+++|+|++|+.||............+.... ....+....+++.+.+|
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDF 240 (267)
T ss_pred ccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHH
Confidence 234688899999999887765 459999999999999999999985443221111111111 22223334689999999
Q ss_pred HHHhcccCCCCCCC-HHHHhcCcccC
Q 024572 151 LSRIFVANPSRRIT-IKEIKSHPWFL 175 (265)
Q Consensus 151 i~~~L~~dP~~R~s-~~ell~h~~f~ 175 (265)
|.+||..+|.+|++ ++++++||||+
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999996 69999999996
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=220.04 Aligned_cols=169 Identities=30% Similarity=0.384 Sum_probs=129.1
Q ss_pred Cccccc-chHHHHHHh------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLE------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.+ +|.+++... .++.+++.++.+||++||+||||+|+||+++.++. ++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~ 155 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADG 155 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccC
Confidence 566654 788877542 24677899999999999999999999999998765 999999998654433
Q ss_pred CCC-----CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC---C
Q 024572 68 SRP-----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---D 139 (265)
Q Consensus 68 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~ 139 (265)
... ....++..|+|||.+......+.++|+|||||++|+|++|+.||........+...... .....+ .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGAD 232 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCccc
Confidence 221 23458889999999877633455699999999999999999999876554333332221 111111 1
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 140 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 140 ~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
...++..+.+++.+||..||.+|||+.++++||||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 23578899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=227.73 Aligned_cols=173 Identities=28% Similarity=0.473 Sum_probs=127.8
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+|||++.++. +||+|||++........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGT 157 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCC
Confidence 67764 48998886522 3677899999999999999999999999987765 99999999865433222
Q ss_pred C--CCCcCCCCCcccccccC----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC-CCCC
Q 024572 70 P--KSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVH 142 (265)
Q Consensus 70 ~--~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 142 (265)
. ....||+.|+|||++.. ....+.++||||+||++|+|++|+.||........+..+.... .....+ ....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~ 235 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--EHFQFPPDVTD 235 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CcccCCCccCC
Confidence 1 22468999999999863 2233456999999999999999999998765433333322111 111122 2235
Q ss_pred CCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 024572 143 ISQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKN 177 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~--R~s~~ell~h~~f~~~ 177 (265)
++..+++||.+||..++.+ |+++.++++||||...
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 7899999999998764443 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=229.77 Aligned_cols=173 Identities=27% Similarity=0.453 Sum_probs=128.2
Q ss_pred Ccccc-cchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++... .++.+++.++.|||++||+||||||+|||++.++. +||+|||++........
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGT 157 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCc
Confidence 68775 4899998652 23567889999999999999999999999987765 99999999865432222
Q ss_pred --CCCCcCCCCCcccccccC----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC-CCCC
Q 024572 70 --PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVH 142 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 142 (265)
....+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||........+..+.... .....| ....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~ 235 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTD 235 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCcccc
Confidence 223469999999999863 2223456999999999999999999998765433333322111 111222 2235
Q ss_pred CCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 024572 143 ISQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKN 177 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~--R~s~~ell~h~~f~~~ 177 (265)
++..+++||.+||..++.+ |+++.++++||||...
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 7999999999999765544 6899999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=220.35 Aligned_cols=167 Identities=25% Similarity=0.347 Sum_probs=126.8
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~- 67 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~~ 175 (282)
T cd06636 98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV 175 (282)
T ss_pred EEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhccc
Confidence 678766 8888876422 3567899999999999999999999999987765 999999998644322
Q ss_pred CCCCCCcCCCCCcccccccC-----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 68 SRPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
.......++..|+|||.+.. ..++ .++|+|||||++|+|++|+.||........... .............
T Consensus 176 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 250 (282)
T cd06636 176 GRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKLKSKK 250 (282)
T ss_pred cCCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCCcccc
Confidence 22234568899999999863 2343 459999999999999999999976543222211 1111111112235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
++..+.+||.+||..||.+|||+.++++||||
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=218.13 Aligned_cols=174 Identities=25% Similarity=0.351 Sum_probs=129.2
Q ss_pred Cccccc-chHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.+ +|..++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccccc
Confidence 566655 666665431 24667899999999999999999999999987765 9999999986543221
Q ss_pred CCCCCcCCCCCcccccccC-----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 69 RPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
......++..|+|||++.. ..+ +.++|+||+||++|+|++|+.||.............. ......+.+..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRW 234 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---cCCCCCCCcccc
Confidence 2233468899999999842 223 3459999999999999999999977554332222211 111122333467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
+..+.+||.+||..+|.+||++.++++||||+.....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence 8999999999999999999999999999999865443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=224.65 Aligned_cols=156 Identities=28% Similarity=0.405 Sum_probs=133.1
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHh
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 96 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 96 (265)
...+|+-+|.+||+.+||+|||||+|||+|+.|+ |+|+|+|+|............+||..|||||++.+..|+.. .|
T Consensus 292 YAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s-~D 368 (591)
T KOG0986|consen 292 YAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFS-PD 368 (591)
T ss_pred HHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCC-cc
Confidence 4566788899999999999999999999998887 99999999998887777777899999999999999887655 89
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcC
Q 024572 97 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI-----TIKEIKSH 171 (265)
Q Consensus 97 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~ell~h 171 (265)
+|||||++|+|+.|+.||..........++-+++.......+ ..+|+++++|.+.+|.+||.+|. ++.++.+|
T Consensus 369 wf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 369 WFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred HHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 999999999999999999876654444444444544444444 37899999999999999999998 57799999
Q ss_pred cccCCC
Q 024572 172 PWFLKN 177 (265)
Q Consensus 172 ~~f~~~ 177 (265)
|||+.-
T Consensus 447 pfFk~l 452 (591)
T KOG0986|consen 447 PFFKDL 452 (591)
T ss_pred cccccC
Confidence 999863
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=218.21 Aligned_cols=172 Identities=24% Similarity=0.365 Sum_probs=128.6
Q ss_pred CcccccchHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVSSLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.++|.+++... .++.+++.++.|||++|++||||+|+||+++.++. +||+|||++.......
T Consensus 78 ~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVR 155 (284)
T ss_pred eeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcc
Confidence 677777777776542 23567889999999999999999999999998776 9999999986543221
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh--------------c
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------Q 134 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------~ 134 (265)
......++..|+|||.+.+....+.++|+|||||++|+|++|+.||................... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 12233568889999998776654566999999999999999999998765544333322211100 0
Q ss_pred ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 135 YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 135 ~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
...+ ....++..++++|.+||..||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000 012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=223.93 Aligned_cols=170 Identities=31% Similarity=0.523 Sum_probs=143.2
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||-|-+ .|-..++.|+. +.-+++++.|||++|||+|||||+|++++.+|. +||.|||+|+........
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCce
Confidence 454544 55555555553 445688999999999999999999999999987 999999999998888888
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
.++|||+.|.|||++.+++.+. ++|.||||+++|||++|.+||.+.+....+..+++.+-... +| ..++..+.+|
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~-avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~--~P--r~I~k~a~~L 651 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDR-AVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE--FP--RRITKTATDL 651 (732)
T ss_pred eeecCCcccccchhhhccCcch-hhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh--cc--cccchhHHHH
Confidence 8999999999999999988864 49999999999999999999999888777766666554332 33 3688899999
Q ss_pred HHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
|+++...+|.+|.. +.+|..|.||..-
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 99999999999985 8999999999753
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=214.25 Aligned_cols=169 Identities=36% Similarity=0.575 Sum_probs=135.5
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC-CCCCCCCCcCCCCCcccccccCCcCCCchHh
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 96 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 96 (265)
-..|..+|-|||+++||+||||.+|+|+|.++. +||+|||+|+... .....+++|||+.|+|||++....|. .++|
T Consensus 274 GaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYg-raVD 350 (516)
T KOG0690|consen 274 GAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYG-RAVD 350 (516)
T ss_pred hHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccceeccccCChhhcCchhhcccccc-ceee
Confidence 345788999999999999999999999999887 9999999998543 34556778999999999999988875 5599
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcC
Q 024572 97 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI-----TIKEIKSH 171 (265)
Q Consensus 97 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~ell~h 171 (265)
+|.+|+++|+|++|+.||...+....+.- +.....++|. .++++++.|+..+|.+||.+|. .+.+|.+|
T Consensus 351 WWG~GVVMYEMmCGRLPFyn~dh~kLFeL----Il~ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 351 WWGVGVVMYEMMCGRLPFYNKDHEKLFEL----ILMEDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hhhhhHHHHHHHhccCcccccchhHHHHH----HHhhhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 99999999999999999998776544333 3334445555 6899999999999999999998 58999999
Q ss_pred cccCCCCChhhHHHHHHHhhhcCCCCCCCcC
Q 024572 172 PWFLKNLPRELTETAQAIYYRKENPTFSLQS 202 (265)
Q Consensus 172 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (265)
+||..... +.....+-.|++..+.
T Consensus 425 ~FF~~v~W-------~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 425 RFFASVDW-------EATYRKKIEPPFKPQV 448 (516)
T ss_pred hhhccCCH-------HHHHHhccCCCCCCCc
Confidence 99976432 3333444445554443
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=214.33 Aligned_cols=166 Identities=23% Similarity=0.365 Sum_probs=128.1
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++... .++.+++.++.+||++||+||||||+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~ 156 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQC 156 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccC
Confidence 677754 888887652 23566888999999999999999999999987765 9999999987543222
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......+++.|+|||++.+..++ .++|+|||||++|+|++|+.||......... ..+..... .+....++..+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~ 230 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLV----YRIIEGKL-PPMPKDYSPEL 230 (257)
T ss_pred CccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHhcCC-CCCccccCHHH
Confidence 22334688899999999887665 4599999999999999999999765432221 22222111 12234578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.++|.+||..+|.+|||+.++++||||
T Consensus 231 ~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 231 GELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=220.98 Aligned_cols=175 Identities=26% Similarity=0.354 Sum_probs=131.7
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||+.+++|.+++.... ++.+++.+|.|||++||+||||||+||+++.++. ++|+|||+++...... .
T Consensus 81 ~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 81 FEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNRK 158 (298)
T ss_pred EcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCcc
Confidence 6778778888887654 3677899999999999999999999999998765 9999999987544332 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-------cC-----
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------KI----- 137 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~----- 137 (265)
.....++..|+|||.+.+....+.++|+|||||++|+|++|.+||........+............ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 223356788999999866544456699999999999999998888776554433333221100000 00
Q ss_pred -----C-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 138 -----P-----DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 138 -----~-----~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+ .....+..+.++|.+||..+|++|||+.+++.|+||.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0 012357889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=214.80 Aligned_cols=172 Identities=27% Similarity=0.415 Sum_probs=136.3
Q ss_pred CcccccchHHHHHHh-------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLE-------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~sL~~~~~~~-------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||+-..+|.+++... .++.|.+.++.|||+.||+||||||+||++..+.. +||.|||+|+.....-..+..
T Consensus 100 ~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~~~~mtpy 177 (369)
T KOG0665|consen 100 MELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDTDFMMTPY 177 (369)
T ss_pred HHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccCcccccCch
Confidence 677777888777643 35677888999999999999999999999988876 999999999866555455667
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-------------------
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------------- 134 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------------- 134 (265)
+.+..|+|||++.+..+... +||||+||++.+|++|+..|.+....+++.++........
T Consensus 178 VvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~ 256 (369)
T KOG0665|consen 178 VVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRP 256 (369)
T ss_pred hheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcCh
Confidence 89999999999999887655 9999999999999999999998766666555544321110
Q ss_pred -c-------cCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 135 -Y-------KIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 135 -~-------~~~~~---------~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
+ .+|+. ..-+..+++++.+||..+|++|.|+.++|+||||+
T Consensus 257 ~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 257 QYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 01110 01234678999999999999999999999999997
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=218.88 Aligned_cols=172 Identities=24% Similarity=0.337 Sum_probs=130.1
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++..+|.+++..+. ++.+++.+|.|||++||+||||||+||+++.++. +||+|||++...... ..
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPLKP 162 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCccc
Confidence 6788888888776532 3667899999999999999999999999998765 999999998755443 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh----------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------- 133 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 133 (265)
.....++..|+|||.+.+....+.++|+||+|+++|+|++|..||...................
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 2334578899999998765544566999999999999999999998766544433332211000
Q ss_pred -ccc-------CCCCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 134 -QYK-------IPDYVH--ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 134 -~~~-------~~~~~~--~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
... ...... +++.+.++|.+||..+|++|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 000 000111 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=223.12 Aligned_cols=172 Identities=28% Similarity=0.396 Sum_probs=132.4
Q ss_pred cccccchHHHHHHhcc-----------ccchHHHHHhhhhcCceecCCCcCcEEEcCCC------------------CCc
Q 024572 2 QLGVSSLSEFVMLEGS-----------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSP------------------APR 52 (265)
Q Consensus 2 e~~~~sL~~~~~~~~~-----------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~------------------~~~ 52 (265)
|+.+.|+.||+..++. ..|++.++.+||+.+++|.||||+|||+.++. ...
T Consensus 171 ellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~ 250 (415)
T KOG0671|consen 171 ELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTA 250 (415)
T ss_pred eccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcc
Confidence 6778899999987543 56889999999999999999999999983211 124
Q ss_pred EEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh
Q 024572 53 LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 132 (265)
Q Consensus 53 vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 132 (265)
|+|+|||.|+.. .......+.|..|+|||++.+.+++.+ +||||+||||+|+.+|...|+..++.+.+ .+++++..
T Consensus 251 I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMerIlG 326 (415)
T KOG0671|consen 251 IKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMMERILG 326 (415)
T ss_pred eEEEecCCccee--ccCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHHHhhC
Confidence 899999998743 333456679999999999999999766 99999999999999999999988766544 33333322
Q ss_pred hc------------------ccCCC---------------CC--------CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 133 VQ------------------YKIPD---------------YV--------HISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 133 ~~------------------~~~~~---------------~~--------~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.. ..++. +. .-...+.+||++||.+||.+|+|+.|+|.|
T Consensus 327 p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 327 PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 10 01110 00 011357899999999999999999999999
Q ss_pred cccCCC
Q 024572 172 PWFLKN 177 (265)
Q Consensus 172 ~~f~~~ 177 (265)
|||+..
T Consensus 407 pFF~~~ 412 (415)
T KOG0671|consen 407 PFFARL 412 (415)
T ss_pred HHhhcC
Confidence 999754
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=225.62 Aligned_cols=176 Identities=26% Similarity=0.356 Sum_probs=128.0
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--- 69 (265)
||++.++|.+.+..+. ++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 164 (336)
T cd07849 87 QELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTG 164 (336)
T ss_pred ehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccccccC
Confidence 5677777776665432 4667899999999999999999999999988765 99999999865432211
Q ss_pred -CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-----------h-----
Q 024572 70 -PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-----------A----- 132 (265)
Q Consensus 70 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------~----- 132 (265)
.....++..|+|||.+.+....+.++|+||+||++|+|++|+.||.+............... .
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (336)
T cd07849 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARN 244 (336)
T ss_pred CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhh
Confidence 12346788999999876544445669999999999999999999976543222111111000 0
Q ss_pred ----hc--ccCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 133 ----VQ--YKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 133 ----~~--~~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.. ...+ .....+..+.++|.+||..+|.+|||+.++++||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 245 YIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 0000 0124578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=218.01 Aligned_cols=172 Identities=23% Similarity=0.385 Sum_probs=126.2
Q ss_pred Ccccccc-hHHHHH---------HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSS-LSEFVM---------LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~s-L~~~~~---------~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.+. |..++. ...++.+++.++.|||++||+||||||+||+++.++. +||+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDD 156 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccc
Confidence 5676664 443332 2234677899999999999999999999999987765 9999999987554332 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh---------------c
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------Q 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 134 (265)
.....++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+................. .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 2334578899999998764444556999999999999999999998766544333222111000 0
Q ss_pred ccCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 135 YKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 135 ~~~~~----------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
...+. ...++..+.+||.+||..+|++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00111 12467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=215.76 Aligned_cols=171 Identities=30% Similarity=0.491 Sum_probs=132.4
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||+.. ++|.+++.... ++.+++.++.|||++|++|+||+|+||+++.++. ++|+|||+++........
T Consensus 72 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 72 MEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred EecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCccccc
Confidence 56654 58998887654 3457889999999999999999999999988765 999999998765443333
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+..++. ++|+||+|+++|+|++|..||....... ......+.........+...+..+.++
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDF-SVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYIDKAAKDL 226 (262)
T ss_pred ccccCCcCccChhHhcCCCCCC-hhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 3456888999999987766654 4999999999999999999998765211 222222222122223333458899999
Q ss_pred HHHhcccCCCCCCC-----HHHHhcCcccCC
Q 024572 151 LSRIFVANPSRRIT-----IKEIKSHPWFLK 176 (265)
Q Consensus 151 i~~~L~~dP~~R~s-----~~ell~h~~f~~ 176 (265)
|.+||..+|.+||+ +.++++||||+.
T Consensus 227 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred HHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 99999999999999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=222.26 Aligned_cols=169 Identities=31% Similarity=0.458 Sum_probs=131.7
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+||+++.++. ++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhcccccc
Confidence 576654 8988876431 3568899999999999999999999999988765 9999999976432211
Q ss_pred C------------------------------CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Q 024572 69 R------------------------------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE 118 (265)
Q Consensus 69 ~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 118 (265)
. .....|+..|+|||++.+..++ .++||||||+++|+|++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 0 1123578889999999877664 55999999999999999999998766
Q ss_pred ChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCcccCC
Q 024572 119 DPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT----IKEIKSHPWFLK 176 (265)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s----~~ell~h~~f~~ 176 (265)
....+... .......+....++..+.++|.+||..+|++||| +.++++||||++
T Consensus 237 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 237 RDETFSNI----LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred hHHHHHHH----hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 54433332 2223334443347899999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=218.84 Aligned_cols=173 Identities=25% Similarity=0.390 Sum_probs=131.5
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~ 70 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||++........ .
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhcccccccc
Confidence 576654 898887543 23567889999999999999999999999987765 99999998864432221 2
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....+++.|+|||.+.+..++ .++|+|||||++|+|++|+.||............ ........+.+..++..+.++
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~l 249 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDF 249 (296)
T ss_pred CcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHHHH
Confidence 234688899999999876664 4599999999999999999999775543222211 111112223334678899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
|.+||..+|.+|||+.++++||||....+
T Consensus 250 i~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 99999999999999999999999975433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=217.91 Aligned_cols=173 Identities=24% Similarity=0.400 Sum_probs=127.8
Q ss_pred Cccccc-chHHHH-----HHhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCc
Q 024572 1 MQLGVS-SLSEFV-----MLEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV 74 (265)
Q Consensus 1 me~~~~-sL~~~~-----~~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 74 (265)
||++.+ +|..+. .....+.+++.++.|||++||+|+||||+||+++.++. ++|+|||++..... .......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~-~~~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVN-SIAKTYV 154 (279)
T ss_pred EecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceeccc-ccccCCC
Confidence 566666 454332 22345778999999999999999999999999988776 99999999875432 2233457
Q ss_pred CCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 024572 75 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN---FRKTISRIMAVQYKIPDYVHISQDCRNLL 151 (265)
Q Consensus 75 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li 151 (265)
++..|+|||.+.+..+. .++|+|||||++|+|++|+.||........ .......+.............++++.++|
T Consensus 155 ~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 155 GTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence 89999999999877765 459999999999999999999965332111 11111111111111111234778999999
Q ss_pred HHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 152 SRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 152 ~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+||..+|.+||++.++++||||...
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=218.73 Aligned_cols=171 Identities=27% Similarity=0.414 Sum_probs=131.4
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||+..+ +|.+++.... ++.+++.++.|||++||+||||+|+||+++.++. +||+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGK 149 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCC
Confidence 566654 8888876654 2567889999999999999999999999988775 9999999987544333
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......++..|+|||.+.+..++ .++|+|||||++|+|++|+.||................... ....+..+++.+.
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 226 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM--AVEYPDKFSPEAK 226 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc--cccCCccCCHHHH
Confidence 33445678899999998876654 45999999999999999999997755422222222222211 1222335789999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 024572 149 NLLSRIFVANPSRRI-----TIKEIKSHPWFLK 176 (265)
Q Consensus 149 ~li~~~L~~dP~~R~-----s~~ell~h~~f~~ 176 (265)
++|.+||..+|.+|| ++.++++||||+.
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred HHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 999999999999999 8888999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=214.86 Aligned_cols=173 Identities=25% Similarity=0.307 Sum_probs=132.3
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~ 70 (265)
||++.+ +|.+++... ..+.+++.++.|||+++|+||||+|+||+++.++. ++|+|||+++..... ...
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccc
Confidence 456554 788887764 24777889999999999999999999999998776 999999998755433 223
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+..++ .++|+||||+++|+|++|+.||........ ...+............++..+.++
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRV----LFLIPKNNPPSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHH----HHHhhhcCCCCCcccccCHHHHHH
Confidence 345688899999999887754 559999999999999999999976543222 111111111111111278899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
+.+||..+|++|||+.++++||||++....
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 999999999999999999999999876554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=224.02 Aligned_cols=175 Identities=25% Similarity=0.299 Sum_probs=132.1
Q ss_pred CcccccchHHHHHHh---------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC---
Q 024572 1 MQLGVSSLSEFVMLE---------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~---------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--- 68 (265)
||++.++|.+++... .++.+++.++.|||++||+||||||.||+++.++. ++|+|||++.......
T Consensus 83 ~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 83 TELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEK 160 (330)
T ss_pred ecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeeccccccc
Confidence 677777888776543 24677899999999999999999999999988765 9999999987554432
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-------------
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------- 134 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 134 (265)
......++..|+|||.+.+....+.++|+||||+++|+|++|+.||........+..+........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240 (330)
T ss_pred ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence 223346788999999998873445569999999999999999999987665433333222110000
Q ss_pred -------cc--C---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 -------YK--I---PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 -------~~--~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.. . .....++..+.++|.+||..+|.+|||+.++++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00 0 0012367889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=220.95 Aligned_cols=175 Identities=23% Similarity=0.309 Sum_probs=129.0
Q ss_pred CcccccchHHHHHHh---------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC--
Q 024572 1 MQLGVSSLSEFVMLE---------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~---------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-- 69 (265)
||+++.+|.+++... .++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~ 162 (332)
T cd07857 85 EELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGEN 162 (332)
T ss_pred EecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceecccccccc
Confidence 567777888777533 24678899999999999999999999999988765 99999999875432211
Q ss_pred ---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-----------hh--
Q 024572 70 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-----------AV-- 133 (265)
Q Consensus 70 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-----------~~-- 133 (265)
.....++..|+|||.+.+....+.++|+||+||++|++++|+.||........+...+.... ..
T Consensus 163 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (332)
T cd07857 163 AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKA 242 (332)
T ss_pred cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhH
Confidence 12346889999999887644345669999999999999999999987554332222211100 00
Q ss_pred --------ccc---C-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 134 --------QYK---I-PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 134 --------~~~---~-~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
... . ......+..+.+|+.+||..+|.+|||+.+++.||||.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 243 QNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000 0 0112357889999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=216.66 Aligned_cols=172 Identities=24% Similarity=0.323 Sum_probs=128.9
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||+.+.+|.+++.... ++.+++.++.|||+++++||||+|+||+++.++. ++|+|||+++......
T Consensus 77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 77 FEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVR 154 (283)
T ss_pred EeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCcc
Confidence 5777778888876654 3567889999999999999999999999988665 9999999986443222
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh--------------c
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------Q 134 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------~ 134 (265)
......++..|+|||++.+......++|+||||+++|+|++|+.||................... .
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 11233568899999988765444556999999999999999999998765443333322211000 0
Q ss_pred ccC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 135 YKI---------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 135 ~~~---------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
... .....++..+.++|.+||..+|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 000 0123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=214.58 Aligned_cols=166 Identities=28% Similarity=0.385 Sum_probs=127.4
Q ss_pred Cccccc-chHHHHHHh---------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLE---------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~---------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++... .++.+++.++.|||++|++||||+|+||+++.++. ++|+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06628 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLS 162 (267)
T ss_pred EEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccccccc
Confidence 566644 788777653 24677889999999999999999999999987765 9999999987543211
Q ss_pred -----CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 69 -----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 69 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
......++..|+|||.+.+..+. .++|+|||||++|+|++|+.||........... +.. ......+..+
T Consensus 163 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~ 236 (267)
T cd06628 163 TKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----IGE-NASPEIPSNI 236 (267)
T ss_pred CCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----Hhc-cCCCcCCccc
Confidence 11223578899999999877665 448999999999999999999987544322221 111 1112223357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+..+.++|.+||..+|.+||++.++++||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=218.96 Aligned_cols=171 Identities=22% Similarity=0.361 Sum_probs=126.1
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||+++++|.+++..+. ++.+++.++.|||++||+|+||||+||+++.++. +||+|||++........
T Consensus 98 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~ 175 (310)
T cd07865 98 FEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNS 175 (310)
T ss_pred EcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCcccccCCccc
Confidence 6888888877766442 3677899999999999999999999999987765 99999999875433221
Q ss_pred ----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-----------
Q 024572 70 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ----------- 134 (265)
Q Consensus 70 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 134 (265)
.....++..|+|||.+.+....+.++|+||||+++|+|++|+.||.......... .+..+....
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 254 (310)
T cd07865 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLCGSITPEVWPGVDKL 254 (310)
T ss_pred CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChhhcccccch
Confidence 1233577889999998765544556999999999999999999997765432221 121111000
Q ss_pred -----ccCCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 135 -----YKIPD-----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 135 -----~~~~~-----------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
...+. ....+..+.+||.+||..||.+|||+.++++||||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 255 ELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00000 00135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=244.54 Aligned_cols=172 Identities=23% Similarity=0.315 Sum_probs=131.1
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhc-------CceecCCCcCcEEEcCC-----------
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQ-------QICHRDLKLENTLLDGS----------- 48 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~-------~ivH~dlkp~NIll~~~----------- 48 (265)
|||+.+ +|.+++... .++.+|+.+|.|||+. +||||||||+||||+..
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 788876 899888642 2367889999999984 59999999999999642
Q ss_pred ----CCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCC-cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHH
Q 024572 49 ----PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF 123 (265)
Q Consensus 49 ----~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~ 123 (265)
+.+.+||+|||++.............+|+.|+|||++.+. ...+.++|||||||++|+|++|+.||........+
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql 252 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252 (1021)
T ss_pred cccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH
Confidence 2234899999999765444444455799999999998653 22345699999999999999999999876544333
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 124 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...+. . ....+ ....+.++.+||.+||..+|.+||++.++|.|+|++..
T Consensus 253 i~~lk---~-~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 253 ISELK---R-GPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHh---c-CCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 22221 1 11122 23468899999999999999999999999999999744
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=218.85 Aligned_cols=173 Identities=28% Similarity=0.466 Sum_probs=131.2
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~ 70 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. ++|+|||++....... ..
T Consensus 98 ~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 98 MEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred EeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccC
Confidence 677765 787776432 23677889999999999999999999999987765 9999999986433222 22
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+..++ .++|+||||+++|+|++|+.||........... +.. ......+....++..+.++
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~l 251 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRD--NLPPRVKDSHKVSSVLRGF 251 (292)
T ss_pred ceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHh--cCCCccccccccCHHHHHH
Confidence 334688999999999776665 459999999999999999999987554332221 111 1111222333578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
|.+||..+|.+|||+.++++||||...-+
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 99999999999999999999999985443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=222.08 Aligned_cols=174 Identities=17% Similarity=0.263 Sum_probs=123.6
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+ .++.+++.+|.|||++||+||||||+|||++.++. ++++||+.+.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHG 155 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccc
Confidence 577764 888887542 23567889999999999999999999999987765 9999998654322111
Q ss_pred --------CCCCCcCCCCCcccccccCC--cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-----
Q 024572 69 --------RPKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----- 133 (265)
Q Consensus 69 --------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 133 (265)
......++..|+|||++.+. .+ +.++|||||||++|+|++|+.||...................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccccc
Confidence 11223467789999998763 34 455999999999999999999997654332222111100000
Q ss_pred -----c------------------------------ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 134 -----Q------------------------------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 134 -----~------------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
. ...+....+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0 0001112356789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=221.43 Aligned_cols=172 Identities=23% Similarity=0.311 Sum_probs=124.9
Q ss_pred CcccccchHHHHHHh--------------ccccchHHHHHhhhhcCceecCCCcCcEEEcC----CCCCcEEEeccCCcc
Q 024572 1 MQLGVSSLSEFVMLE--------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDG----SPAPRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~~sL~~~~~~~--------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~----~~~~~vkl~Dfg~a~ 62 (265)
||+++++|.+++... .++.+++.++.|||+++|+||||||+||+++. ++. +||+|||+++
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg~~~ 160 (316)
T cd07842 83 FDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLGLAR 160 (316)
T ss_pred EeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCcccc
Confidence 688888777766422 24567899999999999999999999999987 554 9999999987
Q ss_pred cCCCCCC----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChH---------HHHHHHHH
Q 024572 63 SSLLHSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK---------NFRKTISR 129 (265)
Q Consensus 63 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~---------~~~~~~~~ 129 (265)
....... .....++..|+|||.+.+....+.++|+|||||++|+|++|+.||....... .+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 5433221 2234578899999998765544566999999999999999999997654322 11111110
Q ss_pred Hhhh-------------------cccCCCC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 130 IMAV-------------------QYKIPDY------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 130 ~~~~-------------------~~~~~~~------------~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+... ....... ...+..+.++|.+||..||++|||+.++++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000 0000001 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=224.17 Aligned_cols=176 Identities=25% Similarity=0.311 Sum_probs=130.2
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC-
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP- 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~- 70 (265)
||+++++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++........
T Consensus 87 ~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 164 (334)
T cd07855 87 MDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPTEH 164 (334)
T ss_pred EehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccCcCC
Confidence 6788788888775443 3567899999999999999999999999998776 999999998654322211
Q ss_pred ----CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh---------------
Q 024572 71 ----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------------- 131 (265)
Q Consensus 71 ----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--------------- 131 (265)
....++..|+|||.+.+....+.++|+|||||++|+|++|+.||........+........
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~ 244 (334)
T cd07855 165 KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRV 244 (334)
T ss_pred CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhH
Confidence 2346888999999986644345669999999999999999999977654332221111100
Q ss_pred ----h-hcccCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 132 ----A-VQYKIP-----DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 132 ----~-~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
. .....+ .....+..++++|.+||..+|.+|||+.+++.||||.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 245 RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0 000000 0124688999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=217.92 Aligned_cols=171 Identities=25% Similarity=0.393 Sum_probs=130.2
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~ 70 (265)
||++.+ +|.+++.... .+.+++.++.|||++||+||||||+||+++.++. +||+|||++........ .
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccC
Confidence 455544 7877766433 3566888999999999999999999999987765 99999999875433222 2
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+..+. .++|+|||||++|+|++|+.||............. .........+..+++.+.++
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred CCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCHHHHHH
Confidence 234688899999999877665 45999999999999999999998765433222111 11111222344678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
|.+||..+|.+|||+.+++.||||+..
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=216.47 Aligned_cols=172 Identities=26% Similarity=0.419 Sum_probs=130.1
Q ss_pred Ccccc-cchHHHHHHh----------ccccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE----------GSVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~----------~~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. .+|.+++... .++.+++.++.|||+ .|++|+||||+||+++.++. ++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHH
Confidence 56777 5888888754 246678899999999 99999999999999998765 9999999886443222
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHHhhhcccCCCCCC-CCHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-PKNFRKTISRIMAVQYKIPDYVH-ISQD 146 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 146 (265)
. ....++..|+|||.+.+..+. .++|+||||+++|+|++|+.||..... .......+........ ...+.. ++..
T Consensus 156 ~-~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (265)
T cd06605 156 A-KTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-PRLPSGKFSPD 232 (265)
T ss_pred h-hcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-CCCChhhcCHH
Confidence 2 226688899999999887665 459999999999999999999976521 1122222332222211 111112 7889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+.++|.+||..+|.+|||+.+++.||||++.
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=226.04 Aligned_cols=176 Identities=23% Similarity=0.304 Sum_probs=132.3
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
||+++.+|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||++..... ....
T Consensus 99 ~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~~--~~~~ 174 (343)
T cd07851 99 THLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTDD--EMTG 174 (343)
T ss_pred EecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEccccccccccc--cccC
Confidence 5777788888775432 4677899999999999999999999999988765 99999999875432 2334
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-------------------
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV------------------- 133 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 133 (265)
..++..|+|||.+.+....+.++|+|||||++|++++|+.||........+..+.......
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07851 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQS 254 (343)
T ss_pred CcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHh
Confidence 5678899999998764444566999999999999999999998765443333222211000
Q ss_pred cccC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 134 QYKI------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 134 ~~~~------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
.... .....++..+.+||.+||..+|.+|||+.+|++||||.+....
T Consensus 255 ~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 255 LPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred ccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0000 0112358899999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=213.42 Aligned_cols=168 Identities=24% Similarity=0.373 Sum_probs=127.6
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.+ +|.+++.... ++.+++.++.|||+.||+||||+|+||+++.++. +||+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMA 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcc
Confidence 466665 7888775432 4667889999999999999999999999988775 9999999987544332
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......++..|+|||.+.+..++ .++||||||+++|+|++|+.||............. ............++..+.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---NKPPPTLSDPEKWSPEFN 230 (256)
T ss_pred ccccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---cCCCCCCCchhhcCHHHH
Confidence 22334578899999999877665 45999999999999999999997654322211110 011111122234678999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
++|.+||..+|.+|||+.+++.||||
T Consensus 231 ~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=217.89 Aligned_cols=171 Identities=24% Similarity=0.437 Sum_probs=128.7
Q ss_pred CcccccchHHHHHHh-------------ccccchHHHHHhhhhc-CceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVSSLSEFVMLE-------------GSVKMKPDIFFSSLSQ-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~sL~~~~~~~-------------~~~~~i~~~l~~lH~~-~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||+++++|.+++... .++.+++.++.|||++ +++||||||+||+++.++. +||+|||++.....
T Consensus 79 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~ 156 (283)
T cd06617 79 MEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVD 156 (283)
T ss_pred hhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeeccccccccc
Confidence 678888887776542 2356788999999997 9999999999999988765 99999999875443
Q ss_pred CCCCCCCcCCCCCcccccccC----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhhhcccCCCCC
Q 024572 67 HSRPKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIPDYV 141 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 141 (265)
........++..|+|||.+.+ ..+ +.++|+|||||++|+|++|+.||...... ...... ........+ ..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~-~~ 231 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---VEEPSPQLP-AE 231 (283)
T ss_pred ccccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH---HhcCCCCCC-cc
Confidence 333333568889999998865 223 34589999999999999999999654322 221111 111111122 12
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 142 ~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.++.++.++|.+||..+|.+||++.++++||||.+..
T Consensus 232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 4789999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=216.52 Aligned_cols=166 Identities=30% Similarity=0.496 Sum_probs=132.3
Q ss_pred Cccc-ccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLG-VSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++ +++|.+++.... ++.+++.+|.|||++||+||||+|.||+++.++. +||+|||+++..... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--T 155 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--C
Confidence 6888 669998887654 3567899999999999999999999999988765 999999998754433 3
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....+++.|+|||.+.+.... .++|+||||+++|+|++|+.||....... ....+....... +..++..++++
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~--~~~~~~~l~~l 228 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRF--PSFFSPDAKDL 228 (290)
T ss_pred CCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCccC--CccCCHHHHHH
Confidence 345688999999998776654 55999999999999999999997765322 222222222223 33578999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
|.+||..+|.+|+ ++.++++||||...
T Consensus 229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 9999999999999 99999999999654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=215.33 Aligned_cols=172 Identities=26% Similarity=0.356 Sum_probs=130.3
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++...+ ++.+++.++.|||+++|+||||||+||+++.++. +||+|||++...... ..
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~ 152 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KP 152 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CC
Confidence 577654 7887775443 4667889999999999999999999999987765 999999998644322 22
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+....+.++|+||+||++|+|++|+.||........ .............. +..++..+.++
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~--~~~~s~~~~~l 229 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVEL--PDSFSPELRSL 229 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCC--CCcCCHHHHHH
Confidence 3457899999999987543334559999999999999999999976532211 11111112222222 23568999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCcccCCCC
Q 024572 151 LSRIFVANPSRRI-----TIKEIKSHPWFLKNL 178 (265)
Q Consensus 151 i~~~L~~dP~~R~-----s~~ell~h~~f~~~~ 178 (265)
+.+||..+|.+|+ ++.++++||||+...
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 9999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=216.64 Aligned_cols=161 Identities=19% Similarity=0.220 Sum_probs=125.2
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+.. +.+++.++.|||+ .+++||||||+|||++.++. +||+|||+++.... .
T Consensus 101 ~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~--~ 176 (283)
T PHA02988 101 LEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSS--P 176 (283)
T ss_pred EEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhcc--c
Confidence 677776 89998875432 4467888999998 59999999999999998776 99999999875432 2
Q ss_pred CCCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.....++..|+|||++.+ ..+ +.++|||||||++|+|++|+.||........+. .+.......+.+..++..+
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~l 251 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD----LIINKNNSLKLPLDCPLEI 251 (283)
T ss_pred cccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcCCCCCCCCcCcHHH
Confidence 234568899999999976 444 455999999999999999999998765433222 2222223333334688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++||.+||+.||.+|||+.++++
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999999985
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=217.52 Aligned_cols=170 Identities=24% Similarity=0.303 Sum_probs=126.1
Q ss_pred Cccccc-chHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||+..+ +|.+++.. ..++.+++.++.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~~ 180 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTS 180 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhccc
Confidence 466644 88887652 113567889999999999999999999999987765 99999999875433
Q ss_pred CC-CCCCCcCCCCCcccccccCCcC----CCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCC
Q 024572 67 HS-RPKSTVGTPAYIAPEVLSRREY----DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 141 (265)
Q Consensus 67 ~~-~~~~~~~~~~y~aPE~~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (265)
.. ......++..|+|||.+..... .+.++|+|||||++|+|++|+.||.............. ..........
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 257 (291)
T cd06639 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPTLLHPE 257 (291)
T ss_pred ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCCCCccc
Confidence 22 2233468889999999864321 24559999999999999999999987544333222111 1111122233
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 142 ~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
.++..+.+||.+||..+|++||++.++++||||+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 4677899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=239.93 Aligned_cols=169 Identities=26% Similarity=0.403 Sum_probs=130.8
Q ss_pred CcccccchHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEcC---CCCCcEEEeccCCcccC
Q 024572 1 MQLGVSSLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDG---SPAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~---~~~~~vkl~Dfg~a~~~ 64 (265)
.|+|.++|.|++.. +..++|++.++.|||+.+||||||||.||||.. ++..+++|+|||+|+..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 48999999999988 234788999999999999999999999999976 45557999999999876
Q ss_pred CCCCC----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhhhcccCCC
Q 024572 65 LLHSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQYKIPD 139 (265)
Q Consensus 65 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (265)
..... .....||..|+|||++...... +++||||+||++|+.++| .+||......+ .++ ....+..-.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NI----l~~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANI----LTGNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHHhh--hhh----hcCccceee
Confidence 55433 2334699999999999876654 469999999999999996 89997643211 122 222221111
Q ss_pred CC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 140 YV-HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 140 ~~-~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.. ....++.+||.+||.++|..||+|.++|.||||-.
T Consensus 735 L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 735 LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 00 01128899999999999999999999999999964
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=223.00 Aligned_cols=174 Identities=25% Similarity=0.317 Sum_probs=128.7
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CCC
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~ 70 (265)
||+++++|.+++...+ ++.+++.++.|||++|++||||||+||+++.++. +||+|||+++..... ...
T Consensus 88 ~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~ 165 (337)
T cd07858 88 YELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKGDFM 165 (337)
T ss_pred EeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCCcccc
Confidence 5788888887775433 3667899999999999999999999999987765 999999998754433 222
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH-------------------h
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-------------------M 131 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-------------------~ 131 (265)
....++..|+|||.+.+....+.++|+|||||++|+|++|+.||.+.............. .
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (337)
T cd07858 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI 245 (337)
T ss_pred cccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHH
Confidence 344678899999988754334456999999999999999999997654322111111000 0
Q ss_pred hhcccC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 132 AVQYKI------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 132 ~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
...... .....++..+.+||.+||..+|.+|||+.++++||||..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 246 RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000000 012357889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=214.01 Aligned_cols=172 Identities=24% Similarity=0.330 Sum_probs=126.2
Q ss_pred Cccccc-chHHHHHH----------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-C
Q 024572 1 MQLGVS-SLSEFVML----------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-S 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~----------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~ 68 (265)
||++.+ +|..++.. ..++.+++.++.|||++||+||||||+||+++.++. +||+|||++...... .
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceecccccc
Confidence 567766 56655432 224777889999999999999999999999987665 999999988643222 1
Q ss_pred CCCCCcCCCCCcccccccCC----cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 69 RPKSTVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
......++..|+|||.+.+. ...+.++|+|||||++|+|++|..||............. ............++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 242 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLSQPSKWS 242 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh---cCCCccCCCCcccC
Confidence 22334688899999998532 112345999999999999999999997654322221111 11111222334678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.++.++|.+||..+|++||++.++++||||...
T Consensus 243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 899999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=214.20 Aligned_cols=166 Identities=26% Similarity=0.421 Sum_probs=125.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++++ +|.+++...+ .+.+++.++.|||++||+|+||||+||+++.++. +||+|||++....... .
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccc
Confidence 678765 8998876543 3667889999999999999999999999987765 9999999986443221 2
Q ss_pred CCCCcCCCCCccccccc---CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC---CCCCC
Q 024572 70 PKSTVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYVHI 143 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 143 (265)
.....++..|+|||++. ...+ +.++|+|||||++|+|++|..||............ .......+ ....+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM----TKSNFQPPKLKDKMKW 237 (267)
T ss_pred cccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh----hccCCCCCcccccCCC
Confidence 23446899999999974 2334 45699999999999999999999765432222111 11111111 22246
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPW 173 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~ 173 (265)
+..+.++|.+||..+|++|||+.++++|||
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=212.10 Aligned_cols=166 Identities=25% Similarity=0.371 Sum_probs=128.7
Q ss_pred Ccccc-cchHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++... .++.+++.++.|||++||+||||||+||+++.++. ++|+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~ 155 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCcc
Confidence 57764 5899988764 23567889999999999999999999999987765 9999999987544332
Q ss_pred C-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 R-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
. .....++..|+|||++.+..++ .++|+|||||++|+|++|+.||......... ..+..... .+....++..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~ 229 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALI----LKIIRGVF-PPVSQMYSQQL 229 (256)
T ss_pred chhhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCC-CCCccccCHHH
Confidence 2 2234688899999999887765 4599999999999999999999776532222 22222111 12222578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.++|.+||..+|++||++.++++|||+
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 230 AQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=215.94 Aligned_cols=169 Identities=25% Similarity=0.343 Sum_probs=126.2
Q ss_pred Cccccc-chHHHHHHhc-------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||+|+||+++.++. +||+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~ 165 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDS 165 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccceeccc
Confidence 567765 7888776532 4667899999999999999999999999988765 99999999864332
Q ss_pred C-CCCCCCcCCCCCcccccccCCc----CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCC
Q 024572 67 H-SRPKSTVGTPAYIAPEVLSRRE----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 141 (265)
Q Consensus 67 ~-~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (265)
. .......++..|+|||.+.... ..+.++|||||||++|+|++|+.||.............. ..........
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 242 (275)
T cd06608 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPTLKSPE 242 (275)
T ss_pred chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCCCCchh
Confidence 2 2223456888999999875422 223458999999999999999999976543332222211 1111222222
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 142 ~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.++..+++||.+||..||.+|||+.++++|||+
T Consensus 243 ~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 243 NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 467899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=213.63 Aligned_cols=167 Identities=31% Similarity=0.472 Sum_probs=128.9
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++...+ ++.+++.++.|||++||+||||+|+||+++.++. +||+|||+++.... .
T Consensus 76 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~ 150 (260)
T cd05611 76 MEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---N 150 (260)
T ss_pred EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---c
Confidence 577755 8888876533 3677899999999999999999999999987765 99999998864332 2
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--cCCCCCCCCHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCR 148 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 148 (265)
....++..|+|||.+.+..+. .++|+||||+++|+|++|..||........+.. ...... .......++..+.
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN----ILSRRINWPEEVKEFCSPEAV 225 (260)
T ss_pred ccCCCCcCccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcccCCCCcccccCCHHHH
Confidence 344688899999999877654 559999999999999999999977654332222 222221 1122235789999
Q ss_pred HHHHHhcccCCCCCCC---HHHHhcCcccCCC
Q 024572 149 NLLSRIFVANPSRRIT---IKEIKSHPWFLKN 177 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s---~~ell~h~~f~~~ 177 (265)
++|.+||..+|++||+ +.+++.||||++.
T Consensus 226 ~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 226 DLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 9999999999999995 5799999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=215.92 Aligned_cols=172 Identities=24% Similarity=0.366 Sum_probs=125.3
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++...... .
T Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 82 FEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKT 159 (291)
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCcc
Confidence 6888888888776532 2567899999999999999999999999988776 9999999986432221 1
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh----------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------- 133 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 133 (265)
.....++..|+|||.+.+....+.++||||+|+++|+|++|+.||............+......
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 1223467889999998764434556999999999999999999997655322211111111000
Q ss_pred cccCC---------CCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 134 QYKIP---------DYVHIS--QDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 134 ~~~~~---------~~~~~~--~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
....+ ....++ ..+.++|.+||..+|.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000 001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=214.88 Aligned_cols=168 Identities=31% Similarity=0.559 Sum_probs=137.9
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
|||+.+ .|.--++.-+. +..|+.+|.+||++|||+||||.+||+++..+. |||+|||+++.... ...
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeecccccccccCCcc
Confidence 788877 77777776654 334778899999999999999999999998886 99999999985433 345
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
..+++||+.|+|||++...+| ++++|+||+|++||||+.|++||.+.+....+..+. ......| ..+|.++.+
T Consensus 507 TkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~----ehnvsyP--KslSkEAv~ 579 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM----EHNVSYP--KSLSKEAVA 579 (683)
T ss_pred eeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----HccCcCc--ccccHHHHH
Confidence 567899999999999998887 466999999999999999999999987765555443 3333333 478999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
+.+.+|.+.|.+|.. -.+|..||||+..
T Consensus 580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 999999999999985 3679999999754
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=215.40 Aligned_cols=172 Identities=25% Similarity=0.333 Sum_probs=130.6
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.++|.+++..+ .++.+++.++.|||++||+|+||||+||+++.++. ++|+|||.+....... .
T Consensus 77 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 77 FEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRP 154 (283)
T ss_pred EeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCccc
Confidence 678888888877664 24677899999999999999999999999987765 9999999986554332 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc---------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------------- 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 134 (265)
.....++..|+|||.+.+....+.++|+||||+++|+|++|+.||........+...........
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 22345788999999988763445669999999999999999999987665444333322211100
Q ss_pred ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 135 YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 135 ~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
...+ ....++..++++|.+||..||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0000 012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=214.75 Aligned_cols=172 Identities=22% Similarity=0.316 Sum_probs=131.1
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||+++++|.+++.... ++.+++.++.|||++||+|+||+|+||+++.++. ++|+|||+++.......
T Consensus 77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 77 FEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPP 154 (283)
T ss_pred EecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCC
Confidence 6888888888877653 3567889999999999999999999999998766 99999999876544444
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh---------------hc
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQ 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~ 134 (265)
.....++..|+|||.+.+....+.++|+||||+++++|++|+.||.................. ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 445568889999998865444455699999999999999999999876654443332221000 00
Q ss_pred ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 135 YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 135 ~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
...+ .....+..+.++|.+||..+|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0000 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=215.01 Aligned_cols=171 Identities=26% Similarity=0.334 Sum_probs=130.3
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.++|.+++.... ++.+++.++.|||+++|+|+||+|+||+++.++. +||+|||++........
T Consensus 85 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~~~~~~ 162 (287)
T cd07838 85 FEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEMA 162 (287)
T ss_pred ehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceeccCCcc
Confidence 5777777877765432 3667889999999999999999999999998865 99999999876544433
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-ccC-----------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKI----------- 137 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~----------- 137 (265)
.....++..|+|||.+.+..+.. ++|+|||||++|+|++|+.||........+........... ...
T Consensus 163 ~~~~~~~~~~~~PE~~~~~~~~~-~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (287)
T cd07838 163 LTSVVVTLWYRAPEVLLQSSYAT-PVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSF 241 (287)
T ss_pred cccccccccccChHHhccCCCCC-cchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhc
Confidence 33445788999999998877654 49999999999999999999987665554444433211100 000
Q ss_pred C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 138 P---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 138 ~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+ ....++..+.++|.+||..||.+||++.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 242 PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 011345778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=214.92 Aligned_cols=173 Identities=27% Similarity=0.418 Sum_probs=128.6
Q ss_pred Cccccc-chHHHHHHh------------ccccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLE------------GSVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~------------~~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|..++... .++.+++.++.|||+ +||+||||||+||+++.++. +||+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~ 155 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA 155 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccC
Confidence 677766 777776652 235668889999996 69999999999999988665 99999999865432
Q ss_pred CCCCCCCcCCCCCcccccccCCcC-----CCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCC
Q 024572 67 HSRPKSTVGTPAYIAPEVLSRREY-----DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 141 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (265)
.......++..|+|||.+.+... .+.++|+|||||++|+|++|+.||......... ..+..+.... ....+.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~-~~~~~~ 232 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVDGD-PPTLPS 232 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHhhcC-CCCCCc
Confidence 22334467889999999865432 245599999999999999999999765433222 2222222211 122233
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 142 ~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.++.++.+||.+||..+|.+||++.++++||||...-
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 5889999999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=213.13 Aligned_cols=167 Identities=29% Similarity=0.377 Sum_probs=125.5
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++.... ++.+++.++.|||+++|+||||||+||+++.++. +||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICMS 162 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCcccccccccc
Confidence 566654 8888876543 3677899999999999999999999999987765 9999999986443211
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
......++..|+|||.+.+..++ .++|+||+||++|+|++|+.||........... ..........+..+++.
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTNPQLPSHISEH 237 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCCCCCchhcCHH
Confidence 11224578899999999876664 459999999999999999999986544332222 11111111122346788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
++++| +||..+|++||++.++++||||+
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 89998 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=214.50 Aligned_cols=172 Identities=24% Similarity=0.331 Sum_probs=124.1
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.++|.+++..+ .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++...... .
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 82 FEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQT 159 (291)
T ss_pred EecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCC
Confidence 678877887776542 23667899999999999999999999999987765 9999999987433221 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHHHHh-----------hh-cc-
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF-RKTISRIM-----------AV-QY- 135 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~-----------~~-~~- 135 (265)
.....++..|+|||.+.+....+.++|+|||||++|+|++|+.||......... ........ .. .+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 233457889999999876443345599999999999999999999765432211 11110000 00 00
Q ss_pred ----c--CC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 136 ----K--IP-------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 136 ----~--~~-------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
. .+ .....+..+.+++.+||..||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00 001135688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=216.18 Aligned_cols=175 Identities=23% Similarity=0.272 Sum_probs=128.7
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||+++.+|.+++..+. ++.+++.++.|||++||+||||+|+||+++..+. .+||+|||++.......
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVR 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCcc
Confidence 6777778877765432 3457899999999999999999999999985432 48999999986443221
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc--------------
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-------------- 134 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 134 (265)
......++..|+|||.+.+....+.++|+||+||++|+|++|+.||..........+.........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 122345788999999987654445569999999999999999999987654443333222111000
Q ss_pred ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 135 YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 135 ~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
...+ ....++..+.++|.+||..+|.+||++.++++||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 0000 01246788999999999999999999999999999964
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=215.14 Aligned_cols=172 Identities=24% Similarity=0.363 Sum_probs=129.9
Q ss_pred CcccccchHHHHHHhc------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.++|.+++..+. ++.+++.++.|||++||+||||||+||++++++. ++|+|||++.......
T Consensus 77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 77 FEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPV 154 (284)
T ss_pred EecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCc
Confidence 6788888888876543 3677899999999999999999999999987765 9999999986443221
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh--------------
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------- 133 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 133 (265)
......++..|++||++.+....+.++|+|||||++|+|++|+.||.+.................
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 12234578899999998765544566999999999999999999998776554433332211000
Q ss_pred cccCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 134 QYKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 134 ~~~~~~---------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
....+. ...++..++++|.+||..||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000000 11357789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=216.15 Aligned_cols=148 Identities=16% Similarity=0.150 Sum_probs=114.8
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--------CCCCCcCCCCCcccccccCC
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--------RPKSTVGTPAYIAPEVLSRR 88 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~~ 88 (265)
++.+++.++.|||+++|+||||||+|||++.++. ++|+|||+|+...... ......||+.|+|||++.+.
T Consensus 131 i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~ 208 (294)
T PHA02882 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA 208 (294)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC
Confidence 5778999999999999999999999999987665 9999999987543211 11234699999999999887
Q ss_pred cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHH-----HHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 024572 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK-----TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI 163 (265)
Q Consensus 89 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 163 (265)
.++ .++|||||||++|+|++|+.||.+......... .+.++..... ....++..+.+++..||..+|.+||
T Consensus 209 ~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp 284 (294)
T PHA02882 209 CVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKP 284 (294)
T ss_pred CCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCC
Confidence 775 559999999999999999999987643332221 1222222222 2234688999999999999999999
Q ss_pred CHHHHhc
Q 024572 164 TIKEIKS 170 (265)
Q Consensus 164 s~~ell~ 170 (265)
++.++++
T Consensus 285 ~~~~l~~ 291 (294)
T PHA02882 285 DYDALIK 291 (294)
T ss_pred CHHHHHH
Confidence 9999875
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=215.25 Aligned_cols=172 Identities=30% Similarity=0.483 Sum_probs=130.3
Q ss_pred Ccccc-cchHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CC
Q 024572 1 MQLGV-SSLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~ 70 (265)
||++. .+|.+++... .++.+++.++.|||++||+||||+|+||+++.++. ++|+|||++....... ..
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCccc
Confidence 45554 4888876542 24677899999999999999999999999987765 9999999876433221 12
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-ccCCCCCCCCHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVHISQDCRN 149 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 149 (265)
....++..|+|||.+.+..+.. ++|+||||+++|+|++|+.||.......... .+.... ........++..+.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~ 247 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK----RIRDNLPPKLKNLHKVSPRLRS 247 (285)
T ss_pred ccccCCccccCHHHhcCCCCCC-cccHHHHHHHHHHHHhCCCCCcCCCHHHHHH----HHHhcCCCCCcccccCCHHHHH
Confidence 2346889999999998776654 4999999999999999999997754332222 222111 112222347889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
+|.+||..+|.+|||+.++++|+||++..+
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 248 FLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=210.06 Aligned_cols=167 Identities=30% Similarity=0.428 Sum_probs=129.7
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||+..+ +|.+++..+. ++.+++.++.|||++||+||||+|+||+++.++. .+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKS 156 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCc
Confidence 567754 8888886542 2557888999999999999999999999975543 48999999987655444
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......++..|+|||.+.+..++ .++|+||||+++|+|++|+.||............ .... ..+....++..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~l~ 230 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKI----MSGT-FAPISDRYSPDLR 230 (256)
T ss_pred cccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHH----HhcC-CCCCCCCcCHHHH
Confidence 44445688899999999876654 4599999999999999999999776543322222 1111 1222335789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+++.+||..+|.+|||+.++++||||
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=219.08 Aligned_cols=176 Identities=24% Similarity=0.286 Sum_probs=132.7
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC----
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---- 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---- 67 (265)
||++.++|.+++..+. ++.+++.++.|||++||+||||+|+||+++.++. +||+|||.++.....
T Consensus 99 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg~~~~~~~~~~~~ 176 (335)
T PTZ00024 99 MDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSD 176 (335)
T ss_pred EeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCccceeecccccccc
Confidence 6888888888886543 4677899999999999999999999999988765 999999998644311
Q ss_pred -----------CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc
Q 024572 68 -----------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 68 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
.......++..|+|||.+.+....+.++|+|||||++|+|++|+.||........+..+..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~ 256 (335)
T PTZ00024 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNED 256 (335)
T ss_pred cccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchh
Confidence 111223467889999998775544566999999999999999999998776544443333221111000
Q ss_pred -C------C---------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 137 -I------P---------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 137 -~------~---------------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
+ + .....+..+.++|.+||..+|.+|||+.+++.||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 257 NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred hCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 0 0 0123578899999999999999999999999999998653
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=213.89 Aligned_cols=172 Identities=24% Similarity=0.346 Sum_probs=129.7
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhccccc
Confidence 677766 8888776532 4677899999999999999999999999987765 9999999876433221
Q ss_pred CCCCCcCCCCCcccccccCC----cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-ccCCCCCCC
Q 024572 69 RPKSTVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVHI 143 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 143 (265)
......++..|+|||.+... ...+.++|+|||||++|+|++|+.||........... +.... .....+..+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 234 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK----ILKSEPPTLDQPSKW 234 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH----HhcCCCCCcCCcccC
Confidence 22334688899999997532 2223459999999999999999999977543322221 11111 112223357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
+..+.++|.+||..+|.+||++.++++||||.+..
T Consensus 235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 88999999999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=220.98 Aligned_cols=174 Identities=28% Similarity=0.319 Sum_probs=130.2
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC----
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---- 68 (265)
||++.++|.+++.... ++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 88 ~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~~~~ 165 (337)
T cd07852 88 FEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEENPE 165 (337)
T ss_pred ecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccccccc
Confidence 6788888887765432 4677899999999999999999999999998776 9999999987543322
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh---------------
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------------- 131 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--------------- 131 (265)
......++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+...............
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (337)
T cd07852 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFA 245 (337)
T ss_pred CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhH
Confidence 112345888999999887655445669999999999999999999977654433222211100
Q ss_pred ----h----hccc--CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 132 ----A----VQYK--IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 132 ----~----~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
. .... ......++..+.++|.+||..+|.+|||+.++++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 246 ATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 0 0000 0011236889999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=239.63 Aligned_cols=168 Identities=26% Similarity=0.345 Sum_probs=125.0
Q ss_pred CcccccchHHHHHHh-cc----------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC----
Q 024572 1 MQLGVSSLSEFVMLE-GS----------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL---- 65 (265)
Q Consensus 1 me~~~~sL~~~~~~~-~~----------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~---- 65 (265)
||||+.+|...+..+ .. .++|++|+.|+|++|||||||||.||+++.+.. |||+|||+|+...
T Consensus 675 MEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~ 752 (1351)
T KOG1035|consen 675 MEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLE 752 (1351)
T ss_pred HhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC--eeecccccchhhhhhhh
Confidence 999999655444444 33 467999999999999999999999999997776 9999999986410
Q ss_pred ---------------CCCCCCCCcCCCCCcccccccCCc--CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 024572 66 ---------------LHSRPKSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 128 (265)
Q Consensus 66 ---------------~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 128 (265)
.....+..+||..|+|||++.+.. .+..|+|+||||+|++||+ .||... .....++.
T Consensus 753 ~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~Ts---MERa~iL~ 826 (1351)
T KOG1035|consen 753 SIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTS---MERASILT 826 (1351)
T ss_pred hHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCch---HHHHHHHH
Confidence 111234567999999999998755 2345599999999999998 456543 22234444
Q ss_pred HHhhhcccCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 129 RIMAVQYKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 129 ~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.+.....+.+. +..--+.-..+|+.||+.||.+||||.++|++.||-.
T Consensus 827 ~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 827 NLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred hcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 44444444440 1122345578999999999999999999999999973
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=210.40 Aligned_cols=176 Identities=30% Similarity=0.535 Sum_probs=133.5
Q ss_pred ccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCC-CCCcEEEeccCCcccCCCC-------
Q 024572 5 VSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLH------- 67 (265)
Q Consensus 5 ~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~------- 67 (265)
+++|..-|..+. .++-|+.+|.+||.+||.||||||+|||.... ....||||||.+.......
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 345555555443 37778999999999999999999999999543 3335899999886533222
Q ss_pred -CCCCCCcCCCCCccccccc----CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh-----------HHHHHHHHHHh
Q 024572 68 -SRPKSTVGTPAYIAPEVLS----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----------KNFRKTISRIM 131 (265)
Q Consensus 68 -~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~ 131 (265)
....+.+|+..|||||++. ...++.+++|.||||+|+|-|++|.+||.+.-.. .-.......+.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 1223457888999999863 2334467799999999999999999999764221 12234455566
Q ss_pred hhcccCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 132 AVQYKIP--DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 132 ~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
...+.+| +|..+|.+.++||+.+|..|+.+|.++.++++|||++.-.+.
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 6677766 577899999999999999999999999999999999865443
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=211.62 Aligned_cols=168 Identities=22% Similarity=0.295 Sum_probs=128.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC----
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---- 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~---- 66 (265)
||++.+ +|.+++.... .+.+++.++.|||+.||+|+||+|+||+++.++. ++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhcccc
Confidence 577755 8988886543 3567889999999999999999999999987765 99999999864321
Q ss_pred ---CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 67 ---HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 67 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
........++..|+|||.+.+..+. .++|+|||||++|+|++|..||............. .......+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 234 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG---AHRGLMPRLPDSF 234 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh---hccCCCCCCCCCC
Confidence 1111234588899999999877665 45999999999999999999997654332221111 1111112233457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+..+.++|.+||..+|.+||++.++++||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=217.03 Aligned_cols=172 Identities=26% Similarity=0.393 Sum_probs=130.2
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~ 70 (265)
||+..+ +|.+++.... ++.+++.++.|||+.||+||||||+||+++.++. ++|+|||++........ .
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCc
Confidence 577654 8888875432 3567889999999999999999999999987765 99999999865433222 2
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....+++.|+|||.+.+..+. .++|+|||||++|++++|..||............ ..........+..++..+++|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred CcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCCCCCCCCccccCHHHHHH
Confidence 234688899999999876664 5599999999999999999999765432221111 011111122334578889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
+.+||..+|.+||++.++++||||+...
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCchhcccc
Confidence 9999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=212.40 Aligned_cols=169 Identities=24% Similarity=0.314 Sum_probs=127.3
Q ss_pred Cccccc-chHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++++ +|.+++... .++.+++.++.|||++||+||||+|+||+++.++. +||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIA 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhh
Confidence 677665 888877654 24777899999999999999999999999998765 9999999987543322
Q ss_pred CCCCCcCCCCCcccccccCC---cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 RPKSTVGTPAYIAPEVLSRR---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
......++..|+|||.+.+. .++ .++|+|||||++|+|++|+.||................. ..........++.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKLKDKEKWSP 234 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccccchhhhhH
Confidence 22344688899999998765 554 459999999999999999999987654332222111100 0011112224577
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPW 173 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~ 173 (265)
++.++|.+||..+|..|||+.+++.|+|
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=216.50 Aligned_cols=172 Identities=22% Similarity=0.280 Sum_probs=125.8
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||+...+|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 94 ~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 171 (311)
T cd07866 94 TPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPN 171 (311)
T ss_pred EecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccchhccCCCcc
Confidence 466666666665532 24778899999999999999999999999988776 99999999864332211
Q ss_pred -----------CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc----
Q 024572 70 -----------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---- 134 (265)
Q Consensus 70 -----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---- 134 (265)
.....+++.|+|||.+.+....+.++|||||||++|+|++|++||.+..................
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (311)
T cd07866 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW 251 (311)
T ss_pred cccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 11224678899999987654345569999999999999999999987665444333322111000
Q ss_pred ------------c---cCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 135 ------------Y---KIP-----DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 135 ------------~---~~~-----~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
. ..+ ....+++.+.++|.+||..+|.+|||+.+++.||||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 252 PGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 000 012345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=213.72 Aligned_cols=174 Identities=24% Similarity=0.398 Sum_probs=129.0
Q ss_pred CcccccchHHHHHH----------hccccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVML----------EGSVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~----------~~~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||+.+++|.++... ..++.+++.++.|||+ +||+||||+|+||+++.++. +||+|||++........
T Consensus 93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVDSKA 170 (296)
T ss_pred eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccCCCc
Confidence 56776666665543 2357778999999997 69999999999999987765 99999999875443333
Q ss_pred CCCCcCCCCCcccccccCCc---CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-cccCCCCCCCCH
Q 024572 70 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIPDYVHISQ 145 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 145 (265)
.....++..|+|||.+.+.. ..+.++|+||||+++|+|++|+.||....... ..+..+... ....+....++.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQEEPPSLPPNEGFSP 247 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHHHhcCCCCCCCCCCCCCH
Confidence 33445788999999987543 12345999999999999999999997643221 122222221 122233335788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
.+.+||.+||..+|.+||++.++++|+||.....
T Consensus 248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 9999999999999999999999999999976544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=234.55 Aligned_cols=162 Identities=27% Similarity=0.467 Sum_probs=131.7
Q ss_pred Ccccc-cchHHHHHHhcc-----------ccchHHHHHhhhhcC--ceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGV-SSLSEFVMLEGS-----------VKMKPDIFFSSLSQQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~~-----------~~~i~~~l~~lH~~~--ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||||. ++|-||+..|.- ..++.+++.+||..+ |||||||-+||||..++. .||||||.|.....
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATTKIL 198 (738)
T ss_pred hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccccccC
Confidence 99999 599999996642 445678899999888 999999999999998886 99999999863322
Q ss_pred CCCCC----------CCcCCCCCccccccc---CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh
Q 024572 67 HSRPK----------STVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 133 (265)
Q Consensus 67 ~~~~~----------~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 133 (265)
..... ...-|+.|+|||++- +... +.|+|||+|||+||.|+....||...... .+...
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l--------aIlng 269 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL--------AILNG 269 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce--------eEEec
Confidence 22111 123689999999873 3444 45699999999999999999999876432 24567
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 024572 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173 (265)
Q Consensus 134 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~ 173 (265)
.+.+|.+..++..+++||+.||..||.+||++-+++.+-+
T Consensus 270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 7888988899999999999999999999999999987644
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=221.16 Aligned_cols=175 Identities=21% Similarity=0.272 Sum_probs=127.7
Q ss_pred CcccccchHHHHHH--------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---
Q 024572 1 MQLGVSSLSEFVML--------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~--------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--- 69 (265)
||+++++|.+++.. +.++.+++.++.|||++||+||||||+||+++..+. .+||+|||.++.......
T Consensus 95 ~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg~~~~~~~~~~~~~ 173 (342)
T cd07854 95 QEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLARIVDPHYSHKG 173 (342)
T ss_pred eecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcccceecCCcccccc
Confidence 67787888777643 234678999999999999999999999999975432 489999999864422111
Q ss_pred -CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH------------------
Q 024572 70 -PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------ 130 (265)
Q Consensus 70 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~------------------ 130 (265)
.....++..|+|||.+.+....+.++|||||||++|+|++|+.||................
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (342)
T cd07854 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSF 253 (342)
T ss_pred ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhh
Confidence 1223578899999987654444566999999999999999999997765433332222110
Q ss_pred hh---hcccCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 131 MA---VQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 131 ~~---~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.. .....+ ....++.++++||.+||..||.+|||+.+++.||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 254 VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 000000 01246788999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=212.03 Aligned_cols=172 Identities=25% Similarity=0.352 Sum_probs=129.9
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||+++++|.+++.... ++.+++.++.|||++||+||||+|+||+++.++. ++|+|||+++...... .
T Consensus 77 ~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 77 FEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRT 154 (282)
T ss_pred ecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccc
Confidence 6788889998887652 3667889999999999999999999999988765 9999999987543322 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh--------------cc
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------QY 135 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~ 135 (265)
.....++..|+|||.+.+....+.++|+|||||++|++++|+.||........+.......... ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2233567789999998776344556999999999999999999998765544333332211000 00
Q ss_pred cCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 136 KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 136 ~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
..+ ....++..+.++|.+||..+|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 001 111347789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=214.06 Aligned_cols=169 Identities=22% Similarity=0.287 Sum_probs=125.6
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++... ..+.+++.++.|||+++|+||||||+||+++.++. +||+|||+++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~ 176 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTS 176 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeeccc
Confidence 677754 888876521 14567889999999999999999999999988765 99999999875433
Q ss_pred CC-CCCCCcCCCCCcccccccCC----cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCC
Q 024572 67 HS-RPKSTVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 141 (265)
Q Consensus 67 ~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (265)
.. ......++..|+|||++... ...+.++|+||+||++|+|++|+.||............. ...........
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~ 253 (286)
T cd06638 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP---RNPPPTLHQPE 253 (286)
T ss_pred CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc---ccCCCcccCCC
Confidence 22 22334688999999998532 112455999999999999999999997654332222111 11111122223
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 142 ~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.++..+.+||.+||..+|++|||+.++++|+||
T Consensus 254 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 467889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=209.14 Aligned_cols=168 Identities=29% Similarity=0.395 Sum_probs=129.3
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++.... .+.+++.++.|||+.||+|+||+|+||+++.++. +||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 567654 8888876544 3667889999999999999999999999987765 999999998754443333
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+......+.++|+|||||++|+|++|+.||........... ..........+..++..+.++
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHHH
Confidence 4556889999999987655234559999999999999999999977653222211 111111112233578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+.+||..+|.+||++.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=222.55 Aligned_cols=173 Identities=27% Similarity=0.437 Sum_probs=128.0
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGT 157 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCc
Confidence 788754 8999887532 2567889999999999999999999999987765 99999999875433222
Q ss_pred C--CCCcCCCCCcccccccCC----cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCC-CCC
Q 024572 70 P--KSTVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVH 142 (265)
Q Consensus 70 ~--~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 142 (265)
. ....|++.|+|||++.+. ...+.++|+|||||++|+|++|+.||........+..+... ......|. ...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~ 235 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITD 235 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCcccc
Confidence 1 234699999999998752 22245599999999999999999999876543333222211 11112222 235
Q ss_pred CCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 024572 143 ISQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKN 177 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~--R~s~~ell~h~~f~~~ 177 (265)
++..++++|.+||...+.+ |+++.++++|+||...
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 7899999999999876554 5689999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=213.17 Aligned_cols=163 Identities=21% Similarity=0.322 Sum_probs=125.3
Q ss_pred Cccccc-chHHHHHHh-------------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLE-------------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +|
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~~ 164 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT--VK 164 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc--EE
Confidence 566654 888888654 24677899999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++...... ......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+....... ..+
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~----~~i 239 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI----EMI 239 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHH
Confidence 99999987433221 12233567889999998877765 45999999999999998 99999876543322 222
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.. ....+.+..++..+.+|+.+||..||.+||++.+++++
T Consensus 240 ~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred Hc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 21 12223344689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=213.03 Aligned_cols=172 Identities=23% Similarity=0.336 Sum_probs=128.5
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||+...+|.+++... .++.+++.++.|||++|++|+||+|+||+++.++. +||+|||++.......
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 79 FEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSA 156 (287)
T ss_pred eccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCcc
Confidence 567777777777654 24677899999999999999999999999998776 9999999987554332
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-ccCC---------
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIP--------- 138 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--------- 138 (265)
......++..|+|||.+.+....+.++||||||+++|+|++|+.||.................... ...+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 122345678899999887654445669999999999999999999987665443333322111000 0000
Q ss_pred --------------CCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 139 --------------DYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 139 --------------~~~~-~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.... ++..+.++|.+||..+|.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=217.63 Aligned_cols=174 Identities=21% Similarity=0.341 Sum_probs=124.9
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+ ..+.+++.++.|||++||+||||||+||+++.++. +||+|||.+.......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHG 155 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccc
Confidence 577764 788877643 23677899999999999999999999999987765 9999999876432211
Q ss_pred C--------CCCCcCCCCCcccccccCC--cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-----
Q 024572 69 R--------PKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----- 133 (265)
Q Consensus 69 ~--------~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 133 (265)
. .....++..|+|||++.+. .+ +.++|+||+||++|+|++|+.||...................
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccC
Confidence 1 1223467789999998763 34 355999999999999999999998754433222211100000
Q ss_pred -----------------------cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 134 -----------------------QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 134 -----------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
....+....++.++.+|+.+||..||++|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00000111234678899999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=212.62 Aligned_cols=172 Identities=26% Similarity=0.392 Sum_probs=126.7
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+++.+.+..+ ..+.+++.++.|||++||+||||+|+||+++.++. +||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPAS 156 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccc
Confidence 577777554443322 23667899999999999999999999999998765 9999999987554433
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc------------c-
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------Y- 135 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------~- 135 (265)
......++..|+|||++.+....+.++|+||||+++|+|++|+.||.................... .
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 223456788999999998873445669999999999999999999987654433222211100000 0
Q ss_pred --cCC-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 136 --KIP-----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 136 --~~~-----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
..+ ....++..+++||++||..+|++|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000 011247889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=220.41 Aligned_cols=157 Identities=26% Similarity=0.300 Sum_probs=118.7
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHh
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 96 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 96 (265)
++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.... ......++..|+|||.+.+....+.++|
T Consensus 122 ~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~D 197 (342)
T cd07879 122 LVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVD 197 (342)
T ss_pred HHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHH
Confidence 4677899999999999999999999999988765 99999999874322 2234467889999999876443455699
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-------------------hhcccCC------CCCCCCHHHHHHH
Q 024572 97 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-------------------AVQYKIP------DYVHISQDCRNLL 151 (265)
Q Consensus 97 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-------------------~~~~~~~------~~~~~~~~~~~li 151 (265)
+|||||++|+|++|+.||.+......+...+.... ......+ .....+..+.+||
T Consensus 198 v~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 277 (342)
T cd07879 198 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLL 277 (342)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHH
Confidence 99999999999999999987654333322221100 0000000 0124678899999
Q ss_pred HHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 152 SRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 152 ~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+||..||.+||++.+++.||||...
T Consensus 278 ~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 278 EKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHcCCChhhCcCHHHHhcCcchhhc
Confidence 99999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=221.46 Aligned_cols=161 Identities=22% Similarity=0.356 Sum_probs=130.6
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
|||... ||.+|++... ...||++++.||.++++|||||-..||||+.+.. +||+|||+|+......
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDDE 357 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCCc
Confidence 566555 9999999722 2667899999999999999999999999998876 9999999999433222
Q ss_pred CCC--CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 RPK--STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
... ..--...|.|||.+....++.+ ||||||||+||||+| |+.||.+....+.+. .....+++|.+..+|+
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~-----~le~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-----LLERGYRLPRPEGCPD 431 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHH-----HHhccCcCCCCCCCCH
Confidence 211 1123457999999999888766 999999999999999 899998876543332 2345678898889999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHh
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIK 169 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell 169 (265)
.+.++|..||..+|++|||+..+.
T Consensus 432 ~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999999999999999998664
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=219.76 Aligned_cols=175 Identities=22% Similarity=0.304 Sum_probs=129.0
Q ss_pred CcccccchHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
|++++++|.+++..+ .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++... .....
T Consensus 101 ~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~--~~~~~ 176 (345)
T cd07877 101 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD--DEMTG 176 (345)
T ss_pred ehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccc--ccccc
Confidence 456667777665432 24678899999999999999999999999988775 9999999987432 22234
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-------------------hh
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-------------------AV 133 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-------------------~~ 133 (265)
..++..|+|||.+.+....+.++|+|||||++|+|++|+.||................. ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (345)
T cd07877 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 256 (345)
T ss_pred cccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHH
Confidence 56888999999987644345569999999999999999999976554333322211100 00
Q ss_pred cccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 134 QYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 134 ~~~~~------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
....+ .....++.+++||.+||..||.+||++.++++||||++...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 257 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred hcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 00001 01235788999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=211.19 Aligned_cols=172 Identities=24% Similarity=0.387 Sum_probs=128.8
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~ 70 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 81 MEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCcccc
Confidence 566644 8888876543 2557889999999999999999999999998665 99999999875443322 2
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+....+.++|+||||+++|+|++|..||......... ..+............++.++.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 234 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM----MLIPKSKPPRLEDNGYSKLLREF 234 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh----hccccCCCCCCCcccCCHHHHHH
Confidence 33468889999999876544455699999999999999999999765432211 11111111111111367899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
+.+||..||.+||++.+++.|+||+...
T Consensus 235 i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 235 VAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-31 Score=228.37 Aligned_cols=169 Identities=34% Similarity=0.589 Sum_probs=147.0
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
|||+.+ .+++++..++. ..|+..++.|||+++|||||||.+|||++.+.. +||+|||++..+......
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLML 211 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccc
Confidence 677666 78888887664 667899999999999999999999999998876 999999999988888888
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
.+.+|++.|.|||++.+..|.++.+|+||+|+++|.|++|..||.+..- ...-.++....+++|. .++.++.++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----k~Lr~rvl~gk~rIp~--~ms~dce~l 285 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----KELRPRVLRGKYRIPF--YMSCDCEDL 285 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----ccccchheeeeecccc--eeechhHHH
Confidence 8999999999999999999999999999999999999999999988643 2333444556666666 478899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
|+++|..+|.+|+++++++.|.|....
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchh
Confidence 999999999999999999999998643
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=213.97 Aligned_cols=171 Identities=28% Similarity=0.479 Sum_probs=127.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||+ ++|+||||||+|||++.++. +||+|||++..... ..
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-cc
Confidence 677765 8999886543 36678899999997 69999999999999987765 99999999864432 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH--------------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR-------------------- 129 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-------------------- 129 (265)
.....++..|+|||.+.+..+. .++|+|||||++|+|++|+.||...... ........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred cccCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCC
Confidence 3445788999999998776654 4599999999999999999999654321 11111100
Q ss_pred -------------Hhhhc-ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 130 -------------IMAVQ-YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 130 -------------~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+.... ...| ...++.++++||.+||..+|++|||+.++++||||.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000 0001 11367889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-31 Score=228.07 Aligned_cols=172 Identities=34% Similarity=0.572 Sum_probs=143.0
Q ss_pred CcccccchHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcC-CCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVSSLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||-..+...++|... -.+.||+.+|.|||-++|||+||||+|||+.+ +..+++||||||+|+......
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 666667666666533 23778999999999999999999999999954 344679999999999888777
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
-..+.+||+.|+|||++++++|... -|+||+|+++|.-++|.+||....+. ...++. ....++...|..+++.+.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdI---ndQIQN-AaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDI---NDQIQN-AAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccch---hHHhhc-cccccCCCchhhcCHHHH
Confidence 7788899999999999999998644 89999999999999999999876542 222222 234455556788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+||..+|+..-.+|.|+...+.|||++..
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999999864
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=208.21 Aligned_cols=166 Identities=25% Similarity=0.411 Sum_probs=129.6
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhh-----hcCceecCCCcCcEEEcCCCCCcEEEeccCCc
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSL-----SQQICHRDLKLENTLLDGSPAPRLKICDFGYS 61 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH-----~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a 61 (265)
||++.+ +|.+++... .++.+++.++.||| +.+|+|+||||+||+++.++. +||+|||++
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~ 157 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLA 157 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEeccccc
Confidence 677755 888887643 23667899999999 999999999999999987765 999999998
Q ss_pred ccCCCCCC-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCC
Q 024572 62 KSSLLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 140 (265)
Q Consensus 62 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (265)
........ .....++..|+|||.+.+..++ .++|+||||+++|+|++|+.||..... .. ....+..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~-~~---~~~~~~~~~~-~~~~ 231 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQ-LQ---LASKIKEGKF-RRIP 231 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCH-HH---HHHHHhcCCC-CCCc
Confidence 76544332 3344688999999999876654 559999999999999999999987652 22 2222222221 1223
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 141 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 141 ~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
..++..+.+++.+||..+|.+||++.++++|||+
T Consensus 232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 3678999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=243.11 Aligned_cols=169 Identities=15% Similarity=0.168 Sum_probs=121.5
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCC-----------------CCCcE
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGS-----------------PAPRL 53 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~-----------------~~~~v 53 (265)
||+.+.+|.+++... .+++||+.+|.|||++||+||||||+||||+.. ....+
T Consensus 59 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ 138 (793)
T PLN00181 59 LECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATT 138 (793)
T ss_pred hccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcc
Confidence 688888999998642 236789999999999999999999999999542 22347
Q ss_pred EEeccCCcccCCCCC-----------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCC
Q 024572 54 KICDFGYSKSSLLHS-----------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFED 116 (265)
Q Consensus 54 kl~Dfg~a~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 116 (265)
|++|||+++...... ......+|++|+|||++.+..+. .++|||||||++|||++|..|+..
T Consensus 139 ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 139 KSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSN-CASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred cccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCC-chhhhhhHHHHHHHHhhCCCchhh
Confidence 778888775321100 00113578899999999888775 559999999999999999888653
Q ss_pred CCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 117 QEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.. ..+...... ...+...........++.+||..+|.+||++.++++||||...
T Consensus 218 ~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 218 KS--RTMSSLRHR-----VLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred HH--HHHHHHHHh-----hcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 21 111111111 1111111224567789999999999999999999999999753
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=212.32 Aligned_cols=171 Identities=22% Similarity=0.286 Sum_probs=130.2
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.++|.+++..+. ++.+++.++.|||++||+||||+|+||+++.++. +||+|||++.... ..
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---PA 174 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---CC
Confidence 6888888888776533 3567899999999999999999999999987765 9999999876322 22
Q ss_pred CCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 71 KSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
....++..|+|||.+.. ......++|+|||||++|+|++|..||............. ...........++..++
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~ 250 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNDSPTLQSNEWTDSFR 250 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCCccccCHHHH
Confidence 34568889999999853 2223455999999999999999999998765433332221 11111112234678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
+|+.+||..+|.+||++.+++.||||+...+.
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~ 282 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCCCchh
Confidence 99999999999999999999999999875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=210.36 Aligned_cols=172 Identities=27% Similarity=0.338 Sum_probs=125.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++...+ ++.+++.++.|||++|++||||+|+||+++.++. ++|+|||+++......
T Consensus 87 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~ 164 (272)
T cd06629 87 LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDN 164 (272)
T ss_pred EecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeeccccccccccccc
Confidence 566644 7888776543 3567899999999999999999999999987765 9999999987433211
Q ss_pred -CCCCCcCCCCCcccccccCCc-CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 69 -RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
......++..|+|||.+.... ..+.++|+||||+++|++++|..||............................++..
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (272)
T cd06629 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244 (272)
T ss_pred cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHH
Confidence 122335788999999987654 234559999999999999999999975443322222111111111111112356889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+.++|.+||..+|.+|||+.++++||||
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 245 ALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=233.81 Aligned_cols=160 Identities=20% Similarity=0.229 Sum_probs=108.9
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC--CCCCCCcCCCCCcccccccCCcCC---
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAYIAPEVLSRREYD--- 91 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~--- 91 (265)
++.+++.+|.|||++||+||||||+|||++... +.+||+|||+|+..... ......++++.|+|||.+......
T Consensus 260 i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~ 338 (566)
T PLN03225 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 338 (566)
T ss_pred HHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCC
Confidence 466788999999999999999999999998532 24999999999754322 223445789999999976432211
Q ss_pred ------------------CchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH----------hhhccc------C
Q 024572 92 ------------------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI----------MAVQYK------I 137 (265)
Q Consensus 92 ------------------~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~------~ 137 (265)
..++|||||||++|+|+++..++.. ....+...+... ...... .
T Consensus 339 ~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (566)
T PLN03225 339 PSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGF 416 (566)
T ss_pred ccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhh
Confidence 1236999999999999987666432 112222211110 000000 0
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 138 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 138 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
..........++||.+||.+||.+|||+.++|+||||+....
T Consensus 417 ~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 417 EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 000012334568999999999999999999999999986543
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=211.72 Aligned_cols=171 Identities=24% Similarity=0.291 Sum_probs=128.5
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.++|.+++.... ++.+++.++.|||++||+||||+|+||+++.++. +||+|||++..... .
T Consensus 94 ~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~---~ 168 (307)
T cd06607 94 MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP---A 168 (307)
T ss_pred HHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC---C
Confidence 5777788777765422 3667899999999999999999999999988775 99999998864332 2
Q ss_pred CCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 71 KSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
....++..|+|||++.+ ....+.++||||||+++|+|++|+.||........... +............++..++
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH----HhcCCCCCCCchhhCHHHH
Confidence 34567889999998853 22234459999999999999999999976543222111 1111111111224678999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
++|.+||..+|.+||++.+++.||||....+.
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 276 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRERPP 276 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence 99999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=207.76 Aligned_cols=170 Identities=28% Similarity=0.448 Sum_probs=128.4
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++. ++|.+++.... ++.+++.++.|||++||+|+||+|+||+++.++. +||+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCc
Confidence 46665 48888876543 3567889999999999999999999999988665 999999998754332221
Q ss_pred -----CCCcCCCCCcccccccCCc--CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 71 -----KSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 71 -----~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
....++..|+|||.+.+.. ....++|+||||+++|++++|+.||............+ ........|....+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV--GAGHKPPIPDSLQL 233 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH--hcCCCCCCCccccc
Confidence 1245788999999987654 13455999999999999999999997654322211111 11222334444456
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+..+.++|.+||..+|.+|||+.+++.|||+
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=213.00 Aligned_cols=172 Identities=23% Similarity=0.314 Sum_probs=127.6
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++.++|.+++..+ .++.+++.++.|||++||+||||||+||+++.++. +||+|||++........
T Consensus 95 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~~ 172 (302)
T cd07864 95 FEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLARLYNSEESR 172 (302)
T ss_pred EcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccccccccCCccc
Confidence 567777666665532 23677899999999999999999999999988776 99999999875433221
Q ss_pred -CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-cC----------
Q 024572 70 -PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI---------- 137 (265)
Q Consensus 70 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~---------- 137 (265)
.....++..|+|||.+.+....+.++|||||||++|+|++|+.||........+............ ..
T Consensus 173 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T cd07864 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFN 252 (302)
T ss_pred ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccccc
Confidence 122346778999998876544456699999999999999999999876554443333322111000 00
Q ss_pred -------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 138 -------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 138 -------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.....++..+.++|.+||..+|.+|||+.+++.||||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 253 TMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0122468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=211.73 Aligned_cols=167 Identities=24% Similarity=0.341 Sum_probs=124.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++...... .
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccc
Confidence 677765 8988876443 3667899999999999999999999999987765 9999999987543222 2
Q ss_pred CCCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc---CCCCCCCC
Q 024572 70 PKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK---IPDYVHIS 144 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 144 (265)
.....++..|+|||.+.. ....+.++|+||+||++|+|++|+.||.......... ........ .+....++
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----LMSKSNFQPPKLKDKTKWS 238 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----eeecCCCCCCCCccccccC
Confidence 233468889999998853 2222456999999999999999999996543221111 11111111 11223468
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSHPW 173 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h~~ 173 (265)
..+.+||.+||..+|.+|||+.++++|+|
T Consensus 239 ~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 239 STFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 89999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=220.58 Aligned_cols=147 Identities=22% Similarity=0.344 Sum_probs=112.6
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC---CCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||++||+||||||+|||++.++. +||+|||+++........ ....++..|+|||++.+..++ .
T Consensus 217 i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~ 293 (374)
T cd05106 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYT-V 293 (374)
T ss_pred HHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCC-c
Confidence 3567899999999999999999999999987665 999999998754322211 122345679999999877665 4
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++|||||||++|+|++ |+.||........+.... ......+.+..+++++.++|.+||..||.+|||+.++++
T Consensus 294 ~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 294 QSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred cccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----HcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5999999999999997 999998755433332222 222233333356899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=208.93 Aligned_cols=172 Identities=27% Similarity=0.385 Sum_probs=128.6
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++|++|+||+|+||+++.++. .+||+|||++........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccccccccccccccc
Confidence 456554 8888876533 3678899999999999999999999999976542 489999999865433211
Q ss_pred ----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.....++..|+|||.+.+..++ .++|+||+|+++|+|++|..||.......... ..............+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHHHhccCCCCCCchhhCH
Confidence 1223578899999998876665 45999999999999999999997554322222 22222222222223335788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
++.+++.+||..+|.+||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=209.55 Aligned_cols=171 Identities=26% Similarity=0.386 Sum_probs=131.8
Q ss_pred Ccccc-cchHHHHHHh---------ccccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE---------GSVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~---------~~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++... .++.+++.++.|||+ +|++||||+|+||+++.++. ++|+|||++........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLD 155 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCC
Confidence 56777 5898888752 347778999999999 99999999999999988765 99999999875543333
Q ss_pred CC-CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC-CCHHH
Q 024572 70 PK-STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDC 147 (265)
Q Consensus 70 ~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 147 (265)
.. ...++..|+|||.+.+..++ .++|+||||+++|+|++|+.||...... ........+..... ...... ++..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYS-YAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPP-PSLPAEEFSPEF 232 (264)
T ss_pred cccceeecccccCHhhhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCC-CCCCcccCCHHH
Confidence 22 34578899999998877654 4599999999999999999999776421 12222333222221 222223 78899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.++|.+||..+|++||++.++++||||+.
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=214.25 Aligned_cols=171 Identities=28% Similarity=0.477 Sum_probs=129.1
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~ 70 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||++....... ..
T Consensus 97 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 97 MEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred EecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccc
Confidence 466554 677765432 24677899999999999999999999999987775 9999999986433222 22
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+..+. .++|+|||||++|+|++|+.||........... +.. ...........++..+.++
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRD--SPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred cceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-Hhc--cCCCCccccCCCCHHHHHH
Confidence 335688999999999876664 459999999999999999999986544332221 111 1111122233578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
|.+||..+|.+||++.++++||||.+.
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccC
Confidence 999999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=208.02 Aligned_cols=170 Identities=27% Similarity=0.367 Sum_probs=124.5
Q ss_pred Ccccc-cchHHHHHHhc------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||++. ++|.+++.... .+.+++.++.|||++||+||||||+||+++... +.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGI 162 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccC
Confidence 46665 48988887541 245788999999999999999999999997532 24999999998644322
Q ss_pred C-CCCCCcCCCCCcccccccCCc-CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 68 S-RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 68 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
. ......++..|+|||.+.+.. ..+.++|+||+|+++|+|++|+.||........... ...... .....+..+++
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~ 239 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFK--IHPEIPESLSA 239 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhhhc--cCCCCCcccCH
Confidence 2 122345788999999986543 234569999999999999999999976443221111 011111 11122335788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.+++|+.+||..+|.+|||+.+++.||||
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=208.74 Aligned_cols=167 Identities=31% Similarity=0.406 Sum_probs=126.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+|+||||+||+++.++. ++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 162 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLS 162 (265)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCcccccccccccc
Confidence 567754 8988876543 3667889999999999999999999999987765 999999998743321
Q ss_pred -CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 68 -SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 68 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.......++..|+|||.+.+..++ .++|+|||||++|+|++|+.||.......... ...........+..++..
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 163 GTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLPPHVSDH 237 (265)
T ss_pred ccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCchhhCHH
Confidence 112234588899999999876664 45999999999999999999997654332221 111111112223356788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
+.++|.+||. +|.+||+++++++|||+.
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999999994 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=211.68 Aligned_cols=176 Identities=26% Similarity=0.426 Sum_probs=128.3
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++... .++.+++.++.|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeeccccccccc
Confidence 577754 888775431 24666889999999999999999999999987765 99999999864432
Q ss_pred CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhhhc-ccCCC----C
Q 024572 67 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQ-YKIPD----Y 140 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~-~~~~~----~ 140 (265)
.. .....++..|+|||.+.+..++. ++|+|||||++|+|++|+.||...... .........+.... ...+. .
T Consensus 158 ~~-~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd06621 158 SL-AGTFTGTSFYMAPERIQGKPYSI-TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235 (287)
T ss_pred cc-cccccCCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence 22 22345788999999998777654 499999999999999999999865220 01111122111111 11111 1
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 141 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 141 ~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
..+++.+.+||.+||..+|.+|||+.+++.||||++....
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 2356789999999999999999999999999999765543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=208.59 Aligned_cols=168 Identities=27% Similarity=0.402 Sum_probs=131.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+|+||+|+||+++.++. ++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccc
Confidence 466654 8888876552 3667899999999999999999999999988776 999999998765444334
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+..+. .++|+||||+++|+|++|..||...... ........... .....+..++..+.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET--ADVLYPATWSTEAIDA 232 (258)
T ss_pred cccCCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc--ccccCcccCcHHHHHH
Confidence 455688899999999876654 4599999999999999999999876542 11112222111 2223334678999999
Q ss_pred HHHhcccCCCCCCCH--HHHhcCccc
Q 024572 151 LSRIFVANPSRRITI--KEIKSHPWF 174 (265)
Q Consensus 151 i~~~L~~dP~~R~s~--~ell~h~~f 174 (265)
|.+||..+|.+||++ .++++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=206.86 Aligned_cols=168 Identities=29% Similarity=0.436 Sum_probs=131.1
Q ss_pred Cccc-ccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLG-VSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++ +++|.+++.... ++.+++.++.|||++|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEeccccccc
Confidence 5666 558888877653 4677899999999999999999999999988665 99999999875554432
Q ss_pred --CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.....++..|+|||.+.+.... .++|+||||+++|+|++|..||....... .....+.........+..++..+
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYG-RAADIWSLGCTVIEMATGKPPWSELGNPM---AALYKIGSSGEPPEIPEHLSEEA 233 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHhccccCCCcCCCcccCHHH
Confidence 3445688899999999876654 45999999999999999999998765222 12222221112222333568999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.++|.+||..+|.+||++.++++||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=206.84 Aligned_cols=166 Identities=24% Similarity=0.358 Sum_probs=129.9
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+ .++.+++.++.|||+.|++||||+|+||+++.++. +||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEY 155 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEccccc
Confidence 677764 899988764 23567888999999999999999999999988765 9999999987543332
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......++..|+|||.+.+..++ .++|+||||+++|+|++|..||.......... .+...... +....++..+
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~ 229 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVV----KIVQGNYT-PVVSVYSSEL 229 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHcCCCC-CCccccCHHH
Confidence 22345689999999999876654 44899999999999999999997754433222 22222222 2224578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.++|.+||..+|.+||++.++++|+|+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=210.84 Aligned_cols=172 Identities=23% Similarity=0.352 Sum_probs=125.1
Q ss_pred Cccccc-chHHHHHH---------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVS-SLSEFVML---------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~---------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.+ +|.++... ..++.+++.++.|||++||+||||+|+||+++.++. ++|+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccc
Confidence 466666 44444332 224667889999999999999999999999988765 9999999987543322 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh---------------hc
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQ 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~ 134 (265)
.....++..|+|||.+.+....+.++||||||+++|+|++|+.||.................. ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 223457889999999876554456699999999999999999999765543332222211000 00
Q ss_pred ccCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 135 YKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 135 ~~~~----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
...+ ....++..+.+|+.+||..+|.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0001 123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=232.91 Aligned_cols=174 Identities=30% Similarity=0.432 Sum_probs=135.7
Q ss_pred Ccc-cccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQL-GVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~-~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||| +||.|-.++.... .+.-+.-+|..+|+.|+|||||||+|||||..|+ |||+|||.|-.....+
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCcE
Confidence 454 3447777766555 2444667788899999999999999999998886 9999999986554333
Q ss_pred CCCCCcCCCCCcccccccC----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 69 RPKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.....+|||-|.+||+++. .+.+++.+|+||+||++|+|++|..||...+-...+.+++..- ..+.+|.-..+|
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk--~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK--ESLSFPDETDVS 309 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh--hhcCCCcccccC
Confidence 3345679999999999964 2445677999999999999999999998866655555555442 244566556799
Q ss_pred HHHHHHHHHhcccCCCCCCC---HHHHhcCcccCCCCC
Q 024572 145 QDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKNLP 179 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s---~~ell~h~~f~~~~~ 179 (265)
.++++||.+++. +|..|.. ++++..||||.+.-.
T Consensus 310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 999999999874 6889987 999999999986544
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=212.17 Aligned_cols=169 Identities=31% Similarity=0.502 Sum_probs=127.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++...+ ++.+++.++.|||++||+||||||.||+++.++. +||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCccc
Confidence 677755 8888886543 2556788999999999999999999999987765 9999999886321100
Q ss_pred --------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc
Q 024572 69 --------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 134 (265)
Q Consensus 69 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 134 (265)
......++..|+|||.+.+..+. .++|+|||||++|++++|..||.+..... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~vl~el~~g~~pf~~~~~~~----~~~~~~~~~ 232 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEE----LFGQVISDD 232 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcc
Confidence 00123467889999998876665 55999999999999999999998654322 222222222
Q ss_pred ccCCC-CCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccCC
Q 024572 135 YKIPD-YVHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLK 176 (265)
Q Consensus 135 ~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s---~~ell~h~~f~~ 176 (265)
...+. ...++..+.++|.+||..+|.+||+ +.++++||||..
T Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 22222 1257889999999999999999997 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=207.37 Aligned_cols=169 Identities=35% Similarity=0.552 Sum_probs=131.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++...+ ++.+++.+|.|||++||+||||+|+||+++.++. ++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 72 MEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCccc
Confidence 566654 8888876533 4677899999999999999999999999998776 9999999986433221
Q ss_pred -------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCC
Q 024572 69 -------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 141 (265)
Q Consensus 69 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (265)
......++..|+|||.+.+.... .++|+||||+++|++++|..||........ ...+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~ 224 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHS-KTVDWWSLGCILYEFLVGIPPFHGETPEEI----FQNILNGKIEWPEDV 224 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCcCCCccc
Confidence 11233578899999998876654 559999999999999999999977654332 222222333344433
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCH---HHHhcCcccCC
Q 024572 142 HISQDCRNLLSRIFVANPSRRITI---KEIKSHPWFLK 176 (265)
Q Consensus 142 ~~~~~~~~li~~~L~~dP~~R~s~---~ell~h~~f~~ 176 (265)
.++..+.+++.+||..+|.+|||+ .++++||||++
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 458999999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=206.32 Aligned_cols=159 Identities=25% Similarity=0.306 Sum_probs=122.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ++++|||.+...... .
T Consensus 64 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~ 139 (237)
T cd05576 64 LQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--C 139 (237)
T ss_pred EecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--c
Confidence 677765 8988876543 3567889999999999999999999999988776 999999987643322 2
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+..++ .++|+||+|+++|+|++|+.||....... . .......| ..++..++++
T Consensus 140 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~------~--~~~~~~~~--~~~~~~~~~l 208 (237)
T cd05576 140 DGEAVENMYCAPEVGGISEET-EACDWWSLGAILFELLTGKTLVECHPSGI------N--THTTLNIP--EWVSEEARSL 208 (237)
T ss_pred ccCCcCccccCCcccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhc------c--cccccCCc--ccCCHHHHHH
Confidence 234567789999998776664 45999999999999999998875432110 0 00111222 3578899999
Q ss_pred HHHhcccCCCCCCCH-----HHHhcCccc
Q 024572 151 LSRIFVANPSRRITI-----KEIKSHPWF 174 (265)
Q Consensus 151 i~~~L~~dP~~R~s~-----~ell~h~~f 174 (265)
|.+||..||++|+++ .++++||||
T Consensus 209 i~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 209 LQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=205.79 Aligned_cols=167 Identities=28% Similarity=0.400 Sum_probs=128.6
Q ss_pred Ccccc-cchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. .+|.+++... .++.+++.++.+||++|++||||+|+||+++.++. ++|+|||.+........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccc
Confidence 46666 5888887665 24677899999999999999999999999987765 99999999875544332
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....++..|+|||.+.+..++ .++|+||||+++|+|++|+.||............. .......+....++..+.+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYD-YKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred ccceecCCcccCHHHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCCCCcCcccccCHHHHH
Confidence 3445688899999999876654 45999999999999999999997754322222111 1111222333335889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcc
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPW 173 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~ 173 (265)
+|.+||..||.+|||+.++++|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=217.94 Aligned_cols=173 Identities=25% Similarity=0.289 Sum_probs=129.3
Q ss_pred CcccccchHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
||+++++|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||++..... ....
T Consensus 99 ~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~--~~~~ 174 (343)
T cd07880 99 MPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQTDS--EMTG 174 (343)
T ss_pred EecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccccccccc--Cccc
Confidence 577777887776532 24678899999999999999999999999987765 99999999874432 2233
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh----------------hccc
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----------------VQYK 136 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------------~~~~ 136 (265)
..+++.|+|||.+.+....+.++|+|||||++|++++|+.||............+..... ....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07880 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKK 254 (343)
T ss_pred cccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHh
Confidence 467889999999876443456699999999999999999999876543333222211000 0000
Q ss_pred CC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 137 IP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 137 ~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+ ....++..+.++|.+||..||.+|||+.+++.||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 255 LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00 112467889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-31 Score=213.42 Aligned_cols=174 Identities=23% Similarity=0.327 Sum_probs=139.7
Q ss_pred Cccccc-chHHHHHHhcc----------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEGS----------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-S 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~----------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~ 68 (265)
||||+- |.+|.++.|.. ++--+.+|.|||-..-+|||||..|||++..+. .||+|||.|...... .
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMA 184 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHH
Confidence 899998 99999998753 445577899999999999999999999998886 999999998654432 3
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
..++.+||+.|||||++...+|++. +||||||++..+|..|++||...... +.+..--......+..+..++.++.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~KPE~WS~~F~ 260 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFKKPEEWSSEFN 260 (502)
T ss_pred hhCccccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCCChHhhhhHHH
Confidence 4456789999999999999999877 89999999999999999999775432 1111111112222233446788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
+|+++||.+.|++|.|+.++++|||.++....
T Consensus 261 DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 261 DFIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred HHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 99999999999999999999999999876553
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=211.56 Aligned_cols=167 Identities=20% Similarity=0.243 Sum_probs=121.8
Q ss_pred Cccccc-chHHHHHHh----------------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE----------------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAP 51 (265)
Q Consensus 1 me~~~~-sL~~~~~~~----------------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~ 51 (265)
||++.+ +|.+++..+ .++.+++.++.|||++||+||||||+|||++.++.
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~- 176 (304)
T cd05096 98 TEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT- 176 (304)
T ss_pred EecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCcc-
Confidence 677755 888887543 25667899999999999999999999999987765
Q ss_pred cEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh--CCCCCCCCCChHHHHHH
Q 024572 52 RLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPKNFRKT 126 (265)
Q Consensus 52 ~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~ 126 (265)
+||+|||+++....... .....++..|+|||++.+..++ .++|||||||++|+|++ +..||............
T Consensus 177 -~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~ 254 (304)
T cd05096 177 -IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENA 254 (304)
T ss_pred -EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHH
Confidence 99999999875432211 1223457789999998877665 45999999999999986 56788765443332222
Q ss_pred HHHHhhh--cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 127 ISRIMAV--QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 127 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
....... ......+..++..+.+||.+||..+|.+|||+.+|.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 255 GEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 1111111 1111223357889999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=211.16 Aligned_cols=147 Identities=22% Similarity=0.317 Sum_probs=111.6
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHh
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 96 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 96 (265)
++.+++.++.|||++||+||||||+|||++.++. +||+|||++..............+..|+|||.+.+..++ .++|
T Consensus 124 i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~D 200 (297)
T cd05089 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYT-TKSD 200 (297)
T ss_pred HHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EEECCcCCCccccceeccCCCCcCccccCchhhccCCCC-chhh
Confidence 3567888999999999999999999999987765 999999998633221111222235579999998877665 4599
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 97 VWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 97 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
||||||++|+|++ |..||........... +. .....+.+..++..+.+||.+||..+|.+|||+.++++.
T Consensus 201 vwSlG~il~el~t~g~~pf~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 201 VWSFGVLLWEIVSLGGTPYCGMTCAELYEK----LP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999997 9999977654332222 11 122223334688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=211.33 Aligned_cols=173 Identities=28% Similarity=0.478 Sum_probs=130.9
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~ 70 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||+|+||+++.++. ++|+|||++....... ..
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 96 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccc
Confidence 677765 777765432 24677899999999999999999999999988765 9999999876443222 22
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+..+. .++|+||+|+++|+|++|..||.......... .+... ..........++..+.++
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~l~~l 249 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDN--LPPKLKNLHKVSPSLKGF 249 (292)
T ss_pred cccccCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhh--CCcccCCcccCCHHHHHH
Confidence 334688899999998766654 45999999999999999999998654432222 11111 111222333578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
+.+||..+|.+||++.++++||||.+..+
T Consensus 250 i~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=209.66 Aligned_cols=170 Identities=26% Similarity=0.318 Sum_probs=129.0
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~ 70 (265)
||++.+ +|.+++.... .+.+++.++.|||+++++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccc
Confidence 677755 8888876433 3567888999999999999999999999987765 99999999865433221 2
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+...+ .++|+|||||++|+|++|..||.......... .+. ..........++..+.++
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~l 232 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLF----LIP-KNNPPTLTGEFSKPFKEF 232 (277)
T ss_pred ccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hhh-cCCCCCCchhhhHHHHHH
Confidence 234578899999999876664 45999999999999999999997654322211 111 111112223467889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
|.+||..+|.+||++.++++|+||.+..
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 9999999999999999999999996543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=199.42 Aligned_cols=174 Identities=21% Similarity=0.315 Sum_probs=130.0
Q ss_pred cccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC---
Q 024572 2 QLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--- 68 (265)
Q Consensus 2 e~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--- 68 (265)
.+|+..|.-.+..+ ...+++..+|+|+|+..|+|||+|+.|+||+.++. +||+|||+++.+....
T Consensus 104 ~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs~~~n~~ 181 (376)
T KOG0669|consen 104 DFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARAFSTSKNVV 181 (376)
T ss_pred HHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccceecccccC
Confidence 45555555554433 34677899999999999999999999999998887 9999999997543322
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc--ccCCC-----
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD----- 139 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~----- 139 (265)
..+..+.|.+|++||.+.+...++++.|||..||++.+|++|.+.+.+.....++..+ ..+...- ..+|.
T Consensus 182 kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I-s~LcGs~tkevWP~~d~lp 260 (376)
T KOG0669|consen 182 KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI-SQLCGSITKEVWPNVDNLP 260 (376)
T ss_pred CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH-HHHhccCCcccCCCcccch
Confidence 2233457999999999999777777799999999999999999999887665544332 2221100 00110
Q ss_pred -----------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 140 -----------------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 140 -----------------------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
+..-.+++.+|+.+||..||.+|+++.++++|.||.+..
T Consensus 261 L~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 261 LYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred HHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 001245788999999999999999999999999997543
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=207.34 Aligned_cols=166 Identities=26% Similarity=0.387 Sum_probs=127.7
Q ss_pred Ccccc-cchHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++... .++.+++.++.|||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTV 155 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcch
Confidence 56664 4788777543 23567899999999999999999999999987765 9999999987543322
Q ss_pred C-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 R-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
. .....++..|+|||.+.+..++ .++|+|||||++|+|++|+.||............ .... ..+.+..++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~ 229 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI----IRGS-YPPVSSHYSYDL 229 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH----hcCC-CCCCcccCCHHH
Confidence 1 1233578889999999876665 4589999999999999999999765443322222 2222 122334678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.++|.+||..+|.+||++.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=221.74 Aligned_cols=165 Identities=25% Similarity=0.440 Sum_probs=130.9
Q ss_pred ccchHHHHHHhc---------cccchHHHHHhhhhcC--ceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 5 VSSLSEFVMLEG---------SVKMKPDIFFSSLSQQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 5 ~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~--ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
.++|..|+.+.+ |.+||+.+|.|||++. |||||||.+||||+++ .|.|||+|+|+|..... ......
T Consensus 127 SGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl~r~-s~aksv 204 (632)
T KOG0584|consen 127 SGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATLLRK-SHAKSV 204 (632)
T ss_pred CCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHHhhc-ccccee
Confidence 348888887654 6889999999999765 9999999999999865 35799999999975443 333447
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 153 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 153 (265)
+|||.|||||+.. ..|+. .+||||||++++||+|+..||..+....++.+.+ .....+.....--.+++++||.+
T Consensus 205 IGTPEFMAPEmYE-E~YnE-~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV---~SGiKP~sl~kV~dPevr~fIek 279 (632)
T KOG0584|consen 205 IGTPEFMAPEMYE-ENYNE-LVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV---TSGIKPAALSKVKDPEVREFIEK 279 (632)
T ss_pred ccCccccChHHHh-hhcch-hhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH---HcCCCHHHhhccCCHHHHHHHHH
Confidence 8999999999987 45654 4999999999999999999999988765544433 32222211112236799999999
Q ss_pred hcccCCCCCCCHHHHhcCcccCCC
Q 024572 154 IFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 154 ~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
||.. .+.|+|+.++|.||||...
T Consensus 280 Cl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 280 CLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HhcC-chhccCHHHHhhChhhccc
Confidence 9999 9999999999999999765
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=209.10 Aligned_cols=173 Identities=24% Similarity=0.401 Sum_probs=128.2
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++...+ ...+++.++.|||+ ++|+||||||+||+++.++. ++|+|||++..... ..
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~-~~ 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELIN-SI 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhh-hc
Confidence 577765 7888776533 35567888999996 69999999999999987765 99999998864322 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh-------HHHHHHHHHHhhhcccCCCCCC
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-------KNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
.....++..|+|||++.+..++. ++|+|||||++|++++|+.||...... .........+............
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTV-KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred cCccccCcccCCHHHHccCCCCc-cchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 23456899999999987766554 499999999999999999999865432 1111222222221111111123
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++..+.+|+.+||..||.+|||+.++++|+||.+.
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 67889999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=206.09 Aligned_cols=163 Identities=21% Similarity=0.339 Sum_probs=127.5
Q ss_pred Cccc-ccchHHHHHHh------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCc
Q 024572 1 MQLG-VSSLSEFVMLE------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYS 61 (265)
Q Consensus 1 me~~-~~sL~~~~~~~------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a 61 (265)
||++ +++|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccc
Confidence 6777 56899988765 23677889999999999999999999999998765 999999998
Q ss_pred ccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccC
Q 024572 62 KSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKI 137 (265)
Q Consensus 62 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 137 (265)
....... ......++..|+|||.+....++ .++|+|||||++|+|++ |..||........... +.. ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~ 226 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY----LRK-GYRL 226 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCC
Confidence 7654432 22334578899999998876654 45999999999999999 6999987644322222 221 2233
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 138 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 138 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.+..++..+.+++.+||..+|.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4444678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=216.84 Aligned_cols=147 Identities=25% Similarity=0.360 Sum_probs=112.8
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC---CCCcCCCCCcccccccCCcCCCch
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRREYDGKL 94 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~ 94 (265)
+.+++.++.|||++||+||||||+|||++.++. +||+|||+++........ ....++..|+|||.+.+..++ .+
T Consensus 220 ~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~ 296 (375)
T cd05104 220 SYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYT-FE 296 (375)
T ss_pred HHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCC-CC
Confidence 457899999999999999999999999987665 999999998754332211 122345679999999887765 45
Q ss_pred HhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 95 ADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 95 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+|||||||++|+|++ |..||........+.+.+.. ......+...+.++.+||.+||..||++|||+.++++.
T Consensus 297 sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 297 SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999998 88999776544433333322 22222233568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=207.18 Aligned_cols=162 Identities=23% Similarity=0.356 Sum_probs=123.5
Q ss_pred Cccccc-chHHHHHHhc-----------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEe
Q 024572 1 MQLGVS-SLSEFVMLEG-----------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKIC 56 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~ 56 (265)
||++.+ +|.+++...+ ++.+++.++.|||++||+||||||+||+++.++. +||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~kl~ 164 (280)
T cd05049 87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--VKIG 164 (280)
T ss_pred EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--EEEC
Confidence 566654 8888886543 3667889999999999999999999999988765 9999
Q ss_pred ccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhh
Q 024572 57 DFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMA 132 (265)
Q Consensus 57 Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 132 (265)
|||+++...... ......++..|+|||.+.+..++ .++|||||||++|+|++ |..||.......... .+..
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~----~~~~ 239 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE----CITQ 239 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc
Confidence 999986432221 11233456789999999887765 45999999999999998 999997765433222 2222
Q ss_pred hcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 133 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 133 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
... ......++..+.+++.+||..||.+||++.++++
T Consensus 240 ~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 222 2223367899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=216.86 Aligned_cols=174 Identities=17% Similarity=0.260 Sum_probs=121.7
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+||+++.++. ++++||+.+.......
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNG 155 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccC
Confidence 455554 788877643 24667899999999999999999999999987765 9999997543221111
Q ss_pred C--------CCCCcCCCCCcccccccCCcC-CCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh--------
Q 024572 69 R--------PKSTVGTPAYIAPEVLSRREY-DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-------- 131 (265)
Q Consensus 69 ~--------~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-------- 131 (265)
. .....++..|+|||++.+... .+.++||||+||++|+|++|+.||............+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 0 011234567999999876421 24569999999999999999999977543322222111000
Q ss_pred ---------------------------------hhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 132 ---------------------------------AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 132 ---------------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
......+....++..+.+||++||..||++|||+.++++||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 000011112235678999999999999999999999999999953
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=208.68 Aligned_cols=174 Identities=28% Similarity=0.407 Sum_probs=131.2
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++..+.. +.+++.++.|||++|++||||+|+|||++.++. +||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~ 161 (290)
T cd05613 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEVE 161 (290)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceeccccccc
Confidence 566665 88888765442 447899999999999999999999999987765 9999999987543322
Q ss_pred CCCCCcCCCCCcccccccCCc-CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......++..|+|||.+.+.. ....++|+||||+++|+|++|..||...............+..... +.+..++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 239 (290)
T cd05613 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALA 239 (290)
T ss_pred ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCCHHH
Confidence 122345888999999987532 2345599999999999999999999754433333333333332222 2233578899
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCcccCCCC
Q 024572 148 RNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNL 178 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~-----s~~ell~h~~f~~~~ 178 (265)
.+++.+||..+|.+|| ++.+++.||||.+..
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999997 899999999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=209.82 Aligned_cols=172 Identities=25% Similarity=0.414 Sum_probs=132.3
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++. .+|.+++..+. .+.+++.++.|||++||+|+||+|+||+++.++. ++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKS 171 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchh
Confidence 56777 59999988874 3677889999999999999999999999987765 9999999876433221
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......++..|+|||.+.+..++ .++|+||||+++|+|++|+.||............. .......+....++..+.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcchhhCCHHHH
Confidence 11233578899999998877665 45999999999999999999997654432222111 111112223334788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
++|.+||..+|.+|||+.+++.|+||++..
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=203.12 Aligned_cols=165 Identities=35% Similarity=0.517 Sum_probs=130.0
Q ss_pred Cccc-ccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLG-VSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++ +++|.+++.... ++.+++.++.|||+++++|+||+|+||+++.++. ++|+|||.+...... ..
T Consensus 72 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 72 LEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSR 149 (250)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCc
Confidence 6777 568888876542 3667899999999999999999999999988765 999999998754333 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....++..|+|||.+.+.... .++|+||||+++|++++|..||...... .....+.... .+.+..++..+.+
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~--~~~~~~~~~~l~~ 222 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDP--LRFPEFLSPEARD 222 (250)
T ss_pred ccCCcCCccccChHHhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCC--CCCCCCCCHHHHH
Confidence 3345688899999999876654 4599999999999999999999765432 2222222222 3333356899999
Q ss_pred HHHHhcccCCCCCCCH---HHHhcCccc
Q 024572 150 LLSRIFVANPSRRITI---KEIKSHPWF 174 (265)
Q Consensus 150 li~~~L~~dP~~R~s~---~ell~h~~f 174 (265)
+|.+||..||.+||++ .++++||||
T Consensus 223 ~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 223 LISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 9999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=211.16 Aligned_cols=172 Identities=25% Similarity=0.388 Sum_probs=130.0
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~ 70 (265)
||++.+ +|.+++.... .+.+++.++.|||++|++||||||+||+++.++. ++|+|||++........ .
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccccc
Confidence 466654 8888776532 4667889999999999999999999999987765 99999998764433222 2
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....+++.|+|||.+.+..++ .++|+||||+++|++++|+.||............. .......+....++..+.++
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred ccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh---cCCCCCCCCccccCHHHHHH
Confidence 234588899999998876664 45999999999999999999997754432211111 11111222333567889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
|.+||..+|.+||++.+++.|+||+...
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=209.18 Aligned_cols=168 Identities=24% Similarity=0.284 Sum_probs=127.1
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~ 70 (265)
||++.+ +|.+++... ..+.+++.++.|||++||+|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhh
Confidence 577765 787766533 24677889999999999999999999999987765 99999999875433221 2
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+..++ .++|+|||||++|+|++|+.||.......... .+... ........++..+.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~l 232 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPKN-SPPTLEGQYSKPFKEF 232 (277)
T ss_pred hcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhcC-CCCCCCcccCHHHHHH
Confidence 234578899999999877665 45999999999999999999997543322111 11111 1111122467889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
|.+||..+|.+||++.++++||||..
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHH
Confidence 99999999999999999999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=213.44 Aligned_cols=148 Identities=23% Similarity=0.356 Sum_probs=114.1
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||++||+||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..++.+
T Consensus 178 ~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 255 (337)
T cd05054 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQ 255 (337)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCcc
Confidence 3567899999999999999999999999997765 99999999875432211 122345678999999988777655
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+|||||||++|+|++ |..||.+......+...+.. ......+...++.+.+++.+||..+|++||++.++++|
T Consensus 256 -~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 256 -SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE----GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc----cCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999997 99999775443333332221 11222233578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=209.86 Aligned_cols=170 Identities=24% Similarity=0.313 Sum_probs=128.2
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.++|.+++..+. .+.+++.++.|||++|++||||+|+||+++.++. ++|+|||++..... .
T Consensus 94 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~---~ 168 (308)
T cd06634 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---A 168 (308)
T ss_pred EEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC---c
Confidence 6788788877765432 2556788999999999999999999999987765 99999998864332 2
Q ss_pred CCCcCCCCCcccccccC---CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 71 KSTVGTPAYIAPEVLSR---REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
....++..|+|||.+.+ ..+ +.++|||||||++|+|++|..||............ ............++..+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 243 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEYF 243 (308)
T ss_pred ccccCCccccCHHHHhhcccCCC-CcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH----hhcCCCCcCcccccHHH
Confidence 34468889999999753 233 44599999999999999999998765432222211 11111111223578889
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
.+||.+||..+|.+||++.+++.|||+....+.
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred HHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 999999999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=203.03 Aligned_cols=162 Identities=20% Similarity=0.257 Sum_probs=121.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++.. +|.+++.... ++.+++.++.|||++||+||||||.||+++.++. +||+|||+++.......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 74 MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENY 151 (257)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCe
Confidence 566664 7888876432 3667889999999999999999999999987765 99999999875433221
Q ss_pred ---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.....++..|+|||.+....++ .++|+|||||++|+|++ |..||........ ... +.. ....+.+..+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~---i~~-~~~~~~~~~~~~ 225 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-TQM---IES-GERMECPQRCPP 225 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHH---HHC-CCCCCCCCCCCH
Confidence 1122345789999998766654 45999999999999998 9999976543222 222 222 122333446899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++.++|.+||..||++||++.+|..
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHHHhccCchhCcCHHHHHH
Confidence 9999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=207.43 Aligned_cols=162 Identities=24% Similarity=0.364 Sum_probs=122.0
Q ss_pred Ccccc-cchHHHHHHhc----------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEec
Q 024572 1 MQLGV-SSLSEFVMLEG----------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICD 57 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~D 57 (265)
||++. ++|.+++...+ ++.+++.++.|||++||+||||||+||+++.++. +||+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~kl~d 163 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGD 163 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEecc
Confidence 56665 48888876433 3667899999999999999999999999988765 99999
Q ss_pred cCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhh
Q 024572 58 FGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAV 133 (265)
Q Consensus 58 fg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 133 (265)
||+++....... .....++..|+|||.+.+..++ .++|+|||||++|+|++ |..||......... ..+...
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~----~~i~~~ 238 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI----ECITQG 238 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcC
Confidence 999875432211 1223356789999999876665 45999999999999998 89999776543322 222222
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 134 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.. .+....++..+.+|+.+||..+|.+|||+.+++.
T Consensus 239 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 RV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred Cc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 21 2223357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=206.50 Aligned_cols=165 Identities=18% Similarity=0.257 Sum_probs=123.3
Q ss_pred Ccccc-cchHHHHHHhc----------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcc
Q 024572 1 MQLGV-SSLSEFVMLEG----------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~ 62 (265)
||++. ++|.+++.... ++.+++.++.|||+++++||||||+||+++.++ ...+||+|||+++
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcccc
Confidence 57774 58998886543 466788999999999999999999999998654 2348999999987
Q ss_pred cCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCC
Q 024572 63 SSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIP 138 (265)
Q Consensus 63 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 138 (265)
....... ......+..|+|||++.+..++ .++|||||||++|+|++ |..||........ ...+. ......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~----~~~~~~ 241 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-MEFVT----GGGRLD 241 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHH----cCCcCC
Confidence 5422211 1122335679999999877765 45999999999999997 9999987554322 22211 111223
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+..++..+.+++.+||..+|++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 334678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=222.36 Aligned_cols=160 Identities=23% Similarity=0.323 Sum_probs=121.5
Q ss_pred cccc-chHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC---CCC
Q 024572 3 LGVS-SLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL---LHS 68 (265)
Q Consensus 3 ~~~~-sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~---~~~ 68 (265)
+|++ +|+.+++.. .+++||+.++.|||.++|||||||..|||+.+++. |||+|||++.... ...
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeecccc
Confidence 5666 787777644 45899999999999999999999999999987765 9999999985322 222
Q ss_pred CCCCCcCCCCCcccccccCC---cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC----CCC
Q 024572 69 RPKSTVGTPAYIAPEVLSRR---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP----DYV 141 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 141 (265)
......|...|||||+++.. +| ++.+|||||||++|||++|..||... ..+++ +-.+... +-.| ...
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~-~~dqI---ifmVGrG-~l~pd~s~~~s 619 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQ-NRDQI---IFMVGRG-YLMPDLSKIRS 619 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCC-Chhhe---EEEeccc-ccCccchhhhc
Confidence 33445688899999999753 34 45599999999999999999999843 33222 1111111 1112 234
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 142 HISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 142 ~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.++.++++|+..||.+++++||.+.+||.
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 57789999999999999999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=209.12 Aligned_cols=170 Identities=25% Similarity=0.329 Sum_probs=129.7
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.++|.+++..+. ++.+++.++.|||++||+||||+|+||+++.++. +||+|||++.... ..
T Consensus 104 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~ 178 (317)
T cd06635 104 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PA 178 (317)
T ss_pred EeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---Cc
Confidence 6888888877765432 3567889999999999999999999999987765 9999999876432 22
Q ss_pred CCCcCCCCCcccccccC---CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 71 KSTVGTPAYIAPEVLSR---REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
....++..|+|||.+.. ..+ +.++|+|||||++|+|++|+.||............ ............++..+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l 253 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPTLQSNEWSDYF 253 (317)
T ss_pred ccccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----HhccCCCCCCccccHHH
Confidence 34568889999999742 333 45599999999999999999999775433322222 22222222233578889
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
+++|.+||..+|.+||++.++++|+|+....+.
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 999999999999999999999999999765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=206.24 Aligned_cols=168 Identities=21% Similarity=0.312 Sum_probs=125.7
Q ss_pred Ccccc-cchHHHHHHh-------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCC
Q 024572 1 MQLGV-SSLSEFVMLE-------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGY 60 (265)
Q Consensus 1 me~~~-~sL~~~~~~~-------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~ 60 (265)
||++. ++|.+++... ..+.+++.++.|||++||+||||||+||+++.++. ++|+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L~Dfg~ 165 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGM 165 (288)
T ss_pred EeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEECcCCc
Confidence 67775 4899998642 23556888999999999999999999999987765 99999999
Q ss_pred cccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhccc
Q 024572 61 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 61 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
++....... .....++..|+|||.+.+..++ .++|+|||||++|+|++ |..||.+...... ...+.... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~~~-~ 239 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQV----LKFVMDGG-Y 239 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCC-C
Confidence 874432221 1122356789999999876665 45999999999999998 7889876543222 12222111 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CcccCC
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS------HPWFLK 176 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~------h~~f~~ 176 (265)
.+....++..+.+++.+||..+|.+|||+.++++ ||||..
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 2223356889999999999999999999999986 888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=206.06 Aligned_cols=163 Identities=20% Similarity=0.277 Sum_probs=121.7
Q ss_pred Cccccc-chHHHHHHh-------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGY 60 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~ 60 (265)
||++.+ +|.+++... .++.+++.++.|||++|++||||||+||+++.++. ++|+|||+
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~dfg~ 165 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGM 165 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEECCCCC
Confidence 576654 898887642 13556889999999999999999999999997765 99999999
Q ss_pred cccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhccc
Q 024572 61 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 61 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
++....... .....++..|+|||.+.+..++ .++|+|||||++|+|++ |..||.+....... ..+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~~~- 239 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL----RFVMEGGL- 239 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHcCCc-
Confidence 864432211 1122456789999999876665 45999999999999999 78898765432222 11111111
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+....++..+.+++.+||..+|.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=210.94 Aligned_cols=173 Identities=24% Similarity=0.371 Sum_probs=127.5
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
||+++++|.+++.... ++.+++.++.|||++||+||||+|+||+++.++. +||+|||.+..... ....
T Consensus 89 ~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~--~~~~ 164 (328)
T cd07856 89 TELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDP--QMTG 164 (328)
T ss_pred eehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCC--CcCC
Confidence 6788888877765322 3667889999999999999999999999987765 99999999874322 2233
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH--------------------hh
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------------------MA 132 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--------------------~~ 132 (265)
..++..|+|||.+.+....+.++|+|||||++|+|++|+.||................ ..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence 4678899999998764444566999999999999999999997654322211111100 00
Q ss_pred hcc--cCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 133 VQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 133 ~~~--~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
... ..+ ....++..+.++|.+||..+|.+|||+.+++.||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 000 001 112467899999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=206.26 Aligned_cols=162 Identities=20% Similarity=0.309 Sum_probs=120.5
Q ss_pred Ccccc-cchHHHHHHh-------------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGV-SSLSEFVMLE-------------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~-~sL~~~~~~~-------------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++. ++|.+++..+ .++.+++.++.|||++||+||||||+||+++.++. +|
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~k 152 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK 152 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EE
Confidence 56665 4888887643 23566788999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhh
Q 024572 55 ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAV 133 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 133 (265)
|+|||++..............+..|+|||++.+..++ .++|+|||||++|+|++ |..||.......... .+. .
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~----~~~-~ 226 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KLP-Q 226 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHH----HHh-C
Confidence 9999998633221111222345679999998776654 55999999999999997 999997654332222 111 1
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 134 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
....+....++..+.+++.+||..+|.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2222333457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=207.41 Aligned_cols=162 Identities=22% Similarity=0.338 Sum_probs=122.8
Q ss_pred Ccccc-cchHHHHHHh-------------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGV-SSLSEFVMLE-------------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~-~sL~~~~~~~-------------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++. ++|.+++... .++.+++.++.|||++||+||||||+||+++.++. ++
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~~ 163 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VK 163 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EE
Confidence 57764 4888888643 24667899999999999999999999999988765 99
Q ss_pred EeccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++...... ......++..|+|||.+.+..++ .++|||||||++|+|++ |+.||......... ..+
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~----~~~ 238 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVI----ECI 238 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH
Confidence 99999986443221 12233467889999999877765 45999999999999998 99998765543222 222
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.... .......++..+.+++.+||..+|.+|||+.++++
T Consensus 239 ~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 2211 11223357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=203.39 Aligned_cols=166 Identities=29% Similarity=0.404 Sum_probs=129.0
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++..+ .++.+++.++.|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~ 155 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSS 155 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeeccc
Confidence 566654 888887764 23667899999999999999999999999987665 99999999875433
Q ss_pred CC-CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 67 HS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 67 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.. ......+++.|+|||.+.+..+.. ++|+||+|+++|+|++|+.||....... ......... ..+.+..++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~ 229 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNY-KSDIWSLGCVLYELCTLKHPFEGENLLE----LALKILKGQ-YPPIPSQYSS 229 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCc-cccHHHHHHHHHHHHcCCCCCCCCcHHH----HHHHHhcCC-CCCCCCCCCH
Confidence 32 223346888999999988777654 4999999999999999999997655322 222222211 2223336789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.+.+++.+||..+|.+|||+.++++||||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=202.82 Aligned_cols=162 Identities=20% Similarity=0.289 Sum_probs=122.5
Q ss_pred Cccc-ccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLG-VSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++ +++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~ 158 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDT 158 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccce
Confidence 5665 458988876532 3567889999999999999999999999987765 9999999987543322
Q ss_pred CCC--CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 RPK--STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
... ....+..|+|||.+.+..++. ++|||||||++|+|++ |..||.+......... + . .......+..++.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~---~-~~~~~~~~~~~~~ 232 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-L---E-KGYRMERPEGCPP 232 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H---H-CCCCCCCCCCCCH
Confidence 111 122456799999998777654 4999999999999998 9999977543322211 1 1 1223334456889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.++|.+||..+|++|||+.++++
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=206.11 Aligned_cols=147 Identities=20% Similarity=0.309 Sum_probs=113.0
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||++||+||||||+||+++.++. +||+|||+++...... ......++..|+|||.+.+..++ .
T Consensus 129 i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~ 205 (283)
T cd05090 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH--VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-S 205 (283)
T ss_pred HHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--EEeccccccccccCCcceecccCCCccceecChHHhccCCCC-c
Confidence 4557889999999999999999999999987765 9999999987543221 12233456789999999876665 4
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
++|+|||||++|+|++ |..||.+.... .....+ . .....+.+..++..+.+++.+||..+|.+||++.+++++
T Consensus 206 ~~Dv~slG~il~el~~~g~~p~~~~~~~-~~~~~~---~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQ-EVIEMV---R-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred hhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH---H-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5999999999999998 99999765432 112221 1 122233444688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=203.37 Aligned_cols=162 Identities=26% Similarity=0.356 Sum_probs=120.8
Q ss_pred ccccchHHHHHhhhhcCceecCCCcCcEEEcCC--CCCcEEEeccCCcccCCCCCCC----CCCcCCCCCcccccccCCc
Q 024572 16 GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGS--PAPRLKICDFGYSKSSLLHSRP----KSTVGTPAYIAPEVLSRRE 89 (265)
Q Consensus 16 ~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~--~~~~vkl~Dfg~a~~~~~~~~~----~~~~~~~~y~aPE~~~~~~ 89 (265)
.++-||++++.|||++=|+||||||.|||+..+ ..++|||+|||+++.+...-.. ...+.|.+|+|||++.+..
T Consensus 136 silwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~ 215 (438)
T KOG0666|consen 136 SILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR 215 (438)
T ss_pred HHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccc
Confidence 346678999999999999999999999999655 3356999999999865543222 2345789999999999988
Q ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCCCCCh---------HHHHHHHHHHhhhc-ccC------CCC-------------
Q 024572 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---------KNFRKTISRIMAVQ-YKI------PDY------------- 140 (265)
Q Consensus 90 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~---------~~~~~~~~~~~~~~-~~~------~~~------------- 140 (265)
.++++.|+|++|||+.||++-.+.|.+.... +++.+++.-+..+. ..+ |.+
T Consensus 216 hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~ 295 (438)
T KOG0666|consen 216 HYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYD 295 (438)
T ss_pred cccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcC
Confidence 8889999999999999999998888764311 11222221111000 001 111
Q ss_pred -----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 141 -----------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 141 -----------~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
..-++...+|+.+||.+||-+|+|++++|+|+||...
T Consensus 296 n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 296 NVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred cchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 0124557899999999999999999999999999865
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=210.88 Aligned_cols=163 Identities=20% Similarity=0.313 Sum_probs=122.0
Q ss_pred Ccccc-cchHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGV-SSLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++. ++|.+++.... .+.+++.++.|||++||+||||||+|||++.++. +|
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--~k 164 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK 164 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--EE
Confidence 56765 48888886432 3567889999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhh
Q 024572 55 ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAV 133 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 133 (265)
|+|||+++.............+..|+|||.+.+..+. .++|||||||++|+|++ |..||.......... .+ ..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~-~~ 238 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL-PQ 238 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHHH----HH-hc
Confidence 9999998632221111222345679999998776654 55999999999999998 999997654432221 11 11
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 134 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
......+..++..+.+||.+||..+|++||++.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22223334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=210.25 Aligned_cols=159 Identities=20% Similarity=0.319 Sum_probs=122.1
Q ss_pred ccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCC---
Q 024572 5 VSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--- 71 (265)
Q Consensus 5 ~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~--- 71 (265)
.++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.........
T Consensus 92 ~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~ 169 (316)
T cd05108 92 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEYHAE 169 (316)
T ss_pred CCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCCCcceecc
Confidence 347888776532 3567899999999999999999999999987765 9999999997554332211
Q ss_pred CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 72 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 72 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....+..|+|||.+.+..++ .++|||||||++|+|++ |+.||.+.... .+.. +.......+.+..++..+.++
T Consensus 170 ~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~l 243 (316)
T cd05108 170 GGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISS----ILEKGERLPQPPICTIDVYMI 243 (316)
T ss_pred CCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----HHhCCCCCCCCCCCCHHHHHH
Confidence 12345679999999877765 45999999999999997 99999765432 2222 222333444455678899999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 024572 151 LSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h 171 (265)
+.+||..+|.+||++.+++.+
T Consensus 244 i~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 244 MVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=206.70 Aligned_cols=147 Identities=22% Similarity=0.296 Sum_probs=113.0
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|+|++||+||||||+||+++.++. +||+|||+++....... .....+++.|+|||.+.+..++ .
T Consensus 129 ~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~ 205 (283)
T cd05091 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-I 205 (283)
T ss_pred HHHHHHHHHHHHHHcCccccccchhheEecCCCc--eEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-c
Confidence 4568899999999999999999999999987765 99999999875432221 1223457789999998776665 4
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
++|||||||++|+|++ |..||.+..... ....+.... ..+....++..+.+|+.+||+.+|.+||++.++++.
T Consensus 206 ~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 206 DSDIWSYGVVLWEVFSYGLQPYCGYSNQD----VIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 5999999999999998 888887654432 222222222 123334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=204.96 Aligned_cols=165 Identities=32% Similarity=0.567 Sum_probs=129.6
Q ss_pred Cccc-ccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLG-VSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++ +++|.+++.... ++.+++.++.+||++|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 6788 669998887653 3667899999999999999999999999987765 99999999864432221
Q ss_pred --------------------CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH
Q 024572 70 --------------------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR 129 (265)
Q Consensus 70 --------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 129 (265)
.....++..|+|||.+.+..+. .++|+||||++++++++|+.||........+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~ 233 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG-KSSDLWALGCIIYQMLTGKPPFRGSNEYLTF----QK 233 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCccHHHHH----HH
Confidence 1223477899999998776654 5599999999999999999999876533222 22
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccc
Q 024572 130 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITI----KEIKSHPWF 174 (265)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~----~ell~h~~f 174 (265)
+.......+ ..+++.+.+||.+||..+|.+|||+ .++++||||
T Consensus 234 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCC--CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 222222333 3678999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=202.32 Aligned_cols=167 Identities=26% Similarity=0.373 Sum_probs=126.4
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++.... ++.+++.++.|||+++|+|+||||+||+++.++. .+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSM 156 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCc
Confidence 466644 8888775432 3567889999999999999999999999987643 37999999987543322
Q ss_pred CC-CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 RP-KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.. ....++..|+|||.+.+..++ .++|+||||+++|++++|..||.......... ...... ..+....++..+
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~ 230 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL----KICQGY-FAPISPNFSRDL 230 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHH----HHhccc-CCCCCCCCCHHH
Confidence 21 223588899999998776654 45999999999999999999997654332222 222111 122233578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.++|.+||..+|++|||+.++++||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=206.15 Aligned_cols=174 Identities=28% Similarity=0.398 Sum_probs=129.5
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++.+ +|.+++..+. ++.+++.++.|||++|++||||||.||+++.++. ++|+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 161 (288)
T cd05583 84 LDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEEEE 161 (288)
T ss_pred EecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECcccccccccccc
Confidence 566654 8888776543 3557899999999999999999999999987765 99999999875433322
Q ss_pred -CCCCcCCCCCcccccccCCc-CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 70 -PKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 70 -~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||.................... .+.+..++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 239 (288)
T cd05583 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTMSAEA 239 (288)
T ss_pred ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CCCCcccCHHH
Confidence 12235788999999987644 234559999999999999999999965433222223223322222 23334578899
Q ss_pred HHHHHHhcccCCCCCCC---HHHHhcCcccCCCC
Q 024572 148 RNLLSRIFVANPSRRIT---IKEIKSHPWFLKNL 178 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s---~~ell~h~~f~~~~ 178 (265)
.++|.+||..+|++||| +.++++||||+...
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 99999999999999998 56779999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=203.81 Aligned_cols=147 Identities=22% Similarity=0.314 Sum_probs=112.6
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+..++ .
T Consensus 117 ~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~ 193 (272)
T cd05075 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-T 193 (272)
T ss_pred HHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcC-h
Confidence 3567889999999999999999999999987765 99999999875433221 1222456789999999877665 4
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
++|+|||||++|+|++ |+.||........ ...+... ...+....++..+.++|.+||..+|.+|||+.+++++
T Consensus 194 ~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 194 KSDVWSFGVTMWEIATRGQTPYPGVENSEI----YDYLRQG-NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5999999999999999 8899976543222 2222221 1223334678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=204.90 Aligned_cols=164 Identities=19% Similarity=0.334 Sum_probs=118.7
Q ss_pred Cccccc-chHHHHHHh--------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC
Q 024572 1 MQLGVS-SLSEFVMLE--------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 65 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccc
Confidence 677765 899887653 23457889999999999999999999999988775 9999999986432
Q ss_pred CCC---CCCCCcCCCCCcccccccCC------cCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcc
Q 024572 66 LHS---RPKSTVGTPAYIAPEVLSRR------EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY 135 (265)
Q Consensus 66 ~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 135 (265)
... ......++..|+|||++... ...+.++|||||||++|+|++ |..||........+...... ...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---~~~ 228 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE---QDI 228 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc---cCc
Confidence 221 11223456779999997532 223456999999999999999 78888766544333332221 111
Q ss_pred cCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 136 KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 136 ~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+ ....++..+.+++..|| .||++|||+.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 222 22357888899999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=207.50 Aligned_cols=163 Identities=23% Similarity=0.358 Sum_probs=123.1
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +|
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~--~k 172 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV--MK 172 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe--EE
Confidence 566544 8888886532 4678899999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++....... .....++..|+|||.+.+..++ .++|||||||++|++++ |..||........... +
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~--- 247 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL-L--- 247 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH-H---
Confidence 999999875433221 1112345679999998776665 44999999999999997 9999977554332221 1
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
........+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 248 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 -KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1122223334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=203.70 Aligned_cols=158 Identities=19% Similarity=0.311 Sum_probs=119.7
Q ss_pred ccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC---C
Q 024572 5 VSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---K 71 (265)
Q Consensus 5 ~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---~ 71 (265)
+++|.+++..+. ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++........ .
T Consensus 92 ~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~~~~~~~ 169 (279)
T cd05109 92 YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHAD 169 (279)
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecccccceeecC
Confidence 348888876532 3677899999999999999999999999987665 999999998755432221 1
Q ss_pred CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 72 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 72 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...++..|+|||.+.+..++ .++|||||||++|+|++ |..||...... .....+ ......+....++..+.++
T Consensus 170 ~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~l 243 (279)
T cd05109 170 GGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDLL----EKGERLPQPPICTIDVYMI 243 (279)
T ss_pred CCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH----HCCCcCCCCccCCHHHHHH
Confidence 12345689999999877765 45999999999999998 89998765432 222222 2222334445688999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 024572 151 LSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~ 170 (265)
+.+||..||++||++.+++.
T Consensus 244 i~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 244 MVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=201.90 Aligned_cols=160 Identities=19% Similarity=0.317 Sum_probs=122.1
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~- 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceecccc-
Confidence 577754 8999887543 2456888999999999999999999999988775 999999998743322
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......+..|+|||++.+..++ .++|||||||++|+|++ |+.||....... ....+.. .........+++.+
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~ 228 (256)
T cd05082 156 -QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEK-GYKMDAPDGCPPVV 228 (256)
T ss_pred -CCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHhc-CCCCCCCCCCCHHH
Confidence 1233456689999999877665 45999999999999997 999997654322 2222211 22223334678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+++.+||..+|++|||+.++++
T Consensus 229 ~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 229 YDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=201.10 Aligned_cols=172 Identities=27% Similarity=0.429 Sum_probs=130.0
Q ss_pred CcccccchHHHHHHhcccc--------------chHHHHHhhh-hcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC
Q 024572 1 MQLGVSSLSEFVMLEGSVK--------------MKPDIFFSSL-SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~~sL~~~~~~~~~~~--------------~i~~~l~~lH-~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 65 (265)
|||-.-||..|-....-++ -...+|.||- ...|||||+||+|||++..|. |||||||++....
T Consensus 142 MELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 142 MELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLV 219 (361)
T ss_pred HHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHH
Confidence 6777777666555432211 1356788886 678999999999999998876 9999999987665
Q ss_pred CCCCCCCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC----C
Q 024572 66 LHSRPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP----D 139 (265)
Q Consensus 66 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~ 139 (265)
..-..+...|...|||||.+.. .+|+-+ +|+||||++|||+.||++|+..... ....+..+.....+.- .
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecCccc
Confidence 5555556679999999999864 346555 9999999999999999999987643 2333333333332211 2
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 140 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 140 ~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
..+++..++.+|..||.+|-+.||+..+++.+||++...
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 235788999999999999999999999999999997544
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=202.74 Aligned_cols=162 Identities=21% Similarity=0.311 Sum_probs=122.1
Q ss_pred Cccc-ccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLG-VSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++ +++|.+++..+. ++.+++.++.|||++|++||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYPDDK 164 (279)
T ss_pred EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccCCCc
Confidence 3444 458888886532 4678899999999999999999999999987765 99999999875432221
Q ss_pred ---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.....++..|+|||.+.+..++ .++|||||||++|++++ |+.||.+.... .....+ ......+....++.
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~~~~ 238 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPH-EVPDLL----EKGERLAQPQICTI 238 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH----HCCCcCCCCCCCCH
Confidence 1223466789999999877765 45999999999999998 99999765432 222222 22222333345678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+++.+||..+|.+|||+.++++
T Consensus 239 ~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 239 DVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=203.87 Aligned_cols=162 Identities=22% Similarity=0.302 Sum_probs=123.2
Q ss_pred Ccccc-cchHHHHHHh-------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCC
Q 024572 1 MQLGV-SSLSEFVMLE-------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGY 60 (265)
Q Consensus 1 me~~~-~sL~~~~~~~-------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~ 60 (265)
||++. ++|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~dfg~ 165 (277)
T cd05032 88 MELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGM 165 (277)
T ss_pred EecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECCccc
Confidence 67775 5899887542 24567889999999999999999999999998776 99999999
Q ss_pred cccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhccc
Q 024572 61 SKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 61 a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
++...... ......++..|+|||.+.+..++ .++|||||||++|++++ |..||........ .+.. . ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~---~-~~~~ 239 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-LKFV---I-DGGH 239 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHH-HHHH---h-cCCC
Confidence 87543222 11233467789999998776665 45999999999999998 9999976543322 2222 2 1122
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+..++..+.++|.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2333457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=202.74 Aligned_cols=162 Identities=16% Similarity=0.240 Sum_probs=122.9
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++|++||||||+||+++.++. +|++|||.+........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccccch
Confidence 788876 8888887532 2556788999999999999999999999987765 99999998754322211
Q ss_pred CC--CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 PK--STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.. ...++..|+|||.+.+..++ .++|||||||++|++++ |..||........ +..+. .....+.+..++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~ 236 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDV----IKAVE-DGFRLPAPRNCPNL 236 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHH----HHHHH-CCCCCCCCCCCCHH
Confidence 11 22345789999999877765 45999999999999775 9999987654322 22221 22334455578899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.+++.+||..+|.+||++.++++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=199.81 Aligned_cols=166 Identities=28% Similarity=0.412 Sum_probs=127.9
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||+..+ +|.+++.... ++.+++.++.+||++||+||||+|+||+++.++. ++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKD 155 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCccc
Confidence 466654 8888776532 3677889999999999999999999999987665 99999999875443322
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....++..|+|||.+.+..+ +.++|+||+|+++|+|++|+.||............. .. ...+....++..+.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~ 229 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV---QD--DHPPLPEGISPELKD 229 (254)
T ss_pred ccccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---cc--CCCCCCCCCCHHHHH
Confidence 223468889999999877664 455999999999999999999997654322222211 11 112233467899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
++.+||..+|++|||+.+++.||||
T Consensus 230 ~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 230 FLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=204.24 Aligned_cols=167 Identities=22% Similarity=0.269 Sum_probs=121.1
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-- 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-- 69 (265)
||++.. +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~ 164 (283)
T cd05080 87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYY 164 (283)
T ss_pred ecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCCcchhh
Confidence 676665 7888776432 3677899999999999999999999999987765 99999999875433221
Q ss_pred --CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHH-H---------HHHHHHHhhhcccC
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-F---------RKTISRIMAVQYKI 137 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~-~---------~~~~~~~~~~~~~~ 137 (265)
.....++..|+|||.+.+..++ .++||||||+++|+|++|..||........ . ..............
T Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd05080 165 RVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243 (283)
T ss_pred ccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC
Confidence 1122356679999998876665 459999999999999999999865332100 0 00001111111222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 138 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 138 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+....++..+.+++.+||..+|++|||+.++++
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 334467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=201.24 Aligned_cols=163 Identities=19% Similarity=0.311 Sum_probs=123.1
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQY 155 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccc
Confidence 57764 48999886532 3567889999999999999999999999988775 99999999875432211
Q ss_pred C--CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 P--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
. ....++..|+|||.+.+..+.. ++|+||||+++|++++ |+.||.......... .+. .....+.+..++..
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~ 229 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSS-KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SVS-AGYRLYRPKLAPTE 229 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCc-hhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----HHH-cCCcCCCCCCCCHH
Confidence 1 1122345799999998777654 5999999999999999 899997654432222 111 12223334467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.+++.+||..+|++|||+.++++.
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=196.50 Aligned_cols=164 Identities=24% Similarity=0.308 Sum_probs=122.4
Q ss_pred cccchHHHHHHhcc-------------ccchHHHHHhhhhcC--ceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 4 GVSSLSEFVMLEGS-------------VKMKPDIFFSSLSQQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 4 ~~~sL~~~~~~~~~-------------~~~i~~~l~~lH~~~--ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
..+||.|.+.++.. ...+.++|.+||+.. ++||||||.|||+.+++. ++|.|||.+.......
T Consensus 106 ~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~a~i~i 183 (302)
T KOG2345|consen 106 KRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQAPIQI 183 (302)
T ss_pred ccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEeccCccccceEe
Confidence 45577777776654 334678899999999 999999999999988665 9999999987543322
Q ss_pred CCC----------CCcCCCCCcccccccCCcCC--CchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc
Q 024572 69 RPK----------STVGTPAYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 69 ~~~----------~~~~~~~y~aPE~~~~~~~~--~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
... ....|..|+|||++.-+... +.++|||||||++|.|+.|..||........ ...-.+...++.
T Consensus 184 ~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg--SlaLAv~n~q~s 261 (302)
T KOG2345|consen 184 EGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG--SLALAVQNAQIS 261 (302)
T ss_pred echHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC--eEEEeeeccccc
Confidence 111 22478899999998654332 4559999999999999999999954211000 000012334566
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+|....+|+.+.+||+.||..||.+||++.+++.+
T Consensus 262 ~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 262 IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 77777799999999999999999999999999864
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=204.82 Aligned_cols=163 Identities=22% Similarity=0.309 Sum_probs=123.5
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.. +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +|
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~--~k 177 (304)
T cd05101 100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MK 177 (304)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCc--EE
Confidence 677755 8998887642 2457899999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++....... .....++..|+|||++.+..++ .++||||||+++|++++ |..||........ .. .+
T Consensus 178 l~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~---~~ 252 (304)
T cd05101 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FK---LL 252 (304)
T ss_pred ECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHH-HH---HH
Confidence 999999875433221 1122356789999999877665 44999999999999998 7888876543222 22 22
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
. .......+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 253 ~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 253 K-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 1 112223344688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=204.27 Aligned_cols=146 Identities=23% Similarity=0.342 Sum_probs=112.6
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+..++ .
T Consensus 132 i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~ 208 (290)
T cd05045 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-T 208 (290)
T ss_pred HHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-h
Confidence 4667899999999999999999999999987765 99999999874432211 1223456789999998776665 5
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++||||||+++|+|++ |..||.+..... +.... ......+.+..++..+.+++.+||..+|.+||++.++++
T Consensus 209 ~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 209 QSDVWSFGVLLWEIVTLGGNPYPGIAPER-LFNLL----KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HhHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH----hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 5999999999999998 999997654322 22222 222333444568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=200.80 Aligned_cols=166 Identities=31% Similarity=0.399 Sum_probs=126.0
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
||++. .+|.+++...+ ++.+++.++.|||++||+|+||||+||+++.++. ++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMS 162 (264)
T ss_pred EEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcccccccccccccc
Confidence 46664 48888876543 3567899999999999999999999999987765 999999998754321
Q ss_pred -CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 68 -SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 68 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.......++..|+|||.+.+..++ .++|+|||||++|++++|+.||......... ............+..+++.
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAI----FKIATQPTKPMLPDGVSDA 237 (264)
T ss_pred CccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHH----HHHHcCCCCCCCCcccCHH
Confidence 111234588899999999876654 4599999999999999999999765433222 2222222222233468899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+.++|.+||. +|.+||++.+++.|||.
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=200.22 Aligned_cols=163 Identities=25% Similarity=0.341 Sum_probs=124.5
Q ss_pred Ccccc-cchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++..+. ++.+++.++.|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNE 151 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccc
Confidence 56664 48888886654 2567899999999999999999999999988765 9999999987553321
Q ss_pred C----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 69 R----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 69 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
. .....++..|+|||.+.+..++. ++|||||||++|+|++ |+.||........... +.......+.+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 226 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSH-ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK----IDKEGERLERPEAC 226 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhcCCcCCCCccC
Confidence 1 11234677899999988777654 4999999999999998 9999976544332222 22222233334467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+..+.+++.+||..+|.+|||+.++++
T Consensus 227 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 227 PQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=201.35 Aligned_cols=162 Identities=22% Similarity=0.345 Sum_probs=124.4
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDV 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcc
Confidence 677765 898888642 24567889999999999999999999999988775 9999999986543221
Q ss_pred C-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 69 R-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 69 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
. .....++..|+|||.+.+..+. .++|+||||+++|+|++ |+.||........+... . .....+.+..++..
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~ 232 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI----T-AGYRMPCPAKCPQE 232 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----H-hCCcCCCCCCCCHH
Confidence 1 1122356679999998876665 45999999999999998 89999775543332222 2 22334444578899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.++|.+||..+|.+|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 233 IYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=198.42 Aligned_cols=165 Identities=31% Similarity=0.387 Sum_probs=127.2
Q ss_pred Cccc-ccchHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLG-VSSLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~-~~sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||+. +.+|.+++..+ .++.+++.++.|||++|++||||+|+||+++.++. +||+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~ 155 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKK 155 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhcc
Confidence 5665 44888887652 23556888999999999999999999999988665 99999999875544
Q ss_pred CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 67 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
. ......++..|+|||.+.+..++ .++|+||||+++|+|++|+.||........ ...+..... .+....++.+
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~ 228 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDL----RYKVQRGKY-PPIPPIYSQD 228 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCC-CCCchhhCHH
Confidence 3 33345688899999999877665 459999999999999999999977653221 112222221 1222367889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
+++++.+||..+|.+||++.++++||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=199.29 Aligned_cols=162 Identities=19% Similarity=0.281 Sum_probs=123.2
Q ss_pred Cccc-ccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLG-VSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++ +++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDI 157 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCc
Confidence 6787 569999986543 3566889999999999999999999999998776 9999999987554221
Q ss_pred CCC--CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 RPK--STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
... ....+..|+|||.+.+..++. ++|+||||+++|+|++ |+.||.+........ .+. .....+....++.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~ 231 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSI-KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ----QVD-QGYRMPCPPGCPK 231 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCc-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHH-cCCCCCCCCcCCH
Confidence 111 112345799999988766654 4999999999999999 999997754332222 211 1223344446789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+++.+||..+|.+||++.++++
T Consensus 232 ~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 232 ELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=199.82 Aligned_cols=162 Identities=20% Similarity=0.301 Sum_probs=121.1
Q ss_pred Cccccc-chHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+ .++.+++.++.|||++|++||||||+||+++.++. +||+|||+++.......
T Consensus 73 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 73 MEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDS 150 (257)
T ss_pred EEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCcc
Confidence 577654 888887642 23667889999999999999999999999987765 99999999874332211
Q ss_pred C----CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
. ....++..|+|||.+.+..++ .++|+|||||++|++++ |..||......... ..+ . .....+.+..++
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~---~-~~~~~~~~~~~~ 224 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFI---E-QGKRLDCPAECP 224 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-HHH---H-CCCCCCCCCCCC
Confidence 1 111235689999998876664 45999999999999996 99999876543322 111 1 112223334678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+++.++|.+||..+|++||++.++.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=203.16 Aligned_cols=146 Identities=21% Similarity=0.340 Sum_probs=111.6
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||.+.+..++ .
T Consensus 127 ~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~ 203 (280)
T cd05092 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-T 203 (280)
T ss_pred HHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-c
Confidence 3567889999999999999999999999987665 99999999864332211 1222356789999999887765 4
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++|||||||++|+|++ |..||............. .. .....+..+++.+.+||.+||..||.+||++.++++
T Consensus 204 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 204 ESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT----QG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH----cC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 5999999999999998 899997655433222211 11 122233467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=205.36 Aligned_cols=163 Identities=22% Similarity=0.323 Sum_probs=122.6
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.. +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +|
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~--~k 180 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MK 180 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCc--EE
Confidence 577765 8998887542 2567889999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCCCC---CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++........ ....++..|+|||.+.+..++ .++|+|||||++|+|++ |..||..... ......+.
T Consensus 181 L~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~~~~-- 256 (307)
T cd05098 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLK-- 256 (307)
T ss_pred ECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHH--
Confidence 9999998754322111 112245689999999876664 55999999999999998 8888866432 22222221
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.....+.+..++.++.+||.+||..+|.+|||+.+++++
T Consensus 257 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 257 --EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred --cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 122233344678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=202.44 Aligned_cols=169 Identities=25% Similarity=0.305 Sum_probs=128.2
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~ 70 (265)
||++.+ +|.+++... ..+.+++.++.+||++|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhh
Confidence 567765 777776532 24677889999999999999999999999987765 9999999986543322 12
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....++..|+|||.+.+...+ .++|+|||||++|+|++|..||........ ...+... ........++..+.++
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~ 232 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKV----LFLIPKN-NPPTLEGNYSKPLKEF 232 (277)
T ss_pred ccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHH----HHHHhcC-CCCCCCcccCHHHHHH
Confidence 234578899999998776654 459999999999999999999976443221 1111111 1111223578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+.+||..+|.+||++.++++||||.+.
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=200.46 Aligned_cols=161 Identities=20% Similarity=0.268 Sum_probs=117.3
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC-----CcEEEeccCCcccC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA-----PRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~-----~~vkl~Dfg~a~~~ 64 (265)
||++.+ +|..++..+. ++.+++.++.|||++||+||||||+|||++.++. ..++++|||++...
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~ 162 (262)
T cd05077 83 EEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162 (262)
T ss_pred EecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence 577765 6776665432 4678899999999999999999999999975442 13899999988643
Q ss_pred CCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 65 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 65 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
.. .....++..|+|||.+......+.++|||||||++|+|+ +|..||........ .. ....... .....
T Consensus 163 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~----~~~~~~~--~~~~~ 232 (262)
T cd05077 163 LS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ER----FYEGQCM--LVTPS 232 (262)
T ss_pred cC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HH----HHhcCcc--CCCCC
Confidence 22 223457888999999875444455699999999999998 58888866432211 11 1111111 12234
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.++.+||.+||..||.+||++.+|+++
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 6789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=199.65 Aligned_cols=162 Identities=20% Similarity=0.279 Sum_probs=121.8
Q ss_pred Ccccc-cchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++..+ .++.+++.++.|||++||+||||||+||+++.++. +||+|||.++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCce
Confidence 67775 4888887642 23567889999999999999999999999987765 99999998875432221
Q ss_pred C--CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 P--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
. ....++..|+|||.+.+..+. .++|+||||+++|+|++ |+.||........... +.... ....+...+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~----i~~~~-~~~~~~~~~~~ 229 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM----ISRGF-RLYRPKLASMT 229 (256)
T ss_pred eccCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHCCC-CCCCCCCCCHH
Confidence 1 122345689999999876665 45999999999999999 8999977654332222 22211 22223346788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.+++.+||..+|.+||++.++++
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=200.40 Aligned_cols=162 Identities=20% Similarity=0.325 Sum_probs=123.1
Q ss_pred Ccccc-cchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++.... ++.+++.++.|||+++++||||||+||+++.++. +||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNE 157 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCc
Confidence 57764 58988886532 3567889999999999999999999999988765 9999999987543322
Q ss_pred C--CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 R--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
. .....++..|+|||.+.+..++ .++|+|||||++|+|++ |+.||........... +. .....+....++.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~ 231 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----LQ-RGYRMPRMENCPD 231 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----HH-cCCCCCCCCCCCH
Confidence 1 1122356689999998876664 45999999999999998 9999976543322221 11 1233444456889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+++.+||..+|++||+++++++
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=199.39 Aligned_cols=161 Identities=19% Similarity=0.240 Sum_probs=119.4
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC------CcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA------PRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~------~~vkl~Dfg~a~~ 63 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +.++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 688766 8988887543 3567889999999999999999999999976543 1379999998764
Q ss_pred CCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 64 SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA-YPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 64 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
... .....++..|+|||++.+....+.++|+|||||++|+|++|. .||...... ..... .......|. .
T Consensus 158 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~~~~----~~~~~~~~~--~ 227 (258)
T cd05078 158 VLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KKLQF----YEDRHQLPA--P 227 (258)
T ss_pred cCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HHHHH----HHccccCCC--C
Confidence 332 223467889999999987544455699999999999999985 555443322 11111 111222222 4
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+.++.+||.+||..+|++|||+.++++.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 228 KWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 56889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=205.04 Aligned_cols=162 Identities=22% Similarity=0.322 Sum_probs=121.2
Q ss_pred Ccccc-cchHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGV-SSLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+|||++.++. +|
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~--~k 174 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MK 174 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCc--EE
Confidence 56664 48999887532 2457899999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++....... .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||........ ...+.
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~-- 250 (314)
T cd05099 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-FKLLR-- 250 (314)
T ss_pred EccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHH--
Confidence 999999975432211 1112244679999999876665 45999999999999999 8899976543222 22221
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
. ......+..++.++++++.+||..+|.+|||+.++++
T Consensus 251 -~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 251 -E-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred -c-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1 1122233467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=200.25 Aligned_cols=162 Identities=21% Similarity=0.289 Sum_probs=123.4
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ++|+|||+++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCc
Confidence 677765 8988886532 3567889999999999999999999999988765 9999999986543222
Q ss_pred CC--CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 RP--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.. ....++..|+|||.+.+..++ .++|+||||+++|+|++ |..||.+......... +. .....+.+..++.
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~ 230 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----VE-RGYRMPCPQGCPE 230 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCCCCCCCcccCH
Confidence 11 122356789999998776654 55999999999999999 8999987554332222 11 1223334446789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+++.+||..+|.+||++.++++
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 231 SLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=199.38 Aligned_cols=162 Identities=24% Similarity=0.324 Sum_probs=122.9
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++. ++|.+++..+. ++.+++.++.|||.+||+||||||+||+++.++. +||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDY 151 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcc
Confidence 56654 48998887644 4677899999999999999999999999988775 999999998754332221
Q ss_pred C----CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 71 K----STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 71 ~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
. ...++..|+|||.+.+..+.. ++|||||||++|++++ |..||....... ....+ . .....+.+..++.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~~~~~g~~p~~~~~~~~-~~~~~---~-~~~~~~~~~~~~~ 225 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSS-KSDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAML---E-SGERLPRPEECPQ 225 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCc-cchHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHH---H-cCCcCCCCCCCCH
Confidence 1 112346799999998777654 5999999999999998 999997654322 22222 1 1222344456889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.++++|.+||..+|.+||++.++++
T Consensus 226 ~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 226 EIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=199.45 Aligned_cols=163 Identities=21% Similarity=0.303 Sum_probs=122.8
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... .+.+++.++.|||++||+|+||||.||+++.++. +||+|||.++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCce
Confidence 677754 7888876532 3667889999999999999999999999987765 99999999875433221
Q ss_pred C--CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 P--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
. ....++..|+|||.+.+..+. .++|+|||||++|+|++ |..||............ ... ...+.....+..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~ 229 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----SQG-LRLYRPHLASEK 229 (256)
T ss_pred eecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----hcC-CCCCCCCCCCHH
Confidence 1 122355689999999876665 45999999999999998 99999765543322222 111 122223356889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+++++.+||..+|.+||++.+++.+
T Consensus 230 ~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 230 VYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=198.17 Aligned_cols=162 Identities=25% Similarity=0.369 Sum_probs=119.9
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++...+ ++.+++.++.|||++||+||||||+||+++.++. +||+|||++........
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVY 149 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccc
Confidence 677654 8988886533 3567889999999999999999999999987765 99999999874332111
Q ss_pred CC---CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 PK---STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.. ....+..|+|||.+.+..+. .++|+|||||++|+|++ |..||....... ....+. .....+.+..++.
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~~~----~~~~~~~~~~~~~ 223 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQ-TREAIE----QGVRLPCPELCPD 223 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHH-HHHHHH----cCCCCCCcccCCH
Confidence 11 11224569999999877765 45999999999999998 888886644322 111111 1222333446789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+|+.+||..+|++|||+.++++
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=199.72 Aligned_cols=165 Identities=28% Similarity=0.345 Sum_probs=123.8
Q ss_pred Cccccc-chHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++.. ..++.+++.++.|||++|++|+||+|+||+++.+ .++|+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence 466654 77776653 1235678899999999999999999999999753 399999999875433
Q ss_pred CCC-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 67 HSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 67 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
... .....++..|+|||.+.+..++.+ +|+||||+++|+|++|..||....... ......... .......++.
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~ 231 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLS----VVLRIVEGP-TPSLPETYSR 231 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHcCC-CCCCcchhcH
Confidence 222 223457889999999877666544 999999999999999999997543322 222222111 1112235788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.+.++|.+||..+|++||++.++++||||
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=198.29 Aligned_cols=160 Identities=20% Similarity=0.324 Sum_probs=123.0
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||.++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEccccccccccccc
Confidence 677764 8999887554 4677899999999999999999999999987765 9999999987553221
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.....+..|+|||.+.+..+. .++|+||||+++|++++ |..||....... ....+ . .......+..+++.+
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~---~-~~~~~~~~~~~~~~~ 228 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPHV---E-KGYRMEAPEGCPPEV 228 (256)
T ss_pred --ccCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH---h-cCCCCCCccCCCHHH
Confidence 123356679999998776665 45999999999999997 999997654322 22211 1 122223334678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.++|.+||..+|.+|||+.++++
T Consensus 229 ~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 229 YKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHhccChhhCcCHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=199.79 Aligned_cols=162 Identities=19% Similarity=0.284 Sum_probs=122.7
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||.++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNE 156 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeeccccc
Confidence 577665 888888642 23567889999999999999999999999987765 9999999987543322
Q ss_pred CC--CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 RP--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.. ....++..|+|||...+..++ .++|+|||||++|+|++ |..||.......... .+. .....+....++.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~ 230 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVE-RGYRMPCPPECPE 230 (262)
T ss_pred cccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----HHh-cCCCCCCccccCH
Confidence 11 123356789999998777665 45999999999999999 888987655433222 111 1222333446889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+++.+||..+|.+||++.++++
T Consensus 231 ~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 231 SLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=200.93 Aligned_cols=147 Identities=21% Similarity=0.291 Sum_probs=112.6
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC---CCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||++||+||||||+||+++.++. +||+|||+++........ .....+..|+|||.+.+..++ .
T Consensus 118 ~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~ 194 (273)
T cd05035 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-S 194 (273)
T ss_pred HHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCccceeeccccccccccccccCCccccCHhhcccCCCC-c
Confidence 3677899999999999999999999999987765 999999998754332211 112346689999998776665 4
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
++|||||||++|+|++ |..||.+....... ..+... .....+..++..+.+++.+||..||.+|||+.+++++
T Consensus 195 ~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 195 KSDVWAFGVTMWEIATRGQTPYPGVENHEIY----DYLRHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ccchHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5999999999999999 88999765543322 222211 1223334688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=203.25 Aligned_cols=163 Identities=25% Similarity=0.378 Sum_probs=123.7
Q ss_pred Ccccc-cchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++.... +..+++.++.|||++||+|+||||+||+++.++. ++|+|||+++......
T Consensus 118 ~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 118 TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDIMNDS 195 (302)
T ss_pred EEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCcccccccCCC
Confidence 56655 58988886532 2457888999999999999999999999987665 9999999987543322
Q ss_pred C---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 69 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 69 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
. .....++..|+|||.+.+..++ .++||||+||++|+|++ |..||........+..... .....+.....+
T Consensus 196 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 270 (302)
T cd05055 196 NYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRMAQPEHAP 270 (302)
T ss_pred ceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcCCCCCCCC
Confidence 1 1123456789999999877765 45999999999999998 9999987655443333222 222223334578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+.+++.+||..+|++|||+.++++
T Consensus 271 ~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 271 AEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 89999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=200.30 Aligned_cols=164 Identities=23% Similarity=0.353 Sum_probs=118.0
Q ss_pred Ccccc-cchHHHHHHh--------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC
Q 024572 1 MQLGV-SSLSEFVMLE--------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~-~sL~~~~~~~--------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 65 (265)
||++. ++|.+++... .++.+++.++.|||++|++||||||+||+++.++. +||+|||+++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCcccccccc
Confidence 67776 4898887642 23457888999999999999999999999987765 9999999986432
Q ss_pred CCCC---CCCCcCCCCCcccccccCCc------CCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcc
Q 024572 66 LHSR---PKSTVGTPAYIAPEVLSRRE------YDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY 135 (265)
Q Consensus 66 ~~~~---~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 135 (265)
.... .....++..|+|||++.+.. ..+.++|+||||+++|+|++ |+.||............. .....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~ 228 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---REQQL 228 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---hcccC
Confidence 2211 12234678899999986432 12456999999999999996 999997655433222211 11112
Q ss_pred cCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 136 KIPD---YVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 136 ~~~~---~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+. ....+..+.+++.+|+ .+|++|||+.+|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 2221 1246788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=199.42 Aligned_cols=162 Identities=20% Similarity=0.277 Sum_probs=121.7
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNE 156 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcc
Confidence 566654 888887642 23567889999999999999999999999987765 9999999987543322
Q ss_pred CC--CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 RP--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.. ....++..|+|||.+.+..++ .++|+||||+++|+|++ |..||.......... .+. .....+.+...+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~ 230 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLE----QVE-RGYRMPCPQDCPI 230 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHH-cCCCCCCCCcCCH
Confidence 11 122345679999998776665 45999999999999999 899997654332222 211 1223344456789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+|+.+||..+|.+|||+.++.+
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=199.44 Aligned_cols=163 Identities=26% Similarity=0.367 Sum_probs=124.3
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++... .++.+++.++.|||++||+|+||||+||+++.++. ++|+|||.+.......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPG 154 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccc
Confidence 567654 788777542 13677899999999999999999999999987765 9999999986543322
Q ss_pred C-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 R-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
. .....++..|+|||++.+..++ .++|+||||+++|+|++|..||........ ...+..... .+.+..++..+
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~ 228 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQGSY-KPLPSHYSYEL 228 (255)
T ss_pred cccccccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHH----HHHHhcCCC-CCCCcccCHHH
Confidence 2 2234688899999999877664 459999999999999999999976543222 222222222 22334678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+||.+||..||.+|||+.++++-
T Consensus 229 ~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 229 RSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=202.06 Aligned_cols=167 Identities=21% Similarity=0.241 Sum_probs=121.4
Q ss_pred Cccccc-chHHHHHHhc---------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEecc
Q 024572 1 MQLGVS-SLSEFVMLEG---------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDF 58 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Df 58 (265)
||++.+ +|.+++..+. ++.+++.++.|||++|++||||||+||+++.++. +||+||
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~--~kl~df 173 (295)
T cd05097 96 TEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADF 173 (295)
T ss_pred EecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCc--EEeccc
Confidence 677765 8888876432 3567889999999999999999999999987765 999999
Q ss_pred CCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHHhh-
Q 024572 59 GYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPKNFRKTISRIMA- 132 (265)
Q Consensus 59 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~~- 132 (265)
|++........ .....++..|+|||.+.+..++ .++|+|||||++|+|++ +..||..................
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 252 (295)
T cd05097 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQ 252 (295)
T ss_pred ccccccccCcceeccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhc
Confidence 99875432211 1122346789999998876664 55999999999999988 66788765543332222111111
Q ss_pred -hcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 133 -VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 133 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..........++..+.+|+.+||..+|.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 253 GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11112223357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=199.70 Aligned_cols=165 Identities=24% Similarity=0.355 Sum_probs=123.0
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++... .++.+++.++.|||++||+|+||||+||+++.++. ++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhcccc
Confidence 566655 888877531 12567889999999999999999999999987765 99999998865433
Q ss_pred CCC-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 67 HSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 67 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
... .....++..|+|||.+.+..++ .++|+||||+++|+|++|..||...... .......+............++.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE 235 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccH
Confidence 222 2234688899999999877665 4599999999999999999999764322 12222222222222222335788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.++++|.+||..+|.+|||+.+|++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=200.72 Aligned_cols=166 Identities=24% Similarity=0.351 Sum_probs=122.9
Q ss_pred Cccccc-chHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++.. ..++.+++.++.|||++||+||||||+||+++.++. ++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~ 158 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccc
Confidence 566665 78877642 123567889999999999999999999999987765 99999998875433
Q ss_pred CCC-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 67 HSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 67 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
... .....++..|+|||.+.+..++ .++|+||+|+++|+|++|+.||...... .......+............++.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSE 235 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCH
Confidence 221 1234688899999999877665 4599999999999999999999664321 12222222222221111224678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+.++|.+||..+|.+||++.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 89999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=202.76 Aligned_cols=167 Identities=22% Similarity=0.272 Sum_probs=121.8
Q ss_pred Ccccc-cchHHHHHHhc--------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccC
Q 024572 1 MQLGV-SSLSEFVMLEG--------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFG 59 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~--------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg 59 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ++|+|||
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~--~~l~dfg 175 (296)
T cd05051 98 MEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT--IKIADFG 175 (296)
T ss_pred EecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCc--eEEcccc
Confidence 45554 47888876543 3567899999999999999999999999988765 9999999
Q ss_pred CcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHHh--h
Q 024572 60 YSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPKNFRKTISRIM--A 132 (265)
Q Consensus 60 ~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~--~ 132 (265)
+++...... ......++..|+|||.+.+..+. .++|||||||++|+|++ +..||........+........ .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 254 (296)
T cd05051 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG 254 (296)
T ss_pred ceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc
Confidence 987543222 11233456789999998876665 45999999999999998 7788876554333222221100 1
Q ss_pred hcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 133 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 133 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.....+....++.++.+++.+||..+|.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 255 RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 11112233456789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=199.02 Aligned_cols=163 Identities=21% Similarity=0.330 Sum_probs=123.7
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ++|+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccccc
Confidence 677755 8988876532 3567888999999999999999999999988765 99999999876542111
Q ss_pred C---CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 P---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
. ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||........ ...+. .....+....++.
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~~~ 235 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSYGERPYWDMSNQDV----IKAVE-DGYRLPPPMDCPS 235 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCcc-ccchHHHHHHHHHHHccCCCCCCCCCHHHH----HHHHH-cCCCCCCCCCCCH
Confidence 1 1123456899999998777654 4999999999999998 9999976543322 12221 2223344456889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+.+++.+||..+|++||++.+++++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=205.55 Aligned_cols=163 Identities=23% Similarity=0.315 Sum_probs=122.7
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+|||++.++. +|
T Consensus 97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~--~k 174 (334)
T cd05100 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MK 174 (334)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EE
Confidence 566654 8999887532 2457899999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++....... .....++..|+|||++.+..++. ++|||||||++|+|++ |..||........ .. .+
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~---~~ 249 (334)
T cd05100 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-FK---LL 249 (334)
T ss_pred ECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc-hhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-HH---HH
Confidence 999999875432221 11123456799999998777654 4999999999999998 8889876543222 22 11
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
. .....+.+..++..+.+++.+||..+|.+|||+.+++++
T Consensus 250 ~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 250 K-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred H-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 1 122233344678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=198.24 Aligned_cols=167 Identities=20% Similarity=0.289 Sum_probs=119.1
Q ss_pred Cccccc-chHHHHHHhc-------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++.... ++.+++.++.|||+++|+||||||+|||++.++. +||+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~ 151 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYK 151 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCc
Confidence 678775 8998886532 2456888999999999999999999999987765 99999998753221
Q ss_pred C---CCCCCCcCCCCCcccccccCCc------CCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhccc
Q 024572 67 H---SRPKSTVGTPAYIAPEVLSRRE------YDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 67 ~---~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
. .......++..|+|||++.... ..+.++|||||||++|+|++ |..||........+.............
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCC
Confidence 1 1122346788999999985321 12345899999999999997 577887655444333333221111111
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
......+++.+.+++..|| .+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 232 PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 1122347888999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=189.08 Aligned_cols=155 Identities=21% Similarity=0.240 Sum_probs=112.7
Q ss_pred cchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcC
Q 024572 6 SSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG 75 (265)
Q Consensus 6 ~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 75 (265)
++|.+++..+ .++.+++.+|.|||+++ ||+|||++.++. +|+ ||+++..... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence 3566666543 34778999999999998 999999987765 888 9998754322 2368
Q ss_pred CCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC--CCCCCCCH--HHHHHH
Q 024572 76 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQ--DCRNLL 151 (265)
Q Consensus 76 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~li 151 (265)
++.|+|||++.+..+. .++|||||||++|+|++|+.||............+.......... +....++. .++++|
T Consensus 67 ~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 8999999999888775 459999999999999999999976543222222221111111000 11112333 689999
Q ss_pred HHhcccCCCCCCCHHHHhcCcccC
Q 024572 152 SRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 152 ~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
.+||..+|.+||++.++++|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=201.39 Aligned_cols=167 Identities=21% Similarity=0.262 Sum_probs=122.0
Q ss_pred Ccccc-cchHHHHHHh--------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccC
Q 024572 1 MQLGV-SSLSEFVMLE--------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFG 59 (265)
Q Consensus 1 me~~~-~sL~~~~~~~--------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg 59 (265)
||++. ++|.+++... .++.+++.++.|||++||+||||||+|||++.++. ++|+|||
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg 175 (296)
T cd05095 98 TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFG 175 (296)
T ss_pred EEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCC--EEeccCc
Confidence 56665 4898888653 23567889999999999999999999999987665 9999999
Q ss_pred CcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHHh--h
Q 024572 60 YSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPKNFRKTISRIM--A 132 (265)
Q Consensus 60 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~--~ 132 (265)
+++....... ......+..|++||...+..++ .++|+|||||++|+|++ |..||................. .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 254 (296)
T cd05095 176 MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQG 254 (296)
T ss_pred ccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhcc
Confidence 9875432221 1122345789999988776664 45999999999999998 7788876554333222111110 1
Q ss_pred hcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 133 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 133 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.....+.+..++..+.+|+.+||..||.+||++.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 255 RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11123344467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=206.10 Aligned_cols=147 Identities=24% Similarity=0.362 Sum_probs=111.5
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCch
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKL 94 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 94 (265)
..+++.++.|||++||+||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..++. +
T Consensus 185 ~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~ 261 (343)
T cd05103 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI-Q 261 (343)
T ss_pred HHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCc-h
Confidence 457899999999999999999999999987765 99999999875422211 11223556799999988776654 5
Q ss_pred HhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 95 ADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 95 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+||||||+++|+|++ |..||............+. .....+.+..+++.+.+++.+||..+|.+|||+.++++|
T Consensus 262 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 262 SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh----ccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999997 9999977544333222221 111222233467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=181.93 Aligned_cols=163 Identities=23% Similarity=0.360 Sum_probs=129.2
Q ss_pred HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CCCCCcCCCCCcccccccCCcCCC
Q 024572 14 LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRREYDG 92 (265)
Q Consensus 14 ~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~ 92 (265)
.+..+-|++.++.++|++++.||||||.|+||+.++. +||+|||+++.+.... .....+.|.+|++|.++.+...++
T Consensus 103 ~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcysaevvtlwyrppdvlfgakly~ 180 (292)
T KOG0662|consen 103 VRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180 (292)
T ss_pred HHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhc
Confidence 3445677899999999999999999999999998887 9999999998665443 233456899999999999988777
Q ss_pred chHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcc-c------CCCC----------------CCCCHHHH
Q 024572 93 KLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY-K------IPDY----------------VHISQDCR 148 (265)
Q Consensus 93 ~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~-~------~~~~----------------~~~~~~~~ 148 (265)
...|+||.||++.++.. |++.|.+.+-.+++.++...+..... . .|++ +.++..-+
T Consensus 181 tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~gr 260 (292)
T KOG0662|consen 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGR 260 (292)
T ss_pred cchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhH
Confidence 77999999999999986 78888887777777666554432211 1 1111 12345578
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
+|+.++|.-+|.+|++++.+++||||....
T Consensus 261 dllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 261 DLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred HHHHHHhccCcccccCHHHHhcCccccccC
Confidence 999999999999999999999999997643
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=196.51 Aligned_cols=163 Identities=21% Similarity=0.282 Sum_probs=118.3
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++. ++|.+++.... ++.+++.++.|||+++|+||||||+|||++.++. +||+|||+++......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEY 153 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcc
Confidence 45554 48888876432 2457899999999999999999999999987765 9999999987433211
Q ss_pred ----CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 69 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 69 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
......++..|+|||.+.+..++ .++|||||||++|+|++| .+||....... ....+... ...+....+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~ 227 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFD----ITVYLLQG-RRLLQPEYC 227 (262)
T ss_pred eeecccccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhcC-CCCCCCCcC
Confidence 11122356789999998876665 459999999999999995 55665443222 22222211 122233356
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+..+.+++.+||..+|++||++.++++.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=196.21 Aligned_cols=160 Identities=21% Similarity=0.374 Sum_probs=121.9
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++.... ++.+++.++.|||++|++||||||+||+++.++. +||+|||+++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc-
Confidence 677764 8988887543 2557889999999999999999999999987765 999999998743221
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......+..|+|||.+.+..+. .++|+|||||++|+|++ |+.||....... ....+ . .....+....++..+
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~~~~---~-~~~~~~~~~~~~~~~ 226 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-VKECV---E-KGYRMEPPEGCPADV 226 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHH---h-CCCCCCCCCcCCHHH
Confidence 1223345689999998776665 45999999999999997 999997754322 22211 1 122233334678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+++.+||..+|.+||++.+++.
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=209.78 Aligned_cols=146 Identities=25% Similarity=0.439 Sum_probs=112.7
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCch
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKL 94 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 94 (265)
+.+++.++.|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||.+.+..+. .+
T Consensus 243 ~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~ 319 (400)
T cd05105 243 TYQVARGMEFLASKNCVHRDLAARNVLLAQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TL 319 (400)
T ss_pred HHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-ch
Confidence 456889999999999999999999999987765 99999999875432211 1223467789999999877665 45
Q ss_pred HhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 95 ADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 95 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+|||||||++|+|++ |..||........+...+ ......+....++..+.+++.+||..+|++|||+.++.+
T Consensus 320 ~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 320 SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI----KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH----hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 999999999999997 999997654333222222 222233444568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=193.79 Aligned_cols=162 Identities=22% Similarity=0.312 Sum_probs=120.2
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|+|++|++||||||+||+++.++. +||+|||++........
T Consensus 71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIY 148 (250)
T ss_pred EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceecccccc
Confidence 577654 8888775432 2556778899999999999999999999987765 99999999864332211
Q ss_pred CC--CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 PK--STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.. ...++..|+|||++.+..+. .++|+||||+++|++++ |..||......... ..+. .......+..++..
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~ 222 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAR----EQVE-KGYRMSCPQKCPDD 222 (250)
T ss_pred ccCCCCCCcccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH----HHHH-cCCCCCCCCCCCHH
Confidence 11 12345679999999876664 45999999999999998 99999765433221 1111 12222334467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.+++.+||..+|.+||++.++++
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=199.97 Aligned_cols=167 Identities=23% Similarity=0.296 Sum_probs=121.4
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccccCcc
Confidence 67774 58998876432 3567889999999999999999999999987765 99999999875433221
Q ss_pred ----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHhhhc
Q 024572 70 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-----------PKNFRKTISRIMAVQ 134 (265)
Q Consensus 70 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~~~~ 134 (265)
.....++..|+|||.+.+..+. .++|||||||++|+|++++.|+..... .......... ....
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 242 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-LEEG 242 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-HHcC
Confidence 1233466789999998876665 459999999999999998766532110 0001111111 1112
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 135 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 135 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
...+.+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2334445688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=196.91 Aligned_cols=165 Identities=25% Similarity=0.369 Sum_probs=122.2
Q ss_pred Cccccc-chHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++.. ..++.+++.++.|||++||+||||+|+||+++.++. ++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~ 158 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccC
Confidence 577765 88887753 123567889999999999999999999999987765 99999999865433
Q ss_pred CC-CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 67 HS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 67 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.. ......++..|+|||.+.+..++. ++|+|||||++|+|++|+.||...... ....................++.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDYPPLPADHYSE 235 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCc-hhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhcCCCCCCChhhcCH
Confidence 22 122346888999999998777654 499999999999999999999654321 12222222221111111125778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=222.86 Aligned_cols=164 Identities=23% Similarity=0.313 Sum_probs=120.7
Q ss_pred Cccccc-chHHHHHHh--------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccC
Q 024572 1 MQLGVS-SLSEFVMLE--------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFG 59 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg 59 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFG 158 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWG 158 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecC
Confidence 677765 888887531 23467889999999999999999999999987776 9999999
Q ss_pred CcccCCCC-------------------CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh
Q 024572 60 YSKSSLLH-------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP 120 (265)
Q Consensus 60 ~a~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 120 (265)
+++..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 98754110 011124689999999999887765 5599999999999999999999774432
Q ss_pred HHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 121 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..... ..............+++.+.+++.+||..||++|++..+.+.
T Consensus 238 ki~~~---~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 238 KISYR---DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhh---hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 21111 111111112223467899999999999999999987655443
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=195.26 Aligned_cols=160 Identities=20% Similarity=0.248 Sum_probs=118.4
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCC-----cEEEeccCCcccC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAP-----RLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~-----~vkl~Dfg~a~~~ 64 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++..+.. .+||+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 566655 8888887644 25688999999999999999999999999876521 4999999998754
Q ss_pred CCCCCCCCCcCCCCCcccccccCC-cCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 65 LLHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 65 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
.. .....++..|+|||.+.+. ...+.++|+|||||++|+|++ |..||...... ....... .....+. .
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~~----~~~~~~~--~ 228 (259)
T cd05037 159 LS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFYQ----DQHRLPM--P 228 (259)
T ss_pred cc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHHh----cCCCCCC--C
Confidence 32 2234567789999998876 233456999999999999999 57777665422 1111111 1111222 1
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
....+.++|.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=197.77 Aligned_cols=164 Identities=21% Similarity=0.348 Sum_probs=124.9
Q ss_pred Ccccc-cchHHHHHHhc------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCc
Q 024572 1 MQLGV-SSLSEFVMLEG------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYS 61 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a 61 (265)
||++. ++|.+++.... .+.+++.+|.|||++||+||||||+||+++.++. ++|+|||++
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~~~ 164 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLSLS 164 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccccc
Confidence 67776 48999887544 2567899999999999999999999999988765 999999998
Q ss_pred ccCCCCC--CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCC
Q 024572 62 KSSLLHS--RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIP 138 (265)
Q Consensus 62 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 138 (265)
+...... ......++..|+|||.+.+.... .++||||||+++|++++ |..||....... .+..........+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~~~~~~~ 239 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAGKLELP 239 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHcCCcCCC
Confidence 6432211 11223456779999998776654 55999999999999998 788987654322 2222332333344
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
....++..+.+++.+||..+|.+|||+.++++.
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 444688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=199.39 Aligned_cols=163 Identities=20% Similarity=0.331 Sum_probs=122.1
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEK 164 (303)
T ss_pred ehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccCccc
Confidence 34554 47888876532 3567889999999999999999999999987665 99999999875432221
Q ss_pred C---CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 P---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
. ....++..|+|||.+.+..++ .++|||||||++|++++ |..||.+... ......+ ......+....++.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~~~~ 238 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL----EKGERLPQPPICTI 238 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HCCCCCCCCCCCCH
Confidence 1 122356789999998876664 45999999999999997 8999976532 2222222 22233344446788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+.+++.+||..+|++||++.++++.
T Consensus 239 ~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 239 DVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=185.55 Aligned_cols=160 Identities=22% Similarity=0.296 Sum_probs=125.8
Q ss_pred ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchH
Q 024572 16 GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 95 (265)
Q Consensus 16 ~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 95 (265)
..+.+++.+|.||||+||+|||+||.|++|+.... .++|+|+|+|.........+..+.+..|.-||++...+....+-
T Consensus 136 yY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSL 214 (338)
T KOG0668|consen 136 YYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSL 214 (338)
T ss_pred HHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccH
Confidence 34667899999999999999999999999987654 69999999998777777777778899999999998877666768
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHHHhhh---------c---------------------ccCCCCC-CC
Q 024572 96 DVWSCGVTLYVMLVGAYPFEDQE-DPKNFRKTISRIMAV---------Q---------------------YKIPDYV-HI 143 (265)
Q Consensus 96 DiwslG~~l~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~---------~---------------------~~~~~~~-~~ 143 (265)
|+|||||++..|+..+.||.... ..+++.++.+-+... . +..+... -.
T Consensus 215 D~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~ 294 (338)
T KOG0668|consen 215 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLV 294 (338)
T ss_pred HHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccC
Confidence 99999999999999998876544 444444433221100 0 0001111 24
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
++++.+|+.++|.+|-.+|+|+.|++.||||..
T Consensus 295 ~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 295 SPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred ChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 689999999999999999999999999999953
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=196.70 Aligned_cols=162 Identities=19% Similarity=0.316 Sum_probs=122.0
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccccc
Confidence 676665 8888876432 3566788999999999999999999999987765 99999999865432221
Q ss_pred CC----CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 PK----STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.. ....+..|+|||.+.+..++ .++|+|||||++|++++ |+.||......... ..+.. ....+....++
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~----~~i~~-~~~~~~~~~~~ 236 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVM----KAIND-GFRLPAPMDCP 236 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH----HHHhc-CCCCCCCCCCC
Confidence 11 11234579999999877665 45999999999999997 99999765543222 22221 23444455688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=196.18 Aligned_cols=164 Identities=25% Similarity=0.325 Sum_probs=123.7
Q ss_pred Cccccc-chHHHHHH-------------hccccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC
Q 024572 1 MQLGVS-SLSEFVML-------------EGSVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~~-sL~~~~~~-------------~~~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 65 (265)
||++.+ +|.+++.. ..++.+++.++.|||+ +||+||||+|+||+++.++. +||+|||.+....
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~ 165 (269)
T cd08528 88 MDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQKQ 165 (269)
T ss_pred EecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecccceeecc
Confidence 577654 78777632 1235578899999996 78999999999999988765 9999999987654
Q ss_pred CCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 66 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 66 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.........++..|+|||.+.+..+. .++|+||||+++|+|++|+.||........ ...+............++.
T Consensus 166 ~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd08528 166 PESKLTSVVGTILYSCPEIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLSL----ATKIVEAVYEPLPEGMYSE 240 (269)
T ss_pred cccccccccCcccCcChhhhcCCCCc-hHHHHHHHHHHHHHHHhCCCcccccCHHHH----HHHHhhccCCcCCcccCCH
Confidence 44333445688899999999876664 559999999999999999999976543222 2222222222222225788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+.++|.+||..||++||++.++..+
T Consensus 241 ~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 241 DVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 99999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=195.50 Aligned_cols=162 Identities=20% Similarity=0.333 Sum_probs=122.7
Q ss_pred Ccccc-cchHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++... .++.+++.++.|||++|++||||||+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNE 156 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCC
Confidence 56664 4888877542 23667889999999999999999999999988775 9999999986543221
Q ss_pred C--CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 R--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
. .....++..|+|||.+.+..+. .++|+||||+++|++++ |+.||.+......... + ......+.+..++.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~ 230 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-L----ERGYRMPRPDNCPE 230 (260)
T ss_pred cccccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-H----HcCCCCCCCCCCCH
Confidence 1 1123356789999998876664 45999999999999999 9999987654332221 1 12223344456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.++|.+||..+|++|||+++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=195.93 Aligned_cols=162 Identities=20% Similarity=0.300 Sum_probs=122.7
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++... .++.+++.++.|||++||+|+||||+||+++.++. +||+|||+++......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDE 157 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchh
Confidence 566654 888888653 24667889999999999999999999999988765 9999999987543221
Q ss_pred CC--CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 RP--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.. .....+..|+|||.+.+..+. .++|+||+|+++|++++ |+.||.+.......... . .....+.+...+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~ 231 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV----E-RGYRMPRPPNCPE 231 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----H-cCCCCCCCCCCCH
Confidence 11 122345689999999876654 45999999999999998 99999765543322222 1 1223344446788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+++.+||..+|.+||++.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=195.67 Aligned_cols=163 Identities=22% Similarity=0.366 Sum_probs=123.1
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++|++||||||+||+++.++. +||+|||+++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESY 162 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccccc
Confidence 567654 8988886532 3567889999999999999999999999987765 99999999875433321
Q ss_pred C--CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 P--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
. ....++..|+|||.+....+. .++|+||||+++|++++ |..||........... +. .....+.+..++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~-~~~~~~~~~~~~~~ 236 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IE-NGERLPMPPNCPPT 236 (270)
T ss_pred eecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HH-cCCcCCCCCCCCHH
Confidence 1 112244679999998776665 45999999999999986 9999977654332222 11 12223444568899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.++|.+||..+|.+|||+.+++..
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=196.55 Aligned_cols=161 Identities=20% Similarity=0.297 Sum_probs=118.5
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC-----CcEEEeccCCcccC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA-----PRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~-----~~vkl~Dfg~a~~~ 64 (265)
|||+.+ +|..++.... ++.+++.++.|||++||+||||||+|||++..+. ..+|++|||++...
T Consensus 95 ~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 95 EEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccc
Confidence 677776 7777775421 3677899999999999999999999999975432 24899999987533
Q ss_pred CCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 65 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 65 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
... ....++..|+|||.+.+....+.++|+|||||++|+++ +|+.||........ .... ......+. ..
T Consensus 175 ~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~----~~~~~~~~--~~ 244 (274)
T cd05076 175 LSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFY----EKKHRLPE--PS 244 (274)
T ss_pred ccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHH----HhccCCCC--CC
Confidence 221 23357788999999876444456699999999999985 68999976543221 1111 11122222 35
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
++.+.++|.+||..+|.+|||+.+++++
T Consensus 245 ~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 245 CKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred ChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 6789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=195.44 Aligned_cols=164 Identities=20% Similarity=0.311 Sum_probs=120.9
Q ss_pred Ccccc-cchHHHHHHh----------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCC---CCcEEEeccCC
Q 024572 1 MQLGV-SSLSEFVMLE----------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP---APRLKICDFGY 60 (265)
Q Consensus 1 me~~~-~sL~~~~~~~----------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~---~~~vkl~Dfg~ 60 (265)
||+.. ++|.+++... .++.+++.++.|||+++++|+||||+||+++.+. ...++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 56654 4888887642 1355778889999999999999999999998765 12499999999
Q ss_pred cccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhccc
Q 024572 61 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 61 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
++....... .....++..|+|||.+.+..+. .++|||||||++|+|++ |+.||........ ...+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~ellt~g~~p~~~~~~~~~----~~~~~-~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPYPALNNQEV----LQHVT-AGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcc-cchhHHHHHHHHHHHHHcCCCCCcccCHHHH----HHHHh-cCCc
Confidence 864432211 1223456789999999877764 55999999999999998 9999976543222 11111 1122
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
...+..++..+.++|.+||..+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2333467899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=194.44 Aligned_cols=162 Identities=23% Similarity=0.365 Sum_probs=122.5
Q ss_pred Ccccc-cchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++.... ++.+++.++.|||++|++||||||+||+++..+. +||+|||.+.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNE 156 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCC
Confidence 67775 48988886532 3567899999999999999999999999987765 9999999986543221
Q ss_pred C--CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 R--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
. .....++..|+|||.+.+..++ .++|+|||||++|++++ |+.||........... + ......+.....+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~ 230 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-L----ERGYRMPRPENCPE 230 (260)
T ss_pred cccccCCcccccccCHhHhccCCcC-ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-H----hCCCCCCCcccCCH
Confidence 1 1122355679999999876654 45999999999999998 9999987544322221 1 12233344456789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+++.+||..+|++||++.++++
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=197.12 Aligned_cols=146 Identities=21% Similarity=0.305 Sum_probs=110.9
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||++|++||||||+||+++.++. ++|+|||+++....... ......+..|+|||.+.+..+. .
T Consensus 135 ~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~ 211 (288)
T cd05050 135 IAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-T 211 (288)
T ss_pred HHHHHHHHHHHHHhCCeecccccHhheEecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-c
Confidence 5677889999999999999999999999987765 99999999864432211 1122345679999998877765 4
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++|+|||||++|+|++ |..||.+..... ....+.... ..+.+..++..+.+||.+||..+|.+|||+.++++
T Consensus 212 ~~Dv~slG~il~el~~~~~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 212 ESDVWAYGVVLWEIFSYGMQPYYGMAHEE----VIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5999999999999997 888987654332 222222221 12223357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=209.87 Aligned_cols=158 Identities=21% Similarity=0.230 Sum_probs=112.9
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC--CcCCCCCcccccccCCcCC---
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS--TVGTPAYIAPEVLSRREYD--- 91 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~--- 91 (265)
++.+++.++.|||+++|+||||||+|||++.++. +||+|||+++.......... ..+++.|+|||.+......
T Consensus 314 i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~ 391 (507)
T PLN03224 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRA 391 (507)
T ss_pred HHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCcc
Confidence 4567888999999999999999999999987765 99999999864433222222 2357899999998542211
Q ss_pred ------------------CchHhHHHHHHHHHHHHhCCC-CCCCCCChHH-H------HHHHHHHhhhcccCCCCCCCCH
Q 024572 92 ------------------GKLADVWSCGVTLYVMLVGAY-PFEDQEDPKN-F------RKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 92 ------------------~~~~DiwslG~~l~~ll~g~~-pf~~~~~~~~-~------~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
..+.|+||+||++|+|++|.. ||........ + ...........+.++.+...++
T Consensus 392 ~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~ 471 (507)
T PLN03224 392 PAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKE 471 (507)
T ss_pred chhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccCh
Confidence 123699999999999999875 6653211110 0 0111112223334445556789
Q ss_pred HHHHHHHHhcccCC---CCCCCHHHHhcCcccCC
Q 024572 146 DCRNLLSRIFVANP---SRRITIKEIKSHPWFLK 176 (265)
Q Consensus 146 ~~~~li~~~L~~dP---~~R~s~~ell~h~~f~~ 176 (265)
..++|+.+||..+| .+|+|+.++|+||||..
T Consensus 472 ~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 472 AGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 99999999999866 68999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=190.98 Aligned_cols=168 Identities=33% Similarity=0.523 Sum_probs=129.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||+.+. +|.+++.... ++.+++.++.+||+.+|+|+||+|.||+++.++. ++|+|||.+.........
T Consensus 66 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~ 143 (244)
T smart00220 66 MEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLL 143 (244)
T ss_pred EeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeecccccc
Confidence 466666 8888775533 4666888999999999999999999999988765 999999998765444344
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCC-CCCHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV-HISQDCRN 149 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 149 (265)
....++..|++||.+.+..++. ++|+||+|++++++++|..||............ ............ .++..+.+
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 219 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELFKK---IGKPKPPFPPPEWKISPEAKD 219 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HhccCCCCccccccCCHHHHH
Confidence 4556888999999998766654 699999999999999999999774333322222 222222222111 17889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
++.+||..+|++||++.++++||||
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHccCCchhccCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=192.89 Aligned_cols=162 Identities=25% Similarity=0.344 Sum_probs=119.8
Q ss_pred Cccc-ccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLG-VSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||+. +++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIY 148 (251)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcc
Confidence 5666 458888875432 2456778899999999999999999999987765 99999999874432111
Q ss_pred C---CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 P---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
. .....+..|+|||.+.+..+. .++|+||||+++|+|++ |..||........ ...+ ......+.+..++.
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-~~~~----~~~~~~~~~~~~~~ 222 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQT-RERI----ESGYRMPAPQLCPE 222 (251)
T ss_pred eeccccCcceeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHH-HHHH----hcCCCCCCCccCCH
Confidence 1 112235579999998876664 55999999999999999 8888876553222 2211 11223333446789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+++.+||..+|.+|||+.++++
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=196.94 Aligned_cols=167 Identities=20% Similarity=0.252 Sum_probs=120.0
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||+.. ++|.+++.... .+.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccCCCc
Confidence 56664 58999886532 2567889999999999999999999999987765 99999999875433221
Q ss_pred C----CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChH-----------HHHHHHHHHhhhc
Q 024572 70 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----------NFRKTISRIMAVQ 134 (265)
Q Consensus 70 ~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~-----------~~~~~~~~~~~~~ 134 (265)
. ....++..|+|||.+.+..+. .++|+|||||++|+|++|..++....... .....+.......
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 1 111234569999999876664 55999999999999999877654322100 0000111112222
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 135 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 135 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
...+....++..+.+||.+||..+|++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 333444568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=198.55 Aligned_cols=167 Identities=22% Similarity=0.279 Sum_probs=124.2
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. ++|+|||.+........
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKD 164 (284)
T ss_pred EecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccccCCc
Confidence 67775 49999987644 4677899999999999999999999999988765 99999999875542211
Q ss_pred C----CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChH----------HHHHHHHHHhhhcc
Q 024572 70 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK----------NFRKTISRIMAVQY 135 (265)
Q Consensus 70 ~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~----------~~~~~~~~~~~~~~ 135 (265)
. ....++..|+|||.+.+..+. .++|+||||+++|+|++|+.||....... .....+........
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 1 112345679999998776664 44899999999999999999986543211 00111222222233
Q ss_pred cCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 136 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 136 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+....++..+.+++.+||..+|.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 34444567889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=196.78 Aligned_cols=146 Identities=17% Similarity=0.303 Sum_probs=112.4
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||+++|+||||||+||+++.++. +||+|||+++....... .....++..|+|||.+.+..++ .
T Consensus 122 i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~ 198 (280)
T cd05043 122 MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-S 198 (280)
T ss_pred HHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-c
Confidence 3557889999999999999999999999987765 99999999875432211 1223456789999999876665 4
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++|||||||++|++++ |+.||...... .+...+ ......+....+++.+.+++.+||..+|++|||+.++++
T Consensus 199 ~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 199 ASDVWSFGVLLWELMTLGQTPYVEIDPF-EMAAYL----KDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred hhhHHHhHHHHHHHhcCCCCCcCcCCHH-HHHHHH----HcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5999999999999998 99999765432 222211 122333444467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=199.05 Aligned_cols=162 Identities=28% Similarity=0.448 Sum_probs=119.1
Q ss_pred Ccccc-cchHHHHHHh--c---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE--G---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~--~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++..+ . ++.+++.++.|||+++|+|++|+++|||++.++. +||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKS 157 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc
Confidence 57776 4899998887 1 2677899999999999999999999999998775 9999999987552211
Q ss_pred ---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 69 ---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 69 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
..........|+|||.+.+..+ +.++||||||+++|++++ |+.||..... .. ....+. .....+....++
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~---~~~~~~-~~~~~~~~~~~~ 231 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDN-EE---IIEKLK-QGQRLPIPDNCP 231 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HH---HHHHHH-TTEETTSBTTSB
T ss_pred ccccccccccccccccccccccccc-ccccccccccccccccccccccccccccc-cc---cccccc-ccccceeccchh
Confidence 1122346678999999988776 456999999999999999 7899877633 22 222222 222334445689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+.++|.+||..+|.+|||+.++++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=195.65 Aligned_cols=162 Identities=20% Similarity=0.340 Sum_probs=121.4
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++|++||||||+||+++.++. +||+|||+++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccCcc
Confidence 677765 8888876532 2467789999999999999999999999987665 99999998864432221
Q ss_pred CCCC---c---CCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 70 PKST---V---GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 70 ~~~~---~---~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
.... . .+..|+|||.+.+..++ .++|||||||++|++++ |..||........ ...+ ......+.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~----~~~i-~~~~~~~~~~~ 235 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDV----INAI-EQDYRLPPPMD 235 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHH----HHHH-HcCCcCCCccc
Confidence 1111 1 23479999999877765 45999999999999886 9999977543322 2222 12234444557
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++..+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=205.24 Aligned_cols=146 Identities=24% Similarity=0.403 Sum_probs=113.1
Q ss_pred cchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchH
Q 024572 19 KMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLA 95 (265)
Q Consensus 19 ~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~ 95 (265)
.+++.++.|||+++|+||||||+|||++.++. +||+|||+++...... ......++..|+|||.+.+..+. .++
T Consensus 246 ~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~ 322 (401)
T cd05107 246 YQVANGMEFLASKNCVHRDLAARNVLICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT-TLS 322 (401)
T ss_pred HHHHHHHHHHhcCCcCcccCCcceEEEeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC-cHh
Confidence 47889999999999999999999999987665 9999999987432211 11233567889999999876665 459
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 96 DVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 96 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
|+|||||++|+|++ |..||............+. .....+.+..++..+.+|+.+||..+|.+||++.++++.
T Consensus 323 DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~----~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 323 DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK----RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHH----cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999998 8899976554333222221 222333444678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=195.13 Aligned_cols=162 Identities=23% Similarity=0.315 Sum_probs=121.7
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEK 164 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccCccc
Confidence 46654 48888876532 3577899999999999999999999999987765 99999999875543222
Q ss_pred CCC---CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 PKS---TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
... ..++..|+|||.+....++ .++|+|||||++|++++ |+.||....... +...+ . .....+.+..++.
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~---~-~~~~~~~~~~~~~ 238 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDLL---E-KGERLPQPPICTI 238 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHH---h-CCCCCCCCCCCCH
Confidence 111 1235679999998766665 45999999999999998 999997764322 22222 1 1223344445788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+++.+||..+|..||++.++++
T Consensus 239 ~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 239 DVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-28 Score=208.23 Aligned_cols=167 Identities=26% Similarity=0.418 Sum_probs=125.8
Q ss_pred chHHHHHHhc------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCc
Q 024572 7 SLSEFVMLEG------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV 74 (265)
Q Consensus 7 sL~~~~~~~~------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 74 (265)
+|.+.+..-| ..+|+.-+|.+|-..||+|.||||+|||++.+.. .+||||||.|...... ..+.+.
T Consensus 519 NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~en-eitPYL 596 (752)
T KOG0670|consen 519 NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASEN-EITPYL 596 (752)
T ss_pred hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccccc-cccHHH
Confidence 5666665443 3778888899999999999999999999987654 5999999998755443 334455
Q ss_pred CCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH--------HhhhcccC---------
Q 024572 75 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR--------IMAVQYKI--------- 137 (265)
Q Consensus 75 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~--------- 137 (265)
.+..|+|||++.|.+|+.. .|+||+||+||+|.||+..|.+......+.-.+.- +....+..
T Consensus 597 VSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf 675 (752)
T KOG0670|consen 597 VSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNF 675 (752)
T ss_pred HHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccce
Confidence 7789999999999999876 89999999999999999999998765544322210 00000000
Q ss_pred ---------------------C---------CCCCC-------CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 138 ---------------------P---------DYVHI-------SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 138 ---------------------~---------~~~~~-------~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
| ....+ -..+++||.+||..||++|.|+.++|.||||..
T Consensus 676 ~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 676 LYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred EEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 0 00001 145889999999999999999999999999964
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=191.26 Aligned_cols=162 Identities=22% Similarity=0.341 Sum_probs=121.8
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++.... ++.+++.++.+||++|++||||||+||+++.++. ++|+|||+++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDD 157 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceeccccc
Confidence 566654 8888876533 3667889999999999999999999999988775 9999999987544332
Q ss_pred CCC--CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 RPK--STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
... ...++..|+|||.+.+..+. .++|+||+|+++|+|++ |..||.......... .+... ...+....++.
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~ 231 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE----YLKKG-YRLPKPENCPP 231 (258)
T ss_pred ccccccCCCcccccChHHhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHhcC-CCCCCCCcCCH
Confidence 111 12366789999998665554 55999999999999998 788887644322222 22211 22333345789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+++.+||..+|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=191.65 Aligned_cols=163 Identities=22% Similarity=0.348 Sum_probs=120.1
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++|++||||||+||+++.++. +||+|||.++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCcc
Confidence 566654 7888776432 3456788899999999999999999999987665 99999999864432211
Q ss_pred --CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.....++..|+|||.+.+..+. .++|+||||+++|+|++ |..||....... ....+... .....+...+..
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~ 229 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSE----VVETINAG-FRLYKPRLASQS 229 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----HHHHHhCC-CCCCCCCCCCHH
Confidence 1122345689999999876665 45999999999999998 999997654322 22222111 122223346889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.+|+.+||..+|++|||+.+++++
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=192.95 Aligned_cols=162 Identities=20% Similarity=0.334 Sum_probs=122.5
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ++|+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccccc
Confidence 677754 8988887542 2456788999999999999999999999987765 99999999875433221
Q ss_pred C----CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
. ....++..|+|||.+.+..++ .++|+|||||++|++++ |..||.......... .+.. ....+....++
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~ 235 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK----AIEE-GYRLPAPMDCP 235 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH----HHhC-CCcCCCCCCCC
Confidence 1 111234679999999876665 45999999999999886 999997755432222 2221 22344445678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+.+++.+||..+|.+||++.++++
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=207.19 Aligned_cols=171 Identities=30% Similarity=0.465 Sum_probs=128.7
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC----
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---- 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~---- 66 (265)
|+|..+ .+..++.+.++ +..+.-++.+.|..|+|||||||+|||||.+|. |||+|||+|..+.-
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceecccc
Confidence 555544 77777777665 333445688899999999999999999998887 99999999852210
Q ss_pred -----CC----------------------------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHH
Q 024572 67 -----HS----------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM 107 (265)
Q Consensus 67 -----~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l 107 (265)
.. .....+||+.|+|||++...+|... +|+||.|+|||+|
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHH
Confidence 00 0012369999999999998888644 9999999999999
Q ss_pred HhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccCCC
Q 024572 108 LVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKN 177 (265)
Q Consensus 108 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---s~~ell~h~~f~~~ 177 (265)
+.|+.||..........+++. ....+.++...+++.++.+||.++. .+++.|. .+++|..||||+..
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~n--w~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVIN--WRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred hhCCCCccCCCCCcceeeeee--hhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 999999987665443333222 1233456666789999999999854 5688888 47789999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=189.67 Aligned_cols=159 Identities=25% Similarity=0.356 Sum_probs=121.9
Q ss_pred hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC--CCCcCCCCCcccccccCCcCCC
Q 024572 15 EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KSTVGTPAYIAPEVLSRREYDG 92 (265)
Q Consensus 15 ~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~ 92 (265)
+.++.||+.+|.|||+.+|+||||||.|+|++++-. +||||||+++........ +..+-|.+|+|||++.+...++
T Consensus 159 KVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs 236 (449)
T KOG0664|consen 159 KVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYT 236 (449)
T ss_pred hhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhc
Confidence 345888999999999999999999999999998876 999999999854433222 2335788999999999977767
Q ss_pred chHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH-------------------hhhcccCCCC---------CCCC
Q 024572 93 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-------------------MAVQYKIPDY---------VHIS 144 (265)
Q Consensus 93 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~---------~~~~ 144 (265)
.+.||||+||++.|++-++..|...+...++.-+..-+ .+...+.|.. ....
T Consensus 237 ~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~ 316 (449)
T KOG0664|consen 237 GAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKN 316 (449)
T ss_pred CccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccc
Confidence 77999999999999999999998766555443322211 1111222211 1233
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
.+...++.++|..||++|.+..+++.|++..
T Consensus 317 heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 317 HEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 5677899999999999999999999999964
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=188.82 Aligned_cols=158 Identities=31% Similarity=0.491 Sum_probs=124.4
Q ss_pred cchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCCCCCCcCCCCCcccccccCCcCCCchHhH
Q 024572 19 KMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRREYDGKLADV 97 (265)
Q Consensus 19 ~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 97 (265)
..|.-+|.|||++|||+||||.+|||++..+. +||+|+|+++.... .....+++||+.|.|||++++..|. ..+|+
T Consensus 358 ~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeyg-fsvdw 434 (593)
T KOG0695|consen 358 AEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG-FSVDW 434 (593)
T ss_pred HHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhcCCCCCcccccccCCCcccchhhhcccccC-ceehH
Confidence 34667899999999999999999999998886 99999999986443 4455678999999999999998874 55999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC---ChHHHH-HHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCC------CHHH
Q 024572 98 WSCGVTLYVMLVGAYPFEDQE---DPKNFR-KTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI------TIKE 167 (265)
Q Consensus 98 wslG~~l~~ll~g~~pf~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------s~~e 167 (265)
|+||+++++|+.|+.||.--. ...+.. -..+-+...+.++|. .++-.+..+++..|.+||.+|. .+.+
T Consensus 435 walgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~d 512 (593)
T KOG0695|consen 435 WALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSD 512 (593)
T ss_pred HHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhh
Confidence 999999999999999996321 111111 223334455556665 5777888999999999999997 4789
Q ss_pred HhcCcccCCCCChhh
Q 024572 168 IKSHPWFLKNLPREL 182 (265)
Q Consensus 168 ll~h~~f~~~~~~~~ 182 (265)
+..|+||+ .+....
T Consensus 513 ik~h~ffr-~idwd~ 526 (593)
T KOG0695|consen 513 IKSHAFFR-SIDWDL 526 (593)
T ss_pred hhcchhhh-hCCHHH
Confidence 99999998 444443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=213.60 Aligned_cols=97 Identities=31% Similarity=0.621 Sum_probs=76.2
Q ss_pred CCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCC-CCCCCHHHHHHHHH
Q 024572 75 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQDCRNLLSR 153 (265)
Q Consensus 75 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ 153 (265)
||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+......+..+ ......++. ...++..+.+++.+
T Consensus 542 GT~~Y~APE~l~~~~~~-~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~i----l~~~~~~p~~~~~~~~~~~~~l~~ 616 (669)
T cd05610 542 GTPDYLAPELLLGKPHG-PAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNI----LNRDIPWPEGEEKLSVNAQNAIEI 616 (669)
T ss_pred eCccccCHHHcCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HhcCCCCCcccccCCHHHHHHHHH
Confidence 58889999999987765 5599999999999999999999876543333322 222222222 22567889999999
Q ss_pred hcccCCCCCCCHHHHhcCcccCC
Q 024572 154 IFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 154 ~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
||..||.+||++.++++||||..
T Consensus 617 lL~~dP~~R~ta~e~l~h~~~~~ 639 (669)
T cd05610 617 LLTMDPTKRAGLKELKQHPLFHG 639 (669)
T ss_pred HcccChhHCcCHHHHHhCHhhcC
Confidence 99999999999999999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=189.87 Aligned_cols=147 Identities=20% Similarity=0.333 Sum_probs=110.8
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||++||+||||||+||+++.++. +||+|||+++....... .....++..|++||.+.+..++ .
T Consensus 118 ~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~ 194 (273)
T cd05074 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-T 194 (273)
T ss_pred HHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccc-h
Confidence 4667889999999999999999999999987665 99999999875432221 1222355789999998877665 4
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
++|||||||++|+|++ |+.||......... . .+... .........+..+.+++.+||..+|++|||+.+++++
T Consensus 195 ~sDi~slG~il~el~~~g~~p~~~~~~~~~~-~---~~~~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 195 HSDVWAFGVTMWEIMTRGQTPYAGVENSEIY-N---YLIKG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred hhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH-H---HHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5999999999999999 88998765432221 1 11111 1122223578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-27 Score=203.27 Aligned_cols=163 Identities=24% Similarity=0.356 Sum_probs=132.0
Q ss_pred Cccccc-chHHHHHHhcc----------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS----------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~----------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||||.+ +|.+++...+- +.+++.|+.|||++++|||||-..|+|+..++. +||+|||+++.......
T Consensus 240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQYVM 317 (474)
T ss_pred EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcceee
Confidence 899988 99999998762 444688899999999999999999999988775 89999999875432222
Q ss_pred CC-CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 70 PK-STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 70 ~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.. ..--...|+|||.+....++. ++|||||||++||+++ |..||.+.... .....+....++.+.+...+..+
T Consensus 318 ~~~~~klPirWLAPEtl~~~~~s~-kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTGIFSF-KTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred ccccccCcceecChhhhccCcccc-ccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCCCCCCHHHH
Confidence 22 112457899999999887654 4999999999999999 78899887653 33444445566677777889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..++.+||..+|+.|||+.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999865
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=206.11 Aligned_cols=170 Identities=26% Similarity=0.363 Sum_probs=134.1
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-C
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-H 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~ 67 (265)
||||++ |.-|++... .++..++.++.|||.+.++|||||-.|||++.++. |||+|||.+..... .
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDSTV 177 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeeccc
Confidence 899998 888877533 23555678899999999999999999999998886 99999999865443 3
Q ss_pred CCCCCCcCCCCCcccccccC-----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 68 SRPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
....+.+||+.|||||++.. ..|+.. +|+||||++..+|.-|.+|+...... +.++.....+......+..
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPm---raLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchh---hhhccCCCCCCccccchhh
Confidence 44566789999999999864 234444 89999999999999999999775442 2222222223333334557
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
++.++.+||..||.+|..+||+..++++|||.+.
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 8899999999999999999999999999999973
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=206.37 Aligned_cols=145 Identities=26% Similarity=0.357 Sum_probs=120.8
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC---CcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS---TVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.||+.++.||-++.+|||||-..|+||..+.. |||+|||+++........+. ..-..+|||||.+...++++.
T Consensus 608 iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte 685 (774)
T KOG1026|consen 608 IATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE 685 (774)
T ss_pred HHHHHHHHHHHHHhCcccccchhhhhceeccceE--EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch
Confidence 4678999999999999999999999999998876 99999999986544433322 234568999999999999766
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 169 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell 169 (265)
+||||+||+|||+++ |+.||.+..+.+.+ ..+..... ++.+..+|.++.+||..||..+|.+||++.+|-
T Consensus 686 -SDVWs~GVvLWEIFsyG~QPy~glSn~EVI----e~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 686 -SDVWSFGVVLWEIFSYGKQPYYGLSNQEVI----ECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred -hhhhhhhhhhhhhhccccCcccccchHHHH----HHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999999999999998 99999998775443 33333444 666778999999999999999999999999984
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=210.17 Aligned_cols=158 Identities=22% Similarity=0.323 Sum_probs=125.4
Q ss_pred ccchHHHHHHh------c----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 5 VSSLSEFVMLE------G----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 5 ~~sL~~~~~~~------~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
+++|..|++.. . +..+++.+..||+++++|||||...|+|++.... |||+|||+|+......
T Consensus 779 gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDFGlArDiy~~~ 856 (1025)
T KOG1095|consen 779 GGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADFGLARDIYDKD 856 (1025)
T ss_pred cCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEcccchhHhhhhch
Confidence 34788888865 1 2455788999999999999999999999998865 9999999998433222
Q ss_pred CCCC---CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 69 RPKS---TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 69 ~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.... ..-...|||||.+....++++ +|||||||++||++| |..||.+....+.+.. +.... +++.+..|+
T Consensus 857 yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~----~~~gg-RL~~P~~CP 930 (1025)
T KOG1095|consen 857 YYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD----VLEGG-RLDPPSYCP 930 (1025)
T ss_pred heeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHH----HHhCC-ccCCCCCCC
Confidence 2111 123468999999998888666 999999999999999 8999988766443322 22222 667777899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+.++|..||..+|++||++..|++
T Consensus 931 ~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999987
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-26 Score=197.93 Aligned_cols=162 Identities=24% Similarity=0.396 Sum_probs=132.2
Q ss_pred Cccccc-chHHHHHHhcc----------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS----------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~----------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
|||+.. -|..|+..+.- ..||..++.||||+.+|||||-..|||+.+... |||+|||+++.......
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAY 546 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccch
Confidence 788877 89999887753 567889999999999999999999999988776 99999999987665554
Q ss_pred CCCCcC--CCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 PKSTVG--TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~~~~~~--~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.+...| ...|||||.+.-..+++ ++|||-||+++||++. |..||.+-...+.+.. .....+.|.+..|++.
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTt-ASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-----iEnGeRlP~P~nCPp~ 620 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTT-ASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-----IENGERLPCPPNCPPA 620 (974)
T ss_pred hhccccccceeecCccccchhcccc-hhhHHHHHHHHHHHHHhcCCccccccccceEEE-----ecCCCCCCCCCCCChH
Confidence 444333 45799999998888754 5999999999999987 9999998765443221 2334567778899999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+..|+.+||.++|.+||.+.++..
T Consensus 621 LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHHH
Confidence 999999999999999999887643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-26 Score=208.51 Aligned_cols=175 Identities=31% Similarity=0.457 Sum_probs=138.6
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC---
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--- 68 (265)
||||...|+.+++..+ ..+|++.++.|+|+.||.||||||+|+++..++. +||+|||.+.......
T Consensus 400 mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchh
Confidence 8999999999999863 3888999999999999999999999999998876 9999999986443322
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH---HhhhcccCCCCCCC
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR---IMAVQYKIPDYVHI 143 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 143 (265)
.....+|+..|+|||++.+..|+....||||.|++++.|.+|+.||......++....... .............+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 2234579999999999999999999999999999999999999999775543332100000 00000011122347
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+...+.+|.+||+.+|.+|.|+++|++.+||+..
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 7889999999999999999999999999999753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=188.29 Aligned_cols=178 Identities=24% Similarity=0.365 Sum_probs=135.2
Q ss_pred CcccccchHHHHH----------HhccccchHHHHHhhhh--cCceecCCCcCcEEEc-CCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVM----------LEGSVKMKPDIFFSSLS--QQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~----------~~~~~~~i~~~l~~lH~--~~ivH~dlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
.|||+++=.||-. .|.++-||..+|.||.. ..|||-||||.|||+. ++..+.+||+|||+++.+...
T Consensus 547 LEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMddd 626 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDD 626 (775)
T ss_pred eeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCC
Confidence 4788886445543 24457789999999984 5699999999999984 344456999999999866543
Q ss_pred CCC--------CCCcCCCCCcccccccCC---cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc
Q 024572 68 SRP--------KSTVGTPAYIAPEVLSRR---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 68 ~~~--------~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
... ....||.||++||++.-. +-.+.++||||+|||+|..+.|+.||........+...-.-+......
T Consensus 627 Sy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVq 706 (775)
T KOG1151|consen 627 SYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQ 706 (775)
T ss_pred ccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceecc
Confidence 322 334699999999998643 222456999999999999999999998765543333222223344555
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
+|.-+-++.++++||++||.+.-+.|..+.++..||||....
T Consensus 707 FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 707 FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 666667999999999999999999999999999999997543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=197.72 Aligned_cols=162 Identities=29% Similarity=0.402 Sum_probs=121.4
Q ss_pred Cccccc-chHHHHHHhc------------cccchHHHHHhhhhcCceecCCCcCcEEEcCC--CCCcEEEeccCCcccCC
Q 024572 1 MQLGVS-SLSEFVMLEG------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGS--PAPRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~--~~~~vkl~Dfg~a~~~~ 65 (265)
||+|.+ ||...+..=. ++.-+..|+.|||.+|||||||||.||++... +..-.||+|||.|+...
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 788888 8888876421 25556788999999999999999999998432 33346999999999888
Q ss_pred CCCCCCCCcCCCCCcccccccC-CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh------------
Q 024572 66 LHSRPKSTVGTPAYIAPEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA------------ 132 (265)
Q Consensus 66 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------ 132 (265)
......+..||..|.+||+... +.|... +|.|||||++|+++||..||.....+.+...++..+..
T Consensus 176 d~s~~~S~vGT~~YLhPel~E~q~~y~~t-VDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 176 DNSLFTSLVGTEEYLHPELYERQKKYTAT-VDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred CCCeeeeecCchhhcChHHHhhccCcCce-eehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 8888888899999999999985 555444 99999999999999999999876655432333222211
Q ss_pred -------hcccCCCCCCCCHH----HHHHHHHhcccCCCCCC
Q 024572 133 -------VQYKIPDYVHISQD----CRNLLSRIFVANPSRRI 163 (265)
Q Consensus 133 -------~~~~~~~~~~~~~~----~~~li~~~L~~dP~~R~ 163 (265)
....+|.+..++.. +-.++..+|..+|.+|.
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11223444444444 34577888999999999
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=194.98 Aligned_cols=165 Identities=25% Similarity=0.355 Sum_probs=133.9
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
|||+.. ||.+-++.. ..+.||+.++.||.++++|||||-..|+|+..... |||+|||+.+......
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKICDFGLMRALGENE 266 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeeecccceeccCCCC
Confidence 678877 888887761 23778999999999999999999999999987655 9999999998766655
Q ss_pred CCCCCc----CCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 69 RPKSTV----GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 69 ~~~~~~----~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
...... -...|+|||.++...++.. +|+|++||++|||++ |..||.+.... .+++++- ...+++.+..|
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~----qIL~~iD-~~erLpRPk~c 340 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGI----QILKNID-AGERLPRPKYC 340 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHH----HHHHhcc-ccccCCCCCCC
Confidence 444322 3457999999999888655 999999999999998 78999997663 3344433 44556777789
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPW 173 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~ 173 (265)
++++.+++++||..+|..|||+..|...-+
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 999999999999999999999999865433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=187.36 Aligned_cols=157 Identities=22% Similarity=0.272 Sum_probs=109.5
Q ss_pred HHHHhccccchHHHHHhhhhcC---ceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCCCCCC-cCCCCCcccccc
Q 024572 11 FVMLEGSVKMKPDIFFSSLSQQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKST-VGTPAYIAPEVL 85 (265)
Q Consensus 11 ~~~~~~~~~~i~~~l~~lH~~~---ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~-~~~~~y~aPE~~ 85 (265)
|.++-.++..++.+|.|||... ||||||||+|||+|.+.. .||+|||+|+.... ....... .||..|+|||++
T Consensus 173 W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~ 250 (361)
T KOG1187|consen 173 WETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYA 250 (361)
T ss_pred HHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccccceeeecCCCCccCChhhh
Confidence 3344445666888999999754 999999999999998887 99999999975544 3322233 799999999999
Q ss_pred cCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHHHhhh----cccCCCC--CCCC-----HHHHHHHH
Q 024572 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE--DPKNFRKTISRIMAV----QYKIPDY--VHIS-----QDCRNLLS 152 (265)
Q Consensus 86 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~----~~~~~~~--~~~~-----~~~~~li~ 152 (265)
.....+ .++||||||+++.|+++|+.+..... ....+..+....... ....|.. ...+ ..+..+..
T Consensus 251 ~~g~lt-~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~ 329 (361)
T KOG1187|consen 251 STGKLT-EKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELAL 329 (361)
T ss_pred ccCCcC-cccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHH
Confidence 876665 44999999999999999998877532 111122221111111 1111111 1222 22556778
Q ss_pred HhcccCCCCCCCHHHHhc
Q 024572 153 RIFVANPSRRITIKEIKS 170 (265)
Q Consensus 153 ~~L~~dP~~R~s~~ell~ 170 (265)
+|+..+|..||++.++++
T Consensus 330 ~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 330 RCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHcCcCCCcCcCHHHHHH
Confidence 999999999999999754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=182.04 Aligned_cols=122 Identities=25% Similarity=0.456 Sum_probs=83.5
Q ss_pred EEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCC------ChHHHHHH
Q 024572 53 LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE------DPKNFRKT 126 (265)
Q Consensus 53 vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~------~~~~~~~~ 126 (265)
|||+|||-|... ....+..+.|..|+|||++.+.+|.+. +||||++|++|||+||...|...+ +.+.+..+
T Consensus 393 vKIaDlGNACW~--~khFT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 393 VKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEEeeccchhhh--hhhhchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 566666665422 233344568899999999999999877 899999999999999999986432 22222222
Q ss_pred HHHHhhhcc-----------------------cCCCC---------CCC----CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 127 ISRIMAVQY-----------------------KIPDY---------VHI----SQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 127 ~~~~~~~~~-----------------------~~~~~---------~~~----~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+..+..... ++..| ..+ ..++.+||.-||+.+|++||||.++|+
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 221111000 00000 011 246789999999999999999999999
Q ss_pred CcccCCC
Q 024572 171 HPWFLKN 177 (265)
Q Consensus 171 h~~f~~~ 177 (265)
|||++..
T Consensus 550 hPwLn~~ 556 (590)
T KOG1290|consen 550 HPWLNPV 556 (590)
T ss_pred CccccCC
Confidence 9999743
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=186.25 Aligned_cols=158 Identities=20% Similarity=0.307 Sum_probs=129.6
Q ss_pred cccchHHHHHHhcc-----------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 4 GVSSLSEFVMLEGS-----------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 4 ~~~sL~~~~~~~~~-----------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
|-++|.||++.+.. ..||.+++.||..+++|||||-..|+|+..+.. ||++|||+++.+..... +.
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTY-TA 422 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTY-TA 422 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCce-ec
Confidence 45689999987653 667899999999999999999999999988776 99999999986544322 22
Q ss_pred Cc---CCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 73 TV---GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 73 ~~---~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
.. -...|.|||.+....++.+ +|||+||++||++.| |-.||.+.+.. .+..+....+++..+..|++.+.
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~LLEkgyRM~~PeGCPpkVY 496 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYGLLEKGYRMDGPEGCPPKVY 496 (1157)
T ss_pred ccCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHHHHhccccccCCCCCCHHHH
Confidence 22 3457999999988888766 999999999999998 88899886532 23344556778888889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 024572 149 NLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~ 170 (265)
+|++.||.+.|..||++.++.+
T Consensus 497 eLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 497 ELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHhcCCcccCccHHHHHH
Confidence 9999999999999999998854
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-24 Score=194.01 Aligned_cols=146 Identities=24% Similarity=0.384 Sum_probs=116.6
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCC--CCc--CCCCCcccccccCCcCCCc
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STV--GTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~--~~~--~~~~y~aPE~~~~~~~~~~ 93 (265)
..||+.++.||+++.+|||||-..|||+..+.. +||+|||+|+......... ... -...|||||.+....++.+
T Consensus 424 a~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 424 AYQIANGMEYLASVPCVHRDLAARNVLITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred HHHHHHHHHHHhhCCccchhhhhhhEEecCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc
Confidence 678999999999999999999999999998866 9999999998543332221 112 2345999999999777655
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+||||+|+++||+++ |..||.+......+.+ ......+...+..++.++.++++.||..+|.+||++.++..
T Consensus 502 -SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~----~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 502 -SDVWSFGILLWEIFTLGGTPYPGIPPTEELLE----FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred -chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH----HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 899999999999998 8899987543333322 23445566667789999999999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=164.50 Aligned_cols=117 Identities=31% Similarity=0.435 Sum_probs=91.2
Q ss_pred CcccccchHHHHHHhc-------------cccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVSSLSEFVMLEG-------------SVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-------------~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||+-..||..|-.... ++-.+..++.|||+ ..|+|||+||+||||+..+. ||+||||++.....
T Consensus 124 ME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 124 MELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVD 201 (282)
T ss_pred HHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehh
Confidence 6666777776655321 12335778999995 57999999999999988776 99999999876555
Q ss_pred CCCCCCCcCCCCCcccccccC----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh
Q 024572 67 HSRPKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP 120 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 120 (265)
....+...|...|||||.+.. ..|+-+ +||||||+.+.||.++++||......
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCH
Confidence 444444678899999999854 355544 99999999999999999999887654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=192.65 Aligned_cols=158 Identities=22% Similarity=0.366 Sum_probs=129.6
Q ss_pred cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CCCCCc
Q 024572 6 SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTV 74 (265)
Q Consensus 6 ~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~ 74 (265)
++|..|++.+. .++-|++++.||-..|+|||||...|||++.+-. +|++|||+++...... ...+..
T Consensus 715 GsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~~~ytt~ 792 (996)
T KOG0196|consen 715 GSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTL 792 (996)
T ss_pred CcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCCcccccc
Confidence 48888888764 3556899999999999999999999999998876 9999999998553333 111222
Q ss_pred ---CCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 75 ---GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 75 ---~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
-..+|.|||.+...++++. +||||+|+++||+++ |..||...+..+.+.. ....+++|.+.+++..+.+|
T Consensus 793 GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-----Ie~gyRLPpPmDCP~aL~qL 866 (996)
T KOG0196|consen 793 GGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-----IEQGYRLPPPMDCPAALYQL 866 (996)
T ss_pred CCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHH-----HHhccCCCCCCCCcHHHHHH
Confidence 2368999999998888654 999999999999887 9999998876544333 34567888888999999999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 024572 151 LSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h 171 (265)
+..||++|-..||++.+|+.+
T Consensus 867 MldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 867 MLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999998764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-23 Score=181.39 Aligned_cols=162 Identities=21% Similarity=0.295 Sum_probs=126.5
Q ss_pred cchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCC---
Q 024572 6 SSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--- 71 (265)
Q Consensus 6 ~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~--- 71 (265)
+.|.+|++.+. +.+||++++.||.+.++|||||.+.|||++.+++ +||+|||+++.........
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCceeeec
Confidence 58999999873 3778999999999999999999999999998887 9999999998554443322
Q ss_pred CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHHhhh---cccCCCCCCCCHH
Q 024572 72 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPKNFRKTISRIMAV---QYKIPDYVHISQD 146 (265)
Q Consensus 72 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 146 (265)
..+-...|||+|.+...++++. +|+|+||+++||+++ ...||....+.....+.. ..... ..-.+.+.-++..
T Consensus 698 r~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~-~~~~~~~~~~~l~~P~~cp~~ 775 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG-EFFRDQGRQVVLSRPPACPQG 775 (807)
T ss_pred ceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh-hhcCCCCcceeccCCCcCcHH
Confidence 2345679999999998888655 999999999999865 788998766544333222 21111 1123445578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.++|.+||..+-.+||+++++..|
T Consensus 776 lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 776 LYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred HHHHHHHHhchhhhcCCCHHHHHHH
Confidence 9999999999999999999998653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=176.76 Aligned_cols=159 Identities=27% Similarity=0.388 Sum_probs=113.0
Q ss_pred ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCccc-----------------CCC-C----------
Q 024572 16 GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------------SLL-H---------- 67 (265)
Q Consensus 16 ~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~-----------------~~~-~---------- 67 (265)
..+.-++.++.++|++|||||||||.|+|.+... .+-.|+|||+|.. ... .
T Consensus 136 ~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t-~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~ 214 (418)
T KOG1167|consen 136 WYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT-QRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVA 214 (418)
T ss_pred HHHHHHHHHhhhhhccCccccCCCcccccccccc-CCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccc
Confidence 3466678899999999999999999999997543 3578999999851 000 0
Q ss_pred ------C-----------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHH-
Q 024572 68 ------S-----------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-NFRKTIS- 128 (265)
Q Consensus 68 ------~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~-~~~~~~~- 128 (265)
. ......||+.|+|||++...+..+.++||||.|+|+..+++++.||....+.. .+.++..
T Consensus 215 ~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~ti 294 (418)
T KOG1167|consen 215 TASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATI 294 (418)
T ss_pred cccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHH
Confidence 0 00122589999999999887766777999999999999999999996543321 1111110
Q ss_pred -------HH---------hh--------------------hccc-------CCC-CCCCCHHHHHHHHHhcccCCCCCCC
Q 024572 129 -------RI---------MA--------------------VQYK-------IPD-YVHISQDCRNLLSRIFVANPSRRIT 164 (265)
Q Consensus 129 -------~~---------~~--------------------~~~~-------~~~-~~~~~~~~~~li~~~L~~dP~~R~s 164 (265)
+. .. .... ... ....+..+.+|+.+||..||.+|.|
T Consensus 295 fG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit 374 (418)
T KOG1167|consen 295 FGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT 374 (418)
T ss_pred hChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc
Confidence 00 00 0000 000 0123457889999999999999999
Q ss_pred HHHHhcCcccC
Q 024572 165 IKEIKSHPWFL 175 (265)
Q Consensus 165 ~~ell~h~~f~ 175 (265)
++++|.||||.
T Consensus 375 AEeALkHpFF~ 385 (418)
T KOG1167|consen 375 AEDALKHPFFD 385 (418)
T ss_pred HHHHhcCcCCc
Confidence 99999999997
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=197.36 Aligned_cols=164 Identities=15% Similarity=0.140 Sum_probs=112.1
Q ss_pred Cccccc-chHHHHHH------hccccchHHHHHhhh---hcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVML------EGSVKMKPDIFFSSL---SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~------~~~~~~i~~~l~~lH---~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
|||+.+ +|.+++.. ..++.+++.++.||| +++|+||||||+||+++.+.. .++. ||...... ..
T Consensus 762 ~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~ 835 (968)
T PLN00113 762 HEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TD 835 (968)
T ss_pred EeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cC
Confidence 688764 89888753 334678899999999 779999999999999987765 4443 55443221 11
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhhh-------cccCCC---
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAV-------QYKIPD--- 139 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~-------~~~~~~--- 139 (265)
....++..|+|||++.+..++. ++|||||||++|||++|+.||...... ............. ......
T Consensus 836 ~~~~~t~~y~aPE~~~~~~~~~-~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (968)
T PLN00113 836 TKCFISSAYVAPETRETKDITE-KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914 (968)
T ss_pred CCccccccccCcccccCCCCCc-ccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence 2336789999999998877754 499999999999999999998543211 1111111110000 000000
Q ss_pred -CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 140 -YVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 140 -~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
......++.+++.+||..+|.+|||+.++++.
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00112356789999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=166.79 Aligned_cols=158 Identities=16% Similarity=0.307 Sum_probs=124.1
Q ss_pred ccchHHHHHHhcc-----------------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 5 VSSLSEFVMLEGS-----------------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 5 ~~sL~~~~~~~~~-----------------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
-++|..|+..+.. ..|++.++.|||++||||.||-..|++|++.-. |||+|=.+++-.-+.
T Consensus 372 ~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--VkltDsaLSRDLFP~ 449 (563)
T KOG1024|consen 372 VGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--VKLTDSALSRDLFPG 449 (563)
T ss_pred cchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--EEeccchhccccCcc
Confidence 4578888874332 456788899999999999999999999998754 999999888744322
Q ss_pred C---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 68 S---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 68 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
. ..........||+||.+.+..|++. +|+||||+++|||+| |+.|+...+..+. ... ....++...+.++
T Consensus 450 DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm-~~y----lkdGyRlaQP~NC 523 (563)
T KOG1024|consen 450 DYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEM-EHY----LKDGYRLAQPFNC 523 (563)
T ss_pred cccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHH-HHH----HhccceecCCCCC
Confidence 2 1122235668999999999888655 999999999999998 8999977654332 222 3345666777799
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.++..++.-||...|++||+++++..
T Consensus 524 PDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 524 PDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 999999999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-22 Score=171.67 Aligned_cols=162 Identities=22% Similarity=0.260 Sum_probs=112.1
Q ss_pred ccchHHHHHHhcc--------ccchHHHHHhhh---------hcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 5 VSSLSEFVMLEGS--------VKMKPDIFFSSL---------SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 5 ~~sL~~~~~~~~~--------~~~i~~~l~~lH---------~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
.+||.+|+..+.+ +..++.+|.||| +..|+|||||..||||.++.. ..|+|||+|......
T Consensus 292 kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 292 KGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLALRLEPG 369 (534)
T ss_pred CCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccceeEEecCC
Confidence 3589999887653 666789999998 467999999999999998887 999999999766543
Q ss_pred CCC---CCCcCCCCCcccccccCCcCCC-----chHhHHHHHHHHHHHHhCCCCCC-CC---------------CChHHH
Q 024572 68 SRP---KSTVGTPAYIAPEVLSRREYDG-----KLADVWSCGVTLYVMLVGAYPFE-DQ---------------EDPKNF 123 (265)
Q Consensus 68 ~~~---~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwslG~~l~~ll~g~~pf~-~~---------------~~~~~~ 123 (265)
... ...+||.+|||||++.+.-... +..||||+|.++|||+++..-+. +. ...+.+
T Consensus 370 ~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m 449 (534)
T KOG3653|consen 370 KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM 449 (534)
T ss_pred CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH
Confidence 322 2357999999999997743322 45899999999999998644332 10 011112
Q ss_pred HHHHHHHhhhcccCCC-CC--CCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 024572 124 RKTISRIMAVQYKIPD-YV--HISQDCRNLLSRIFVANPSRRITIKEIK 169 (265)
Q Consensus 124 ~~~~~~~~~~~~~~~~-~~--~~~~~~~~li~~~L~~dP~~R~s~~ell 169 (265)
...+.+ ...+..+|. +. .-...+++.+..||..||+.|.|+.-+.
T Consensus 450 q~~VV~-kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 450 QELVVR-KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred HHHHHh-hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 221111 111111221 11 1235678999999999999999987654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-23 Score=164.78 Aligned_cols=172 Identities=22% Similarity=0.323 Sum_probs=118.4
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK 71 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 71 (265)
||++.. +|..=+...| ..+|++++|.|+|++++||||||.+||||-.....+|||||||..+.... ...
T Consensus 101 qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--tV~ 178 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--TVK 178 (378)
T ss_pred eccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--eeh
Confidence 455544 5554444433 37789999999999999999999999999655445899999998764322 222
Q ss_pred CCcCCCCCcccccccCCc---C-CCchHhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhhhcccCC-CCCCCCH
Q 024572 72 STVGTPAYIAPEVLSRRE---Y-DGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIP-DYVHISQ 145 (265)
Q Consensus 72 ~~~~~~~y~aPE~~~~~~---~-~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~ 145 (265)
..-.+..|.+||...... + ..+.+|+|.||+++|.+++|++||...... ..+.+..+.........| .+..+++
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~ 258 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSE 258 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCH
Confidence 223566789998764321 1 234589999999999999999999854322 233344433333333334 3456889
Q ss_pred HHHHHHHHhcccCCCCC---CCHHHHhcCccc
Q 024572 146 DCRNLLSRIFVANPSRR---ITIKEIKSHPWF 174 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R---~s~~ell~h~~f 174 (265)
.+..+.++-|..+|+.| .++.......|.
T Consensus 259 ~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 259 KALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 99999999999999999 455555555554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=177.83 Aligned_cols=174 Identities=27% Similarity=0.400 Sum_probs=133.1
Q ss_pred Cccccc-chHHHHHHhccccc---------hHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEGSVKM---------KPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~~~~---------i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||||++ +|.|--...+.++. .+.++.|||++|-+|||||-.|||+++.+. +|++|||.+..... -..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhh
Confidence 899998 89887776665443 456789999999999999999999998887 99999999754332 344
Q ss_pred CCCCcCCCCCccccccc---CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC---CCCCC
Q 024572 70 PKSTVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYVHI 143 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 143 (265)
.+.++||+.|||||+.. ...| ...+|+|++|+...++---++|....... +.+.-.....+..| +...+
T Consensus 169 rksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpm----r~l~LmTkS~~qpp~lkDk~kw 243 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPM----RALFLMTKSGFQPPTLKDKTKW 243 (829)
T ss_pred hhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchH----HHHHHhhccCCCCCcccCCccc
Confidence 56788999999999863 3344 45599999999999998777775543322 22222223333333 34467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCChh
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~~ 181 (265)
++-+.+|++.+|.++|++||+++.+|+|||......+.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~r 281 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRR 281 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhH
Confidence 89999999999999999999999999999998775543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=164.72 Aligned_cols=163 Identities=23% Similarity=0.322 Sum_probs=113.8
Q ss_pred ccchHHHHHHhcc--------ccchHHHHHhhh--------hcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-
Q 024572 5 VSSLSEFVMLEGS--------VKMKPDIFFSSL--------SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH- 67 (265)
Q Consensus 5 ~~sL~~~~~~~~~--------~~~i~~~l~~lH--------~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~- 67 (265)
.+||+||+.+... +..++.+|.||| +..|.|||||..|||+.+++. .-|+|+|+|......
T Consensus 293 ~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv~h~~~t 370 (513)
T KOG2052|consen 293 HGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSDT 370 (513)
T ss_pred CCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeEEecccC
Confidence 3699999997653 334677899999 456999999999999998887 999999998643322
Q ss_pred ----CCCCCCcCCCCCcccccccCC----cCC-CchHhHHHHHHHHHHHHhC----------CCCCCCCCChHHHHHHHH
Q 024572 68 ----SRPKSTVGTPAYIAPEVLSRR----EYD-GKLADVWSCGVTLYVMLVG----------AYPFEDQEDPKNFRKTIS 128 (265)
Q Consensus 68 ----~~~~~~~~~~~y~aPE~~~~~----~~~-~~~~DiwslG~~l~~ll~g----------~~pf~~~~~~~~~~~~~~ 128 (265)
...+..+||.+|||||++-.. .+. .+.+||||||+++||++.+ +.||.+..+.+.-.+.+.
T Consensus 371 ~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMr 450 (513)
T KOG2052|consen 371 DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMR 450 (513)
T ss_pred CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHh
Confidence 233556899999999998542 111 2348999999999999853 578876544433333333
Q ss_pred HHhh-hcccCCCCCCC--C---HHHHHHHHHhcccCCCCCCCHHHHh
Q 024572 129 RIMA-VQYKIPDYVHI--S---QDCRNLLSRIFVANPSRRITIKEIK 169 (265)
Q Consensus 129 ~~~~-~~~~~~~~~~~--~---~~~~~li~~~L~~dP~~R~s~~ell 169 (265)
.+.. ...+...+..+ . ..+..+|+.||..+|..|.|+-.+.
T Consensus 451 kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 451 KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 3222 22222221111 1 3456789999999999999987664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=152.00 Aligned_cols=133 Identities=36% Similarity=0.530 Sum_probs=107.9
Q ss_pred Ccccc-cchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcC-CCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. .+|.+++... .++.+++.++.+||++|++|+||+|.||+++. .+. ++|+|||.+.......
T Consensus 70 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 70 MEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDK 147 (215)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCc
Confidence 56777 5888887754 24667888999999999999999999999987 554 9999999987443322
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......+...|++||.+......+.+.|+|++|++++++ ..+
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~ 190 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PEL 190 (215)
T ss_pred chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHH
Confidence 123345788899999987752334559999999999998 477
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHP 172 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~ 172 (265)
.+++.+|+..+|.+||++.++++|+
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 8999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-21 Score=170.69 Aligned_cols=158 Identities=23% Similarity=0.350 Sum_probs=126.1
Q ss_pred ccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCc
Q 024572 5 VSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV 74 (265)
Q Consensus 5 ~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 74 (265)
.++|.|+.+.+. +..||+.++.|||.+++|||||-..|||+.+-.. +|+.|||+++............
T Consensus 781 ~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey~~~ 858 (1177)
T KOG1025|consen 781 LGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEYSAP 858 (1177)
T ss_pred cchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCccccccccc
Confidence 457888877543 4778999999999999999999999999987665 9999999998665544333222
Q ss_pred ---CCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 75 ---GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 75 ---~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
-.+.|||-|.+....+... +|||||||++||++| |..|+.+....+ +........+++.+..++-++.-+
T Consensus 859 ~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~dlle~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 859 GGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAEE-----IPDLLEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred ccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHHH-----hhHHHhccccCCCCCCccHHHHHH
Confidence 3457899999988888655 999999999999998 899998865432 223334444577777899999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 024572 151 LSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~ 170 (265)
+.+||..|+..||+++++..
T Consensus 933 mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHhccCcccCccHHHHHH
Confidence 99999999999999988754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=168.99 Aligned_cols=107 Identities=32% Similarity=0.481 Sum_probs=94.7
Q ss_pred chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCC
Q 024572 7 SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP 77 (265)
Q Consensus 7 sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 77 (265)
.|.+||..+. +.+|++.++.+||++||||||||-+||.++++|. +||+|||.|.. ........++||.
T Consensus 656 DLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa~-~ksgpfd~f~gtv 732 (772)
T KOG1152|consen 656 DLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAAY-TKSGPFDVFVGTV 732 (772)
T ss_pred chhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchhh-hcCCCcceeeeec
Confidence 7888887654 4788999999999999999999999999998887 99999998863 3445566788999
Q ss_pred CCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCC
Q 024572 78 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFED 116 (265)
Q Consensus 78 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 116 (265)
.|.|||++.+.+|-++..|||++|++||.++....||.+
T Consensus 733 ~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 733 DYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999999989999999999999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=172.89 Aligned_cols=149 Identities=34% Similarity=0.545 Sum_probs=119.0
Q ss_pred HHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC----------------CCCCCcCCCCCcccccc
Q 024572 22 PDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS----------------RPKSTVGTPAYIAPEVL 85 (265)
Q Consensus 22 ~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~----------------~~~~~~~~~~y~aPE~~ 85 (265)
+.++.|+|+.||+|||+||+|.+|..-+. +|++|||+++...... ..+..+||+.|+|||++
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 46789999999999999999999987765 9999999986322110 11344799999999999
Q ss_pred cCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCC-CCCCCHHHHHHHHHhcccCCCCCC-
Q 024572 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQDCRNLLSRIFVANPSRRI- 163 (265)
Q Consensus 86 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~- 163 (265)
...+|. +.+|+|++|+|+|+.+.|+.||.+....+.+...+.... .+|. -..++++++++|.++|..+|..|.
T Consensus 231 lrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i----~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 231 LRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----EWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc----cccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 988885 559999999999999999999999876655555444322 2222 224788999999999999999997
Q ss_pred --CHHHHhcCcccCCC
Q 024572 164 --TIKEIKSHPWFLKN 177 (265)
Q Consensus 164 --s~~ell~h~~f~~~ 177 (265)
.+-++.+|+||+..
T Consensus 306 t~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 306 TGGALEVKQHGFFQLL 321 (1205)
T ss_pred cchhhhhhhccceeec
Confidence 57789999999754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-20 Score=161.36 Aligned_cols=160 Identities=24% Similarity=0.351 Sum_probs=114.6
Q ss_pred Cccccc-chHHHHHHhcc------------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS------------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~------------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
|++|.. +|.||+..+.. .+|+..++.| +|.+|+|+||.||+...+.. +||+|||+.......
T Consensus 335 Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ts~~~~ 409 (516)
T KOG1033|consen 335 MNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVTSQDKD 409 (516)
T ss_pred hhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhheeecccC
Confidence 889988 89999975432 5556666666 99999999999999977765 999999998654433
Q ss_pred C-------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCC
Q 024572 68 S-------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPD 139 (265)
Q Consensus 68 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (265)
. ..+...||.+||+||.+.+..|..+ +||||||++++++++ -...|.. ......+....++...
T Consensus 410 ~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 410 ETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER-------IATLTDIRDGIIPPEF 481 (516)
T ss_pred CcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH-------HHhhhhhhcCCCChHH
Confidence 3 3344579999999999999888655 999999999999996 2222211 1222222222221112
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 140 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 140 ~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
..+. +.-..|+.+||...|.+||++.+.-.|.|.
T Consensus 482 ~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 2222 344689999999999999988777777664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.8e-19 Score=147.58 Aligned_cols=158 Identities=22% Similarity=0.323 Sum_probs=112.8
Q ss_pred ccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEE--cCCCCCcEEEeccCCcccCCCCC------
Q 024572 5 VSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHS------ 68 (265)
Q Consensus 5 ~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll--~~~~~~~vkl~Dfg~a~~~~~~~------ 68 (265)
..+|.+++..+. ++.|+++++.|||.+||.|||+|.+|||+ +.+..+.+.|+|||+|-....+.
T Consensus 326 ~~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~ 405 (598)
T KOG4158|consen 326 RQTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYE 405 (598)
T ss_pred hhhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccc
Confidence 446777766543 47788999999999999999999999998 56667789999999874322211
Q ss_pred -CCCCCcCCCCCcccccccCCc-----CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 69 -RPKSTVGTPAYIAPEVLSRRE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
..-...|+-.-||||+....+ ....++|.|+.|.+.||++....||........-....+ ..+ -.+.+..
T Consensus 406 S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq---e~q-LPalp~~ 481 (598)
T KOG4158|consen 406 SDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ---ESQ-LPALPSR 481 (598)
T ss_pred cccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh---hhh-CCCCccc
Confidence 111224777889999986422 122348999999999999999999987432110011111 111 1234457
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHH
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIK 166 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ 166 (265)
+++.+++|+..+|..||++|++..
T Consensus 482 vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 482 VPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred CChHHHHHHHHHhcCCccccCCcc
Confidence 899999999999999999999854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.5e-20 Score=150.89 Aligned_cols=131 Identities=22% Similarity=0.281 Sum_probs=87.0
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCC-------cC
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR-------EY 90 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~ 90 (265)
..|++.++.+||+.||||+||+|+|++++.+|. ++|+||+........... ...+..|.|||..... ..
T Consensus 151 T~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~ 226 (288)
T PF14531_consen 151 TVQMIRLVANLHSYGLVHGDIKPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAP 226 (288)
T ss_dssp HHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred HHHHHHHHHHHhhcceEecccceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccce
Confidence 355678889999999999999999999998876 999999876543322111 3345789999977442 12
Q ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 024572 91 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRR 162 (265)
Q Consensus 91 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 162 (265)
.+.+.|.|+||+++|.|+|+..||......... ...+....++++.++.||.++|..+|.+|
T Consensus 227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~----------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 227 YTFATDAWQLGITLYSLWCGRLPFGLSSPEADP----------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp E-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS----------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred eeeccCHHHHHHHHHHHHHccCCCCCCCccccc----------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 245689999999999999999999865332110 00223333688999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=159.65 Aligned_cols=153 Identities=31% Similarity=0.462 Sum_probs=121.0
Q ss_pred hHHHHHHhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccC
Q 024572 8 LSEFVMLEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87 (265)
Q Consensus 8 L~~~~~~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~ 87 (265)
.+++...+...--++-++.++|+.+|+|||+|++||+++.+|. +++.|||.++........ |||..|||||++.+
T Consensus 93 ~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cgt~eymApEI~~g 167 (612)
T KOG0603|consen 93 MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CGTYEYRAPEIING 167 (612)
T ss_pred chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---ccchhhhhhHhhhc
Confidence 3444444444555666788999999999999999999998886 999999998865444332 89999999999983
Q ss_pred CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCC---
Q 024572 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT--- 164 (265)
Q Consensus 88 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s--- 164 (265)
. ..++|.||+|+++++|++|..||.. ..+.++.......|. .++..+++++..++..+|.+|.-
T Consensus 168 --h-~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~ 234 (612)
T KOG0603|consen 168 --H-LSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLFKRNPENRLGAGP 234 (612)
T ss_pred --c-CCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHHHhccCc
Confidence 2 2348999999999999999999987 334444444444444 68899999999999999999984
Q ss_pred --HHHHhcCcccCCCC
Q 024572 165 --IKEIKSHPWFLKNL 178 (265)
Q Consensus 165 --~~ell~h~~f~~~~ 178 (265)
+.++++|+||....
T Consensus 235 ~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 235 DGVDEIKQHEFFQSID 250 (612)
T ss_pred chhHHHhccchheeee
Confidence 57999999997653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=139.18 Aligned_cols=113 Identities=35% Similarity=0.529 Sum_probs=89.7
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.+ +|.+++.... .+.+++.++.+||+++++|+||+|.||+++.++. ++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLA 153 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCccc
Confidence 456666 8888876543 3566788899999999999999999999987754 9999999987554332
Q ss_pred -CCCCCcCCCCCcccccc-cCCcCCCchHhHHHHHHHHHHHHhCCCCCCC
Q 024572 69 -RPKSTVGTPAYIAPEVL-SRREYDGKLADVWSCGVTLYVMLVGAYPFED 116 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~-~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 116 (265)
......++..|++||.+ ....+.. ++|+|+||+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678889999998 4444444 69999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.9e-17 Score=138.69 Aligned_cols=168 Identities=20% Similarity=0.109 Sum_probs=119.8
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-C--CcEEEeccCCcc--cC
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-A--PRLKICDFGYSK--SS 64 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~--~~vkl~Dfg~a~--~~ 64 (265)
|++.++||.++..... +..|++.+|.++|+.|++||||||.|+++.... . ..+.|.|||+++ ..
T Consensus 100 M~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~ 179 (322)
T KOG1164|consen 100 MSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKY 179 (322)
T ss_pred EeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccc
Confidence 8899999999886554 144678889999999999999999999997553 1 359999999998 32
Q ss_pred CCCC--------C-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc
Q 024572 65 LLHS--------R-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 135 (265)
Q Consensus 65 ~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 135 (265)
.... . ...+.||..|.++.+..+.... ++.|+||++.++.+++.|..||.................. ..
T Consensus 180 ~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~-r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~-~~ 257 (322)
T KOG1164|consen 180 VGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQG-RRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK-LL 257 (322)
T ss_pred cCCCCcccccCCCCccCCCCccccccHHHhCCCccC-CchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh-hc
Confidence 1111 1 1234599999999998887765 4489999999999999999999776543332222211111 11
Q ss_pred cCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 136 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 136 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
........+..+..+...+-..+...+|....+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 258 TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred cccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 11122234567777777777788888998777654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.9e-17 Score=136.90 Aligned_cols=159 Identities=31% Similarity=0.462 Sum_probs=114.6
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-------CCCCCcCCCCCcccccccCC-
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-------RPKSTVGTPAYIAPEVLSRR- 88 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-------~~~~~~~~~~y~aPE~~~~~- 88 (265)
.+.+++.++.|+|+.|++|||+||+||+++.... .++++|||.++...... ......++..|++||.+.+.
T Consensus 106 ~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~ 184 (384)
T COG0515 106 ILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184 (384)
T ss_pred HHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCC
Confidence 3666788888999999999999999999987652 38999999987443332 23456799999999999874
Q ss_pred -cCCCchHhHHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHHHhhhcccCCCCCCC----CHHHHHHHHHhcccCCC
Q 024572 89 -EYDGKLADVWSCGVTLYVMLVGAYPFEDQED---PKNFRKTISRIMAVQYKIPDYVHI----SQDCRNLLSRIFVANPS 160 (265)
Q Consensus 89 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~ 160 (265)
.......|+|++|++++++++|..||..... .......+..........+..... ...+.+++.+++..+|.
T Consensus 185 ~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (384)
T COG0515 185 LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPK 264 (384)
T ss_pred CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCch
Confidence 3445569999999999999999999876653 222222222211110111111111 25789999999999999
Q ss_pred CCCCHHHHhcCcccCC
Q 024572 161 RRITIKEIKSHPWFLK 176 (265)
Q Consensus 161 ~R~s~~ell~h~~f~~ 176 (265)
.|.+......++|...
T Consensus 265 ~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 265 NRLSSSSDLSHDLLAH 280 (384)
T ss_pred hcCCHHHHhhchHhhC
Confidence 9999999888866543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.8e-17 Score=152.38 Aligned_cols=143 Identities=20% Similarity=0.266 Sum_probs=101.0
Q ss_pred hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCC----CC----cCCCCCccccccc
Q 024572 15 EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK----ST----VGTPAYIAPEVLS 86 (265)
Q Consensus 15 ~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~----~~----~~~~~y~aPE~~~ 86 (265)
+.++=|++.++..+|..||+|||||.+||||++-.- +.|+||..-+......... .+ ....+|.|||.+.
T Consensus 123 kWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv 200 (1431)
T KOG1240|consen 123 KWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFV 200 (1431)
T ss_pred HHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhh
Confidence 334557889999999999999999999999987554 8999998766433222211 11 2345799999985
Q ss_pred CCc----------CCCchHhHHHHHHHHHHHHh-CCCCCCCCCC-------hHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 87 RRE----------YDGKLADVWSCGVTLYVMLV-GAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 87 ~~~----------~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
... .-.++.||||+||++.||++ |++||.-..- .......+.. ++ +..++
T Consensus 201 ~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~-------Ie-----d~~~R 268 (1431)
T KOG1240|consen 201 SALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEK-------IE-----DVSLR 268 (1431)
T ss_pred ccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHh-------Cc-----CccHH
Confidence 422 12456899999999999998 7888843110 0001111111 11 33689
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 024572 149 NLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h 171 (265)
+||..|++.||.+|.++++.|+.
T Consensus 269 nlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 269 NLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHHccCchhccCHHHHHHh
Confidence 99999999999999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.1e-16 Score=138.85 Aligned_cols=166 Identities=22% Similarity=0.251 Sum_probs=117.6
Q ss_pred cccc-chHHHHHHhc----------cccchHHHHHhhhhcCc-eecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 3 LGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQI-CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 3 ~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~i-vH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
+|.. +|.|.+.... +++-|+.++.|+|+-.| .|+.|++.|++++.... +||+|||+.......
T Consensus 28 ~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~--lklt~~Gl~~~~~~~~~~ 105 (484)
T KOG1023|consen 28 YCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWV--LKLTDFGLNSLLEETAEP 105 (484)
T ss_pred eecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEE--EEechhhhcccccccccc
Confidence 4544 7777777633 36678889999997776 99999999999998876 999999987644221
Q ss_pred CCCCCCcCCCCCcccccccCCcC------CCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--cCCC
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREY------DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPD 139 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~------~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~ 139 (265)
...........|.|||.+..... .+++.|+||+|++++++++.+.||..........+++..+..... ..|.
T Consensus 106 ~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~ 185 (484)
T KOG1023|consen 106 EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPS 185 (484)
T ss_pred cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcc
Confidence 11112224557999999977421 245589999999999999999999875433322334433333111 1121
Q ss_pred ---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 140 ---YVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 140 ---~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.....+.+..++.+||..+|.+||++.++-.
T Consensus 186 i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 186 IELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred hhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 1145567899999999999999999988754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=124.56 Aligned_cols=118 Identities=24% Similarity=0.284 Sum_probs=96.5
Q ss_pred CcccccchHHHHHHhcc----------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCC---CcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLEGS----------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA---PRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~~~----------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~---~~vkl~Dfg~a~~~~~~ 67 (265)
|||.++||+|+.-.++. ++|++..+.|+|++.+|.|||||+|+||...+. ..|.++|||+|+.....
T Consensus 103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 78999999999987764 666778899999999999999999999964332 24899999999865433
Q ss_pred CC--------CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCC
Q 024572 68 SR--------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED 119 (265)
Q Consensus 68 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 119 (265)
.. .++..||..||+--...+...+.. .|+=|||-++++.|.|..||.+...
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC
Confidence 22 234569999999988888776544 8999999999999999999988643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=119.82 Aligned_cols=164 Identities=17% Similarity=0.164 Sum_probs=116.6
Q ss_pred CcccccchHHHHHHhcc----------ccchHHHHHhhhhcCceecCCCcCcEEEcCC-CCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEGS----------VKMKPDIFFSSLSQQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~~----------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
|+|.++||.++...+.. +.|++..+.|+|.+++|||||||+|+|..-. -..++.|+|||+|+.......
T Consensus 90 MdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 90 MDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred eeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 89999999998876542 5566778999999999999999999998432 123589999999986543322
Q ss_pred --------CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC---
Q 024572 70 --------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--- 138 (265)
Q Consensus 70 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 138 (265)
.....||..|.+--...+...+ ...|+=|+|.++.++..|..||.+...... .+....+.......|
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~tk-~QKyEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAATK-KQKYEKISEKKMSTPIEV 247 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchhhH-HHHHHHHHHhhcCCCHHH
Confidence 2334689999987777665544 448999999999999999999998654322 122222322222222
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIK 166 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~ 166 (265)
....+|.++.-.+.-|-..--++-|...
T Consensus 248 LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 248 LCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 2346788888888888777667777643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6e-16 Score=141.37 Aligned_cols=158 Identities=31% Similarity=0.482 Sum_probs=124.5
Q ss_pred cccchHHHHHhhh-hcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CC---CCCCCcC-CCCCcccccccCCcC
Q 024572 17 SVKMKPDIFFSSL-SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS---RPKSTVG-TPAYIAPEVLSRREY 90 (265)
Q Consensus 17 ~~~~i~~~l~~lH-~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~---~~~~~~~-~~~y~aPE~~~~~~~ 90 (265)
.++++..++.|+| ..++.|+||||+|.+++.++. .++++|||+|..... .. .....+| ++.|+|||...+..+
T Consensus 128 ~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~ 206 (601)
T KOG0590|consen 128 YLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY 206 (601)
T ss_pred hhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhh
Confidence 4677888999999 999999999999999998873 399999999976544 22 2233468 999999999998777
Q ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 91 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 91 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+..|+||.|+++..+++|..|+................. .......+..++....+++.+++..+|..|.+.+++..
T Consensus 207 ~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 207 RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 77779999999999999999999976554332111111100 12234455678889999999999999999999999999
Q ss_pred CcccCC
Q 024572 171 HPWFLK 176 (265)
Q Consensus 171 h~~f~~ 176 (265)
++|+..
T Consensus 286 d~~~~~ 291 (601)
T KOG0590|consen 286 DNWLSS 291 (601)
T ss_pred cccccc
Confidence 999976
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.9e-14 Score=113.69 Aligned_cols=116 Identities=12% Similarity=0.052 Sum_probs=80.5
Q ss_pred Cccccc-chHHHHHHh--ccccchHHHHHhhhhcCceecCC-CcCcEEEcCCCCCcEEEeccCCcccCCCCCCC----C-
Q 024572 1 MQLGVS-SLSEFVMLE--GSVKMKPDIFFSSLSQQICHRDL-KLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----K- 71 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--~~~~~i~~~l~~lH~~~ivH~dl-kp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----~- 71 (265)
||+..+ +|.+..... ....+++.++.++|++||+|||| ||.|||++.++. ++|+|||+|......... .
T Consensus 77 meyI~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~r~L~~ 154 (218)
T PRK12274 77 RSYLAGAAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWMRLLAR 154 (218)
T ss_pred EeeecCccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchHHHHHHH
Confidence 566545 676543211 24567788999999999999999 799999987665 999999999744432210 0
Q ss_pred ---------CCcCCCCCcccccccCC-cCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Q 024572 72 ---------STVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQE 118 (265)
Q Consensus 72 ---------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 118 (265)
....++.|++|+...-. ..+-...+.++.|+-+|.++|++.++.+..
T Consensus 155 rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 155 EDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 01256777777754332 222233688899999999999998876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.7e-13 Score=109.04 Aligned_cols=139 Identities=22% Similarity=0.273 Sum_probs=104.0
Q ss_pred hHHHHHhhhhcC--ceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCC--CchHh
Q 024572 21 KPDIFFSSLSQQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD--GKLAD 96 (265)
Q Consensus 21 i~~~l~~lH~~~--ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~D 96 (265)
++.++.|||+.. |.---|....|+||.+-..++-.+|--++. ........+.|++||.+..++.+ ..++|
T Consensus 298 iargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------qe~gr~y~pawmspealqrkped~n~raad 371 (448)
T KOG0195|consen 298 IARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAAD 371 (448)
T ss_pred HHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------eccccccCcccCCHHHHhcCchhcchhhhh
Confidence 677899999754 555678899999998887666677754432 12234567899999999876644 35689
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 024572 97 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 169 (265)
Q Consensus 97 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell 169 (265)
+|||++++|++.|...||......+.-.+ +.-...+...++.++..+..|+.-|+..||.+||.+..++
T Consensus 372 mwsfaillwel~trevpfadlspmecgmk----ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 372 MWSFAILLWELNTREVPFADLSPMECGMK----IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHHhhccccccccCCchhhhhh----hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999988765433222 2222333444457899999999999999999999987654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.2e-14 Score=121.21 Aligned_cols=85 Identities=15% Similarity=0.069 Sum_probs=63.0
Q ss_pred Cccccc-chHHHHH--HhccccchHHHHHhhhhcCceecCC-CcCcEEEcCCCCCcEEEeccCCcccCCCCCCC------
Q 024572 1 MQLGVS-SLSEFVM--LEGSVKMKPDIFFSSLSQQICHRDL-KLENTLLDGSPAPRLKICDFGYSKSSLLHSRP------ 70 (265)
Q Consensus 1 me~~~~-sL~~~~~--~~~~~~~i~~~l~~lH~~~ivH~dl-kp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~------ 70 (265)
||++.+ +|..... ...++.+++.++.|||++||+|||| ||+|||++.++. +||+|||+|+........
T Consensus 97 mE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~~~~~~~~~~~~~ 174 (365)
T PRK09188 97 RGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVFRRRGALYRIAAY 174 (365)
T ss_pred EEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceecccCcchhhhhhh
Confidence 788865 6753211 1235677899999999999999999 999999976654 999999999854332211
Q ss_pred ---CCCcCCCCCcccccccC
Q 024572 71 ---KSTVGTPAYIAPEVLSR 87 (265)
Q Consensus 71 ---~~~~~~~~y~aPE~~~~ 87 (265)
....++..|+|||.+..
T Consensus 175 ~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 175 EDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhccCccCCcccCCh
Confidence 23357788999999854
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.7e-14 Score=113.05 Aligned_cols=93 Identities=13% Similarity=0.117 Sum_probs=66.9
Q ss_pred Cccccc-chHHHHHH-hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCC
Q 024572 1 MQLGVS-SLSEFVML-EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 78 (265)
Q Consensus 1 me~~~~-sL~~~~~~-~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~ 78 (265)
||++.+ +|.++... ...+.++..++..+|+.|++|||+||.||+++.++ ++|+|||..+........
T Consensus 122 mEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a~-------- 190 (232)
T PRK10359 122 IEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKAK-------- 190 (232)
T ss_pred EEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhhH--------
Confidence 788887 89887432 12355788889999999999999999999998655 999999977533211110
Q ss_pred CcccccccCCcCCCchHhHHHHHHHHHHHH
Q 024572 79 YIAPEVLSRREYDGKLADVWSCGVTLYVML 108 (265)
Q Consensus 79 y~aPE~~~~~~~~~~~~DiwslG~~l~~ll 108 (265)
.-++....+. .++|+|+||+++..+.
T Consensus 191 ---d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 191 ---DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ---HHHHHHhHhc-ccccccceeEeehHHH
Confidence 1133334455 4589999999987654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.4e-12 Score=119.37 Aligned_cols=110 Identities=24% Similarity=0.219 Sum_probs=83.1
Q ss_pred ccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcC-----CCCCcEEEeccCCcccCC-
Q 024572 2 QLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDG-----SPAPRLKICDFGYSKSSL- 65 (265)
Q Consensus 2 e~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-----~~~~~vkl~Dfg~a~~~~- 65 (265)
||... +|-|++.-.+ ++.+++.++.+||..+||||||||+|+||.. ....-++|+|||.+.-+.
T Consensus 774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 44444 6666665332 2556788999999999999999999999932 122249999999885332
Q ss_pred --CCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCC
Q 024572 66 --LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAY 112 (265)
Q Consensus 66 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~ 112 (265)
........++|-.+-.+|...|.+++.. +|.|.|+.+++.||.|+.
T Consensus 854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 2333445578899999999999988655 999999999999999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-12 Score=116.18 Aligned_cols=152 Identities=16% Similarity=0.211 Sum_probs=108.4
Q ss_pred hHHHHHhhh-hcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC----------CCCcCCCCCcccccccCCc
Q 024572 21 KPDIFFSSL-SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----------KSTVGTPAYIAPEVLSRRE 89 (265)
Q Consensus 21 i~~~l~~lH-~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~ 89 (265)
..+|+.++| +.++||++|.|++|.++.++. +||+.|+++......... ........|.|||++.+..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 457889999 688999999999999998876 999999998644332111 0112456799999998844
Q ss_pred CCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 024572 90 YDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 168 (265)
Q Consensus 90 ~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~el 168 (265)
. +.++|+||+|+++|.+.. |+..+.................... ......++.++++=|.++|..++..||++..+
T Consensus 186 ~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~--~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 186 N-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA--FGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred c-cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc--ccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 4 455999999999999984 5555544332222111111111111 11224688999999999999999999999999
Q ss_pred hcCcccCCC
Q 024572 169 KSHPWFLKN 177 (265)
Q Consensus 169 l~h~~f~~~ 177 (265)
+..+||...
T Consensus 263 ~~~~ff~D~ 271 (700)
T KOG2137|consen 263 LSIPFFSDP 271 (700)
T ss_pred hcccccCCc
Confidence 999999754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.4e-11 Score=97.48 Aligned_cols=60 Identities=18% Similarity=0.066 Sum_probs=45.4
Q ss_pred Cccccc-chHHHHHH---------hccccchHHHHHhh-hhcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVML---------EGSVKMKPDIFFSS-LSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~~---------~~~~~~i~~~l~~l-H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||++++ +|...... ...+.+++.++.++ |+.||+||||||+|||++. + .++|+|||+|..
T Consensus 96 mE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~v~LiDFG~a~~ 166 (190)
T cd05147 96 MEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--KLYIIDVSQSVE 166 (190)
T ss_pred EEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--cEEEEEcccccc
Confidence 788876 34333221 22356678899998 7999999999999999984 3 499999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.3e-11 Score=111.71 Aligned_cols=155 Identities=31% Similarity=0.476 Sum_probs=116.6
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC------C------------------------
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL------H------------------------ 67 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~------~------------------------ 67 (265)
+-.+.....+||+..+.|+|++|.|+++..++. .++++||....... .
T Consensus 910 i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~ 987 (1205)
T KOG0606|consen 910 ILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSAD 987 (1205)
T ss_pred hHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccCcCCcccccccCccccccccccccccccc
Confidence 334455678999999999999999999987776 89999973221000 0
Q ss_pred --CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCC-CCCCC
Q 024572 68 --SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHIS 144 (265)
Q Consensus 68 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 144 (265)
.......+|+-|.+||.+.+...... +|+|++|+++++.++|.+||........+.. +......+|. ....+
T Consensus 988 ~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~tpq~~f~n----i~~~~~~~p~g~~~~s 1062 (1205)
T KOG0606|consen 988 EARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAETPQQIFEN----ILNRDIPWPEGPEEGS 1062 (1205)
T ss_pred hhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcchhhhhhc----cccCCCCCCCCccccC
Confidence 00122358999999999998776544 8999999999999999999988766554433 3333444443 33578
Q ss_pred HHHHHHHHHhcccCCCCCCCHH---HHhcCcccCCCCC
Q 024572 145 QDCRNLLSRIFVANPSRRITIK---EIKSHPWFLKNLP 179 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~---ell~h~~f~~~~~ 179 (265)
..+++++.++|..+|.+|..+. ++..|+||+..-.
T Consensus 1063 ~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1063 YEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 8999999999999999999887 8999999986543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.8e-11 Score=95.80 Aligned_cols=45 Identities=16% Similarity=0.070 Sum_probs=39.1
Q ss_pred cccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccC
Q 024572 17 SVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 64 (265)
Q Consensus 17 ~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 64 (265)
++.+++.++.++|+ +||+||||||+||+++ ++ .++|+|||+++..
T Consensus 122 i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--~~~liDFG~a~~~ 167 (190)
T cd05145 122 LYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--KPYIIDVSQAVEL 167 (190)
T ss_pred HHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--CEEEEEcccceec
Confidence 45678899999999 9999999999999998 44 4999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.5e-11 Score=98.77 Aligned_cols=149 Identities=14% Similarity=0.201 Sum_probs=95.7
Q ss_pred ccccchHHHHHhhhhc--CceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-----CCCCCCCcCCCCCcccccccCC
Q 024572 16 GSVKMKPDIFFSSLSQ--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-----HSRPKSTVGTPAYIAPEVLSRR 88 (265)
Q Consensus 16 ~~~~~i~~~l~~lH~~--~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~~~~~y~aPE~~~~~ 88 (265)
.|+.+|+.+|.|||+. -|+|+++..+.|++..++. +|+.--........ ........+.+.|.+||.-...
T Consensus 180 kw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t 257 (458)
T KOG1266|consen 180 KWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT 257 (458)
T ss_pred HHHHHHHhhhhhhhccCCccccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc
Confidence 3678899999999975 4999999999999987765 66643211100000 0011123467789999986555
Q ss_pred cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 024572 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 168 (265)
Q Consensus 89 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~el 168 (265)
...+. +|||++|+...+|..+..--............+.+.... .. ..--+.++.+||...|..||+++.+
T Consensus 258 n~~~a-~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~---le-----n~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 258 NTTGA-SDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG---LE-----NGLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred ccccc-hhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee---cc-----CccccCcCcccccCCCCCCcchhhh
Confidence 54444 899999999999988764322222111111112111110 00 1122578999999999999999999
Q ss_pred hcCcccC
Q 024572 169 KSHPWFL 175 (265)
Q Consensus 169 l~h~~f~ 175 (265)
+.||.+-
T Consensus 329 lfHpllf 335 (458)
T KOG1266|consen 329 LFHPLLF 335 (458)
T ss_pred hcCceee
Confidence 9999754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6e-11 Score=104.96 Aligned_cols=165 Identities=19% Similarity=0.167 Sum_probs=117.8
Q ss_pred cccccchHHHHHHhcc----------ccchHH----HHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 2 QLGVSSLSEFVMLEGS----------VKMKPD----IFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 2 e~~~~sL~~~~~~~~~----------~~~i~~----~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
|+|+.+|..+...... +..... ++.++|+.+|+|-|+||.||++..+.. ..+++|||+.......
T Consensus 198 E~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~-s~~~~df~~v~~i~~~ 276 (524)
T KOG0601|consen 198 ELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT-SCKLTDFGLVSKISDG 276 (524)
T ss_pred ccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc-eeecCCcceeEEccCC
Confidence 6777777777765443 222344 888999999999999999999987732 4899999998755443
Q ss_pred CCC------CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCC--CChHHHHHHHHHHhhhcccCCC
Q 024572 68 SRP------KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ--EDPKNFRKTISRIMAVQYKIPD 139 (265)
Q Consensus 68 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~ 139 (265)
... ....+...|++||..++.. +.+.|+|++|.++.+..++..+.... .....++... .+...
T Consensus 277 ~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-------ip~e~ 347 (524)
T KOG0601|consen 277 NFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-------IPLEF 347 (524)
T ss_pred ccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------Cchhh
Confidence 321 1125778899999997644 45589999999999999987666544 2222222111 11112
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 140 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 140 ~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
....+..+...+..|+..+|..|++++.+++|++...
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 2245666777999999999999999999999998763
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-10 Score=93.67 Aligned_cols=60 Identities=17% Similarity=0.173 Sum_probs=48.0
Q ss_pred Cccccc--chHHHHHHhc----cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 1 MQLGVS--SLSEFVMLEG----SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~~--sL~~~~~~~~----~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
||++.+ +|.+++.... .+.+++.++.+||++||+||||||.|||++.++. ++|+|||.+.
T Consensus 125 ~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg~~~ 190 (239)
T PRK01723 125 IERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFDRGE 190 (239)
T ss_pred EEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECCCcc
Confidence 455553 7877765322 2567889999999999999999999999987654 9999999876
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.4e-10 Score=90.66 Aligned_cols=60 Identities=18% Similarity=0.122 Sum_probs=44.3
Q ss_pred Ccccc---cchHHHHHHhc------cccchHHHH-HhhhhcCceecCCCcCcEEEcCC--CCCcEEEeccCC
Q 024572 1 MQLGV---SSLSEFVMLEG------SVKMKPDIF-FSSLSQQICHRDLKLENTLLDGS--PAPRLKICDFGY 60 (265)
Q Consensus 1 me~~~---~sL~~~~~~~~------~~~~i~~~l-~~lH~~~ivH~dlkp~NIll~~~--~~~~vkl~Dfg~ 60 (265)
||+++ ++|.+++.... .+.+++.++ .|||+++|+||||||+|||++.. +..+++|+||+.
T Consensus 84 ~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred ecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 57755 59999986432 134555555 89999999999999999999743 233699999553
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.99 E-value=3e-10 Score=90.44 Aligned_cols=61 Identities=21% Similarity=0.169 Sum_probs=47.7
Q ss_pred Cccccc-chHHHHH---HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVM---LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~---~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||++.+ +|.+... ....+.+++.++.++|++||+||||||.||+++.++. ++|+|||.+..
T Consensus 110 ~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~--~~liDfg~~~~ 174 (198)
T cd05144 110 MEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK--IYIIDWPQMVS 174 (198)
T ss_pred EEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc--EEEEECCcccc
Confidence 566655 6655533 2234667888899999999999999999999987654 99999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.8e-10 Score=93.09 Aligned_cols=45 Identities=18% Similarity=0.087 Sum_probs=39.7
Q ss_pred hccccchHHHHHhhhhcC-ceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 15 EGSVKMKPDIFFSSLSQQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 15 ~~~~~~i~~~l~~lH~~~-ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++++++.++.+||++| |+||||||+||+++ .+ .++|+|||.+.
T Consensus 151 ~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~--~i~LiDFg~a~ 196 (237)
T smart00090 151 FELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG--KVVIIDVSQSV 196 (237)
T ss_pred HHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC--CEEEEEChhhh
Confidence 346788999999999999 99999999999998 44 49999999876
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.92 E-value=9.1e-10 Score=87.60 Aligned_cols=60 Identities=20% Similarity=0.243 Sum_probs=50.5
Q ss_pred Cccccc-chHHHHHHh--ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVMLE--GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||++.+ +|.+++... ..+.+++.++.++|+.|++|||++|.||+++ ++ .++++|||.++.
T Consensus 76 ~e~~~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~--~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD--KLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC--cEEEEECCCCcC
Confidence 677755 898887664 4678889999999999999999999999998 43 499999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-09 Score=99.89 Aligned_cols=60 Identities=25% Similarity=0.285 Sum_probs=50.2
Q ss_pred Cccccc-chHHHHH-HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVM-LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~-~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||++.+ +|.+++. ...++.+++.++.+||++||+||||||+|||++ ++ .++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence 678766 8998874 344677899999999999999999999999994 33 499999999863
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=6.6e-09 Score=89.07 Aligned_cols=154 Identities=14% Similarity=0.153 Sum_probs=103.0
Q ss_pred HHHHhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccC---
Q 024572 11 FVMLEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR--- 87 (265)
Q Consensus 11 ~~~~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--- 87 (265)
|-..-...+-++.++.-||..|.+-+|++++|+|+.+.+. |.|.|-..-............+|...|++||.-.-
T Consensus 116 w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf 193 (637)
T COG4248 116 WDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSF 193 (637)
T ss_pred cHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeeccCCceEecccCccccCCHHHhccccc
Confidence 3333334566888999999999999999999999987776 88887654433334444455679999999998642
Q ss_pred --CcCCCchHhHHHHHHHHHHHHhC-CCCCCCCCCh----HHHH-HHHHH------Hhhhcc----cCCCCCCCCHHHHH
Q 024572 88 --REYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDP----KNFR-KTISR------IMAVQY----KIPDYVHISQDCRN 149 (265)
Q Consensus 88 --~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~----~~~~-~~~~~------~~~~~~----~~~~~~~~~~~~~~ 149 (265)
..-+.. .|.|.||+++++++.| ++||.+.... ..+. .+... .....+ ..+.+..+++++..
T Consensus 194 ~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqA 272 (637)
T COG4248 194 VGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQA 272 (637)
T ss_pred cccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHH
Confidence 222223 7999999999999986 9999764211 1111 11000 001111 11234457899999
Q ss_pred HHHHhccc--CCCCCCCHHH
Q 024572 150 LLSRIFVA--NPSRRITIKE 167 (265)
Q Consensus 150 li~~~L~~--dP~~R~s~~e 167 (265)
|..+|+.. ++.-|||++.
T Consensus 273 lF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 273 LFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred HHHHHhcccCCCCCCCCHHH
Confidence 99999965 4668998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.9e-09 Score=86.47 Aligned_cols=60 Identities=20% Similarity=0.227 Sum_probs=49.4
Q ss_pred Cccccc-chHHHHHH-----hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVML-----EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~~-----~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||++.+ +|.+++.. ...+.++..++.++|++|++|||++|.|||++ ++ .++|+|||.++.
T Consensus 78 ~e~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~--~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG--KIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC--CEEEEECCcccC
Confidence 677755 89888764 24567788889999999999999999999998 33 499999998763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.1e-09 Score=82.90 Aligned_cols=47 Identities=19% Similarity=0.165 Sum_probs=40.1
Q ss_pred HhccccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 14 LEGSVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 14 ~~~~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
.+..+.+++.++.++|+ +||+||||||+||+++ ++ .++|+|||.+..
T Consensus 116 ~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~--~~~liDfg~a~~ 163 (187)
T cd05119 116 PEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG--KVYIIDVPQAVE 163 (187)
T ss_pred HHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--cEEEEECccccc
Confidence 34457778899999999 9999999999999998 44 499999998863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.5e-08 Score=78.02 Aligned_cols=59 Identities=20% Similarity=0.244 Sum_probs=48.8
Q ss_pred Cccccc-chHHHHHHh--ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 1 MQLGVS-SLSEFVMLE--GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
||+.++ .|.|++... ..++-+=..+.-||..||||+||.++||++.+.. +.++|||++.
T Consensus 78 me~I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~ 139 (204)
T COG3642 78 MEYIEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE 139 (204)
T ss_pred EEEeCChhHHHHHHhcchHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence 778777 788888877 4455556667889999999999999999997654 8999999876
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.4e-08 Score=77.29 Aligned_cols=44 Identities=16% Similarity=0.098 Sum_probs=36.1
Q ss_pred cccchHHHHHhh-hhcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 17 SVKMKPDIFFSS-LSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 17 ~~~~i~~~l~~l-H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
.+.+++.++..+ |..|||||||++.||++..+ .+.|+|||.+..
T Consensus 129 i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~~---~v~iIDF~qav~ 173 (197)
T cd05146 129 AYYQVLSMMKQLYKECNLVHADLSEYNMLWHDG---KVWFIDVSQSVE 173 (197)
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEECC---cEEEEECCCcee
Confidence 355677778777 89999999999999999743 399999997753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.2e-08 Score=87.18 Aligned_cols=145 Identities=19% Similarity=0.145 Sum_probs=97.7
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCc--ccccccCCcCCCchH
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI--APEVLSRREYDGKLA 95 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~~ 95 (265)
..+++.++.++|++.++|+|+||+||++..++ ...++.|||....... ......+..++. ++.......+ ..+.
T Consensus 372 ~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~-~~~~ 447 (524)
T KOG0601|consen 372 TAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAF--SSGVFHHIDRLYPIAEILLEDYPH-LSKA 447 (524)
T ss_pred HHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccccce--ecccccccccccccchhhcccccc-cccc
Confidence 45567778899999999999999999998764 3479999998764211 112223344444 4444444444 4458
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 96 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 96 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
|++|||..+.+.+++...-....... . +... ..+........+..+.+.++..++..|+.+.++..|.-|.
T Consensus 448 ~~~sl~~~~~e~~~~~~ls~~~~~~~---~----i~~~--~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 448 DIFSLGLSVDEAITGSPLSESGVQSL---T----IRSG--DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ccccccccccccccCcccCcccccce---e----eecc--cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 99999999999998865433322111 1 1111 1233333447788899999999999999999998887653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.7e-07 Score=76.65 Aligned_cols=62 Identities=18% Similarity=0.152 Sum_probs=47.5
Q ss_pred Cccccc--chHHHHH-----------HhccccchHHHHHhhhhcCceecCCCcCcEEEcC-----CCCCcEEEeccCCcc
Q 024572 1 MQLGVS--SLSEFVM-----------LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDG-----SPAPRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~~--sL~~~~~-----------~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-----~~~~~vkl~Dfg~a~ 62 (265)
||..++ +|.+++. .+.++++++..+..||..||+|+|+++.|||++. .+...+.|+||+.++
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 454444 6888764 2245667888899999999999999999999975 234469999999764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.2e-07 Score=82.73 Aligned_cols=62 Identities=21% Similarity=0.232 Sum_probs=46.4
Q ss_pred Cccccc-chHHHHHHh--c-----cccchHH-HHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC
Q 024572 1 MQLGVS-SLSEFVMLE--G-----SVKMKPD-IFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--~-----~~~~i~~-~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 64 (265)
||++.+ +|.++.... + +...++. .+..+|..|++|+|+||.||+++.++. ++++|||++...
T Consensus 237 mE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~--i~liDfG~~~~l 307 (437)
T TIGR01982 237 MEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGK--IIALDFGIVGRL 307 (437)
T ss_pred EEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCc--EEEEeCCCeeEC
Confidence 788876 888876532 1 1222233 356789999999999999999987765 999999988643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.2e-06 Score=77.57 Aligned_cols=90 Identities=13% Similarity=0.145 Sum_probs=66.2
Q ss_pred ccccchHHHHHhhh-hcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-CCCCcCCCCCcccccccCCcCCCc
Q 024572 16 GSVKMKPDIFFSSL-SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 16 ~~~~~i~~~l~~lH-~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
..+.||+.+|.+|| .++++|++|.-+.|+++..|. .||++|.++........ .......-.|..|+.+....+
T Consensus 108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~--- 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW--- 182 (690)
T ss_pred HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc---
Confidence 34778999999997 889999999999999998887 99999988754332221 112222334667766543332
Q ss_pred hHhHHHHHHHHHHHHhC
Q 024572 94 LADVWSCGVTLYVMLVG 110 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~g 110 (265)
..|.|-|||++++++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 26999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.6e-07 Score=69.29 Aligned_cols=47 Identities=26% Similarity=0.388 Sum_probs=38.6
Q ss_pred HhccccchHHHHHhhhh---cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 14 LEGSVKMKPDIFFSSLS---QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 14 ~~~~~~~i~~~l~~lH~---~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
......+++.++.++|. .+++|+||+|.||+++..+ .++++|||.+.
T Consensus 88 ~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~ 137 (155)
T cd05120 88 KEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAG 137 (155)
T ss_pred HHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEeccccc
Confidence 34456778888999997 4799999999999998744 49999999775
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=6e-07 Score=69.14 Aligned_cols=63 Identities=21% Similarity=0.272 Sum_probs=49.6
Q ss_pred Cccccc--chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCC-cEEEeccCCccc
Q 024572 1 MQLGVS--SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAP-RLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~--sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~-~vkl~Dfg~a~~ 63 (265)
||+..+ ++.+|+.... ..+.|=+.+.-||..+|+||||..+||++...+.. .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 788877 8889888653 34556667888999999999999999999665432 358999998763
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.3e-07 Score=70.75 Aligned_cols=43 Identities=30% Similarity=0.470 Sum_probs=36.7
Q ss_pred cccchHHHHHhhhhcCc-----eecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 17 SVKMKPDIFFSSLSQQI-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~i-----vH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
.+.+++.++..||+.++ +|||++|.||+++ ++ .++++|||.+.
T Consensus 88 ~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~ 135 (170)
T cd05151 88 NLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence 45678899999999985 9999999999998 33 39999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.5e-07 Score=71.35 Aligned_cols=56 Identities=18% Similarity=0.248 Sum_probs=46.4
Q ss_pred chHHHHHH---------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcc
Q 024572 7 SLSEFVML---------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSK 62 (265)
Q Consensus 7 sL~~~~~~---------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~ 62 (265)
+|.+++.. ..+++++...+.-||.+||+|+|+++.|||++... ...+.|+||+.++
T Consensus 104 ~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 104 DLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred cHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 67777764 44577788889999999999999999999998765 3358999999765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.8e-07 Score=69.62 Aligned_cols=60 Identities=23% Similarity=0.237 Sum_probs=37.4
Q ss_pred Ccccc--c-chHHHHHHh-------ccccchHH-HHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGV--S-SLSEFVMLE-------GSVKMKPD-IFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~--~-sL~~~~~~~-------~~~~~i~~-~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||+.+ + .+..+.... ..+..++. ....+|+.||+||||++.||+++.+ . +.++|||.+..
T Consensus 85 ME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf~qav~ 155 (188)
T PF01163_consen 85 MEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDFGQAVD 155 (188)
T ss_dssp EE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--GTTEEE
T ss_pred EEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEecCccee
Confidence 67777 4 344433332 23444455 3445789999999999999999876 3 99999997753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.3e-06 Score=68.27 Aligned_cols=59 Identities=14% Similarity=0.117 Sum_probs=45.6
Q ss_pred Cccccc-chHHHHHHhc-cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 1 MQLGVS-SLSEFVMLEG-SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
||+.++ .|.++..... ....+.+.+.-+|+.|++|+|.+|.|+++..++ ++++||+..+
T Consensus 122 ~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k~ 182 (229)
T PF06176_consen 122 MEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGKR 182 (229)
T ss_pred EEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECcccc
Confidence 677777 6766544322 235677889999999999999999999998654 8999998544
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.8e-06 Score=73.87 Aligned_cols=64 Identities=25% Similarity=0.412 Sum_probs=44.7
Q ss_pred Cccccc-chHHHHHH--hcc-ccchH----H-HHHhhhhcCceecCCCcCcEEEcCCC--CCcEEEeccCCcccC
Q 024572 1 MQLGVS-SLSEFVML--EGS-VKMKP----D-IFFSSLSQQICHRDLKLENTLLDGSP--APRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~-sL~~~~~~--~~~-~~~i~----~-~l~~lH~~~ivH~dlkp~NIll~~~~--~~~vkl~Dfg~a~~~ 64 (265)
||++.+ .+.++... .+. .+.++ . .+..++..|++|+|+||.||+++.++ .++++++|||++...
T Consensus 240 mE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 240 MERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred EeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 788887 88875432 221 11222 2 24456789999999999999998765 235999999998644
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=3.4e-05 Score=61.39 Aligned_cols=56 Identities=13% Similarity=0.074 Sum_probs=45.4
Q ss_pred chHHHHHH-----------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 7 SLSEFVML-----------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 7 sL~~~~~~-----------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+|.+++.. +.+++.++.++.-||..|+.|+|+.+.||+++..+...++++||.-++
T Consensus 112 ~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 112 SIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred cHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 67777643 345777888899999999999999999999986554459999998654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.00023 Score=58.50 Aligned_cols=43 Identities=16% Similarity=0.159 Sum_probs=34.4
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+..|+.-+..+-..||||+|+++-||+++.++. +.++||--+.
T Consensus 208 l~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vIDwPQ~v 250 (304)
T COG0478 208 LDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVIDWPQAV 250 (304)
T ss_pred HHHHHHHHHHHHHcCccccCCchheEEEecCCC--EEEEeCcccc
Confidence 445555555566999999999999999998876 9999996543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00067 Score=65.67 Aligned_cols=144 Identities=19% Similarity=0.199 Sum_probs=93.7
Q ss_pred hccccchHHHHHhhhhcCceecCCCcC---cEEEcCCCCCcEEEe--ccCCcccCCCCCCCCCCcCCCCCcccccccCCc
Q 024572 15 EGSVKMKPDIFFSSLSQQICHRDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89 (265)
Q Consensus 15 ~~~~~~i~~~l~~lH~~~ivH~dlkp~---NIll~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 89 (265)
+.+..+++.++.++|+....|.-|..+ +.-++..+. +.++ ||+.++................+.++|......
T Consensus 289 r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~--~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~ 366 (1351)
T KOG1035|consen 289 RILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGV--VAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENT 366 (1351)
T ss_pred HHHHHHHhhhHHHHHHhccceeEEecccccccccCccce--eecchhhhcccccCCCcccchhhcCcccccccccccccc
Confidence 334566788999999997666655554 222233333 5555 888877655554444555666778888876655
Q ss_pred CCC-chHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 024572 90 YDG-KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 168 (265)
Q Consensus 90 ~~~-~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~el 168 (265)
... ...|+|.+|.+...+..|..+-..... ...+... .......+++.+|+.-++++|+++.++
T Consensus 367 ~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~-------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 367 AKKSRLTDLWCLGLLLLQLSQGEDISEKSAV-------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred chhhhhhHHHHHHHHHhhhhhcCcccccccc-------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhh
Confidence 432 236999999999999887654322111 1111000 111156788999999999999999999
Q ss_pred hcCcccC
Q 024572 169 KSHPWFL 175 (265)
Q Consensus 169 l~h~~f~ 175 (265)
+.|+|.+
T Consensus 432 l~~~f~~ 438 (1351)
T KOG1035|consen 432 LTHPFLR 438 (1351)
T ss_pred hhchhcc
Confidence 9999965
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0061 Score=54.51 Aligned_cols=123 Identities=19% Similarity=0.269 Sum_probs=83.0
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhH
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 97 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 97 (265)
+-|+..+|.++|+.|+..+-|.|.+||++++. +++|...|+........ . +.+.+ .++-|.
T Consensus 399 ~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~-----------~--~~le~----~Qq~D~ 459 (655)
T KOG3741|consen 399 ISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP-----------T--EPLES----QQQNDL 459 (655)
T ss_pred HHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCC-----------C--cchhH----HhhhhH
Confidence 56789999999999999999999999998765 48888777654322221 0 11222 123688
Q ss_pred HHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 98 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 98 wslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
=.||.+++.|.||..--......... .+..+. ..++.+++++|.-+...+++. -++.+++.+
T Consensus 460 ~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I~---------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 460 RDLGLLLLALATGTENSNRTDSTQSS--HLTRIT---------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHhhcccccccccchHHH--HHHHhh---------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 89999999999995431111111111 011111 146789999999999888887 688888765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0024 Score=51.94 Aligned_cols=46 Identities=20% Similarity=0.132 Sum_probs=35.8
Q ss_pred HhccccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 14 LEGSVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 14 ~~~~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..+..+++++.+.-|-. .++||+||+.-|||+.. +. +.++|||-|.
T Consensus 168 ~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~-~~--p~iID~~QaV 214 (268)
T COG1718 168 AEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD-GE--PYIIDVSQAV 214 (268)
T ss_pred HHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC-Ce--EEEEECcccc
Confidence 34456666777666655 99999999999999983 33 8999999765
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.0031 Score=56.48 Aligned_cols=83 Identities=14% Similarity=0.154 Sum_probs=53.8
Q ss_pred hHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 024572 94 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-------PDYVHISQDCRNLLSRIFVANPSRRITIK 166 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 166 (265)
++|||++|.++.++..|...+...........+ .......... -....++.....+..+|+...|..||...
T Consensus 111 KsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i-~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 111 KSDVWSLGFIILELYLGISLEAELTESEYLEIL-LKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred chhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHH-HHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 599999999999999987766543322221111 1110000000 00113566778899999999999999999
Q ss_pred HHhcCcccCCC
Q 024572 167 EIKSHPWFLKN 177 (265)
Q Consensus 167 ell~h~~f~~~ 177 (265)
++.+++-|...
T Consensus 190 ~~~k~~i~~ev 200 (725)
T KOG1093|consen 190 ELSKRCSFTEV 200 (725)
T ss_pred HHhcCccHHHH
Confidence 99999887644
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.0023 Score=63.95 Aligned_cols=135 Identities=13% Similarity=0.068 Sum_probs=85.9
Q ss_pred ceecCCCcCcEEEcCCCCCcEEEeccCCccc-CCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCC
Q 024572 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA 111 (265)
Q Consensus 33 ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~ 111 (265)
.+|++||+-|.+|..+.. +|++++|+.+. ...........+++.|+.|++...-.+..+ +|+|..|+.+|....|.
T Consensus 1361 ~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred chhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhccc
Confidence 789999999999988776 99999999882 222223344567888999998877776544 99999999999998777
Q ss_pred CCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 112 YPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 112 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
.+|... ....++.+.............|.+.-.....+|-..-..||.-...+.-+.|-
T Consensus 1438 ~~fi~f-----lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1438 AYFIFF-----LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHHH-----HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 665221 11111111111111111112234444455555555667888887777766653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.011 Score=53.61 Aligned_cols=62 Identities=19% Similarity=0.229 Sum_probs=44.0
Q ss_pred Cccccc-chHHHHHHhc--c-ccchHHH-----HHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC
Q 024572 1 MQLGVS-SLSEFVMLEG--S-VKMKPDI-----FFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--~-~~~i~~~-----l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 64 (265)
||+..+ .+.+...... . .+.|+.. +..+-..|++|.|.+|-||+++.++. +.+.|||+....
T Consensus 245 mE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~--i~~lDfGi~g~l 315 (517)
T COG0661 245 MEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGR--IVLLDFGIVGRL 315 (517)
T ss_pred EEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCccccCCCccceEEecCCc--EEEEcCcceecC
Confidence 677777 6777743332 2 1233332 34455799999999999999998865 999999987644
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.0078 Score=48.11 Aligned_cols=33 Identities=18% Similarity=0.352 Sum_probs=26.5
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
...++|+|++|.||+++.+....+.|+||+.+.
T Consensus 173 ~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 173 RPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred CcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 578999999999999987422237899999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.0054 Score=56.19 Aligned_cols=145 Identities=21% Similarity=0.189 Sum_probs=95.1
Q ss_pred ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhH
Q 024572 18 VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 97 (265)
Q Consensus 18 ~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 97 (265)
++.-+..+.++|+-.=+|+| ||+..+.. .+..+|+............+..+++.++|||+.....+... .|.
T Consensus 342 ~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~-p~~ 413 (829)
T KOG0576|consen 342 LRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGC-PDS 413 (829)
T ss_pred hhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccccCCCCCCCCCchhhcccccccC-CCc
Confidence 44456678899988778998 88876543 79999998876555445667789999999999988888766 799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc--ccCCCCCCCCHHHH-HHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 98 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHISQDCR-NLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 98 wslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
|++|.--.++.-|-+|-..... . ...+.... .........+.... ++...|+..-|..|+..-.++-|.+|
T Consensus 414 ~~~~~~~~~~ap~~pPr~~P~~--~----~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvf 487 (829)
T KOG0576|consen 414 GSLAVSAIQMAPGLPPRSSPPA--V----LPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVF 487 (829)
T ss_pred cCCCcchhhcCCCCCCCCCCcc--c----cCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHh
Confidence 9999877777666665433100 0 00000000 00000000111112 46778888899999999999888888
Q ss_pred CC
Q 024572 175 LK 176 (265)
Q Consensus 175 ~~ 176 (265)
..
T Consensus 488 ng 489 (829)
T KOG0576|consen 488 NG 489 (829)
T ss_pred cc
Confidence 64
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.01 Score=50.74 Aligned_cols=31 Identities=26% Similarity=0.426 Sum_probs=25.2
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..|+||+|++|.||+++.+.. .-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~--~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRL--SGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCce--EEEEeccccc
Confidence 458999999999999985542 4799999764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.02 Score=48.76 Aligned_cols=31 Identities=29% Similarity=0.497 Sum_probs=26.2
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..+++|+|+++.||+++.++. +.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 478999999999999987653 6899999654
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.015 Score=47.38 Aligned_cols=31 Identities=26% Similarity=0.303 Sum_probs=24.8
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..+++|+|+.+.||+++.... .-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i--~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRL--SAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCE--EEEEeCcccC
Confidence 456999999999999986532 4699999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.043 Score=43.55 Aligned_cols=54 Identities=22% Similarity=0.317 Sum_probs=39.1
Q ss_pred cchHHHHHHhccccchHH----HHHhhhhcCceecCCCcCcEEEcCCCCC--cEEEec-cC
Q 024572 6 SSLSEFVMLEGSVKMKPD----IFFSSLSQQICHRDLKLENTLLDGSPAP--RLKICD-FG 59 (265)
Q Consensus 6 ~sL~~~~~~~~~~~~i~~----~l~~lH~~~ivH~dlkp~NIll~~~~~~--~vkl~D-fg 59 (265)
.+|.+++........+.. ...||-..+|+.+||+|.||++.....+ .+.|+| ||
T Consensus 108 ~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G 168 (199)
T PF10707_consen 108 PTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLG 168 (199)
T ss_pred ccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCC
Confidence 488999976555443333 3568999999999999999999654433 477777 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.029 Score=47.26 Aligned_cols=30 Identities=30% Similarity=0.485 Sum_probs=25.1
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
.+++|+|+.|.||+++.++. +.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 57999999999999987543 5799998654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.054 Score=49.36 Aligned_cols=64 Identities=13% Similarity=0.108 Sum_probs=43.0
Q ss_pred Cccccc-chH--HHHHHhccccc-----hHHH-HHhhhhcCceecCCCcCcEEEcCC--CCCcEEEeccCCcccC
Q 024572 1 MQLGVS-SLS--EFVMLEGSVKM-----KPDI-FFSSLSQQICHRDLKLENTLLDGS--PAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~-sL~--~~~~~~~~~~~-----i~~~-l~~lH~~~ivH~dlkp~NIll~~~--~~~~vkl~Dfg~a~~~ 64 (265)
||++.+ .+. +.+..+++-.. +..+ ..-+-..|++|+|-+|-||++..+ +...+.+.|||+....
T Consensus 281 ME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 281 MEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred EEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 888888 333 44555554222 2222 223557899999999999999853 3456999999987643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.016 Score=46.51 Aligned_cols=31 Identities=32% Similarity=0.453 Sum_probs=20.5
Q ss_pred hcCceecCCCcCcEEEc-CCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLD-GSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~-~~~~~~vkl~Dfg~a~ 62 (265)
...++|+|+.|.||+++ .++ ++.|+||+.+.
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~--~i~iID~e~a~ 196 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDG--RIGIIDFEDAG 196 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTT--EEEE--GTT-E
T ss_pred CcEEEEeccccccceeeeccc--eeEEEecccce
Confidence 57799999999999998 333 36799998653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.027 Score=47.72 Aligned_cols=31 Identities=35% Similarity=0.578 Sum_probs=25.7
Q ss_pred hcCceecCCCcCcEEEcCC----CCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGS----PAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~----~~~~vkl~Dfg~a~ 62 (265)
..+++|+|+.|.||+++.+ +. ++++||..|.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~--i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKK--LVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCc--EEEEeeCCCC
Confidence 3578999999999999864 43 9999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.029 Score=45.59 Aligned_cols=31 Identities=26% Similarity=0.513 Sum_probs=25.6
Q ss_pred hcCceecCCCcCcEEEcC-CCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~ 62 (265)
..+++|+|+.+.|||++. ++ .+.|+||..|.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~--~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKN--SVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCC--CEEEEEcccCC
Confidence 357999999999999986 34 39999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.04 Score=43.23 Aligned_cols=28 Identities=25% Similarity=0.392 Sum_probs=24.1
Q ss_pred CceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 32 ~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
-.+|+|+.|.||++.+++ ++|+||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~---~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG---LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC---EEEEeCCccc
Confidence 469999999999997654 8999999775
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.046 Score=43.28 Aligned_cols=34 Identities=21% Similarity=0.232 Sum_probs=26.5
Q ss_pred hhcCceecCCCcCcEEEcCCCCC---cEEEeccCCcc
Q 024572 29 LSQQICHRDLKLENTLLDGSPAP---RLKICDFGYSK 62 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~~~~~---~vkl~Dfg~a~ 62 (265)
+...++|||+.+.||++..++.+ .+.++||..++
T Consensus 118 ~~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 118 EFNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred CceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 35679999999999999754322 48999998764
|
subfamily of choline kinases |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.046 Score=44.67 Aligned_cols=31 Identities=23% Similarity=0.245 Sum_probs=25.5
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
...++|+|+.|.|||++.... +.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~--~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKF--SGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcE--EEEEEccccc
Confidence 456999999999999987543 6899998653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.84 E-value=0.051 Score=46.11 Aligned_cols=30 Identities=30% Similarity=0.620 Sum_probs=24.9
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..+++|||+.+.||+++. +. +.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 468999999999999986 33 8999998553
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=93.81 E-value=0.035 Score=47.30 Aligned_cols=40 Identities=13% Similarity=0.175 Sum_probs=32.5
Q ss_pred hHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 21 KPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 21 i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+...+--|-.+|+||+|..--||+++.+.. ++++||--+.
T Consensus 211 lm~~Iv~la~~GlIHgDFNEFNimv~dd~~--i~vIDFPQmv 250 (465)
T KOG2268|consen 211 LMGLIVRLANHGLIHGDFNEFNIMVKDDDK--IVVIDFPQMV 250 (465)
T ss_pred HHHHHHHHHHcCceecccchheeEEecCCC--EEEeechHhh
Confidence 344555688999999999999999987665 9999997543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.73 E-value=0.055 Score=44.66 Aligned_cols=29 Identities=24% Similarity=0.347 Sum_probs=24.8
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++|+|+.|.||+++.++ +.|+||..+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC---CEEEeccccC
Confidence 3689999999999998755 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=93.30 E-value=0.068 Score=43.39 Aligned_cols=29 Identities=21% Similarity=0.263 Sum_probs=24.3
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++|+|+.|.||+++..+ +.++||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~---~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG---TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC---cEEEechhcC
Confidence 4578999999999997654 7899999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.21 E-value=0.11 Score=43.30 Aligned_cols=29 Identities=34% Similarity=0.546 Sum_probs=25.2
Q ss_pred CceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 32 ~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
-++|+|+.|.|++.++.+. ++|+||..|.
T Consensus 154 v~cH~Dl~~~N~l~t~~~~--l~LIDWEyAg 182 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGG--LFLIDWEYAG 182 (269)
T ss_pred eeecCCCCccceEEcCCCc--EEEEecccCC
Confidence 6999999999999987554 9999998664
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.19 E-value=0.069 Score=42.69 Aligned_cols=30 Identities=33% Similarity=0.639 Sum_probs=19.3
Q ss_pred cCceecCCCcCcEEE-cCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLL-DGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll-~~~~~~~vkl~Dfg~a~ 62 (265)
..++|+||.|.||++ +.++. ++|+||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~--~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGE--VKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSC--EEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCe--EEEecHHHHh
Confidence 579999999999999 44444 9999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.91 E-value=0.069 Score=45.75 Aligned_cols=34 Identities=32% Similarity=0.415 Sum_probs=24.9
Q ss_pred hcCceecCCCcCcEEEcCCCC----------------CcEEEeccCCccc
Q 024572 30 SQQICHRDLKLENTLLDGSPA----------------PRLKICDFGYSKS 63 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~----------------~~vkl~Dfg~a~~ 63 (265)
-...+|-||||+|||+-++.. .+++|.||.+++.
T Consensus 297 c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 297 CTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred cceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 457999999999999954332 1356778887763
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.87 E-value=0.089 Score=44.91 Aligned_cols=20 Identities=35% Similarity=0.411 Sum_probs=16.4
Q ss_pred hcCceecCCCcCcEEEcCCC
Q 024572 30 SQQICHRDLKLENTLLDGSP 49 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~ 49 (265)
-...+|-||||+|||+-++.
T Consensus 301 c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 301 CDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred cceeeeccCCCCcEEEecCC
Confidence 45799999999999995443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.83 E-value=0.097 Score=44.99 Aligned_cols=34 Identities=26% Similarity=0.299 Sum_probs=26.6
Q ss_pred hhhcC--ceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 28 SLSQQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 28 lH~~~--ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+.+.+ +||+|+.|.||+++.... -+.++||+-|.
T Consensus 192 lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 192 LPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred CCcccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 34445 999999999999987653 27899999654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.82 E-value=0.095 Score=51.98 Aligned_cols=33 Identities=30% Similarity=0.476 Sum_probs=26.5
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEE-EeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLK-ICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vk-l~Dfg~a~ 62 (265)
.+++||+|+.+.|||++.+...++. |+|||-+.
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4679999999999999876522355 99999765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.82 E-value=0.091 Score=45.54 Aligned_cols=33 Identities=27% Similarity=0.598 Sum_probs=26.3
Q ss_pred hhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 29 LSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+...++|+|+++.||+++... ..+.++||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 345799999999999997532 249999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.50 E-value=0.076 Score=45.22 Aligned_cols=30 Identities=20% Similarity=0.268 Sum_probs=25.8
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
.+++|+|+.++|||+++++. +.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 47999999999999987765 8999998664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.50 E-value=0.094 Score=43.97 Aligned_cols=32 Identities=22% Similarity=0.313 Sum_probs=25.0
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
...++|+|++|.||+++.++. ..-|+||+.+.
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 456999999999999986432 24699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.36 E-value=0.21 Score=42.71 Aligned_cols=32 Identities=16% Similarity=0.289 Sum_probs=27.4
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
...++|+|+++.||+++.... +-+.||+.+..
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~l 228 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRP--TGVLDWELATL 228 (321)
T ss_pred CceeeeCCcccCCEEEeCCCe--eEEEecccccc
Confidence 456899999999999987765 88999998763
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.00 E-value=0.15 Score=43.80 Aligned_cols=29 Identities=17% Similarity=0.148 Sum_probs=23.9
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++||+|+.+.|||++ + . +.|+||+-+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~--~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-G--PHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-C--cEEEeCCCCC
Confidence 46799999999999995 3 2 7899999654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=90.87 E-value=0.21 Score=44.09 Aligned_cols=31 Identities=16% Similarity=0.259 Sum_probs=26.1
Q ss_pred hhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 29 LSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+...++|||+.+.||++..+. ++++||-++.
T Consensus 221 ~~~~l~HgDl~~gni~~~~~~---~~viD~E~a~ 251 (401)
T PRK09550 221 KAEALLHGDLHTGSIFVTEEE---TKVIDPEFAF 251 (401)
T ss_pred CCCceeeccCCcccEEeeCCC---cEEEeccccc
Confidence 467799999999999997653 8999998664
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=90.74 E-value=0.17 Score=42.56 Aligned_cols=32 Identities=22% Similarity=0.427 Sum_probs=25.2
Q ss_pred cCceecCCCcCcEEEcCCCCC---cEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAP---RLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~---~vkl~Dfg~a~ 62 (265)
+-|+|||+++.|||+..++.+ .+++.||-.++
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 449999999999999665432 58999997654
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=90.29 E-value=0.22 Score=43.88 Aligned_cols=31 Identities=19% Similarity=0.302 Sum_probs=26.4
Q ss_pred hhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 29 LSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+...++||||+|.||+++.++ +|++|..++.
T Consensus 225 ~~~aLlHGDlHtGSI~v~~~~---~kvIDpEFAf 255 (409)
T PRK12396 225 NAQALIHGDLHTGSVFVKNDS---TKVIDPEFAF 255 (409)
T ss_pred cchhhccCcCCCCCEEecCCc---eEEEcccccc
Confidence 467799999999999998765 7999987764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.05 E-value=0.31 Score=39.41 Aligned_cols=34 Identities=24% Similarity=0.194 Sum_probs=28.5
Q ss_pred HHhhh--hcCceecCCCcCcEEEcCCCCCcEEEeccCC
Q 024572 25 FFSSL--SQQICHRDLKLENTLLDGSPAPRLKICDFGY 60 (265)
Q Consensus 25 l~~lH--~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~ 60 (265)
|.-.| +.+.+|||..|+||+-|+.|. +||.|-+.
T Consensus 154 L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~ 189 (308)
T PF07387_consen 154 LMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVC 189 (308)
T ss_pred HHHhhccCCCeecCCCChhheeecCCCC--EEecChhh
Confidence 44456 577999999999999998887 99999774
|
The function of this family is unknown. |
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.01 E-value=0.23 Score=49.20 Aligned_cols=33 Identities=24% Similarity=0.241 Sum_probs=25.9
Q ss_pred hcCceecCCCcCcEEEcCCCCCc---EEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPR---LKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~---vkl~Dfg~a~ 62 (265)
..|+||+|+++.||+++.+..+. .-|+|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 68899999999999998653221 3799999764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=89.98 E-value=0.23 Score=43.11 Aligned_cols=31 Identities=16% Similarity=0.253 Sum_probs=26.2
Q ss_pred hhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 29 LSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+...++|||+.+.||++...+ ++++|+.++.
T Consensus 190 ~~~~llHGDl~~gNi~~~~~~---~~~iD~e~~~ 220 (370)
T TIGR01767 190 SAETLLHGDLHSGSIFVSEHE---TKVIDPEFAF 220 (370)
T ss_pred CcceeeeccCCcccEEEcCCC---CEEEcCcccc
Confidence 577899999999999997654 7899998664
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=89.57 E-value=0.32 Score=38.25 Aligned_cols=51 Identities=10% Similarity=-0.042 Sum_probs=39.3
Q ss_pred HHHHHhccccchHHHHHhhhh---cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 10 EFVMLEGSVKMKPDIFFSSLS---QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 10 ~~~~~~~~~~~i~~~l~~lH~---~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
.+..+..++.++++.+.+++. ..+.-.|++|+|+-+++++. +|++|...+.
T Consensus 57 ~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 57 PWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 445555566677777777775 55888999999999997765 9999998654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=89.26 E-value=0.34 Score=41.72 Aligned_cols=30 Identities=30% Similarity=0.476 Sum_probs=24.2
Q ss_pred CceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 32 ~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
-++|.|+.+.|||++.++ +.++++||..|.
T Consensus 183 v~CHnDl~~~NiL~~~~~-~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDE-GKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCC-CcEEEEcccccC
Confidence 379999999999997442 249999998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.18 E-value=0.25 Score=42.92 Aligned_cols=31 Identities=32% Similarity=0.528 Sum_probs=26.4
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
.-..-|||+...||||+ +|. |.|+||-+++.
T Consensus 340 kf~fehrnlt~~niLId-~Gn--vtLIDfklsRl 370 (488)
T COG5072 340 KFPFEHRNLTLDNILID-EGN--VTLIDFKLSRL 370 (488)
T ss_pred cCCcccccccccceeee-cCc--eEEEEeeeeec
Confidence 34588999999999998 555 99999999873
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=86.11 E-value=0.65 Score=45.22 Aligned_cols=33 Identities=21% Similarity=0.382 Sum_probs=25.4
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
..+||+|+++.||+++......+-|.||.++..
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 469999999999999753322257999998763
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=84.02 E-value=1.3 Score=34.63 Aligned_cols=59 Identities=17% Similarity=0.158 Sum_probs=40.6
Q ss_pred Cccccc-chHHHHHH--hccccchHHHHHhhhhcCceecCCC-c-CcEEEcCCCCCcEEEeccCCcc
Q 024572 1 MQLGVS-SLSEFVML--EGSVKMKPDIFFSSLSQQICHRDLK-L-ENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~~-sL~~~~~~--~~~~~~i~~~l~~lH~~~ivH~dlk-p-~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
||+..+ +|.+.... +..+.-+++.-+-|-..||-|+.|+ | .||++..+ . +.|+||..|+
T Consensus 91 me~i~G~~L~~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-~--~~iIDFd~At 154 (201)
T COG2112 91 MEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-D--VYIIDFDSAT 154 (201)
T ss_pred hhhhcCcchhhhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC-c--EEEEEccchh
Confidence 777777 77776663 3333344455555889999999997 3 45666433 3 8999999775
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=81.69 E-value=1.1 Score=39.70 Aligned_cols=30 Identities=17% Similarity=0.331 Sum_probs=0.0
Q ss_pred hhcCceecCCCcCcEEEcCCCCCcEEEeccCCc
Q 024572 29 LSQQICHRDLKLENTLLDGSPAPRLKICDFGYS 61 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a 61 (265)
+...++||||.|.||++..++ .+++|..++
T Consensus 228 ~~~~L~HGDl~~g~i~~~~~~---~~~id~ef~ 257 (418)
T PLN02756 228 RAQALVHGDLHTGSVMVTPDS---TQVIDPEFA 257 (418)
T ss_pred cccceeecCCCCCcEEEcCCC---ceEecchhh
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 265 | ||||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-80 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-80 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-79 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-78 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-75 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-74 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-30 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-26 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-26 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-26 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-26 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-26 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-26 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-26 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-26 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-26 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-25 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-24 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-24 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-24 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-24 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-23 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-22 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-22 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-22 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-22 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-22 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-21 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-21 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-21 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-21 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-21 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-21 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-21 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-21 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-21 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-21 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-21 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-21 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-21 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-21 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-21 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-21 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-21 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-21 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-21 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-21 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-21 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-21 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-21 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-21 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-20 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-20 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-20 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-19 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-19 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-19 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-18 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-18 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-18 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-18 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-18 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-18 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-18 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-18 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-18 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-18 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-18 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-18 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-18 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-18 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-18 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-17 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-16 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-16 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-16 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-16 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-16 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-16 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-14 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-14 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-04 |
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 265 | |||
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-108 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-79 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-74 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-59 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-59 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 6e-59 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-58 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-58 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-57 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-57 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-57 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-57 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-56 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-56 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-56 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-56 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-55 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-55 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 4e-52 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-46 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-45 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-44 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-43 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-43 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-43 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-43 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-42 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 8e-42 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-41 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-41 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-41 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-40 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-40 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-40 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-40 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-40 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-40 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-40 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-40 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-40 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-40 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-39 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-39 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-39 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-39 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-39 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-39 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-39 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-39 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-39 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-39 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-39 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 9e-39 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-38 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-38 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-38 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-38 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-38 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-38 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-38 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-37 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-37 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-37 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-37 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-37 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-36 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-36 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-36 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-35 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-35 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-35 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-35 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-34 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-34 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-34 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 5e-34 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-34 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 7e-34 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-33 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-33 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-33 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-33 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 4e-33 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-33 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 7e-33 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 9e-33 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-32 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-32 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-32 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-32 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-32 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-31 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-30 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-30 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-28 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-27 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-26 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-26 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-25 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-25 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 4e-23 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-23 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 6e-21 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 7e-21 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 7e-21 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-21 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-20 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-20 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-20 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-20 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-20 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 7e-20 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-19 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-19 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-19 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 9e-19 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-18 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-18 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-18 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 8e-18 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-17 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-17 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-17 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-17 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-16 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-16 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-16 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 5e-16 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-16 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 8e-16 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 9e-16 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-15 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-15 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-15 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-15 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 6e-15 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 6e-15 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 6e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 7e-15 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 7e-15 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-15 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 9e-15 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-14 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-14 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-14 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-14 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-14 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 4e-14 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 4e-14 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 8e-14 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-13 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-13 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-13 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-13 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-13 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-13 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-13 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-13 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-13 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-13 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-12 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-12 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-10 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-10 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-10 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-09 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-09 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-09 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-08 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-08 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-07 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-07 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-06 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-06 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-06 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-06 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-06 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-06 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 5e-06 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 5e-06 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-06 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-06 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 6e-06 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-06 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-05 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-05 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-05 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-05 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-05 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-05 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-05 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-05 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-05 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-05 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 8e-05 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 8e-05 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 9e-05 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 9e-05 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-04 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-04 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-04 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-04 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-04 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-04 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-04 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-04 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-04 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-04 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-04 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-04 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-04 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-04 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-04 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 9e-04 |
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-108
Identities = 134/218 (61%), Positives = 168/218 (77%), Gaps = 1/218 (0%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R+E
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDGK+ADVWSCGVTLYVMLVGAYPFED E+P+++RKTI RI++V+Y IPD + IS +C +
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKI 209
L+SRIFVA+P+ RI+I EIK+H WFLKNLP +L + +E P +QS++ I +I
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE-PEQPMQSLDTIMQI 312
Query: 210 VEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEED 247
+ EA +P +R + F + D+ ++ E D
Sbjct: 313 ISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEID 350
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 9e-79
Identities = 65/211 (30%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLS 86
I HRD+K EN LLD LKI DFG + ++R GT Y+APE+L
Sbjct: 123 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIPDYVHISQ 145
RRE+ + DVWSCG+ L ML G P++ D + + + + + + I
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDS 236
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF---SLQS 202
LL +I V NPS RITI +IK W+ K L + E+P+ +QS
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQS 296
Query: 203 VEEITKIVEEAKVPPPVSRSIGGFGWGGEED 233
+ + + ++ P G GW E
Sbjct: 297 NLDFSPVNSASRTP--------GSGWSKEHH 319
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 1e-74
Identities = 56/157 (35%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLS 86
I HRD+K EN LLD LKI DFG + ++R GT Y+APE+L
Sbjct: 123 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIPDYVHISQ 145
RRE+ + DVWSCG+ L ML G P++ D + + + + + + I
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDS 236
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
LL +I V NPS RITI +IK W+ K L +
Sbjct: 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-59
Identities = 60/154 (38%), Positives = 84/154 (54%), Gaps = 17/154 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS-----KSSLLHSRPKSTVGTPAYIAPEV 84
Q+I HRD+K N L+ +KI DFG S +LL + TVGTPA++APE
Sbjct: 155 YQKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGSDALLSN----TVGTPAFMAPES 208
Query: 85 LS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142
LS R+ + GK DVW+ GVTLY + G PF D+ K I + + PD
Sbjct: 209 LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK----IKSQALEFPDQPD 264
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
I++D ++L++R+ NP RI + EIK HPW +
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 6e-59
Identities = 61/157 (38%), Positives = 84/157 (53%), Gaps = 16/157 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVL 85
+ HRDLK EN LLD KI DFG S L + + G+P Y APEV+
Sbjct: 129 RHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRT----SCGSPNYAAPEVI 182
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
S R Y G D+WSCGV LY +L G PF+D+ P F+K I + IP+ ++++
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPE--YLNR 236
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
LL + +P +R TIK+I+ H WF ++LP L
Sbjct: 237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-58
Identities = 68/157 (43%), Positives = 94/157 (59%), Gaps = 16/157 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVL 85
+I HRDLK EN LLD + +KI DFG S + L + + G+P Y APEV+
Sbjct: 126 RHKIVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKT----SCGSPNYAAPEVI 179
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
+ + Y G DVWSCG+ LYVMLVG PF+D+ P F+K + + Y +PD +S
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPD--FLSP 233
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
++L+ R+ VA+P +RITI+EI+ PWF NLP L
Sbjct: 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL 270
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 7e-58
Identities = 49/161 (30%), Positives = 69/161 (42%), Gaps = 20/161 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSLLHSRPKSTVGTPAYIAP 82
SQ I H+D+K N LL LKI G + + + G+PA+ P
Sbjct: 127 SQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALHPFAADDTCRT----SQGSPAFQPP 180
Query: 83 EVLS-RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 141
E+ + + G D+WS GVTLY + G YPFE N K I Y IP
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSYAIPGD- 235
Query: 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
+LL + P++R +I++I+ H WF K P
Sbjct: 236 -CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-57
Identities = 56/155 (36%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
++I HRDLK EN LLD +KI DFG+S + + + G P Y APE+ ++
Sbjct: 132 QKRIVHRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
YDG DVWS GV LY ++ G+ PF+ Q + + ++ +Y+IP Y+ S DC N
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFYM--STDCEN 243
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE 184
LL R V NP +R T+++I W + +
Sbjct: 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-57
Identities = 45/158 (28%), Positives = 83/158 (52%), Gaps = 10/158 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRR 88
S I HRDL L N LL + +KI DFG + + T+ GTP YI+PE+ +R
Sbjct: 130 SHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+ + +DVWS G Y +L+G PF+ + T+++++ Y++P +S + +
Sbjct: 188 AHGLE-SDVWSLGCMFYTLLIGRPPFDT----DTVKNTLNKVVLADYEMPS--FLSIEAK 240
Query: 149 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 186
+L+ ++ NP+ R+++ + HP+ +N + +
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-57
Identities = 57/154 (37%), Positives = 85/154 (55%), Gaps = 10/154 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S+++ HRD+K EN LL + LKI DFG+S + SR GT Y+ PE++ R
Sbjct: 127 SKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRM 183
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
+D K D+WS GV Y LVG PFE +++T RI V++ PD +++ R+
Sbjct: 184 HDEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARD 236
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 183
L+SR+ NPS+R ++E+ HPW N +
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-57
Identities = 50/160 (31%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+++ HRD+K EN L+ LKI DFG+S + R ++ GT Y+ PE++ +
Sbjct: 132 ERKVIHRDIKPENLLMGYKG--ELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKT 188
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
+D K D+W GV Y LVG PF+ + R+ I+ V K P ++ S ++
Sbjct: 189 HDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLKFPPFL--SDGSKD 241
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAI 189
L+S++ +P +R+ +K + HPW N R L Q+
Sbjct: 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-56
Identities = 55/159 (34%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRR 88
++ HRDLKL N L+ +KI DFG + K + GTP YIAPEVLS++
Sbjct: 133 RNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+ + DVWS G +Y +LVG PFE ++T RI +Y IP HI+
Sbjct: 191 GHSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAA 243
Query: 149 NLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTETA 186
+L+ ++ +P+ R TI E+ + +F +P L T
Sbjct: 244 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 282
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-56
Identities = 52/159 (32%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAPEVLS 86
+ + HRD+K EN L+D + LK+ DFG K ++ GT Y PE +
Sbjct: 167 NCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWIR 221
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
Y G+ A VWS G+ LY M+ G PFE E I+ Q +S +
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ--RVSSE 269
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLK-NLPRELTE 184
C++L+ PS R T +EI++HPW LP+E E
Sbjct: 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-56
Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 30/184 (16%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRRE 89
ICHRD+K N L+D + R+K+ DFG S+ + + GT ++ PE S
Sbjct: 173 ICHRDVKPSNILMDKNG--RVKLSDFGESEYMVDKKIKG----SRGTYEFMPPEFFSNES 226
Query: 90 -YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV------- 141
Y+G D+WS G+ LYVM PF + + + + I + P
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SLVELFNNIRTKNIEYPLDRNHFLYPL 283
Query: 142 ----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYY 191
+S + + L NP+ RIT ++ H W +L E ++ +Y
Sbjct: 284 TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
Query: 192 RKEN 195
+++
Sbjct: 344 KRKK 347
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-56
Identities = 59/157 (37%), Positives = 81/157 (51%), Gaps = 16/157 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVL 85
+ HRDLK EN LLD KI DFG S L + + G+P Y APEV+
Sbjct: 134 RHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRT----SCGSPNYAAPEVI 187
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
S R Y G D+WS GV LY +L G PF+D P F+K I + P +++
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQ--YLNP 241
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
+LL + +P +R TIK+I+ H WF ++LP+ L
Sbjct: 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYL 278
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-55
Identities = 48/153 (31%), Positives = 65/153 (42%), Gaps = 20/153 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAPEVLS 86
S+ + HRD+K EN L+D K+ DFG GT Y PE +S
Sbjct: 157 SRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYTD----FDGTRVYSPPEWIS 211
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R +Y A VWS G+ LY M+ G PFE + I+ + P H+S D
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EILEAELHFPA--HVSPD 259
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
C L+ R PS R +++EI PW
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-55
Identities = 55/159 (34%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRR 88
++ HRDLKL N L+ +KI DFG + K + GTP YIAPEVLS++
Sbjct: 159 RNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+ + DVWS G +Y +LVG PFE ++T RI +Y IP HI+
Sbjct: 217 GHSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAA 269
Query: 149 NLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTETA 186
+L+ ++ +P+ R TI E+ + +F +P L T
Sbjct: 270 SLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 308
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-52
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVL 85
+ I HRD+K EN ++ +K+ DFG + + L ++ GT Y APEVL
Sbjct: 148 LKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERGKLFYT----FCGTIEYCAPEVL 201
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
Y G ++WS GVTLY ++ PF + + + P V S+
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCE----------LEETVEAAIHPPYLV--SK 249
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
+ +L+S + P RR T++++ + PW + +
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEV 84
+Q ICHRD+K EN L + + +K+ DFG SK ++ + + GTP ++APEV
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
Query: 85 LSRREYD-GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYV 141
L+ G D WS GV L+++L+GA PF D + ++ + P+Y
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYN 301
Query: 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
+S R+LLS + N R HPW +
Sbjct: 302 VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-45
Identities = 41/161 (25%), Positives = 64/161 (39%), Gaps = 19/161 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLS 86
I H DLK N L+ LK+ DFG + + S VGT Y+ PE +
Sbjct: 145 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 87 RREYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136
+DVWS G LY M G PF+ + + I+ ++
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHE 258
Query: 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
I +D +++L +P +RI+I E+ +HP+
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-44
Identities = 41/163 (25%), Positives = 65/163 (39%), Gaps = 19/163 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLS 86
I H DLK N L+ LK+ DFG + + S VGT Y+ PE +
Sbjct: 126 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 87 RREYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136
+DVWS G LY M G PF+ + + + I+ ++
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHE 239
Query: 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
I +D +++L +P +RI+I E+ +HP+
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-43
Identities = 45/198 (22%), Positives = 77/198 (38%), Gaps = 20/198 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLS 86
I H DLK N L+ LK+ DFG + + S VG Y+ PE +
Sbjct: 173 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 87 RREYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136
+DVWS G LY M G PF+ + + + I+ ++
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHE 286
Query: 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP 196
I +D +++L +P +RI+I E+ +HP+ + + + A+ +
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV-QIQTHPVNQMAKGTTEEMKYV 345
Query: 197 TFSLQSVEEITKIVEEAK 214
L + I++ AK
Sbjct: 346 LGQLVGLNSPNSILKAAK 363
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-43
Identities = 52/153 (33%), Positives = 74/153 (48%), Gaps = 9/153 (5%)
Query: 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
+ HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+VL
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EG 182
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQD 146
Y G D WS GV +YV+L G PF D + K I + D++++S
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQ 237
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
+L+ R+ +P +RIT + H WF K L
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-43
Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
SQ + H+DLK EN L SP +KI DFG ++ + GT Y+APEV +R
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KR 200
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDC 147
+ D+WS GV +Y +L G PF + +K + + ++
Sbjct: 201 DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQA 255
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWF 174
+LL ++ +P RR + ++ H WF
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-43
Identities = 34/183 (18%), Positives = 66/183 (36%), Gaps = 32/183 (17%)
Query: 30 SQQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
I HR++K N + + K+ DFG ++ + S GT Y+ P++ R
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 88 REYD-------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY----- 135
G D+WS GVT Y G+ PF E P+ ++ + +I+ +
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 136 --------------KIPDYVHISQDCRN----LLSRIFVANPSRRITIKEIKSHPWFLKN 177
+P +S+ + +L+ I A+ + + + + +
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
Query: 178 LPR 180
Sbjct: 310 RGN 312
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 48/155 (30%), Positives = 71/155 (45%), Gaps = 4/155 (2%)
Query: 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
I HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEVL
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV 316
Query: 89 EYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
+ D WS GV L++ L G PF + + + I+ + + +S+
Sbjct: 317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GKYNFIPEVWAEVSEK 375
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
+L+ ++ V +P R T +E HPW +
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 8e-42
Identities = 24/163 (14%), Positives = 45/163 (27%), Gaps = 26/163 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ H L+ + +LD + + F + + + + PE+ +RR
Sbjct: 224 HYGLVHTYLRPVDIVLDQRG--GVFLTGFEHLVR---DGARVVSSVSRGFEPPELEARRA 278
Query: 90 ----------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 139
D W+ G+ +Y + P
Sbjct: 279 TISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCK-------- 330
Query: 140 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
+I Q R LL R+ + P + + L EL
Sbjct: 331 --NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTEL 370
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
S I HR+LK EN LL + +K+ DFG + GTP Y++PEVL +
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQD 146
Y K D+W+CGV LY++LVG PF D++ + + + I A Y P++ ++ +
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPE 237
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180
++L+ + NP +RIT + PW
Sbjct: 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-41
Identities = 54/160 (33%), Positives = 83/160 (51%), Gaps = 13/160 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
I HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE++
Sbjct: 142 KLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM 199
Query: 90 YD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVH 142
D GK D+WS GV +Y +L G+ PF ++ R IM+ Y+ P++
Sbjct: 200 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFGSPEWDD 255
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
S ++L+SR V P +R T +E +HP+F + + E+
Sbjct: 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-41
Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 10/151 (6%)
Query: 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
I HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEVL
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV 191
Query: 89 EYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQYKIPDYV--HI 143
+ D WS GV L++ L G PF + + + I + +Y V +
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYNFIPEVWAEV 247
Query: 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
S+ +L+ ++ V +P R T +E HPW
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWL 278
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 54/151 (35%), Positives = 78/151 (51%), Gaps = 9/151 (5%)
Query: 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
I HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL R
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RG 197
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQD 146
Y + DVWS GV LY++L G PF + + ++ + + +P + IS D
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDD 252
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
++L+ ++ +PS RIT + HPW K
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 51/152 (33%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 87
S I HRD+K EN L LK+ DFG++K ++ TP Y+APEVL
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGP 203
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQ 145
+YD K D+WS GV +Y++L G PF RI QY P++ +S+
Sbjct: 204 EKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
D + L+ + +P+ R+TI + +HPW ++
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-40
Identities = 43/155 (27%), Positives = 79/155 (50%), Gaps = 8/155 (5%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSR 87
+ HRDLK EN L D + +KI DFG+++ ++P T T Y APE+L++
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPF---EDQEDPKNFRKTISRIMAVQY--KIPDYVH 142
YD + D+WS GV LY ML G PF + + + + +I + + + +
Sbjct: 184 NGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
+SQ+ ++L+ + +P++R+ + ++ + W
Sbjct: 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-40
Identities = 56/155 (36%), Positives = 80/155 (51%), Gaps = 9/155 (5%)
Query: 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
I HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL R
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RG 197
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQD 146
Y + DVWS GV LY++L G PF + + ++ + +Y +P + IS D
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDD 252
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
++L+ ++ +PS RIT + HPW K E
Sbjct: 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-40
Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 25/162 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SLLHSRPKSTV 74
SQ I HRDLK N +D S +KI DFG +K+ S +
Sbjct: 134 SQGIIHRDLKPMNIFIDESR--NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 75 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 134
GT Y+A EVL + + D++S G+ + M+ E +K + +V
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK----LRSVS 245
Query: 135 YKIPDYV--HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ P + + + ++ + +P++R + + + W
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-40
Identities = 50/149 (33%), Positives = 79/149 (53%), Gaps = 9/149 (6%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
S++I H DLK EN +L P PR+K+ DFG + + K+ GTP ++APE+++
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 185
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQ 145
G AD+WS GV Y++L GA PF + + I AV Y + + + S+
Sbjct: 186 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNTSE 240
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++ + R+ V +P RR+TI + H W
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-40
Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
I HRD+K EN LL + + +KI DFG S + + +GT YIAPEVL ++
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL-KK 222
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQD 146
+Y + DVWSCGV +Y++L G PF Q D +K + + D+ +IS +
Sbjct: 223 KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK----VEKGKYYFDFNDWKNISDE 277
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
+ L+ + + ++R T +E + W K
Sbjct: 278 AKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-40
Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 9/149 (6%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
+++I H DLK EN +L P P +K+ DFG + K+ GTP ++APE+++
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQ 145
G AD+WS GV Y++L GA PF + I +V Y + + H S+
Sbjct: 193 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITSVSYDFDEEFFSHTSE 247
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++ + ++ V +R+TI+E HPW
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWI 276
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-40
Identities = 53/151 (35%), Positives = 82/151 (54%), Gaps = 4/151 (2%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
S I HRD+K EN L P LK+ DFG++K + H+ + TP Y+APEVL
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 238
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQD 146
+YD K D+WS GV +Y++L G PF +RI QY P++ +S++
Sbjct: 239 KYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 297
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
+ L+ + P++R+TI E +HPW +++
Sbjct: 298 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-40
Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 9/156 (5%)
Query: 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
+I HRDLK EN LL+ S ++I DFG S + K +GT YIAPEVL
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HG 202
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQD 146
Y + DVWS GV LY++L G PF + +K + +++P + +S+
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKK----VEKGKYTFELPQWKKVSES 257
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
++L+ ++ PS RI+ ++ H W ++
Sbjct: 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 8/148 (5%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
I H DLK +N LL P +KI DFG S+ + +GTP Y+APE+L+
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 146
D+W+ G+ Y++L PF +++ + + I V + + +SQ
Sbjct: 209 PI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVSQL 263
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ + + V NP +R T + SH W
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWL 291
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 51/149 (34%), Positives = 78/149 (52%), Gaps = 9/149 (6%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
S QI H DLK EN +L P PR+KI DFG + + K+ GTP ++APE+++
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQ 145
G AD+WS GV Y++L GA PF + + AV Y + + + S
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNTSA 246
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++ + R+ V +P +R+TI++ HPW
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-39
Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 18/154 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAPEVLS 86
+ I HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L+
Sbjct: 148 GKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
+ K +D+W+ G +Y ++ G PF + F+K I+ ++Y P+
Sbjct: 206 EKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPK 258
Query: 147 CRNLLSRIFVANPSRRITIK------EIKSHPWF 174
R+L+ ++ V + ++R+ + +K+HP+F
Sbjct: 259 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 52/155 (33%), Positives = 81/155 (52%), Gaps = 9/155 (5%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
I HRDLK EN LL +KI DFG S + K +GT YIAPEVL R+
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RK 212
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQD 146
+Y + DVWS GV L+++L G PF Q D + RK + + P++ ++S+
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK----VEKGKYTFDSPEWKNVSEG 267
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
++L+ ++ + RRI+ ++ HPW + ++
Sbjct: 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 41/221 (18%), Positives = 78/221 (35%), Gaps = 38/221 (17%)
Query: 30 SQQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
I HR++K N + + K+ DFG ++ + S GT Y+ P++ R
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 88 REYD-------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY----- 135
G D+WS GVT Y G+ PF E P+ ++ + +I+ +
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 136 --------------KIPDYVHISQDCR----NLLSRIFVANPSRRITIKEIKSHPWFLKN 177
+P +S+ + +L+ I A+ + + + + +
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
Query: 178 LP----RELTETAQAIYYRKENPTFS--LQSVEEITKIVEE 212
L + Y T + + V + TKI+
Sbjct: 310 RMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISS 350
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-39
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
+++I H DLK EN +L P P +K+ DFG + K+ GTP ++APE+++
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQ 145
G AD+WS GV Y++L GA PF + I AV Y + + S+
Sbjct: 193 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITAVSYDFDEEFFSQTSE 247
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++ + ++ V +R+TI+E HPW
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWI 276
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-39
Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
S I HR+LK EN LL + +K+ DFG + GTP Y++PEVL +
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQD 146
Y K D+W+CGV LY++LVG PF D++ + + + I A Y P++ ++ +
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPE 260
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
++L+ + NP +RIT + PW
Sbjct: 261 AKSLIDSMLTVNPKKRITADQALKVPWICNR 291
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-39
Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 7/150 (4%)
Query: 30 SQQICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLS 86
+Q + HRDLK N L ++ICDFG++K + T T ++APEVL
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE 193
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHIS 144
R+ YD D+WS GV LY ML G PF + D + ++RI + ++ + +S
Sbjct: 194 RQGYD-AACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++L+S++ +P +R+T + HPW
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-39
Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 8/168 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
I H DLK EN L A ++KI DFG ++ + K GTP ++APEV+ +
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYD 263
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDC 147
+ D+WS GV Y++L G PF D +T++ I+A ++ + ++ IS++
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACRWDLEDEEFQDISEEA 319
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 195
+ +S++ + S RI+ E HPW L + +AQ R +
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPW-LSDHKLHSRLSAQKKKNRGSD 366
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-39
Identities = 52/152 (34%), Positives = 77/152 (50%), Gaps = 11/152 (7%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 87
I HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL++
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQ 181
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQ 145
+ Y K D WS GV Y++L G PF ++ + K F K I Y+ P + IS+
Sbjct: 182 KPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISE 236
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
++ + + +P+ R T ++ SHPW N
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-39
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 7/150 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
I H D+K EN + + A +KI DFG + K T T + APE++ R
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDC 147
G D+W+ GV YV+L G PF ++D +T+ + + + +S +
Sbjct: 227 V-GFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEA 281
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
++ + + P +R+T+ + HPW +
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-39
Identities = 38/160 (23%), Positives = 63/160 (39%), Gaps = 17/160 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----------VGTPAY 79
++ HRDLK N LL + + D G + +H T +Y
Sbjct: 152 AKGYAHRDLKPTNILLGDEG--QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 80 IAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI 137
APE+ S + + + DVWS G LY M+ G P++ + +++ + Q I
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQNQLSI 266
Query: 138 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
P S LL+ + +P +R I + S L+
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ I HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+L
Sbjct: 218 ANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSM 275
Query: 90 YD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--H 142
+ GK D+W+CGV L+ +L G+ PF + R IM QY+
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSSPEWDD 331
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
S ++L+SR+ +P R+T ++ HP+F +
Sbjct: 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
+Q+I HRD+K +N LLD G + I DF + ++ + GT Y+APE+ S
Sbjct: 133 NQRIIHRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 88 REYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
R+ G D WS GVT Y +L G P+ + + ++ + P SQ
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPSA--WSQ 245
Query: 146 DCRNLLSRIFVANPSRRI-TIKEIKSHPWF 174
+ +LL ++ NP +R + ++++ P+
Sbjct: 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-38
Identities = 42/167 (25%), Positives = 66/167 (39%), Gaps = 25/167 (14%)
Query: 28 SLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-------------V 74
I HRDLK+EN LL +K+CDFG + + + +
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 75 GTPAYIAPEV--LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 132
TP Y PE+ L G+ D+W+ G LY++ +PFED RI+
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AKLRIVN 263
Query: 133 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
+Y IP + +L+ + NP R++I E+ +
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 40/147 (27%), Positives = 63/147 (42%), Gaps = 7/147 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDC 147
D+WS G +YV+L G PF + + ++ I IM +Y + IS +
Sbjct: 180 V-STATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWF 174
+ + R+ V R+T E HPW
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 2e-38
Identities = 25/157 (15%), Positives = 48/157 (30%), Gaps = 9/157 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S+ + H +N + RL + D + +R ++ Y E L+
Sbjct: 212 SKGLVHGHFTPDNLFIMPDG--RLMLGDVSALWK--VGTRGPASSVPVTYAPREFLNAST 267
Query: 90 YD-GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF---RKTISRIMAVQYKIPDYVHISQ 145
+ W G+++Y + PF R ++ +
Sbjct: 268 ATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD 327
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
+ L+ R + RR+ E P F L E+
Sbjct: 328 FVKTLIGRFLNFDRRRRLLPLEAMETPEF-LQLQNEI 363
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 5e-38
Identities = 45/213 (21%), Positives = 75/213 (35%), Gaps = 27/213 (12%)
Query: 30 SQQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
+I HRDLK EN +L G KI D GY+K VGT Y+APE+L ++
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 198
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI--------------SRIMAVQ 134
+Y D WS G + + G PF P + + + +
Sbjct: 199 KYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFS 257
Query: 135 YKIPDYVHISQDCRNLLSRIF----VANPSRRITIKEIKSHPWFLKNLPRELTETAQAIY 190
+P H+S L R + + +R T + + F + L L+ ++
Sbjct: 258 SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF-QALDSILSLKLLSVM 316
Query: 191 YRKENPTFSLQSVEEIT------KIVEEAKVPP 217
+ E + ++ +P
Sbjct: 317 NMVSGRVHTYPVTENENLQNLKSWLQQDTGIPE 349
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-38
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 88
+ HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y++PE ++R
Sbjct: 134 GHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHISQDC 147
Y+ K +D+WS G LY + PF + ++ +I ++ +IP S +
Sbjct: 192 SYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY--RYSDEL 244
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178
+++R+ R +++EI +P L++
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLILEHH 275
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR 87
I HRD+K LL + +K+ FG + VGTP ++APEV+ R
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQ 145
Y GK DVW CGV L+++L G PF ++ + I+ +YK + HIS+
Sbjct: 208 EPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWSHISE 261
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
++L+ R+ + +P+ RIT+ E +HPW +
Sbjct: 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-37
Identities = 35/150 (23%), Positives = 62/150 (41%), Gaps = 13/150 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S+++ +RDLK N L + ++KI DFG S + + GT Y++PE +S ++
Sbjct: 140 SKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD 197
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y + D+++ G+ L +L + K + + I D + +
Sbjct: 198 YGKE-VDLYALGLILAELLHVCDTAFETS------KFFTDLR--DGIISD--IFDKKEKT 246
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
LL ++ P R EI K P
Sbjct: 247 LLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 52/153 (33%), Positives = 75/153 (49%), Gaps = 7/153 (4%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
I HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQD 146
Y G D+WS G+ Y++L G PF D+ + RI+ +Y P + +S +
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNCEYYFISPWWDEVSLN 281
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
++L+ ++ V +P +R+T + HPW
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
H DLK EN + + LK+ DFG + K T GT + APEV +
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDC 147
G D+WS GV Y++L G PF + D +T+ + + + + IS+D
Sbjct: 333 V-GYYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDG 387
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
++ + ++ +A+P+ R+TI + HPW
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPG 417
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 52/155 (33%), Positives = 84/155 (54%), Gaps = 15/155 (9%)
Query: 30 SQQICHRDLKLENTLL----DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 84
+ HR+LK EN LL G+ +K+ DFG + + GTP Y++PEV
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVH 142
L + Y GK D+W+CGV LY++LVG PF D++ + +++ I A Y P++
Sbjct: 185 LRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDT 239
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
++ + ++L++++ NPS+RIT E HPW
Sbjct: 240 VTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 18/196 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 88
++I HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+ +
Sbjct: 143 DRKILHRDIKSQNIFLTKDG--TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDC 147
Y+ K +D+W+ G LY + + FE + + + +I++ + + H S D
Sbjct: 201 PYNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFPPVSL--HYSYDL 253
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEIT 207
R+L+S++F NP R ++ I + K + + L+ A F L++ +
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA-------EEFCLKTFSKFG 306
Query: 208 KIVEEAKVPPPVSRSI 223
AK P SI
Sbjct: 307 SQPIPAKRPASGQNSI 322
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 56/153 (36%), Positives = 89/153 (58%), Gaps = 19/153 (12%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 86
S I +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV++
Sbjct: 144 SLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
RR + + AD WS GV ++ ML G PF+ K+ ++T++ I+ + +P + +S +
Sbjct: 200 RRGH-TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPE 252
Query: 147 CRNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
++LL +F NP+ R+ ++EIK H +F
Sbjct: 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-36
Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 28/185 (15%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSLLHSRPKSTVGTPAY 79
++ I HRDLK EN L + +P +KICDF S + + G+ Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 80 IAPEVLSRREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 135
+APEV+ + K D+WS GV LY++L G PF + A Q
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 136 KI-------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
+ D+ HIS ++L+S++ V + +R++ ++ HPW P
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307
Query: 183 TETAQ 187
T
Sbjct: 308 LPTPM 312
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-35
Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 19/153 (12%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 86
+ I +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+L
Sbjct: 139 QKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R + + D WS G +Y ML GA PF + N +KTI +I+ + +P Y ++Q+
Sbjct: 195 RSGH-NRAVDWWSLGALMYDMLTGAPPFTGE----NRKKTIDKILKCKLNLPPY--LTQE 247
Query: 147 CRNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
R+LL ++ N + R+ E+++HP+F
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAYIAPEVL 85
I +RD+KLEN LLD G + + DFG SK + R GT Y+AP+++
Sbjct: 177 KLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 86 SRREY-DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
+ K D WS GV +Y +L GA PF + + + RI+ + P +S
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MS 290
Query: 145 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
++L+ R+ + +P +R+ EIK H +F
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 57/152 (37%), Positives = 85/152 (55%), Gaps = 20/152 (13%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
S+ I +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+S
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
+ Y K D WS G+ +Y ML G PF D + KT +I+ + + P ++D
Sbjct: 178 KPY-NKSIDWWSFGILIYEMLAGYTPFYD-SNTM---KTYEKILNAELRFPP--FFNEDV 230
Query: 148 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
++LLSR+ + S+R+ +++K+HPWF
Sbjct: 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-35
Identities = 41/179 (22%), Positives = 69/179 (38%), Gaps = 34/179 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSLLHSRPKST 73
S +I HRDLK +N L+ S R+ I DFG K S + +
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 74 VGTPAYIAPEVLSRREYD------GKLADVWSCGVTLYVMLVGAY-PFEDQEDPKNFRKT 126
GT + APE+L + D++S G Y +L PF D+
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS------R 246
Query: 127 ISRIMAVQYKIPDYV-----HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180
S I+ + + + + + +L+S++ +P +R T ++ HP F +
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 20/152 (13%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
S + +RDLK EN L+D G +++ DFG++K + R + GTP +APE++
Sbjct: 159 SLDLIYRDLKPENLLIDQQG----YIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILS 212
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
+ Y K D W+ GV +Y M G PF + P + +I++ + + P H S D
Sbjct: 213 KGY-NKAVDWWALGVLIYEMAAGYPPFFA-DQPI---QIYEKIVSGKVRFPS--HFSSDL 265
Query: 148 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
++LL + + ++R + +IK+H WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 26/165 (15%), Positives = 47/165 (28%), Gaps = 19/165 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SLLHSRPKSTVGTPAYIAPEVLSR 87
+ H L+ + +LD + + F + + S P A +L
Sbjct: 229 HYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPF 286
Query: 88 REYDGKL----ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
++ L D W+ G+ +Y + P D +I
Sbjct: 287 GQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC----------KNI 336
Query: 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQA 188
Q R LL R+ + P + + L EL+
Sbjct: 337 PQPVRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTELSAALPL 380
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 86
S+ + +RD+KLEN +LD G +KI DFG K + T GTP Y+APEVL
Sbjct: 123 SRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
+Y G+ D W GV +Y M+ G PF +Q+ + F I+ + + P +S +
Sbjct: 179 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPRT--LSPE 231
Query: 147 CRNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
++LL+ + +P +R+ KE+ H +F
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 56/149 (37%), Positives = 84/149 (56%), Gaps = 15/149 (10%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 86
S+ I +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE+L
Sbjct: 136 SKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
++Y D WS GV LY ML+G PF Q++ + F I P + + ++
Sbjct: 192 GQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRW--LEKE 244
Query: 147 CRNLLSRIFVANPSRRITIK-EIKSHPWF 174
++LL ++FV P +R+ ++ +I+ HP F
Sbjct: 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-34
Identities = 52/153 (33%), Positives = 80/153 (52%), Gaps = 19/153 (12%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 86
S+ I +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE+++
Sbjct: 139 SKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
+ Y GK D W+ GV LY ML G PFE +++ + F+ IM P +S++
Sbjct: 195 YQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKE 247
Query: 147 CRNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
+ + +P +R+ ++IK H +F
Sbjct: 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-34
Identities = 51/152 (33%), Positives = 76/152 (50%), Gaps = 18/152 (11%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 86
S I +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APEVL
Sbjct: 157 SLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
++ Y + D W G LY ML G PF + + + I+ ++ +I+
Sbjct: 213 KQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQLKP--NITNS 265
Query: 147 CRNLLSRIFVANPSRRI----TIKEIKSHPWF 174
R+LL + + ++R+ EIKSH +F
Sbjct: 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 51/152 (33%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
+ I +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 142 DKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y G D W+ GV LY ML G PFE + + F I+ + P + +D
Sbjct: 200 LY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPT--WLHEDAT 252
Query: 149 NLLSRIFVANPSRRI------TIKEIKSHPWF 174
+L NP+ R+ I HP+F
Sbjct: 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 58/155 (37%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--HSRPKSTVGTPAYIAPEVLSR 87
S HRD+K +N LLD S LK+ DFG R + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 88 REYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVH 142
+ D G+ D WS GV LY MLVG PF + T S+IM PD
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMNHKNSLTFPDDND 299
Query: 143 ISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWF 174
IS++ +NL+ F+ + R+ ++EIK H +F
Sbjct: 300 ISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 17/156 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 87
HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 193 QLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 88 REYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYV 141
E G D WS GV +Y ML G PF + + +T +IM +++ P V
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKERFQFPTQV 306
Query: 142 -HISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 174
+S++ ++L+ R+ + R + I++ K HP+F
Sbjct: 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 41/156 (26%), Positives = 61/156 (39%), Gaps = 15/156 (9%)
Query: 30 SQQICHRDLKLENTLL---DGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAP 82
S I HRDLK N L+ + + I DFG K SR GT +IAP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 83 EVLSRREYD--GKLADVWSCGVTLYVMLVGAY-PFEDQEDPKNFRKTISRIMAVQYKIPD 139
E+LS + D++S G Y ++ PF R+ + A
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQANILLGACSLDCLH 251
Query: 140 Y-VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
H R L+ ++ +P +R + K + HP+F
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-33
Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 21/159 (13%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 86
+ I +RDLKL+N LLD G +K+ D+G K L ST GTP YIAPE+L
Sbjct: 128 ERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIMAVQYKIPDYV 141
+Y G D W+ GV ++ M+ G PF D D I+ Q +IP
Sbjct: 184 GEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS- 241
Query: 142 HISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWF 174
+S ++L +P R+ +I+ HP+F
Sbjct: 242 -LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
++ + +RDLK N LLD ++I D G + +P ++VGT Y+APEVL +
Sbjct: 310 NRFVVYRDLKPANILLDEHG--HVRISDLGLACD-FSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
AD +S G L+ +L G PF K+ + + + ++PD S + R+
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRS 423
Query: 150 LLSRIFVANPSRRI-----TIKEIKSHPWF 174
LL + + +RR+ +E+K P+F
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-33
Identities = 36/145 (24%), Positives = 59/145 (40%), Gaps = 11/145 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
SQ + H D+K N L P R K+ DFG + G P Y+APE+L +
Sbjct: 175 SQGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGS 231
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y ADV+S G+T+ + E + R+ + +S + R+
Sbjct: 232 YGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP-----EFTA--GLSSELRS 283
Query: 150 LLSRIFVANPSRRITIKEIKSHPWF 174
+L + +P R T + + + P
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVL 308
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 9e-33
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 15/151 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRR 88
S+ I +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE+++ +
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y GK D W+ GV LY ML G PFE +++ + F+ IM P +S++
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKEAV 570
Query: 149 NLLSRIFVANPSRRI-----TIKEIKSHPWF 174
+ + +P +R+ ++IK H +F
Sbjct: 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 51/148 (34%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRREYD 91
+ +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +Y
Sbjct: 270 VVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY- 326
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151
G+ D W GV +Y M+ G PF +Q+ K F I+ + + P + + ++LL
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEAKSLL 380
Query: 152 SRIFVANPSRRI-----TIKEIKSHPWF 174
S + +P +R+ KEI H +F
Sbjct: 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 21/159 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--HSRPKSTVGTPAYIAPEVLSR 87
HRD+K +N LLD +++ DFG R VGTP Y++PE+L
Sbjct: 180 RLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 88 REYD------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPD 139
G D W+ GV Y M G PF + +T +I+ +P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD----STAETYGKIVHYKEHLSLPL 293
Query: 140 Y-VHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWF 174
+ ++ R+ + R + P R+ + ++HP+F
Sbjct: 294 VDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
++I +RDLK EN LLD ++I D G + K VGT Y+APEV+
Sbjct: 304 RERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y D W+ G LY M+ G PF+ ++ + + V + + S R+
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARS 418
Query: 150 LLSRIFVANPSRRI-----TIKEIKSHPWF 174
L S++ +P+ R+ + +E+K HP F
Sbjct: 419 LCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 51/159 (32%), Positives = 73/159 (45%), Gaps = 21/159 (13%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 86
+ I +RDLKL+N LLD G +K+ D+G K L ST GTP YIAPE+L
Sbjct: 171 ERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIMAVQYKIPDYV 141
+Y G D W+ GV ++ M+ G PF D D I+ Q +IP
Sbjct: 227 GEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-- 283
Query: 142 HISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWF 174
+S ++L +P R+ +I+ HP+F
Sbjct: 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 15/153 (9%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLS 86
+ I +RDLK EN LLD G ++I D G + ++ K GTP ++APE+L
Sbjct: 307 QRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
EY D ++ GVTLY M+ PF + + ++ R++ PD S
Sbjct: 363 GEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPA 419
Query: 147 CRNLLSRIFVANPSRRI-----TIKEIKSHPWF 174
++ + +P +R+ + +++HP F
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-31
Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 25/151 (16%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
S I HRD+K EN L P LK+ DFG A E
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-GE 173
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HISQD 146
+YD K D+WS GV +Y++L G PF +RI QY+ P+ +S++
Sbjct: 174 KYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 232
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
+ L+ + P++R+TI E +HPW +++
Sbjct: 233 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-30
Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 8/154 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 88
S+++ HRD+K N + + +K+ D G + S + S VGTP Y++PE +
Sbjct: 154 SRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDC 147
Y+ K +D+WS G LY M PF D N +I Y +P H S++
Sbjct: 212 GYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPS-DHYSEEL 267
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
R L++ +P +R + + +
Sbjct: 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-30
Identities = 36/172 (20%), Positives = 67/172 (38%), Gaps = 24/172 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSLLHSRPKSTVGT 76
S+ + HRDLK N +K+ DFG ++R VGT
Sbjct: 136 SKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193
Query: 77 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136
Y++PE + Y K D++S G+ L+ +L YPF Q + +T++ + +++
Sbjct: 194 KLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV---RTLTDVRNLKFP 246
Query: 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK-NLPRELTETAQ 187
P + ++ + +P R I + F + P + +
Sbjct: 247 -PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQR 297
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 32/158 (20%), Positives = 61/158 (38%), Gaps = 23/158 (14%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-------------VGT 76
S+ + HRDLK N +K+ DFG + ++ VGT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 77 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 136
Y++PE + Y K D++S G+ L+ +L Y F Q + I+ + +++
Sbjct: 240 KLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFSTQM---ERVRIITDVRNLKFP 292
Query: 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ ++ + +P+ R +I + F
Sbjct: 293 -LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-27
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 26/156 (16%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEVL--S 86
QI HRD+K +N L++ + + LKI DFG SK + ++ ++ GT Y+APE++
Sbjct: 140 DNQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--------- 137
R Y AD+WS G T+ M G PF + +P A +K+
Sbjct: 199 PRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEP----------QAAMFKVGMFKVHPEI 247
Query: 138 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
P+ +S + + + + F +P +R ++ +
Sbjct: 248 PE--SMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 33/167 (19%), Positives = 55/167 (32%), Gaps = 27/167 (16%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPE 83
+++I H D+K +N LL R +CDFG++ GT ++APE
Sbjct: 168 TRRILHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 84 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV-- 141
V+ + D K D+WS + ML G +P+ + KI
Sbjct: 227 VVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFR-----------GPLCLKIASEPPP 274
Query: 142 ------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
+ + P R + E++ L
Sbjct: 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-26
Identities = 33/173 (19%), Positives = 61/173 (35%), Gaps = 28/173 (16%)
Query: 30 SQQICHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSLLHSRP---KSTVGTP 77
+I H D+K +N +L + L + D G S L + + T
Sbjct: 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249
Query: 78 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI---------- 127
+ E+LS + ++ + D + T+Y ML G Y E + + +
Sbjct: 250 GFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMW 308
Query: 128 SRIMAVQYKIPDYVHIS--QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178
+ V IPD H+ R L ++F + + +I + + L
Sbjct: 309 NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI---RALRNRLIVLLL 358
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 23/186 (12%)
Query: 27 SSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 86
S + + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFE 176
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDYV 141
Y K DV+S G+ L+ ++ PF++ P RIM + + +
Sbjct: 177 GSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAVHNGTRPPLIKNL 229
Query: 142 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQ 201
+ +L++R + +PS+R +++EI + +L R + + Y ++ SL
Sbjct: 230 P--KPIESLMTRCWSKDPSQRPSMEEIVKI---MTHLMRYFPGADEPLQYPCQH---SLP 281
Query: 202 SVEEIT 207
E+
Sbjct: 282 PGEDGR 287
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-25
Identities = 33/165 (20%), Positives = 56/165 (33%), Gaps = 30/165 (18%)
Query: 30 SQQICHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSLLHSRPKS 72
S + H D+K N + S KI D G+ S P+
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSPQV 189
Query: 73 TVGTPAYIAPEVLS-RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM 131
G ++A EVL + K AD+++ +T+ + + R+
Sbjct: 190 EEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLP-- 246
Query: 132 AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
+IP +SQ+ LL + +P RR + + H L
Sbjct: 247 ----RIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-23
Identities = 37/143 (25%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 92
I HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +YD
Sbjct: 152 IIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY-EEKYDE 208
Query: 93 KLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQYKIPDYVHISQDCRNLL 151
DV++ G+ + M YP+ + ++ +R+ S + + + ++
Sbjct: 209 S-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDK--VAIPEVKEII 263
Query: 152 SRIFVANPSRRITIKEIKSHPWF 174
N R +IK++ +H +F
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFF 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-23
Identities = 39/151 (25%), Positives = 63/151 (41%), Gaps = 20/151 (13%)
Query: 28 SLSQQICHRDLKLENTLLDG---SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 84
+ + I HRDL+ N L + K+ DFG S+ S +G ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWMAPET 197
Query: 85 LSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----I 137
+ E Y K AD +S + LY +L G PF++ K I I ++ + I
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGLRPTI 251
Query: 138 PDYVHISQDCRNLLSRIFVANPSRRITIKEI 168
P+ RN++ + +P +R I
Sbjct: 252 PEDCP--PRLRNVIELCWSGDPKKRPHFSYI 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 6e-21
Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 30/168 (17%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLS 86
+Q + HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+S
Sbjct: 159 AQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-------- 138
R Y + D+WS G+ + M+ G P+ + P + ++
Sbjct: 215 RSLYATE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMKRLRDSPPPKLK 262
Query: 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN--LPRELTE 184
+ +S R+ L R+ V +P R T +E+ HP FL LP L
Sbjct: 263 NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP-FLLQTGLPECLVP 309
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-21
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 20/162 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLS 86
++ I HRDLK N L +KI DFG + + + G+ ++APEV+
Sbjct: 138 AKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 87 RRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
++ Y + +DV++ G+ LY ++ G P+ + N R I ++ PD +
Sbjct: 196 MQDSNPYSFQ-SDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPDLSKV 250
Query: 144 SQDC----RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
+C + L++ R + I + ++ L RE
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAE---IEELARE 289
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-21
Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 30/168 (17%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLS 86
S Q+ HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV++
Sbjct: 134 SNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-------- 138
R+ Y K D+WS G+ M+ G P+ + E+P + Y I
Sbjct: 190 RKAYGPK-VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRALYLIATNGTPELQ 237
Query: 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN--LPRELTE 184
+ +S R+ L+R + +R + KE+ H FLK LT
Sbjct: 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ-FLKIAKPLSSLTP 284
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 8e-21
Identities = 45/183 (24%), Positives = 71/183 (38%), Gaps = 42/183 (22%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 91
+I HRD+K N L++ +K+CDFG S L+ S S VGT +Y++PE L Y
Sbjct: 152 KIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYS 208
Query: 92 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY----------- 140
+ +D+WS G++L M VG YP + + ++ + P
Sbjct: 209 VQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 141 ---VHISQDCRNLLSRI-------------------FVA-----NPSRRITIKEIKSHPW 173
LL I FV NP+ R +K++ H +
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 174 FLK 176
+
Sbjct: 328 IKR 330
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-20
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 26/157 (16%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV----LS 86
+ HRD+K N L++ ++K+CDFG S L+ K G Y+APE L+
Sbjct: 130 SVIHRDVKPSNVLINALG--QVKMCDFGISGY-LVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY------ 140
++ Y K +D+WS G+T+ + + +P++ P ++ +
Sbjct: 187 QKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP----------FQQLKQVVEEPSPQLP 235
Query: 141 -VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
S + + S+ N R T E+ HP+F
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-20
Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRRE- 89
+ HRD+K N LLD ++K+CDFG S L+ + K G AY+APE + +
Sbjct: 145 GVIHRDVKPSNILLDERG--QIKLCDFGISGR-LVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 90 ----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYVH 142
YD + ADVWS G++L + G +P+ ++ K + ++++ +Q + P ++
Sbjct: 202 TKPDYDIR-ADVWSLGISLVELATGQFPY---KNCKTDFEVLTKV--LQEEPPLLPGHMG 255
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
S D ++ + + +R ++ H + + E
Sbjct: 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 32/148 (21%), Positives = 54/148 (36%), Gaps = 22/148 (14%)
Query: 28 SLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
+L I L + ++D +I S + + PA++APE L +
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQK 182
Query: 88 REYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDY 140
+ D + AD+WS V L+ ++ PF D + M V + IP
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADL-------SNMEIGMKVALEGLRPTIPP- 234
Query: 141 VHISQDCRNLLSRIFVANPSRRITIKEI 168
IS L+ +P++R I
Sbjct: 235 -GISPHVSKLMKICMNEDPAKRPKFDMI 261
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-20
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 88
S++ HRD+K N LL +K+ DFG + + + + VGTP ++APEV+ +
Sbjct: 137 SEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 194
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV------H 142
YD K AD+WS G+T + G P + P M V + IP +
Sbjct: 195 AYDSK-ADIWSLGITAIELARGEPPHSE-LHP----------MKVLFLIPKNNPPTLEGN 242
Query: 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177
S+ + + PS R T KE+ H + L+N
Sbjct: 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-20
Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 23/167 (13%)
Query: 28 SLSQQICHRDLKLENTLLDGSPAPRLKICDFGYS--KSSLLHSRPKSTVGTPAYIAPEVL 85
+ + I HR+LK N L+D +K+CDFG S K+S S KS GTP ++APEVL
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKY--TVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVL 211
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDY 140
+ K +DV+S GV L+ + P+ + + AV +K IP
Sbjct: 212 RDEPSNEK-SDVYSFGVILWELATLQQPWGNLNP-------AQVVAAVGFKCKRLEIPRN 263
Query: 141 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ 187
++ ++ + P +R + I L+ L +
Sbjct: 264 LN--PQVAAIIEGCWTNEPWKRPSFATIMDL---LRPLIKSAVPPPN 305
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-20
Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 35/183 (19%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVL 85
+ HRD+K N LL +G K+ DFG + L + K + +GTP ++APEV+
Sbjct: 143 FMRKIHRDIKAGNILLNTEG----HAKLADFGVA-GQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP------- 138
Y+ AD+WS G+T M G P+ D P M + IP
Sbjct: 198 QEIGYNCV-ADIWSLGITAIEMAEGKPPYAD-IHP----------MRAIFMIPTNPPPTF 245
Query: 139 -DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP-----RELTETAQAIYYR 192
S + + + + V +P +R T ++ HP F+++ R+L A + +
Sbjct: 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP-FVRSAKGVSILRDLINEAMDVKLK 304
Query: 193 KEN 195
++
Sbjct: 305 RQE 307
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 9/150 (6%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL----S 86
+I HRD+K N LLD S +K+CDFG S L+ S K+ G Y+APE + S
Sbjct: 146 KIIHRDIKPSNILLDRSG--NIKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
R+ YD + +DVWS G+TLY + G +P+ + + + Q + S
Sbjct: 203 RQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 261
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
N ++ + S+R KE+ HP+ L
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 39/150 (26%), Positives = 58/150 (38%), Gaps = 22/150 (14%)
Query: 33 ICHRDLKLENTLLDGSPAPR------LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 86
I HRDLK N L+ LKI DFG ++ + S G A++APEV+
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-WHRTTKMSAAGAYAWMAPEVIR 187
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDYV 141
+ +DVWS GV L+ +L G PF + ++ V IP
Sbjct: 188 ASMFSKG-SDVWSYGVLLWELLTGEVPFRGID-------GLAVAYGVAMNKLALPIPSTC 239
Query: 142 HISQDCRNLLSRIFVANPSRRITIKEIKSH 171
+ L+ + +P R + I
Sbjct: 240 P--EPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-18
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 32/167 (19%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLS 86
++ HRD+K +N LL + +K+ DFG S + R + +GTP ++APEV++
Sbjct: 147 QHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 87 RRE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--- 138
E YD K +D+WS G+T M GA P D P M + IP
Sbjct: 203 CDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD-MHP----------MRALFLIPRNP 250
Query: 139 ----DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
S+ ++ + V N S+R +++ HP F+++ P E
Sbjct: 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNE 296
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-18
Identities = 40/172 (23%), Positives = 60/172 (34%), Gaps = 44/172 (25%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVL-- 85
I HRDLK +N L+ + + I D G + ++ L VGT Y+APEVL
Sbjct: 134 IAHRDLKSKNILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 86 ----SRREYDGKLADVWSCGVTLYVMLVGAY----------PFEDQ--EDP--------- 120
+ + D+W+ G+ L+ + PF D DP
Sbjct: 192 TIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250
Query: 121 --KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170
R I + + ++C NPS R+T IK
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWY-------QNPSARLTALRIKK 295
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-18
Identities = 30/174 (17%), Positives = 64/174 (36%), Gaps = 40/174 (22%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPE 83
++ I H+DLK +N D ++ I DFG + + + G ++APE
Sbjct: 148 AKGILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 84 VLSRRE---------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-------KNFRKTI 127
++ + + +DV++ G Y + +PF+ Q + +
Sbjct: 205 IIRQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263
Query: 128 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
S+I + ++ ++L + R T ++ L+ LP+
Sbjct: 264 SQI-----------GMGKEISDILLFCWAFEQEERPTFTKLMDM---LEKLPKR 303
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 8e-18
Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 25/172 (14%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYS------KSSLLHSRPKSTVGTPAYIA 81
HRD+K N LL DGS ++I DFG S + K+ VGTP ++A
Sbjct: 139 KNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 82 PEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAV 133
PEV+ + R YD K AD+WS G+T + GA P+ +N ++ +
Sbjct: 195 PEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE-LTE 184
+ + Y + R ++S +P +R T E+ H +F K +E L E
Sbjct: 254 KEMLKKY---GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-17
Identities = 53/179 (29%), Positives = 77/179 (43%), Gaps = 36/179 (20%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLS 86
S++I HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV+
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 87 RRE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--- 138
YD K AD+WS G+TL M P + +P M V KI
Sbjct: 191 CETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP----------MRVLLKIAKSD 238
Query: 139 -----DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP----RELTETAQA 188
S + R+ L NP R + ++ HP+ REL A+A
Sbjct: 239 PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKA 297
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-17
Identities = 39/196 (19%), Positives = 71/196 (36%), Gaps = 49/196 (25%)
Query: 32 QICHRDLKLENTLLDGSPAPR----LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
I H D+K EN L++ +P +KI D G + +++ T Y +PEVL
Sbjct: 152 GIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSIQTREYRSPEVLLG 209
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT--ISRIMAV------------ 133
+ AD+WS ++ ++ G + FE E + I++I+ +
Sbjct: 210 APWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 268
Query: 134 ------------------------QYKIPDYVHISQDCR----NLLSRIFVANPSRRITI 165
+ + + S+D + LS + +P +R
Sbjct: 269 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328
Query: 166 KEIKSHPWFLKNLPRE 181
+ +HPW L E
Sbjct: 329 GGLVNHPWLKDTLGME 344
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-17
Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 34/173 (19%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV-LS 86
S ICHRD+K +N LLD A LK+CDFG +K L + + + Y APE+
Sbjct: 174 SFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQ--LVRGEPNVSYICSRYYRAPELIFG 230
Query: 87 RREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED-----------PKNFRKTISRI--M 131
+Y + DVWS G L +L+G +P + D P R+ I +
Sbjct: 231 ATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT--REQIREMNPN 287
Query: 132 AVQYKIPDYV----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++K P + L SR+ P+ R+T E +H +F
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 34/173 (19%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV-LS 86
S ICHRD+K +N LLD LK+ DFG +K L + + + + Y APE+
Sbjct: 159 SIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKI--LIAGEPNVSYICSRYYRAPELIFG 215
Query: 87 RREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED-----------PKNFRKTISRIMA- 132
Y + D+WS G + ++ G +P E D P R+ I +
Sbjct: 216 ATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS--REQIKTMNPN 272
Query: 133 -VQYKIPDYV----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+++K P D +L+SR+ PS R+T E HP+F
Sbjct: 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 42/193 (21%), Positives = 68/193 (35%), Gaps = 47/193 (24%)
Query: 23 DIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTP 77
+I + I HRDLK +N L+ + I D G + + + P VGT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 78 AYIAPEVL------SRREYDGKLADVWSCGVTLYVMLVG----------AYPFEDQ--ED 119
Y+APEVL E + AD+++ G+ + + P+ D D
Sbjct: 216 RYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 120 P-----------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 168
P + R I + I ++C + AN + R+T I
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC-------WYANGAARLTALRI 327
Query: 169 KSHPWFLKNLPRE 181
K L L ++
Sbjct: 328 KKT---LSQLSQQ 337
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 39/182 (21%), Positives = 67/182 (36%), Gaps = 44/182 (24%)
Query: 23 DIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTP 77
+IF + I HRDLK +N L+ + I D G + ++ + P + VGT
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 78 AYIAPEVL------SRREYDGKLADVWSCGVTLYVMLVG----------AYPFED--QED 119
Y+ PEVL + + AD++S G+ L+ + P+ D D
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 120 P-----------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 168
P K R + + + + +C + NP+ R+T +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC-------WAHNPASRLTALRV 322
Query: 169 KS 170
K
Sbjct: 323 KK 324
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-16
Identities = 49/182 (26%), Positives = 75/182 (41%), Gaps = 35/182 (19%)
Query: 30 SQQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS- 86
S + HRD+K N LL G +K+ DFG +S++ S VGTP ++APEV+
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGS--ASIMAPA-NSFVGTPYWMAPEVILA 224
Query: 87 --RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP------ 138
+YDGK DVWS G+T + P + + M+ Y I
Sbjct: 225 MDEGQYDGK-VDVWSLGITCIELAERKPPLFN-MNA----------MSALYHIAQNESPA 272
Query: 139 -DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP----RELTETAQAIYYRK 193
H S+ RN + P R T + + H + L+ P +L + +
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVREL 332
Query: 194 EN 195
+N
Sbjct: 333 DN 334
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 31/173 (17%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEV-LSR 87
S +CHRD+K N L++ + LK+CDFG +K L S P + + + Y APE+
Sbjct: 149 SVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAK-KLSPSEPNVAYICSRYYRAPELIFGN 206
Query: 88 REYDGKLADVWSCGVTLYVMLVGA--YPFEDQED---------------------PKNFR 124
+ Y + D+WS G M++G + ++ P +
Sbjct: 207 QHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD 265
Query: 125 KTISRIMAVQYK--IPDYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ + + D+ +++ +LLS + P R+ E HP+F
Sbjct: 266 VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 8e-16
Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 34/173 (19%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV-LS 86
S ICHRD+K +N L++ LK+CDFG +K L S + + Y APE+ L
Sbjct: 159 SLGICHRDIKPQNLLVNSKDN-TLKLCDFGSAKK--LIPSEPSVAYICSRFYRAPELMLG 215
Query: 87 RREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED-----------PKNFRKTISRI--M 131
EY + D+WS G +++G + E D P ++ + R+
Sbjct: 216 ATEYTPSI-DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT--KEQMIRMNPH 272
Query: 132 AVQYKIPDYVHIS----------QDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ + P +LL +I P RI E +HP+F
Sbjct: 273 YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-16
Identities = 39/180 (21%), Positives = 72/180 (40%), Gaps = 39/180 (21%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL-S 86
S I HRD+K N ++D +L++ D+G ++ H + V + + PE+L
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVD 204
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPF------EDQ----------EDPKNFRKTISRI 130
+ YD L D+WS G L M+ PF DQ ED ++ +
Sbjct: 205 YQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263
Query: 131 MAVQYK--IPDY--------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ ++ + + +S + + L ++ + R+T +E HP+F
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 21/88 (23%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S + + DLK EN +L +LK+ D G + GTP + APE++
Sbjct: 200 SIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEIVRTGP 253
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQ 117
D+++ G TL + + +
Sbjct: 254 TVA--TDIYTVGRTLAALTLDLPTRNGR 279
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 2e-15
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 48/186 (25%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 87
S+ + HRDLK +N L++ + LK+ +FG +++ + R S V T Y P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAV-------- 133
+ Y + D+WS G + P +DQ + RI +
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQ---------LKRIFRLLGTPTEEQ 226
Query: 134 ---QYKIPDYV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
K+PDY ++ R+LL + NP +RI+ +E HP+F
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
Query: 175 LKNLPR 180
+
Sbjct: 287 -SDFCP 291
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-15
Identities = 44/175 (25%), Positives = 65/175 (37%), Gaps = 33/175 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEV- 84
S + HRDLK N ++ + LKI DFG ++ H K + T Y +P +
Sbjct: 138 SANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL 196
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFE------------------DQED----PKN 122
LS Y K D+W+ G ML G F +ED
Sbjct: 197 LSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSV 255
Query: 123 FRKTISRIMAVQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
I + P IS++ + L +I +P R+T +E SHP+
Sbjct: 256 IPVYIRN-DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-15
Identities = 46/186 (24%), Positives = 73/186 (39%), Gaps = 45/186 (24%)
Query: 30 SQQICHRDLKLENTLLDGSPAPR---LKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL 85
S++ HRDLK +N LL S A LKI DFG +++ + R + + T Y PE+L
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL 209
Query: 86 -SRREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM-------- 131
R Y + D+WS ML+ F DQ I ++
Sbjct: 210 LGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLF------KIFEVLGLPDDTTW 262
Query: 132 -AVQYKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
V +PD+ + + +LL+ + +P +RI+ K HP+
Sbjct: 263 PGVT-ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
Query: 174 FLKNLP 179
F +
Sbjct: 322 F-SHND 326
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 41/213 (19%), Positives = 63/213 (29%), Gaps = 56/213 (26%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+I H DLK EN LL +K+ DFG S H R + + + Y APEV+
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTYIQSRFYRAPEVILGAR 275
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPF----------------------------------- 114
Y + D+WS G L +L G
Sbjct: 276 YGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS 334
Query: 115 ----------EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR--------NLLSRIFV 156
D P+ + + L +
Sbjct: 335 SKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394
Query: 157 ANPSRRITIKEIKSHPWFLKNLPRELTETAQAI 189
+P+ R+T + HPW + LP+ T ++
Sbjct: 395 WDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSV 427
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-15
Identities = 48/200 (24%), Positives = 79/200 (39%), Gaps = 47/200 (23%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 87
HRD+K EN L+ +K+CDFG+++ S V T Y +PE+L
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM----------- 131
+Y G DVW+ G +L G + DQ I + +
Sbjct: 178 TQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ------LYLIRKTLGDLIPRHQQVF 230
Query: 132 -----AVQYKIPDYV----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF-- 174
KIPD +IS LL +P+ R+T +++ HP+F
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290
Query: 175 ---LKNLPRELTETAQAIYY 191
+++L +E + A+ +Y+
Sbjct: 291 IREIEDLAKEHDKPAENLYF 310
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-15
Identities = 36/172 (20%), Positives = 61/172 (35%), Gaps = 30/172 (17%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV-LSRR 88
+ HRDL N LL + + ICDF ++ + V Y APE+ + +
Sbjct: 152 EAGVVHRDLHPGNILLADNN--DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK 209
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFE------------------DQED-----PKNFRK 125
+ KL D+WS G + M F ED + R
Sbjct: 210 GFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARD 268
Query: 126 TISRIMAVQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ ++ +L++++ NP RRI+ ++ HP+F
Sbjct: 269 YLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-15
Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 35/173 (20%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV-LS 86
S + HRDLK N ++ LKI DFG ++ + + T V T Y APEV LS
Sbjct: 144 SAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHA----DAEMTGYVVTRWYRAPEVILS 197
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISRIMA 132
Y+ + D+WS G + ML G F+ DQ F + ++ A
Sbjct: 198 WMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256
Query: 133 VQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
Y +P + S +LL ++ + +R+T + +HP+F
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 8e-15
Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 44/186 (23%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 87
+I HRDLK +N L++ LK+ DFG +++ + R + V T Y AP+VL
Sbjct: 137 QHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------AV 133
++Y + D+WS G M+ G F +DQ I I+ V
Sbjct: 195 KKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLP------KIFSILGTPNPREWPQV 247
Query: 134 QYKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
Q ++P + Q+ +LLS + +P++RI+ ++ +HP+F K
Sbjct: 248 Q-ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-K 305
Query: 177 NLPREL 182
+L ++
Sbjct: 306 DLDPQI 311
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 9e-15
Identities = 34/205 (16%), Positives = 64/205 (31%), Gaps = 54/205 (26%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSLLHSRPKSTVGTPAYIA 81
HR +K + L+ + + + + ++H PK +V +++
Sbjct: 146 HMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 82 PEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED-----------QEDP-------- 120
PEVL + + YD K +D++S G+T + G PF+D
Sbjct: 204 PEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262
Query: 121 ---------------------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 159
T P + S + + + NP
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322
Query: 160 SRRITIKEIKSHPWFLKNLPRELTE 184
R + + +H F K + R +E
Sbjct: 323 DARPSASTLLNHS-FFKQIKRRASE 346
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 9/90 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVL 85
+ HRD+K EN L+ S + DFG + L ++ +TVGT Y+APE
Sbjct: 152 AAGATHRDVKPENILV--SADDFAYLVDFGIASATTDEKL--TQLGNTVGTLYYMAPERF 207
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFE 115
S + AD+++ LY L G+ P++
Sbjct: 208 SESHATYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 35/177 (19%), Positives = 66/177 (37%), Gaps = 32/177 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK---------------SSLLHSRPKSTV 74
S I HRDL N L+ + + + DFG ++ + + V
Sbjct: 126 SMNIIHRDLNSHNCLVRENK--NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 75 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 134
G P ++APE+++ R YD K DV+S G+ L ++ D P+ +
Sbjct: 184 GNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPD-YLPRT------MDFGLN 235
Query: 135 YKIPDYVHISQDC----RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ 187
+ + +C + R +P +R + +++ +L+ L L
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE---HWLETLRMHLAGHLP 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 44/193 (22%), Positives = 71/193 (36%), Gaps = 43/193 (22%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSR- 87
S I HRD+K EN L+ S +K+CDFG++++ V T Y APE+L
Sbjct: 142 SHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD 199
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM----------- 131
+Y GK DVW+ G + M +G F DQ I +
Sbjct: 200 VKY-GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ------LYHIMMCLGNLIPRHQELF 252
Query: 132 -----AVQYKIPDYVH----------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
++P+ +S+ +L + +P +R E+ H +F
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312
Query: 177 -NLPRELTETAQA 188
++ Q
Sbjct: 313 DGFAERFSQELQL 325
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 3e-14
Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 42/177 (23%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 87
+++ HRDLK +N L++ LKI DFG +++ + R + + T Y AP+VL
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------AV 133
++Y + D+WS G M+ G F DQ I RI+ V
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLM------RIFRILGTPNSKNWPNV 228
Query: 134 QYKIPDYV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++P Y + + +LLS++ +P++RIT K+ H +F
Sbjct: 229 T-ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-14
Identities = 40/186 (21%), Positives = 74/186 (39%), Gaps = 44/186 (23%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 87
Q++ HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++L
Sbjct: 118 RQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------AV 133
+Y ++ D+W G Y M G F E+Q I RI+ +
Sbjct: 176 TDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLH------FIFRILGTPTEETWPGI 228
Query: 134 QYKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
++ + D +LL+++ RI+ ++ HP+F
Sbjct: 229 L-SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF-L 286
Query: 177 NLPREL 182
+L +
Sbjct: 287 SLGERI 292
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-14
Identities = 33/169 (19%), Positives = 60/169 (35%), Gaps = 42/169 (24%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLS--- 86
I HRD+K +N LL + I DFG + + VGT Y+APEVL
Sbjct: 152 ISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI 209
Query: 87 --RREYDGKLADVWSCGVTL--------------------YVMLVGAYP-FEDQED---P 120
+R+ + D+++ G+ L + +G +P ED ++
Sbjct: 210 NFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVH 268
Query: 121 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 169
K R + + ++C + + R++ +
Sbjct: 269 KKKRPVLRDYWQKHAGMAMLCETIEECWD-------HDAEARLSAGCVG 310
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-14
Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 35/173 (20%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV-LS 86
S I HRDLK N ++ LKI DFG ++ + + T V T Y APE+ L+
Sbjct: 150 SADIIHRDLKPSNLAVNEDC--ELKILDFGLARH----TADEMTGYVATRWYRAPEIMLN 203
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISRIMA 132
Y+ + D+WS G + +L G F DQ K IS A
Sbjct: 204 WMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 262
Query: 133 VQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
Y + ++ + +LL ++ V + +RIT + +H +F
Sbjct: 263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-14
Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 35/173 (20%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV-LS 86
+ I HRDLK N ++ LKI DFG ++ + + T V T Y APEV L+
Sbjct: 146 AAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQ----ADSEMTGYVVTRWYRAPEVILN 199
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISRIMA 132
Y + D+WS G + M+ G F+ DQ P F + + A
Sbjct: 200 WMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 133 VQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
Y +P+ + S NLL ++ V + +R+T E +HP+F
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-14
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 34/181 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 87
+I HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+VL
Sbjct: 126 ENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQ------------ED--P-------- 120
R Y + D+WSCG L M+ G F E+Q E P
Sbjct: 184 RTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 121 -KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
N ++ R + + + + + L + NP R++ K+ HPWF
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF-AEYY 301
Query: 180 R 180
Sbjct: 302 H 302
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-13
Identities = 40/181 (22%), Positives = 60/181 (33%), Gaps = 44/181 (24%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ I HRDLK EN L+ +K+ DFG ++ V T Y APEVL +
Sbjct: 138 ANCIVHRDLKPENILVTSG--GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST 195
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAV---------- 133
Y + D+WS G M P DQ + +I +
Sbjct: 196 YATPV-DMWSVGCIFAEMFRRK-PLFCGNSEADQ---------LGKIFDLIGLPPEDDWP 244
Query: 134 ------QYKIPDYV---------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178
+ P + + LL + NP +RI+ H + K+
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304
Query: 179 P 179
Sbjct: 305 G 305
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 45/181 (24%), Positives = 67/181 (37%), Gaps = 39/181 (21%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 145 SAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFE------------------DQED------------ 119
Y + D+WS G + M+ G F E
Sbjct: 203 YK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261
Query: 120 ---PKNFRKTISRIMAVQYKIPDYVHISQ---DCRNLLSRIFVANPSRRITIKEIKSHPW 173
PK + ++ D H R+LLS++ V + S+RI++ E HP+
Sbjct: 262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321
Query: 174 F 174
Sbjct: 322 I 322
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 47/175 (26%), Positives = 72/175 (41%), Gaps = 33/175 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEV- 84
S + HRDLK N LL+ + LKICDFG ++ + V T Y APE+
Sbjct: 146 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISRI 130
L+ + Y K D+WS G L ML F DQ + + I +
Sbjct: 204 LNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 131 MAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
A Y +P + + +LL ++ NP +RI +++ +HP+
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 46/181 (25%), Positives = 72/181 (39%), Gaps = 43/181 (23%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S ++ HRDLK +N L+ S ++K+ DFG ++ S V T Y APEVL +
Sbjct: 138 SHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIMAV----------- 133
Y + D+WS G M F DQ + +I+ V
Sbjct: 196 YATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQ---------LGKILDVIGLPGEEDWPR 245
Query: 134 -----QYKIPDYV---------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
+ I + ++LL + NP++RI+ SHP+F ++L
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF-QDLE 304
Query: 180 R 180
R
Sbjct: 305 R 305
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 54/187 (28%), Positives = 73/187 (39%), Gaps = 52/187 (27%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL- 85
I HRDLK N LLD G LK+ DFG +KS +R + V T Y APE+L
Sbjct: 130 QHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAV------ 133
R Y + D+W+ G L +L+ PF DQ ++RI
Sbjct: 186 GARMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLDQ---------LTRIFETLGTPTE 234
Query: 134 -----QYKIPDYV---------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
+PDYV D +L+ +F+ NP RIT + +
Sbjct: 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
Query: 174 FLKNLPR 180
F N P
Sbjct: 295 F-SNRPG 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 42/199 (21%), Positives = 67/199 (33%), Gaps = 50/199 (25%)
Query: 30 SQQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKST----VGTPAYIAPE 83
+ + HRDLK N L+ G R +KI D G+++ +P + V T Y APE
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
Query: 84 VL-SRREYDGKLADVWSCGVTLYVML---------------------------------- 108
+L R Y K D+W+ G +L
Sbjct: 206 LLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 109 -------VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSR 161
+ P R T + ++Y V +LL ++ +P +
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324
Query: 162 RITIKEIKSHPWFLKNLPR 180
RIT ++ P+F P
Sbjct: 325 RITSEQAMQDPYF-LEDPL 342
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 33/88 (37%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSR 87
+I HRD+K +N L+D LKI DFG +K S ++ +GT Y +PE
Sbjct: 129 DMRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFE 115
D D++S G+ LY MLVG PF
Sbjct: 187 EATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-13
Identities = 45/215 (20%), Positives = 73/215 (33%), Gaps = 50/215 (23%)
Query: 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSLLHSRPKSTVGTPAYIAP 82
I HRDL N L+ I DFG S + S VGT Y+AP
Sbjct: 140 AISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAP 197
Query: 83 EVLSRR------EYDGKLADVWSCGVTLYVML---VGAYPFEDQEDPKNFRKTISRIMAV 133
EVL E K D+++ G+ + + +P E +
Sbjct: 198 EVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE-------------- 243
Query: 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKE-IKSHPWFLKNLPRELTET-----AQ 187
Y++ + ++ V+ +R E K + +++L +E E A+
Sbjct: 244 -YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL-KETIEDCWDQDAE 301
Query: 188 AIYYRKENPTFS--LQSVEEITKIVEEAKVPPPVS 220
A R T + + E+ I E K P +
Sbjct: 302 A---R---LTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-13
Identities = 45/213 (21%), Positives = 65/213 (30%), Gaps = 61/213 (28%)
Query: 25 FFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 84
F ++ I H DLK EN LL +KI DFG S L R + + Y +PEV
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVG---------------------------------- 110
L YD + D+WS G L M G
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288
Query: 111 ----------AYPFEDQEDPKN-----FRKTISRIMAVQYKIP---DYVHISQDCRN--- 149
+ + +D K + + I+ V+ P +
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348
Query: 150 ---LLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
L+ R+ +P RI H +F K
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 9e-13
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVL 85
I HRD+K N ++ S +K+ DFG + S ++ + +GT Y++PE
Sbjct: 134 QNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFE 115
D + +DV+S G LY +L G PF
Sbjct: 192 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFT 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 51/183 (27%), Positives = 76/183 (41%), Gaps = 41/183 (22%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKST-------VGTPA 78
+ HRDLK N L++ + LK+CDFG +S+ +S P V T
Sbjct: 130 GSNVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 79 YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED----------PKN 122
Y APEV L+ +Y + DVWSCG L + + F Q N
Sbjct: 188 YRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 123 FRKTISRIMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171
+ I A +Y +P + ++ +LL R+ V +P++RIT KE H
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 172 PWF 174
P+
Sbjct: 307 PYL 309
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-12
Identities = 41/182 (22%), Positives = 65/182 (35%), Gaps = 41/182 (22%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 182 SAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFE------------------DQED------------ 119
Y + D+WS G + M+ F E
Sbjct: 240 YK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 120 -------PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 172
F K + + + R+LLS++ V +P++RI++ + HP
Sbjct: 299 ENRPKYAGLTFPKLFPDSLFPADSEHNK-LKASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 173 WF 174
+
Sbjct: 358 YI 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 43/206 (20%), Positives = 66/206 (32%), Gaps = 60/206 (29%)
Query: 32 QICHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSLLHSRPKST- 73
Q+ H DLK EN L S +++ DFG S+ +T
Sbjct: 143 QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHEHHTTI 199
Query: 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLY---------------------VMLVGAY 112
V T Y PEV+ + DVWS G L+ ++G
Sbjct: 200 VATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 113 P------------FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD-----CRNLLSRIF 155
P F + + R + K + +L+ R+
Sbjct: 259 PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318
Query: 156 VANPSRRITIKEIKSHPWFLKNLPRE 181
+P++RIT+ E HP+F P E
Sbjct: 319 EFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-10
Identities = 38/179 (21%), Positives = 67/179 (37%), Gaps = 39/179 (21%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRP-KSTVGTPAYIAPEV 84
+I HRD+K N L+ LK+ DFG +S + + V T Y PE+
Sbjct: 142 RNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199
Query: 85 L-SRREYDGKLADVWSCGVTLYVMLVGAYPF------EDQ-------------------- 117
L R+Y + D+W G + M + P + Q
Sbjct: 200 LLGERDYGPPI-DLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 118 --EDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
E + + V+ ++ YV +L+ ++ V +P++RI + +H +F
Sbjct: 258 NYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 67/209 (32%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---------------- 73
S + HRD+K N LL+ +K+ DFG S+S + R +
Sbjct: 127 SGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 74 ------VGTPAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVG---------------- 110
V T Y APE+ L +Y K D+WS G L +L G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 111 -------------------------AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
+ + + N R ++ + KI ++
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ +LL ++ NP++RI+ + HP+
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 43/207 (20%), Positives = 71/207 (34%), Gaps = 61/207 (29%)
Query: 32 QICHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSLLHSRPKST- 73
++ H DLK EN L S P +K+ DFG S+ ST
Sbjct: 138 KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDEHHSTL 194
Query: 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLY---------------------VMLVGAY 112
V T Y APEV+ + DVWS G L ++G
Sbjct: 195 VSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 113 P-------------FEDQEDPKNFRKTISRIMAVQYKIPDYVHIS----QDCRNLLSRIF 155
P D+ D + + +++ + +L+ ++
Sbjct: 254 PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313
Query: 156 VANPSRRITIKEIKSHPWFLKNLPREL 182
+P++RIT++E HP+F L + +
Sbjct: 314 EYDPAKRITLREALKHPFF-DLLKKSI 339
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 46/222 (20%), Positives = 67/222 (30%), Gaps = 80/222 (36%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----------- 78
I HRDLK N LL+ +K+CDFG +++
Sbjct: 147 ESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 79 ------------YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVG--------------- 110
Y APE+ L + Y K D+WS G +L
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263
Query: 111 ---------AYPFEDQEDPKNFRKTISRIM------------------AVQY--KIPD-- 139
+ K+ R ++ I ++Y P
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323
Query: 140 -------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
Y IS D NLL + NP++RITI + HP+
Sbjct: 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 4e-09
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 17/100 (17%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-----GTPAYIAPEVL 85
HRD+K N LLD + KI DFG ++ ++ + GT AY+APE L
Sbjct: 152 NHHIHRDIKSANILLDEAFTA--KISDFGLAR--ASEKFAQTVMTSRIVGTTAYMAPEAL 207
Query: 86 SRREYDGKL---ADVWSCGVTLYVMLVGAYPFEDQEDPKN 122
G++ +D++S GV L ++ G ++ +P+
Sbjct: 208 R-----GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 35/166 (21%), Positives = 54/166 (32%), Gaps = 45/166 (27%)
Query: 51 PRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG 110
++KI D G + +H + T Y + EVL Y+ AD+WS + + G
Sbjct: 233 LKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATG 289
Query: 111 AYPFE--DQEDPKNFRKTISRIMAVQYKIP------------------DYVHIS------ 144
Y FE E+ I+ I+ + K+P D HI+
Sbjct: 290 DYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349
Query: 145 ----------------QDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ L + P +R T E HPW
Sbjct: 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 4e-08
Identities = 42/282 (14%), Positives = 83/282 (29%), Gaps = 73/282 (25%)
Query: 4 GVSSLSEFVMLEGSVKMKPD--IFFSSLS------------QQICHRDLKLENTLLDGSP 49
G + ++ V L V+ K D IF+ +L Q++ ++ + D S
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS 221
Query: 50 APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS---------- 99
+L+I LL S+P + VL +V +
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYEN----CLL---VL-----L----NVQNAKAWNAFNLS 265
Query: 100 C---------GVTLYVMLVGAYPFEDQEDPKNFRKTISR-IMAVQYKIPDYVHIS-QDCR 148
C VT ++ + ++ Y+ QD
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL------KYLDCRPQDLP 319
Query: 149 NLLSRIFVANPSRRITI--KEIKSHP--W-FLKNLPRELTETAQAIYYRKENPTFSLQSV 203
+ NP RR++I + I+ W K++ + T P +
Sbjct: 320 REVLTT---NP-RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF 375
Query: 204 EEITKIVEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADE 245
+ ++ A +P + I W D + + ++
Sbjct: 376 DRLSVFPPSAHIPTILLSLI----WF---DVIKSDVMVVVNK 410
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 38/207 (18%), Positives = 64/207 (30%), Gaps = 68/207 (32%)
Query: 32 QICHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSSLLHS 68
+ H DLK EN LLD +K+ DFG + S
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CATFKS 213
Query: 69 RPKST-VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED------ 119
+ + T Y APEV+ +D D+WS G L + G+ + + +
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLLFRTHEHMEHLAMME 272
Query: 120 ------PKNFRKTISRIMAVQY--------------KIPDYVHISQDCR----------- 148
PKN ++ +Y + + + C
Sbjct: 273 SIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332
Query: 149 -NLLSRIFVANPSRRITIKEIKSHPWF 174
+ L I +P+ R + E+ H +
Sbjct: 333 CDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 1e-07
Identities = 30/80 (37%), Positives = 36/80 (45%), Gaps = 17/80 (21%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-----GTPAYIAPEVLSR 87
I HRD+K N LLD + DFG +K L + V GT +IAPE LS
Sbjct: 155 IIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVRGTIGHIAPEYLST 209
Query: 88 REYDGKL---ADVWSCGVTL 104
GK DV+ GV L
Sbjct: 210 ----GKSSEKTDVFGYGVML 225
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-07
Identities = 35/84 (41%), Positives = 44/84 (52%), Gaps = 12/84 (14%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STV--GTPAYIAPEVLSRRE 89
I HRD+K N LLD + P KI DFG SK + STV GT YI PE +
Sbjct: 160 IIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-- 215
Query: 90 YDGKL---ADVWSCGVTLYVMLVG 110
G+L +DV+S GV L+ +L
Sbjct: 216 --GRLTEKSDVYSFGVVLFEVLCA 237
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 33/112 (29%), Positives = 45/112 (40%), Gaps = 12/112 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYI-----APE 83
S++ HRDL N L+ S A +KI DFG +K LL V P APE
Sbjct: 145 SRRCVHRDLAARNILV-ESEA-HVKIADFGLAK--LLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 84 VLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQ 134
LS + + +DVWS GV LY + + + A+
Sbjct: 201 SLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 37/158 (23%), Positives = 64/158 (40%), Gaps = 19/158 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
S+ HRDL N L+ LKI DFG S+ + G + APE
Sbjct: 231 SKCCIHRDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEA 286
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
L+ Y + +DVWS G+ L+ +GA P+ + N ++T + ++P
Sbjct: 287 LNYGRYSSE-SDVWSFGILLWETFSLGASPYPNL---SN-QQTREFVEK-GGRLPCPELC 340
Query: 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
L+ + + P +R + I L+++ +
Sbjct: 341 PDAVFRLMEQCWAYEPGQRPSFSTIY---QELQSIRKR 375
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 10/88 (11%), Positives = 20/88 (22%), Gaps = 29/88 (32%)
Query: 33 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 92
+ + S + + PA +
Sbjct: 150 VALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA--------N 180
Query: 93 KLADVWSCGVTLYVMLVGAYPFEDQEDP 120
D+ G +LY +LV +P +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVR 208
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-06
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 9/81 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
+++ HRDL N L+ + R+KI DFG +K L + V P APE
Sbjct: 132 TKRYIHRDLATRNILV-ENEN-RVKIGDFGLTKV-LPQDKEFFKVKEPGESPIFWYAPES 188
Query: 85 LSRREYDGKLADVWSCGVTLY 105
L+ ++ +DVWS GV LY
Sbjct: 189 LTESKFSVA-SDVWSFGVVLY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 9/81 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
+++ HRDL N L+ + R+KI DFG +K L + V P APE
Sbjct: 163 TKRYIHRDLATRNILV-ENEN-RVKIGDFGLTKV-LPQDKEYYKVKEPGESPIFWYAPES 219
Query: 85 LSRREYDGKLADVWSCGVTLY 105
L+ ++ +DVWS GV LY
Sbjct: 220 LTESKFSVA-SDVWSFGVVLY 239
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 5e-06
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 7/86 (8%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT--P-AYIAPEVLSRREYD 91
HRDL N L+ +P +KI DFG +K + G P ++A E + R Y
Sbjct: 140 HRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 92 GKLADVWSCGVTLY-VMLVGAYPFED 116
+ +DVWS GVT++ +M G+ P++
Sbjct: 198 HQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 5e-06
Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY--IAPEVLSR 87
+ HR+L N L+ + +K+ DFG S+ + APE L+
Sbjct: 336 KKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 88 REYDGKLADVWSCGVTLY-VMLVGAYPFED 116
++ K +DVW+ GV L+ + G P+
Sbjct: 394 NKFSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-06
Identities = 38/190 (20%), Positives = 67/190 (35%), Gaps = 46/190 (24%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----------- 78
S I HRDLK N L++ +K+CDFG +++ S +
Sbjct: 174 SAGILHRDLKPANCLVNQDC--SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 79 -----------------YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP 120
Y APE+ L + Y + DVWS G +L ++
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIFAELLNMI---KENVAY 287
Query: 121 KNFRKTI------SRIMAVQYKIPDYVHISQDCRNLLSRIF--VANPSRRITIKEIKSHP 172
R + + Q D+ ++ R+ L+ IF + PS I+ ++
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEE-DIEALEKED 346
Query: 173 W--FLKNLPR 180
+++ P+
Sbjct: 347 AKRYIRIFPK 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 5e-06
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 7/102 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPA-YIAPEVLS 86
S++ HRDL N LL +KICDFG ++ K P ++APE +
Sbjct: 211 SRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 268
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTI 127
R Y + +DVWS GV L+ + +GA P+ + + F + +
Sbjct: 269 DRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 6e-06
Identities = 22/90 (24%), Positives = 34/90 (37%), Gaps = 6/90 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY--IAPEVLSR 87
HRDL+ N L+ + K+ DFG ++ + APE
Sbjct: 298 RMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 88 REYDGKLADVWSCGVTLY-VMLVGAYPFED 116
+ K +DVWS G+ L + G P+
Sbjct: 356 GRFTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 6e-06
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 10/93 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
S++ HRDL N LL + +KI DFG ++ L + + + APE
Sbjct: 139 SKRFIHRDLAARNLLL-ATRD-LVKIGDFGLMRA-LPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
L R + +D W GVTL+ + G P+
Sbjct: 196 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 7e-06
Identities = 22/90 (24%), Positives = 34/90 (37%), Gaps = 6/90 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY--IAPEVLSR 87
HRDL+ N L+ + K+ DFG ++ + APE
Sbjct: 381 RMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 88 REYDGKLADVWSCGVTLY-VMLVGAYPFED 116
+ K +DVWS G+ L + G P+
Sbjct: 439 GRFTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-05
Identities = 28/81 (34%), Positives = 37/81 (45%), Gaps = 9/81 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
+Q HRDL N LL + +KI DFG +K+ + V APE
Sbjct: 152 AQHYIHRDLAARNVLL-DNDR-LVKIGDFGLAKA-VPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 85 LSRREYDGKLADVWSCGVTLY 105
L ++ +DVWS GVTLY
Sbjct: 209 LKEYKFYYA-SDVWSFGVTLY 228
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 12/91 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLS 86
HRDL N L+ K+ DFG +K + + + APE L
Sbjct: 307 GNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALR 359
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
+++ K +DVWS G+ L+ + G P+
Sbjct: 360 EKKFSTK-SDVWSFGILLWEIYSFGRVPYPR 389
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
+ HR+L N LL SP+ ++++ DFG + LL K + + A A E
Sbjct: 133 EHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALES 188
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
+ +Y + +DVWS GVT++ +M GA P+
Sbjct: 189 IHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 8/92 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYI---APEVL 85
HRDL N L+D + K+ DFG S+ +T G I APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 86 SRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
+ R + +DVWS GV ++ V+ G P+ +
Sbjct: 227 AFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 29/94 (30%), Positives = 41/94 (43%), Gaps = 12/94 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGT--P-AYIAPE 83
HRDL N LL + KI DFG SK L + K+ P + APE
Sbjct: 135 ESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPE 190
Query: 84 VLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
++ ++ K +DVWS GV ++ G P+
Sbjct: 191 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 11/88 (12%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVLSRRE 89
HRDL N L+ +P +KI DFG +K LL + K + A E + R
Sbjct: 140 HRDLAARNVLV-KTPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 90 YDGKLADVWSCGVTLY-VMLVGAYPFED 116
Y + +DVWS GVT++ +M G+ P++
Sbjct: 196 YTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 29/82 (35%), Positives = 42/82 (51%), Gaps = 11/82 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYI-----APE 83
S+Q HRDL N L+ S ++KI DFG +K + + + TV APE
Sbjct: 144 SRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 84 VLSRREYDGKLADVWSCGVTLY 105
L + ++ +DVWS GVTL+
Sbjct: 200 CLMQSKFYIA-SDVWSFGVTLH 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 37/177 (20%), Positives = 66/177 (37%), Gaps = 30/177 (16%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
+ HRDL N LL + KI DFG SK+ L T + APE
Sbjct: 128 EKNFVHRDLAARNVLL-VNRH-YAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAPEC 184
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRI-----MAVQYKIP 138
++ R++ + +DVWS GVT++ + G P++ K + ++ I M + P
Sbjct: 185 INFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKM---KG-PEVMAFIEQGKRMECPPECP 239
Query: 139 DYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE 194
++ + DC R ++ ++ L + ++
Sbjct: 240 PELYALMSDCWI-------YKWEDRPDFLTVE---QRMRACYYSLASKVEGHHHHHH 286
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYI---APEVL 85
+ HRDL N L++ + K+ DFG S+ +T G I APE +
Sbjct: 165 NMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 86 SRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
S R++ +DVWS G+ ++ VM G P+ +
Sbjct: 223 SYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 7e-05
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 12/89 (13%)
Query: 35 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYI---APEVLSRR 88
HR+L N LL + KI DFG SK L + + + APE ++ R
Sbjct: 459 HRNLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 89 EYDGKLADVWSCGVTLY-VMLVGAYPFED 116
++ + +DVWS GVT++ + G P++
Sbjct: 515 KFSSR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 8e-05
Identities = 25/92 (27%), Positives = 37/92 (40%), Gaps = 10/92 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYI-----APE 83
HRD+ N LL R+ KI DFG ++ ++ G A + PE
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKWMPPE 215
Query: 84 VLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 114
+ K D WS GV L+ + +G P+
Sbjct: 216 AFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 8e-05
Identities = 25/93 (26%), Positives = 39/93 (41%), Gaps = 16/93 (17%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
HRDL N L+ S K+ DFG + + S+ + APE
Sbjct: 135 GNNFVHRDLAARNVLV--SEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWTAPEA 185
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
L +++ K +DVWS G+ L+ + G P+
Sbjct: 186 LREKKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 9e-05
Identities = 25/92 (27%), Positives = 37/92 (40%), Gaps = 10/92 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYI-----APE 83
HRD+ N LL R+ KI DFG ++ ++ G A + PE
Sbjct: 199 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGYYRKGGCAMLPVKWMPPE 256
Query: 84 VLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 114
+ K D WS GV L+ + +G P+
Sbjct: 257 AFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 9e-05
Identities = 39/183 (21%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
S++ HRDL N L+ + +KI DFG ++ +H T + APE
Sbjct: 209 SKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMAPEA 264
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
L R Y + +DVWS GV L+ + +G P+ + F+ +++ +
Sbjct: 265 LFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-----HRMDKPSNC 318
Query: 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSV 203
+ + ++ + A PS+R T K++ L + + Y+ + + + +
Sbjct: 319 TNELYMMMRDCWHAVPSQRPTFKQLV---EDLDRIVALTSNQEMGYYHHHHHHDYDIPTT 375
Query: 204 EEI 206
E +
Sbjct: 376 ENL 378
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYI---APE 83
HRDL N L++ + K+ DFG + +L P +T G I +PE
Sbjct: 165 DMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 84 VLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
++ R++ +DVWS G+ L+ VM G P+ +
Sbjct: 221 AIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 8/91 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLS 86
+ HRDL+ N L+ S KI DFG ++ + + + G I APE ++
Sbjct: 302 QRNYIHRDLRAANILVSASLV--CKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAIN 358
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
+ K +DVWS G+ L ++ G P+
Sbjct: 359 FGSFTIK-SDVWSFGILLMEIVTYGRIPYPG 388
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 6/90 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-PA-YIAPEVLSR 87
+ HRDL N L+ + +K+ DFG S+ + P + APE L+
Sbjct: 129 KKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 88 REYDGKLADVWSCGVTLY-VMLVGAYPFED 116
++ K +DVW+ GV L+ + G P+
Sbjct: 187 NKFSIK-SDVWAFGVLLWEIATYGMSPYPG 215
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 1e-04
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLS 86
+ HRDL N L+ + +K+ DFG ++ +L + S+ GT + +PEV S
Sbjct: 122 EACVIHRDLAARNCLVGENQV--IKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
Y K +DVWS GV ++ V G P+E+
Sbjct: 179 FSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 1e-04
Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLS 86
S Q HRDL N L+D +K+ DFG ++ +L + S+VGT + APEV
Sbjct: 122 SHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
+Y K +DVW+ G+ ++ V +G P++
Sbjct: 179 YFKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 24/94 (25%), Positives = 40/94 (42%), Gaps = 14/94 (14%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG------TPAYIAPE 83
+ HRDL+ N L+ + + KI DFG ++ + T APE
Sbjct: 127 ERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWT----APE 180
Query: 84 VLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
++ + K +DVWS G+ L ++ G P+
Sbjct: 181 AINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 22/173 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
SQ+ HRDL N L+ + +KI DFG ++ +++ T + APE
Sbjct: 175 SQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEA 230
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
L R Y + +DVWS GV ++ + +G P+ + F+ +++ +
Sbjct: 231 LFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-----HRMDKPANC 284
Query: 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP 196
+ + ++ + A PS+R T K++ L R LT T Y P
Sbjct: 285 TNELYMMMRDCWHAVPSQRPTFKQLVED------LDRILTLTTNEEYLDLSQP 331
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 4e-04
Identities = 39/151 (25%), Positives = 61/151 (40%), Gaps = 21/151 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
S+ HRD+ N LL + KI DFG ++ + + V A + APE
Sbjct: 182 SKNCIHRDVAARNVLL--TNGHVAKIGDFGLAR--DIMNDSNYIVKGNARLPVKWMAPES 237
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISR--IMAVQYKIPDYV 141
+ Y + +DVWS G+ L+ + +G P+ F K + MA P +
Sbjct: 238 IFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNI 296
Query: 142 H-ISQDCRNLLSRIFVANPSRRITIKEIKSH 171
+ I Q C P+ R T ++I S
Sbjct: 297 YSIMQACWA-------LEPTHRPTFQQICSF 320
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 4e-04
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 22/164 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
SQ+ HRDL N L+ + +KI DFG ++ +++ T + APE
Sbjct: 221 SQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYKKTTNGRLPVKWMAPEA 276
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
L R Y + +DVWS GV ++ + +G P+ + F+ +++ +
Sbjct: 277 LFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-----HRMDKPANC 330
Query: 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ 187
+ + ++ + A PS+R T K++ L R LT T
Sbjct: 331 TNELYMMMRDCWHAVPSQRPTFKQLVED------LDRILTLTTN 368
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 26/91 (28%), Positives = 42/91 (46%), Gaps = 11/91 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
S+ HRDL N +L + + DFG S+ ++S G + + A E
Sbjct: 155 SRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYYRQGCASKLPVKWLALES 210
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPF 114
L+ Y +DVW+ GVT++ +M G P+
Sbjct: 211 LADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 5e-04
Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 11/90 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
S+ HRDL N LL KICDFG ++ + + V A + APE
Sbjct: 163 SKNCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKNDSNYVVKGNARLPVKWMAPES 218
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYP 113
+ Y + +DVWS G+ L+ + +G+ P
Sbjct: 219 IFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 6e-04
Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 23/157 (14%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
SQ HRDL N L+ +KI DFG S+ ++S VG + PE
Sbjct: 151 SQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPES 206
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS-RIMAVQYKIPDYVH 142
+ R++ + +DVWS GV L+ + G P+ + + R++ P V+
Sbjct: 207 IMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY 265
Query: 143 -ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178
+ C P +R+ IKEI L L
Sbjct: 266 DVMLGCWQ-------REPQQRLNIKEIY---KILHAL 292
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 6e-04
Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLS 86
S+Q HRDL N L++ +K+ DFG S+ +L S+VG+ + PEVL
Sbjct: 138 SKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM 194
Query: 87 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 116
++ K +D+W+ GV ++ + +G P+E
Sbjct: 195 YSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 6e-04
Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 11/91 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
S++ HRDL N LL +KICDFG ++ ++ P A + APE
Sbjct: 166 SRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKGDARLPLKWMAPET 221
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPF 114
+ R Y + +DVWS GV L+ + +GA P+
Sbjct: 222 IFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 7e-04
Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
++ HRDL N +L + + DFG SK ++S G A + A E
Sbjct: 165 NRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYRQGRIAKMPVKWIAIES 220
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYPF 114
L+ R Y K +DVW+ GVT++ + G P+
Sbjct: 221 LADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 9e-04
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 14/90 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 84
+Q HRDL N L+ + KI DFG S+ ++ T + A E
Sbjct: 160 QKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVY-----VKKTMGRLPVRWMAIES 212
Query: 85 LSRREYDGKLADVWSCGVTLY-VMLVGAYP 113
L+ Y +DVWS GV L+ ++ +G P
Sbjct: 213 LNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 265 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.98 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.98 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.98 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.98 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.98 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.98 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.98 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.91 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.67 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.41 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.23 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.78 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.69 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.64 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.45 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 95.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.88 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.19 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.26 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 93.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.57 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 93.38 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 93.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 93.07 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 92.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.72 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.42 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 89.97 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 89.74 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 87.86 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.01 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 83.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 81.44 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=316.65 Aligned_cols=173 Identities=36% Similarity=0.604 Sum_probs=137.4
Q ss_pred CcccccchHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK 71 (265)
Q Consensus 1 me~~~~sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 71 (265)
||||+++|.+++..++. ++|++.||.|||++||+||||||+|||++.++. +||+|||+|+.........
T Consensus 92 mEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~~ 169 (275)
T 3hyh_A 92 IEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFLK 169 (275)
T ss_dssp EECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC----------
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCccC
Confidence 89999999999987653 778999999999999999999999999988776 9999999998665555556
Q ss_pred CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 024572 72 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151 (265)
Q Consensus 72 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 151 (265)
+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+.. .....+.......| ..+++++++||
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~~i~~~~~~~p--~~~s~~~~~li 243 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFKNISNGVYTLP--KFLSPGAAGLI 243 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCC--TTSCHHHHHHH
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCCCCCC--CCCCHHHHHHH
Confidence 6789999999999999888777799999999999999999999875432 33344444444444 36899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCcccCCCCChh
Q 024572 152 SRIFVANPSRRITIKEIKSHPWFLKNLPRE 181 (265)
Q Consensus 152 ~~~L~~dP~~R~s~~ell~h~~f~~~~~~~ 181 (265)
.+||..||.+|||+.++++||||+..+|..
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~~~p~~ 273 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKVDLPEY 273 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHTTCCGG
T ss_pred HHHccCChhHCcCHHHHHcCcccccCCChh
Confidence 999999999999999999999998877653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=310.62 Aligned_cols=173 Identities=27% Similarity=0.469 Sum_probs=142.1
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~ 70 (265)
||||.+ +|.+++.... ++.|++.+|.|||++|||||||||+||||+.++. +||+|||+|+..... ...
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCB
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCcc
Confidence 899986 9999887543 3778999999999999999999999999998876 999999999865433 334
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
.+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+......+..+.. ......+.+..+++++++|
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SSCCCCSCGGGSCHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCCccccCCHHHHHH
Confidence 567899999999999988885 559999999999999999999987654433322211 1222334455789999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
|.+||..||++|||+.++++||||++..+
T Consensus 304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999999999999999999999987654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=305.24 Aligned_cols=168 Identities=28% Similarity=0.528 Sum_probs=140.9
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
||||.+ +|.+++..++. +.||+.+|.|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCc
Confidence 899977 99999987653 678999999999999999999999999988776 999999999865432
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
....+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+.. ..+..+....+.+|. .+++++
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~~~~~~p~--~~s~~~ 261 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKIIKLEYDFPE--KFFPKA 261 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCT--TCCHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCc--ccCHHH
Confidence 233456899999999999988875 5699999999999999999999876543 334444455555554 689999
Q ss_pred HHHHHHhcccCCCCCCCHHH------HhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKE------IKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~e------ll~h~~f~~~ 177 (265)
++||.+||.+||.+|||+.| +++||||+.-
T Consensus 262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 99999999999999999988 5899999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=299.15 Aligned_cols=169 Identities=22% Similarity=0.391 Sum_probs=134.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcC--ceecCCCcCcEEEcC-CCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQ--ICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~--ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||||.+ +|.+++...+ ++.||+.||.|||++| ||||||||+|||+++ ++. +||+|||+|+... .
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~~-~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR-A 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGCC-T
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEeCC-C
Confidence 799976 9999998764 3678999999999999 999999999999975 454 9999999997433 3
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
....+.+||+.|||||++.+ .|+ .++|||||||++|+|+||+.||.+......+.. .+.....+...+..+++++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~ 259 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCHHH
T ss_pred CccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH---HHHcCCCCCCCCccCCHHH
Confidence 33445689999999999875 464 569999999999999999999987655443332 2332222222334578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++||.+||..||++|||+.++++||||++.
T Consensus 260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=311.82 Aligned_cols=173 Identities=27% Similarity=0.469 Sum_probs=142.2
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~ 70 (265)
||||.+ +|.+++.... ++.+|+.||.|||++|||||||||+||||+.++. +||+|||+|+..... ...
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCB
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCccc
Confidence 899986 9999887543 3778999999999999999999999999998876 999999999865433 334
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
.+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+......+..+.. ......+.+..+++++++|
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSCTTSSCHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCcccccCCHHHHHH
Confidence 567899999999999988885 559999999999999999999987654433322211 1222344555789999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
|.+||..||.+|||+.++|+||||++..+
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 99999999999999999999999987544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=301.44 Aligned_cols=168 Identities=33% Similarity=0.501 Sum_probs=138.8
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||||.+ +|.+++..++. +.|++.+|.|||++|||||||||+|||++.++. +||+|||+|+.... ...
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----CC
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCCcc
Confidence 899976 99999987653 678999999999999999999999999998876 99999999985433 334
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
..+.+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+... .+..+.......| ..+|+++++
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~ 255 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTMILKAKLGMP--QFLSPEAQS 255 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTSCHHHHH
T ss_pred ccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHH----HHHHHHcCCCCCC--CcCCHHHHH
Confidence 4567899999999999988876 45999999999999999999998765433 3333444444444 468999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
||.+||..||.+||| ++++++||||+..
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 999999999999998 5799999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=308.16 Aligned_cols=174 Identities=24% Similarity=0.384 Sum_probs=141.9
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||||.+ +|.+++..+. ++.||+.+|.|||++|||||||||+||||+.++. +||+|||+|+......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTV 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCc
Confidence 899975 9999997542 3678999999999999999999999999988776 9999999998554321
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.....+||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+....+ ..+....+ .+.+..+++++
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i~~~~~-~~~~~~~s~~~ 253 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLV----LKIISGSF-PPVSLHYSYDL 253 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCC-CCCCTTSCHHH
T ss_pred ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHcCCC-CCCCccCCHHH
Confidence 12345799999999999988875 5599999999999999999999876543333 33333333 23445789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCChhh
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~~~ 182 (265)
++||.+||..||.+|||+.++|+||||++...+.+
T Consensus 254 ~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~ 288 (350)
T 4b9d_A 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFL 288 (350)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGGGTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHHhhcCCCcCC
Confidence 99999999999999999999999999987665443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=303.50 Aligned_cols=221 Identities=60% Similarity=0.997 Sum_probs=156.2
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++...+ ++.+++.+|.|||++||+||||||+|||++.++.+++||+|||+++........
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 788854 9999886544 377899999999999999999999999998777667999999999755444455
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....||+.|+|||++.+..+.++++|||||||++|+|++|+.||.+......+...+..+.......+....+++.+++|
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence 56679999999999988888777689999999999999999999887766666777777777777777777899999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCChhhHHHHHHHhhhcCCCCCCCcCHHHHHHHHHHhCCCCCcccc
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRS 222 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (265)
|.+||..||.+|||+.++++||||.+..+......... ......+....++.+.+.+.+.....+....+.
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (361)
T 3uc3_A 255 ISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNT-GSQFQEPEQPMQSLDTIMQIISEATIPAVRNRC 325 (361)
T ss_dssp HHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC-------------------CCHHHHHHHHHHHTCC------
T ss_pred HHHHccCChhHCcCHHHHHhCcchhcCCchhhhccccc-cccccCCcccccCHHHHHHHHhhccCccccccc
Confidence 99999999999999999999999988776554322211 122233345567788888888877776654443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=304.40 Aligned_cols=176 Identities=24% Similarity=0.285 Sum_probs=142.1
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-----
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL----- 66 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~----- 66 (265)
|||++++|.+++..++ ++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+....
T Consensus 138 mE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~~~~~~ 215 (398)
T 4b99_A 138 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTSPAEH 215 (398)
T ss_dssp EECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecccCcccc
Confidence 8999999999987544 4788999999999999999999999999998776 99999999975432
Q ss_pred CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-----------
Q 024572 67 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY----------- 135 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 135 (265)
.....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+....+..+.........
T Consensus 216 ~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~ 295 (398)
T 4b99_A 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 295 (398)
T ss_dssp CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CH
T ss_pred ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhh
Confidence 223345689999999999988777677799999999999999999999987766555554433211110
Q ss_pred -----cCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 136 -----KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 136 -----~~~~---------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
..+. +..+++++++||.+||.+||.+|||+.++|+||||++..
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 296 RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0110 124689999999999999999999999999999998643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=297.62 Aligned_cols=175 Identities=25% Similarity=0.403 Sum_probs=131.5
Q ss_pred Cccccc-chHHHHH------HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC------
Q 024572 1 MQLGVS-SLSEFVM------LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH------ 67 (265)
Q Consensus 1 me~~~~-sL~~~~~------~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~------ 67 (265)
|||+.+ +|.+++. .+.++.|++.||.|||++|||||||||+|||++.+. +.+||+|||+|+.....
T Consensus 99 mE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~~~~ 177 (361)
T 4f9c_A 99 MPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIELLK 177 (361)
T ss_dssp EECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCGGGG
T ss_pred EeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccccccc
Confidence 799864 8988874 344588899999999999999999999999998652 25999999999743221
Q ss_pred -----------------------CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHH
Q 024572 68 -----------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR 124 (265)
Q Consensus 68 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 124 (265)
......+||+.|+|||++.+...++.++||||+||++|+|++|+.||....+.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l 257 (361)
T 4f9c_A 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL 257 (361)
T ss_dssp GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 112345799999999999887655677999999999999999999997665433222
Q ss_pred HHHHHHhh-----------------------------------hc--------------ccCCCCCCCCHHHHHHHHHhc
Q 024572 125 KTISRIMA-----------------------------------VQ--------------YKIPDYVHISQDCRNLLSRIF 155 (265)
Q Consensus 125 ~~~~~~~~-----------------------------------~~--------------~~~~~~~~~~~~~~~li~~~L 155 (265)
..+..+.. .. .....+..+++++++||.+||
T Consensus 258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL 337 (361)
T 4f9c_A 258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLL 337 (361)
T ss_dssp HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHT
T ss_pred HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 11111100 00 011223467899999999999
Q ss_pred ccCCCCCCCHHHHhcCcccCC
Q 024572 156 VANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 156 ~~dP~~R~s~~ell~h~~f~~ 176 (265)
.+||.+|+|+.|+|+||||+.
T Consensus 338 ~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 338 DLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp CSCTTTSCCHHHHHTSGGGTT
T ss_pred cCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=295.35 Aligned_cols=171 Identities=23% Similarity=0.277 Sum_probs=136.3
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||||.+ +|.+++..++. +.|++.+|.|||++|||||||||+||||+.++. ++||+|||+|+......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcc
Confidence 899986 99999987653 678999999999999999999999999987752 49999999998654322
Q ss_pred ----CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC-CCCCCC
Q 024572 69 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-PDYVHI 143 (265)
Q Consensus 69 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 143 (265)
.....+||+.|||||++.+..|+. ++|||||||++|+|++|+.||.+......+..+.. ..... ..+..+
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~ 282 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDA-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPPIREIPPSC 282 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCGGGGSCTTS
T ss_pred cceecCCccccCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCCchhcCccC
Confidence 123357999999999999988764 59999999999999999999988665544443332 12111 123468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHH-------------hcCcccCCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEI-------------KSHPWFLKN 177 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~el-------------l~h~~f~~~ 177 (265)
++.+++||.+||.+||.+|||+.|+ ++|||+...
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 9999999999999999999999997 578998654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=302.41 Aligned_cols=171 Identities=26% Similarity=0.367 Sum_probs=140.4
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
|||+.+ +|.+++..++. +.+|+.||.|||++|||||||||+||||+.++. +||+|||+|+.... ...
T Consensus 271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~-~~~ 347 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-KKP 347 (689)
T ss_dssp ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-CCC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC-CCC
Confidence 899976 99999987663 678999999999999999999999999998876 99999999986543 334
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
.+.+||+.|||||++.+...++.++|||||||++|+|++|++||.+..... ...+...+.......| ..+++++++|
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p--~~~S~~a~dL 424 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELP--DSFSPELRSL 424 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCC--ccCCHHHHHH
Confidence 567899999999999754434566999999999999999999997654322 2233444444444444 4689999999
Q ss_pred HHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
|.+||..||.+|++ +.+|++||||+..
T Consensus 425 I~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 99999999999998 7999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=280.15 Aligned_cols=169 Identities=21% Similarity=0.277 Sum_probs=127.7
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-- 67 (265)
||||.+ +|.+++..+. ++.+++.||.|||+++||||||||+|||++.++. +||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCc
Confidence 799986 9999997543 3678899999999999999999999999998775 999999999754322
Q ss_pred -CCCCCCcCCCCCcccccccCCc--CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 68 -SRPKSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 68 -~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
......+||+.|||||++.+.. ..+.++|||||||++|+|+||+.||.+..........+............+..++
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 2234557999999999997532 2345699999999999999999999887665444333322111111112244689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.+.+||.+||..||++|||+.+++++
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999988654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=281.58 Aligned_cols=166 Identities=22% Similarity=0.334 Sum_probs=123.4
Q ss_pred Cccccc-chHHHHHHhc------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||||.+ +|.+++..++ ++.|++.||.|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 94 mE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DFGla~~~~~~ 171 (299)
T 4g31_A 94 MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQD 171 (299)
T ss_dssp EECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCCCC------
T ss_pred EecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccCccceecCCC
Confidence 799976 9999997543 3568899999999999999999999999988776 999999999754332
Q ss_pred C-------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc
Q 024572 68 S-------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 134 (265)
Q Consensus 68 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 134 (265)
. .....+||+.|||||++.+..|+ .++|||||||++|+|++ ||.... .....+..+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~---~~~~~~~~~~~~~ 244 (299)
T 4g31_A 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQM---ERVRTLTDVRNLK 244 (299)
T ss_dssp --------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHH---HHHHHHHHHHTTC
T ss_pred ccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCcc---HHHHHHHHHhcCC
Confidence 1 12335799999999999988875 55999999999999996 775421 1122222222222
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 135 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 135 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
+ .+.+...++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 245 ~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 245 F-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp C-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 1 1122245677889999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=301.23 Aligned_cols=172 Identities=26% Similarity=0.467 Sum_probs=142.8
Q ss_pred Cccccc-chHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
|||+.+ +|.+++..+ .++.||+.+|.|||++||+||||||+|||++.+..+.+||+|||+|+.......
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 789875 999988643 247889999999999999999999999999876555699999999987665555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 147 (265)
....+||+.|+|||++.+..|. .++|||||||++|+|++|+.||.+...... +..+....+.++ .+..+++++
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDET----LRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTTCCCCCSGGGTTSCHHH
T ss_pred eeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----HHHHHhCCCCCCcccccCCCHHH
Confidence 5567899999999999998875 559999999999999999999988665433 333344433333 345789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++||.+||..||.+|||+.++|+||||+..
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999999854
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=279.34 Aligned_cols=164 Identities=23% Similarity=0.347 Sum_probs=134.3
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||||.+ +|.+++..+. ++.||+.|+.|||+++||||||||+|||++.++. +|
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--vK 225 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VK 225 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EE
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC--EE
Confidence 799987 9999997532 2567999999999999999999999999998876 99
Q ss_pred EeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+|+....... ....+||+.|||||++.+..|+ .++|||||||++|||+| |+.||.+......+...+..
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~- 303 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE- 303 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc-
Confidence 999999986543322 2234689999999999988875 55999999999999998 89999887655444443322
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
..+.+.+..+++++.+||.+||..||.+|||+.+|++|
T Consensus 304 ---g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 304 ---GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 23344455789999999999999999999999999987
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=271.31 Aligned_cols=163 Identities=21% Similarity=0.305 Sum_probs=132.8
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||||.+ +|.+++..+. ++.+|+.|+.|||+++||||||||+||||+.++. +|
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--~K 185 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VK 185 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--EE
Confidence 789876 9999996532 4668999999999999999999999999998876 99
Q ss_pred EeccCCcccCCCC---CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+|+..... ......+||+.|||||++.+..++ .++|||||||++|||+| |+.||.+...... +..+
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~----~~~i 260 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV----VEMI 260 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH----HHHH
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHH----HHHH
Confidence 9999999754322 223345799999999999988875 55999999999999998 8999988654332 2222
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.. ....|.+..+++.+.+||.+||..||.+|||+.+|+++
T Consensus 261 ~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22 23345566899999999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=273.11 Aligned_cols=163 Identities=20% Similarity=0.325 Sum_probs=125.9
Q ss_pred Cccccc-chHHHHHHh------------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEE
Q 024572 1 MQLGVS-SLSEFVMLE------------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKI 55 (265)
Q Consensus 1 me~~~~-sL~~~~~~~------------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl 55 (265)
|||+.+ +|.+++..+ .++.+++.++.|||+++||||||||+|||++.++. +||
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~Ki 199 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKI 199 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--EEE
Confidence 799987 999998643 34678999999999999999999999999998776 999
Q ss_pred eccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHh
Q 024572 56 CDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIM 131 (265)
Q Consensus 56 ~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 131 (265)
+|||+|+...... .....+||+.|||||++.+..++ .++|||||||++|||+| |+.||.+......+ ..+.
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~----~~i~ 274 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI----DCIT 274 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH----HHHH
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHH----HHHH
Confidence 9999998543322 22345699999999999988875 55999999999999999 89999886543332 2222
Q ss_pred hhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 132 AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
. ..+.+.+..+++++.+||.+||..||++|||+.+|+++
T Consensus 275 ~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 Q-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp H-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred c-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 2 22344555799999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=272.17 Aligned_cols=161 Identities=24% Similarity=0.339 Sum_probs=130.3
Q ss_pred Cccccc-chHHHHHHhc----------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEec
Q 024572 1 MQLGVS-SLSEFVMLEG----------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICD 57 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~D 57 (265)
||||.+ +|.+++..++ ++.+++.|+.|||+++||||||||+|||++.++. +||+|
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~D 171 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGD 171 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEECC
Confidence 799976 9999997642 4778999999999999999999999999998876 99999
Q ss_pred cCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhh
Q 024572 58 FGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAV 133 (265)
Q Consensus 58 fg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 133 (265)
||+|+...... ......||+.|||||++.+..++ .++|||||||++|||+| |+.||.+...... +..+...
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~----~~~i~~~ 246 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEV----IECITQG 246 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHHHHT
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHcC
Confidence 99997543322 12234689999999999988875 55999999999999998 8999988654332 2222222
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 024572 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 169 (265)
Q Consensus 134 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell 169 (265)
...+.+..+++++.+||.+||..||++|||+.+++
T Consensus 247 -~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 247 -RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 22344557999999999999999999999999994
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=268.08 Aligned_cols=169 Identities=34% Similarity=0.637 Sum_probs=142.1
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++. ++|.+++..++ ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCcc
Confidence 78885 49999987654 3678999999999999999999999999988776 999999999766555555
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.... .....+....+..|. .+++++.+|
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~l 244 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----ELRERVLRGKYRIPF--YMSTDCENL 244 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCHHHHHH
Confidence 56789999999999998888777799999999999999999999876543 333334444444444 589999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
|.+||..||.+|||+.++++||||+..
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=269.28 Aligned_cols=172 Identities=38% Similarity=0.634 Sum_probs=141.6
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK 71 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~ 71 (265)
||+++++|.+++..++ ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++.........
T Consensus 88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTTC
T ss_pred EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcccc
Confidence 7999999999887654 4678999999999999999999999999988775 9999999998665555556
Q ss_pred CCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHH
Q 024572 72 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 151 (265)
Q Consensus 72 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 151 (265)
..+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||......... ..+...... .+..+++.+.+||
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~--~p~~~s~~~~~li 239 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----KKVNSCVYV--MPDFLSPGAQSLI 239 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----CCCCSSCCC--CCTTSCHHHHHHH
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCCC--CcccCCHHHHHHH
Confidence 6789999999999998887667799999999999999999999775432211 111111222 2335899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 152 SRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 152 ~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
.+||..||.+|||+.++++||||+...+.
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 268 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWFNVNLPD 268 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred HHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence 99999999999999999999999876654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=259.14 Aligned_cols=174 Identities=23% Similarity=0.275 Sum_probs=138.7
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||+++++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 98 ~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~ 175 (308)
T 3g33_A 98 FEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMA 175 (308)
T ss_dssp EECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSCSCTTTSTTCCC
T ss_pred ehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeCccccccCCCcc
Confidence 6888899999887643 4678899999999999999999999999987775 99999999986655555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-cCC----------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIP---------- 138 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~---------- 138 (265)
.....+|+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.........+......... .++
T Consensus 176 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (308)
T 3g33_A 176 LTPVVVTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF 254 (308)
T ss_dssp SGGGGCCCSSCCHHHHHTSCCCS-THHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGS
T ss_pred cCCccccccccCchHHcCCCCCc-hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 55667999999999998877754 599999999999999999999887665555444433211110 000
Q ss_pred ----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 139 ----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 139 ----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
....+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 255 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 012478899999999999999999999999999999764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=269.10 Aligned_cols=176 Identities=25% Similarity=0.297 Sum_probs=136.2
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-----
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH----- 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~----- 67 (265)
||+++++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 90 ~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~ 167 (388)
T 3oz6_A 90 FDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRRVTN 167 (388)
T ss_dssp EECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCCCCCC
T ss_pred ecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccccccc
Confidence 7899999998887543 4678999999999999999999999999988776 999999999754321
Q ss_pred -----------------CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH
Q 024572 68 -----------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 68 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 130 (265)
......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..++..+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 247 (388)
T 3oz6_A 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247 (388)
T ss_dssp CGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 112335799999999999875545667999999999999999999999876655544443221
Q ss_pred hhhc-----------------------------------------ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 024572 131 MAVQ-----------------------------------------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 169 (265)
Q Consensus 131 ~~~~-----------------------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell 169 (265)
.... ........+++.+.+||.+||..||.+|||+.+++
T Consensus 248 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l 327 (388)
T 3oz6_A 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDAL 327 (388)
T ss_dssp CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHh
Confidence 1000 00011225789999999999999999999999999
Q ss_pred cCcccCCCC
Q 024572 170 SHPWFLKNL 178 (265)
Q Consensus 170 ~h~~f~~~~ 178 (265)
+||||+...
T Consensus 328 ~Hp~~~~~~ 336 (388)
T 3oz6_A 328 KHPFVSIFH 336 (388)
T ss_dssp TSTTTTTTC
T ss_pred CCHHHHHhc
Confidence 999997543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.58 Aligned_cols=175 Identities=24% Similarity=0.319 Sum_probs=137.7
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 98 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 98 FEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC-
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCccc
Confidence 7889999888877543 3678999999999999999999999999988775 999999999755432 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc-C-----------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-I----------- 137 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~----------- 137 (265)
.....+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......... .
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 3345789999999999875544567999999999999999999998877766655554432211100 0
Q ss_pred ---C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 138 ---P---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 138 ---~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
. ....+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0 012467899999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=254.58 Aligned_cols=174 Identities=25% Similarity=0.380 Sum_probs=139.1
Q ss_pred Cccc-ccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CC
Q 024572 1 MQLG-VSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP 70 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~ 70 (265)
||++ +++|.+++..+. ++.+++.++.|||++||+||||||+|||++.++. +||+|||++....... ..
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCB
T ss_pred EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCccccc
Confidence 7888 459999887543 4778899999999999999999999999988776 9999999987544332 23
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....||+.|+|||++.+..++ .++|||||||++|+|++|+.||............. .........+..++..+.+|
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSCCCSCGGGSCHHHHHH
T ss_pred CCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCCCCCCccccCHHHHHH
Confidence 345799999999999888775 45999999999999999999998765433332222 12222333445689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
|.+||..||.+|||+.++++||||+...+.
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 279 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLKIAKPL 279 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HHHHccCChhHCcCHHHHhhChhhcccCcc
Confidence 999999999999999999999999866543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=257.77 Aligned_cols=168 Identities=30% Similarity=0.522 Sum_probs=136.9
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... .+.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCCc
Confidence 788865 9988887654 3567899999999999999999999999988776 99999999975332 233
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++.+..+. .++|+|||||++|+|++|+.||.+..... ....+.......| ..+++++++
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~ 234 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRFP--RTLSPEAKS 234 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTSCHHHHH
T ss_pred ccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCC--CCCCHHHHH
Confidence 4456799999999999887775 45999999999999999999998765432 2233333333444 368999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
||.+||..||.+|| ++.++++||||+..
T Consensus 235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 89999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=263.44 Aligned_cols=172 Identities=27% Similarity=0.439 Sum_probs=136.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC-CCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~-~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+|+... ....
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCCCc
Confidence 788866 9988887654 3677899999999999999999999999988876 9999999997532 3334
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHHHHHhhhcccCCCCCCCC
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-----FRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||........ .......+.......|. .++
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s 286 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS 286 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSC
T ss_pred cccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCC
Confidence 4566899999999999988775 559999999999999999999975432111 12233333444444443 689
Q ss_pred HHHHHHHHHhcccCCCCCCCH------HHHhcCcccCCC
Q 024572 145 QDCRNLLSRIFVANPSRRITI------KEIKSHPWFLKN 177 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~------~ell~h~~f~~~ 177 (265)
..+++||.+||..||.+||++ .++++||||+..
T Consensus 287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 999999999999999999985 799999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=256.95 Aligned_cols=177 Identities=23% Similarity=0.328 Sum_probs=138.2
Q ss_pred CcccccchHHHHHHhc---------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC
Q 024572 1 MQLGVSSLSEFVMLEG---------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 65 (265)
||++.++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 82 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 82 FEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFG 159 (317)
T ss_dssp EECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETT
T ss_pred EEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecC
Confidence 7899999999887653 2458899999999999999999999999988776 9999999997554
Q ss_pred CC-CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc---------
Q 024572 66 LH-SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------- 135 (265)
Q Consensus 66 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 135 (265)
.. .......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.........
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 32 22344578999999999987554456699999999999999999999887665544444332211000
Q ss_pred -------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 136 -------------------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 136 -------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
.......++..+.+||.+||..||.+|||+.++++||||++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 00011247889999999999999999999999999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=269.83 Aligned_cols=177 Identities=24% Similarity=0.309 Sum_probs=136.6
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||+++++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++...+||+|||+++... ..
T Consensus 178 ~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~--~~ 255 (429)
T 3kvw_A 178 FELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QR 255 (429)
T ss_dssp ECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT--CC
T ss_pred EeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC--Cc
Confidence 7899999999988654 3778899999999999999999999999988765559999999986432 33
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------------- 135 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 135 (265)
....++|+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+..++........
T Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~ 334 (429)
T 3kvw_A 256 VYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS 334 (429)
T ss_dssp CCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBC
T ss_pred ccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccC
Confidence 4456799999999999988775 5599999999999999999999887665554444332110000
Q ss_pred --cC-----------------------------CC--------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 136 --KI-----------------------------PD--------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 136 --~~-----------------------------~~--------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.. +. ....++.+.+||.+||..||.+|||+.++|+||||++
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 335 SKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414 (429)
T ss_dssp TTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-
T ss_pred CCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhcc
Confidence 00 00 0123678999999999999999999999999999987
Q ss_pred CCCh
Q 024572 177 NLPR 180 (265)
Q Consensus 177 ~~~~ 180 (265)
..+.
T Consensus 415 ~~~~ 418 (429)
T 3kvw_A 415 RLPK 418 (429)
T ss_dssp ----
T ss_pred CCCC
Confidence 6554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=264.44 Aligned_cols=172 Identities=29% Similarity=0.491 Sum_probs=139.3
Q ss_pred Cccc-ccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC--CcEEEeccCCcccCCCCC
Q 024572 1 MQLG-VSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~--~~vkl~Dfg~a~~~~~~~ 68 (265)
||++ +++|.+++..++ ++.+++.++.|||++||+||||||+|||++.++. ..+||+|||+++......
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~ 173 (361)
T 2yab_A 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173 (361)
T ss_dssp EECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC
Confidence 7888 459999886543 4778999999999999999999999999976652 259999999998665555
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQD 146 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 146 (265)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+...... +..+....+.++ .+..++..
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 174 EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQET----LANITAVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp CCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTTCCCCCHHHHTTSCHH
T ss_pred ccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCCCCchhccCCCHH
Confidence 55667899999999999887765 559999999999999999999988654333 233333333332 23468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+++||.+||..||.+|||+.++++||||+..
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 9999999999999999999999999999854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=262.81 Aligned_cols=168 Identities=30% Similarity=0.469 Sum_probs=134.3
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNGVT 180 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC----
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCCcc
Confidence 788876 9998887654 3677899999999999999999999999988776 99999999975332 233
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+...... ...+.......|. .++..+.+
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~ 253 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYPT--WLHEDATG 253 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHH
T ss_pred ccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHH
Confidence 3456799999999999887775 559999999999999999999987654333 3333444444443 58999999
Q ss_pred HHHHhcccCCCCCCCH------HHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITI------KEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~------~ell~h~~f~~~ 177 (265)
||.+||..||.+||++ .++++||||+..
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999999999998 899999999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=254.15 Aligned_cols=174 Identities=22% Similarity=0.326 Sum_probs=132.9
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.++|.+++... .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRK 156 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC----
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCccccc
Confidence 688888888887753 24778999999999999999999999999988775 999999998754322 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc-------CC----
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-------IP---- 138 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~---- 138 (265)
.....+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.................... .+
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 2345689999999999875544567999999999999999999998876555444443322111000 00
Q ss_pred ------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 139 ------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 139 ------------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
....+++.+.+||.+||..||.+|||+.++++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 11247899999999999999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=251.35 Aligned_cols=176 Identities=22% Similarity=0.301 Sum_probs=134.1
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.++|.+++... .++.+++.++.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccc
Confidence 788888887776542 24778999999999999999999999999988776 999999999755432 23
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-c------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-K------------ 136 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------------ 136 (265)
.....+|+.|+|||++.+....+.++|||||||++|+|++|..||............+........ .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 344578999999999988765566799999999999999988886555444333222222111000 0
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 137 -----------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 137 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
......++..+++||.+||..||.+|||+.++++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 001124788999999999999999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=271.64 Aligned_cols=175 Identities=26% Similarity=0.353 Sum_probs=132.1
Q ss_pred CcccccchHHHHH-------HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVM-------LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~sL~~~~~-------~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||++.++|.+.+. .+.++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 146 ~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~ 223 (464)
T 3ttj_A 146 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 223 (464)
T ss_dssp EECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC-----CCCC---
T ss_pred EeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecCCCcccCCC
Confidence 7888888777654 3345788999999999999999999999999998776 999999999866555455667
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc---------------ccCC
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---------------YKIP 138 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~ 138 (265)
+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+..++..+.... ...+
T Consensus 224 ~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~ 302 (464)
T 3ttj_A 224 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 302 (464)
T ss_dssp -CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSC
T ss_pred cccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhccc
Confidence 899999999999988776 459999999999999999999998776555555443321100 0001
Q ss_pred CCCC---------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 139 DYVH---------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 139 ~~~~---------------------~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.... .++++++||.+||..||.+|||+.++|+||||+...
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 303 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred ccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0000 146789999999999999999999999999998644
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=267.73 Aligned_cols=176 Identities=32% Similarity=0.533 Sum_probs=131.4
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.+ +|.+++..++ ++.+++.+|.|||++||+||||||+|||++... .+.+||+|||+++.....
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 788865 9999987543 367789999999999999999999999998632 245999999999865544
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc--CCCCCCCCH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQ 145 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 145 (265)
......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...............+....+. .+.+..++.
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 296 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296 (400)
T ss_dssp ---------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCH
Confidence 445566899999999999887775 55999999999999999999998754322111112222233333 334457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++++||.+||..||.+|||+.++++||||.+.
T Consensus 297 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=255.88 Aligned_cols=165 Identities=23% Similarity=0.263 Sum_probs=129.1
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||+++++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence 7899999999887654 3678899999999999999999999999988776 999999998766555455
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.... .. ..+............+++.+.+|
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGE---GW----QQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHH---HH----HHHTTTCCCHHHHTTSCHHHHHH
T ss_pred cccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCcc---HH----HHHhccCCCcccccCCCHHHHHH
Confidence 55679999999999876 44 456999999999999999977765421 11 11111111111223578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
|.+||..||.+|||+.++++||||++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=264.96 Aligned_cols=175 Identities=25% Similarity=0.298 Sum_probs=137.9
Q ss_pred CcccccchHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEc-CCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVSSLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+++.+.+.. +.++.+++.+|.|||++||+||||||+|||++ .++ .+||+|||+++....
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIA 194 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECCT
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccccC
Confidence 68888876655442 23467899999999999999999999999998 455 499999999987655
Q ss_pred CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh----------c--
Q 024572 67 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------Q-- 134 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------~-- 134 (265)
........+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..++...... .
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 5555667899999999999876545567999999999999999999999877665555554422110 0
Q ss_pred -ccCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 -YKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 -~~~~----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...+ ....+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 0111 112478899999999999999999999999999999854
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=257.34 Aligned_cols=168 Identities=32% Similarity=0.518 Sum_probs=137.2
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++...+ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccCCcc
Confidence 788865 9999988654 3677899999999999999999999999988776 99999999975332 233
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++.+..+. .++|+|||||++|+|++|+.||.+..... ....+.......| ..++.++++
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~ 250 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAYP--KSMSKEAVA 250 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTSCHHHHH
T ss_pred cccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHH----HHHHHHhCCCCCC--CCCCHHHHH
Confidence 4456799999999999887775 55999999999999999999998765433 3333344444444 368999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
||.+||..||.+||+ +.++++||||+..
T Consensus 251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 999999999999995 6999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=266.06 Aligned_cols=175 Identities=26% Similarity=0.336 Sum_probs=137.5
Q ss_pred CcccccchHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.++|.+++.. ..++.+++.+|.|||++||+||||||+|||++.++. .+||+|||+++.....
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG 210 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCTT
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhcccC
Confidence 67888877766542 234678999999999999999999999999986532 4899999999866555
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-------------c
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------Q 134 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------~ 134 (265)
......++|+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..++..+... .
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~ 290 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 555567899999999999876444566999999999999999999999877666555554432110 0
Q ss_pred ccCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 135 YKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 135 ~~~~~----------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
+.++. ...+++++++||.+||..||.+|||+.++++||||..
T Consensus 291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 11111 1246889999999999999999999999999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=267.97 Aligned_cols=171 Identities=35% Similarity=0.591 Sum_probs=141.8
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++. ++|.+++..++ ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCB
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccc
Confidence 78884 59998876443 4778999999999999999999999999988776 999999999866555555
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||........+ ..+....+..| ..+++.+.+|
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~L 246 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF----KKICDGIFYTP--QYLNPSVISL 246 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH----HHHHTTCCCCC--TTCCHHHHHH
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH----HHHhcCCcCCC--ccCCHHHHHH
Confidence 56789999999999998877677799999999999999999999876654333 33333333333 3689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
|.+||..||.+|||+.++++||||++..+
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 99999999999999999999999987554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.55 Aligned_cols=167 Identities=34% Similarity=0.541 Sum_probs=137.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~~ 160 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VT 160 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CB
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--cc
Confidence 788865 9999987654 3677899999999999999999999999988776 99999999975432 23
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...+||+.|+|||++.+..++ .++|+|||||++|+|++|+.||........ ...+.......| ..++.++++|
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~~l 233 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKT----YEKILNAELRFP--PFFNEDVKDL 233 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHCCCCCC--TTSCHHHHHH
T ss_pred ccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCC--CCCCHHHHHH
Confidence 456799999999999887775 459999999999999999999987654333 333333444444 3689999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCcccCCCC
Q 024572 151 LSRIFVANPSRRI-----TIKEIKSHPWFLKNL 178 (265)
Q Consensus 151 i~~~L~~dP~~R~-----s~~ell~h~~f~~~~ 178 (265)
|.+||..||.+|| ++.++++||||+...
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 9999999999999 999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=257.78 Aligned_cols=168 Identities=33% Similarity=0.532 Sum_probs=137.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++...+ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK 174 (345)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccCCCc
Confidence 788854 9999987644 3677899999999999999999999999988775 99999999975432 223
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++.+..++ .++|+|||||++|+|++|+.||.+...... ...+.......| ..++..+++
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~ 247 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRMDNPFYP--RWLEKEAKD 247 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCC--TTSCHHHHH
T ss_pred ccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHHhCCCCCC--cccCHHHHH
Confidence 4456799999999999887775 559999999999999999999987654332 233333333333 358999999
Q ss_pred HHHHhcccCCCCCCCHH-HHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITIK-EIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~-ell~h~~f~~~ 177 (265)
||.+||..||.+||++. ++++||||+..
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 99999999999999998 99999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=259.61 Aligned_cols=174 Identities=24% Similarity=0.289 Sum_probs=137.4
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
||+++++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ....
T Consensus 109 ~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~--~~~~ 184 (367)
T 1cm8_A 109 MPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADS--EMTG 184 (367)
T ss_dssp EECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCS--SCCS
T ss_pred EecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccccccc--ccCc
Confidence 6888889999887533 4778999999999999999999999999988775 99999999975432 3345
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc------------------
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------------ 134 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------------ 134 (265)
..+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+......+..+........
T Consensus 185 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 264 (367)
T 1cm8_A 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264 (367)
T ss_dssp SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH
T ss_pred CcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHh
Confidence 67899999999998744345669999999999999999999988766555444433211100
Q ss_pred -ccC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 135 -YKI------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 135 -~~~------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
... ..+..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 265 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000 01235689999999999999999999999999999997643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=263.69 Aligned_cols=171 Identities=31% Similarity=0.587 Sum_probs=137.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCC-CCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+|||++.. ..+.+||+|||+++......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 788866 9999887654 47789999999999999999999999999853 22459999999997554332
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--cCCCCCCCCHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQD 146 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 146 (265)
......||+.|+|||++.+..++ .++|||||||++|+|++|..||.+......+ ..+..... ..+.+..+++.
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLY----QQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCCTTTTTTSCHH
T ss_pred eeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHhCCCCCCccccccCCHH
Confidence 22446799999999999887775 5599999999999999999999876543332 33333333 33445578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
+++||.+||..||.+|||+.++++||||+.
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999999999999999999999999999963
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=255.20 Aligned_cols=175 Identities=21% Similarity=0.313 Sum_probs=132.4
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.++|.+++...+ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccc
Confidence 7899999999887643 3678899999999999999999999999988775 9999999987543222 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------------- 135 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 135 (265)
.....+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 234568999999999987554556799999999999999999999887655544443332211100
Q ss_pred -cCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 136 -KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 136 -~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
..+ ....+++++.+||.+||..||.+|||+.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 000 112468899999999999999999999999999999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=254.90 Aligned_cols=172 Identities=27% Similarity=0.430 Sum_probs=135.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ...
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTTCC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCCCc
Confidence 788855 9998887654 3677899999999999999999999999988775 99999999975332 233
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----KNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
....+||+.|+|||++.+..+. .++|+|||||++|+|++|+.||...... .........+.......| ..++
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~s 243 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLS 243 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC--TTSC
T ss_pred ccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC--CCCC
Confidence 4456799999999999887775 5599999999999999999999753221 111222333333444444 3689
Q ss_pred HHHHHHHHHhcccCCCCCCCH------HHHhcCcccCCC
Q 024572 145 QDCRNLLSRIFVANPSRRITI------KEIKSHPWFLKN 177 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~------~ell~h~~f~~~ 177 (265)
..+++||.+||..||.+||++ .++++||||+..
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 999999999999999999995 899999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=256.14 Aligned_cols=173 Identities=31% Similarity=0.530 Sum_probs=138.0
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC--CCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~--~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++ ...+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~ 172 (326)
T 2y0a_A 93 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172 (326)
T ss_dssp EECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC
Confidence 68885 59999886543 477889999999999999999999999998765 2259999999998665444
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQD 146 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 146 (265)
......||+.|+|||++.+..++ .++|||||||++|+|++|..||.+......+. .+.......+ .+..++..
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 247 (326)
T 2y0a_A 173 EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLA----NVSAVNYEFEDEYFSNTSAL 247 (326)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHHTCCCCCHHHHTTSCHH
T ss_pred ccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH----HHHhcCCCcCccccccCCHH
Confidence 55566799999999999877765 55999999999999999999998765433322 2222222222 22467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
+.+||.+||..||.+|||+.++++||||+...
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 99999999999999999999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=262.60 Aligned_cols=173 Identities=32% Similarity=0.445 Sum_probs=139.1
Q ss_pred Cccc-ccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--C
Q 024572 1 MQLG-VSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R 69 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--~ 69 (265)
||++ +++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+|+...... .
T Consensus 148 ~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp ECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSEEE
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCccc
Confidence 7888 459999886543 3677899999999999999999999999988776 9999999997554332 2
Q ss_pred CCCCcCCCCCcccccccCCcC---CCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREY---DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~---~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
....+||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+......+..++... .....|....++..
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~ 303 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDISKE 303 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCTTCCCCHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--ccccCCCcccccHH
Confidence 335679999999999986541 3456999999999999999999998866544444433321 22445555679999
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHhcCcccCCC
Q 024572 147 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKN 177 (265)
Q Consensus 147 ~~~li~~~L~~dP~~--R~s~~ell~h~~f~~~ 177 (265)
+++||.+||..+|.+ |+++.+|++||||+..
T Consensus 304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 999999999999988 9999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=259.23 Aligned_cols=171 Identities=30% Similarity=0.566 Sum_probs=138.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC-CcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~-~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. ..+||+|||+++.......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 788866 8988876543 3678999999999999999999999999976532 3599999999986655544
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC--CCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 147 (265)
.....||+.|+|||++.+..++ .++|||||||++|+|++|..||.+..... ....+....+.. +.+..+++.+
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred cccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCcccccCCCHHH
Confidence 5566899999999999887765 55999999999999999999998765432 223333333333 3345689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
++||.+||..||.+|||+.++++||||..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=261.01 Aligned_cols=172 Identities=24% Similarity=0.413 Sum_probs=138.2
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+|||++....+.+||+|||+++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 788875 9999886543 36788999999999999999999999999874445699999999986554444
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 147 (265)
.....+|+.|+|||++.+..++ .++|||||||++|+|++|..||......... ..+.......+ .+..++.++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQII----ENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCCHHHHTTSCHHH
T ss_pred cccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHH----HHHHcCCCCCChhhhccCCHHH
Confidence 4455799999999999887664 5699999999999999999999876543332 33333333322 234689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+||.+||..||.+|||+.++++||||++.
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=260.13 Aligned_cols=174 Identities=23% Similarity=0.309 Sum_probs=138.9
Q ss_pred CcccccchHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEcC-CCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVSSLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.++|.+.+.. ..++.+++.+|.|||++||+||||||+|||++. ++ .+||+|||+++....
T Consensus 117 ~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~~ 194 (383)
T 3eb0_A 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCDFGSAKKLIP 194 (383)
T ss_dssp ECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTT--EEEECCCTTCEECCT
T ss_pred EecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCC--cEEEEECCCCcccCC
Confidence 78999988877763 224678999999999999999999999999974 44 499999999986655
Q ss_pred CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-------------
Q 024572 67 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV------------- 133 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------- 133 (265)
........+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+......+..++......
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 274 (383)
T 3eb0_A 195 SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT 274 (383)
T ss_dssp TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-
T ss_pred CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccc
Confidence 5555667899999999999876644567999999999999999999999877666555554322110
Q ss_pred cccCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 134 QYKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 134 ~~~~~----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
....+ .+..+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 275 EVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp -CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred cccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 00111 12247889999999999999999999999999999964
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=263.84 Aligned_cols=177 Identities=25% Similarity=0.309 Sum_probs=127.3
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC---
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--- 68 (265)
||+++++|.+++.... ++.+|+.+|.|||++|||||||||+|||++.++. +||+|||+++......
T Consensus 136 ~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~~~~~ 213 (458)
T 3rp9_A 136 LEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGN 213 (458)
T ss_dssp ECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTSCTTCC
T ss_pred EeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccCccccc
Confidence 7899999999887543 4778999999999999999999999999988776 9999999997543221
Q ss_pred -------------------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-----------CCC
Q 024572 69 -------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-----------GAY 112 (265)
Q Consensus 69 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-----------g~~ 112 (265)
.....+||+.|+|||++......+.++|||||||++|+|++ |++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p 293 (458)
T 3rp9_A 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293 (458)
T ss_dssp CCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCC
T ss_pred cccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccc
Confidence 12334689999999987554444566999999999999998 677
Q ss_pred CCCCCCC--------------------hHHHHHHHHHHhhh----------------cccC---------CCCCCCCHHH
Q 024572 113 PFEDQED--------------------PKNFRKTISRIMAV----------------QYKI---------PDYVHISQDC 147 (265)
Q Consensus 113 pf~~~~~--------------------~~~~~~~~~~~~~~----------------~~~~---------~~~~~~~~~~ 147 (265)
+|.+... ...+..+...+... .... ..+..+++++
T Consensus 294 ~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 373 (458)
T 3rp9_A 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADA 373 (458)
T ss_dssp SCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHH
T ss_pred cCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHH
Confidence 7765431 01111111100000 0000 0123568999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
.+||.+||..||.+|||+.++|+||||+....
T Consensus 374 ~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 374 IHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 99999999999999999999999999986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=268.29 Aligned_cols=171 Identities=14% Similarity=0.153 Sum_probs=133.4
Q ss_pred CcccccchHHHHHHh----------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC
Q 024572 1 MQLGVSSLSEFVMLE----------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 64 (265)
||++.++|.+++..+ .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 167 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~ 244 (371)
T 3q60_A 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR--LMLGDVSALWKV 244 (371)
T ss_dssp ECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSC--EEECCGGGEEET
T ss_pred ecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCC--EEEEecceeeec
Confidence 789999999999863 33478999999999999999999999999988775 999999999754
Q ss_pred CCCCCCCCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHH--HHH-HHHHHhhhcccCCC
Q 024572 65 LLHSRPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN--FRK-TISRIMAVQYKIPD 139 (265)
Q Consensus 65 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~ 139 (265)
.. ......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||........ +.. ............+.
T Consensus 245 ~~--~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (371)
T 3q60_A 245 GT--RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS 321 (371)
T ss_dssp TC--EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTT
T ss_pred CC--CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhh
Confidence 32 1224557799999999976 455 4669999999999999999999987632210 000 00000112233444
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 140 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 140 ~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
...+++.+.+||.+||..||.+|||+.++++||||++
T Consensus 322 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 4578999999999999999999999999999999964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=256.04 Aligned_cols=177 Identities=24% Similarity=0.328 Sum_probs=131.7
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC---CCcEEEeccCCcccCCCC-
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP---APRLKICDFGYSKSSLLH- 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~---~~~vkl~Dfg~a~~~~~~- 67 (265)
||++.++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++ .+.+||+|||+++.....
T Consensus 112 ~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 112 FEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp EECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred EecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 7899999999987653 467889999999999999999999999995322 234999999998754322
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc-------CCCC
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-------IPDY 140 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~ 140 (265)
.......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......... .+.+
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 223345689999999999876645667999999999999999999998876655554444332111100 0000
Q ss_pred -----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 141 -----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 141 -----------------~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 0167899999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=254.89 Aligned_cols=166 Identities=28% Similarity=0.481 Sum_probs=136.8
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++. ++|.+++...+ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~--~~ 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CB
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--Cc
Confidence 78885 59999988654 3677899999999999999999999999988776 99999999975433 23
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... ....+.......| ..++..+.+|
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~~~~~~~l 268 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIVSGKVRFP--SHFSSDLKDL 268 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTCCHHHHHH
T ss_pred ccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHH----HHHHHHcCCCCCC--CCCCHHHHHH
Confidence 456799999999999887775 55999999999999999999998765433 2333333444444 3689999999
Q ss_pred HHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
|.+||..||.+||+ +.++++||||+..
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 99999999999998 9999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=254.61 Aligned_cols=176 Identities=20% Similarity=0.306 Sum_probs=134.2
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC----
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---- 66 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~---- 66 (265)
||++.++|.+.+... .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 103 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~ 180 (351)
T 3mi9_A 103 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNS 180 (351)
T ss_dssp EECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCCCSSS
T ss_pred EeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhcccccccccc
Confidence 688888888777643 34778999999999999999999999999988775 99999999875432
Q ss_pred -CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc-CCCCC---
Q 024572 67 -HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYV--- 141 (265)
Q Consensus 67 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 141 (265)
........+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......... .+...
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 260 (351)
T 3mi9_A 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 260 (351)
T ss_dssp SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCG
T ss_pred cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccch
Confidence 2222345689999999999875544567999999999999999999998876544443333221111100 00000
Q ss_pred ----------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 142 ----------------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 142 ----------------------~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
..++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 261 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp GGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred hhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 0267799999999999999999999999999997543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=261.22 Aligned_cols=177 Identities=22% Similarity=0.311 Sum_probs=126.0
Q ss_pred CcccccchHHHHHH------------------hccccchHHHHHhhhhcCceecCCCcCcEEEcC--CCCCcEEEeccCC
Q 024572 1 MQLGVSSLSEFVML------------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDG--SPAPRLKICDFGY 60 (265)
Q Consensus 1 me~~~~sL~~~~~~------------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~--~~~~~vkl~Dfg~ 60 (265)
||+++++|.+++.. +.++.+++.+|.|||++||+||||||+|||+.. ...+.+||+|||+
T Consensus 99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 78899998888763 334778999999999999999999999999932 1223599999999
Q ss_pred cccCCCC----CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh---------HHHHHHH
Q 024572 61 SKSSLLH----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---------KNFRKTI 127 (265)
Q Consensus 61 a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~---------~~~~~~~ 127 (265)
++..... ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.... ..+..++
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 9754332 22234578999999999988665567799999999999999999999765431 2222222
Q ss_pred HHHhhhccc-------C-------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 128 SRIMAVQYK-------I-------------------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 128 ~~~~~~~~~-------~-------------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
..+...... . ......+..+.+||.+||..||.+|||+.++|+||||+
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~ 338 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence 211100000 0 00112367899999999999999999999999999997
Q ss_pred CC
Q 024572 176 KN 177 (265)
Q Consensus 176 ~~ 177 (265)
..
T Consensus 339 ~~ 340 (405)
T 3rgf_A 339 ED 340 (405)
T ss_dssp SS
T ss_pred cC
Confidence 64
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=252.06 Aligned_cols=171 Identities=25% Similarity=0.391 Sum_probs=137.5
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQI 171 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTCCB
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCCce
Confidence 678854 9998887653 3668899999999999999999999999988776 999999999866555555
Q ss_pred CCCcCCCCCcccccccCC---cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 71 KSTVGTPAYIAPEVLSRR---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
...+||+.|+|||++.+. .+ +.++|||||||++|+|++|+.||....... .......+.......| ..++..+
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~p--~~~s~~~ 247 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYP--SAWSQEM 247 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCCCCCC--TTSCHHH
T ss_pred eccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcccCCC--CcCCHHH
Confidence 667899999999999742 34 455999999999999999999997654322 2233333333333333 4689999
Q ss_pred HHHHHHhcccCCCCCCC-HHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRIT-IKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s-~~ell~h~~f~~~ 177 (265)
.+||.+||..||.+||+ +.++++||||+..
T Consensus 248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 99999999999999998 8999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=252.26 Aligned_cols=169 Identities=35% Similarity=0.497 Sum_probs=132.1
Q ss_pred Cccccc-chHHHH--------HHhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CC
Q 024572 1 MQLGVS-SLSEFV--------MLEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP 70 (265)
Q Consensus 1 me~~~~-sL~~~~--------~~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~ 70 (265)
||++.+ +|.++. ....++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...... ..
T Consensus 117 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 194 (298)
T 2zv2_A 117 FELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH--IKIADFGVSNEFKGSDALL 194 (298)
T ss_dssp EECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECSSSSCEE
T ss_pred EecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCC--EEEecCCCccccccccccc
Confidence 566653 554432 23335778999999999999999999999999988775 9999999997544322 22
Q ss_pred CCCcCCCCCcccccccCCcC--CCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
....||+.|+|||++.+... .+.++|||||||++|+|++|+.||...... .....+.......+....+++.+.
T Consensus 195 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~ 270 (298)
T 2zv2_A 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM----CLHSKIKSQALEFPDQPDIAEDLK 270 (298)
T ss_dssp CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCSSSCCCHHHH
T ss_pred cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH----HHHHHHhcccCCCCCccccCHHHH
Confidence 34579999999999976542 356699999999999999999999775432 222333334445555567899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
+||.+||..||.+|||+.++++||||+
T Consensus 271 ~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 271 DLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 999999999999999999999999995
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=255.00 Aligned_cols=169 Identities=21% Similarity=0.207 Sum_probs=119.9
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhc--------CceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQ--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~--------~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
|||+.+ +|.+++..+. +..+++.++.|||++ +||||||||+|||++.++. +||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence 799975 9999997654 356789999999987 9999999999999998876 99999999975
Q ss_pred CCCCC-----CCCCCcCCCCCcccccccCCcC-----CCchHhHHHHHHHHHHHHhCCCCCCCCCC----------h-HH
Q 024572 64 SLLHS-----RPKSTVGTPAYIAPEVLSRREY-----DGKLADVWSCGVTLYVMLVGAYPFEDQED----------P-KN 122 (265)
Q Consensus 64 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~~l~~ll~g~~pf~~~~~----------~-~~ 122 (265)
..... .....+||+.|||||++.+... .+.++|||||||++|||+||+.||..... . ..
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 43322 1233579999999999976421 23569999999999999999876643211 1 01
Q ss_pred HHHHHHHHhhhcccCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 123 FRKTISRIMAVQYKIPDYV-----HISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.......+.....+.+.+. ..+..+.+|+.+||..||++|||+.+|++.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1222222222222211111 123468899999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=261.27 Aligned_cols=173 Identities=23% Similarity=0.441 Sum_probs=138.3
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.+..+.+||+|||+++.......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 688755 8988876442 36788999999999999999999999999865555699999999986554444
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc--CCCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 147 (265)
.....||+.|+|||++.+..+. .++|||||||++|+|++|..||.+......+ ..+...... ...+..+++.+
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHCCCCCCSSTTTTSCHHH
T ss_pred eeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCccccccCCHHH
Confidence 4455799999999999887764 5599999999999999999999876543332 222222222 23345689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
++||.+||..||.+|||+.++++||||+...
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 9999999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=254.17 Aligned_cols=174 Identities=32% Similarity=0.477 Sum_probs=138.0
Q ss_pred Cccccc-chHHHHHHh---------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 1 MQLGVS-SLSEFVMLE---------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~---------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEE
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcc
Confidence 678855 887776543 34778999999999999999999999999988775 999999999744322
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||........... .........+.+..++..+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHH
Confidence 2223557999999999998877766779999999999999999999987655432222 1222233334445689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
.+||.+||..||.+|||+.++++||||++...
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 99999999999999999999999999986543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=252.62 Aligned_cols=175 Identities=25% Similarity=0.312 Sum_probs=138.2
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.++|.+++..+. ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 91 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~ 168 (346)
T 1ua2_A 91 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRA 168 (346)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCC
T ss_pred EEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccCCccc
Confidence 6888889888887543 3677899999999999999999999999988775 999999999765332 23
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-cCCC---------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPD--------- 139 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~--------- 139 (265)
.....+|+.|+|||++.+....+.++|||||||++|+|++|.+||.+......+..+......... .++.
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccc
Confidence 344578999999999977654566799999999999999999999887665555554443221110 0000
Q ss_pred ------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 140 ------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 140 ------------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...++..+++||.+||..||.+|||+.++++||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 249 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred ccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13467899999999999999999999999999999764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=254.82 Aligned_cols=168 Identities=30% Similarity=0.467 Sum_probs=137.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCC-CCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~-~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++... ....
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCCCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccCCCc
Confidence 788865 9999887654 3677899999999999999999999999988776 9999999997533 2334
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++.+..++ .++|+|||||++|+|++|+.||.+......+ ..+.......+ ..++..+++
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~ 268 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY----DNILNKPLQLK--PNITNSARH 268 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHH----HHHHHSCCCCC--SSSCHHHHH
T ss_pred cccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHhcccCCC--CCCCHHHHH
Confidence 4566899999999999887765 5599999999999999999999876543333 33333333333 368999999
Q ss_pred HHHHhcccCCCCCCCH----HHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITI----KEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~----~ell~h~~f~~~ 177 (265)
||.+||..||.+||++ .++++||||+..
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 9999999999999986 699999999754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=255.67 Aligned_cols=177 Identities=24% Similarity=0.333 Sum_probs=138.7
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC----
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---- 68 (265)
||+++++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 109 ~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~ 186 (364)
T 3qyz_A 109 QDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTG 186 (364)
T ss_dssp EECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCC
T ss_pred EcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCCCccc
Confidence 6888899998876543 4778999999999999999999999999988776 9999999997543322
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc--------------
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-------------- 134 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 134 (265)
.....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+........
T Consensus 187 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 266 (364)
T 3qyz_A 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266 (364)
T ss_dssp TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence 123457999999999987655445679999999999999999999988776655554433211100
Q ss_pred --ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 135 --YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 135 --~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
...+ ....++..+.+||.+||..||.+|||+.++++||||++...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 0001 01357899999999999999999999999999999987644
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=260.53 Aligned_cols=168 Identities=32% Similarity=0.508 Sum_probs=135.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~ 68 (265)
||++.+ +|.+++.... ++.+++.+|.|||+ +||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGA 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC---
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCc
Confidence 788866 8988887654 36778999999998 99999999999999988775 99999999975332 23
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+...... ...+.......| ..+++.+.
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~ 377 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFP--RTLGPEAK 377 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCC--TTSCHHHH
T ss_pred ccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHHhCCCCCC--ccCCHHHH
Confidence 34456799999999999887775 559999999999999999999987654332 223333333333 36899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 149 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 149 ~li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
+||.+||..||.+|| ++.++++||||+..
T Consensus 378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 999999999999999 99999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=259.60 Aligned_cols=172 Identities=28% Similarity=0.474 Sum_probs=137.7
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||+..+..+.+||+|||+++.......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 788864 8988886543 36689999999999999999999999999544444699999999986655555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 147 (265)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+..+. ......+ .+..+++.+
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL----ACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HTCCCSCSGGGTTSCHHH
T ss_pred cccccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hccCCCChhhhccCCHHH
Confidence 5556799999999999876654 56999999999999999999998876544333332 2222222 234689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++||.+||..||.+|||+.++++||||+..
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=257.63 Aligned_cols=172 Identities=24% Similarity=0.300 Sum_probs=131.5
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCC---------------------
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGS--------------------- 48 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~--------------------- 48 (265)
||+++++|.+++..+. ++.+++.+|.|||++||+||||||+|||++..
T Consensus 115 ~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~ 194 (360)
T 3llt_A 115 FEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194 (360)
T ss_dssp ECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEE
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccccc
Confidence 7899889999998654 36778999999999999999999999999751
Q ss_pred --CCCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Q 024572 49 --PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT 126 (265)
Q Consensus 49 --~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 126 (265)
..+.+||+|||+++.... ......||+.|+|||++.+..++. ++|||||||++|+|++|+.||........+..+
T Consensus 195 ~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 271 (360)
T 3llt_A 195 RTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDV-SSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271 (360)
T ss_dssp EESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCC-ccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 134599999999975332 334567999999999999887754 599999999999999999999876554433322
Q ss_pred HHHHhhh----------------------cccCCCC------------------CCCCHHHHHHHHHhcccCCCCCCCHH
Q 024572 127 ISRIMAV----------------------QYKIPDY------------------VHISQDCRNLLSRIFVANPSRRITIK 166 (265)
Q Consensus 127 ~~~~~~~----------------------~~~~~~~------------------~~~~~~~~~li~~~L~~dP~~R~s~~ 166 (265)
....... ...+|.. ...++.+.+||.+||..||.+|||+.
T Consensus 272 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~ 351 (360)
T 3llt_A 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPA 351 (360)
T ss_dssp HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHH
Confidence 2111000 0000100 01236788999999999999999999
Q ss_pred HHhcCcccC
Q 024572 167 EIKSHPWFL 175 (265)
Q Consensus 167 ell~h~~f~ 175 (265)
++|+||||+
T Consensus 352 elL~hp~f~ 360 (360)
T 3llt_A 352 ELLKHKFLE 360 (360)
T ss_dssp HHTTSGGGC
T ss_pred HHhcCcccC
Confidence 999999995
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=257.96 Aligned_cols=175 Identities=22% Similarity=0.302 Sum_probs=123.8
Q ss_pred CcccccchHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
||+++++|.+++... .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... ....
T Consensus 113 ~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~ 188 (367)
T 2fst_X 113 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTAD--EMTG 188 (367)
T ss_dssp EECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC---------------
T ss_pred ecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeeccccccccc--cCCC
Confidence 577778888877543 34778999999999999999999999999988775 99999999975432 2345
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc------------------
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------------ 134 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------------ 134 (265)
..+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+...+....
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 268 (367)
T 2fst_X 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 268 (367)
T ss_dssp --CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHT
T ss_pred cCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhc
Confidence 67999999999998744445669999999999999999999988766555444433211100
Q ss_pred -ccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 135 -YKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 135 -~~~~------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
...+ ....+++.+.+||.+||..||.+|||+.++++||||+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 269 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 0001 01246889999999999999999999999999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=259.09 Aligned_cols=178 Identities=27% Similarity=0.318 Sum_probs=128.4
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC---
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--- 68 (265)
||+++++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 109 ~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~ 186 (432)
T 3n9x_A 109 LEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTN 186 (432)
T ss_dssp EECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC-------
T ss_pred EecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCccccccccccc
Confidence 7899999999887643 4778999999999999999999999999988775 9999999997543321
Q ss_pred --------------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhC-----------CCCCCCC
Q 024572 69 --------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-----------AYPFEDQ 117 (265)
Q Consensus 69 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g-----------~~pf~~~ 117 (265)
.....+||+.|+|||++......+.++|||||||++|+|++| .++|.+.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~ 266 (432)
T 3n9x_A 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266 (432)
T ss_dssp ------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCS
T ss_pred ccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCc
Confidence 124567999999999975555446679999999999999984 3444332
Q ss_pred CC-----------------hHHHHHHHHHH--------------------hhhcccCC-----CCCCCCHHHHHHHHHhc
Q 024572 118 ED-----------------PKNFRKTISRI--------------------MAVQYKIP-----DYVHISQDCRNLLSRIF 155 (265)
Q Consensus 118 ~~-----------------~~~~~~~~~~~--------------------~~~~~~~~-----~~~~~~~~~~~li~~~L 155 (265)
.. ...+..++..+ .......+ .+..+++.+.+||.+||
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL 346 (432)
T 3n9x_A 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESML 346 (432)
T ss_dssp CSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHS
T ss_pred cccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHh
Confidence 21 11111111100 00000001 11357999999999999
Q ss_pred ccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 156 VANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 156 ~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
..||.+|||+.++|+||||+.....
T Consensus 347 ~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 347 KFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp CSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred cCCcccCCCHHHHhcChhhhhccCc
Confidence 9999999999999999999875443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=256.34 Aligned_cols=172 Identities=26% Similarity=0.363 Sum_probs=131.9
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC---
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--- 68 (265)
||+++++|.+++..+. ++.+++.+|.|||++||+||||||+|||++. + .+||+|||+++......
T Consensus 135 ~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~--~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 135 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S--CEEECCCSSSCCC-------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C--eEEEEecCccccccCCCccc
Confidence 7877789999987543 3678899999999999999999999999964 3 49999999997554322
Q ss_pred CCCCCcCCCCCcccccccCC----------cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC
Q 024572 69 RPKSTVGTPAYIAPEVLSRR----------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 138 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 138 (265)
.....+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||....... ..+..+.......+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIE 288 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTSCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccccCC
Confidence 22345799999999998652 223566999999999999999999998754422 22233333333333
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.+...+..+.+||.+||..||.+|||+.++++||||+...
T Consensus 289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 3445688999999999999999999999999999997543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=256.73 Aligned_cols=174 Identities=25% Similarity=0.293 Sum_probs=133.7
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhh--hcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSL--SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH--~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||+++++|.+++.... ++.+++.++.||| ++||+||||||+|||++.+..+.+||+|||+++...
T Consensus 135 ~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~-- 212 (382)
T 2vx3_A 135 FEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-- 212 (382)
T ss_dssp EECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT--
T ss_pred EecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc--
Confidence 7899999999987653 3677899999999 579999999999999965444569999999997543
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc------------
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY------------ 135 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------ 135 (265)
.......+|+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+..+.........
T Consensus 213 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (382)
T 2vx3_A 213 QRIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKF 291 (382)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHH
T ss_pred cccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHH
Confidence 233456799999999999987765 5599999999999999999999987665555444432211000
Q ss_pred --cCC-------------------CCCC-------------------------CCHHHHHHHHHhcccCCCCCCCHHHHh
Q 024572 136 --KIP-------------------DYVH-------------------------ISQDCRNLLSRIFVANPSRRITIKEIK 169 (265)
Q Consensus 136 --~~~-------------------~~~~-------------------------~~~~~~~li~~~L~~dP~~R~s~~ell 169 (265)
..+ .... .++.+++||.+||..||.+|||+.++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L 371 (382)
T 2vx3_A 292 FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYAL 371 (382)
T ss_dssp EEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred HHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHh
Confidence 000 0000 013789999999999999999999999
Q ss_pred cCcccCCC
Q 024572 170 SHPWFLKN 177 (265)
Q Consensus 170 ~h~~f~~~ 177 (265)
+||||++.
T Consensus 372 ~hp~f~~~ 379 (382)
T 2vx3_A 372 QHSFFKKT 379 (382)
T ss_dssp TSGGGCC-
T ss_pred cCcccccC
Confidence 99999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=249.43 Aligned_cols=168 Identities=29% Similarity=0.485 Sum_probs=132.5
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++. ++|.+++...+ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 177 (327)
T 3a62_A 100 LEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESIHDGTV 177 (327)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC---------
T ss_pred EeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccccccCCcc
Confidence 78886 49999887654 3667899999999999999999999999987775 999999998753322 23
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||......... ..+.......| ..++..+++
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~ 250 (327)
T 3a62_A 178 THTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTI----DKILKCKLNLP--PYLTQEARD 250 (327)
T ss_dssp -CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCC--TTSCHHHHH
T ss_pred ccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCCHHHHH
Confidence 3455799999999999887764 5699999999999999999999876543332 33333333333 368999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
||.+||..||.+|| ++.++++||||+..
T Consensus 251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 99999999999999 88999999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=253.53 Aligned_cols=175 Identities=21% Similarity=0.295 Sum_probs=136.0
Q ss_pred CcccccchHHHHHH-------------hccccchHHHHHhhh--hcCceecCCCcCcEEEcC-CCCCcEEEeccCCcccC
Q 024572 1 MQLGVSSLSEFVML-------------EGSVKMKPDIFFSSL--SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~sL~~~~~~-------------~~~~~~i~~~l~~lH--~~~ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~ 64 (265)
||++.++|.+.+.. ..++.+++.++.||| ++||+||||||+|||++. ++ .+||+|||+++..
T Consensus 105 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 105 MEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGSAKKL 182 (360)
T ss_dssp EECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTTCBCC
T ss_pred eecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCCceec
Confidence 68888887665542 224677899999999 999999999999999986 54 4999999999866
Q ss_pred CCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc---------
Q 024572 65 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------- 135 (265)
Q Consensus 65 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 135 (265)
..........+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+.........
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3e3p_A 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS 262 (360)
T ss_dssp CTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred CCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccc
Confidence 65555556679999999999977664566799999999999999999999887665555444432111000
Q ss_pred -----------------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 136 -----------------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 136 -----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
........+..+.+||.+||..||.+|||+.++++||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 000111256789999999999999999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=268.06 Aligned_cols=172 Identities=28% Similarity=0.405 Sum_probs=139.2
Q ss_pred Ccccc-cchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++...+ ++.+|+.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQ 340 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceecccCc
Confidence 78885 59998887543 3567899999999999999999999999988776 9999999998665444
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+...+.......+ ..++++++
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~ 417 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQAR 417 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred cccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHH
Confidence 44556899999999999887775 5599999999999999999999876543222333333333333333 46899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 149 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 149 ~li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
+||.+||..||.+|| ++.++++||||+..
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 999999999999999 79999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=253.03 Aligned_cols=174 Identities=32% Similarity=0.546 Sum_probs=128.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcC-CCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..++ ++.+++.+|.|||++||+||||||+|||++. +..+.+||+|||+++.......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 688864 9988876543 4678899999999999999999999999975 2234599999999976544444
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc--CCCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 147 (265)
.....||+.|+|||++.+..+. .++|||||||++|+|++|+.||......... ...+...... .+.+..++..+
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~ 282 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFM---FRRILNCEYYFISPWWDEVSLNA 282 (349)
T ss_dssp ------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHHTTCCCCCTTTTTTSCHHH
T ss_pred cccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHHhCCCccCCchhhhCCHHH
Confidence 4556799999999999887765 5599999999999999999999876654322 2222333222 23345789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
++||.+||..||.+|||+.++++||||....
T Consensus 283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999999998654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=260.07 Aligned_cols=172 Identities=24% Similarity=0.383 Sum_probs=138.3
Q ss_pred Cccccc-chHHHHHHhc-------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++.... ++.+|+.+|.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKA 341 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeeccC
Confidence 788865 9988886532 2667899999999999999999999999998776 99999999976544
Q ss_pred CCCC-CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 67 HSRP-KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 67 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.... ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+...+.......| ..++.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s~ 418 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSP 418 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSCH
T ss_pred CCcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccCH
Confidence 3332 345899999999999987775 5599999999999999999999876543333344444444444444 46899
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 146 DCRNLLSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
.+++||.+||..||.+||+ +.++++||||+..
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 9999999999999999996 5899999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=270.19 Aligned_cols=168 Identities=32% Similarity=0.525 Sum_probs=139.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++...+ ++.+|+.+|.|||++|||||||||+||||+.++. +||+|||+++.... ...
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTTCC
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCCcc
Confidence 788865 9999988654 3677899999999999999999999999998876 99999999975332 333
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+..... ....+......+|. .++.++++
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~ 571 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAYPK--SMSKEAVA 571 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHSSCCCCCT--TSCHHHHH
T ss_pred cccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHH----HHHHHHhCCCCCCc--cCCHHHHH
Confidence 4556799999999999888775 55999999999999999999998865433 33344444444443 68999999
Q ss_pred HHHHhcccCCCCCCCH-----HHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITI-----KEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~-----~ell~h~~f~~~ 177 (265)
||.+||..||.+|+++ .+|++||||+..
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999999999997 999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=242.49 Aligned_cols=173 Identities=30% Similarity=0.555 Sum_probs=138.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC-CcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~-~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. ..+||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 678765 8888877654 3678899999999999999999999999976542 3599999999976655555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc--ccCCCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 147 (265)
.....+++.|+|||++.+..++ .++||||||+++|+|++|+.||.......... .+.... ...+.+..+++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYA----QIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCCTTTTTTSCHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHH----HHHhccccCCchhhcccCHHH
Confidence 5556799999999999887765 55999999999999999999998765433222 222222 2333445789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.+||.+||..||.+|||+.++++||||++..
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999999997653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=246.98 Aligned_cols=171 Identities=23% Similarity=0.337 Sum_probs=123.6
Q ss_pred CcccccchHHHHHHh-------------ccccchHHHHHhhhhc-CceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVSSLSEFVMLE-------------GSVKMKPDIFFSSLSQ-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~sL~~~~~~~-------------~~~~~i~~~l~~lH~~-~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.++|.+++... .++.+++.++.|||++ ||+||||||+||+++.++. +||+|||+++....
T Consensus 85 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYLVD 162 (290)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC--------
T ss_pred EehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccccc
Confidence 788988988877541 2467889999999998 9999999999999987765 99999999976555
Q ss_pred CCCCCCCcCCCCCccccccc---CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 67 HSRPKSTVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
........+|+.|+|||++. .....+.++|||||||++|+|++|+.||.......... ...............+
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 239 (290)
T 3fme_A 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVEEPSPQLPADKF 239 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH---HHHHHSCCCCCCTTTS
T ss_pred cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH---HHHhccCCCCcccccC
Confidence 44445557999999999973 22333566999999999999999999998654432221 1222222222223468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 999999999999999999999999999999964
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=246.80 Aligned_cols=173 Identities=28% Similarity=0.453 Sum_probs=135.3
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~ 70 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...... ..
T Consensus 121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~ 198 (321)
T 2c30_A 121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKR 198 (321)
T ss_dssp ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCB
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccc
Confidence 688755 888876543 24778899999999999999999999999987765 9999999987544332 23
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-ccCCCCCCCCHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVHISQDCRN 149 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 149 (265)
....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......... .+.... ........+++.+.+
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK----RLRDSPPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSSCCCCTTGGGSCHHHHH
T ss_pred ccccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCCCCcCccccCCHHHHH
Confidence 445799999999999887765 45999999999999999999998765433222 222211 122233457899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
||.+||..||.+|||+.++++||||.+....
T Consensus 274 li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 304 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDHPFLLQTGLP 304 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred HHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence 9999999999999999999999999865443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=259.70 Aligned_cols=173 Identities=27% Similarity=0.460 Sum_probs=136.6
Q ss_pred Cccc-ccchHHHHHHh-c---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLG-VSSLSEFVMLE-G---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~-~~sL~~~~~~~-~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++ +++|.+++... + ++.+++.+|.|||++|||||||||+|||++.++. +||+|||+|+.......
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGT 230 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSC
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCCC
Confidence 7888 55999999763 2 3678899999999999999999999999998776 99999999975443322
Q ss_pred --CCCCcCCCCCccccccc-----CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCC-CC
Q 024572 70 --PKSTVGTPAYIAPEVLS-----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YV 141 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 141 (265)
....+||+.|+|||++. ...+ +.++|||||||++|+|++|+.||.+......+..++.... ....|. ..
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~ 307 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQFPTQVT 307 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCSSCC
T ss_pred cccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--cccCCcccc
Confidence 23457999999999997 3344 4569999999999999999999988765544444433221 223333 24
Q ss_pred CCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccCCCC
Q 024572 142 HISQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKNL 178 (265)
Q Consensus 142 ~~~~~~~~li~~~L~~dP~~--R~s~~ell~h~~f~~~~ 178 (265)
.+++++++||++||..+|++ |+++.++++||||+..-
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 58999999999999988888 99999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=250.93 Aligned_cols=165 Identities=27% Similarity=0.386 Sum_probs=135.4
Q ss_pred Ccccc-c-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-S-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. + +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 108 ~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~ 185 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYLERGKL 185 (335)
T ss_dssp EECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTCC
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceECCCCCc
Confidence 56553 3 8888887653 4778899999999999999999999999988765 99999999986655544
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||..... .. ......+..+++.+.+
T Consensus 186 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~--~~~~~~~~~~~~~l~~ 253 (335)
T 3dls_A 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TV--EAAIHPPYLVSKELMS 253 (335)
T ss_dssp BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GT--TTCCCCSSCCCHHHHH
T ss_pred eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HH--hhccCCCcccCHHHHH
Confidence 45567999999999999888767779999999999999999999976321 11 1122333458999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
||.+||..||.+|||+.++++||||++...
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 283 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence 999999999999999999999999987654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=254.93 Aligned_cols=177 Identities=21% Similarity=0.294 Sum_probs=130.1
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 113 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~ 190 (362)
T 3pg1_A 113 TELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLAREDTADANK 190 (362)
T ss_dssp EECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCTTC----------
T ss_pred EccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEecCccccccccccc
Confidence 7889999988887543 4678999999999999999999999999987775 999999999755554455
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc----------------
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---------------- 134 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 134 (265)
....+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+........
T Consensus 191 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 270 (362)
T 3pg1_A 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL 270 (362)
T ss_dssp -----CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHT
T ss_pred ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHH
Confidence 5567999999999998744445679999999999999999999988765544444332211100
Q ss_pred ----ccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 135 ----YKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 135 ----~~~~------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
...+ ....+++.+.+||.+||..||.+|||+.++++||||+....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp TTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 0000 11246888999999999999999999999999999987543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=247.97 Aligned_cols=177 Identities=19% Similarity=0.282 Sum_probs=133.3
Q ss_pred Cccccc-chHHHHH------HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVS-SLSEFVM------LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~-sL~~~~~------~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||++.+ +|.+++. ...++.+++.+|.|||++||+||||||+|||++.++. .+||+|||+++...........
T Consensus 112 ~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~ 190 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVR 190 (330)
T ss_dssp EECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSC
T ss_pred EeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCccccc
Confidence 566664 6766643 2335778999999999999999999999999986652 4999999999866555555666
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh----------hcc--------
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----------VQY-------- 135 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------~~~-------- 135 (265)
.++..|+|||++.+....+.++|||||||++|+|++|+.||............+..... ...
T Consensus 191 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (330)
T 3nsz_A 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270 (330)
T ss_dssp CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHH
T ss_pred cccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhh
Confidence 89999999999987554566799999999999999999999665443222111111100 000
Q ss_pred --------------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 136 --------------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 136 --------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.......+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0011122789999999999999999999999999999998653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=256.59 Aligned_cols=171 Identities=25% Similarity=0.428 Sum_probs=134.1
Q ss_pred Cccc-ccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLG-VSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++ +++|.+++...+ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGT 217 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSC
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCc
Confidence 7888 559999998753 2667899999999999999999999999998776 99999999975543322
Q ss_pred --CCCCcCCCCCcccccccC-------CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCC-
Q 024572 70 --PKSTVGTPAYIAPEVLSR-------REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD- 139 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 139 (265)
....+||+.|+|||++.. ..+ +.++|||||||++|+|++|+.||........+..++... .....|.
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~ 294 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK--EHLSLPLV 294 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCC--
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCcCCCcc
Confidence 234579999999999973 334 456999999999999999999998866544444433221 1122332
Q ss_pred CCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcccCCC
Q 024572 140 YVHISQDCRNLLSRIFVANPSRR---ITIKEIKSHPWFLKN 177 (265)
Q Consensus 140 ~~~~~~~~~~li~~~L~~dP~~R---~s~~ell~h~~f~~~ 177 (265)
...+++++++||.+||. +|.+| +++.++++||||+..
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 24689999999999999 99998 599999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=250.96 Aligned_cols=172 Identities=26% Similarity=0.379 Sum_probs=130.2
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC--
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-- 69 (265)
||+++++|.+++..+. ++.+++.+|.|||++||+||||||+|||++. + .+||+|||+++.......
T Consensus 88 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 88 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp ECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC-------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccCcccccc
Confidence 7888889999987654 3678899999999999999999999999973 3 499999999975543322
Q ss_pred -CCCCcCCCCCcccccccC----------CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC
Q 024572 70 -PKSTVGTPAYIAPEVLSR----------REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 138 (265)
Q Consensus 70 -~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 138 (265)
....+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||....... ..+...........
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIE 241 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHCTTSCCC
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH---HHHHHHhcCCcccC
Confidence 234579999999999864 1233556999999999999999999998754432 12222233333333
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.+...+..+.+||.+||..||.+|||+.++++||||+...
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 3445778999999999999999999999999999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=246.98 Aligned_cols=174 Identities=25% Similarity=0.297 Sum_probs=138.5
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.++|.+++.... ++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 98 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~ 175 (326)
T 1blx_A 98 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMA 175 (326)
T ss_dssp EECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGG
T ss_pred EecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcccccccCCCC
Confidence 6888899999887642 3678899999999999999999999999988775 99999999876544333
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-ccC-----------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKI----------- 137 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~----------- 137 (265)
.....+++.|+|||++.+..+. .++|||||||++|+|++|+.||.+......+..++....... ..+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (326)
T 1blx_A 176 LTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 254 (326)
T ss_dssp GCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS
T ss_pred ccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhh
Confidence 4456789999999999887765 559999999999999999999988766555444443221100 000
Q ss_pred ---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 138 ---------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 138 ---------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.....++..+++||.+||..||.+|||+.++++||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 255 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0123578899999999999999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=242.73 Aligned_cols=172 Identities=35% Similarity=0.619 Sum_probs=130.5
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||++.........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC----
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcce
Confidence 67885 49999987653 3677899999999999999999999999987765 999999999765544444
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....+++.|+|||++.+..+.+.++||||||+++|+|++|+.||....... ....+.......+ ..++..+.++
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~--~~~~~~l~~l 241 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT----LFKKIRGGVFYIP--EYLNRSVATL 241 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHhhcCcccCc--hhcCHHHHHH
Confidence 456789999999999887765667999999999999999999997754322 2222222322233 3678999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
|.+||..||.+|||+.++++||||++..+.
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQDLPS 271 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred HHHHccCChhhCCCHHHHHhChhhccCchh
Confidence 999999999999999999999999877654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=253.55 Aligned_cols=169 Identities=31% Similarity=0.573 Sum_probs=135.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||++.........
T Consensus 179 ~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~~~~~~ 256 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKL 256 (365)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCB
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccCCCccc
Confidence 788876 9999887543 3678899999999999999999999999988775 999999998766555555
Q ss_pred CCCcCCCCCcccccccCC------cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC--CCCCC
Q 024572 71 KSTVGTPAYIAPEVLSRR------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVH 142 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 142 (265)
....||+.|+|||++.+. .+ +.++|||||||++|+|++|+.||......... ..+....... +.+..
T Consensus 257 ~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 257 RELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILML----RMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp CCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCHHHHSS
T ss_pred ccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCCCccccc
Confidence 566899999999998642 33 45599999999999999999999875443222 2222222222 22346
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
++..+.+||.+||..||.+|||+.++++||||++
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 7899999999999999999999999999999963
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=260.27 Aligned_cols=160 Identities=18% Similarity=0.191 Sum_probs=127.5
Q ss_pred CcccccchHHHHHHh----------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC
Q 024572 1 MQLGVSSLSEFVMLE----------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 64 (265)
||+++++|.+++..+ .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 179 ~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~ 256 (377)
T 3byv_A 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRD 256 (377)
T ss_dssp EECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEET
T ss_pred EeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEechhheec
Confidence 789989999998753 25678899999999999999999999999997765 999999999743
Q ss_pred CCCCCCCCCcCCCCCcccccccCC-----------cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh
Q 024572 65 LLHSRPKSTVGTPAYIAPEVLSRR-----------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 133 (265)
Q Consensus 65 ~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 133 (265)
. ......+| +.|+|||++.+. .+ +.++|||||||++|+|++|+.||.........
T Consensus 257 ~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~---------- 322 (377)
T 3byv_A 257 G--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIYWIWCADLPITKDAALGGS---------- 322 (377)
T ss_dssp T--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHHHHHHSSCCC------CCS----------
T ss_pred C--CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHHHHHHCCCCCcccccccch----------
Confidence 2 22334567 999999999876 55 46699999999999999999999764432111
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 134 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.........+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 323 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 323 EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 1111223468999999999999999999999999999999963
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=248.45 Aligned_cols=174 Identities=29% Similarity=0.485 Sum_probs=138.2
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC--CcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~--~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++.... ++.+++.+|.|||++||+||||||+||+++.++. ..+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~ 173 (321)
T 2a2a_A 94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173 (321)
T ss_dssp ECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc
Confidence 68885 59999987543 3677899999999999999999999999987652 149999999998665554
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQD 146 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 146 (265)
......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+....... ..+.......+ .+..++..
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 174 EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETL----ANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTCCHH
T ss_pred cccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcccccChhhhcccCHH
Confidence 45566799999999999877765 5599999999999999999999876543322 22232222222 12367899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
+.+||.+||..||.+|||+.++++||||+....
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 999999999999999999999999999976543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=258.69 Aligned_cols=175 Identities=27% Similarity=0.365 Sum_probs=125.2
Q ss_pred CcccccchHHHHHH-------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVML-------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~sL~~~~~~-------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||++.++|.+++.. ..++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 109 ~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~ 186 (371)
T 2xrw_A 109 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 186 (371)
T ss_dssp EECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-------------
T ss_pred EEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccccccccCCc
Confidence 78999998887752 235778999999999999999999999999988775 999999999765444444556
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh---------------cccCC
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------QYKIP 138 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~ 138 (265)
.+|+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+..++...... ....+
T Consensus 187 ~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (371)
T 2xrw_A 187 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP 265 (371)
T ss_dssp ---CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSC
T ss_pred eecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCc
Confidence 799999999999887775 45999999999999999999998876544443332211000 00001
Q ss_pred CCC---------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 139 DYV---------------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 139 ~~~---------------------~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
... ..+..+++||.+||..||.+|||+.++++||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 266 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred cccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 000 0146789999999999999999999999999997543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=251.69 Aligned_cols=170 Identities=29% Similarity=0.555 Sum_probs=133.7
Q ss_pred Cccccc-chHHHHHHhc-------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCC
Q 024572 1 MQLGVS-SLSEFVMLEG-------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~ 65 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++ ...+||+|||+++...
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence 788874 8988776542 367899999999999999999999999997643 2359999999997654
Q ss_pred CCCC-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCC
Q 024572 66 LHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVH 142 (265)
Q Consensus 66 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 142 (265)
.... ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.. . .....+.......+ .+..
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~--~---~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 185 ESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK--E---RLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp TTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH--H---HHHHHHHHTCCCCCHHHHTT
T ss_pred CCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH--H---HHHHHHHcCCCCCCcccccc
Confidence 3322 3345799999999999887775 55999999999999999999998742 1 22222333322222 2246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
++..+++||.+||..||.+|||+.++++||||+.
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 8999999999999999999999999999999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=252.10 Aligned_cols=174 Identities=28% Similarity=0.515 Sum_probs=136.6
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC--CCcEEEeccCCcccCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLLH- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~--~~~vkl~Dfg~a~~~~~~- 67 (265)
||++.+ +|.+++..++ ++.+++.+|.|||++||+||||||+|||+.... .+.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 789865 9999887654 367789999999999999999999999985432 134999999999754433
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQ 145 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 145 (265)
......++|+.|+|||++.+..++ .++|||||||++|+|++|..||..... .....+...+....+..+ .+..++.
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 252 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSD 252 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred CceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCH
Confidence 233456799999999999876664 559999999999999999999986432 122334444444444333 3457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.+++||.+||..||.+|||+.++++||||..
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 9999999999999999999999999999954
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=249.22 Aligned_cols=172 Identities=26% Similarity=0.346 Sum_probs=132.5
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-----------------CCc
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-----------------APR 52 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-----------------~~~ 52 (265)
||+++++|.+++..+. ++.+++.+|.|||++||+||||||+|||++..+ .+.
T Consensus 96 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (339)
T 1z57_A 96 FELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175 (339)
T ss_dssp EECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCC
T ss_pred EcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCC
Confidence 7899889999988664 366789999999999999999999999998643 345
Q ss_pred EEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh
Q 024572 53 LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 132 (265)
Q Consensus 53 vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 132 (265)
+||+|||+++... .......+|+.|+|||++.+..++ .++|||||||++|+|++|+.||............ .....
T Consensus 176 ~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~ 251 (339)
T 1z57_A 176 IKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM-ERILG 251 (339)
T ss_dssp EEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH-HHHHC
T ss_pred ceEeeCcccccCc--cccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhC
Confidence 9999999987533 233456799999999999887765 5599999999999999999999876554332222 21111
Q ss_pred hcc---------------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 024572 133 VQY---------------------------------------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173 (265)
Q Consensus 133 ~~~---------------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~ 173 (265)
... ........++.+.+||.+||..||.+|||+.++++|||
T Consensus 252 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 331 (339)
T 1z57_A 252 PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPF 331 (339)
T ss_dssp SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHH
Confidence 000 00001123467899999999999999999999999999
Q ss_pred cCC
Q 024572 174 FLK 176 (265)
Q Consensus 174 f~~ 176 (265)
|+.
T Consensus 332 f~~ 334 (339)
T 1z57_A 332 FDL 334 (339)
T ss_dssp GGG
T ss_pred HHH
Confidence 974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=245.11 Aligned_cols=175 Identities=25% Similarity=0.354 Sum_probs=128.6
Q ss_pred Cccccc-chHHHHHHh---------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLE---------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~---------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++...... .
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccc
Confidence 677777 566665533 24667899999999999999999999999987775 9999999997544322 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh---------------hc
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQ 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~ 134 (265)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.||.+................ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 334578999999999987554456799999999999999999999887655444333222110 00
Q ss_pred ccCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 YKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 ~~~~~----------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...+. ...++..+.+||.+||..||.+|||+.++++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 01111 13578899999999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=251.66 Aligned_cols=173 Identities=28% Similarity=0.410 Sum_probs=136.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 138 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~ 215 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETE 215 (355)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGGG
T ss_pred eecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecccCCCC
Confidence 788865 9999987654 3667899999999999999999999999988775 9999999987543221
Q ss_pred CCCCCcCCCCCcccccccCCc-CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...........+...+..... +.+..++..+
T Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 293 (355)
T 1vzo_A 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALA 293 (355)
T ss_dssp GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CCCcccCHHH
Confidence 223356999999999998632 2356699999999999999999999865443333344444333333 3334689999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
.+||.+||..||.+|| |+.++++||||++.
T Consensus 294 ~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 9999999999999999 99999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=261.19 Aligned_cols=171 Identities=34% Similarity=0.553 Sum_probs=135.5
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++..+ .+.+||+|||+++.......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 688865 8988886544 477889999999999999999999999996432 23599999999986655555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--cCCCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 147 (265)
....+||+.|+|||++.+. + +.++|||||||++|+|++|+.||.+......+ ..+....+ ..+.+..+++.+
T Consensus 180 ~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDIL----KRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp --CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCSCSGGGGGSCHHH
T ss_pred cCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCCcccCCCCHHH
Confidence 5566899999999999763 4 45699999999999999999999886543332 23333332 334455789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++||.+||..||.+|||+.++++||||++.
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=252.25 Aligned_cols=161 Identities=31% Similarity=0.523 Sum_probs=123.4
Q ss_pred ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-----CCCCCcCCCCCcccccccCC-c
Q 024572 16 GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-----RPKSTVGTPAYIAPEVLSRR-E 89 (265)
Q Consensus 16 ~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~ 89 (265)
.++.+++.++.|||++||+||||||+|||++.++...+||+|||+++...... ......||+.|+|||++.+. .
T Consensus 172 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 172 NIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence 35778999999999999999999999999987764469999999987543221 12345699999999999752 3
Q ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 024572 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 169 (265)
Q Consensus 90 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell 169 (265)
..+.++|||||||++|+|++|+.||.+............. ......+.+..+++.+.+||.+||..||.+|||+.+++
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK--KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc--ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 3345699999999999999999999887654443333221 11122233335789999999999999999999999999
Q ss_pred cCcccCCCC
Q 024572 170 SHPWFLKNL 178 (265)
Q Consensus 170 ~h~~f~~~~ 178 (265)
+||||+...
T Consensus 330 ~hp~~~~~~ 338 (345)
T 3hko_A 330 QHPWISQFS 338 (345)
T ss_dssp HSHHHHTTS
T ss_pred cChhhccCh
Confidence 999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=261.02 Aligned_cols=170 Identities=31% Similarity=0.529 Sum_probs=137.2
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++..+ .+.+||+|||+++.......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 788866 8988887653 477889999999999999999999999997643 24599999999986655555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc--CCCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 147 (265)
....+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+......+ ..+....+. .+.+..+++.+
T Consensus 195 ~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEIL----RKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp BCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCSGGGTTSCHHH
T ss_pred ccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCchhcccCCHHH
Confidence 556789999999999864 45 45699999999999999999999886553332 233333332 33445789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
++||.+||..||.+|||+.++++||||+.
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 99999999999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=248.86 Aligned_cols=176 Identities=26% Similarity=0.475 Sum_probs=118.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH-S 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~-~ 68 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++ ...+||+|||+++..... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp ECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred EEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 788866 9999987654 477889999999999999999999999997654 225999999999754332 2
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhhhcccCCC--CCCC
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYKIPD--YVHI 143 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~ 143 (265)
.....++|+.|+|||++.+..++ .++|||||||++|+|++|+.||...... ......+..+.......+. +..+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp -------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred cccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 23445689999999999887765 5599999999999999999999765431 1123334444444333322 2358
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++.+++||.+||..||.+|||+.++++||||+..
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 9999999999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=250.22 Aligned_cols=176 Identities=23% Similarity=0.313 Sum_probs=132.3
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCC-----------------CCCc
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGS-----------------PAPR 52 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~-----------------~~~~ 52 (265)
||+++++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.. ..+.
T Consensus 101 ~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~ 180 (355)
T 2eu9_A 101 FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180 (355)
T ss_dssp EECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCC
T ss_pred EeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCc
Confidence 7899888888877654 36788999999999999999999999999432 1235
Q ss_pred EEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh
Q 024572 53 LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 132 (265)
Q Consensus 53 vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 132 (265)
+||+|||+++... .......||+.|+|||++.+..++ .++|||||||++|+|++|+.||..................
T Consensus 181 ~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (355)
T 2eu9_A 181 IRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP 257 (355)
T ss_dssp EEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999999997533 233456799999999999887775 4599999999999999999999876554433222211100
Q ss_pred hc--------------------------------------ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 133 VQ--------------------------------------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 133 ~~--------------------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.. .........+..+.+||.+||..||.+|||+.++++||||
T Consensus 258 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 337 (355)
T 2eu9_A 258 IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337 (355)
T ss_dssp CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGG
T ss_pred CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 00 0000011124578899999999999999999999999999
Q ss_pred CCCCC
Q 024572 175 LKNLP 179 (265)
Q Consensus 175 ~~~~~ 179 (265)
+...+
T Consensus 338 ~~~~~ 342 (355)
T 2eu9_A 338 AGLTP 342 (355)
T ss_dssp GGCCH
T ss_pred cCCCh
Confidence 86543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=247.99 Aligned_cols=175 Identities=25% Similarity=0.357 Sum_probs=133.4
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC----
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~---- 68 (265)
||++.++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 93 ~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~ 170 (353)
T 2b9h_A 93 QELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNS 170 (353)
T ss_dssp ECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC-------
T ss_pred EeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEeccccccccccccccc
Confidence 6888899998876543 4778899999999999999999999999987765 9999999987543221
Q ss_pred -------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc-------
Q 024572 69 -------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------- 134 (265)
Q Consensus 69 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------- 134 (265)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+........
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T 2b9h_A 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRC 250 (353)
T ss_dssp ---------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTT
T ss_pred CccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccc
Confidence 112346899999999987644456679999999999999999999988765443333222111000
Q ss_pred -------------ccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 -------------YKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 -------------~~~~------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...+ .+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 251 IESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0000 013578999999999999999999999999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=253.59 Aligned_cols=175 Identities=17% Similarity=0.255 Sum_probs=129.9
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC--
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-- 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-- 66 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+|||++.++. +||+|||.+.....
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHG 182 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGGGCEECEETT
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccccceeecccc
Confidence 688864 899988764 24678899999999999999999999999987775 99999998753221
Q ss_pred ------CCCCCCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-----
Q 024572 67 ------HSRPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----- 133 (265)
Q Consensus 67 ------~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 133 (265)
........||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+..........+......
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 122233478999999999987 345 456999999999999999999998766544433322111000
Q ss_pred -----------------------------------cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 134 -----------------------------------QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 134 -----------------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
....+.+..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 001112335788999999999999999999999999999997643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=242.17 Aligned_cols=170 Identities=26% Similarity=0.458 Sum_probs=126.0
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCC-CCCcEEEeccCCcccCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~ 65 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+||+++.. ..+.+||+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 688866 888887543 246788999999999999999999999999542 23459999999997655
Q ss_pred CCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC-CCCCCCC
Q 024572 66 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-PDYVHIS 144 (265)
Q Consensus 66 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 144 (265)
.........+++.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+....... .......... .....++
T Consensus 179 ~~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 179 SDEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ----QKATYKEPNYAVECRPLT 252 (285)
T ss_dssp --------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCC--CCCC
T ss_pred CcccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHH----hhhccCCcccccccCcCC
Confidence 5444556679999999999864 34 46699999999999999999999876533222 1111111111 1223478
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
+.+.+||.+||..||.+|||+.++++||||++
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 99999999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=249.72 Aligned_cols=175 Identities=24% Similarity=0.430 Sum_probs=132.2
Q ss_pred Cccccc-chHHHHHH-----------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVML-----------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~-----------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.+ +|.+++.. ..++.+++.+|.|||++||+||||||+|||++... .+.+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 677755 77776632 23477899999999999999999999999998621 235999999999866554
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.............. .......+.+..++..+
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~ 264 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ--VNVDYSEETFSSVSQLA 264 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTTTTTSCHHH
T ss_pred cccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh--cccccCchhhcccCHHH
Confidence 444556799999999999887765 559999999999999999999988655433322221 12222333445789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.+||.+||..||.+|||+.++++||||+...
T Consensus 265 ~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 9999999999999999999999999997653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=240.96 Aligned_cols=169 Identities=32% Similarity=0.539 Sum_probs=134.5
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEE---cCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll---~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||++ +.++ .+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~--~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS--PLKLIDFGLAARFKPG 162 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC--CEEECCCTTCEECCTT
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC--cEEEEecccceeccCc
Confidence 688855 8988877654 37778999999999999999999999999 4444 4999999999766555
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCC--CCCCCH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQ 145 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 145 (265)
.......+|+.|+|||++.+. + +.++||||||+++|+|++|+.||.......... .+.......+. +..+++
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML----KIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCHHHHTTSCH
T ss_pred cchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCchhhhcCCH
Confidence 555566799999999998764 4 455999999999999999999998765433322 22223332222 235789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+.+||.+||..||.+|||+.++++||||++.
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=250.02 Aligned_cols=173 Identities=23% Similarity=0.296 Sum_probs=130.5
Q ss_pred CcccccchHHHHH-------HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVM-------LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~sL~~~~~-------~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||++.++|.+++. ...++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++... ......
T Consensus 126 ~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~--~~~~~~ 201 (371)
T 4exu_A 126 MPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD--AEMTGY 201 (371)
T ss_dssp EECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----------CT
T ss_pred EccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc--cCcCCc
Confidence 6778887776553 2345778999999999999999999999999988776 9999999997443 233456
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-------------------c
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------------Q 134 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~ 134 (265)
.+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..++...... .
T Consensus 202 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (371)
T 4exu_A 202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 281 (371)
T ss_dssp TCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHS
T ss_pred ccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhcc
Confidence 789999999999874444566999999999999999999998876555444443321100 0
Q ss_pred ccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 YKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 ~~~~------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...+ .+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 282 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred CCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0000 123568999999999999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=244.74 Aligned_cols=177 Identities=29% Similarity=0.495 Sum_probs=129.4
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC-CcEEEeccCCcccCCCCC-
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~-~~vkl~Dfg~a~~~~~~~- 68 (265)
||++. ++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. ..+||+|||+++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 78886 59999987654 3678899999999999999999999999986543 349999999986443211
Q ss_pred -------CCCCCcCCCCCcccccccC-----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChH-----------HHHH
Q 024572 69 -------RPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----------NFRK 125 (265)
Q Consensus 69 -------~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~-----------~~~~ 125 (265)
.....+||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+..... ....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHT-TTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCC-cccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1123459999999999875 3343 45999999999999999999998754321 1122
Q ss_pred HHHHHhhhcccCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 126 TISRIMAVQYKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 126 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
....+.......+. +..++..+++||.+||..||.+|||+.++++||||+...
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 23333333333332 235789999999999999999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=246.70 Aligned_cols=170 Identities=25% Similarity=0.327 Sum_probs=135.0
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.... .
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~---~ 207 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---A 207 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---B
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCC---C
Confidence 7899999888876432 4677899999999999999999999999997765 99999999875432 2
Q ss_pred CCCcCCCCCccccccc---CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 71 KSTVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
....||+.|+|||++. ...+ +.++|||||||++|+|++|+.||........... +............++..+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYF 282 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCCCTTSCHHH
T ss_pred CcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCCCCCCCCCCHHH
Confidence 3457999999999985 3344 4569999999999999999999987654333222 222222223334689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
.+||.+||..||.+|||+.++++||||....+.
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999999999765543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=257.48 Aligned_cols=173 Identities=30% Similarity=0.454 Sum_probs=126.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++ ...+||+|||+++.......
T Consensus 218 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~ 297 (419)
T 3i6u_A 218 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297 (419)
T ss_dssp EECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC----
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCcc
Confidence 677755 8877765433 467899999999999999999999999997543 23599999999986655544
Q ss_pred CCCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC--CCCCCCCH
Q 024572 70 PKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQ 145 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 145 (265)
....+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||............+. ...... ..+..+++
T Consensus 298 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~ 374 (419)
T 3i6u_A 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVWAEVSE 374 (419)
T ss_dssp -------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---TTCCCCCHHHHTTSCH
T ss_pred ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---cCCCCCCchhhcccCH
Confidence 556679999999999864 22234569999999999999999999987654433333222 222211 12246789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.+.+||.+||..||.+|||+.++++||||+.
T Consensus 375 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 9999999999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=239.05 Aligned_cols=175 Identities=32% Similarity=0.480 Sum_probs=136.2
Q ss_pred Cccccc-chHHHHHHh---------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 1 MQLGVS-SLSEFVMLE---------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~---------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
||++.+ +|.+++..+ .++.+++.+|.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEE
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcch
Confidence 577755 787776533 34778899999999999999999999999987765 999999998744322
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.......+++.|+|||++.+..+.+.++||||||+++|+|++|+.||............ ........+.+..++..+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 238 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAP 238 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHTTCTTSTTGGGSCHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhhcccccCchhhcCHHH
Confidence 12234568999999999988776566799999999999999999999876543222221 122222233345689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
.+||.+||..||.+|||+.++++||||++....
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred HHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence 999999999999999999999999999876543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=240.47 Aligned_cols=174 Identities=31% Similarity=0.541 Sum_probs=136.8
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||++.........
T Consensus 103 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 180 (298)
T 1phk_A 103 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKL 180 (298)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCB
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhhcCCCccc
Confidence 68886 49999987653 3677899999999999999999999999988776 999999999765554444
Q ss_pred CCCcCCCCCcccccccC-----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc--CCCCCCC
Q 024572 71 KSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHI 143 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 143 (265)
....+++.|+|||++.+ ....+.++||||||+++|+|++|+.||.......... .+...... .+.+..+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 256 (298)
T 1phk_A 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR----MIMSGNYQFGSPEWDDY 256 (298)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCCTTTGGGS
T ss_pred ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH----HHhcCCcccCccccccc
Confidence 55679999999999852 2223456999999999999999999998765433222 22222222 2333468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
+..+.+||.+||..||.+|||+.++++||||++....
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 9999999999999999999999999999999876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=253.72 Aligned_cols=172 Identities=22% Similarity=0.310 Sum_probs=129.1
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhc-CceecCCCcCcEEEcCCC-------------------
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQ-QICHRDLKLENTLLDGSP------------------- 49 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~-~ivH~dlkp~NIll~~~~------------------- 49 (265)
||+++++|.+++..+. ++.+++.+|.|||++ ||+||||||+|||++.++
T Consensus 124 ~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 203 (397)
T 1wak_A 124 FEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203 (397)
T ss_dssp ECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC--------
T ss_pred EeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCC
Confidence 7899888888877653 377889999999998 999999999999998653
Q ss_pred ----------------------------CCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHH
Q 024572 50 ----------------------------APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCG 101 (265)
Q Consensus 50 ----------------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 101 (265)
...+||+|||+++.... ......||+.|+|||++.+..++ .++||||||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG 280 (397)
T 1wak_A 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYN-TPADIWSTA 280 (397)
T ss_dssp -------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCC-THHHHHHHH
T ss_pred CCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCC-cHHHHHHHH
Confidence 02499999999875433 23455799999999999987775 459999999
Q ss_pred HHHHHHHhCCCCCCCCCChH------HHHHHHHHHhhh--------ccc----------------------------CCC
Q 024572 102 VTLYVMLVGAYPFEDQEDPK------NFRKTISRIMAV--------QYK----------------------------IPD 139 (265)
Q Consensus 102 ~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~--------~~~----------------------------~~~ 139 (265)
|++|+|++|+.||....... ....+....... .+. ...
T Consensus 281 ~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (397)
T 1wak_A 281 CMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEW 360 (397)
T ss_dssp HHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCC
T ss_pred HHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhccc
Confidence 99999999999997654321 111111110000 000 000
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 140 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 140 ~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
....+..+.+||.+||..||.+|||+.++++||||+
T Consensus 361 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 361 SQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred chhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 112345688999999999999999999999999996
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=238.14 Aligned_cols=167 Identities=32% Similarity=0.553 Sum_probs=130.9
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||++..... ...
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~-~~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-ccc
Confidence 678875 8888876543 4678899999999999999999999999987776 99999998864332 223
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....+++.|+|||++.+..+. .++||||||+++|+|++|+.||........ ...+.......+ ..++..+.+|
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~l 237 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQET----YKRISRVEFTFP--DFVTEGARDL 237 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCC--TTSCHHHHHH
T ss_pred cccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHH----HHHHHhCCCCCC--CcCCHHHHHH
Confidence 445789999999999887665 459999999999999999999987543322 223333333333 3589999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
|.+||..||.+|||+.++++||||+..
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHhhCccccCC
Confidence 999999999999999999999999643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=237.83 Aligned_cols=169 Identities=21% Similarity=0.358 Sum_probs=131.0
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcC--ceecCCCcCcEEEc-CCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQ--ICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~--ivH~dlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.+ +|.+++.... ++.+++.++.|||++| |+||||||+|||++ .++. +||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~~~~~- 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRA- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCCT-
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCcccccc-
Confidence 688855 9999997643 3677899999999999 99999999999997 4444 99999999864332
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.......+++.|+|||++.+. + +.++|||||||++|+|++|+.||............ +.............++.+
T Consensus 185 ~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTTCCCGGGGGCCCHHH
T ss_pred cccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH---HhccCCccccCCCCCHHH
Confidence 223345689999999988753 4 45699999999999999999999876654433322 222222222233567899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+||.+||..||.+|||+.++++||||+..
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 999999999999999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=244.21 Aligned_cols=173 Identities=23% Similarity=0.285 Sum_probs=130.1
Q ss_pred CcccccchHHHHH-------HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVM-------LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~sL~~~~~-------~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||++.++|.+++. ...++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.... .....
T Consensus 108 ~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~--~~~~~ 183 (353)
T 3coi_A 108 MPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADA--EMTGY 183 (353)
T ss_dssp EECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC----------
T ss_pred eccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCCC--Ccccc
Confidence 6777777776543 3345788999999999999999999999999988775 99999999875432 23345
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh--------------------
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------------- 133 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------------- 133 (265)
.+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+..+.......
T Consensus 184 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (353)
T 3coi_A 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 263 (353)
T ss_dssp CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTS
T ss_pred ccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhC
Confidence 789999999999874444566999999999999999999998876544443333211000
Q ss_pred -c---cc-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 134 -Q---YK-IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 134 -~---~~-~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
. .. ......+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 264 PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred cCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 00 01123578999999999999999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=248.33 Aligned_cols=166 Identities=19% Similarity=0.296 Sum_probs=127.2
Q ss_pred Cccccc-chHHHHHHh------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLE------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.+ +|.+++..+ .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 140 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQD 217 (332)
T ss_dssp EECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC
T ss_pred EEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccc
Confidence 688876 999998753 34678899999999999999999999999987775 999999999755433
Q ss_pred C-------------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc
Q 024572 68 S-------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 134 (265)
Q Consensus 68 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 134 (265)
. ......||+.|+|||++.+..++ .++|||||||++|+|++|..|+.. ............
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~~ 290 (332)
T 3qd2_B 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME------RVRIITDVRNLK 290 (332)
T ss_dssp --------------CCCSCC-CGGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTTC
T ss_pred hhhccccccccccccccccCCCcCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhccC
Confidence 1 22345699999999999887765 559999999999999998766421 122222222221
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 135 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 135 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.. ......++.+.+||.+||..||.+|||+.++++||||++
T Consensus 291 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 291 FP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp CC-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred CC-cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 11 111235678899999999999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=262.36 Aligned_cols=171 Identities=29% Similarity=0.520 Sum_probs=135.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCC-CCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~-~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.. ..+.+||+|||+++.......
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 677754 8988886543 47789999999999999999999999999532 233599999999976554444
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--cCCCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 147 (265)
....+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+......+ ..+....+ ..+.+..+++.+
T Consensus 185 ~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDIL----KKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp HHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCSGGGGGSCHHH
T ss_pred cccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHcCCCCCCCcccccCCHHH
Confidence 445579999999999976 44 45699999999999999999999886543332 23333332 334455789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++||.+||..||.+|||+.++++||||+..
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999999743
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=259.53 Aligned_cols=172 Identities=31% Similarity=0.501 Sum_probs=138.3
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC-CcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~-~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. ..+||+|||+++.......
T Consensus 125 ~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 204 (504)
T 3q5i_A 125 TEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204 (504)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc
Confidence 788865 9988887654 4778899999999999999999999999987653 2599999999986655555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC--CCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 147 (265)
....+||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+...... +..+....+.. +.+..+++.+
T Consensus 205 ~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~ 278 (504)
T 3q5i_A 205 LRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDI----IKKVEKGKYYFDFNDWKNISDEA 278 (504)
T ss_dssp BCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCHHHHTTSCHHH
T ss_pred cccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCccccCCCCHHH
Confidence 556689999999999874 45 4569999999999999999999988654333 23333333322 2335689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
++||.+||..||.+|||+.++++||||++..
T Consensus 279 ~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 279 KELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 9999999999999999999999999997544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=250.86 Aligned_cols=170 Identities=25% Similarity=0.381 Sum_probs=126.6
Q ss_pred CcccccchHHHHHHhc----------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-----------CCcE
Q 024572 1 MQLGVSSLSEFVMLEG----------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-----------APRL 53 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-----------~~~v 53 (265)
||+++++|.+++.... ++.+++.+|.|||++||+||||||+|||++..+ ...+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 7999999999987542 467889999999999999999999999997532 3369
Q ss_pred EEeccCCcccCCCCCC-----CCCCcCCCCCcccccccCC------cCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChH
Q 024572 54 KICDFGYSKSSLLHSR-----PKSTVGTPAYIAPEVLSRR------EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 121 (265)
Q Consensus 54 kl~Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 121 (265)
||+|||+++....... .....||+.|+|||++.+. ...+.++|||||||++|+|++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999975543221 2234799999999999751 233566999999999999999 999997654322
Q ss_pred HHHHHHHHHhhhcccCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 122 NFRKTISRIMAVQYKIPDY-----VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
...+ ......+.. ..++.++.+||.+||..||.+|||+.++++||||..
T Consensus 248 --~~i~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 --SNII----RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp --HHHH----HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred --HHHh----cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 1111 222222211 124578999999999999999999999999999964
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=243.17 Aligned_cols=175 Identities=24% Similarity=0.373 Sum_probs=129.4
Q ss_pred Cccccc-chHHHHHH---------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVS-SLSEFVML---------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~---------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.+ +|.++... ..++.+++.++.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC---------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCccc
Confidence 677777 45555432 234778999999999999999999999999987775 999999998754332 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh---------------hc
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQ 134 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~ 134 (265)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.||.................. ..
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 334578999999999987644566799999999999999999999887665544443322110 00
Q ss_pred ccCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 YKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 ~~~~~----------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...+. ...+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 01111 12578999999999999999999999999999999754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=252.23 Aligned_cols=172 Identities=27% Similarity=0.429 Sum_probs=125.4
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcC---CCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDG---SPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~---~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||+++++|.+++..+. ++.+++.+|.|||++||+||||||+|||++. .+..++||+|||+++.....
T Consensus 97 ~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 97 IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp EECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred EECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 7999999999997653 3677899999999999999999999999953 33345899999999755432
Q ss_pred ----CCCCCCcCCCCCcccccccCC--cCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhccc-CCC
Q 024572 68 ----SRPKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK-IPD 139 (265)
Q Consensus 68 ----~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 139 (265)
.......||+.|+|||++.+. ...+.++|||||||++|+|++ |..||........ ... ....... ...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~~--~~~~~~~~~~~ 252 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NIL--LGACSLDCLHP 252 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HHH--TTCCCCTTSCT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HHH--hccCCccccCc
Confidence 122345699999999999742 223456999999999999999 8999965433211 111 1111111 111
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 140 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 140 ~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
....+..+++||.+||..||.+|||+.++++||||..
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 1223456889999999999999999999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=243.43 Aligned_cols=183 Identities=27% Similarity=0.459 Sum_probs=139.1
Q ss_pred Cccccc-chHHH------HH-----------HhccccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCc
Q 024572 1 MQLGVS-SLSEF------VM-----------LEGSVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYS 61 (265)
Q Consensus 1 me~~~~-sL~~~------~~-----------~~~~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a 61 (265)
||++.+ +|.++ +. ...++.+++.++.|||+ +||+||||||+||+++.++. +||+|||++
T Consensus 122 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~ 199 (348)
T 2pml_X 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR--VKLSDFGES 199 (348)
T ss_dssp EECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSC--EEECCCTTC
T ss_pred EeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCc--EEEeccccc
Confidence 567765 77766 32 23357789999999999 99999999999999987775 999999998
Q ss_pred ccCCCCCCCCCCcCCCCCcccccccCC-cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCC
Q 024572 62 KSSLLHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 140 (265)
Q Consensus 62 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (265)
...... ......++..|+|||++.+. .+...++|||||||++|+|++|+.||......... ...+.......+..
T Consensus 200 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~ 275 (348)
T 2pml_X 200 EYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL---FNNIRTKNIEYPLD 275 (348)
T ss_dssp EECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH---HHHHTSCCCCCCCS
T ss_pred cccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHhccCcCCccc
Confidence 754332 33445799999999999876 44443699999999999999999999876653222 22233333333311
Q ss_pred -----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCChhhHHHHHHH
Q 024572 141 -----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAI 189 (265)
Q Consensus 141 -----------------~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~~~~~~~~~~ 189 (265)
..++..+.+||.+||..||.+|||+.++++||||+......+......+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~~~~~~~~ 341 (348)
T 2pml_X 276 RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKEL 341 (348)
T ss_dssp SSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHHHHHHHHH
T ss_pred hhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHHHHHHHHH
Confidence 4688999999999999999999999999999999876655554444433
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=235.92 Aligned_cols=166 Identities=29% Similarity=0.554 Sum_probs=134.3
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||++...... ..
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~-~~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPSL-RR 169 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSSS-CB
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCccc-cc
Confidence 688865 9999887654 3677899999999999999999999999987775 999999998644322 23
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....+++.|+|||++.+..++ .++||||||+++|+|++|+.||........ ...+.......+ ..++..+++|
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~l 242 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTET----HRRIVNVDLKFP--PFLSDGSKDL 242 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCC--TTSCHHHHHH
T ss_pred ccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHH----HHHHhccccCCC--CcCCHHHHHH
Confidence 445789999999999887765 459999999999999999999987654332 222333333333 4689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
|.+||..||.+|||+.++++||||+.
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 99999999999999999999999964
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=256.40 Aligned_cols=160 Identities=16% Similarity=0.164 Sum_probs=127.5
Q ss_pred CcccccchHHHHH----------------HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC
Q 024572 1 MQLGVSSLSEFVM----------------LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~sL~~~~~----------------~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 64 (265)
|+++.++|.+++. +..++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 184 ~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~--~kL~DFG~a~~~ 261 (413)
T 3dzo_A 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRD 261 (413)
T ss_dssp EECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEET
T ss_pred eehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCe--EEEEeccceeec
Confidence 5667788888883 2234588999999999999999999999999998876 999999998754
Q ss_pred CCCCCCCCCcCCCCCcccccc----------cCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc
Q 024572 65 LLHSRPKSTVGTPAYIAPEVL----------SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 134 (265)
Q Consensus 65 ~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 134 (265)
... ....+| +.|+|||++ .+..+ +.++|||||||++|+|++|+.||......... .
T Consensus 262 ~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~----------~ 327 (413)
T 3dzo_A 262 GAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIWCADLPNTDDAALGGS----------E 327 (413)
T ss_dssp TEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS----------G
T ss_pred CCc--cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhhhH----------H
Confidence 332 344567 999999999 33334 45699999999999999999999775432211 1
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 135 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 135 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
........+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 328 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 328 WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 112233468899999999999999999999999999999963
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=247.00 Aligned_cols=175 Identities=30% Similarity=0.510 Sum_probs=113.8
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++ .+.+||+|||+++....
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~- 183 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ- 183 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-
Confidence 788866 9999987653 367789999999999999999999999997533 34599999999975432
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh--hcccCCCCCCCCH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQ 145 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 145 (265)
.......+|+.|+|||++.+..++ .++|||||||++|+|++|+.||...............+.. .....+.+..++.
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262 (336)
T ss_dssp --------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence 233445789999999999776664 5599999999999999999999775543322222222222 2223344457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+++||.+||..||.+|||+.++++||||++.
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 99999999999999999999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=246.93 Aligned_cols=176 Identities=21% Similarity=0.285 Sum_probs=128.4
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhc-CceecCCCcCcEEEcCCC----CCcEEEeccCCcccC
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQ-QICHRDLKLENTLLDGSP----APRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~-~ivH~dlkp~NIll~~~~----~~~vkl~Dfg~a~~~ 64 (265)
||+++++|.+++.... ++.+++.+|.|||++ ||+||||||+|||++..+ ...+||+|||+++..
T Consensus 109 ~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~ 188 (373)
T 1q8y_A 109 FEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188 (373)
T ss_dssp ECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEET
T ss_pred EecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEccccccccc
Confidence 6888889999987632 367889999999998 999999999999995322 225999999999754
Q ss_pred CCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHHHHHhhh-----
Q 024572 65 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP------KNFRKTISRIMAV----- 133 (265)
Q Consensus 65 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~----- 133 (265)
.. ......+|+.|+|||++.+..++ .++|||||||++|+|++|+.||...... ..+..+.......
T Consensus 189 ~~--~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 265 (373)
T 1q8y_A 189 DE--HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLL 265 (373)
T ss_dssp TB--CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHH
T ss_pred CC--CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHH
Confidence 33 23445789999999999887765 5599999999999999999999865421 1111211111000
Q ss_pred -------------------------------cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 134 -------------------------------QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 134 -------------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
.........++..+.+||.+||..||.+|||+.++++||||++...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 266 RNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred hccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 0000111134577899999999999999999999999999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=239.64 Aligned_cols=170 Identities=33% Similarity=0.559 Sum_probs=133.6
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEE---cCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll---~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.+ +|.+++..++ ++.+++.++.|||++||+||||||+||++ +.++ .+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS--KIMITDFGLSKMEQN- 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC--CEEBCSCSTTCCCCC-
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC--CEEEccCCcceecCC-
Confidence 688854 9999887654 36778999999999999999999999999 4444 499999999864322
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc--CCCCCCCCH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQ 145 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 145 (265)
.......+++.|+|||++.+..++ .++|||||||++|+|++|+.||......... ..+...... .+.+..++.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 162 GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLF----EKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHCCCCCCTTTTTTSCH
T ss_pred CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHcCCCCCCccccccCCH
Confidence 222334689999999999887664 5699999999999999999999876543322 222222222 233456899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
.+.+||.+||..||.+|||+.++++||||....
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999997653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=242.35 Aligned_cols=176 Identities=23% Similarity=0.273 Sum_probs=132.2
Q ss_pred CcccccchHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC----C
Q 024572 1 MQLGVSSLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH----S 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~----~ 68 (265)
||++.++|.+++... .++.+++.++.|||++||+||||||+||+++..+ +.+||+|||+++..... .
T Consensus 101 ~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~~~~~~~~~~~~~ 179 (320)
T 2i6l_A 101 QEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGLARIMDPHYSHKG 179 (320)
T ss_dssp EECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTTCBCC--------
T ss_pred eeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCccccccCCCccccc
Confidence 688888998887542 2477899999999999999999999999997443 24999999998754322 1
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-----------------
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM----------------- 131 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------- 131 (265)
......++..|+|||++.+....+.++|||||||++|+|++|+.||.+...............
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (320)
T 2i6l_A 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVY 259 (320)
T ss_dssp CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHH
T ss_pred ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCccc
Confidence 223345789999999987644446679999999999999999999988765444333332110
Q ss_pred -hhcccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 132 -AVQYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 132 -~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
......+ ....++..+++||.+||..||.+|||+.++++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 260 IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred ccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 0000001 113578999999999999999999999999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=236.83 Aligned_cols=168 Identities=25% Similarity=0.499 Sum_probs=112.4
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-S 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~ 68 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||++...... .
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCC
Confidence 678854 8988887542 3678899999999999999999999999987765 999999998754322 2
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......+++.|+|||++.+..+. .++|||||||++|+|++|+.||......... ..+...... .+..++..+.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~ 240 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NKVVLADYE--MPSFLSIEAK 240 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCC--CCTTSCHHHH
T ss_pred cceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHH----HHHhhcccC--CccccCHHHH
Confidence 22345689999999999877665 4599999999999999999999876543222 122222222 2335889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+||.+||..||.+|||+.++++||||...
T Consensus 241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=239.23 Aligned_cols=171 Identities=31% Similarity=0.526 Sum_probs=131.2
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC--CCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~--~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++ ...+||+|||++.......
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~ 166 (283)
T 3bhy_A 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166 (283)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---
T ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC
Confidence 68885 59999987543 367789999999999999999999999997665 2259999999997655444
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQD 146 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 146 (265)
......+++.|+|||++.+..+. .++||||||+++|+|++|+.||......... ..+.......+ .+..++..
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 167 EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETL----TNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp -----CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCCHHHHTTCCHH
T ss_pred cccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHH----HHhHhcccCCcchhcccCCHH
Confidence 44556799999999999877765 5599999999999999999999876543322 22222222221 12357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
+.+||.+||..||.+|||+.++++||||+.
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=236.23 Aligned_cols=166 Identities=17% Similarity=0.157 Sum_probs=127.0
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCC-----------------
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP----------------- 49 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~----------------- 49 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+|||++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 688855 999998764 2367889999999999999999999999997442
Q ss_pred CCcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH
Q 024572 50 APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR 129 (265)
Q Consensus 50 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 129 (265)
...+||+|||++...... ....+++.|+|||++.+....+.++|||||||++|+|++|.+++.... ....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~---- 239 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE---- 239 (289)
T ss_dssp CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH----
T ss_pred ceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH----
Confidence 225999999998754332 334689999999999876555567999999999999999988775432 1111
Q ss_pred HhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 130 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+.... ....+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 240 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 240 IRQGR-LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHTTC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHcCC-CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 11111 122334689999999999999999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=240.64 Aligned_cols=168 Identities=33% Similarity=0.490 Sum_probs=135.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..... ..
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGER 197 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCccc
Confidence 688874 8998887644 3678899999999999999999999999988765 999999999755422 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....+++.|+|||++.+..+. .++|||||||++|+|++|+.||........ ...+.......+ ..++..+.+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~ 270 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEYSIP--KHINPVAAS 270 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCC--TTSCHHHHH
T ss_pred ccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHhcCCCCCC--ccCCHHHHH
Confidence 3345699999999999887764 559999999999999999999987554332 222233333333 368899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
||.+||..||.+|||+.++++||||...
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999999999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=244.47 Aligned_cols=172 Identities=26% Similarity=0.399 Sum_probs=130.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhc-CceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQ-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~-~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++...+ ++.+++.++.|||++ ||+||||||+|||++.++. +||+|||+++.... ..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~ 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-cc
Confidence 788865 9999988653 366789999999996 9999999999999988776 99999999864322 12
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHH-------------------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR------------------------- 124 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~------------------------- 124 (265)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||..........
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 3345789999999999887765 55999999999999999999997654322111
Q ss_pred -------------HHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 125 -------------KTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 125 -------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.....+............++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 1111111111111122347889999999999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=237.26 Aligned_cols=171 Identities=30% Similarity=0.484 Sum_probs=134.3
Q ss_pred CcccccchHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC--
Q 024572 1 MQLGVSSLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-- 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-- 67 (265)
||++.++|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 87 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~ 164 (305)
T 2wtk_C 87 MEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAA 164 (305)
T ss_dssp EECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCS
T ss_pred ehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccCcccc
Confidence 688888877777653 24668899999999999999999999999987765 999999998754322
Q ss_pred -CCCCCCcCCCCCcccccccCCc-CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 68 -SRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 68 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.......+++.|+|||++.+.. ..+.++|||||||++|+|++|+.||....... ....+....... +..++.
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~~~~~~~--~~~~~~ 238 (305)
T 2wtk_C 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LFENIGKGSYAI--PGDCGP 238 (305)
T ss_dssp SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHCCCCC--CSSSCH
T ss_pred ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHHHHhcCCCCC--CCccCH
Confidence 1223446899999999987643 23556999999999999999999998754322 223333333333 346899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
.+.+||.+||..||.+|||+.++++||||++..+
T Consensus 239 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 9999999999999999999999999999986544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=237.20 Aligned_cols=171 Identities=26% Similarity=0.376 Sum_probs=128.8
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC--
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-- 69 (265)
||+++++|.+++..+. ++.+++.+|.|||++||+||||||+|||++. + .+||+|||+++.......
T Consensus 107 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 107 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp ECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC--------
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccccCccccc
Confidence 6878889999987654 3678899999999999999999999999964 3 499999999875433221
Q ss_pred -CCCCcCCCCCcccccccCC----------cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC
Q 024572 70 -PKSTVGTPAYIAPEVLSRR----------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 138 (265)
Q Consensus 70 -~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 138 (265)
.....+++.|+|||++.+. ...+.++|||||||++|+|++|+.||........ .+...........
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 260 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIE 260 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCCC
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhcccccC
Confidence 2234689999999998752 2334569999999999999999999987654322 2222233333333
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+...+..+.+||.+||..||.+|||+.++++||||+..
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 344568899999999999999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=234.87 Aligned_cols=168 Identities=33% Similarity=0.468 Sum_probs=134.9
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~ 69 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++..... ..
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCccc
Confidence 67887 48988887654 3677899999999999999999999999987765 999999998754422 22
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....+++.|+|||++.+..++ .++||||||+++|+|++|+.||........ ...+....... +..++..+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~ 244 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEYSI--PKHINPVAAS 244 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCC--CTTSCHHHHH
T ss_pred cccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhhccCCC--ccccCHHHHH
Confidence 3345689999999999877664 559999999999999999999987654332 22223333333 3368899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
||.+||..||.+|||+.++++||||...
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHcccChhhCcCHHHHhhChheecC
Confidence 9999999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=242.84 Aligned_cols=174 Identities=30% Similarity=0.446 Sum_probs=131.3
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++ ...+||+|||+++.......
T Consensus 93 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 172 (322)
T 2ycf_A 93 LELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172 (322)
T ss_dssp EECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH
T ss_pred EecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccc
Confidence 678855 8888775433 467889999999999999999999999997654 23599999999875433222
Q ss_pred CCCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCH
Q 024572 70 PKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQ 145 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 145 (265)
.....|++.|+|||++.+ ....+.++|||||||++|+|++|..||........+...+.. ...... .+..++.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 249 (322)
T 2ycf_A 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEVWAEVSE 249 (322)
T ss_dssp HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCCCCHHHHTTSCH
T ss_pred cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---CccccCchhhhhcCH
Confidence 223468999999999742 222345699999999999999999999876544333332221 111111 1235789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+.+||.+||..||.+|||+.++++||||+..
T Consensus 250 ~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 99999999999999999999999999999753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=238.85 Aligned_cols=165 Identities=30% Similarity=0.464 Sum_probs=132.5
Q ss_pred Ccccc--cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEc-CCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV--SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~--~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++..++ ++.+++.+|.|||++||+||||||+|||++ .++ .+||+|||+++.....
T Consensus 127 ~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~~~~~- 203 (320)
T 3a99_A 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALLKDT- 203 (320)
T ss_dssp EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECCSS-
T ss_pred EEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCccccccccc-
Confidence 56665 58999887654 366889999999999999999999999998 444 4999999998754432
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......+|+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... .. .... ......+++.+.
T Consensus 204 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~----~~~~--~~~~~~~~~~~~ 271 (320)
T 3a99_A 204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI----IRGQ--VFFRQRVSSECQ 271 (320)
T ss_dssp CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH----HHCC--CCCSSCCCHHHH
T ss_pred cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hh----hccc--ccccccCCHHHH
Confidence 23345699999999999877776677999999999999999999996521 11 1111 223346899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
+||.+||..||.+|||+.++++||||+.....
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred HHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 99999999999999999999999999876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=239.84 Aligned_cols=177 Identities=25% Similarity=0.303 Sum_probs=127.2
Q ss_pred Ccccc-cchHHHHHH-----------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 1 MQLGV-SSLSEFVML-----------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~-~sL~~~~~~-----------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
||++. ++|.+++.. ..++.+++.++.|||++||+||||||+||+++.++. +||+|||++.
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~ 169 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSA 169 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccchh
Confidence 67884 589988864 123678899999999999999999999999987765 9999999986
Q ss_pred cCCCCC------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc--
Q 024572 63 SSLLHS------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-- 134 (265)
Q Consensus 63 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-- 134 (265)
...... ......+++.|+|||++.+....+.++|||||||++|+|++|+.||....................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 443221 123346899999999987633335669999999999999999999988665443332221100000
Q ss_pred --ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 135 --YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 135 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
........++..+.+||.+||..||.+|||+.++++||||++...
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 001122357889999999999999999999999999999976543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=238.43 Aligned_cols=172 Identities=24% Similarity=0.339 Sum_probs=128.2
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~- 67 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV 183 (326)
T ss_dssp EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC------
T ss_pred EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCcCc
Confidence 688866 9999987532 3677899999999999999999999999987765 999999998754322
Q ss_pred CCCCCCcCCCCCccccccc-----CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 68 SRPKSTVGTPAYIAPEVLS-----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
.......+++.|+|||++. +..+ +.++|||||||++|+|++|+.||.......... .+............
T Consensus 184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~ 258 (326)
T 2x7f_A 184 GRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNPAPRLKSKK 258 (326)
T ss_dssp -------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCSCSC
T ss_pred cccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH----HhhcCccccCCccc
Confidence 1223456899999999987 3334 455999999999999999999997765432222 22222222223346
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
++..+.+||.+||..||.+|||+.++++||||+....
T Consensus 259 ~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 8999999999999999999999999999999986543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=233.81 Aligned_cols=172 Identities=23% Similarity=0.340 Sum_probs=125.8
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-- 67 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~ 171 (303)
T 1zy4_A 94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLD 171 (303)
T ss_dssp EECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCCSCTTC---
T ss_pred EecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcchhhcccccc
Confidence 688855 9999987543 3678899999999999999999999999987775 999999998754321
Q ss_pred -------------CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc
Q 024572 68 -------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 134 (265)
Q Consensus 68 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 134 (265)
.......+++.|+|||++.+....+.++|||||||++|+|++ ||.... ........+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---~~~~~~~~~~~~~ 245 (303)
T 1zy4_A 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---ERVNILKKLRSVS 245 (303)
T ss_dssp ----------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHHHHHHHHHSTT
T ss_pred hhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---hHHHHHHhccccc
Confidence 122344689999999999876444567999999999999998 554322 1122333333332
Q ss_pred ccCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 135 YKIP--DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 135 ~~~~--~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
...+ .....+..+.+||.+||..||.+|||+.++++||||+.....
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293 (303)
T ss_dssp CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence 2222 233567789999999999999999999999999999866443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=234.17 Aligned_cols=174 Identities=23% Similarity=0.332 Sum_probs=135.6
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBS
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhcc
Confidence 688866 9999987432 3677899999999999999999999999987765 9999999986543322
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......+++.|+|||++.+..++. ++|||||||++|+|++|+.||............ .............++..+.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNC-VADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFT 256 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCT-THHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHHH
T ss_pred ccCccCCCCCccChhhcCCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCcccCCcccCCHHHH
Confidence 223456899999999998877654 499999999999999999999876543222111 1111112223345789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
+||.+||..||.+|||+.++++||||+.....
T Consensus 257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 257 DFVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288 (314)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence 99999999999999999999999999876543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=236.16 Aligned_cols=172 Identities=21% Similarity=0.361 Sum_probs=122.9
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhc-CceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQ-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~-~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||+++..+..+.... .++.+++.++.|||++ ||+||||||+||+++.++. +||+|||++........
T Consensus 103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDKA 180 (318)
T ss_dssp ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC--------
T ss_pred EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCcc
Confidence 688866666555432 2467789999999995 9999999999999987775 99999999875544444
Q ss_pred CCCCcCCCCCcccccccC----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.....+++.|+|||++.. ....+.++|||||||++|+|++|+.||............+ ........+....++.
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 258 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEPPLLPGHMGFSG 258 (318)
T ss_dssp ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH--HHSCCCCCCSSSCCCH
T ss_pred ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH--hccCCCCCCccCCCCH
Confidence 445579999999999852 2223456999999999999999999998755433222211 1122223344446899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.+.+||.+||..||.+|||+.++++||||+.
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 9999999999999999999999999999964
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=243.75 Aligned_cols=170 Identities=27% Similarity=0.448 Sum_probs=111.5
Q ss_pred CcccccchHHHHHH--------------hccccchHHHHHhhhhc-CceecCCCcCcEEEcCCCCCcEEEeccCCcccCC
Q 024572 1 MQLGVSSLSEFVML--------------EGSVKMKPDIFFSSLSQ-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~~sL~~~~~~--------------~~~~~~i~~~l~~lH~~-~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 65 (265)
||++.++|.+++.. ..++.+++.++.|||++ ||+||||||+|||++.++. +||+|||+++...
T Consensus 100 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQLV 177 (327)
T ss_dssp ECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSCC--
T ss_pred EeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCceecc
Confidence 78888888887763 12367789999999999 9999999999999987765 9999999997655
Q ss_pred CCCCCCCCcCCCCCccccccc----CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc---ccCC
Q 024572 66 LHSRPKSTVGTPAYIAPEVLS----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---YKIP 138 (265)
Q Consensus 66 ~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~ 138 (265)
.........|++.|+|||++. +..+ +.++|||||||++|+|++|+.||....... ..+..+.... ....
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQLSNS 253 (327)
T ss_dssp ----------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCC
T ss_pred cccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCCCCc
Confidence 444444457999999999984 3344 456999999999999999999997643211 1111111111 1111
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
....+++.+.+||.+||..||.+|||+.++++||||..
T Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 12358899999999999999999999999999999963
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=232.47 Aligned_cols=173 Identities=26% Similarity=0.350 Sum_probs=130.7
Q ss_pred Ccccc-cchHHHHHHhc------------cccchHHHHHhhhhcCceecCCCcCcEEEcC-CCCCcEEEeccCCcccCCC
Q 024572 1 MQLGV-SSLSEFVMLEG------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+||+++. ++. +||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAG 175 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCC
Confidence 67884 59999887542 2567899999999999999999999999986 444 99999999875433
Q ss_pred CC-CCCCCcCCCCCcccccccCCc-CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 67 HS-RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 67 ~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.. ......+++.|+|||++.+.. ..+.++||||||+++|+|++|+.||........... ...........+..++
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 252 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVHPEIPESMS 252 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH---HHHHHCCCCCCCTTSC
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH---hhccccccccccccCC
Confidence 22 233456899999999987643 235669999999999999999999976544322111 1111122223344689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
..+.+||.+||..||.+|||+.++++||||+...
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999999997543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=235.38 Aligned_cols=170 Identities=34% Similarity=0.560 Sum_probs=133.6
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++ ...+||+|||++........
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 67775 48888876543 367789999999999999999999999997643 23599999999876554444
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--cCCCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 147 (265)
.....+++.|+|||++.+. + +.++||||||+++|+|++|+.||.+...... ...+..... ..+.+..++..+
T Consensus 180 ~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDI----LKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCSGGGTTSCHHH
T ss_pred cccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCchhhhhcCHHH
Confidence 4445688999999998764 4 4569999999999999999999987654322 222223322 233345689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.+||.+||..||.+|||+.++++||||++
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 99999999999999999999999999964
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=240.41 Aligned_cols=168 Identities=23% Similarity=0.313 Sum_probs=126.9
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++. ++|.+++..++ ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 95 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~ 172 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNS 172 (311)
T ss_dssp EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC---------
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccccccc
Confidence 78885 59999987654 3677899999999999999999999999988776 9999999987543321
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC--CCCCCCC
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHIS 144 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 144 (265)
......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+............ ..... .....++
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 173 VTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR----EDPIPPSARHEGLS 247 (311)
T ss_dssp ---------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----CCCCCHHHHSTTCC
T ss_pred cccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc----CCCCCcccccCCCC
Confidence 22234689999999999887765 559999999999999999999987654333222221 11111 1123588
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
..+.+||.+||..||.+||++.+++.|+|++
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 9999999999999999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=238.81 Aligned_cols=169 Identities=22% Similarity=0.359 Sum_probs=129.6
Q ss_pred Ccccc-cchHHHHHHhc------------cccchHHHHHhhhhcCceecCCCcCcEEE----cCCCCCcEEEeccCCccc
Q 024572 1 MQLGV-SSLSEFVMLEG------------SVKMKPDIFFSSLSQQICHRDLKLENTLL----DGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll----~~~~~~~vkl~Dfg~a~~ 63 (265)
||++. ++|.+++.... ++.+++.+|.|||++||+||||||+|||+ +.++ .+||+|||+++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a~~ 165 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARE 165 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTCEE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCcee
Confidence 78885 59999887643 36778999999999999999999999998 4444 499999999986
Q ss_pred CCCCCCCCCCcCCCCCccccccc--------CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc
Q 024572 64 SLLHSRPKSTVGTPAYIAPEVLS--------RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 135 (265)
Q Consensus 64 ~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 135 (265)
...........||+.|+|||++. +..+ +.++|||||||++|+|++|+.||............+..+.....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred cCCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 65555555667999999999986 3444 45599999999999999999999865554443444444333221
Q ss_pred -------------------cCCCC----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 024572 136 -------------------KIPDY----VHISQDCRNLLSRIFVANPSRRITIKEIKSHP 172 (265)
Q Consensus 136 -------------------~~~~~----~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~ 172 (265)
..+.. ..++..+.+||.+||..||.+|||+.++++||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 11111 12345788999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=229.78 Aligned_cols=168 Identities=18% Similarity=0.195 Sum_probs=128.1
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC---CcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA---PRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~---~~vkl~Dfg~a~~~~~~ 67 (265)
||+++++|.+++...+ ++.+++.++.|||++||+||||||+|||++.++. ..+||+|||+++.....
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 7899889999998643 3777899999999999999999999999975432 24999999999754432
Q ss_pred C--------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC-
Q 024572 68 S--------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP- 138 (265)
Q Consensus 68 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 138 (265)
. ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||......... .....+.......+
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEKKQSTPL 242 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHHHHHHHHSCH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccH-HHHHHHHhhccCccH
Confidence 2 12345699999999999887764 5699999999999999999999875432221 11111111111111
Q ss_pred --CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 139 --DYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 139 --~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
....+++.+.+||.+||..||.+|||+.++++
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 12357899999999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=231.56 Aligned_cols=169 Identities=26% Similarity=0.320 Sum_probs=133.0
Q ss_pred Cccccc-chHHHHHHh--------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLE--------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~--------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~ 70 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||++....... ..
T Consensus 99 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBCCB
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCcccccc
Confidence 677765 888877532 34778899999999999999999999999987765 9999999987544332 22
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
....+++.|+|||++.+..++ .++|||||||++|+|++|+.||.......... .+... ........++..+.+|
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLF----LIPKN-NPPTLEGNYSKPLKEF 250 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHS-CCCCCCSSCCHHHHHH
T ss_pred CccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHH----HhhcC-CCCCCccccCHHHHHH
Confidence 345689999999999887765 45999999999999999999997754332221 11111 1222334689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
|.+||..||.+|||+.++++||||.+.
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 999999999999999999999999654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=234.49 Aligned_cols=171 Identities=20% Similarity=0.302 Sum_probs=122.6
Q ss_pred Cccccc-chHHHHHHhc---------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC
Q 024572 1 MQLGVS-SLSEFVMLEG---------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 64 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~--~kl~Dfg~a~~~ 187 (323)
T 3qup_A 110 LPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSRKI 187 (323)
T ss_dssp EECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC----
T ss_pred EEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--EEEeeccccccc
Confidence 567766 8998886432 3677899999999999999999999999988765 999999999754
Q ss_pred CCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCC
Q 024572 65 LLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 140 (265)
Q Consensus 65 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (265)
..... .....+++.|+|||.+.+..++ .++|||||||++|+|++ |+.||.+........... . ....+..
T Consensus 188 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~ 261 (323)
T 3qup_A 188 YSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI----G-GNRLKQP 261 (323)
T ss_dssp -------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----T-TCCCCCC
T ss_pred cccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh----c-CCCCCCC
Confidence 33222 1223467789999999887765 56999999999999999 999998876544333222 1 2223444
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCcccCCCCC
Q 024572 141 VHISQDCRNLLSRIFVANPSRRIT-------IKEIKSHPWFLKNLP 179 (265)
Q Consensus 141 ~~~~~~~~~li~~~L~~dP~~R~s-------~~ell~h~~f~~~~~ 179 (265)
..++..+.+||.+||..||.+||| +++++.|+|+.....
T Consensus 262 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 578999999999999999999999 778899999976544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=237.96 Aligned_cols=169 Identities=14% Similarity=0.136 Sum_probs=127.3
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||+++++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.+..+.+||+|||+++.......
T Consensus 131 ~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~ 210 (364)
T 3op5_A 131 MDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210 (364)
T ss_dssp EECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCC
T ss_pred EeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcc
Confidence 7899889999987652 36778999999999999999999999999843334599999999965432211
Q ss_pred -------CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-----cC
Q 024572 70 -------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-----KI 137 (265)
Q Consensus 70 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~ 137 (265)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+................... ..
T Consensus 211 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (364)
T 3op5_A 211 KAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKC 289 (364)
T ss_dssp CCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHH
T ss_pred cccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHh
Confidence 1234599999999999887764 5699999999999999999999864433332222211111000 00
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 138 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 138 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.....++..+.+||.+||..+|.+||++.++++
T Consensus 290 ~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 290 FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 011367899999999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.2e-33 Score=232.80 Aligned_cols=174 Identities=24% Similarity=0.334 Sum_probs=129.6
Q ss_pred Cccccc-chHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CC
Q 024572 1 MQLGVS-SLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~ 68 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||++..... ..
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCcccccccc
Confidence 678755 888887653 23678899999999999999999999999987765 99999998742211 11
Q ss_pred CCCCCcCCCCCccccccc-----CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 69 RPKSTVGTPAYIAPEVLS-----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
......+++.|+|||++. +..+ +.++|||||||++|+|++|+.||.............. ...........+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 248 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SDPPTLLTPSKW 248 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGS
T ss_pred ccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---cCCcccCCcccc
Confidence 223456899999999984 3344 4569999999999999999999987654333222111 111122233467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
+..+.+||.+||..||.+|||+.++++||||+.....
T Consensus 249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 8999999999999999999999999999999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=237.43 Aligned_cols=163 Identities=22% Similarity=0.340 Sum_probs=129.4
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +|
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~k 243 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MK 243 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCC--EE
Confidence 688866 9999998653 3668899999999999999999999999988775 99
Q ss_pred EeccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++...... ......+++.|+|||++.+..++ .++|||||||++|+|++ |+.||.+........ .+
T Consensus 244 l~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~-~~--- 318 (370)
T 2psq_A 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-LL--- 318 (370)
T ss_dssp ECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HH---
T ss_pred EccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HH---
Confidence 99999997543322 12233577899999999887765 55999999999999999 999998765433322 21
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
. .....+.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 319 ~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 319 K-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp H-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred h-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 222333445789999999999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=232.51 Aligned_cols=160 Identities=31% Similarity=0.497 Sum_probs=129.0
Q ss_pred cccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEc-CCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 4 GVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 4 ~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~-~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
.+++|.+++..++ ++.+++.+|.|||++||+||||||+||+++ .++ .+||+|||+++..... .....
T Consensus 122 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~~~~~~-~~~~~ 198 (312)
T 2iwi_A 122 PAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLHDE-PYTDF 198 (312)
T ss_dssp SEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCEECCSS-CBCCC
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhhhcccC-ccccc
Confidence 4569999988654 467789999999999999999999999998 555 4999999998755432 23445
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHH
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 153 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 153 (265)
.++..|+|||++.+..+.+.++|||||||++|+|++|+.||.... . +....... ...++..+.+||.+
T Consensus 199 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~----~~~~~~~~--~~~~~~~~~~li~~ 266 (312)
T 2iwi_A 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------E----ILEAELHF--PAHVSPDCCALIRR 266 (312)
T ss_dssp CSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHTCCCC--CTTSCHHHHHHHHH
T ss_pred CCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------H----HhhhccCC--cccCCHHHHHHHHH
Confidence 689999999999877776657999999999999999999996521 1 11122222 34689999999999
Q ss_pred hcccCCCCCCCHHHHhcCcccCCCC
Q 024572 154 IFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 154 ~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
||..||.+|||+.++++||||+...
T Consensus 267 ~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 267 CLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HccCChhhCcCHHHHhcChhhcCch
Confidence 9999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=231.20 Aligned_cols=163 Identities=23% Similarity=0.323 Sum_probs=121.7
Q ss_pred Cccccc-chHHHHHHhc------------cccchHHHHHhhhhcC--ceecCCCcCcEEEcCCCCCcEEEeccCCcccCC
Q 024572 1 MQLGVS-SLSEFVMLEG------------SVKMKPDIFFSSLSQQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL 65 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~------------~~~~i~~~l~~lH~~~--ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~ 65 (265)
||++.+ +|.+++.... ++.+++.+|.|||++| |+||||||+|||++.++. +||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCcccc
Confidence 688865 9999987543 3668899999999999 999999999999988765 9999999987433
Q ss_pred CCC-CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 66 LHS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 66 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
... ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||......... ..+.........+..++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~ 265 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVV----AAVGFKCKRLEIPRNLN 265 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH----HHHHHSCCCCCCCTTSC
T ss_pred ccccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcCCCCCCCccCC
Confidence 222 22345799999999999887775 4599999999999999999999876543322 22222223334445789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.+.+||.+||..||.+|||+.++++
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-33 Score=238.97 Aligned_cols=170 Identities=15% Similarity=0.123 Sum_probs=127.2
Q ss_pred CcccccchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC--
Q 024572 1 MQLGVSSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-- 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~-- 69 (265)
||+++++|.+++..++ ++.+++.+|.|||++||+||||||+|||++.++.+.+||+|||+++.......
T Consensus 131 ~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~ 210 (345)
T 2v62_A 131 MERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210 (345)
T ss_dssp EECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCC
T ss_pred EeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccc
Confidence 7888779998876543 46778999999999999999999999999877644699999999975432211
Q ss_pred ------CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHH-HHHHHHHHhhhcc----cCC
Q 024572 70 ------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQY----KIP 138 (265)
Q Consensus 70 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~----~~~ 138 (265)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||........ ............. ...
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (345)
T 2v62_A 211 QYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWA 289 (345)
T ss_dssp CCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHS
T ss_pred cchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhc
Confidence 1344699999999999887664 569999999999999999999965332222 2221111111000 001
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
....++..+.+||.+||..||.+|||+.++++.
T Consensus 290 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 290 PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 112588999999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=229.79 Aligned_cols=166 Identities=17% Similarity=0.156 Sum_probs=126.5
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEc---CCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLD---GSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~---~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||+++++|.+++... .++.+++.++.|||++||+||||||+|||++ .++ .+||+|||+++.....
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCT
T ss_pred EEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCccccccc
Confidence 789988999998732 2367889999999999999999999999994 444 4999999998754433
Q ss_pred CC--------CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhhhccc
Q 024572 68 SR--------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYK 136 (265)
Q Consensus 68 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 136 (265)
.. .....|++.|+|||++.+..++ .++|||||||++|+|++|+.||...... ..+............
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred ccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-
Confidence 22 2345799999999999887764 5699999999999999999999874322 222222221111110
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0012357899999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=230.35 Aligned_cols=166 Identities=17% Similarity=0.157 Sum_probs=126.7
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEE---cCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll---~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||+++++|.+++... .++.+++.++.|||++||+||||||+|||+ +.++. +||+|||+++.....
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCT
T ss_pred EEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCc
Confidence 789988999998743 236788999999999999999999999999 55554 999999999754332
Q ss_pred C--------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhhhccc
Q 024572 68 S--------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYK 136 (265)
Q Consensus 68 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 136 (265)
. ......+|+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.... ..+........... .
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~ 239 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-I 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-H
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-h
Confidence 2 12345699999999999887764 5699999999999999999999875432 12222221111110 0
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
......+++.+.+||.+||..||.+|||+.++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0112357899999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=235.26 Aligned_cols=169 Identities=11% Similarity=0.148 Sum_probs=130.2
Q ss_pred CcccccchHHHHHHh--c---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVSSLSEFVMLE--G---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~--~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||+++++|.+++... . ++.+++.+|.|||++||+||||||+|||++.++...+||+|||+++......
T Consensus 137 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 216 (352)
T 2jii_A 137 LPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216 (352)
T ss_dssp EECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGC
T ss_pred ecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCc
Confidence 789988999999864 2 3777899999999999999999999999997763359999999997543221
Q ss_pred -------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHHHhhhcccCC--
Q 024572 69 -------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE-DPKNFRKTISRIMAVQYKIP-- 138 (265)
Q Consensus 69 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~-- 138 (265)
......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.... ...................+
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (352)
T 2jii_A 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGP 295 (352)
T ss_dssp CCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECT
T ss_pred cccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhh
Confidence 11334799999999999887664 56999999999999999999998765 33333333332222211111
Q ss_pred --CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 139 --DYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 139 --~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+..++..+.+||.+||..||.+|||+.++++
T Consensus 296 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 296 CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 12256899999999999999999999999976
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=238.88 Aligned_cols=168 Identities=16% Similarity=0.247 Sum_probs=131.0
Q ss_pred Cccccc-chHHHHHHhc----------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcc
Q 024572 1 MQLGVS-SLSEFVMLEG----------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~ 62 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++ ...+||+|||+++
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 788854 9999998754 467889999999999999999999999998543 2249999999986
Q ss_pred cCCC---CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCC
Q 024572 63 SSLL---HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIP 138 (265)
Q Consensus 63 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 138 (265)
.... ........+|+.|+|||++.+..++ .++|||||||++|+|++ |..||........ ...+.. ....+
T Consensus 233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~----~~~i~~-~~~~~ 306 (367)
T 3l9p_A 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----LEFVTS-GGRMD 306 (367)
T ss_dssp HHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHHHT-TCCCC
T ss_pred ccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHc-CCCCC
Confidence 3221 1223345688999999999887765 55999999999999998 9999987654322 222222 22233
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
.+..++..+.+||.+||..||.+|||+.+++++.++
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 445789999999999999999999999999998765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=236.51 Aligned_cols=148 Identities=24% Similarity=0.364 Sum_probs=118.4
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+..++ .
T Consensus 198 ~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~ 274 (359)
T 3vhe_A 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-I 274 (359)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCC-H
T ss_pred HHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCC-c
Confidence 3567899999999999999999999999987765 99999999975433221 2234578899999999877765 5
Q ss_pred hHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 94 LADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
++|||||||++|+|++ |+.||.+..........+.. ....+.+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 275 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 275 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 6999999999999998 99999887655444333322 22333445689999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=226.71 Aligned_cols=167 Identities=20% Similarity=0.288 Sum_probs=120.3
Q ss_pred Cccccc-chHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC--
Q 024572 1 MQLGVS-SLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-- 67 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC----------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceeccccccccc
Confidence 677764 888887432 34778899999999999999999999999988765 999999998744321
Q ss_pred -CCCCCCcCCCCCccccccc---CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 68 -SRPKSTVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 68 -~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
.......||+.|+|||++. +..+ +.++|||||||++|+|++|+.||............+...............+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC 254 (289)
T ss_dssp --------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred cccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence 1223346899999999986 3333 4569999999999999999999988776555444433311111111122367
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++.+.+||.+||..||.+|||+.++++
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 899999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=230.91 Aligned_cols=163 Identities=20% Similarity=0.298 Sum_probs=127.8
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +|
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~k 182 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK 182 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe--EE
Confidence 788854 9999987653 3677899999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhh
Q 024572 55 ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAV 133 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 133 (265)
|+|||+++............+++.|+|||++.+..++ .++|||||||++|+|++ |+.||.+..... ....+. .
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~----~~~~~~-~ 256 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP-Q 256 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHGG-G
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHH----HHHHhh-c
Confidence 9999998754433333445678899999999877664 55999999999999998 999998765432 222222 2
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 134 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
....+.+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 23334445789999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=233.40 Aligned_cols=163 Identities=21% Similarity=0.324 Sum_probs=129.1
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +|
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~k 231 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MK 231 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCc--EE
Confidence 688865 9999997653 3667899999999999999999999999987775 99
Q ss_pred EeccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++...... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||........ ...+
T Consensus 232 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~~----~~~~ 306 (382)
T 3tt0_A 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL----FKLL 306 (382)
T ss_dssp ECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHH
T ss_pred EcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHH
Confidence 99999997544322 22334577889999999887765 55999999999999999 9999987653322 2222
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
. .......+..++..+.+||.+||..||.+|||+.+++++
T Consensus 307 ~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 307 K-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp H-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 222333445789999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=229.49 Aligned_cols=167 Identities=17% Similarity=0.185 Sum_probs=127.0
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCC---CcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA---PRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~---~~vkl~Dfg~a~~~~~~ 67 (265)
||+++++|.+++... .++.+++.+|.|||++||+||||||+|||++.++. ..+||+|||+++.....
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 84 LELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred EEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 789988999998853 23678899999999999999999999999976542 23999999999754332
Q ss_pred CC--------CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCC
Q 024572 68 SR--------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 139 (265)
Q Consensus 68 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (265)
.. .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+..... ....+..+.......+.
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADT-LKERYQKIGDTKRATPI 241 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSS-HHHHHHHHHHHHHHSCH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCcccccccc-HHHHHHHHHhhhccCCH
Confidence 21 2355799999999999987764 56999999999999999999998764332 22222222222222221
Q ss_pred ---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 140 ---YVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 140 ---~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
...++ .+.++|.+||..||.+||++.++++
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11234 9999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=233.48 Aligned_cols=165 Identities=21% Similarity=0.316 Sum_probs=131.3
Q ss_pred Cccccc-chHHHHHHhc--------------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcC
Q 024572 1 MQLGVS-SLSEFVMLEG--------------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDG 47 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~ 47 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.
T Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 207 (344)
T 1rjb_A 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207 (344)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET
T ss_pred EecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcC
Confidence 688855 9999987643 4668899999999999999999999999987
Q ss_pred CCCCcEEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 024572 48 SPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNF 123 (265)
Q Consensus 48 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~ 123 (265)
++. +||+|||++........ .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+......+
T Consensus 208 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 284 (344)
T 1rjb_A 208 GKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284 (344)
T ss_dssp TTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH
Confidence 765 99999999875433222 1233477889999999877664 56999999999999998 99999887655444
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 024572 124 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 172 (265)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~ 172 (265)
...+. .....+.+..+++.+.+||.+||..||.+|||+.++++|.
T Consensus 285 ~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 285 YKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp HHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHh----cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 43332 2333444456899999999999999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=226.74 Aligned_cols=170 Identities=24% Similarity=0.399 Sum_probs=131.0
Q ss_pred Cccccc-chHHHHHHhc-------------cccchHHHHHhhhhcC-----ceecCCCcCcEEEcCCCCCcEEEeccCCc
Q 024572 1 MQLGVS-SLSEFVMLEG-------------SVKMKPDIFFSSLSQQ-----ICHRDLKLENTLLDGSPAPRLKICDFGYS 61 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------~~~~i~~~l~~lH~~~-----ivH~dlkp~NIll~~~~~~~vkl~Dfg~a 61 (265)
||++.+ +|.+++.... ++.+++.++.|||++| |+||||||+||+++.++. +||+|||++
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~~ 163 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLA 163 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCchh
Confidence 688865 9999987532 3667899999999999 999999999999987765 999999998
Q ss_pred ccCCCCCC-CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCC
Q 024572 62 KSSLLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 140 (265)
Q Consensus 62 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (265)
+....... .....+++.|+|||++.+..++ .++||||||+++|+|++|+.||........ ...+..... .+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~i~~~~~-~~~~ 237 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKEL----AGKIREGKF-RRIP 237 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCC-CCCC
T ss_pred eeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHH----HHHHhhccc-ccCC
Confidence 75432211 1223589999999999887664 569999999999999999999987653222 222222222 2233
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 141 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 141 ~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
..++..+.++|.+||..||.+|||+.++++|+|+....
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 46899999999999999999999999999999997643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=228.12 Aligned_cols=168 Identities=25% Similarity=0.323 Sum_probs=123.4
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhh--------hcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSL--------SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH--------~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||++.+ +|.+++.... ++.+++.++.||| ++||+||||||+|||++.++. +||+|||+++.
T Consensus 85 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~ 162 (301)
T 3q4u_A 85 THYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVM 162 (301)
T ss_dssp ECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred hhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCCeee
Confidence 688866 9999885433 4778899999999 999999999999999987775 99999999864
Q ss_pred CCCCCC-----CCCCcCCCCCcccccccCCcCC-----CchHhHHHHHHHHHHHHhC----------CCCCCCCCChHHH
Q 024572 64 SLLHSR-----PKSTVGTPAYIAPEVLSRREYD-----GKLADVWSCGVTLYVMLVG----------AYPFEDQEDPKNF 123 (265)
Q Consensus 64 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~-----~~~~DiwslG~~l~~ll~g----------~~pf~~~~~~~~~ 123 (265)
...... .....||+.|+|||++.+.... +.++|||||||++|+|++| +.||.........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 332211 2334799999999999875322 2469999999999999999 8888664332221
Q ss_pred HHHHHHHhhhcccCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 124 RKTISRIMAVQYKIPDY------VHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 124 ~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
...+..........+.. ..++..+.+||.+||..||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22222222221111111 124467999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=229.71 Aligned_cols=169 Identities=21% Similarity=0.332 Sum_probs=123.5
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhc--------CceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQ--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~--------~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||++.+ +|.+++.... ++.+++.+|.|||++ ||+||||||+|||++.++. +||+|||+++.
T Consensus 114 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~ 191 (337)
T 3mdy_A 114 TDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVK 191 (337)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred EeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCcee
Confidence 788866 9999987543 367789999999999 9999999999999987775 99999999865
Q ss_pred CCCCCC-----CCCCcCCCCCcccccccCCcCCCc-----hHhHHHHHHHHHHHHhC----------CCCCCCCCChHHH
Q 024572 64 SLLHSR-----PKSTVGTPAYIAPEVLSRREYDGK-----LADVWSCGVTLYVMLVG----------AYPFEDQEDPKNF 123 (265)
Q Consensus 64 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~-----~~DiwslG~~l~~ll~g----------~~pf~~~~~~~~~ 123 (265)
...... .....||+.|+|||++.+...... ++|||||||++|+|++| ..||.........
T Consensus 192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 271 (337)
T 3mdy_A 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271 (337)
T ss_dssp CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence 433222 124579999999999987655433 48999999999999999 6777654322211
Q ss_pred HHHHHHHhhh-cccCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 124 RKTISRIMAV-QYKIPDY-----VHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 124 ~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.......... ......+ ..++..+.+||.+||..||.+|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222221111 1111111 1355679999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=228.56 Aligned_cols=163 Identities=19% Similarity=0.259 Sum_probs=125.9
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDK 170 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCCTT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccccCcccc
Confidence 46665 59999887542 3567899999999999999999999999987765 99999999986543322
Q ss_pred ---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.....++..|+|||++.+..++ .++|||||||++|+|++ |+.||.+....... ..+ ......+.+..++.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~----~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLL----EKGERLAQPQICTI 244 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-HHH----HTTCBCCCCTTBCT
T ss_pred cccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-HHH----HcCCCCCCCCcCcH
Confidence 2334577899999999877765 56999999999999999 99999876543322 211 12223334446788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+.++|.+||..||.+|||+.+++++
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=224.63 Aligned_cols=167 Identities=18% Similarity=0.242 Sum_probs=124.6
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 169 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKE 169 (295)
T ss_dssp EECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-------
T ss_pred EEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccCCcc
Confidence 68884 49999987643 3678899999999999999999999999987765 9999999997543322
Q ss_pred ---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHhhhc
Q 024572 69 ---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-----------PKNFRKTISRIMAVQ 134 (265)
Q Consensus 69 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~~~~ 134 (265)
......++..|+|||++.+..++ .++|||||||++|+|++|..||..... ...............
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 3ugc_A 170 FFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248 (295)
T ss_dssp ------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred eeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence 11223467789999999887764 569999999999999999999865211 011111112222233
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 135 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 135 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
...+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 345556678999999999999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-32 Score=224.58 Aligned_cols=163 Identities=22% Similarity=0.375 Sum_probs=119.6
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC------------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccCcccc
Confidence 688876 9999987653 2567899999999999999999999999987765 99999999875433222
Q ss_pred --CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.........+ .. ....+.+..+++.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----~~-~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPPT 245 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-TCCCCCCTTCCHH
T ss_pred cccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----Hc-CCCCCCCCCCCHH
Confidence 1223467789999999877664 56999999999999996 99999876654433222 11 1223444578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.++|.+||..||.+|||+.+++++
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=226.24 Aligned_cols=164 Identities=24% Similarity=0.342 Sum_probs=130.5
Q ss_pred Cccccc-chHHHHHHhc---------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCc
Q 024572 1 MQLGVS-SLSEFVMLEG---------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPR 52 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~ 52 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+||+++.++.
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-- 183 (313)
T 1t46_A 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI-- 183 (313)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCC--
Confidence 678765 9999987653 3567899999999999999999999999987765
Q ss_pred EEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 024572 53 LKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTIS 128 (265)
Q Consensus 53 vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 128 (265)
+||+|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |+.||............+.
T Consensus 184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 262 (313)
T 1t46_A 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (313)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhc
Confidence 99999999875543322 2233467889999999877664 56999999999999999 9999988765544444333
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 129 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
. ....+....++..+.+||.+||..||.+|||+.+++++
T Consensus 263 ~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 263 E----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp H----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 2 23333445689999999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=227.70 Aligned_cols=169 Identities=27% Similarity=0.355 Sum_probs=123.1
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++..++ ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCcccccccccc
Confidence 788865 9999987664 3667899999999999999999999999988775 9999999997543322
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......||+.|+|||.+.+..++ .++|||||||++|+|++|+.||.+..........+.... ..........+++.+.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 245 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLS 245 (294)
T ss_dssp -------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-CCHHHHSCTTSCHHHH
T ss_pred ccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-CCcchhcccCCCHHHH
Confidence 22334699999999999887765 459999999999999999999987654333222211100 0000112346889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcc
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPW 173 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~ 173 (265)
++|.+||..||.+||+..+.+.+.|
T Consensus 246 ~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 246 NVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp HHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHHhcCCHhHccccHHHHHHHH
Confidence 9999999999999995555555544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=227.87 Aligned_cols=162 Identities=22% Similarity=0.327 Sum_probs=125.9
Q ss_pred Cccccc-chHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC----
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccccCcc
Confidence 788855 999998644 23677899999999999999999999999987765 99999999975433221
Q ss_pred C----CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
. ....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.......... .+. .....+.+..++
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~ 280 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS----SVE-EGYRLPAPMGCP 280 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH----HHH-TTCCCCCCTTCC
T ss_pred ceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHH-cCCCCCCCCCcC
Confidence 1 122357789999999877765 45999999999999999 999998765433222 222 223445556789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+.+||.+||..||.+|||+.++++
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=237.18 Aligned_cols=166 Identities=19% Similarity=0.155 Sum_probs=126.3
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEE---cCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll---~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||+++++|.+++... .++.+|+.+|.|||++|||||||||+|||| +..+. +||+|||+++.....
T Consensus 82 me~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDT 159 (483)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCT
T ss_pred EECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCC
Confidence 799988999998742 246788999999999999999999999999 44544 999999999754432
Q ss_pred CC--------CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC--
Q 024572 68 SR--------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-- 137 (265)
Q Consensus 68 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 137 (265)
.. .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+........ .+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKKVATSI 237 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH-HHHHHHHHHHHSCH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHH-HHHHHhhccccccH
Confidence 22 2245799999999999887765 56999999999999999999998765432211 111111111110
Q ss_pred -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 138 -PDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 138 -~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.....++.++.+||.+||..+|.+||++.+|++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111357899999999999999999999988754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=220.75 Aligned_cols=163 Identities=21% Similarity=0.289 Sum_probs=127.3
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhh
Confidence 68885 48999887653 3677899999999999999999999999988775 99999999875433221
Q ss_pred --CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.....+++.|+|||++.+..++. ++||||||+++|+|++ |+.||........... +.. ......+..+++.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~ 233 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSS-KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VSQ-GHRLYRPHLASDT 233 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEET-THHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHT-TCCCCCCTTSCHH
T ss_pred hcccCCCcCcccCCHHHHhccCCch-hhhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HHc-CCCCCCCCcChHH
Confidence 12334667899999998777654 5999999999999999 9999987654332222 222 2223334467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.++|.+||..||.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=221.65 Aligned_cols=165 Identities=24% Similarity=0.338 Sum_probs=122.4
Q ss_pred Ccccc-cchHHHHHHh--------ccccchHHHHHhhhhcC---ceecCCCcCcEEEcCC------CCCcEEEeccCCcc
Q 024572 1 MQLGV-SSLSEFVMLE--------GSVKMKPDIFFSSLSQQ---ICHRDLKLENTLLDGS------PAPRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~-~sL~~~~~~~--------~~~~~i~~~l~~lH~~~---ivH~dlkp~NIll~~~------~~~~vkl~Dfg~a~ 62 (265)
||++. ++|.+++..+ .++.+++.++.|||++| |+||||||+||+++.. ..+.+||+|||+++
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 67885 4888876432 34778899999999999 9999999999999752 12359999999987
Q ss_pred cCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 63 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 63 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
..... ......+++.|+|||.+.+..++ .++||||||+++|+|++|+.||.+...... ...........+....
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 165 EWHRT-TKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAV----AYGVAMNKLALPIPST 238 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHH----HHHHHTSCCCCCCCTT
T ss_pred ccccc-cccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHhhhcCCCCCCCCcc
Confidence 54332 22345789999999999877664 569999999999999999999987654322 2222333334445557
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+++.+.++|.+||..||.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 89999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=224.66 Aligned_cols=163 Identities=21% Similarity=0.316 Sum_probs=128.3
Q ss_pred Ccccc-cchHHHHHHhc---------------------------------cccchHHHHHhhhhcCceecCCCcCcEEEc
Q 024572 1 MQLGV-SSLSEFVMLEG---------------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLD 46 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~ 46 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+||+++
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~ 184 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA 184 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEc
Confidence 67886 59999987643 366789999999999999999999999999
Q ss_pred CCCCCcEEEeccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHH
Q 024572 47 GSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKN 122 (265)
Q Consensus 47 ~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~ 122 (265)
.++. +||+|||+++...... ......+++.|+|||++.+..++ .++|||||||++|+|++ |+.||.+......
T Consensus 185 ~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 185 EGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp TTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 7765 9999999987543322 12233577889999999877665 55999999999999999 9999987655332
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 123 FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
. ..+ ......+.+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 262 ~-~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 262 F-NLL----KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp H-HHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H-HHh----hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2 222 1222333445789999999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=219.47 Aligned_cols=166 Identities=23% Similarity=0.274 Sum_probs=127.2
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcC--ceecCCCcCcEEEcCCCC---CcEEEeccCCcccC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQ--ICHRDLKLENTLLDGSPA---PRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~--ivH~dlkp~NIll~~~~~---~~vkl~Dfg~a~~~ 64 (265)
||++. ++|.+++..+. ++.+++.++.|||++| |+||||||+|||++.++. ..+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp EECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC
T ss_pred EEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc
Confidence 68886 58988886543 4677899999999999 999999999999975442 23899999998743
Q ss_pred CCCCCCCCCcCCCCCcccccccCC-cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 65 LLHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 65 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
.. ......+++.|+|||++.+. ...+.++|||||||++|+|++|+.||........ ...............+..+
T Consensus 180 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 255 (287)
T 4f0f_A 180 VH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIREEGLRPTIPEDC 255 (287)
T ss_dssp SS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHHHHHHSCCCCCCCTTS
T ss_pred cc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHHHHhccCCCCCCCccc
Confidence 32 33445799999999998432 2234569999999999999999999987654332 1122222333334445578
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++.+.+||.+||..||.+|||+.++++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 256 PPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=221.73 Aligned_cols=164 Identities=22% Similarity=0.268 Sum_probs=131.1
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 176 (284)
T 2a19_B 99 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDG 176 (284)
T ss_dssp ECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEESSCCS
T ss_pred EeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECcchhheeccccc
Confidence 688876 9999987542 3677899999999999999999999999987765 9999999998665554
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
......+++.|+|||++.+..++ .++|||||||++|+|++|..||... ......+... .. ...++..+.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~--~~--~~~~~~~~~ 245 (284)
T 2a19_B 177 KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET------SKFFTDLRDG--II--SDIFDKKEK 245 (284)
T ss_dssp CCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTT--CC--CTTSCHHHH
T ss_pred cccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhcc--cc--cccCCHHHH
Confidence 55556799999999999887765 5599999999999999999887431 1122222211 12 235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 149 NLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+||.+||..||.+|||+.++++|.+..+.
T Consensus 246 ~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 246 TLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 99999999999999999999999876443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=229.01 Aligned_cols=161 Identities=19% Similarity=0.308 Sum_probs=125.5
Q ss_pred ccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC--
Q 024572 3 LGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-- 70 (265)
Q Consensus 3 ~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~-- 70 (265)
+.+++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~ 175 (327)
T 3poz_A 98 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYH 175 (327)
T ss_dssp CTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTTCC---
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCCccccc
Confidence 34458988887632 4678899999999999999999999999988775 999999998754332221
Q ss_pred -CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 71 -KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 71 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
....+|..|+|||++.+..++ .++|||||||++|+|++ |+.||.+...... ...+ ......+.+..++..+.
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~ 249 (327)
T 3poz_A 176 AEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSIL----EKGERLPQPPICTIDVY 249 (327)
T ss_dssp ----CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHH----HTTCCCCCCTTBCHHHH
T ss_pred ccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHH-HHHH----HcCCCCCCCccCCHHHH
Confidence 223467799999999887765 56999999999999999 9999987654332 2222 22233445557899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 024572 149 NLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h 171 (265)
+++.+||..||.+|||+.+++++
T Consensus 250 ~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 250 MIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-32 Score=228.78 Aligned_cols=167 Identities=19% Similarity=0.204 Sum_probs=122.4
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhc----------CceecCCCcCcEEEcCCCCCcEEEeccCCc
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQ----------QICHRDLKLENTLLDGSPAPRLKICDFGYS 61 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~----------~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a 61 (265)
||++.+ +|.+++..+. ++.+++.++.|||++ ||+||||||+|||++.++. +||+|||++
T Consensus 101 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DFg~a 178 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLA 178 (322)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEECCCTTC
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEccCCcc
Confidence 788866 9999987643 367889999999999 9999999999999987765 999999999
Q ss_pred ccCCCCC---CCCCCcCCCCCcccccccCCcC----CCchHhHHHHHHHHHHHHhCCCCCCCCCChH------------H
Q 024572 62 KSSLLHS---RPKSTVGTPAYIAPEVLSRREY----DGKLADVWSCGVTLYVMLVGAYPFEDQEDPK------------N 122 (265)
Q Consensus 62 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~------------~ 122 (265)
+...... ......||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+..... .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 6543322 2233579999999999986322 2345899999999999999999997643211 1
Q ss_pred HHHHHHHHhhhcccCCCCC------CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 123 FRKTISRIMAVQYKIPDYV------HISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
............ ..+... ..+..+.+||.+||..||.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 259 LEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111111111111 111111 12345999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=221.69 Aligned_cols=163 Identities=20% Similarity=0.334 Sum_probs=127.5
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccc
Confidence 688855 8999986543 3677899999999999999999999999987765 9999999987443221
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
......+++.|+|||++.+..++ .++||||||+++|+|++ |+.||.......... .+.. ......+..++..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~ 235 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DIST-GFRLYKPRLASTH 235 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHT-TCCCCCCTTSCHH
T ss_pred ccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHhc-CccCCCCCcCCHH
Confidence 22334567789999999877765 55999999999999999 999998765433222 2222 2233344467999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.++|.+||..||.+|||+.++++|
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=225.97 Aligned_cols=164 Identities=23% Similarity=0.347 Sum_probs=129.4
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +|
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~k 188 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VK 188 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EE
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EE
Confidence 678865 9999887543 3567899999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||............+..
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~- 266 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE- 266 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH-
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhcc-
Confidence 999999875433222 1233578899999999877765 56999999999999998 99999886654443333322
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
....+.+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 267 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 267 ---GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22233344689999999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=228.68 Aligned_cols=163 Identities=20% Similarity=0.272 Sum_probs=126.8
Q ss_pred Cccccc-chHHHHHHhc---------------------------------cccchHHHHHhhhhcCceecCCCcCcEEEc
Q 024572 1 MQLGVS-SLSEFVMLEG---------------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLD 46 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~ 46 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 208 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG 208 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEC
Confidence 688865 9999987642 467889999999999999999999999998
Q ss_pred CCCCCcEEEeccCCcccCCCC---CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHH
Q 024572 47 GSPAPRLKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKN 122 (265)
Q Consensus 47 ~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~ 122 (265)
.++. +||+|||+++..... .......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+......
T Consensus 209 ~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 285 (343)
T 1luf_A 209 ENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285 (343)
T ss_dssp GGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred CCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence 7765 999999998643222 122334678899999999877764 56999999999999999 9999987654322
Q ss_pred HHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 123 FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
...+.... ..+.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 286 ----~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 286 ----IYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp ----HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----HHHHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 22222222 223344689999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=226.14 Aligned_cols=163 Identities=19% Similarity=0.222 Sum_probs=123.4
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKT 163 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccc
Confidence 688866 9999987622 3678899999999999999999999999988776 99999999875432221
Q ss_pred C---------------CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHHHHhhh
Q 024572 70 P---------------KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF-RKTISRIMAV 133 (265)
Q Consensus 70 ~---------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~ 133 (265)
. ....||+.|+|||++.+..++ .++|||||||++|+|++|..||......... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~- 241 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD- 241 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence 1 145699999999999887765 4599999999999999999998764322110 000011111
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 134 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
...+..+++.+.+||.+||..||.+|||+.++++
T Consensus 242 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 ---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1112357889999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=220.75 Aligned_cols=163 Identities=21% Similarity=0.266 Sum_probs=126.0
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC-----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccccccc
Confidence 677764 9999987653 2567899999999999999999999999987765 99999999875433221
Q ss_pred --CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.....+++.|+|||++.+..++ .++|||||||++|+|++ |+.||........... +. .....+.+..+++.
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LE----KGDRLPKPDLCPPV 242 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HH----HTCCCCCCTTCCHH
T ss_pred cccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-Hh----cCCCCCCCCCCCHH
Confidence 2233567889999999876664 56999999999999998 9999987655433222 11 12233444568999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.++|.+||..||.+|||+.+++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=225.42 Aligned_cols=161 Identities=19% Similarity=0.310 Sum_probs=121.3
Q ss_pred ccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC--
Q 024572 3 LGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-- 70 (265)
Q Consensus 3 ~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~-- 70 (265)
+.+++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~~~~~~ 175 (327)
T 3lzb_A 98 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYH 175 (327)
T ss_dssp CSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC------------
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCcccccc
Confidence 34558988887642 3678899999999999999999999999987765 999999999754332221
Q ss_pred -CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHH
Q 024572 71 -KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148 (265)
Q Consensus 71 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (265)
....+++.|+|||++.+..++ .++|||||||++|+|++ |+.||.+...... ...+ ......+.+..++..+.
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~l~ 249 (327)
T 3lzb_A 176 AEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSIL----EKGERLPQPPICTIDVY 249 (327)
T ss_dssp ----CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHH----HTTCCCCCCTTBCHHHH
T ss_pred ccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HHHH----HcCCCCCCCccCCHHHH
Confidence 223467789999999887765 56999999999999999 9999987655432 2222 22333445557899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 024572 149 NLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell~h 171 (265)
+||.+||..||.+|||+.++++.
T Consensus 250 ~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 250 MIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=233.34 Aligned_cols=160 Identities=19% Similarity=0.298 Sum_probs=127.3
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..++ ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc-
Confidence 688865 9999998654 2567889999999999999999999999987765 999999999744322
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.....++..|+|||++.+..++ .++|||||||++|+|++ |+.||............ ......+.+..+++.+
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-----~~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKMDAPDGCPPAV 415 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-----HTTCCCCCCTTCCHHH
T ss_pred -ccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCcCCHHH
Confidence 2233578899999999887765 55999999999999998 99999876654433221 1223445556789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+||.+||..||.+|||+.++++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=228.25 Aligned_cols=175 Identities=20% Similarity=0.239 Sum_probs=121.8
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhc---------CceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQ---------QICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~---------~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++ ||+||||||+|||++.++. +||+|||+++
T Consensus 91 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~DFG~a~ 168 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLSM 168 (336)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECCCTTCE
T ss_pred EecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEeecccee
Confidence 788854 9999987543 467889999999999 9999999999999987765 9999999997
Q ss_pred cCCCC---------CCCCCCcCCCCCcccccccCC------cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHH-----
Q 024572 63 SSLLH---------SRPKSTVGTPAYIAPEVLSRR------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN----- 122 (265)
Q Consensus 63 ~~~~~---------~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~----- 122 (265)
..... .......||+.|+|||++.+. ...+.++|||||||++|+|++|..||........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 54322 112244699999999999763 1223568999999999999999777644322110
Q ss_pred ---------HHHHHHHHhhhcccCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CcccCCC
Q 024572 123 ---------FRKTISRIMAVQYKIPDY------VHISQDCRNLLSRIFVANPSRRITIKEIKS------HPWFLKN 177 (265)
Q Consensus 123 ---------~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~dP~~R~s~~ell~------h~~f~~~ 177 (265)
.................+ ..+++.+.+||.+||..||.+|||+.++++ ++|-+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 011111111111111111 113457999999999999999999999954 5565543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=235.89 Aligned_cols=162 Identities=23% Similarity=0.367 Sum_probs=128.6
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNE 338 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCc
Confidence 788865 9999987432 3677899999999999999999999999988765 9999999997543211
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
......++..|+|||++....++ .++|||||||++|+|++ |+.||.+......... + ......+.+..+++
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~ 412 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----L-ERGYRMPRPENCPE 412 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----H-HHTCCCCCCTTSCH
T ss_pred eeccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCH
Confidence 12233467789999999877765 56999999999999999 9999987654333222 1 12344555667999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+||.+||..||.+|||+.++++
T Consensus 413 ~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 413 ELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=228.68 Aligned_cols=164 Identities=21% Similarity=0.321 Sum_probs=129.9
Q ss_pred Cccccc-chHHHHHHhc-----------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEe
Q 024572 1 MQLGVS-SLSEFVMLEG-----------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKIC 56 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~ 56 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+
T Consensus 129 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~ 206 (333)
T 2i1m_A 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--AKIG 206 (333)
T ss_dssp EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE--EEBC
T ss_pred EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe--EEEC
Confidence 688765 9999987543 3567899999999999999999999999987765 9999
Q ss_pred ccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhh
Q 024572 57 DFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMA 132 (265)
Q Consensus 57 Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 132 (265)
|||+++....... .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+............
T Consensus 207 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---- 281 (333)
T 2i1m_A 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK---- 281 (333)
T ss_dssp CCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH----
T ss_pred ccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh----
Confidence 9999875433221 2234467889999999877665 56999999999999998 9999988765544443332
Q ss_pred hcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 133 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 133 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.....+.+..++..+.+||.+||..||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 282 DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 233344445678999999999999999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=231.11 Aligned_cols=162 Identities=25% Similarity=0.326 Sum_probs=126.5
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++..++ ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVY 268 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCce
Confidence 78885 59999987654 3667889999999999999999999999987775 99999999874332211
Q ss_pred ---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.....++..|+|||++.+..++ .++|||||||++|+|++ |..||........ ... .......+.+..++.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~-~~~----~~~~~~~~~~~~~~~ 342 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQT-REF----VEKGGRLPCPELCPD 342 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-HHH----HHTTCCCCCCTTCCH
T ss_pred eecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHH----HHcCCCCCCCCCCCH
Confidence 1122356779999999877764 55999999999999998 9999987654322 211 222334455557899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+||.+||..||.+|||+.++++
T Consensus 343 ~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 343 AVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=226.98 Aligned_cols=161 Identities=28% Similarity=0.437 Sum_probs=109.7
Q ss_pred CcccccchHHHHHHh------------ccccchHHHHHhhhhcC--ceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVSSLSEFVMLE------------GSVKMKPDIFFSSLSQQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~sL~~~~~~~------------~~~~~i~~~l~~lH~~~--ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.++|.+++... .++.+++.+|.|||++| |+||||||+|||++.++. +||+|||+++....
T Consensus 113 ~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~ 190 (337)
T 3ll6_A 113 TELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTISH 190 (337)
T ss_dssp EECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCTTCBCCSS
T ss_pred EEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCccceeccc
Confidence 789999999988651 23677899999999999 999999999999988775 99999999975443
Q ss_pred CCCC-------------CCCcCCCCCccccccc---CCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHH
Q 024572 67 HSRP-------------KSTVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 67 ~~~~-------------~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 130 (265)
.... ....+|+.|+|||++. +..+ +.++|||||||++|+|++|+.||....... +
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~ 261 (337)
T 3ll6_A 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLR--------I 261 (337)
T ss_dssp CC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred cCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHH--------h
Confidence 2211 1345899999999983 3333 456999999999999999999997643321 1
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 172 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~ 172 (265)
.......+.....+..+.+||.+||..||.+|||+.++++|.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 122233444456788899999999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=224.92 Aligned_cols=163 Identities=20% Similarity=0.280 Sum_probs=127.1
Q ss_pred Cccccc-chHHHHHHhc-------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCC
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGY 60 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~ 60 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+||+++.++. +||+|||+
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~Dfg~ 184 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGM 184 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTC
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEECcCcc
Confidence 688865 9999987532 3667899999999999999999999999988765 99999999
Q ss_pred cccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhccc
Q 024572 61 SKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 61 a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
++...... ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||......... ..+.... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~~~~~~-~ 258 (322)
T 1p4o_A 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL----RFVMEGG-L 258 (322)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----HHHHTTC-C
T ss_pred ccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHH----HHHHcCC-c
Confidence 87443221 11233568899999999877664 56999999999999999 89999776543222 2222222 2
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+....++..+.+||.+||..||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 23345789999999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=222.61 Aligned_cols=163 Identities=18% Similarity=0.275 Sum_probs=122.3
Q ss_pred Cccccc-chHHHHHHh---------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC
Q 024572 1 MQLGVS-SLSEFVMLE---------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~-sL~~~~~~~---------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 64 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++..
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~ 197 (313)
T 3brb_A 120 LPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSKKI 197 (313)
T ss_dssp EECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECSCSCC---
T ss_pred EecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEeecCcceec
Confidence 567765 898888432 24677899999999999999999999999988765 999999998754
Q ss_pred CCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCC
Q 024572 65 LLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 140 (265)
Q Consensus 65 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (265)
.... ......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||............. . ....+.+
T Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~ 271 (313)
T 3brb_A 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL----H-GHRLKQP 271 (313)
T ss_dssp -------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----T-TCCCCCB
T ss_pred ccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH----c-CCCCCCC
Confidence 3322 12233577889999999887765 55999999999999999 889998766544332221 1 2223344
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 141 VHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 141 ~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
..++..+.+||.+||..||.+|||+.+++++
T Consensus 272 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 272 EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5789999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=215.75 Aligned_cols=160 Identities=18% Similarity=0.186 Sum_probs=126.8
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcC--ceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~--ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++.... ++.+++.++.|||++| |+||||||+||+++.++. ++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~~-- 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSF-- 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCTT--
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceeee--
Confidence 688865 9999987653 2667899999999999 999999999999988776 888888876432
Q ss_pred CCCCCCCcCCCCCcccccccCCcCCC--chHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 67 HSRPKSTVGTPAYIAPEVLSRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
......+|+.|+|||++.+..+.. .++|||||||++|+|++|+.||.......... .........+.+..++
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 237 (271)
T 3kmu_A 164 --QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM----KVALEGLRPTIPPGIS 237 (271)
T ss_dssp --SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH----HHHHSCCCCCCCTTCC
T ss_pred --cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH----HHHhcCCCCCCCCCCC
Confidence 223457899999999998765543 26999999999999999999998765433322 2223333344455789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.+.++|.+||..||.+|||+.++++
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=221.14 Aligned_cols=163 Identities=20% Similarity=0.290 Sum_probs=127.1
Q ss_pred Ccccc-cchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGV-SSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++. ++|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHH
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEcccccccccccccc
Confidence 68884 5999998752 23677899999999999999999999999987765 9999999987443221
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
......+++.|+|||++.+..++ .++||||||+++|+|++ |+.||........... +.. ......+..+++.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~ 249 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQ-GLRLYRPHLASEK 249 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHT-TCCCCCCTTCCHH
T ss_pred ccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHH----Hhc-ccCCCCCCcCCHH
Confidence 12233467889999999877764 56999999999999998 9999987654332222 222 2223334467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.+||.+||..||.+|||+.++++|
T Consensus 250 l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 250 VYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=228.33 Aligned_cols=162 Identities=19% Similarity=0.318 Sum_probs=117.9
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccCCc
Confidence 78884 59999987643 3677899999999999999999999999988775 99999999875433221
Q ss_pred C----CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
. ....++..|+|||++.+..++ .++|||||||++|+|++ |+.||......... ..+ ......+.+..++
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~----~~i-~~~~~~~~~~~~~ 276 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----KAV-DEGYRLPPPMDCP 276 (373)
T ss_dssp -----------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH----HHH-HTTEECCCCTTCB
T ss_pred cceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-HcCCCCCCCcccc
Confidence 1 112356789999999877765 55999999999999998 99999876543222 222 2233445555789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+.+||.+||..||.+||++.++++
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=226.10 Aligned_cols=169 Identities=17% Similarity=0.237 Sum_probs=129.5
Q ss_pred Cccc-ccchHHHHHHhc----------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcc
Q 024572 1 MQLG-VSSLSEFVMLEG----------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSK 62 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~----------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~ 62 (265)
||++ +++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++ ...+||+|||+++
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~ 191 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccc
Confidence 6888 559999998653 356789999999999999999999999998433 2359999999986
Q ss_pred cCCCC---CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCC
Q 024572 63 SSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIP 138 (265)
Q Consensus 63 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 138 (265)
..... .......+++.|+|||++.+..++ .++|||||||++|+|++ |+.||........ ...+... ....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~~~~~-~~~~ 265 (327)
T 2yfx_A 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----LEFVTSG-GRMD 265 (327)
T ss_dssp HHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHHHTT-CCCC
T ss_pred ccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHH----HHHHhcC-CCCC
Confidence 33221 122334578899999999877664 56999999999999998 9999987643322 2222222 2233
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
....++..+.+||.+||..||.+|||+.++++|.|+.
T Consensus 266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 3446899999999999999999999999999987763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-31 Score=224.18 Aligned_cols=163 Identities=22% Similarity=0.325 Sum_probs=127.6
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +|
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~k 197 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MK 197 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCC--EE
Confidence 678865 9999987643 3567899999999999999999999999987765 99
Q ss_pred EeccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++...... ......+++.|+|||++.+..++ .++|||||||++|+|++ |+.||.+...... ...+
T Consensus 198 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~--- 272 (334)
T 2pvf_A 198 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLL--- 272 (334)
T ss_dssp ECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHHH---
T ss_pred EccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-HHHH---
Confidence 99999987543322 12233567889999999877664 55999999999999999 9999987653322 2222
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.. ....+.+..++..+.++|.+||..||.+|||+.+++++
T Consensus 273 ~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 273 KE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11 22233445789999999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=220.00 Aligned_cols=164 Identities=26% Similarity=0.377 Sum_probs=121.6
Q ss_pred Cccccc-chHHHHHHhc------------cccchHHHHHhhhh---cCceecCCCcCcEEEcCCCCCcEEEeccCCcccC
Q 024572 1 MQLGVS-SLSEFVMLEG------------SVKMKPDIFFSSLS---QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 64 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~------------~~~~i~~~l~~lH~---~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 64 (265)
||++.+ +|.+++..+. ++.+++.++.|||+ +||+||||||+||+++.++. .+||+|||++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDI 156 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccc
Confidence 688855 9999987543 24577899999999 89999999999999987653 3799999998644
Q ss_pred CCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 65 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 65 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.. ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||........ ...... ......+....++
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~ 230 (307)
T 2eva_A 157 QT--HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAV-HNGTRPPLIKNLP 230 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHH-HTTCCCCCBTTCC
T ss_pred cc--ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHH-hcCCCCCcccccC
Confidence 32 22344689999999999887765 559999999999999999999986543321 111111 1222334445789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
..+.+||.+||..||.+|||+.+++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=222.15 Aligned_cols=162 Identities=17% Similarity=0.201 Sum_probs=123.2
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCC------cEEEeccCCccc
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAP------RLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~------~vkl~Dfg~a~~ 63 (265)
||++. ++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++.. .+||+|||++..
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~ 170 (289)
T 4fvq_A 91 QEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170 (289)
T ss_dssp EECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTT
T ss_pred EECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCccccc
Confidence 78887 59999998654 36778999999999999999999999999766531 289999999864
Q ss_pred CCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 64 SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 64 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
... .....+++.|+|||++.+....+.++|||||||++|+|++|..|+............. ......+ ...
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~----~~~~~~~--~~~ 241 (289)
T 4fvq_A 171 VLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY----EDRHQLP--APK 241 (289)
T ss_dssp TSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTTCCCC--CCS
T ss_pred ccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh----hccCCCC--CCC
Confidence 322 1234578899999999874445667999999999999999655554444333222221 1222222 346
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+..+.+||.+||..||.+|||+.++++|
T Consensus 242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 242 AAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp SCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7889999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=220.82 Aligned_cols=164 Identities=24% Similarity=0.328 Sum_probs=127.6
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDD 176 (291)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CC
T ss_pred EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEcccccccccccccc
Confidence 56765 48988887642 3677899999999999999999999999987765 99999999875433221
Q ss_pred ----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.....++..|+|||++.+..++ .++||||||+++|+|++ |+.||....... ....+.......+....++
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCCCCCCTTCC
T ss_pred chhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHH----HHHHHHccCCCCCCCcCcC
Confidence 1233577789999999877664 56999999999999999 999998765432 2333333444455556789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
..+.++|.+||..||.+|||+.+++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999873
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-31 Score=220.05 Aligned_cols=164 Identities=22% Similarity=0.292 Sum_probs=128.0
Q ss_pred Cccccc-chHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDS 165 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSC
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeeeccCcc
Confidence 677765 898887532 24778899999999999999999999999987765 99999999875433221
Q ss_pred ----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.....+++.|+|||++.+..++ .++|||||||++|+|++ |+.||.......... .+.. ....+.+..++
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~i~~-~~~~~~~~~~~ 239 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQ-GKRMECPPECP 239 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHT-TCCCCCCTTCC
T ss_pred eeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHhc-CCcCCCCCCcC
Confidence 2233468899999999876664 55999999999999998 999998766543322 2222 22233345789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSHP 172 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h~ 172 (265)
+.+.++|.+||..||.+|||+.+++++.
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=228.17 Aligned_cols=163 Identities=20% Similarity=0.261 Sum_probs=119.1
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEF 247 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccccccccc
Confidence 678866 9999987543 3567899999999999999999999999987765 9999999997543221
Q ss_pred ----CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 69 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 69 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
......+++.|+|||++.+..++ .++|||||||++|+|++ |.+||............ .. ....+.+..+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~-~~~~~~p~~~ 321 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQ-GRRLLQPEYC 321 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HT-TCCCCCCTTC
T ss_pred ccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----Hc-CCCCCCCCCC
Confidence 11233467889999999877765 56999999999999999 67788766544332221 11 1223334468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+..+.++|.+||..||.+|||+.+++++
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=220.59 Aligned_cols=166 Identities=22% Similarity=0.271 Sum_probs=127.2
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 104 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 181 (302)
T 4e5w_A 104 MEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKE 181 (302)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCC
T ss_pred EEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECcccccccccCCCc
Confidence 688855 9999985442 3678899999999999999999999999987765 9999999997554332
Q ss_pred ---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----------ChHHHHHHHHHHhhhc
Q 024572 69 ---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE-----------DPKNFRKTISRIMAVQ 134 (265)
Q Consensus 69 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~-----------~~~~~~~~~~~~~~~~ 134 (265)
......+|..|+|||++.+..++ .++|||||||++|+|++|..|+.... ......... ......
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 259 (302)
T 4e5w_A 182 YYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-NTLKEG 259 (302)
T ss_dssp EEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH-HHHHTT
T ss_pred ceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH-HHHhcc
Confidence 22334578889999999887765 55999999999999999998864321 111111222 222233
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 135 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 135 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
...+.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 344555678999999999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=225.76 Aligned_cols=167 Identities=20% Similarity=0.291 Sum_probs=128.3
Q ss_pred Cccc-ccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLG-VSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++ +++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLDKD 182 (327)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCTTCS
T ss_pred EeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccccceecccCCc
Confidence 6888 559999987632 3667899999999999999999999999987765 9999999997543322
Q ss_pred ---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChH-----------HHHHHHHHHhhhc
Q 024572 69 ---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----------NFRKTISRIMAVQ 134 (265)
Q Consensus 69 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~-----------~~~~~~~~~~~~~ 134 (265)
......++..|+|||++.+..++ .++|||||||++|+|++|+.||....... .... +.......
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 260 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR-LLELLEEG 260 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH-HHHHHHTT
T ss_pred cceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH-HHHHhhcc
Confidence 22334578889999999877664 56999999999999999999986532110 1111 11222233
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 135 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 135 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
...+.+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3445556789999999999999999999999999765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=242.67 Aligned_cols=175 Identities=23% Similarity=0.305 Sum_probs=129.3
Q ss_pred Cccc-ccchHHHHHHhc------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCC-CcEEEeccCCcccCCC
Q 024572 1 MQLG-VSSLSEFVMLEG------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~-~~vkl~Dfg~a~~~~~ 66 (265)
||++ +++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. ..+||+|||++.....
T Consensus 97 mEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~ 176 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176 (676)
T ss_dssp EECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTS
T ss_pred EEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccc
Confidence 6888 459999987643 3677899999999999999999999999986543 2489999999987665
Q ss_pred CCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----HHH-----hhhcc-
Q 024572 67 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI-----SRI-----MAVQY- 135 (265)
Q Consensus 67 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~-----~~~-----~~~~~- 135 (265)
........+++.|+|||++.+..++. ++|||||||++|+|++|..||........+.... ... .....
T Consensus 177 ~~~~~~~~gt~~Y~APE~l~~~~~s~-ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~ 255 (676)
T 3qa8_A 177 GELCTEFVGTLQYLAPELLEQKKYTV-TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVK 255 (676)
T ss_dssp CCCCCCCCSCCTTCSSCSSCCSCCST-THHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCC
T ss_pred ccccccccCCcccCChHHhccCCCCc-hhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccc
Confidence 55556678999999999998877754 5999999999999999999997643221110000 000 00000
Q ss_pred ---cCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 136 ---KIPD----YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 136 ---~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
..+. ...++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 256 ~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 256 FSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred cccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 1111 1125678999999999999999999999999999963
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=216.65 Aligned_cols=160 Identities=18% Similarity=0.293 Sum_probs=121.8
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccccc-
Confidence 688866 9999987543 3567899999999999999999999999987765 999999998743322
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.....+++.|+|||++.+..++ .++||||||+++|+|++ |+.||........... +. .....+.+..+++.+
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VE-KGYKMDAPDGCPPAV 243 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HT-TTCCCCCCTTCCHHH
T ss_pred -ccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----Hh-cCCCCCCcccCCHHH
Confidence 2334578899999999876664 55999999999999998 9999987654332221 11 222334445789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.++|.+||..||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=221.44 Aligned_cols=163 Identities=20% Similarity=0.323 Sum_probs=123.1
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 125 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC---------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchhhccccc
Confidence 688866 9999987642 3677899999999999999999999999987765 99999999875433221
Q ss_pred ----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.....++..|+|||++.+..++ .++|||||||++|+|++ |+.||........ ...+. .....+.+..++
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~----~~~~~-~~~~~~~~~~~~ 276 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEV----MKAIN-DGFRLPTPMDCP 276 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHH-TTCCCCCCTTCB
T ss_pred cccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHH----HHHHH-CCCcCCCcccCC
Confidence 1122457789999999877765 55999999999999999 9999977654322 22222 223344555789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
..+.+||.+||..||.+||++.+++++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=217.59 Aligned_cols=162 Identities=19% Similarity=0.261 Sum_probs=125.4
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENY 173 (291)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSE
T ss_pred EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcceeeccCCCc
Confidence 67776 48999987653 3677899999999999999999999999987765 99999999875433221
Q ss_pred ---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.....+++.|+|||++.+..++ .++||||||+++|+|++ |+.||........ .. .+.. ....+.+..++.
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~---~~~~-~~~~~~~~~~~~ 247 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TA---MLEK-GERMGCPAGCPR 247 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HH---HHHT-TCCCCCCTTCCH
T ss_pred ccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HH---HHHc-CCCCCCCCCCCH
Confidence 1223466889999999876664 56999999999999999 9999987654322 22 2221 222333457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.++|.+||..||.+|||+.++++
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=216.42 Aligned_cols=163 Identities=21% Similarity=0.293 Sum_probs=124.7
Q ss_pred Cccc-ccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC--
Q 024572 1 MQLG-VSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-- 67 (265)
Q Consensus 1 me~~-~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-- 67 (265)
||++ +++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREY 179 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCcc
Confidence 4555 569999887522 3567899999999999999999999999987765 999999998744321
Q ss_pred ---CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 68 ---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 68 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.......+++.|+|||.+.+..++ .++|||||||++|+|++|..|+............+. .....+.+..++
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 254 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----QGRRLPQPEYCP 254 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----TTCCCCCCTTCC
T ss_pred cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----cCCCCCCCccch
Confidence 222334578899999999887765 559999999999999996666554444433333222 222334455689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
..+.+||.+||..||.+|||+.++++
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=223.51 Aligned_cols=155 Identities=30% Similarity=0.517 Sum_probs=113.4
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+|||++... .+.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 788865 9999998754 367789999999999999999999999998732 2359999999886322
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQ 145 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 145 (265)
+..+ +.++|||||||++|+|++|+.||...............+.......+ .+..+++
T Consensus 172 -------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (299)
T 3m2w_A 172 -------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231 (299)
T ss_dssp -------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCH
T ss_pred -------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCH
Confidence 1223 35699999999999999999999765432111000001111111111 1145789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
.+.+||.+||..||.+|||+.++++||||++.
T Consensus 232 ~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 99999999999999999999999999999753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=217.39 Aligned_cols=162 Identities=20% Similarity=0.263 Sum_probs=123.5
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEY 183 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCCCSCGGG
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccccccccch
Confidence 678876 9999986533 3567899999999999999999999999987765 9999999997543221
Q ss_pred ----CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 69 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 69 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
......+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||............ .. ......+..+
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~ 257 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQ-GRRLLQPEYC 257 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----HT-TCCCCCCTTC
T ss_pred hccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hc-CCCCCCCccC
Confidence 22234577889999999877765 56999999999999999 56666655443332222 11 1222334468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+..+.++|.+||..||.+|||+.++++
T Consensus 258 ~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 258 PDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=219.23 Aligned_cols=164 Identities=18% Similarity=0.191 Sum_probs=122.2
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC---
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--- 66 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~--- 66 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+||+++ ++ .+||+|||+++....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~--~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG--KVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC-------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC--CEEEeecCCccccccccc
Confidence 78886 48998887543 367789999999999999999999999997 33 499999999764321
Q ss_pred ---CCCCCCCcCCCCCcccccccCC--------cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc
Q 024572 67 ---HSRPKSTVGTPAYIAPEVLSRR--------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 135 (265)
Q Consensus 67 ---~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 135 (265)
........|++.|+|||++.+. ...+.++|||||||++|+|++|+.||......... ..+.....
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~ 260 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII----WQMGTGMK 260 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH----HHHHTTCC
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHhccCCC
Confidence 1122334588999999998752 22356699999999999999999999876543222 22222222
Q ss_pred cCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 136 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 136 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.......++..+.++|.+||..||.+|||+.++++.
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 222233578899999999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=229.37 Aligned_cols=169 Identities=19% Similarity=0.158 Sum_probs=122.3
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++....
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTE 191 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeeccccccccc
Confidence 677754 887776432 34677899999999999999999999999987765 99999999875332
Q ss_pred CC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHH-HHhhhccc----
Q 024572 67 HS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN--FRKTIS-RIMAVQYK---- 136 (265)
Q Consensus 67 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~--~~~~~~-~~~~~~~~---- 136 (265)
.. ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||........ ...... ........
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 21 12234589999999999877765 559999999999999999999976543221 111111 11111100
Q ss_pred ----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 024572 137 ----IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 172 (265)
Q Consensus 137 ----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~ 172 (265)
......++..+.+++.+||..||.+|||+.+++++.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 001112456788999999999999999999999763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=221.26 Aligned_cols=167 Identities=22% Similarity=0.277 Sum_probs=127.8
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC---
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~--- 68 (265)
||++.+ +|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~ 191 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYY 191 (318)
T ss_dssp ECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCTTCSEE
T ss_pred EecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCcccccccccccccc
Confidence 688865 9999876543 4778899999999999999999999999988765 9999999997554332
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCCh----------HHHHHHHHHHhhhcccC
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP----------KNFRKTISRIMAVQYKI 137 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~----------~~~~~~~~~~~~~~~~~ 137 (265)
......++..|+|||++.+..++ .++|||||||++|+|++|+.||...... ......+..........
T Consensus 192 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL 270 (318)
T ss_dssp EC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCC
T ss_pred ccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCC
Confidence 12334578889999999887765 5699999999999999999998653211 11111122222333344
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 138 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 138 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 271 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 271 PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 555678999999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=231.16 Aligned_cols=162 Identities=19% Similarity=0.287 Sum_probs=124.1
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNE 334 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCc
Confidence 788865 999998643 23667899999999999999999999999987765 9999999997543221
Q ss_pred C--CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 R--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
. .....++..|+|||++.+..++ .++|||||||++|+|++ |+.||.+....... ..+ ......+.+..+++
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~----~~i-~~~~~~~~~~~~~~ 408 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVL----DQV-ERGYRMPCPPECPE 408 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHH-HTTCCCCCCTTSCH
T ss_pred eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-HcCCCCCCCCCCCH
Confidence 1 1223467889999999877765 56999999999999999 99999876543322 222 22334555567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+||.+||..||.+|||+.++++
T Consensus 409 ~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 409 SLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=216.00 Aligned_cols=162 Identities=20% Similarity=0.308 Sum_probs=126.1
Q ss_pred Ccccc-cchHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNE 163 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSC
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCcc
Confidence 67774 5999887643 23678899999999999999999999999987765 9999999987544322
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
......++..|+|||++.+..++ .++||||||+++|+|++ |+.||.+....... ..+. .......+..++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI----QNLE-RGYRMVRPDNCPE 237 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHH-TTCCCCCCTTCCH
T ss_pred cccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHH----HHHh-cccCCCCcccccH
Confidence 12233567889999999876664 55999999999999999 99999876543322 2222 1223334457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+||.+||..||.+|||+.++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=218.76 Aligned_cols=166 Identities=23% Similarity=0.346 Sum_probs=118.3
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS 188 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC--------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeecC
Confidence 678876 899888642 24678899999999999999999999999987765 99999999875433
Q ss_pred CC-CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 67 HS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 67 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.. ......+++.|+|||++.+..++ .++||||||+++|+|++|+.||.+.... .......+............++.
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTSCH
T ss_pred CCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCcccccCH
Confidence 22 22334689999999999887664 5599999999999999999999765432 12223333333333223346899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+.+||.+||..||.+|||+.+++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=216.96 Aligned_cols=162 Identities=20% Similarity=0.309 Sum_probs=127.5
Q ss_pred Ccccc-cchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDT 165 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCc
Confidence 67887 59999987532 2567899999999999999999999999987765 9999999987544322
Q ss_pred C--CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 R--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
. .....+++.|+|||++.+..++ .++||||||+++|+|++ |..||......... ..+ ......+.+..+++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-~~~----~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELL----EKDYRMERPEGCPE 239 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHH----HTTCCCCCCTTCCH
T ss_pred cccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHH----hccCCCCCCCCCCH
Confidence 1 1223467889999999877764 56999999999999999 99999876543322 222 22233444557899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+||.+||..||.+|||+.++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999999999999976
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=214.42 Aligned_cols=163 Identities=20% Similarity=0.333 Sum_probs=126.8
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC--
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-- 67 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-- 67 (265)
||++. ++|.+++..+. ++.+++.++.|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEcccccccccccccc
Confidence 68885 49999987643 3567899999999999999999999999987765 999999998754321
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.......++..|+|||++.+..++ .++||||||+++|+|++ |+.||......... ..+.. ......+..++..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~i~~-~~~~~~~~~~~~~ 233 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----EDIST-GFRLYKPRLASTH 233 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHT-TCCCCCCTTSCHH
T ss_pred cccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHH----HHHhc-CCcCCCCccCcHH
Confidence 112234567889999999876664 56999999999999999 89999876543222 22222 2223334467899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.++|.+||..||.+|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 234 VYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=222.69 Aligned_cols=169 Identities=21% Similarity=0.235 Sum_probs=124.6
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhh--------hcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSL--------SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH--------~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||++.+ +|.+++.... ++.+++.++.||| ++||+||||||+|||++.++. +||+|||+++.
T Consensus 119 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~ 196 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 196 (342)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred EeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCcee
Confidence 688876 9999987543 3677899999999 999999999999999988775 99999999865
Q ss_pred CCCCC-----CCCCCcCCCCCcccccccCCcCC-----CchHhHHHHHHHHHHHHhC----------CCCCCCCCChH-H
Q 024572 64 SLLHS-----RPKSTVGTPAYIAPEVLSRREYD-----GKLADVWSCGVTLYVMLVG----------AYPFEDQEDPK-N 122 (265)
Q Consensus 64 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-----~~~~DiwslG~~l~~ll~g----------~~pf~~~~~~~-~ 122 (265)
..... ......+|+.|+|||++.+.... +.++|||||||++|+|++| ..||....... .
T Consensus 197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 276 (342)
T 1b6c_B 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276 (342)
T ss_dssp EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence 43332 23445799999999999765322 1469999999999999999 78887653221 1
Q ss_pred HHHHHHHHhhhcccCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 123 FRKTISRIMAVQYKIPDY-----VHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.......+.........+ ..++..+.+||.+||..||.+|||+.++++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 122222222222211111 1234578999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=232.97 Aligned_cols=162 Identities=19% Similarity=0.306 Sum_probs=128.4
Q ss_pred Ccccc-cchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++. ++|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDT 372 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCc
Confidence 78887 49999987532 2567899999999999999999999999987765 9999999997543322
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
......++..|+|||++.+..++ .++|||||||++|+|++ |..||.+....... .. .......+.+..++.
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~~----~~~~~~~~~~~~~~~ 446 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-EL----LEKDYRMERPEGCPE 446 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HH----HHTTCCCCCCTTCCH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HH----HHcCCCCCCCCCCCH
Confidence 11223466789999999877765 55999999999999999 99999876544322 22 222344455567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+||.+||..||.+|||+.++++
T Consensus 447 ~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 447 KVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999999999999999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=218.94 Aligned_cols=167 Identities=23% Similarity=0.280 Sum_probs=123.4
Q ss_pred Cccc-ccchHHHHHHh------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLG-VSSLSEFVMLE------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~-~~sL~~~~~~~------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||++ +++|.+++... .++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKF 186 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSC
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccccc
Confidence 6777 45898888632 23677899999999999999999999999987765 999999998754332
Q ss_pred CC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--------c
Q 024572 68 SR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------K 136 (265)
Q Consensus 68 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~ 136 (265)
.. .....|++.|+|||++.+. + +.++|||||||++|+|++|..||...........+...+..... .
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred cccccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence 21 2334689999999998763 4 45699999999999999999999876543332222222211110 0
Q ss_pred C-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 137 I-PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 137 ~-~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
. ......+..+.++|.+||..||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 265 MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 1112245678999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-30 Score=235.68 Aligned_cols=162 Identities=22% Similarity=0.287 Sum_probs=124.7
Q ss_pred Cccccc-chHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+ .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGADDS 491 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC----
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCCCc
Confidence 688866 899988533 23677899999999999999999999999987765 99999999975433221
Q ss_pred C----CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
. ....+++.|+|||++.+..++ .++|||||||++|+|++ |+.||.+........ .+. .....+.+..++
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----~i~-~~~~~~~p~~~~ 565 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIE-QGKRMECPPECP 565 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH----HHH-TTCCCCCCTTCC
T ss_pred eeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCcCC
Confidence 1 122356789999999877765 55999999999999998 999998876644322 222 223344455789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.+.+||.+||..||.+||++.++++
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=237.70 Aligned_cols=162 Identities=19% Similarity=0.252 Sum_probs=125.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENY 525 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC----
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccc
Confidence 788865 8999987643 3678899999999999999999999999998775 99999999975433221
Q ss_pred ---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.....+++.|+|||++.+..++ .++|||||||++|+|++ |+.||.+....... ..+. .....+.+..++.
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~----~~i~-~~~~~~~p~~~~~ 599 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----AMLE-KGERMGCPAGCPR 599 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHH-TTCCCCCCTTCCH
T ss_pred cccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHH-cCCCCCCCCCCCH
Confidence 1223467889999999887765 55999999999999998 99999876543322 2222 2233444557899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+||.+||..||.+|||+.++++
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-30 Score=217.90 Aligned_cols=167 Identities=18% Similarity=0.242 Sum_probs=126.7
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+||+++.++. +||+|||+++.......
T Consensus 123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~~~~ 200 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKE 200 (326)
T ss_dssp ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCSSCS
T ss_pred EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhcccccc
Confidence 688855 9999987653 2667899999999999999999999999987765 99999999875443321
Q ss_pred ----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHhhhc
Q 024572 70 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-----------PKNFRKTISRIMAVQ 134 (265)
Q Consensus 70 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~~~~~~ 134 (265)
.....++..|+|||++.+..++ .++|||||||++|+|++|..||..... .......+.......
T Consensus 201 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 201 YYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp EEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred ccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 2233567789999999877664 569999999999999999998864210 011111112222223
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 135 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 135 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
...+.+..++..+.+||.+||..||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 334455678999999999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=217.01 Aligned_cols=163 Identities=23% Similarity=0.297 Sum_probs=116.5
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
||++.+ +|.+++.... ++.+++.++.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC----------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCccccccccc
Confidence 678865 9999987654 3677899999999999999999999999987765 9999999987543322
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-cCCCCCCCCHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHISQDC 147 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 147 (265)
......+++.|+|||++.+..++. ++||||||+++|+|++|+.||...... ..... +..... .......++..+
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATY-RADIYALTCVLYECLTGSPPYQGDQLS-VMGAH---INQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ------CCGGGCCGGGTCC----C-CCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHH---HHSCCCCGGGTSTTCCTHH
T ss_pred cccccCCCcCccCHHHHcCCCCCc-hHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHH---hccCCCCccccCCCCCHHH
Confidence 223456899999999998876654 499999999999999999999875322 11111 111111 111234688999
Q ss_pred HHHHHHhcccCCCCCC-CHHHHhc
Q 024572 148 RNLLSRIFVANPSRRI-TIKEIKS 170 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~-s~~ell~ 170 (265)
.++|.+||..||.+|| ++.++++
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999 8888775
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-31 Score=231.20 Aligned_cols=169 Identities=22% Similarity=0.337 Sum_probs=124.6
Q ss_pred Ccccc-cchHHHHHHhc------------cccchHHHHHhhhhcCceecCCCcCcEEE----cCCCCCcEEEeccCCccc
Q 024572 1 MQLGV-SSLSEFVMLEG------------SVKMKPDIFFSSLSQQICHRDLKLENTLL----DGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll----~~~~~~~vkl~Dfg~a~~ 63 (265)
||++. ++|.+++.... ++.+++.+|.|||++||+||||||+|||+ +.++ .+||+|||+++.
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~DFG~a~~ 165 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARE 165 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE--EEEECCGGGCEE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce--eEEEecCCCceE
Confidence 78885 48988876533 36788999999999999999999999998 4443 499999999986
Q ss_pred CCCCCCCCCCcCCCCCcccccccCC-------cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-
Q 024572 64 SLLHSRPKSTVGTPAYIAPEVLSRR-------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY- 135 (265)
Q Consensus 64 ~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~- 135 (265)
...........||+.|+|||++.+. ...+.++|||||||++|+|++|+.||............+..+.....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 5554444556799999999998652 22245699999999999999999999765433332333333332211
Q ss_pred ------------------cCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 136 ------------------KIPDYV----HISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 136 ------------------~~~~~~----~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
..+... .++..+.++|.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 111111 234578899999999999999999998653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-31 Score=221.98 Aligned_cols=165 Identities=23% Similarity=0.258 Sum_probs=123.4
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 66 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~ 66 (265)
||++.+ +|.+++... .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACI 186 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCE
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhccc
Confidence 677776 999888762 13678899999999999999999999999987765 99999998864322
Q ss_pred CCCC----------CCCcCCCCCcccccccCCcC--CCchHhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhhh
Q 024572 67 HSRP----------KSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAV 133 (265)
Q Consensus 67 ~~~~----------~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~ 133 (265)
.... ....|++.|+|||++.+... .+.++|||||||++|+|++|+.||...... ..... ....
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~ 262 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----AVQN 262 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----HHHC
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----Hhhc
Confidence 1110 12246899999999876432 245699999999999999999999531100 01111 1112
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 134 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
....+....++..+.+||.+||..||.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 33445555789999999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-31 Score=222.65 Aligned_cols=170 Identities=19% Similarity=0.170 Sum_probs=123.4
Q ss_pred Cccccc-chHHHHHHhc-------------cccchHHHHHhhhhc---CceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVMLEG-------------SVKMKPDIFFSSLSQ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------~~~~i~~~l~~lH~~---~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++ ||+||||||+|||++.++. +||+|||+++.
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~ 183 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKL 183 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccc
Confidence 677765 9999887543 367788999999999 9999999999999988765 99999999975
Q ss_pred CCCCCC--CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCC----CChHHHHHHHHHHhhhcc--
Q 024572 64 SLLHSR--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ----EDPKNFRKTISRIMAVQY-- 135 (265)
Q Consensus 64 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~----~~~~~~~~~~~~~~~~~~-- 135 (265)
...... .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||... .........+........
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred cCcccccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 432222 2334589999999999877764 5699999999999999999999521 111111111111111000
Q ss_pred -------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 024572 136 -------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173 (265)
Q Consensus 136 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~ 173 (265)
........+..+.+++.+||..||.+|||+.++++|..
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00001112367899999999999999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=223.60 Aligned_cols=157 Identities=17% Similarity=0.161 Sum_probs=118.7
Q ss_pred Ccccc-cchHHHHHHh--------------ccccchHHHHHhhhhcCceecCCCcCcEEEcC-----------CCCCcEE
Q 024572 1 MQLGV-SSLSEFVMLE--------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDG-----------SPAPRLK 54 (265)
Q Consensus 1 me~~~-~sL~~~~~~~--------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-----------~~~~~vk 54 (265)
||++. ++|.+++... .++.+++.+|.|||++|||||||||+|||++. ++ .+|
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~--~~k 223 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA--GLA 223 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT--TEE
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC--CEE
Confidence 78886 4999999742 24678899999999999999999999999976 44 499
Q ss_pred EeccCCcccCC---CCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHh
Q 024572 55 ICDFGYSKSSL---LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM 131 (265)
Q Consensus 55 l~Dfg~a~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 131 (265)
|+|||+|+... ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........
T Consensus 224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~--------- 293 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGEC--------- 293 (365)
T ss_dssp ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTEE---------
T ss_pred EeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCce---------
Confidence 99999996432 22233455799999999999988765 559999999999999999999965432110
Q ss_pred hhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 132 AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
......+. ...++.+.+++.+||..+|.+|++..+.+.
T Consensus 294 ~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 294 KPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp EECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred eechhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 00011111 124677899999999999999976544444
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=231.71 Aligned_cols=163 Identities=19% Similarity=0.288 Sum_probs=128.0
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+ .++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNE 417 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCc
Confidence 788865 999998643 23667899999999999999999999999987765 9999999997543211
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
......++..|+|||++.+..++ .++|||||||++|+|++ |+.||.+....... ..+ ......+.+..++.
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~----~~i-~~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVL----DQV-ERGYRMPCPPECPE 491 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH----HHH-HTTCCCCCCTTCCH
T ss_pred eecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-HcCCCCCCCCCCCH
Confidence 12233467889999999877764 56999999999999999 99999876543322 222 22334455567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+.+||.+||..||.+|||+.+|++.
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=234.08 Aligned_cols=163 Identities=23% Similarity=0.382 Sum_probs=125.9
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.+|.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC---
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCCcc
Confidence 788874 9999988653 2567899999999999999999999999987765 99999999975533322
Q ss_pred C--CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 P--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
. ....+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+........ .+.. ....+.+..+++.
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~----~i~~-~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG----RIEN-GERLPMPPNCPPT 620 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHH-TCCCCCCTTCCHH
T ss_pred eeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHc-CCCCCCCccccHH
Confidence 1 223467889999999877664 56999999999999997 999998765433222 2222 2233444578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.+||.+||..||.+|||+.++++.
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=216.51 Aligned_cols=148 Identities=12% Similarity=0.125 Sum_probs=109.0
Q ss_pred HhccccchHHHHHhhh-hcCceecCCCcCcEEEcCCCC------------------CcEEEeccCCcccCCCCCCCCCCc
Q 024572 14 LEGSVKMKPDIFFSSL-SQQICHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSLLHSRPKSTV 74 (265)
Q Consensus 14 ~~~~~~~i~~~l~~lH-~~~ivH~dlkp~NIll~~~~~------------------~~vkl~Dfg~a~~~~~~~~~~~~~ 74 (265)
.+.++.|++.+|.||| ++||+||||||+|||++.++. ..+||+|||+|+.... ...+
T Consensus 163 ~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~ 238 (336)
T 2vuw_A 163 AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVV 238 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEE
T ss_pred HHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEE
Confidence 3445888999999999 999999999999999987651 1599999999975432 2457
Q ss_pred CCCCCcccccccCCcCCCchHhHHHHHHH-HHHHHhCCCCCCCCCChHHHHHHHHHHhh-hcccCCC----CCCCCHHHH
Q 024572 75 GTPAYIAPEVLSRREYDGKLADVWSCGVT-LYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPD----YVHISQDCR 148 (265)
Q Consensus 75 ~~~~y~aPE~~~~~~~~~~~~DiwslG~~-l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~ 148 (265)
||+.|+|||++.+.. +.++||||+|++ .+++++|..||..... .......+.. ....... +..++++++
T Consensus 239 gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp CCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred EeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhh---hhHHHHhhhhhhccCcccchhhhhhcCHHHH
Confidence 999999999998765 567999998776 7778889999843110 0111112111 1111111 124678899
Q ss_pred HHHHHhcccCCCCCCCHHHHh-cCcccC
Q 024572 149 NLLSRIFVANPSRRITIKEIK-SHPWFL 175 (265)
Q Consensus 149 ~li~~~L~~dP~~R~s~~ell-~h~~f~ 175 (265)
+||.+||.+| |+.++| +||||+
T Consensus 314 dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHHHHhccC-----CHHHHHhcCCCcC
Confidence 9999999976 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-28 Score=227.26 Aligned_cols=154 Identities=21% Similarity=0.156 Sum_probs=117.4
Q ss_pred Cccccc-chHHHHH-------HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVS-SLSEFVM-------LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~-sL~~~~~-------~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
||++.+ +|.+++. ...++.+++.+|.|||++|||||||||+|||++.+ .+||+|||+++..... ..
T Consensus 163 ~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~---~~ 236 (681)
T 2pzi_A 163 MEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF---GY 236 (681)
T ss_dssp EECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC---SC
T ss_pred EEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC---Cc
Confidence 677765 7877653 23357889999999999999999999999999864 4999999999754332 45
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHH
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 152 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 152 (265)
..||+.|+|||++.+.. +.++|||||||++|+|++|..||.+...... .........++.+.+||.
T Consensus 237 ~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~ 302 (681)
T 2pzi_A 237 LYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------PEDDPVLKTYDSYGRLLR 302 (681)
T ss_dssp CCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------CTTCHHHHHCHHHHHHHH
T ss_pred cCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc------------cccccccccCHHHHHHHh
Confidence 67999999999987643 5669999999999999999988865321100 000000123578999999
Q ss_pred HhcccCCCCCCCHHHHhcCccc
Q 024572 153 RIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 153 ~~L~~dP~~R~s~~ell~h~~f 174 (265)
+||..||.+||+..+.+.|+|+
T Consensus 303 ~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 303 RAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHH
T ss_pred hhccCChhhCCCHHHHHHHHHH
Confidence 9999999999999999998886
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-26 Score=190.36 Aligned_cols=140 Identities=11% Similarity=0.028 Sum_probs=102.7
Q ss_pred Cccccc-chHHHHHHhc-------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
||++.+ +|.+++.... ++.+++.+|.|||++||+||||||+|||++.++. +||+++|.
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~~------------ 175 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPAT------------ 175 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCCC------------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEeccc------------
Confidence 788864 9999874322 4678899999999999999999999999998776 89885542
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccC--CCCCCCCHHHHHH
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNL 150 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 150 (265)
++| .+.++|||||||++|+|++|+.||.+......+...... ....... .....+++.+.+|
T Consensus 176 -------~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l 239 (286)
T 3uqc_A 176 -------MPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-TAGQPIEPADIDRDIPFQISAV 239 (286)
T ss_dssp -------CTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-TTSCBCCHHHHCTTSCHHHHHH
T ss_pred -------cCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-hccCCCChhhcccCCCHHHHHH
Confidence 222 246699999999999999999999876542211000000 0000000 0123588999999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 024572 151 LSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h 171 (265)
|.+||..||.+| |+.++++.
T Consensus 240 i~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 240 AARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHcccCCccC-CHHHHHHH
Confidence 999999999999 99999863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-24 Score=197.85 Aligned_cols=106 Identities=15% Similarity=0.099 Sum_probs=74.7
Q ss_pred Cccccc-chHHHHHHhc------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-CCCC
Q 024572 1 MQLGVS-SLSEFVMLEG------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS 72 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~~~~ 72 (265)
|||+.+ +|.+.+...+ ++.||+.+|.|+|++|||||||||+|||++.++. +||+|||+|+...... ...+
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~~~t 398 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSWPTN 398 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CCSHH
T ss_pred EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCccccC
Confidence 899988 9999998766 4788999999999999999999999999988776 9999999998654332 2344
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhC
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG 110 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g 110 (265)
.+||+.|+|||++.+.. ..++|+||+|++++.+.++
T Consensus 399 ~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 399 LVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp HHHHHHHHHHHHC-------------------CCCCTT
T ss_pred ceechhhccHHHhCCCC--CCcccccccccchhhhccc
Confidence 57999999999998753 2348999999998877554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-18 Score=157.19 Aligned_cols=110 Identities=21% Similarity=0.197 Sum_probs=88.5
Q ss_pred Ccccc-cchHHHHHH-hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC--------C
Q 024572 1 MQLGV-SSLSEFVML-EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--------P 70 (265)
Q Consensus 1 me~~~-~sL~~~~~~-~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~--------~ 70 (265)
||++. ++|.+++.. ..++.+++.++.|||++||+||||||+|||++. .+||+|||+++....... .
T Consensus 418 mE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~~~~~~~~~ 493 (540)
T 3en9_A 418 MSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDKAVDLIVFK 493 (540)
T ss_dssp EECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHHHHHHHHHH
T ss_pred EECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCccccccchhhhh
Confidence 78996 699999875 345788999999999999999999999999987 499999999986543211 1
Q ss_pred CCCcCCCCCcccccccC--CcCCCchHhHHHHHHHHHHHHhCCCCCC
Q 024572 71 KSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFE 115 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~ 115 (265)
....||+.|+|||++.. ..|. ..+|+|+..+-..+.+.++.+|.
T Consensus 494 ~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 494 KAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 24569999999999976 4453 34799999999888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=2.1e-14 Score=119.56 Aligned_cols=70 Identities=24% Similarity=0.171 Sum_probs=56.3
Q ss_pred Cccccc-chHHHHH---HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCC
Q 024572 1 MQLGVS-SLSEFVM---LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT 76 (265)
Q Consensus 1 me~~~~-sL~~~~~---~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 76 (265)
||++.+ +|.+ +. ...++.+++.++.|||++||+||||||+|||++ ++ .+||+|||+|+. +
T Consensus 179 mE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DFG~a~~------------~ 242 (282)
T 1zar_A 179 MELIDAKELYR-VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDFPQSVE------------V 242 (282)
T ss_dssp EECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCCTTCEE------------T
T ss_pred EEecCCCcHHH-cchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEECCCCeE------------C
Confidence 788865 8888 32 123577889999999999999999999999999 55 499999998862 3
Q ss_pred CCCccccccc
Q 024572 77 PAYIAPEVLS 86 (265)
Q Consensus 77 ~~y~aPE~~~ 86 (265)
..++|||.+.
T Consensus 243 ~~~~a~e~l~ 252 (282)
T 1zar_A 243 GEEGWREILE 252 (282)
T ss_dssp TSTTHHHHHH
T ss_pred CCCCHHHHHH
Confidence 4568898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=4e-12 Score=104.31 Aligned_cols=59 Identities=19% Similarity=0.170 Sum_probs=48.8
Q ss_pred Cccccc------chHHHHHH------hccccchHHHHHhhh-hcCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS------SLSEFVML------EGSVKMKPDIFFSSL-SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~------sL~~~~~~------~~~~~~i~~~l~~lH-~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
||+++. +|.++... ..++.+++.++.||| ++||+||||||.|||++. .++|+|||+|..
T Consensus 147 mE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~----~~~liDFG~a~~ 218 (258)
T 1zth_A 147 MEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID----KVYFIDMGQAVT 218 (258)
T ss_dssp EECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS----SEEECCCTTCEE
T ss_pred EEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC----cEEEEECccccc
Confidence 788853 77776543 345778899999999 999999999999999986 399999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.78 E-value=1.2e-09 Score=94.12 Aligned_cols=62 Identities=13% Similarity=0.058 Sum_probs=47.1
Q ss_pred Cccccc-chHHHHH---HhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCC--------cEEEeccCCcc
Q 024572 1 MQLGVS-SLSEFVM---LEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAP--------RLKICDFGYSK 62 (265)
Q Consensus 1 me~~~~-sL~~~~~---~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~--------~vkl~Dfg~a~ 62 (265)
|||+++ +|.++.. ...+..+++.++.+||++|||||||||.|||++.++.+ .+.|+||+-+.
T Consensus 190 ME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 190 MSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred EEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 778776 5554432 12346788999999999999999999999999766532 27899998654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.71 E-value=5.5e-06 Score=69.03 Aligned_cols=81 Identities=20% Similarity=0.198 Sum_probs=47.5
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcCCCCCccc----------------ccccCCcCCCch
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP----------------EVLSRREYDGKL 94 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aP----------------E~~~~~~~~~~~ 94 (265)
..++|+|++|.||+++.+....+.|+||+.+.................-..| +...... ..
T Consensus 191 ~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~---~~ 267 (304)
T 3sg8_A 191 PCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYR---MK 267 (304)
T ss_dssp CEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHH---HH
T ss_pred ceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHH---HH
Confidence 4689999999999998741223789999987532211000000000000122 2221111 11
Q ss_pred HhHHHHHHHHHHHHhCCCCC
Q 024572 95 ADVWSCGVTLYVMLVGAYPF 114 (265)
Q Consensus 95 ~DiwslG~~l~~ll~g~~pf 114 (265)
.+.|++|.++|.+.+|..+|
T Consensus 268 ~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 268 EKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHcCCHHH
Confidence 58999999999999997765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=8.8e-06 Score=66.11 Aligned_cols=30 Identities=23% Similarity=0.264 Sum_probs=24.0
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++|+|++|.||+++.... +.|+||+.+.
T Consensus 183 ~~l~HgDl~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T 3tm0_A 183 LVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp EEEECSSCCTTSEEEETTEE--EEECCCTTCE
T ss_pred ceEECCCCCcCcEEEECCcE--EEEEEchhcc
Confidence 56999999999999975432 5699998653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.64 E-value=8.8e-06 Score=65.73 Aligned_cols=29 Identities=21% Similarity=0.239 Sum_probs=23.7
Q ss_pred CceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 32 ~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+++|+|++|.||+++.+.. +.|+||+.+.
T Consensus 185 ~l~HgDl~~~Nil~~~~~~--~~liD~~~a~ 213 (264)
T 1nd4_A 185 VVTHGDACLPNIMVENGRF--SGFIDCGRLG 213 (264)
T ss_dssp EEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred EEECCCCCCCcEEEECCcE--EEEEcchhcc
Confidence 3999999999999976532 5699999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.45 E-value=5.3e-05 Score=64.54 Aligned_cols=32 Identities=25% Similarity=0.447 Sum_probs=26.2
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
.+++|||++|.||+++.++...+.|+||+.+.
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 57999999999999986643235899999875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.05 E-value=0.0038 Score=52.20 Aligned_cols=31 Identities=29% Similarity=0.486 Sum_probs=25.9
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..+++|+|+++.||+++.++. +.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~--~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQ--IWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGC--EEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCc--EEEEehhhcc
Confidence 478999999999999975544 8999998653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.88 E-value=0.15 Score=39.91 Aligned_cols=125 Identities=14% Similarity=0.067 Sum_probs=69.1
Q ss_pred chHHHHHHhcc----------ccchHHHHHhh-hhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCCcC
Q 024572 7 SLSEFVMLEGS----------VKMKPDIFFSS-LSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG 75 (265)
Q Consensus 7 sL~~~~~~~~~----------~~~i~~~l~~l-H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 75 (265)
||.+.+..++. +.|....|.-+ ..+.-..+=+.|..|++..+|. |.+.+ +.+ ...
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s-----------~~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AAD-----------DAG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-ccc-----------ccc
Confidence 67777776653 33333333322 1112123445578999988876 65543 111 012
Q ss_pred CCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhc
Q 024572 76 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 155 (265)
Q Consensus 76 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 155 (265)
...+.|||... ...+.+.-|||||+++|..+--..|- .....+|+.+..||..|.
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------------~eE~eLS~~LE~LL~~Mt 154 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------------NEERELSPPLEQLIDHMA 154 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------TEEECCCHHHHHHHHHHT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------ccchhhCHHHHHHHHHHH
Confidence 33567888764 22234578999999999988533221 111257889999998887
Q ss_pred cc-------------------------CCCCCCCHHHHhc
Q 024572 156 VA-------------------------NPSRRITIKEIKS 170 (265)
Q Consensus 156 ~~-------------------------dP~~R~s~~ell~ 170 (265)
.- .+..|.++.+|++
T Consensus 155 ~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 155 NTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp TCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred hcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 55 2467788888875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.0099 Score=51.56 Aligned_cols=31 Identities=19% Similarity=0.292 Sum_probs=27.1
Q ss_pred hhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 29 LSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+...++|||++|.||+++.++ ++|+||+.+.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~ 260 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSF 260 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCE
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCcccc
Confidence 578899999999999997653 8999999775
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.26 E-value=0.014 Score=48.42 Aligned_cols=31 Identities=23% Similarity=0.344 Sum_probs=24.8
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..+++|+|+++.||+++.+.. +.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 357999999999999986532 4799998653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=93.96 E-value=0.024 Score=45.71 Aligned_cols=29 Identities=24% Similarity=0.420 Sum_probs=23.6
Q ss_pred CceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 32 QICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 32 ~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
.++|+|+.+.||+++..+. +-|+||+.+.
T Consensus 194 ~l~HGDl~~~Nil~~~~~~--~~viDwe~a~ 222 (272)
T 4gkh_A 194 VVTHGDFSLDNLIFDEGKL--IGCIDVGRVG 222 (272)
T ss_dssp EEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred EEEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence 4899999999999986542 5699998664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.57 E-value=0.027 Score=46.96 Aligned_cols=34 Identities=26% Similarity=0.308 Sum_probs=26.8
Q ss_pred hhcCceecCCCcCcEEEcCCC--CCcEEEeccCCcc
Q 024572 29 LSQQICHRDLKLENTLLDGSP--APRLKICDFGYSK 62 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~~~--~~~vkl~Dfg~a~ 62 (265)
+...++|||+.+.||+++.+. ...+.|+||+.+.
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 356899999999999997631 1248999999775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=93.38 E-value=0.033 Score=46.06 Aligned_cols=33 Identities=24% Similarity=0.338 Sum_probs=25.7
Q ss_pred hhcCceecCCCcCcEEEcC---CCCCcEEEeccCCcc
Q 024572 29 LSQQICHRDLKLENTLLDG---SPAPRLKICDFGYSK 62 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~---~~~~~vkl~Dfg~a~ 62 (265)
....++|+|++|.||+++. ++. .+.|+||+.+.
T Consensus 188 ~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~ 223 (306)
T 3tdw_A 188 YTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAA 223 (306)
T ss_dssp CCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCE
T ss_pred CCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcC
Confidence 4457899999999999986 222 24799999775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=93.20 E-value=0.024 Score=47.82 Aligned_cols=31 Identities=13% Similarity=0.193 Sum_probs=25.0
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
...++|+|++|.||++++.. .+.|+||+.+.
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~--~~~vIDwe~a~ 251 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQ--PVAVLDWEMVA 251 (357)
T ss_dssp CCEEECSSCSGGGEEEETTE--EEEECCGGGCE
T ss_pred CceEEeCCCCCCeEEEeCCc--EEEEEcccccc
Confidence 46899999999999998432 26899998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=92.74 E-value=0.052 Score=46.49 Aligned_cols=31 Identities=16% Similarity=0.234 Sum_probs=25.7
Q ss_pred hhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 29 LSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
+...++|||+.|.||+++.++ ++|+||..+.
T Consensus 225 ~~~~L~HGDl~~~Nil~~~~~---~~lID~e~a~ 255 (397)
T 2olc_A 225 SAETLIHGDLHTGSIFASEHE---TKVIDPEFAF 255 (397)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCE
T ss_pred CCCceeeCCCCcCcEEEeCCC---eEEEeCcccc
Confidence 357899999999999997643 8999997654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.72 E-value=0.046 Score=45.35 Aligned_cols=30 Identities=17% Similarity=0.159 Sum_probs=24.9
Q ss_pred hhcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 29 LSQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 29 H~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
....++|||+++.||+++ + .+.|+||+.+.
T Consensus 193 ~~~~l~HgD~~~~Nil~~-~---~~~lIDfe~a~ 222 (328)
T 1zyl_A 193 FTVLRLHGDCHAGNILWR-D---GPMFVDLDDAR 222 (328)
T ss_dssp SCCEECCSSCSGGGEEES-S---SEEECCCTTCC
T ss_pred CCeeeeeCCCCcccEeEc-C---CCEEEECCCCC
Confidence 346789999999999998 3 38999998664
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.51 E-value=0.056 Score=45.83 Aligned_cols=29 Identities=34% Similarity=0.602 Sum_probs=24.0
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
.+++|+|+++.|||++.+. +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~---~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC---LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C---EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc---EEEEEecCCC
Confidence 5699999999999997543 8999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.42 E-value=0.078 Score=44.52 Aligned_cols=31 Identities=23% Similarity=0.456 Sum_probs=26.1
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..+++|+|+.+.||+++.++. +.|+||+.+.
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~ 235 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEES--IYIIDWDEPM 235 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGC--EEECCCSSCE
T ss_pred CceeEeCCCCcCCEEEeCCCe--EEEEECCCCe
Confidence 457999999999999986544 8999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.47 E-value=0.12 Score=45.02 Aligned_cols=19 Identities=37% Similarity=0.611 Sum_probs=15.8
Q ss_pred hcCceecCCCcCcEEEcCC
Q 024572 30 SQQICHRDLKLENTLLDGS 48 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~ 48 (265)
...++|+|+.+.|||++.+
T Consensus 248 ~~v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 248 PVTFCHNDLQEGNILLPKA 266 (429)
T ss_dssp CEEEECSCCCGGGEEEEC-
T ss_pred CeEEEeCCCCCCeEEeeCC
Confidence 3469999999999999864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=89.97 E-value=0.16 Score=41.54 Aligned_cols=29 Identities=34% Similarity=0.412 Sum_probs=23.3
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++|+|+.+.||+.+ ++. +.|+||..+.
T Consensus 173 ~~l~HgDl~~~Nil~~-~~~--~~lID~e~a~ 201 (301)
T 3dxq_A 173 LAACHCDPLCENFLDT-GER--MWIVDWEYSG 201 (301)
T ss_dssp CEEECSCCCGGGEEEC-SSC--EEECCCTTCE
T ss_pred ceeeccCCCcCCEEEC-CCC--EEEEeccccc
Confidence 4589999999999943 333 8999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=89.74 E-value=0.19 Score=44.10 Aligned_cols=16 Identities=31% Similarity=0.468 Sum_probs=14.8
Q ss_pred cCceecCCCcCcEEEc
Q 024572 31 QQICHRDLKLENTLLD 46 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~ 46 (265)
..++|+|+.+.|||++
T Consensus 290 ~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 290 IVLCHCDLLSSNIINT 305 (458)
T ss_dssp EEEECSCCCGGGEEEC
T ss_pred eeEEecCCCCCcEEee
Confidence 4699999999999997
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.52 E-value=0.21 Score=42.70 Aligned_cols=33 Identities=36% Similarity=0.570 Sum_probs=25.7
Q ss_pred hcCceecCCCcCcEEEcCC--CCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGS--PAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~--~~~~vkl~Dfg~a~ 62 (265)
...++|+|+.+.||+++.+ ..+.+.|+||..+.
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3569999999999999865 11249999998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.01 E-value=0.45 Score=40.84 Aligned_cols=31 Identities=39% Similarity=0.580 Sum_probs=23.7
Q ss_pred CceecCCCcCcEEEcC----CCCCcEEEeccCCcc
Q 024572 32 QICHRDLKLENTLLDG----SPAPRLKICDFGYSK 62 (265)
Q Consensus 32 ~ivH~dlkp~NIll~~----~~~~~vkl~Dfg~a~ 62 (265)
.++|+|+.+.|||+.. +....++++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 3679999999999943 122359999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=83.18 E-value=0.63 Score=40.33 Aligned_cols=29 Identities=28% Similarity=0.504 Sum_probs=23.8
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++|+|+.+.||+ +..+. +.|+||..|.
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~--~~~IDwe~a~ 290 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNN--IRMIDYEYSA 290 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSC--EEECCCTTCE
T ss_pred ceEECCCCCcccee-cCCCc--EEEEecccCC
Confidence 56999999999999 44443 9999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=81.44 E-value=0.62 Score=37.73 Aligned_cols=25 Identities=24% Similarity=0.129 Sum_probs=20.4
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEecc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDF 58 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Df 58 (265)
..+||+|+.+.||+++.++ ..++|-
T Consensus 188 p~LvHGDlw~gNvl~~~~g---~~~iDp 212 (288)
T 3f7w_A 188 PARIHGDLWNGNVLWQDDG---AVVIDP 212 (288)
T ss_dssp CEEECSCCSGGGEEEETTE---EEECSC
T ss_pred CeeeecCCCCCcEEEcCCC---eEEEec
Confidence 4799999999999998776 456663
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 265 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-35 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-30 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-26 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-26 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-25 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-24 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-24 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-23 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-23 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-23 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-22 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-22 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-22 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-22 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-22 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-22 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-22 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-21 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-21 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-19 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-19 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 0.001 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-43
Identities = 57/148 (38%), Positives = 84/148 (56%), Gaps = 10/148 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S+++ HRD+K EN LL + LKI DFG+S SR + GT Y+ PE++ R
Sbjct: 124 SKRVIHRDIKPENLLLGSAG--ELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
+D K D+WS GV Y LVG PFE +++T RI V++ PD +++ R+
Sbjct: 181 HDEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARD 233
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKN 177
L+SR+ NPS+R ++E+ HPW N
Sbjct: 234 LISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 9e-43
Identities = 57/154 (37%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAPEVLS 86
I HRD+K EN LLD LKI DFG + ++R + GT Y+APE+L
Sbjct: 121 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
RRE+ + DVWSCG+ L ML G P+ + P + + S + + + I
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180
LL +I V NPS RITI +IK W+ K L +
Sbjct: 236 PLALLHKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-41
Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 11/200 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDC 147
D+WS G +YV+L G PF + ++ I IM +Y + + IS +
Sbjct: 180 VSTA-TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEIT 207
+ + R+ V R+T E HPW + + R T+ + + +R+ T +++
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIK---KDLN 291
Query: 208 KIVEEAKV-PPPVSRSIGGF 226
+V A++ RS G
Sbjct: 292 MVVSAARISCGGAIRSQKGV 311
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 8e-38
Identities = 37/150 (24%), Positives = 69/150 (46%), Gaps = 7/150 (4%)
Query: 25 FFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 84
F + + I HRDLK +N + G P +KI D G + S K+ +GTP ++APE+
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEM 184
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
+YD DV++ G+ + M YP+ + ++ + R+ +
Sbjct: 185 Y-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAI 239
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ + ++ N R +IK++ +H +F
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 132 bits (334), Expect = 2e-37
Identities = 41/175 (23%), Positives = 76/175 (43%), Gaps = 10/175 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
I H D+K EN + + A +KI DFG + K T T + APE++ R
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDC 147
D+W+ GV YV+L G PF ++D +T+ + ++ + + +S +
Sbjct: 205 VG-FYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWF---LKNLPRELTETAQAIYYRKENPTFS 199
++ + + P +R+T+ + HPW NL + + +K ++
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYA 314
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 132 bits (333), Expect = 3e-37
Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 10/193 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
H DLK EN + + LK+ DFG + K T GT + APEV +
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDC 147
D+WS GV Y++L G PF +N +T+ + + + + D + IS+D
Sbjct: 202 VGYY-TDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLK-NLPRELTETAQAIY--YRKENPTFSLQSVE 204
++ + ++ +A+P+ R+TI + HPW N P ++ + Y R T E
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPE 316
Query: 205 EITKIVEEAKVPP 217
+ + +
Sbjct: 317 PLPPLGRISNYSS 329
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-37
Identities = 57/189 (30%), Positives = 95/189 (50%), Gaps = 5/189 (2%)
Query: 30 SQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
S I HRD+K EN L P LK+ DFG++K + H+ + TP Y+APEVL
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 146
+YD D+WS GV +Y++L G PF +RI QY+ P+ + +S++
Sbjct: 189 KYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEI 206
+ L+ + P++R+TI E +HPW +++ T + +++ + EE+
Sbjct: 248 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE-DVKEEM 306
Query: 207 TKIVEEAKV 215
T + +V
Sbjct: 307 TSALATMRV 315
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 129 bits (325), Expect = 7e-37
Identities = 52/150 (34%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
I HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE++
Sbjct: 128 KLNIVHRDLKPENILLDDDM--NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSM 185
Query: 90 YD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
D GK D+WS GV +Y +L G+ PF ++ R +S Q+ P++ S
Sbjct: 186 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYS 243
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++L+SR V P +R T +E +HP+F
Sbjct: 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 5e-36
Identities = 52/149 (34%), Positives = 82/149 (55%), Gaps = 9/149 (6%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
S QI H DLK EN +L P PR+KI DFG + + K+ GTP ++APE+++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQ 145
AD+WS GV Y++L GA PF ++T++ + AV Y+ D + + S
Sbjct: 191 EPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWF 174
++ + R+ V +P +R+TI++ HPW
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-36
Identities = 52/156 (33%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ + HRD+K EN L+D + LK+ DFG L + GT Y PE +
Sbjct: 128 NCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHR 185
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y G+ A VWS G+ LY M+ G PFE E+ I+ Q +S +C++
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSECQH 233
Query: 150 LLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 184
L+ PS R T +EI++HPW LP+E E
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-35
Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 9/145 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 88
+ HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y++PE ++R
Sbjct: 132 GHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM 189
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y+ K +D+WS G LY + PF + ++ +I +++ Y S +
Sbjct: 190 SYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY-RYSDELN 243
Query: 149 NLLSRIFVANPSRRITIKEIKSHPW 173
+++R+ R +++EI +P
Sbjct: 244 EIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-35
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 7/151 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S Q+ HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV++R+
Sbjct: 134 SNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y K D+WS G+ M+ G P+ ++ + ++ + +S R
Sbjct: 192 AYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFR 247
Query: 149 NLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
+ L+R + +R + KE+ H + P
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-35
Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 18/154 (11%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLS 86
+ I HRDLK EN LL+ ++I DFG +K S R S VGT Y++PE+L+
Sbjct: 126 GKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
+ +D+W+ G +Y ++ G PF N +I+ ++Y P+
Sbjct: 184 EKSACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPK 236
Query: 147 CRNLLSRIFVANPSRRITIKE------IKSHPWF 174
R+L+ ++ V + ++R+ +E +K+HP+F
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-35
Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 10/160 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 88
+I HRDLK N L +K+ DFG S + R S +GTP ++APEV+
Sbjct: 128 DNKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 89 EYDGKL----ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
+ ADVWS G+TL M P + + K + + S
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWS 242
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE 184
+ ++ L + N R T ++ HP+ + + + E
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (311), Expect = 2e-34
Identities = 56/150 (37%), Positives = 85/150 (56%), Gaps = 16/150 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S+ I +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+S +
Sbjct: 122 SKDIIYRDLKPENILLDKNG--HIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVSTKP 177
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y+ D WS G+ +Y ML G PF D N KT +I+ + + P ++D ++
Sbjct: 178 YNKS-IDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPP--FFNEDVKD 230
Query: 150 LLSRIFVANPSRRI-----TIKEIKSHPWF 174
LLSR+ + S+R+ +++K+HPWF
Sbjct: 231 LLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (308), Expect = 5e-34
Identities = 44/155 (28%), Positives = 66/155 (42%), Gaps = 13/155 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL---S 86
S + HRD+K N LL +K+ DFG + + + S VGTP ++APEV+
Sbjct: 133 SHNMIHRDVKAGNILLSEPG--LVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMD 187
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
+YDGK DVWS G+T + P + N + I + H S+
Sbjct: 188 EGQYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEY 242
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
RN + P R T + + H + L+ P
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 1e-33
Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 4/153 (2%)
Query: 30 SQQICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
I HRDLK EN L ++ I DFG SK S + GTP Y+APEVL+++
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y D WS GV Y++L G PF D+ D K F + + ++ P + IS +
Sbjct: 185 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--YEFDSPYWDDISDSAK 241
Query: 149 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
+ + + +P +R T ++ HPW + +
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-33
Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 42/185 (22%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 90
+I HRD+K N L++ +K+CDFG S L+ S S VGT +Y++PE L Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 91 DGKLADVWSCGVTLYVMLVGAYPFE----------------------------------- 115
+ +D+WS G++L M VG YP
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 116 ---DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 172
D P + + I+ S + ++ +++ + NP+ R +K++ H
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 173 WFLKN 177
+ ++
Sbjct: 300 FIKRS 304
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-31
Identities = 47/172 (27%), Positives = 71/172 (41%), Gaps = 25/172 (14%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S ++ HRDLK +N L+ S ++K+ DFG ++ S V T Y APEVL +
Sbjct: 134 SHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-MAVQYKIPDYV------- 141
Y D+WS G M F D K + I + + P V
Sbjct: 192 YATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250
Query: 142 -------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180
I + ++LL + NP++RI+ SHP+F ++L R
Sbjct: 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF-QDLER 301
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 115 bits (289), Expect = 8e-31
Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 11/150 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
++ + +RDLK N LLD ++I D G + +P ++VGT Y+APEVL +
Sbjct: 125 NRFVVYRDLKPANILLD--EHGHVRISDLGLACD-FSKKKPHASVGTHGYMAPEVLQKGV 181
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
AD +S G L+ +L G PF Q K+ + + + ++PD S + R+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD--SFSPELRS 238
Query: 150 LLSRIFVANPSRRIT-----IKEIKSHPWF 174
LL + + +RR+ +E+K P+F
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 9e-31
Identities = 53/147 (36%), Positives = 81/147 (55%), Gaps = 11/147 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S+ I +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+L +
Sbjct: 121 SKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+Y+ D WS GV LY ML+G PF ++ + I P + ++ +
Sbjct: 179 KYNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPR--WLEKEAK 231
Query: 149 NLLSRIFVANPSRRITIK-EIKSHPWF 174
+LL ++FV P +R+ ++ +I+ HP F
Sbjct: 232 DLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-30
Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRR 88
S+ + +RD+KLEN +LD +KI DFG K + + K+ GTP Y+APEVL
Sbjct: 123 SRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+Y D W GV +Y M+ G PF + ++ + I+ + + P +S + +
Sbjct: 181 DYGRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPR--TLSPEAK 233
Query: 149 NLLSRIFVANPSRRI-----TIKEIKSHPWF 174
+LL+ + +P +R+ KE+ H +F
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 5e-30
Identities = 32/156 (20%), Positives = 64/156 (41%), Gaps = 8/156 (5%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSR 87
+ I HRDLK N L +KI DFG + + + G+ ++APEV+
Sbjct: 123 KSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 88 REYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
++ + +DV++ G+ LY ++ G P+ + + + R + +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPR 180
+ L++ R +I + L ++LP+
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 5e-29
Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 27/177 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
S ++ HRDLK +N L++ +K+ DFG +++ + R + V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI-------SRIMAVQYKIPDYV 141
+Y D+WS G M+ F + + + +PDY
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 142 ----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 182
+ +D R+LLS++ +P++RI+ K +HP+F +++ + +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPV 293
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-28
Identities = 46/173 (26%), Positives = 64/173 (36%), Gaps = 26/173 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 88
I HRDLK N LLD + LK+ DFG +KS + V T Y APE+L
Sbjct: 118 QHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-------MAVQYKIPDYV 141
G D+W+ G L +L+ D + + +PDYV
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 142 ---------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
D +L+ +F+ NP RIT + +F N P
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRP 287
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-28
Identities = 52/216 (24%), Positives = 83/216 (38%), Gaps = 30/216 (13%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S ICHRD+K +N LLD A K+CDFG +K + S + + Y APE++
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-------------AVQYK 136
DVWS G L +L+G F + I + ++K
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 137 IPDY----------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 186
P + L SR+ P+ R+T E +H +F EL +
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-----DELRDPN 313
Query: 187 QAIYYRKENPTFSLQSVEEITKIVEEA-KVPPPVSR 221
+ ++ P + +E++ A + PP +R
Sbjct: 314 VKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-28
Identities = 51/227 (22%), Positives = 85/227 (37%), Gaps = 42/227 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVL 85
S + HRDLK N LL+ + LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD------ 139
+ K D+WS G L ML F K++ ++ I+ +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPG----KHYLDQLNHILGILGSPSQEDLNCI 240
Query: 140 -----------------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176
+ + +LL ++ NP +RI +++ +HP+ +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
Query: 177 NLPRELTETAQAIY-YRKENPTFSLQSVEEITKIVEEAKVPPPVSRS 222
A+A + + E + ++E+ I EE P RS
Sbjct: 301 YYDPSDEPIAEAPFKFDMELDDLPKEKLKEL--IFEETARFQPGYRS 345
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-27
Identities = 29/154 (18%), Positives = 58/154 (37%), Gaps = 11/154 (7%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRR 88
HRDL+ N L+ + K+ DFG ++ ++ + + APE
Sbjct: 132 MNYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
+ K +DVWS G+ L + + + R Y++P +
Sbjct: 190 RFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLH 244
Query: 149 NLLSRIFVANPSRRITIKEIKS--HPWFLKNLPR 180
+L+ + + P R T + +++ +F P+
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-27
Identities = 44/174 (25%), Positives = 72/174 (41%), Gaps = 27/174 (15%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRRE 89
+ + HRDLK +N L++ + LK+ +FG +++ + R S V T Y P+VL +
Sbjct: 120 RNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------AVQYKIPDYV 141
D+WS G + P D + K I R++ K+PDY
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 142 ----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179
++ R+LL + NP +RI+ +E HP+F P
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 105 bits (262), Expect = 4e-27
Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 16/150 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S + +RDLK EN L+D +++ DFG++K R + GTP +APE++ +
Sbjct: 159 SLDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKG 214
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y+ D W+ GV +Y M G PF + +I++ + + P H S D ++
Sbjct: 215 YNKA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPS--HFSSDLKD 267
Query: 150 LLSRIFVANPSRRI-----TIKEIKSHPWF 174
LL + + ++R + +IK+H WF
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 5e-27
Identities = 36/189 (19%), Positives = 67/189 (35%), Gaps = 42/189 (22%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEV 84
+I HRD+K N L+ LK+ DFG ++ + +R + V T Y PE+
Sbjct: 135 RNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 85 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-- 142
L G D+W G + M + + + ++ I + I V
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG----NTEQHQLALISQLCGSITPEVWPN 248
Query: 143 ----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+L+ ++ V +P++RI + +H +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 175 LKN-LPREL 182
+ +P +L
Sbjct: 309 WSDPMPSDL 317
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-26
Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 8/151 (5%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
I +RD+KLEN LLD + L + R GT Y+AP+++ +
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 90 Y-DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
K D WS GV +Y +L GA PF + + + RI+ + P +S +
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALAK 264
Query: 149 NLLSRIFVANPSRRI-----TIKEIKSHPWF 174
+L+ R+ + +P +R+ EIK H +F
Sbjct: 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 101 bits (252), Expect = 4e-26
Identities = 40/169 (23%), Positives = 71/169 (42%), Gaps = 26/169 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 88
+++ HRDLK +N L++ LKI DFG +++ + R + + T Y AP+VL
Sbjct: 118 DRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI-------SRIMAVQYKIPDYV 141
+ D+WS G M+ G F + + S+ ++P Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 142 ----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ + +LLS++ +P++RIT K+ H +F
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 7e-26
Identities = 35/190 (18%), Positives = 71/190 (37%), Gaps = 15/190 (7%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAPEVLSR 87
+++ HRDL N L+ +KI DFG +K + ++A E +
Sbjct: 130 RRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
R Y + +DVWS GVT++ ++ D + + ++P + D
Sbjct: 188 RIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----GERLPQPPICTIDV 242
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS-----LQS 202
++ + ++ + R +E+ + P+ +PT S L
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMD 302
Query: 203 VEEITKIVEE 212
E++ +V+
Sbjct: 303 EEDMDDVVDA 312
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (252), Expect = 8e-26
Identities = 33/177 (18%), Positives = 64/177 (36%), Gaps = 33/177 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I HRD+K N ++D +L++ D+G ++ V + + PE+L +
Sbjct: 147 SMGIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------------- 135
D+WS G L M+ PF D + I++++ +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 136 ------------------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174
+ +S + + L ++ + R+T +E HP+F
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-25
Identities = 29/142 (20%), Positives = 57/142 (40%), Gaps = 7/142 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+Q HRDL N L+ + KI DFG S+ ++ + ++A E L+
Sbjct: 145 QKQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV 202
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
Y +DVWS GV L+ ++ + + + Y++ ++ + +
Sbjct: 203 YTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ----GYRLEKPLNCDDEVYD 257
Query: 150 LLSRIFVANPSRRITIKEIKSH 171
L+ + + P R + +I
Sbjct: 258 LMRQCWREKPYERPSFAQILVS 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (246), Expect = 2e-25
Identities = 27/142 (19%), Positives = 53/142 (37%), Gaps = 9/142 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
HRDL N L+ K+ DFG +K S + + APE L ++
Sbjct: 121 GNNFVHRDLAARNVLVSEDN--VAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREKK 176
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149
+ K +DVWS G+ L+ + + K+ + + + PD
Sbjct: 177 FSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--GYKMDAPD--GCPPAVYE 231
Query: 150 LLSRIFVANPSRRITIKEIKSH 171
++ + + + R + +++
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 2e-24
Identities = 26/146 (17%), Positives = 55/146 (37%), Gaps = 12/146 (8%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVL 85
++ HRDL N +LD +K+ DFG ++ ++A E L
Sbjct: 149 KKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
+++ K +DVWS GV L+ ++ P + + + + ++ +
Sbjct: 207 QTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GRRLLQPEYCPD 261
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSH 171
++ + + R + E+ S
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 96.4 bits (239), Expect = 2e-24
Identities = 31/143 (21%), Positives = 57/143 (39%), Gaps = 6/143 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFG--YSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
I HRD+K N ++ + A ++ + S ++ + +GT Y++PE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
D + +DV+S G LY +L G PF + + + +S D
Sbjct: 189 DSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--GLSADL 245
Query: 148 RNLLSRIFVANPSRRI-TIKEIK 169
++ + NP R T E++
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMR 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 3e-24
Identities = 33/146 (22%), Positives = 63/146 (43%), Gaps = 11/146 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLS 86
+ HRDL N L+ +KICDFG ++ S + + ++APE L
Sbjct: 182 FKSCVHRDLAARNVLVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239
Query: 87 RREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
Y K +DVWS G+ L+ + +G P+ NF K ++ +K+ + ++
Sbjct: 240 EGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYK----LIQNGFKMDQPFYATE 294
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSH 171
+ ++ + + +R + + S
Sbjct: 295 EIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 6e-24
Identities = 42/216 (19%), Positives = 77/216 (35%), Gaps = 33/216 (15%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I HRDLK N ++ LKI DFG ++ V T Y APE++
Sbjct: 139 SADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 194
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD---------- 139
+ + D+WS G + +L G F + + + + ++
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 140 ---------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE 184
++ + +LL ++ V + +RIT + +H +F + +
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314
Query: 185 TAQAIYYRKENPTFSLQSVEEITKIVEEAK--VPPP 218
A E+ + + + +E VPPP
Sbjct: 315 VADPYDQSFESRDLLIDEWKSL--TYDEVISFVPPP 348
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 1e-23
Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 12/147 (8%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVL 85
S++ HRDL N LL +KI DFG + + + + A+ APE L
Sbjct: 129 SKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 86 SRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144
R + +D W GVTL+ M G P+ N + + +I ++P
Sbjct: 187 KTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG----LNGSQILHKIDKEGERLPRPEDCP 241
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKSH 171
QD N++ + + P R T ++
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 1e-23
Identities = 50/210 (23%), Positives = 84/210 (40%), Gaps = 39/210 (18%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
+ I HRDLK N ++ LKI DFG ++ S V T Y APEV+
Sbjct: 139 AAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWM 194
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQED--------------PKNFRKTISRIMAVQY 135
+ D+WS G + M+ G F+ + P F + + A Y
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254
Query: 136 K--IPDYV---------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE 184
+P+ + S NLL ++ V + +R+T E +HP+F L +
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-----ESLHD 309
Query: 185 TAQAIYYRKENPTFSLQSVEEITKIVEEAK 214
T +K + +F +++ + ++E K
Sbjct: 310 TEDEPQVQKYDDSF-----DDVDRTLDEWK 334
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.0 bits (233), Expect = 2e-23
Identities = 28/144 (19%), Positives = 53/144 (36%), Gaps = 9/144 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSR 87
+ HRDL N L+ + +K+ DFG ++ ++ T + +PEV S
Sbjct: 119 EACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
Y K +DVWS GV ++ + + + IS +++ S
Sbjct: 177 SRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYKPRLASTHV 231
Query: 148 RNLLSRIFVANPSRRITIKEIKSH 171
+++ + P R +
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.5 bits (236), Expect = 2e-23
Identities = 35/196 (17%), Positives = 70/196 (35%), Gaps = 45/196 (22%)
Query: 30 SQQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 87
I H D+K EN L++ SP ++I + +++ T Y +PEVL
Sbjct: 144 RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG 203
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPF--EDQEDPKNFRKTISRIMAVQYKIPDYV---- 141
+ AD+WS ++ ++ G + F ++ I++I+ + ++P Y+
Sbjct: 204 APWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 262
Query: 142 ------------------------------------HISQDCRNLLSRIFVANPSRRITI 165
+++ + LS + +P +R
Sbjct: 263 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322
Query: 166 KEIKSHPWFLKNLPRE 181
+ +HPW L E
Sbjct: 323 GGLVNHPWLKDTLGME 338
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 3e-23
Identities = 33/161 (20%), Positives = 60/161 (37%), Gaps = 11/161 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVL 85
+ HRDL N L++ + K+ DFG S+ + APE +
Sbjct: 128 NMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 86 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
S R++ +DVWS G+ ++ ++ + K I+ +++P +
Sbjct: 186 SYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMDCPS 240
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 186
L+ + + +RR +I S L P L A
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.2 bits (231), Expect = 3e-23
Identities = 31/144 (21%), Positives = 58/144 (40%), Gaps = 11/144 (7%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRR 88
+Q HRDL N L++ +K+ DFG S+ L S + PEVL
Sbjct: 119 KQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 89 EYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
++ K +D+W+ GV ++ + +G P+E + + ++ S+
Sbjct: 177 KFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLASEKV 230
Query: 148 RNLLSRIFVANPSRRITIKEIKSH 171
++ + R T K + S+
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 1e-22
Identities = 33/153 (21%), Positives = 63/153 (41%), Gaps = 18/153 (11%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVLS 86
+ HRDL N LL + I DFG SK ++ + + APE ++
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 87 RREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHIS 144
R++ + +DVWS GVT++ L G P++ + P + ++ I + + P
Sbjct: 186 FRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIEQGKRMECPP--ECP 238
Query: 145 QDCRNLLSRIFVANPSRRITIKEIKS---HPWF 174
+ L+S ++ R ++ ++
Sbjct: 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (225), Expect = 2e-22
Identities = 31/144 (21%), Positives = 64/144 (44%), Gaps = 9/144 (6%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 87
S++ HRD+ N L+ + +K+ DFG S+ + K++ ++APE ++
Sbjct: 126 SKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
R + +DVW GV ++ +L+ + I ++P +
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----GERLPMPPNCPPTL 238
Query: 148 RNLLSRIFVANPSRRITIKEIKSH 171
+L+++ + +PSRR E+K+
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 91.4 bits (226), Expect = 3e-22
Identities = 32/160 (20%), Positives = 60/160 (37%), Gaps = 22/160 (13%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPEV 84
HRDL N L++ + K+ DFG S+ S ++ + APE
Sbjct: 147 MNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 85 LSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143
+ R++ +DVWS G+ ++ ++ G P+ D + Y++P +
Sbjct: 205 IQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-----YRLPPPMDC 258
Query: 144 SQDCRNLLSRIFVANPSRRITIKEI-------KSHPWFLK 176
L+ + + + R +I +P LK
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 4e-22
Identities = 28/152 (18%), Positives = 59/152 (38%), Gaps = 16/152 (10%)
Query: 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAPEVLS 86
HRDL N LL KI DFG SK+ + + APE ++
Sbjct: 126 SNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 87 RREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
++ K +DVWS GV ++ G P+ + + ++ ++ ++ +
Sbjct: 184 YYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEKGERMGCPAGCPR 237
Query: 146 DCRNLLSRIFVANPSRRITIKEIKS---HPWF 174
+ +L++ + + R ++ + ++
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.1 bits (223), Expect = 5e-22
Identities = 29/149 (19%), Positives = 57/149 (38%), Gaps = 11/149 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSR 87
+ HRDL+ N L+ KI DFG ++ ++ + + APE ++
Sbjct: 127 ERNYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
+ K +DVWS G+ L ++ + + R Y++ + ++
Sbjct: 185 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEEL 239
Query: 148 RNLLSRIFVANPSRRITIKEIKS--HPWF 174
L+ + P R T ++S +F
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 90.6 bits (224), Expect = 5e-22
Identities = 25/175 (14%), Positives = 55/175 (31%), Gaps = 19/175 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPR---LKICDFGYSK--------SSLLHSRPKSTVGTPA 78
+ + +RD+K +N L+ + + + DFG K + + K+ GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 79 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 138
Y++ RE + D+ + G L G+ P++ ++ RI + P
Sbjct: 179 YMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQG-LKAATNKQKYERIGEKKQSTP 236
Query: 139 DYV---HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIY 190
++ + ++ + L T +
Sbjct: 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG---LFSKVLERLNTTEDENF 288
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 90.3 bits (223), Expect = 6e-22
Identities = 30/165 (18%), Positives = 59/165 (35%), Gaps = 17/165 (10%)
Query: 30 SQQICHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSLLHSRPKSTVGTPAYI 80
S+ HRD+K +N L+ G + I DFG +K + + K+ GT Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 81 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 140
+ E + D+ S G L +G+ P++ + +K RI + P
Sbjct: 181 SINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMSTPIE 238
Query: 141 V---HISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKNLP 179
V + L+ + ++++ + + +
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 89.8 bits (222), Expect = 8e-22
Identities = 32/154 (20%), Positives = 61/154 (39%), Gaps = 12/154 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSR 87
+ HRDL N L+ + +K+ DFG S+ + ++ + APE L+
Sbjct: 133 KKNFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 88 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147
++ K +DVW+ GV L+ + D + + + Y++ +
Sbjct: 191 NKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEKV 245
Query: 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 181
L+ + NPS R + EI + + +E
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQ---AFETMFQE 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 89.5 bits (221), Expect = 1e-21
Identities = 27/142 (19%), Positives = 53/142 (37%), Gaps = 10/142 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLS 86
++ HRDL N L+ + +KI DFG S+ S+ + + ++ PE +
Sbjct: 158 ERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
Y + +DVW+ GV L+ + + + + + +
Sbjct: 216 YNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD----GNILACPENCPLE 270
Query: 147 CRNLLSRIFVANPSRRITIKEI 168
NL+ + P+ R + I
Sbjct: 271 LYNLMRLCWSKLPADRPSFCSI 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 9e-21
Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLS 86
S++ HRDL N LL +KICDFG ++ + R ++APE +
Sbjct: 152 SRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF 209
Query: 87 RREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145
R Y + +DVWS GV L+ + A P+ + + F + + + + PD + +
Sbjct: 210 DRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--GTRMRAPD--YTTP 264
Query: 146 DCRNLLSRIFVANPSRRITIKEIKSH 171
+ + + PS+R T E+ H
Sbjct: 265 EMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 5e-19
Identities = 27/140 (19%), Positives = 55/140 (39%), Gaps = 6/140 (4%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 88
S++ HRDL N L+ ++ + + + ++APE L R
Sbjct: 153 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 212
Query: 89 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 148
Y + +DVWS GV L+ + + K + +++ + + +
Sbjct: 213 IYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE----GHRMDKPSNCTNELY 267
Query: 149 NLLSRIFVANPSRRITIKEI 168
++ + A PS+R T K++
Sbjct: 268 MMMRDCWHAVPSQRPTFKQL 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 6e-19
Identities = 35/173 (20%), Positives = 59/173 (34%), Gaps = 28/173 (16%)
Query: 23 DIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSLLHSRPKSTVGTP 77
+I + I HRDLK +N L+ + I D G S + + P VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 78 AYIAPEVLSRREYDGKL-----ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 132
Y+APEVL AD+++ G+ + + ED + +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 133 VQYKIPDYV----------------HISQDCRNLLSRIFVANPSRRITIKEIK 169
++ V + ++ + AN + R+T IK
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (203), Expect = 6e-19
Identities = 48/221 (21%), Positives = 81/221 (36%), Gaps = 47/221 (21%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89
S I HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 137 SAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDYV 141
Y D+WS G + M+ F ++ + K I ++ +Q + +YV
Sbjct: 195 YKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 142 H----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 173
+ R+LLS++ V +P++RI++ + HP+
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313
Query: 174 FLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 214
P + ++E +EE K
Sbjct: 314 I--------NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (198), Expect = 3e-18
Identities = 33/159 (20%), Positives = 67/159 (42%), Gaps = 15/159 (9%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAPEVLS 86
S+ HRDL N LL KICDFG ++ S ++APE +
Sbjct: 163 SKNCIHRDLAARNILLTHG--RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
Y + +DVWS G+ L+ + + +++ +++ H +
Sbjct: 221 NCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS---KFYKMIKEGFRMLSPEHAPAE 276
Query: 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 185
+++ + A+P +R T K+I ++ + ++++E+
Sbjct: 277 MYDIMKTCWDADPLKRPTFKQI------VQLIEKQISES 309
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 7e-18
Identities = 31/154 (20%), Positives = 57/154 (37%), Gaps = 16/154 (10%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLS 86
+ + HRDL N ++ +KI DFG ++ + + + + +++PE L
Sbjct: 151 ANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 208
Query: 87 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146
+ +DVWS GV L+ + A + + + PD +
Sbjct: 209 DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--GGLLDKPD--NCPDM 263
Query: 147 CRNLLSRIFVANPSRRITIKEI------KSHPWF 174
L+ + NP R + EI + P F
Sbjct: 264 LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 36.3 bits (83), Expect = 0.001
Identities = 15/75 (20%), Positives = 23/75 (30%), Gaps = 16/75 (21%)
Query: 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS--- 86
+ I H DL N L+ + I DF S + +V +
Sbjct: 121 HRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVE---VGEEGW----REILERDVRNIIT 170
Query: 87 --RREYDGKLADVWS 99
R Y + D+ S
Sbjct: 171 YFSRTYRTE-KDINS 184
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 265 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.41 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.65 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 93.63 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 93.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 92.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 81.57 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=298.54 Aligned_cols=175 Identities=32% Similarity=0.473 Sum_probs=142.3
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
||||.+ +|.+++..++ ++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEE
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcc
Confidence 899976 9999886543 4778999999999999999999999999988775 999999999854322
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......+||+.|+|||++.+..+++.++|||||||++|+|++|+.||............ ........+.+..+++++
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHH
Confidence 22345679999999999998888777799999999999999999999876544332222 222223334445789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
++||.+||..||.+|||+.++++||||++.+++
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~k 269 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNKPLKK 269 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCcCCCC
Confidence 999999999999999999999999999877653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=290.84 Aligned_cols=173 Identities=25% Similarity=0.394 Sum_probs=140.8
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~~~ 70 (265)
||||.+ +|.+++..+. ++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+..... ...
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCB
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccc
Confidence 898876 9999877544 3778999999999999999999999999988765 999999999865433 233
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+.... .......+.+..+++.+++|
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSCCCSSGGGSCHHHHHH
T ss_pred cccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH---hCCCCCCCCcccCCHHHHHH
Confidence 456799999999999988775 45999999999999999999998765443333222 22223344455789999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
|.+||..||.+|||+.++++||||+...+
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~~~~~~ 278 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhCCCCC
Confidence 99999999999999999999999975543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=290.91 Aligned_cols=166 Identities=33% Similarity=0.573 Sum_probs=138.8
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||||.+ +|.+++...+. +.|++.||.|||++|||||||||+|||++.++. +||+|||+|+.... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-Ccc
Confidence 899876 99999987653 778999999999999999999999999988776 99999999975443 233
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.... .....+.......|. .+++++++|
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~l 234 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFPD--FVTEGARDL 234 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCCT--TSCHHHHHH
T ss_pred cccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCc--cCCHHHHHH
Confidence 456799999999999988775 5599999999999999999999775433 333344444444443 689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 151 LSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 151 i~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
|.+||..||.+|||+.++++||||+.
T Consensus 235 i~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-42 Score=290.96 Aligned_cols=172 Identities=33% Similarity=0.558 Sum_probs=128.0
Q ss_pred Ccccc-cchHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcC-CCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||||. ++|.+++..++ ++.|++.||.|||++||+||||||+|||+.. +..+.+||+|||+|+.......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 89997 59999997654 3778999999999999999999999999964 2234599999999986655555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc--CCCCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 147 (265)
....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+...... ...+...... .+.+..+++++
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKL----FEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp -------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHTTCCCCCTTTTTTSCHHH
T ss_pred eeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHH----HHHHhccCCCCCCccccCCCHHH
Confidence 5667899999999999988775 559999999999999999999987654332 2333333332 34445789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++||.+||..||.+|||+.++++||||++.
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-42 Score=282.74 Aligned_cols=167 Identities=22% Similarity=0.382 Sum_probs=133.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcC--ceecCCCcCcEEEcC-CCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQ--ICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~--ivH~dlkp~NIll~~-~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||++.+ +|.+++.... ++.|++.+|.|||+++ |+||||||+|||+++ ++. +||+|||+|+... .
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~~-~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR-A 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCC-T
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcceecc-C
Confidence 799876 9999988654 3678999999999999 999999999999964 444 9999999997433 2
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+......+.. .+............+++++
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~ 242 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEV 242 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCHHH
T ss_pred CccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH---HHHcCCCCcccCccCCHHH
Confidence 23345679999999999876 45 4569999999999999999999987665443333 2222222222234578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFL 175 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~ 175 (265)
++||.+||..||++|||+.++++||||+
T Consensus 243 ~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=285.67 Aligned_cols=174 Identities=25% Similarity=0.360 Sum_probs=137.7
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-S 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~ 68 (265)
||||.+ +|.+++..+. ++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+..... .
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcc
Confidence 899876 8999876543 2678999999999999999999999999998776 999999998643322 1
Q ss_pred CCCCCcCCCCCcccccccC-----CcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCC
Q 024572 69 RPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 143 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (265)
.....+||+.|+|||++.. ..+ +.++|||||||++|+|++|+.||.+......+..+.. ......+.+..+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~ 241 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRW 241 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH---SCCCCCSSGGGS
T ss_pred cccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc---CCCCCCCccccC
Confidence 2235679999999999853 333 4569999999999999999999988766554433322 111223344578
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
++++++||.+||..||.+|||+.++++||||+.....
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~~ 278 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK 278 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCCH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 9999999999999999999999999999999865543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-42 Score=284.25 Aligned_cols=168 Identities=29% Similarity=0.517 Sum_probs=136.1
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC--
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-- 68 (265)
|||+.+ +|.+++..++. +.|++.+|.|||++|||||||||+|||++.++. +||+|||+|+......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCcc
Confidence 899876 99999887653 677899999999999999999999999988776 9999999998654322
Q ss_pred -CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+... ....+......+| ..+++++
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~ 237 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQKIIKLEYDFP--EKFFPKA 237 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHTTCCCCC--TTCCHHH
T ss_pred cccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHH----HHHHHHcCCCCCC--ccCCHHH
Confidence 23345799999999999988775 56999999999999999999998765433 3334444444444 3689999
Q ss_pred HHHHHHhcccCCCCCCCHHH------HhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKE------IKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~e------ll~h~~f~~~ 177 (265)
++||.+||..||.+|||++| +++||||+..
T Consensus 238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999999999999988 5889999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=292.47 Aligned_cols=177 Identities=32% Similarity=0.534 Sum_probs=141.0
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~ 67 (265)
||||.+ +|.+++..++ ++.+++.|+.|||++||+||||||+|||++... .+.+||+|||+|+.....
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence 899975 9999998653 277799999999999999999999999997633 346999999999876666
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCC--CCCCCH
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQ 145 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 145 (265)
......+||+.|+|||++.+..++ .++|||||||++|+|+||+.||.+.............+.......|. +..+++
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 246 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCH
T ss_pred CccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCH
Confidence 666677899999999999988775 55999999999999999999998765544433333333333333332 235899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
++++||.+||..||++|||+.++++||||.+..
T Consensus 247 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 999999999999999999999999999997543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.1e-42 Score=293.46 Aligned_cols=172 Identities=26% Similarity=0.464 Sum_probs=141.0
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.||+.||.|||++|||||||||+|||++.+..+.+||+|||+|+.......
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 899875 9999985432 37789999999999999999999999999765445699999999987665555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 147 (265)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+ ..+.......+ .+..+++++
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCSCCGGGGGCCHHH
T ss_pred cceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCcccccCCCHHH
Confidence 5567899999999999988875 5699999999999999999999876543333 33333333333 234689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++||.+||..||++|||+.++|+||||+..
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.1e-42 Score=293.06 Aligned_cols=172 Identities=23% Similarity=0.454 Sum_probs=142.0
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||+|.+ +|.+++..++ ++.+|+.||.|||++|||||||||+|||++....+.+||+|||+|+.......
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 899875 9988876543 37889999999999999999999999999865555699999999987665555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 147 (265)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......+ ..+.......+ .+..+++++
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHCCCCCCSSTTTTSCHHH
T ss_pred eeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCcccccCCCHHH
Confidence 5566899999999999988775 5599999999999999999999876554333 33333333333 345789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
++||.+||..||.+|||+.++|+||||+..
T Consensus 260 ~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-41 Score=284.78 Aligned_cols=168 Identities=30% Similarity=0.522 Sum_probs=139.6
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCC-CCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~-~~~ 69 (265)
||++.+ +|.+++...+. +.+++.||.|||++||+||||||+|||++.++. +||+|||+|+.... ...
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCcc
Confidence 788876 89999887653 677899999999999999999999999998876 99999999986543 333
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
....+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+... ....+......+| ..+++++++
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~d 234 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRFP--RTLSPEAKS 234 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTSCHHHHH
T ss_pred cccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHH----HHHHHhcCCCCCC--ccCCHHHHH
Confidence 4456899999999999998885 45999999999999999999998865433 2333344444444 468999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 150 LLSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 150 li~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
||.+||.+||.+|++ +.++++||||+..
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 999999999999994 8999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=288.21 Aligned_cols=172 Identities=26% Similarity=0.390 Sum_probs=131.4
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhh-cCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
|||+.+ +|.+++..++. +.|++.|+.|||+ +||+||||||+|||++.++. +||+|||+|+.... ..
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HT
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-Cc
Confidence 798886 99999986543 6688999999997 59999999999999988776 99999999975432 23
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHH-----------------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT----------------------- 126 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~----------------------- 126 (265)
..+.+||+.|+|||++.+..|+. ++||||+||++|+|++|+.||.+..........
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~-~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCT-THHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred cccccCCccccCchHHcCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 34568999999999999988765 499999999999999999999875432211000
Q ss_pred ---------------HHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 127 ---------------ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 127 ---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
................++.++++||.+||..||.+|||+.++|+||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00000000000111236889999999999999999999999999999964
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.8e-41 Score=288.95 Aligned_cols=171 Identities=25% Similarity=0.346 Sum_probs=138.1
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
|||+.+ +|.+++..+.. +.+|+.||.|||++|||||||||+|||++.++. +||+|||+|+..... ..
T Consensus 86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~-~~ 162 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KP 162 (364)
T ss_dssp ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS-CC
T ss_pred EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCCC-cc
Confidence 899975 99999876653 567999999999999999999999999988776 999999999855433 34
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...+||+.|+|||++......+.++|||||||++|+|++|+.||........ .......... ..+.+..+++++++|
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~--~~~~~~~~s~~~~~l 239 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTM--AVELPDSFSPELRSL 239 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSC--CCCCCSSSCHHHHHH
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccC--CCCCCCCCCHHHHHH
Confidence 4567999999999997655445669999999999999999999987654332 2222222222 233344789999999
Q ss_pred HHHhcccCCCCCCC-----HHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRIT-----IKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~s-----~~ell~h~~f~~~ 177 (265)
|.+||..||.+||| ++++++||||+..
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999999999 7999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-41 Score=282.98 Aligned_cols=170 Identities=24% Similarity=0.300 Sum_probs=134.8
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||+|.+ +|..++..+. ++.|++.||.|||++|||||||||+|||++.++. +||+|||+|+.... .
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---A 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---B
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---C
Confidence 788877 4544444333 3788999999999999999999999999998775 99999999975432 3
Q ss_pred CCCcCCCCCcccccccCC---cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 71 KSTVGTPAYIAPEVLSRR---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
...+||+.|+|||++.+. .| +.++|||||||++|+|++|+.||.+......+ ..+............+++.+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y-~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~s~~~ 243 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNESPALQSGHWSEYF 243 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHSCCCCCSCTTSCHHH
T ss_pred CccccCccccCHHHHhccCCCCc-CchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCCCCCCCCHHH
Confidence 456799999999998652 34 45699999999999999999999876543333 23333333333445689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCCCh
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 180 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~~ 180 (265)
++||.+||..||.+|||+.++++||||.+..+.
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~ 276 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence 999999999999999999999999999766543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-40 Score=281.07 Aligned_cols=166 Identities=34% Similarity=0.536 Sum_probs=137.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++.... +..+++.++.|||++||+||||||+|||++.++. +||+|||+|+.... ..
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CB
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--cc
Confidence 788876 7888777654 3678999999999999999999999999988776 99999999986543 33
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+..... ....+.......| ..++++++++
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~l 231 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNAELRFP--PFFNEDVKDL 231 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCc-hhhccccchhHHHHHhCCCCCCCcCHHH----HHHHHHcCCCCCC--CCCCHHHHHH
Confidence 4568999999999999888864 5999999999999999999998765433 3333444444443 3689999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
|.+||..||.+|+ |++++++||||++.
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 9999999999996 99999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.9e-41 Score=277.65 Aligned_cols=171 Identities=32% Similarity=0.549 Sum_probs=140.8
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
|||+.+ +|.+++..++. +.|++.||.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 89 mE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~ 166 (277)
T d1phka_ 89 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKL 166 (277)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCB
T ss_pred EEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEccCCCce
Confidence 899965 99999987654 778999999999999999999999999988776 999999999876655555
Q ss_pred CCCcCCCCCcccccccCC-----cCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--cCCCCCCC
Q 024572 71 KSTVGTPAYIAPEVLSRR-----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHI 143 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 143 (265)
....||+.|+|||.+.+. ...+.++||||+||++|+|++|+.||.+........ .+..... ..+....+
T Consensus 167 ~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~ 242 (277)
T d1phka_ 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR----MIMSGNYQFGSPEWDDY 242 (277)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCCTTTGGGS
T ss_pred eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH----HHHhCCCCCCCcccccC
Confidence 667899999999998642 223556999999999999999999998865433332 2333333 33445579
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 144 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 144 ~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
|+++++||.+||..||.+|||+.++++||||++.
T Consensus 243 s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 9999999999999999999999999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=279.24 Aligned_cols=166 Identities=24% Similarity=0.407 Sum_probs=125.7
Q ss_pred Cccccc-chHHHHHHh-------------ccccchHHHHHhhhhcC-----ceecCCCcCcEEEcCCCCCcEEEeccCCc
Q 024572 1 MQLGVS-SLSEFVMLE-------------GSVKMKPDIFFSSLSQQ-----ICHRDLKLENTLLDGSPAPRLKICDFGYS 61 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------~~~~~i~~~l~~lH~~~-----ivH~dlkp~NIll~~~~~~~vkl~Dfg~a 61 (265)
||||.+ +|.+++... .++.|++.+|.|||++| ||||||||+|||++.++. +||+|||+|
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a 161 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLA 161 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccce
Confidence 899976 999988642 24778999999999977 999999999999998776 999999999
Q ss_pred ccCCCCC-CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCC
Q 024572 62 KSSLLHS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 140 (265)
Q Consensus 62 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (265)
+...... ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+..... ....+...... +.+
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~~i~~~~~~-~~~ 235 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFR-RIP 235 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCC-CCC
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCC-CCC
Confidence 8654332 33456799999999999887775 56999999999999999999998755432 22333333322 233
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 024572 141 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 174 (265)
Q Consensus 141 ~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f 174 (265)
..+++++++||.+||..||.+|||+.++++|||+
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 4789999999999999999999999999999995
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=278.28 Aligned_cols=175 Identities=25% Similarity=0.297 Sum_probs=136.5
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.+.+...+..+ .+++|++.+|.|||++||+||||||+|||++.++. +||+|||+|+...... .
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCccc
Confidence 788888555544432 24778999999999999999999999999988776 9999999997654332 3
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc-C-----------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-I----------- 137 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~----------- 137 (265)
....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+.+..+.......... .
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 3456799999999999876665677999999999999999999998877665555544332111100 0
Q ss_pred ----C------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 138 ----P------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 138 ----~------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+ ....+++++++||.+||..||++|||+.|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 012468899999999999999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=281.16 Aligned_cols=172 Identities=31% Similarity=0.556 Sum_probs=141.0
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCC--CcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~--~~vkl~Dfg~a~~~~~~~ 68 (265)
||||.+ +|.+++..++. +.+++.||.|||++||+||||||+|||++.++. ..+||+|||+|+......
T Consensus 92 ~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~ 171 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171 (293)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC
T ss_pred EEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc
Confidence 799875 99999987653 677899999999999999999999999976653 259999999998766555
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQD 146 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 146 (265)
......+|+.|+|||++.+..++ .++||||+||++|+|++|+.||.+...... +..+.......+ .+..+++.
T Consensus 172 ~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 172 EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQET----LANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp BCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHTTCCCCCHHHHTTSCHH
T ss_pred cccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHH----HHHHHhcCCCCCchhcCCCCHH
Confidence 56667899999999999987775 559999999999999999999987654333 233333333322 23468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
+++||.+||..||.+|||+.++++||||+..
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999999753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=278.52 Aligned_cols=173 Identities=25% Similarity=0.312 Sum_probs=137.2
Q ss_pred CcccccchHHHHHH-----------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVSSLSEFVML-----------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~sL~~~~~~-----------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+.+..+... +.++.|++.+|.|||++|||||||||+|||++..+. +||+|||+++.......
T Consensus 94 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~~~~~~~ 171 (305)
T d1blxa_ 94 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMA 171 (305)
T ss_dssp EECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGG
T ss_pred EEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhhhhccccc
Confidence 57777754444332 235888999999999999999999999999988776 99999999986655555
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-c------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-K------------ 136 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------------ 136 (265)
.....||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+......+..++........ .
T Consensus 172 ~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 250 (305)
T d1blxa_ 172 LTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250 (305)
T ss_dssp GCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS
T ss_pred CCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhh
Confidence 5667899999999999988875 4599999999999999999999887665555554433211100 0
Q ss_pred --------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 137 --------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 137 --------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
......+++.+++||.+||.+||.+|||+.|+|+||||+.
T Consensus 251 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0012357889999999999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-40 Score=282.74 Aligned_cols=166 Identities=28% Similarity=0.481 Sum_probs=136.4
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 70 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~ 70 (265)
||++.+ +|.+++..++ ++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+.... ..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~--~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CB
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeeccc--cc
Confidence 566655 8888887654 4778999999999999999999999999988775 99999999986543 33
Q ss_pred CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHH
Q 024572 71 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 150 (265)
Q Consensus 71 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 150 (265)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+..... .+..+.......| ..+++++.+|
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~l 268 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIVSGKVRFP--SHFSSDLKDL 268 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTCCHHHHHH
T ss_pred ccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHH----HHHHHhcCCCCCC--ccCCHHHHHH
Confidence 456799999999999988875 55999999999999999999998764432 3333344443333 4789999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCcccCCC
Q 024572 151 LSRIFVANPSRRI-----TIKEIKSHPWFLKN 177 (265)
Q Consensus 151 i~~~L~~dP~~R~-----s~~ell~h~~f~~~ 177 (265)
|.+||..||.+|+ |+.++++||||+..
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 9999999999995 99999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=272.81 Aligned_cols=165 Identities=31% Similarity=0.462 Sum_probs=133.5
Q ss_pred Cccccc--chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS--SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~--sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ ++.+++..+. ++.|++.||.|||++||+||||||+|||++.+. +.+||+|||+|+.... ..
T Consensus 88 ~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~~-~~ 165 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLKD-TV 165 (273)
T ss_dssp EECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCS-SC
T ss_pred EEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceeccc-cc
Confidence 677753 6777776543 477899999999999999999999999998553 2499999999975433 33
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... . +...... ....+|+++++
T Consensus 166 ~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~----i~~~~~~--~~~~~s~~~~~ 233 (273)
T d1xwsa_ 166 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQVF--FRQRVSSECQH 233 (273)
T ss_dssp BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCCC--CSSCCCHHHHH
T ss_pred ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------H----HhhcccC--CCCCCCHHHHH
Confidence 3456799999999999888877777999999999999999999997521 1 1222223 33468999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 150 LLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
||.+||..||.+|||+.++++||||++...
T Consensus 234 li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 999999999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-40 Score=276.23 Aligned_cols=167 Identities=33% Similarity=0.540 Sum_probs=137.9
Q ss_pred Cccccc-chHHHHHHhcc---------ccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVS-SLSEFVMLEGS---------VKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~~---------~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
|||+.+ +|.+++..++. +.+|+.||.|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence 788876 99999986653 677899999999999999999999999998776 9999999998554333 3
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 149 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (265)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+...... ...+.......| ..+++++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~d 232 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRMDNPFYP--RWLEKEAKD 232 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCC--TTSCHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCC--ccCCHHHHH
Confidence 3345799999999999998886 569999999999999999999987654332 333333333333 468999999
Q ss_pred HHHHhcccCCCCCCCHH-HHhcCcccCC
Q 024572 150 LLSRIFVANPSRRITIK-EIKSHPWFLK 176 (265)
Q Consensus 150 li~~~L~~dP~~R~s~~-ell~h~~f~~ 176 (265)
||.+||..||.+|||+. ++++||||++
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 99999999999999995 8999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=272.80 Aligned_cols=175 Identities=24% Similarity=0.357 Sum_probs=138.1
Q ss_pred CcccccchHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC-C
Q 024572 1 MQLGVSSLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-S 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~-~ 68 (265)
||++.+++.+++..+. ++.|++.+|.|||++|||||||||+|||++.++. +||+|||+|+..... .
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcc
Confidence 7888888777765442 3778999999999999999999999999987765 999999999754432 3
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-------------
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY------------- 135 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 135 (265)
......||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+....+............
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 3345579999999999988887778899999999999999999999887655554444432211110
Q ss_pred -cCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 136 -KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 136 -~~~~---------~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
..+. ...+++++++||.+||..||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000 12467899999999999999999999999999999753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-41 Score=282.83 Aligned_cols=173 Identities=24% Similarity=0.422 Sum_probs=142.3
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||||.+ +|.+++..++ ++.+|+.|+.|||++||+||||||+|||++.++...+||+|||+++.......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 899986 9999987654 26789999999999999999999999999876666799999999986655444
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC--CCCCCCHHH
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDC 147 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 147 (265)
.....+++.|+|||.+.+..+. .++|||||||++|+|++|+.||.+...... +..+......++ .+..+++++
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQI----IENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCCHHHHTTSCHHH
T ss_pred ccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCChhhccCCCHHH
Confidence 4556799999999999888775 569999999999999999999988654333 333333343333 234689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
++||.+||..||.+|||+.++++||||++..
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 9999999999999999999999999997653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=269.31 Aligned_cols=169 Identities=20% Similarity=0.256 Sum_probs=128.8
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
|||+.+ +|.+++.... ++.+++.|+.|||++|||||||||+|||++.++. +||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCC
Confidence 789875 9999997543 2678899999999999999999999999998776 9999999997543222
Q ss_pred --CCCCCcCCCCCcccccccCCc--CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 69 --RPKSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
......||+.|+|||++.+.. ..+.++|||||||++|+|+||+.||.+..........+.+.............++
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 223457999999999997532 2356699999999999999999999887665544444332111111112234688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.+.+||.+||..||.+|||+.+++++
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=276.21 Aligned_cols=175 Identities=26% Similarity=0.326 Sum_probs=138.2
Q ss_pred CcccccchHHHHHH-------------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVML-------------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~-------------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~ 67 (265)
||+|++++.+++.. +.+++|++.||.|||++||+||||||+|||++.++. .+||+|||+++.....
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTT
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCC
Confidence 78998876655532 234778999999999999999999999999987652 4999999999876666
Q ss_pred CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-------------c
Q 024572 68 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------Q 134 (265)
Q Consensus 68 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------------~ 134 (265)
......+|++.|+|||.+.+....+.++||||+||++|+|++|+.||........+..+....... .
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 666677899999999998876555677999999999999999999998876655544443321100 0
Q ss_pred ccCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 135 YKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 135 ~~~~----------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
...+ ....+++++++||.+||.+||.+|||+.|+|+||||+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 0011 12347899999999999999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-39 Score=273.10 Aligned_cols=173 Identities=25% Similarity=0.305 Sum_probs=137.5
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
||+++.+|..+..... +++|++.||.|||++||+||||||+|||++.++. +||+|||+|+... .....
T Consensus 102 ~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~--~~~~~ 177 (346)
T d1cm8a_ 102 MPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD--SEMTG 177 (346)
T ss_dssp EECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC--SSCCS
T ss_pred EecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccC--Ccccc
Confidence 7899888888776443 3888999999999999999999999999998876 9999999998543 33455
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh-------------------
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV------------------- 133 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 133 (265)
..+|+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+......+..........
T Consensus 178 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (346)
T d1cm8a_ 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257 (346)
T ss_dssp SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH
T ss_pred ccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhcc
Confidence 6799999999999876666677999999999999999999998876544433332211000
Q ss_pred --ccc----CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 134 --QYK----IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 134 --~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
... ......+++.+++||.+||..||.+|||+.++|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000 00123578999999999999999999999999999999753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=272.13 Aligned_cols=177 Identities=24% Similarity=0.328 Sum_probs=137.5
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC----C
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH----S 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~----~ 68 (265)
|++++++|.+++..+. ++.|++.||.|||++|||||||||+|||++.++. +||+|||+++..... .
T Consensus 90 ~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~~~~~ 167 (345)
T d1pmea_ 90 THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTG 167 (345)
T ss_dssp EECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCC
T ss_pred EeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCCCccce
Confidence 5778889999987654 4888999999999999999999999999987775 999999998754332 2
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh---------------
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------- 133 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------- 133 (265)
.....+||+.|+|||++......+.++||||+||++|+|++|+.||.+.................
T Consensus 168 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T d1pmea_ 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247 (345)
T ss_dssp TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred eeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhc
Confidence 23445799999999999776666777999999999999999999998765444333322211000
Q ss_pred -cccCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 134 -QYKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 134 -~~~~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
....+ ....+++.+++||.+||..||.+|||+.++|+||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred ccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00011 12357889999999999999999999999999999986543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-38 Score=265.23 Aligned_cols=174 Identities=21% Similarity=0.306 Sum_probs=131.2
Q ss_pred CcccccchHHHHHHh----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-C
Q 024572 1 MQLGVSSLSEFVMLE----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R 69 (265)
Q Consensus 1 me~~~~sL~~~~~~~----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~-~ 69 (265)
||++.+.+...+..+ .++++++.+|.|||++|||||||||+|||++.++. +||+|||.|....... .
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccc
Confidence 566777555555432 24778999999999999999999999999988776 9999999987543322 2
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc-------cC-----
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------KI----- 137 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~----- 137 (265)
.....+++.|+|||.+.+..+.+.++|||||||++|+|++|+.||.+....+.+.+.......... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 334468999999999988777677899999999999999999999887655554444332211100 00
Q ss_pred -----------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCC
Q 024572 138 -----------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 176 (265)
Q Consensus 138 -----------~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~ 176 (265)
.....+++.+++||++||.+||++|||+.|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 012346889999999999999999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-39 Score=273.18 Aligned_cols=164 Identities=21% Similarity=0.317 Sum_probs=134.5
Q ss_pred Cccccc-chHHHHHHhc--------------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcC
Q 024572 1 MQLGVS-SLSEFVMLEG--------------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDG 47 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~ 47 (265)
||+|.+ +|.+++..+. ++.+++.|+.|||++|||||||||+|||++.
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~ 199 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 199 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccccc
Confidence 788876 9999986542 4678999999999999999999999999998
Q ss_pred CCCCcEEEeccCCcccCCCCCCC---CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHH
Q 024572 48 SPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNF 123 (265)
Q Consensus 48 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~ 123 (265)
++. +||+|||+|+........ ....||+.|+|||++.+..++ .++|||||||++|+|+| |+.||.+......+
T Consensus 200 ~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~ 276 (325)
T d1rjba_ 200 GKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276 (325)
T ss_dssp TTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHHHHH
Confidence 775 999999999755443322 234579999999999887775 56999999999999997 89999887665544
Q ss_pred HHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 124 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+.+ ....+.+.+..+++++++||.+||..||++|||+.+|++|
T Consensus 277 ~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 277 YKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHH----hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4433 3344555566799999999999999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-38 Score=267.95 Aligned_cols=176 Identities=19% Similarity=0.277 Sum_probs=135.6
Q ss_pred Cccccc-chHHHH------HHhccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVS-SLSEFV------MLEGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~-sL~~~~------~~~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||++.+ +|..+. ..+.+++|++.||.|||++|||||||||+|||++.++. .+||+|||+|+...........
T Consensus 111 ~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~~~ 189 (328)
T d3bqca1 111 FEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVR 189 (328)
T ss_dssp EECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCCSC
T ss_pred EeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCccccc
Confidence 567665 555532 23446889999999999999999999999999986543 4899999999876666666677
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhh----------c---------
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------Q--------- 134 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------~--------- 134 (265)
++|+.|+|||.+.+....+.++||||+||++|+|++|+.||............+...... .
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 269 (328)
T d3bqca1 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269 (328)
T ss_dssp CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGG
T ss_pred ccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccch
Confidence 899999999999887655677999999999999999999998766543322222211100 0
Q ss_pred -------------ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 135 -------------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 135 -------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...+....+++++++||++||.+||.+|||++++|+||||+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp TCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred hcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0011122468899999999999999999999999999999753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-38 Score=266.03 Aligned_cols=175 Identities=19% Similarity=0.307 Sum_probs=130.2
Q ss_pred CcccccchHHHHHH----------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 1 MQLGVSSLSEFVML----------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 1 me~~~~sL~~~~~~----------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
||+++..+...... +.+++|++.++.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 96 ~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~~~~~~ 173 (318)
T d3blha1 96 FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNS 173 (318)
T ss_dssp EECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCC----
T ss_pred EeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeeeccccccc
Confidence 56676655544332 234788999999999999999999999999998876 999999999644321
Q ss_pred --CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC-CC----
Q 024572 68 --SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DY---- 140 (265)
Q Consensus 68 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~---- 140 (265)
......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.........+............ ..
T Consensus 174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 253 (318)
T d3blha1 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253 (318)
T ss_dssp -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh
Confidence 22334579999999999987655566799999999999999999999876554443333322211110000 00
Q ss_pred ---------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCC
Q 024572 141 ---------------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 177 (265)
Q Consensus 141 ---------------------~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~ 177 (265)
...++.+++||.+||.+||++|||+.++|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 0136778899999999999999999999999999753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-39 Score=274.50 Aligned_cols=174 Identities=22% Similarity=0.316 Sum_probs=134.0
Q ss_pred CcccccchHHHHHHhc--------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVMLEG--------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 72 (265)
Q Consensus 1 me~~~~sL~~~~~~~~--------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 72 (265)
|++++++|.+++..+. +++|++.||.|||++||+||||||+|||++.++. +|++|||++.... .....
T Consensus 102 ~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~--~~~~~ 177 (348)
T d2gfsa1 102 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD--DEMTG 177 (348)
T ss_dssp EECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT--GGGSS
T ss_pred EeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC--ccccc
Confidence 4667779999886443 4888999999999999999999999999988876 9999999986432 23345
Q ss_pred CcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhc------------------
Q 024572 73 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------------ 134 (265)
Q Consensus 73 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------------ 134 (265)
..|++.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+........
T Consensus 178 ~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (348)
T d2gfsa1 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257 (348)
T ss_dssp SCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTT
T ss_pred ccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhh
Confidence 67899999999988877666779999999999999999999988765544444333211100
Q ss_pred -ccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 135 -YKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 135 -~~~~------~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
...+ ....+++.+++||.+||..||.+|||+.|+|+||||++..
T Consensus 258 ~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0001 0235789999999999999999999999999999998643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-38 Score=264.05 Aligned_cols=164 Identities=23% Similarity=0.335 Sum_probs=126.5
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||+|.+ +|.+++..+. ++.|++.|+.|||++|||||||||+|||++.++. +|
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~--~K 174 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VK 174 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EE
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc--EE
Confidence 788875 9999986532 3668999999999999999999999999988776 99
Q ss_pred EeccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+|+...... ......||+.|+|||++.+..++ .++|||||||++|+|++| .+||.+......+...+..
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~- 252 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE- 252 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH-
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-
Confidence 99999997543322 22345699999999999887775 569999999999999986 5678776655444443332
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
....+.+..+++++++||.+||..||.+|||+.++++|
T Consensus 253 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 253 ---GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 23344445789999999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-38 Score=264.68 Aligned_cols=172 Identities=28% Similarity=0.417 Sum_probs=138.7
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC--C
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--S 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--~ 68 (265)
||++.+ +|.+++...+ .++|++.++.|||++||+||||||+|||++.++. +||+|||+++..... .
T Consensus 108 ~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~~~~~ 185 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETE 185 (322)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGGG
T ss_pred eecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhcccccc
Confidence 677765 8999887665 3778999999999999999999999999998775 999999999754332 2
Q ss_pred CCCCCcCCCCCcccccccCCc-CCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......|++.|+|||.+.+.. +.+.++|||||||++|+|++|+.||.+.........+......... +.+..+++.+
T Consensus 186 ~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~~~~~s~~~ 263 (322)
T d1vzoa_ 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALA 263 (322)
T ss_dssp GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--CCcccCCHHH
Confidence 234457999999999997654 3456699999999999999999999887665555555554444333 3344789999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHhcCcccCC
Q 024572 148 RNLLSRIFVANPSRRI-----TIKEIKSHPWFLK 176 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~-----s~~ell~h~~f~~ 176 (265)
++||.+||.+||.+|| |++|+++||||++
T Consensus 264 ~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999 5899999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-38 Score=259.80 Aligned_cols=166 Identities=18% Similarity=0.270 Sum_probs=130.5
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++.+ +|.+++..+. ++.+|+.||.|||++|||||||||+|||++.++. +||+|||+++.......
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENY 163 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSE
T ss_pred EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccc
Confidence 799976 9999988654 3667899999999999999999999999998775 99999999975433221
Q ss_pred ---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.....||+.|+|||++.+..++ .++|||||||++|+|++ |+.||.+...... ...+.. ..+.+.+..+++
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~----~~~i~~-~~~~~~p~~~~~ 237 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----TAMLEK-GERMGCPAGCPR 237 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHT-TCCCCCCTTCCH
T ss_pred cccccccCCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHH----HHHHHc-CCCCCCCcccCH
Confidence 2234688999999999887775 55999999999999998 8999987654322 222222 233445567999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHh---cCccc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIK---SHPWF 174 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell---~h~~f 174 (265)
++.+||.+||..||.+|||+.+++ +|+|+
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 999999999999999999999984 45544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-37 Score=255.55 Aligned_cols=177 Identities=23% Similarity=0.304 Sum_probs=133.2
Q ss_pred Cccccc-chHHHHHHh---------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLE---------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR- 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~---------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~- 69 (265)
||++.+ +|..++... .+++|++.+|.|||++||+||||||+|||++.++. +||+|||.++.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCcc
Confidence 344444 555555433 34778999999999999999999999999987765 99999999986554332
Q ss_pred CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcc--------------
Q 024572 70 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------------- 135 (265)
Q Consensus 70 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 135 (265)
.....+++.|+|||++.+..+.+.++||||+||++|+|++|+.||....+.......+........
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 233457889999999988776677799999999999999999997666555443333332211100
Q ss_pred ----------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCCC
Q 024572 136 ----------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 179 (265)
Q Consensus 136 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~~ 179 (265)
.......+++.+++||.+||..||.+|||++|+|+||||++..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 00112346789999999999999999999999999999986543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=256.55 Aligned_cols=168 Identities=18% Similarity=0.230 Sum_probs=130.6
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNE 163 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCc
Confidence 688866 888765433 24777899999999999999999999999998776 9999999998654332
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
......+|+.|+|||++.+..++ .++|||||||++|+|+||..|+........... .+. .....+.+..++++
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~---~i~-~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ---NLE-RGYRMVRPDNCPEE 238 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHH-TTCCCCCCTTCCHH
T ss_pred cccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH---HHH-hcCCCCCcccChHH
Confidence 22345689999999999887775 569999999999999996665544444333222 222 22344445578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc--CcccC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKS--HPWFL 175 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~--h~~f~ 175 (265)
+.+||.+||..||++|||+.++++ |+||.
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999999999988 67774
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-37 Score=256.86 Aligned_cols=163 Identities=20% Similarity=0.325 Sum_probs=122.0
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
|||+.+ +|.+++.... ++.+++.||.|||++||+||||||+|||++.++. +||+|||+|+.......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCC
Confidence 789976 8998877642 3677899999999999999999999999998876 99999999975443222
Q ss_pred C------CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCC
Q 024572 70 P------KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 142 (265)
Q Consensus 70 ~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (265)
. ....+|+.|+|||++.+..++ .++|||||||++|+|+| |+.||.+...... +..+. .....+.+..
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~----~~~i~-~~~~~~~~~~ 257 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDV----INAIE-QDYRLPPPMD 257 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHH-TTCCCCCCTT
T ss_pred cceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHH----HHHHH-cCCCCCCCcc
Confidence 1 123478899999999887775 55999999999999998 8999987654332 22222 2344555667
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 143 ISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 143 ~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
++..+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=257.90 Aligned_cols=166 Identities=22% Similarity=0.304 Sum_probs=131.5
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~- 68 (265)
|||+.+ +|.+++.... ++.+++.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDS 164 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSC
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccccccc
Confidence 799886 9999875432 3778999999999999999999999999998775 9999999997554322
Q ss_pred ---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 69 ---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 69 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
......||+.|+|||++.+..++ .++|||||||++|+|+| |+.||.+....... ..+.. ....+.+..++
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~----~~i~~-~~~~~~p~~~~ 238 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AFIEQ-GKRMECPPECP 238 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH----HHHHT-TCCCCCCTTCC
T ss_pred ccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHH----HHHHc-CCCCCCCCcCC
Confidence 22334688999999999887775 55999999999999998 89999887654322 22222 22344455799
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHh---cCccc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIK---SHPWF 174 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell---~h~~f 174 (265)
+++.+||.+||..||++|||+.+|+ +|+|+
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999998884 55554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-37 Score=252.81 Aligned_cols=164 Identities=18% Similarity=0.258 Sum_probs=119.7
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.||.|||+++|+||||||+|||++.++. +||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC----------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCc
Confidence 788865 9999887543 3677899999999999999999999999998876 99999999975543322
Q ss_pred --CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
.....||+.|+|||++.+..++ .++|||||||++|+|+|+..|+............+ .. ....+.+..+++.+
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i---~~-~~~~~~p~~~~~~l 231 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---ST-GFRLYKPRLASTHV 231 (263)
T ss_dssp --------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH---HH-TCCCCCCTTSCHHH
T ss_pred eeecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH---Hh-cCCCCCccccCHHH
Confidence 2234689999999999988875 56999999999999999544444433333322222 22 23344455789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+||.+||..||++|||+.++++|
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-37 Score=255.67 Aligned_cols=163 Identities=19% Similarity=0.243 Sum_probs=130.4
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+. ++.+++.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDT 169 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCC
Confidence 788875 8999887542 2568899999999999999999999999988776 9999999998544332
Q ss_pred CC--CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 69 RP--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 69 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.. ....|++.|+|||++.+..++ .++|||||||++|+|++|..||............+ ......+.+..+++.
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMERPEGCPEK 244 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTCCCCCCTTCCHH
T ss_pred ceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH----hcCCCCCCCccchHH
Confidence 21 223478899999999888775 56999999999999999877776655544433332 233445555679999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+++||.+||..||.+|||+.++++
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-37 Score=262.79 Aligned_cols=175 Identities=25% Similarity=0.325 Sum_probs=126.1
Q ss_pred CcccccchHHHHHH-------hccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCCCCC
Q 024572 1 MQLGVSSLSEFVML-------EGSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 73 (265)
Q Consensus 1 me~~~~sL~~~~~~-------~~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 73 (265)
||++.+++.+.+.. +.++++++.|+.|||++||+||||||+|||++.++. +|++|||+++...........
T Consensus 101 ~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~~~~~~~ 178 (355)
T d2b1pa1 101 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 178 (355)
T ss_dssp EECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-------------
T ss_pred EeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccccccccccc
Confidence 78888876665542 335888999999999999999999999999998776 999999998876666666667
Q ss_pred cCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhh------------------hcc
Q 024572 74 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA------------------VQY 135 (265)
Q Consensus 74 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~ 135 (265)
++|+.|+|||++.+..++. ++||||+||++|+|++|+.||.+.+.......++..... ...
T Consensus 179 ~~t~~y~aPE~l~~~~~~~-~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (355)
T d2b1pa1 179 VVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257 (355)
T ss_dssp --CCTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSC
T ss_pred cccccccChhhhcCCCCCC-CcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCc
Confidence 8999999999999877754 599999999999999999999877654444333322111 000
Q ss_pred cCC--------------C----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 136 KIP--------------D----YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 136 ~~~--------------~----~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
... . ....++++++||++||..||++|||++|+|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred cccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000 0 001356789999999999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.8e-37 Score=253.87 Aligned_cols=166 Identities=24% Similarity=0.352 Sum_probs=123.5
Q ss_pred Cccccc-chHHHHHHhc---------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---
Q 024572 1 MQLGVS-SLSEFVMLEG---------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--- 67 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~--- 67 (265)
||++.+ +|.+++..++ ++.|++.+|.|||++||+||||||+|||++.++. ++|+|||.++.....
T Consensus 90 mE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~~~ 167 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNS 167 (277)
T ss_dssp EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-----
T ss_pred EECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcccccc
Confidence 899986 8999888765 3778999999999999999999999999988776 999999988643322
Q ss_pred -CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhccc--CCCCCCCC
Q 024572 68 -SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHIS 144 (265)
Q Consensus 68 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 144 (265)
......+||+.|+|||++.+..++ .++|||||||++|+|+||++||.+......+...+ ..... ......+|
T Consensus 168 ~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 168 VTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----REDPIPPSARHEGLS 242 (277)
T ss_dssp -----------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HCCCCCGGGTSSSCC
T ss_pred ccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH----hcCCCCCchhccCCC
Confidence 223345799999999999887775 55999999999999999999998765443333322 22221 12344689
Q ss_pred HHHHHHHHHhcccCCCCCC-CHHHHhcCccc
Q 024572 145 QDCRNLLSRIFVANPSRRI-TIKEIKSHPWF 174 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~-s~~ell~h~~f 174 (265)
+.+.+||.+||..||.+|| |++++ .|+|.
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence 9999999999999999999 55554 45554
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-36 Score=247.44 Aligned_cols=163 Identities=20% Similarity=0.289 Sum_probs=131.2
Q ss_pred Ccccc-cchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGV-SSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~-~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++. ++|.+++.... ++.+++.|+.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCc
Confidence 78886 48888876543 3567899999999999999999999999998776 99999999975443322
Q ss_pred --CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.....+|+.|+|||++.+..++ .++|||||||++|+|+| |+.||.+...... ...+.. ....+.+..+++.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~----~~~i~~-~~~~~~p~~~~~~ 229 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSET----AEHIAQ-GLRLYRPHLASEK 229 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH----HHHHHT-TCCCCCCTTCCHH
T ss_pred eeecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHH----HHHHHh-CCCCCCcccccHH
Confidence 2235689999999999988875 56999999999999998 8999987764332 222222 3344555678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.+||.+||..||++|||+.++++|
T Consensus 230 l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 230 VYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=251.18 Aligned_cols=163 Identities=22% Similarity=0.375 Sum_probs=121.3
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++.... ++.+++.|+.|||++||+||||||+||+++.++. +||+|||+|+.......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC------------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCcc
Confidence 688875 8888766543 2678899999999999999999999999998776 99999999975443222
Q ss_pred --CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 70 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 70 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
.....+|+.|+|||++.+..++ .++|||||||++|+|++ |.+||...........+ .. ....+.+..+++.
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~-~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPPT 237 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-TCCCCCCTTCCHH
T ss_pred eeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCCCCHH
Confidence 2334588999999999887775 56999999999999998 89999877654433322 22 2334555689999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.+||.+||..||.+|||+.+|++|
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-36 Score=248.75 Aligned_cols=163 Identities=19% Similarity=0.264 Sum_probs=121.1
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.. +|.+++.... ++.+++.++.|||+++|+||||||+||||+.++. +||+|||+++.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC---------
T ss_pred EEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCCc
Confidence 567766 6666665432 3667899999999999999999999999998876 99999999975433221
Q ss_pred ----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCH
Q 024572 70 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 145 (265)
Q Consensus 70 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (265)
.....||+.|+|||++.+..++ .++|||||||++|+|++|..||............+ ....+.+.+..++.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i----~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI----NDGFRLPTPMDCPS 240 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTTCCCCCCTTCBH
T ss_pred cceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHH----hccCCCCCchhhHH
Confidence 1234588999999999888775 55999999999999999766665544443333222 22344555667899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 146 DCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 146 ~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
.+.+||.+||..||++|||+.+|++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-36 Score=250.66 Aligned_cols=170 Identities=18% Similarity=0.224 Sum_probs=128.3
Q ss_pred Cccccc-chHHHHHHh-----------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLE-----------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-----------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++... .++.+++.++.|||++||+||||||+||||+.++. +||+|||+++......
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNE 167 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCC
Confidence 677776 777776543 24777899999999999999999999999988776 9999999997543222
Q ss_pred --CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHH
Q 024572 69 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 146 (265)
Q Consensus 69 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (265)
......+|+.|+|||++.+..++ .++|||||||++|+|++|..||............+ . .....+.+..+++.
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i---~-~~~~~~~~~~~~~~ 242 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E-RGYRMPCPPECPES 242 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---H-TTCCCCCCTTSCHH
T ss_pred ceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---H-hcCCCCCCcccCHH
Confidence 22334689999999999887775 56999999999999999766665554443333322 2 22344555679999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc--CcccCCC
Q 024572 147 CRNLLSRIFVANPSRRITIKEIKS--HPWFLKN 177 (265)
Q Consensus 147 ~~~li~~~L~~dP~~R~s~~ell~--h~~f~~~ 177 (265)
+++||.+||..||++|||+.+|++ ++||...
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999999987 8888654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-36 Score=253.02 Aligned_cols=163 Identities=19% Similarity=0.301 Sum_probs=127.6
Q ss_pred cccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCCC-
Q 024572 2 QLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP- 70 (265)
Q Consensus 2 e~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~~- 70 (265)
++++++|.+++..+. ++.+++.||.|||++|||||||||+|||++.++. +||+|||+|+........
T Consensus 91 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~~~~ 168 (317)
T d1xkka_ 91 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEY 168 (317)
T ss_dssp CCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTCC--
T ss_pred eccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecccccccc
Confidence 445568888777653 3668999999999999999999999999998775 999999999765433222
Q ss_pred --CCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 71 --KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 71 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
....||+.|+|||++.+..++ .++|||||||++|+|+| |..||.+..... +...+. .....+.+..+++.+
T Consensus 169 ~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-~~~~i~----~~~~~~~p~~~~~~~ 242 (317)
T d1xkka_ 169 HAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILE----KGERLPQPPICTIDV 242 (317)
T ss_dssp ------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-HHHHHH----HTCCCCCCTTBCHHH
T ss_pred cccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-HHHHHH----cCCCCCCCcccCHHH
Confidence 233589999999999888775 56999999999999998 788887765433 233222 233445556799999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCc
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSHP 172 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h~ 172 (265)
.+||.+||..||.+|||+.++++|.
T Consensus 243 ~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 243 YMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhCCCChhhCcCHHHHHHHH
Confidence 9999999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-36 Score=246.66 Aligned_cols=163 Identities=24% Similarity=0.325 Sum_probs=128.7
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.. +|.+++..+. ++.+++.|+.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CC
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhcccCCC
Confidence 577765 7777766543 3777899999999999999999999999998775 99999999986543322
Q ss_pred ----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.....++..|+|||++.+..++ .++|||||||++|+|+| |+.||.+..... .+..+.......+.+..++
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~ 241 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERLPRPEDCP 241 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCCCCCCTTCC
T ss_pred cceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHH----HHHHHHhCCCCCCCccccc
Confidence 1233578899999999987764 55999999999999998 899998765433 3344444555566667899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
+.+.+||.+||..||++|||+.+|++
T Consensus 242 ~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 242 QDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-35 Score=245.71 Aligned_cols=162 Identities=22% Similarity=0.335 Sum_probs=129.8
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.+ +|.+++..+. ++++++.|+.|||++|||||||||+|||++.++. +|
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~--~k 175 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MK 175 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCC--eE
Confidence 788876 8999987542 3667899999999999999999999999998876 99
Q ss_pred EeccCCcccCCCCC---CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 024572 55 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI 130 (265)
Q Consensus 55 l~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~ 130 (265)
|+|||+++...... ......+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||.+..... ... .+
T Consensus 176 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-~~~---~i 250 (299)
T d1fgka_ 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFK---LL 250 (299)
T ss_dssp ECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH---HH
T ss_pred eccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHH-HHH---HH
Confidence 99999997554332 22335688999999999887775 55999999999999998 688887655432 222 22
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 131 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
......+.+..+++.+++||.+||+.||.+|||+.+|++
T Consensus 251 -~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 251 -KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 223444555678999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-35 Score=248.06 Aligned_cols=163 Identities=20% Similarity=0.278 Sum_probs=129.2
Q ss_pred Cccccc-chHHHHHHhc-------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEE
Q 024572 1 MQLGVS-SLSEFVMLEG-------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLK 54 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vk 54 (265)
||++.+ +|.+++..+. .+.+|+.|+.|||++||+||||||+|||++.++. +|
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~k 167 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK 167 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--eE
Confidence 688885 9999987542 3678999999999999999999999999988776 99
Q ss_pred EeccCCcccCCCCCCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhhh
Q 024572 55 ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA-YPFEDQEDPKNFRKTISRIMAV 133 (265)
Q Consensus 55 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~ 133 (265)
|+|||+++............+|..|+|||.+.+..++ .++|||||||++|+|++|. +||.+.... .....+..
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~----~~~~~i~~- 241 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKLPQ- 241 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHGGG-
T ss_pred EccccccccccccccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHH----HHHHHHHh-
Confidence 9999999866555555556799999999999888875 5599999999999999976 466554432 22333322
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 134 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 134 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
....+.+..+++++++||.+||..||++|||+.+|++|
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 23445556799999999999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-35 Score=245.81 Aligned_cols=173 Identities=17% Similarity=0.126 Sum_probs=126.8
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCC-CCcEEEeccCCcccCCCCC-
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHS- 68 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~-~~~vkl~Dfg~a~~~~~~~- 68 (265)
||+++++|.+.+.... ++.+++.+|.|||++||+||||||+|||++..+ ...+||+|||+|+......
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 7999999888776543 366789999999999999999999999985422 2359999999997543322
Q ss_pred -------CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC---
Q 024572 69 -------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--- 138 (265)
Q Consensus 69 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 138 (265)
......||+.|+|||++.+..++ .++|||||||++|+|++|+.||............... .......+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-SEKKMSTPIEV 239 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH-HHHHHHSCHHH
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh-hcccCCCChhH
Confidence 22345799999999999987775 5699999999999999999999876544332222111 11111111
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCcccC
Q 024572 139 DYVHISQDCRNLLSRIFVANPSRRITIKEI---KSHPWFL 175 (265)
Q Consensus 139 ~~~~~~~~~~~li~~~L~~dP~~R~s~~el---l~h~~f~ 175 (265)
....+|+++.+||.+||..+|.+||++.++ |+|+|.+
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 123688999999999999999999998754 5666543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-35 Score=245.75 Aligned_cols=146 Identities=19% Similarity=0.264 Sum_probs=114.7
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCC---CCCCCCcCCCCCcccccccCCcCCCc
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGK 93 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~ 93 (265)
++.+++.++.|||+++||||||||+|||++.++. +||+|||+|+..... .......+++.|+|||++.+..++ .
T Consensus 145 i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ 221 (301)
T d1lufa_ 145 IARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-T 221 (301)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-H
T ss_pred HHHHHHHHhhhcccCCeEeeEEcccceEECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-h
Confidence 4778899999999999999999999999998776 999999998743322 222345688999999999988876 5
Q ss_pred hHhHHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 94 LADVWSCGVTLYVMLVGA-YPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 94 ~~DiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
++|||||||++|+|++|. +||.+....+. +..+.... ..+.+..+++++.+||.+||..+|.+|||+.+|++
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~----~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEV----IYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhccchhhHHHHHccCCCCCCCCCHHHH----HHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 699999999999999986 56766544332 22223222 33445578999999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=238.00 Aligned_cols=161 Identities=18% Similarity=0.288 Sum_probs=123.2
Q ss_pred Cccccc-chHHHHHHhc-----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG-----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS 68 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~-----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~ 68 (265)
||++.+ +|.+++..+. ++.+++.|+.|||+++|+||||||+|||++.++. +||+|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS-- 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC--
Confidence 688866 9999987543 3677899999999999999999999999998876 99999999975432
Q ss_pred CCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCCHHH
Q 024572 69 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 147 (265)
Q Consensus 69 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (265)
......++..|+|||++.+..++ .++|||||||++|+|+| |++||......... ..+ . .....+.+..+++.+
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~-~~i---~-~~~~~~~~~~~~~~~ 229 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRV---E-KGYKMDAPDGCPPAV 229 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-HHH---T-TTCCCCCCTTCCHHH
T ss_pred CCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH-HHH---H-cCCCCCCCccCCHHH
Confidence 33345688999999999887764 56999999999999998 68888765443322 222 2 223444555789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 024572 148 RNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 148 ~~li~~~L~~dP~~R~s~~ell~h 171 (265)
++||.+||..||.+|||+.+++++
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=243.64 Aligned_cols=164 Identities=18% Similarity=0.227 Sum_probs=126.2
Q ss_pred Cccccc-chHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccCCCCCC
Q 024572 1 MQLGVS-SLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 69 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~~~~~~ 69 (265)
||++.+ +|.+++..+. ++.+++.|+.|||+++|+||||||+|||++.++. +||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEF 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhcccccc
Confidence 688886 8888777443 3667899999999999999999999999988776 99999999975443322
Q ss_pred -----CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCCCCCCCC
Q 024572 70 -----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 144 (265)
Q Consensus 70 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (265)
.....||+.|+|||.+.+..++ .++|||||||++|+|++|+.||........... .+... ...+.+..++
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~~g-~~~~~p~~~~ 260 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQG-RRLLQPEYCP 260 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHH---HHHTT-CCCCCCTTCC
T ss_pred ccceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcC-CCCCCcccCc
Confidence 1224588999999999887774 559999999999999998888766543322222 22222 2334445789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 145 QDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 145 ~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
+.+.+||.+||..||++|||+.+|++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-34 Score=242.24 Aligned_cols=163 Identities=24% Similarity=0.343 Sum_probs=130.2
Q ss_pred Cccccc-chHHHHHHhc---------------------------cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCc
Q 024572 1 MQLGVS-SLSEFVMLEG---------------------------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPR 52 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~---------------------------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~ 52 (265)
||+|.+ +|.+++.... ++.|++.++.|||++|||||||||+||+++.++.
T Consensus 106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~-- 183 (311)
T d1t46a_ 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI-- 183 (311)
T ss_dssp EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--
T ss_pred EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCc--
Confidence 788876 8999886543 4788999999999999999999999999988765
Q ss_pred EEEeccCCcccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 024572 53 LKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTIS 128 (265)
Q Consensus 53 vkl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~ 128 (265)
+||+|||+++....... .....+|+.|+|||++.+..++ .++|||||||++|+|+| |.+||........+.+.+.
T Consensus 184 ~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~ 262 (311)
T d1t46a_ 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262 (311)
T ss_dssp EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH
T ss_pred ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999986543322 2334689999999999877764 56999999999999999 5666666555444444433
Q ss_pred HHhhhcccCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 129 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
...+...+..+++.+.+||.+||..||.+|||+.+|++
T Consensus 263 ----~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 263 ----EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp ----HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33444445578999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=242.79 Aligned_cols=163 Identities=21% Similarity=0.262 Sum_probs=127.8
Q ss_pred Cccccc-chHHHHHHh-------------------ccccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCC
Q 024572 1 MQLGVS-SLSEFVMLE-------------------GSVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGY 60 (265)
Q Consensus 1 me~~~~-sL~~~~~~~-------------------~~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~ 60 (265)
||++.. +|.+++... ..+.+++.|+.|||+++|+||||||+|||++.++. +||+|||+
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~DFGl 179 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGM 179 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTC
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEeeccc
Confidence 677765 899988743 24677899999999999999999999999998776 99999999
Q ss_pred cccCCCCCC---CCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhhhccc
Q 024572 61 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA-YPFEDQEDPKNFRKTISRIMAVQYK 136 (265)
Q Consensus 61 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~ 136 (265)
|+....... .....+|+.|+|||.+.+..++ .++|||||||++|+|+||. .||.+...... +..+... ..
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~----~~~i~~~-~~ 253 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----LRFVMEG-GL 253 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HHHHHTT-CC
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHhC-CC
Confidence 975433222 2334689999999999887775 5599999999999999985 67766544332 2222222 23
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 137 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 137 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.+.+..+++.+.+||.+||+.+|++|||+.+|+++
T Consensus 254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44455789999999999999999999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-33 Score=235.50 Aligned_cols=168 Identities=20% Similarity=0.205 Sum_probs=127.0
Q ss_pred CcccccchHHHHHHhc----------cccchHHHHHhhhhcCceecCCCcCcEEEcCC---CCCcEEEeccCCcccCCCC
Q 024572 1 MQLGVSSLSEFVMLEG----------SVKMKPDIFFSSLSQQICHRDLKLENTLLDGS---PAPRLKICDFGYSKSSLLH 67 (265)
Q Consensus 1 me~~~~sL~~~~~~~~----------~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~---~~~~vkl~Dfg~a~~~~~~ 67 (265)
||+++++|.+++...+ ++.+++.++.|||++||+||||||+|||++.. ..+.+||+|||+|+.....
T Consensus 80 me~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 80 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 7999999999987654 26678899999999999999999999999642 2345999999999754322
Q ss_pred --------CCCCCCcCCCCCcccccccCCcCCCchHhHHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHHhhhcccCC-
Q 024572 68 --------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP- 138 (265)
Q Consensus 68 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 138 (265)
......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+......... ...+.......+
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~-~~~i~~~~~~~~~ 237 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTPL 237 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH-HHHHHHHHHHSCH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH-HHHHHhccCCCCh
Confidence 122345799999999999987775 559999999999999999999986554332211 111111111111
Q ss_pred --CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 024572 139 --DYVHISQDCRNLLSRIFVANPSRRITIKEIKS 170 (265)
Q Consensus 139 --~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~ 170 (265)
....+++++.+++..|+..+|++||+++.+.+
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 12357899999999999999999999877643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=2.7e-33 Score=239.92 Aligned_cols=161 Identities=22% Similarity=0.327 Sum_probs=116.5
Q ss_pred hccccchHHHHHhhhh-cCceecCCCcCcEEEcCCCC----CcEEEeccCCcccCCCCCCCCCCcCCCCCcccccccCCc
Q 024572 15 EGSVKMKPDIFFSSLS-QQICHRDLKLENTLLDGSPA----PRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 89 (265)
Q Consensus 15 ~~~~~~i~~~l~~lH~-~~ivH~dlkp~NIll~~~~~----~~vkl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 89 (265)
+.++.+++.++.|||+ +||+||||||+|||++..+. ..++++|||.+.... ......+||+.|+|||++.+..
T Consensus 128 ~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~ 205 (362)
T d1q8ya_ 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAP 205 (362)
T ss_dssp HHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCC
T ss_pred HHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccc--cccccccccccccChhhccccC
Confidence 4467889999999998 99999999999999975443 248999999987443 2335567999999999999888
Q ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCCCCChH------HHHHHHHHHhh-------------hcc---------------
Q 024572 90 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK------NFRKTISRIMA-------------VQY--------------- 135 (265)
Q Consensus 90 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~-------------~~~--------------- 135 (265)
++ .++|+||+||++++|++|+.||....... .....+..+.. ..+
T Consensus 206 ~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
T d1q8ya_ 206 WG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284 (362)
T ss_dssp CC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC
T ss_pred CC-ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCC
Confidence 76 45999999999999999999997543211 11111110000 000
Q ss_pred --------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccCCCC
Q 024572 136 --------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 178 (265)
Q Consensus 136 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ell~h~~f~~~~ 178 (265)
........++.+++||.+||.+||.+|||+.|+|+||||+...
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 285 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp CHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred chhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 0000112357789999999999999999999999999998543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-33 Score=234.10 Aligned_cols=169 Identities=21% Similarity=0.197 Sum_probs=119.6
Q ss_pred Cccccc-chHHHHHHhc--------cccchHHHHHhhhh--------cCceecCCCcCcEEEcCCCCCcEEEeccCCccc
Q 024572 1 MQLGVS-SLSEFVMLEG--------SVKMKPDIFFSSLS--------QQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 63 (265)
Q Consensus 1 me~~~~-sL~~~~~~~~--------~~~~i~~~l~~lH~--------~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~ 63 (265)
|||+.. +|.+++.... +..+++.++.|+|+ +|||||||||+||||+.++. +||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcccc
Confidence 788866 9999998654 35667889999996 69999999999999988775 99999999875
Q ss_pred CCCCC-----CCCCCcCCCCCcccccccCCcC-----CCchHhHHHHHHHHHHHHhCCCCCCCCCCh-----------HH
Q 024572 64 SLLHS-----RPKSTVGTPAYIAPEVLSRREY-----DGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----------KN 122 (265)
Q Consensus 64 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~~l~~ll~g~~pf~~~~~~-----------~~ 122 (265)
..... ......||+.|+|||++.+... .+.++|||||||++|+|+||..||...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 43322 2234579999999999876432 234689999999999999998877432211 11
Q ss_pred HHHHHHHHhhhcccCCCCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 024572 123 FRKTISRIMAVQYKIPDYV-----HISQDCRNLLSRIFVANPSRRITIKEIKSH 171 (265)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~R~s~~ell~h 171 (265)
.............+.+.+. .....+.+|+.+||..||.+|||+.+|+++
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1122222222222111111 122458899999999999999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.41 E-value=1.2e-14 Score=112.17 Aligned_cols=45 Identities=24% Similarity=0.212 Sum_probs=40.0
Q ss_pred cccchHHHHHhhhhcCceecCCCcCcEEEcCCCCCcEEEeccCCcccC
Q 024572 17 SVKMKPDIFFSSLSQQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 64 (265)
Q Consensus 17 ~~~~i~~~l~~lH~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~~~ 64 (265)
.+.+++.++.|||++||+||||||+|||++.++ ++|+|||.|+..
T Consensus 108 i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~~ 152 (191)
T d1zara2 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVEV 152 (191)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEET
T ss_pred HHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEECCCcccC
Confidence 567899999999999999999999999998654 899999998643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.65 E-value=0.0016 Score=52.21 Aligned_cols=31 Identities=23% Similarity=0.344 Sum_probs=26.1
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..|+||+|+.++||+++++.. .-|+||+.|.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccc--eeEecccccc
Confidence 578999999999999987653 5799999663
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=93.63 E-value=0.014 Score=44.88 Aligned_cols=30 Identities=23% Similarity=0.264 Sum_probs=23.8
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++|+|+.|.||+++.++. +-|+||+.+.
T Consensus 183 ~~l~HgD~~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T d1j7la_ 183 LVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp EEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred cEEEEeeccCcceeecCCce--EEEeechhcc
Confidence 34899999999999986542 4699998654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=93.41 E-value=0.014 Score=44.59 Aligned_cols=30 Identities=20% Similarity=0.213 Sum_probs=24.1
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++|+|+.|.||+++.+.. +-|+||+.+.
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~--~~iID~~~~~ 204 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRF--SGFIDCGRLG 204 (255)
T ss_dssp EEEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred ceEEeCCCCCcceEEeCCce--EEEEEchhcc
Confidence 45899999999999986543 5799998653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.08 E-value=0.019 Score=45.93 Aligned_cols=29 Identities=17% Similarity=0.153 Sum_probs=23.5
Q ss_pred hcCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 30 SQQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 30 ~~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++||+|+.+.|||++++ ..++||+-|.
T Consensus 191 p~~liHgDlh~~NvL~~~~----~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG----PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESSS----EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeCC----ceEEechhcc
Confidence 3579999999999999642 4689999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=92.64 E-value=0.029 Score=46.15 Aligned_cols=29 Identities=17% Similarity=0.261 Sum_probs=24.9
Q ss_pred cCceecCCCcCcEEEcCCCCCcEEEeccCCcc
Q 024572 31 QQICHRDLKLENTLLDGSPAPRLKICDFGYSK 62 (265)
Q Consensus 31 ~~ivH~dlkp~NIll~~~~~~~vkl~Dfg~a~ 62 (265)
..++|||+.|.|||++.+. ++|+||.+|.
T Consensus 223 ~~LiHGDl~~gNIlv~~~~---~~vID~E~a~ 251 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE---TKVIDPEFAF 251 (392)
T ss_dssp CEEECSCCCGGGEEECSSC---EEECCCTTCE
T ss_pred cceeccCCcCCceeEcCCc---eEEechhhcc
Confidence 4699999999999998654 8999998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=81.57 E-value=0.3 Score=39.65 Aligned_cols=16 Identities=44% Similarity=0.748 Sum_probs=13.4
Q ss_pred ceecCCCcCcEEEcCC
Q 024572 33 ICHRDLKLENTLLDGS 48 (265)
Q Consensus 33 ivH~dlkp~NIll~~~ 48 (265)
++|+|+.+.||++...
T Consensus 220 ~CHnDL~~~NiL~~~~ 235 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPKA 235 (395)
T ss_dssp EECSCCCGGGEEEEC-
T ss_pred EEecCCCcccEeeccc
Confidence 6899999999999653
|